<?xml version="1.0"?>
<!-- si deve inserire qualcosa (x es.: iiii) dopo xmlns in xmlns="http://www.loc.gov/mods/v3" 
non so perchè, neanche Miklos. -->
<modsCollection xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd" 
xmlns:iiii="http://www.loc.gov/mods/v3" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <mods>
    <titleInfo>
      <title>15N magnetic resonance hyperpolarization via the reaction of parahydrogen with 15N-Propargylcholine</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ellena</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Alberti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Boi</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Premkumar</namePart>
      <namePart type="given">S.S.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>134</number>
        </detail>
        <detail type="issue">
          <number>27</number>
        </detail>
        <extent unit="pages">
          <start>11146</start>
          <end>11152</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84863811561&amp;partnerID=40&amp;md5=0ae517dde36577c935851c2f2a83be0e</url>
    </location>
    <abstract>15N-Propargylcholine has been synthesized and hydrogenated with para-H 2. Through the application of a field cycling procedure, parahydrogen spin order is transferred to the 15N resonance. Among the different isomers formed upon hydrogenation of 15N- propargylcholine, only the nontransposed derivative contributes to the observed N-15 enhanced emission signal. The parahydrogen-induced polarization factor is about 3000. The precise identification of the isomer responsible for the observed 15N enhancement has been attained through a retro-INEPT ( 15N-1H) experiment. T1 of the hyperpolarized 15N resonance has been estimated to be ca. 150 s, i.e., similar to that reported for the parent propargylcholine (144 s). Experimental results are accompanied by theoretical calculations that stress the role of scalar coupling constants (J HN and J HH) and of the field dependence in the formation of the observed 15N polarized signal. Insights into the good cellular uptake of the compound have been gained. © 2012 American Chemical Society.</abstract>
    <note type="content">AD  - Dipartimento di Chimica IFM, University of Torino, V. P. Giuria 7, 10125 Torino, Italy</note>
    <note type="content">AD  - DiSCAFF, DFB Center, Università Degli Studi Del Piemonte Orientale A. Avogadro, Via Bovio 6, I-28100 Novara, Italy</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: hydrogen, 12385-13-6, 1333-74-0&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: JACSA&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Aime, S.; Dipartimento di Chimica IFM, University of Torino, V. P. Giuria 7, 10125 Torino, Italy; email: silvio.aime@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1021/ja209884h&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Mansson, S., Johansson, E., Magnusson, P., Chai, C.M., Hansson, G., Petersson, J.S., Stahlberg, F., Golman, K., (2006) Eur. Radiol., 16, pp. 57-67. , references therein; Viale, A., Reineri, F., Santelia, D., Ellena, S., Gobetto, R., Aime, S., (2009) Q. J. Nucl. Med. Mol. Imag., 53, pp. 604-617. , references therein; Viale, A., Aime, S., (2010) Curr. Op. Chem. Biol., 14, pp. 90-96. , references therein; Gallagher, F.A., Kettunen, M.I., Brindle, K.M., (2009) Prog. Nucl. Magn. Reson. Spectrosc., 55, pp. 285-295. , references therein; Kohler, S.J., Yen, Y., Wolber, J., Chen, A.P., Albers, M.J., Bok, R., Zhang, V., Hurd, R.E., (2007) Magn. Res. Med., 58, pp. 65-69; Nelson, S.J., Vigneron, D., Kurhanewicz, J., Chen, A., Bok, R., Hurd, R., (2008) Appl. Magn. Reson., 34, pp. 533-544; Chekmenev, E.Y., Hovener, J., Norton, V.A., Harris, K., Batchelder, L.S., Bhattacharya, P., Ross, B.D., Weitekamp, D.P., (2008) J. Am. Chem. Soc., 130, pp. 4212-4213; Reineri, F., Viale, A., Ellena, S., Boi, T., Daniele, V., Gobetto, R., Aime, S., (2011) Angew. Chem., Int. Ed., 32, pp. 7350-7353; Albers, M.J., Bok, R., Chen, A.P., Cunningham, C.H., Zierhut, M.L., Yi Zhang, V., Kohler, S.J., Kurhanewicz, J., (2008) Cancer Res., 68, pp. 8607-8615; Golman, K., Ardenkjaer-Larsen, J.H., Petersson, J.S., Mansson, S., Leunbach, I., (2003) Proc. Natl. Acad. Sci. U. S. A., 100, pp. 10435-10439; Hall, D.A., Maus, D.C., Gerfen, G.J., Inati, S.J., Becerra, L.R., Dahlquist, F.W., Griffin, R.G., (1997) Science, 276, pp. 930-932; Cudalbu, C., Comment, A., Kurdzesau, F., Van Heeswijk, R.B., Jannin, S., Denisov, V., Zirik, D., Gruetter, R., (2010) Phys. Chem. Chem. Phys., 15, pp. 5818-5823; Gabellieri, C., Reynolds, S., Lavie, A., Payne, G.S., Leach, M.O., Eykyn, T.R., (2008) J. Am. Chem. Soc., 130, pp. 4598-4599; Sarkar, R., Comment, A., Vasos, P.R., Jannin, S., Gruetter, R., Bodenhausen, G., Hall, H., Denisov, V.P., (2009) J. Am. Chem. Soc., 131, pp. 16014-16015; Pfeilstikcer, J.A., Ollerenshw, J.E., Norton, V.A., Weitekamp, D.P., (2010) J. Magn. Reson., 205, pp. 125-129; Adams, R.W., Aguilar, J.A., Atkinson, K.D., Cowley, M.J., Elliott, P.I., Duckett, S.B., Green, G.G., Williamson, D.C., (2009) Science, 323, pp. 1708-1711; Natterer, J., Bargon, (1997) J. Prog. Nucl. Magn. Res. Spect., 31, pp. 293-315; Kwim, W., P-Allyl systems in catalysis (1971) Transition Metals in Homogeneous Catalysis, , Marcel Dekker Inc. New York; Barkemeyer, J., Haake, M., Bargon, J., (1995) J. Am. Chem. Soc., 117, pp. 2927-2928; (1993) Annual Reports on NMR Spectroscopy, 25. , Academic Press Inc. San Diego, CA; Reineri, F., Viale, A., Giovenzana, G., Santelia, D., Dastrù, W., Gobetto, R., Aime, S., (2008) J. Am. Chem. Soc., 130, pp. 15047-15053; Johannesson, H., Axelsson, O., Karlsson, M., (2004) C. R. Phys., 5, pp. 315-324; Reineri, F., Viale, A., Dastrù, W., Gobetto, R., Aime, S., (2010) Contrast Med. Mol. Imag., 6, pp. 77-84; Natterer, J., Schedletzky, O., Barkemeyer, J., Bargon, J., Glaser, S.J., (1998) J. Magn. Reson., 133, pp. 92-97; Aime, S., Gobetto, R., Reineri, F., Canet, D., (2003) J. Chem. Phys., 119, pp. 8890-8896; Katz-Brull, R., Degani, H., (1996) Anticancer Res., 16, pp. 1375-1380; Cudalbu, C., Comment, A., Kurdzesau, F., Van Heeswijk, R.B., Jannin, S., Denisov, V., Zirik, D., Gruetter, R., (2010) Phys. Chem. Chem. Phys., 15, pp. 5818-5823&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>15n propargylcholine</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>cell transport</topic>
    </subject>
    <subject>
      <topic>Cellular uptake</topic>
    </subject>
    <subject>
      <topic>chemical analysis</topic>
    </subject>
    <subject>
      <topic>chemical reaction</topic>
    </subject>
    <subject>
      <topic>choline derivative</topic>
    </subject>
    <subject>
      <topic>Enhanced Emission</topic>
    </subject>
    <subject>
      <topic>Field dependence</topic>
    </subject>
    <subject>
      <topic>Field-cycling</topic>
    </subject>
    <subject>
      <topic>Hydrogen</topic>
    </subject>
    <subject>
      <topic>Hydrogenation</topic>
    </subject>
    <subject>
      <topic>hyperpolarization</topic>
    </subject>
    <subject>
      <topic>Hyperpolarized</topic>
    </subject>
    <subject>
      <topic>Isomers</topic>
    </subject>
    <subject>
      <topic>Magnetic resonance</topic>
    </subject>
    <subject>
      <topic>nitrogen nuclear magnetic resonance</topic>
    </subject>
    <subject>
      <topic>Para-hydrogen</topic>
    </subject>
    <subject>
      <topic>Polarization factor</topic>
    </subject>
    <subject>
      <topic>Polarized signals</topic>
    </subject>
    <subject>
      <topic>Scalar coupling</topic>
    </subject>
    <subject>
      <topic>Spin order</topic>
    </subject>
    <subject>
      <topic>Theoretical calculations</topic>
    </subject>
    <subject>
      <topic>unclassified drug</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Arigoni</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barutello</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzardo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Curcio</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Iezzi</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zheng</namePart>
      <namePart type="given">Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barkefors</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Holmgren</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallo</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>305</start>
          <end>316</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">09696970 (ISSN)</identifier>
      <titleInfo>
        <title>Angiogenesis</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angiogenesis</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84865144668&amp;partnerID=40&amp;md5=290265327d63e34bac1f2e51d4ae2e43</url>
    </location>
    <abstract>Angiomotin (Amot) is one of several identified angiostatin receptors expressed by the endothelia of angiogenic tissues. We have shown that a DNA vaccine targeting Amot overcome immune tolerance and induce an antibody response that hampers the progression of incipient tumors. Following our observation of increased Amot expression on tumor endothelia concomitant with the progression from pre-neoplastic lesions to full-fledged carcinoma, we evaluated the effect of anti-Amot vaccination on clinically evident tumors. Electroporation of plasmid coding for the human Amot (pAmot) significantly delayed the progression both of autochthonous tumors in cancer prone BALB-neuT and PyMT genetically engineered mice and transplantable TUBO tumor in wild-type BALB/c mice. The intensity of the inhibition directly correlated with the titer of anti-Amot antibodies induced by the vaccine. Tumor inhibition was associated with an increase of vessels diameter with the formation of lacunar spaces, increase in vessel permeability, massive tumor perivascular necrosis and an effective epitope spreading that induces an immune response against other tumor associated antigens. Greater tumor vessel permeability also markedly enhances the antitumor effect of doxorubicin. These data provide a rationale for the development of novel anticancer treatments based on anti-Amot vaccination in conjunction with chemotherapy regimens. © The Author(s) 2012.</abstract>
    <note type="content">AD  - Aging Research Center, Gabriele D'Annunzio University Foundation, 66013 Chieti, Italy</note>
    <note type="content">AD  - Department of Oncology and Pathology, Cancer Centre Karolinska, Karolinska Institutet, 17176 Stockholm, Sweden</note>
    <note type="content">AD  - Molecular Biotechnology Center, University of Turin, 10126 Turin, Italy</note>
    <note type="content">AD  - Molecular Biotechnology Center, Via Nizza 52, 10126 Turin, Italy</note>
    <note type="content">AD  - Molecular Imaging Center, Department of Chemistry IFM, University of Turin, 10126 Turin, Italy</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: doxorubicin, 23214-92-8, 25316-40-9; Amot protein, mouse; Cancer Vaccines; Intercellular Signaling Peptides and Proteins; Microfilament Proteins; Vaccines, DNA&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: AGIOF&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Cavallo, F.; Molecular Biotechnology Center, Via Nizza 52, 10126 Turin, Italy; email: federica.cavallo@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1007/s10456-012-9263-3&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Cavallo, F., Calogero, R.A., Forni, G., Are oncoantigens suitable targets for anti-tumour therapy? (2007) Nature Reviews Cancer, 7 (9), pp. 707-713. , DOI 10.1038/nrc2208, PII NRC2208; Nanni, P., Nicoletti, G., De Giovanni, C., Landuzzi, L., Di Carlo, E., Cavallo, F., Pupa, S.M., Lollini, P.-L., Combined allogeneic tumor cell vaccination and systematic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice (2001) Journal of Experimental Medicine, 194 (9), pp. 1195-1205. , DOI 10.1084/jem.194.9.1195; Quaglino, E., Mastini, C., Amici, A., Marchini, C., Iezzi, M., Lanzardo, S., De Giovanni, C., Cavallo, F., A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins (2010) Cancer Res, 70 (7), pp. 2604-2612. , doi:10.1158/0008-5472.CAN-09-2548; Cavallo, F., Offringa, R., Van Der Burg, S.H., Forni, G., Melief, C.J.M., Vaccination for treatment and prevention of cancer in animal models (2006) Advances in Immunology, 90, pp. 175-213. , DOI 10.1016/S0065-2776(06)90005-4, PII S0065277606900054; Chiarle, R., Martinengo, C., Mastini, C., Ambrogio, C., D'Escamard, V., Forni, G., Inghirami, G., The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination (2008) Nature Medicine, 14 (6), pp. 676-680. , DOI 10.1038/nm1769, PII NM1769; Lollini, P.-L., Forni, G., Cancer immunoprevention: Tracking down persistent tumor antigens (2003) Trends in Immunology, 24 (2), pp. 62-66. , DOI 10.1016/S1471-4906(02)00030-3, PII S1471490602000303; Lollini, P.-L., Cavallo, F., Nanni, P., Forni, G., Vaccines for tumour prevention (2006) Nature Reviews Cancer, 6 (3), pp. 204-216. , DOI 10.1038/nrc1815, PII N1815; Holmgren, L., Ambrosino, E., Birot, O., Tullus, C., Veitonmaki, N., Levchenko, T., Carlson, L.-M., Kiessling, R., A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth (2006) Proceedings of the National Academy of Sciences of the United States of America, 103 (24), pp. 9208-9213. , DOI 10.1073/pnas.0603110103; Hanahan, D., Folkman, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis (1996) Cell, 86 (3), pp. 353-364. , DOI 10.1016/S0092-8674(00)80108-7; Holmgren, L., O'reilly, M.S., Folkman, J., Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression (1995) Nat Med, 1 (2), pp. 149-153; Troyanovsky, B., Levchenko, T., Mansson, G., Matvijenko, O., Holmgren, L., Angiomotin: An angiostatin binding protein that regulates endothelial cell migration and tube formation (2001) Journal of Cell Biology, 152 (6), pp. 1247-1254. , DOI 10.1083/jcb.152.6.1247; Bratt, A., Wilson, W.J., Troyanovsky, B., Aase, K., Kessler, R., Meir, E.G.V., Holmgren, L., Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains (2002) Gene, 298 (1), pp. 69-77. , DOI 10.1016/S0378-1119(02)00928-9, PII S0378111902009289; Levchenko, T., Bratt, A., Arbiser, J.L., Holmgren, L., Angiomotin expression promotes hemangioendothelioma invasion (2004) Oncogene, 23 (7), pp. 1469-1473. , DOI 10.1038/sj.onc.1207264; Ernkvist, M., Birot, O., Sinha, I., Veitonmaki, N., Nystrom, S., Aase, K., Holmgren, L., Differential roles of p80-and p130-angiomotin in the switch between migration and stabilization of endothelial cells (2008) Biochim Biophys Acta, 1783 (3), pp. 429-437. , doi:10.1016/j.bbamcr.2007.11.018; Boggio, K., Nicoletti, G., Di Carlo, E., Cavallo, F., Landuzzi, L., Melani, C., Giovarelli, M., Forni, G., Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of HER-2/neu transgenic mice (1998) Journal of Experimental Medicine, 188 (3), pp. 589-596. , DOI 10.1084/jem.188.3.589; Rovero, S., Amici, A., Carlo, E.D., Bei, R., Nanni, P., Quaglino, E., Porcedda, P., Forni, G., DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice (2000) J Immunol, 165 (9), pp. 5133-5142; Ernkvist, M., Aase, K., Ukomadu, C., Wohlschlegel, J., Blackman, R., Veitonmaki, N., Bratt, A., Holmgren, L., P130-angiomotin associates to actin and controls endothelial cell shape (2006) FEBS J, 273 (9), pp. 2000-2011. , doi:10.1111/j.1742-4658.2006.05216.x; Cavagna, F.M., Lorusso, V., Anelli, P.L., Maggioni, F., De Haen, C., Preclinical profile and clinical potential of gadocoletic acid trisodium salt (B22956/1), a new intravascular contrast medium for MRI (2002) Academic Radiology, 9 (SUPPL. 2), pp. S491-S494. , DOI 10.1016/S1076-6332(03)80273-8; Medved, M., Karczmar, G., Yang, C., Dignam, J., Gajewski, T.F., Kindler, H., Vokes, E., Stadler, W.M., Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time (2004) Journal of Magnetic Resonance Imaging, 20 (1), pp. 122-128. , DOI 10.1002/jmri.20061; Quaglino, E., Iezzi, M., Mastini, C., Amici, A., Pericle, F., Di Carlo, E., Pupa, S.M., Cavallo, F., Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice (2004) Cancer Research, 64 (8), pp. 2858-2864. , DOI 10.1158/0008-5472.CAN-03-2962; Cifaldi, L., Quaglino, E., Di Carlo, E., Musiani, P., Spadaro, M., Lollini, P.L., Wolf, S., Cavallo, F., A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia (2001) Cancer Research, 61 (7), pp. 2809-2812; Rolla, S., Ria, F., Occhipinti, S., Di Sante, G., Iezzi, M., Spadaro, M., Nicolo, C., Cavallo, F., Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent lowavidity T cells: Potential and limits of its therapeutic efficacy (2010) J Immunol, 184 (11), pp. 6124-6132. , doi:10.4049/jimmunol.0901215; Lin, E.Y., Jones, J.G., Li, P., Zhu, L., Whitney, K.D., Muller, W.J., Pollard, J.W., Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases (2003) American Journal of Pathology, 163 (5), pp. 2113-2126; Jaini, R., Kesaraju, P., Johnson, J.M., Altuntas, C.Z., Jane-Wit, D., Tuohy, V.K., An autoimmune-mediated strategy for prophylactic breast cancer vaccination (2010) Nat Med, 16 (7), pp. 799-803. , doi: 10.1038/nm.2161; Ding, J.W., Zhou, T., Zeng, H., Ma, L., Verbeek, J.S., Yin, D., Shen, J., Chong, A.S., Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors (2008) J Immunol, 180 (1), pp. 261-268. , doi:180/1/26126; Nimmerjahn, F., Lux, A., Albert, H., Woigk, M., Lehmann, C., Dudziak, D., Smith, P., Ravetch, J.V., FcgammaRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo (2010) Proc Natl Acad Sci USA, 107 (45), pp. 19396-19401. , doi:10.1073/pnas.1014515107; Curcio, C., Di Carlo, E., Clynes, R., Smyth, M.J., Boggio, K., Quaglino, E., Spadaro, M., Forni, G., Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas (2003) Journal of Clinical Investigation, 111 (8), pp. 1161-1170. , DOI 10.1172/JCI200317426; Quaglino, E., Mastini, C., Forni, G., Cavallo, F., ErbB2 transgenic mice: A tool for investigation of the immune prevention and treatment of mammary carcinomas (2008) Curr Protoc Immunol, , Chapter 20:Unit 20 29 21- 20 29-10 doi:10.1002/0471142735.im2009s82; Cavallo, F., De Giovanni, C., Nanni, P., Forni, G., Lollini, P.L., 2011: The immune hallmarks of cancer (2011) Cancer Immunol Immunother, 60 (3), pp. 319-326. , doi:10.1007/s00262-010-0968-0; Pan, J., Jin, P., Yan, J., Kabelitz, D., Anti-angiogenic active immunotherapy: A new approach to cancer treatment (2008) Cancer Immunol Immunother, 57 (8), pp. 1105-1114. , doi:10.1007/s00262-008-0452-2; Jiang, W.G., Watkins, G., Douglas-Jones, A., Holmgren, L., Mansel, R.E., Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer (2006) BMC Cancer, 6, p. 16. , doi:10.1186/1471-2407-6-16; Levchenko, T., Veitonmaki, N., Lundkvist, A., Gerhardt, H., Ming, Y., Berggren, K., Kvanta, A., Holmgren, L., Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo (2008) FASEB Journal, 22 (3), pp. 880-889. , http://www.fasebj.org/cgi/reprint/22/3/880, DOI 10.1096/fj.07-9509com; Hylton, N., Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker (2006) Journal of Clinical Oncology, 24 (20), pp. 3293-3298. , DOI 10.1200/JCO.2006.06.8080; Hahn, O.M., Yang, C., Medved, M., Karczmar, G., Kistner, E., Karrison, T., Manchen, E., Stadler, W.M., Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma (2008) J Clin Oncol, 26 (28), pp. 4572-4578. , doi:10.1200/JCO.2007.15.5655; Marzola, P., Degrassi, A., Calderan, L., Farace, P., Nicolato, E., Crescimanno, C., Sandri, M., Osculati, F., Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma (2005) Clinical Cancer Research, 11 (16), pp. 5827-5832. , DOI 10.1158/1078-0432.CCR-04-2655; Geninatti-Crich, S., Szabo, I., Alberti, D., Longo, D., Aime, S., MRI of cells and mice at 1 and 7 Tesla with Gd-targeting agents: When the low field is better! (2011) Contrast Media Mol Imaging, 6 (6), pp. 421-425. , doi:10.1002/cmmi.436; Vandoorne, K., Addadi, Y., Neeman, M., Visualizing vascular permeability and lymphatic drainage using labeled serum albumin (2010) Angiogenesis, 13 (2), pp. 75-85. , doi:10.1007/s10456-010-9170-4; Porzia, A., Lanzardo, S., Citti, A., Cavallo, F., Forni, G., Santoni, A., Galandrini, R., Paolini, R., Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies (2010) J Immunol, 184 (8), pp. 4170-4177. , doi:10.4049/jimmunol.0903375; Park, S., Jiang, Z., Mortenson, E.D., Deng, L., Radkevich-Brown, O., Yang, X., Sattar, H., Fu, Y.X., The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity (2010) Cancer Cell, 18 (2), pp. 160-170. , doi:10.1016/j.ccr.2010.06.014; Nair, S., Boczkowski, D., Moeller, B., Dewhirst, M., Vieweg, J., Gilboa, E., Synergy between tumor immunotherapy and antiangiogenic therapy (2003) Blood, 102 (3), pp. 964-971. , DOI 10.1182/blood-2002-12-3738; Greenberg, J.I., Cheresh, D.A., VEGF as an inhibitor of tumor vessel maturation: Implications for cancer therapy (2009) Expert Opin Biol Ther, 9 (11), pp. 1347-1356. , doi:10.1517/14712590903208883; Goel, S., Duda, D.G., Xu, L., Munn, L.L., Boucher, Y., Fukumura, D., Jain, R.K., Normalization of the vasculature for treatment of cancer and other diseases (2011) Physiol Rev, 91 (3), pp. 1071-1121. , doi: 10.1152/physrev.00038.2010&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>actin binding protein</topic>
    </subject>
    <subject>
      <topic>Amot protein, mouse</topic>
    </subject>
    <subject>
      <topic>Angiomotin</topic>
    </subject>
    <subject>
      <topic>angiomotin vaccine</topic>
    </subject>
    <subject>
      <topic>animal</topic>
    </subject>
    <subject>
      <topic>animal cell</topic>
    </subject>
    <subject>
      <topic>animal experiment</topic>
    </subject>
    <subject>
      <topic>Animals</topic>
    </subject>
    <subject>
      <topic>Antibodies</topic>
    </subject>
    <subject>
      <topic>antibody response</topic>
    </subject>
    <subject>
      <topic>antibody titer</topic>
    </subject>
    <subject>
      <topic>antineoplastic activity</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>Bagg albino mouse</topic>
    </subject>
    <subject>
      <topic>blood vessel permeability</topic>
    </subject>
    <subject>
      <topic>cancer growth</topic>
    </subject>
    <subject>
      <topic>cancer inhibition</topic>
    </subject>
    <subject>
      <topic>cancer vaccine</topic>
    </subject>
    <subject>
      <topic>Cancer Vaccines</topic>
    </subject>
    <subject>
      <topic>capillary permeability</topic>
    </subject>
    <subject>
      <topic>Carcinoma</topic>
    </subject>
    <subject>
      <topic>Cell Line, Tumor</topic>
    </subject>
    <subject>
      <topic>Chemotherapy</topic>
    </subject>
    <subject>
      <topic>controlled study</topic>
    </subject>
    <subject>
      <topic>correlation analysis</topic>
    </subject>
    <subject>
      <topic>DNA vaccination</topic>
    </subject>
    <subject>
      <topic>DNA vaccine</topic>
    </subject>
    <subject>
      <topic>doxorubicin</topic>
    </subject>
    <subject>
      <topic>drug targeting</topic>
    </subject>
    <subject>
      <topic>Electroporation</topic>
    </subject>
    <subject>
      <topic>endothelium</topic>
    </subject>
    <subject>
      <topic>epitope</topic>
    </subject>
    <subject>
      <topic>experimental neoplasm</topic>
    </subject>
    <subject>
      <topic>female</topic>
    </subject>
    <subject>
      <topic>genetics</topic>
    </subject>
    <subject>
      <topic>human</topic>
    </subject>
    <subject>
      <topic>Humans</topic>
    </subject>
    <subject>
      <topic>Immune Tolerance</topic>
    </subject>
    <subject>
      <topic>immunological tolerance</topic>
    </subject>
    <subject>
      <topic>immunology</topic>
    </subject>
    <subject>
      <topic>Intercellular Signaling Peptides and Proteins</topic>
    </subject>
    <subject>
      <topic>metabolism</topic>
    </subject>
    <subject>
      <topic>Mice</topic>
    </subject>
    <subject>
      <topic>Mice, Inbred BALB C</topic>
    </subject>
    <subject>
      <topic>Microfilament Proteins</topic>
    </subject>
    <subject>
      <topic>mouse</topic>
    </subject>
    <subject>
      <topic>Neoplasms, Experimental</topic>
    </subject>
    <subject>
      <topic>neovascularization (pathology)</topic>
    </subject>
    <subject>
      <topic>Neovascularization, Pathologic</topic>
    </subject>
    <subject>
      <topic>nonhuman</topic>
    </subject>
    <subject>
      <topic>pathology</topic>
    </subject>
    <subject>
      <topic>plasmid</topic>
    </subject>
    <subject>
      <topic>priority journal</topic>
    </subject>
    <subject>
      <topic>protein expression</topic>
    </subject>
    <subject>
      <topic>rat</topic>
    </subject>
    <subject>
      <topic>Rats</topic>
    </subject>
    <subject>
      <topic>signal peptide</topic>
    </subject>
    <subject>
      <topic>tumor antigen</topic>
    </subject>
    <subject>
      <topic>tumor cell line</topic>
    </subject>
    <subject>
      <topic>tumor necrosis</topic>
    </subject>
    <subject>
      <topic>tumor vascularization</topic>
    </subject>
    <subject>
      <topic>unclassified drug</topic>
    </subject>
    <subject>
      <topic>Vaccines, DNA</topic>
    </subject>
    <subject>
      <topic>Vessel permeability</topic>
    </subject>
    <subject>
      <topic>wild type</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Boronated compounds for imaging guided BNCT applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Geninatti-Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deagostino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Toppino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Alberti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Venturello</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>12</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>543</start>
          <end>553</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">18715206 (ISSN)</identifier>
      <titleInfo>
        <title>Anti-Cancer Agents in Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Anti-Cancer Agents Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84861716815&amp;partnerID=40&amp;md5=a8b7e785778b53432d7f9b08818f01dc</url>
    </location>
    <abstract>Boron neutron capture therapy (BNCT) is based on the capture of thermal neutrons by boron 10 (                         10B) nuclei that have been selectively delivered to tumor cells. The amount of 10-30 μg of boron for g of tumor mass is needed to attain an acceptable therapeutic advantage. Despite that the potentialities of BNCT have been demonstrated in several preclinical studies, this technique has not yet been fully accepted in the armory of tools for tumor treatment. This is partly due to the differences in the uptake and distribution of                         10B among patients and also to the uncertainty found in the determination of tumor-to-blood                         10B concentration ratio. Attention is now being payed to use the main imaging techniques to determine the in vivo biodistribution of BNCT agents. Most of the work has been devoted to the most promising BNCT agents, namely BPA, BSH and carborane derivatives. This review surveys studies carried out over the last decade, and outlines the role that NMR, PET and SPECT imaging may have to improve the efficacy of BNCT. © 2012 Bentham Science Publishers.</abstract>
    <note type="content">AD  - Dipartimento di Chimica Generale e Chimica Organica, Università degli studi di Torino, Via Pietro Giuria, 7, 10125 Torino, Italy</note>
    <note type="content">AD  - Dipartimento di Chimica IFM, Università degli Studi di Torino, Via Pietro Giuria, 7, 10125 Torino, Italy</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: 4 boronophenylalanine, 76410-58-7; 4 boronophenylalanine b 10, 74923-16-3; levodopa, 59-92-7&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Deagostino, A.; Dipartimento di Chimica Generale e Chimica Organica, Università degli studi di Torino, Via Pietro Giuria, 7, 10125 Torino, Italy; email: annamaria.deagostino@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Barth, R.F., Boron neutron capture therapy at the crossroads: Challenges and opportunities (2009) Appl. Radiat. Isotopes, 67 (7-8 SUPPL. 1), pp. S3-S6; Barth, R.F., Coderre, J.A., Vicente, M.G.H., Blue, T.E., Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects (2005) Clin. Cancer Res., 11 (11), pp. 3987-4002; Mamelak, A.N., Jacoby, D.B., Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601) (2007) Expert Opinion on Drug Delivery, 4 (2), pp. 175-186; Yan, H., Parsons, D.W., Jin, G., McLendon, R., Rasheed, B.A., Yuan, W., Kos, I., Bigner, D.D., IDH1 and IDH2 Mutations in Gliomas (2009) N. Eng. J. Med., 360 (8), pp. 765-773; Macbeth, A.E., Grindlay, D.J.C., Williams, H.C., What's new in skin cancer? An analysis of guidelines and systematic reviews published in 2008-2009 (2011) Clinical and Experimental Dermatology, 36 (5), pp. 453-458; Gavriel, H., McArthur, G., Sizeland, A., Henderson, M., Review: Mucosal melanoma of the head and neck (2011) Melanoma Res., 21 (4), pp. 257-266; Andersen, K.F., Altaf, R., Krarup-Hansen, A., Kromann-Andersen, B., Horn, T., Christensen, N.J., Hendel, H.W., Malignant pheochromocytomas and paragangliomas-The importance of a multidisciplinary approach (2011) Cancer Treatment Reviews, 37 (2), pp. 111-119; Livraghi, T., Makisalo, H., Line, P.D., Treatment options in hepatocellular carcinoma today (2011) Scandinavian Journal of Surgery, 100 (1), pp. 22-29; Clifton, N., Harrison, L., Bradley, P.J., Jones, N.S., Malignant melanoma of nasal cavity and paranasal sinuses: Report of 24 patients and literature review (2011) Journal of Laryngology &amp; Otology, 125 (5), pp. 479-485; Tawfik, A.M., Kreft, A., Wagner, W., Vogl, T.J., MRI of a microcystic adnexal carcinoma of the skin mimicking a fibrous tumour: Case report and literature review (2011) Br. J. Radiol., 84 (1002), pp. E114-E117; de la Fouchardiere, C., Droz, J.P., Targeted therapies and thyroid cancer: An update (2011) Anti-Cancer Drugs, 22 (7), pp. 688-699; Ferraz, C., Eszlinger, M., Paschke, R., Current State and Future Perspective of Molecular Diagnosis of Fine-Needle Aspiration Biopsy of Thyroid Nodules (2011) J. Clin. Endocrinol. Metab., 96 (7), pp. 2016-2026; Snider, H.R., Reedy, A.J., Lennarz, W.J., Synthesis of aromatic boronic acids, aldehydo boronic acids and a boronic acids analog of tyronise (1958) J. Am. Chem. Soc., 80, pp. 835-838; Soloway, A.H., Hatanaka, H., Davis, M.A., Penetration of brain and brain tumor. VII. Tumor-binding sulphydryl boron compounds (1967) J. Med. Chem., 10, pp. 714-717; Hatanaka, H.A., Revised boron-neutron capture therapy for malignant brain tumors: II. Interim clinical result with patients excluding previous treatment (1975) J. Neurol., 209, pp. 81-94; Mishima, Y., Honda, C., Ichihashi, M., Obara, H., Hiratsuka, J., Fukuda, H., Karashima, H., Yoshino, K., Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B compound (1989) The Lancet, 334 (8659), pp. 388-389; Diaz, A.Z., Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view (2003) J. Neurooncol., 62 (1), pp. 101-109; Ichikawa, H., Taniguchi, E., Fujimoto, T., Fukumori, Y., Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer (2009) Appl. Radiat. Isotopes, 67 (7-8), pp. S111-S114; Yokoyama, K., Miyatake, S.I., Kajimoto, Y., Kawabata, S., Doi, A., Yoshida, T., Asano, T., Kuroiwa, T., Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT (2006) J. Neurooncol., 78 (3), pp. 227-232; Valliant, J.F., Guenther, K.J., King, A.S., Morel, P., Schaffer, P., Sogbein, O.O., Stephenson, K.A., The medicinal chemistry of carboranes (2002) Coord. Chem. Rev., 232 (1-2), pp. 173-230; Wu, G., Barth, R.F., Yang, W., Lee, R.J., Tjarks, W., Backer, M.V., Backer, J.M., Boron Containing Macromolecules and Nanovehicles as Delivery Agents for Neutron Capture Therapy (2006) Anti Cancer Agents in Medicinal Chemistry, 6, pp. 167-184; Crossley, E.L., Ziolkowski, E.J., Coderre, J.A., Rendina, L.M., Boronated DNA-Binding Compounds as Potential Agents for Boron Neutron Capture Therapy (2007) Mini reviews in Medicinal Chemistry, 7, pp. 303-313; Sweet, W.H., The use of nuclear desintegrations in the diagnosis and treatment of brain tumor (1951) N. Engl. J. Med., 245, pp. 875-878; Blue, Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects (2005) Clin. Cancer. Res., 11, pp. 3987-4001. , RF. Barth, J. C., GH. Vincente, TE; Ruiz-Cabello, J., Barnett, B.P., Bottomley, P.A., Bulte, J.W.M., Fluorine (19)F) MRS and MRI in biomedicine (2011) Nmr Biomed., 24 (2), pp. 114-129; Hattori, Y., Asano, T., Niki, Y., Kondoh, H., Kirihata, M., Yamaguchi, Y., Wakamiya, T., Study on the compounds containing 19F and 10B atoms in a single molecule for the application to MRI and BNCT (2006) Bioorg. Med. Chem., 14 (10), pp. 3258-3262; Hattori, Y., Yamamoto, H., Ando, H., Kondoh, H., Asano, T., Kirihata, M., Yamaguchi, Y., Wakamiya, T., Synthesis and evaluation as MRI probe of the trifluoromethylated pboronophenylalanine and its alcohol derivative (2007) Bioorg. Med. Chem., 15 (5), pp. 2198-2205; Hattori, Y., Kurihara, K., Kondoh, H., Asano, T., Kirihata, M., Yamaguchi, Y., Wakamiya, T., Biological evaluation of fluorinated p-boronophenylalanine derivatives as a boron carrier (2007) Protein Pept. Lett., 14 (3), pp. 269-272; Capuani, S., Porcari, P., Fasano, F., Campanella, R., Maraviglia, B., 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy (2008) Magn. Reson. Imaging, 26 (7), pp. 987-993; Porcari, P., Capuani, S., Campanella, R., la Bella, A., Migneco, L.M., Maraviglia, B., Multi-nuclear MRS and F-19 MRI of F-19-labelled and B-10-enriched p-boronophenylalanine-fructose complex to optimize boron neutron capture therapy: Phantom studies at high magnetic fields (2006) Phys. Med. Biol., 51 (12), pp. 3141-3154; Capuani, S., Gili, T., Bozzali, M., Russo, S., Porcari, P., Cametti, C., Muolo, M., Pastore, F.S., Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading (2009) Appl. Radiat. Isotopes, 67 (7-8 SUPPL. 1), pp. S34-S36; Porcari, P., Capuani, S., D'Amore, E., Lecce, M., la Bella, A., Fasano, F., Campanella, R., Maraviglia, B., In Vivo F-19 MRI and F-19 MRS of F-19-labelled borophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT) (2008) Phys. Med. Biol., 53 (23), pp. 6979-6989; Porcari, P., Capuani, S., D'Amore, E., Lecce, M., la Bella, A., Fasano, F., Migneco, L.M., Pastore, F.S., In vivo 19F MR imaging and spectroscopy for the BNCT optimization (2009) Appl. Radiat. Isotopes, 67 (7-8 SUPPL. 1), pp. S365-S368; Chen, B.-G., Zhang, M.-Y., Zhao, Y.-Y., Zhang, J., Sun, C.-C., Structural and electronic properties of BPA-fructose complex used in boron neutron capture therapy (2006) Journal of Molecular Structure: THEOCHEM, 766 (1), pp. 35-40; Bendel, P., Koudinova, N., Salomon, Y., In vivo imaging of the neutron capture therapy agent BSH in mice using 10B MRI (2001) Magn. Res. Med., 46 (1), pp. 13-17; Elhanati, G., Salomon, Y., Bendel, P., Significant differences in the retention of the borocaptate monomer (BSH) and dimer (BSSB) in malignant cells (2001) Cancer Lett., 172 (2), pp. 127-132; Bendel, P., Wittig, A., Basilico, F., Mauri, P.L., Sauerwein, W., Metabolism of borono-phenylalanine-fructose complex (BPA-fr) and borocaptate sodium (BSH) in cancer patients--Results from EORTC trial 11001 (2010) J. Pharm. Biomed. Anal., 51 (1), pp. 284-287; Rinck, A., (2003) Magnetic Resonance in Medicine., , Blackwell Scientific Publications: Oxford; Terreno, E., Castelli, D.D., Viale, A., Aime, S., Challenges for molecular magnetic resonance imaging (2010) Chem. Rev., 110 (5), pp. 3019-3042; Caravan, P., Strategies for increasing the sensitivity of gadolinium based MRI contrast agents (2006) Chem. Soc. Rev., 35 (6), pp. 512-523; Aime, S., Cabella, C., Colombatto, S., Geninatti-Crich, S., Gianolio, E., Maggioni, F., Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations (2002) J. Magn. Reson. Imaging, 16, pp. 394-406; Tatham, A.T., Nakamura, H., Wiener, E.C., Yamamoto, Y., Relaxation properties of a dual-labeled probe for MRI and neutron capture therapy (1999) Magn. Reson. Med., 42, pp. 32-36; Takahashi, K., Nakamura, H., Furumoto, S., Yamamoto, K., Fukuda, H., Matsumura, A., Yamamoto, Y., Synthesis and in vivo biodistribution of BPA-Gd-DTPA complex as a potential MRI contrast carrier for neutron capture therapy (2005) Bioorg. Med. Chem., 13, pp. 735-743; Nakamura, H., Fukuda, H., Girald, F., Kobayashi, T., Hiratsuka, J., Akaizawa, T., Nemoto, H., Yoshida, K.Y.Y., In vivo evaluation of carborane gadolinium-DTPA complex as an MR imaging boron carrier (2000) Chem. Pharm. Bull., 48, pp. 1034-1038; Geninatti-Crich, S., Alberti, D., Szabo, I., Deagostino, A., Toppino, A., Barge, A., Ballarini, F., Aime, S., MRIguided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters (2011) Chem.--Eur. J., 17, pp. 8479-8486; Aime, S., Barge, A., Crivello, A., Deagostino, A., Gobetto, R., Nervi, C., Prandi, C., Venturello, P., Synthesis of Gd(III)-C-palmitamidomethyl-C'-DOTAMA-C(6)-o-carborane: A new dual agent for innovative MRI/BNCT applications (2008) Org. Biomol. Chem., 6, pp. 4460-4466; Golberg, D., Bando, Y., Tang, C., Zhi, C., Boronnitridenanotubes (2007) Adv. Mater., 19, pp. 2413-2432; Ciofani, G., Raffa, V., Menciassi, A., Cuschieri, A., Folate functionalized boron nitride nanotubes and their selective uptake by glioblastoma multiforme cells: Implications for their use as boron carriers in clinical boron neutron capture therapy (2009) Nanoscale Res. Lett., 4, pp. 113-121; Menichetti, L., DeMarchi, D., Calucci, L., Ciofani, G., Menciassi, A., Forte, C., Boron nitride nanotubes for boron neutron capture therapy as contrast agents in magnetic resonance imaging a t3T (2011) Appl. Radiat. Isotopes, 25. , in press; Calucci, L., Ciofani, G., DeMarchi, D., Forte, C., Menciassi, A., Menichetti, L., Positano, V., Boron Nitride Nanotubes as T-2-Weighted MRI Contrast Agents (2010) J. Phys. Chem. Lett, 1, pp. 2561-2565; Isobe, T., Matsumura, A., Anno, I., Yoshizawa, T., Nagatomo, Y., Itai, Y., Nose, T., Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction (2002) Magn. Reson. Imaging, 20 (4), pp. 343-349; Yamamoto, Y., Isobe, T., Yamamoto, T., Shibata, Y., Anno, I., Nakai, K., Shirakawa, M., Matsumura, A., T2 corrected quantification method of L-p-boronophenylalanine using proton magnetic resonance spectroscopy for boron neutron capture therapy (2009) Appl. Radiat. Isotopes, 67, pp. S345-S347; Heikkinen, S., Kangasmaki, A., Timonen, M., Kankaanranta, L., Hakkinen, A., Lundborn, N., Vahatalo, J., Savolainen, S., H-1 MRS of a Boron Neutron Capture Therapy B-10 Carrier, L-pboronophenylalanine-fructose complex, BPA-F: Phantom studies at 1.5 and 3.0 T (2003) Phys. Med. Biol., 48 (8), pp. 1027-1039; Bendel, P., Sauerwein, W., Optimal detection of the neutron capture therapy agent borocaptate sodium (BSH): A comparison between [sup 1]H and [sup 10]B NMR (2001) Med. Phys., 28 (2), pp. 178-183; Timonen, M., Kankaanranta, L., Lundbom, N., Collan, J., Kangasmäki, A., Kortesniemi, M., Häkkinen, A.M., Heikkinen, S., 1H MRS studies in the Finnish boron neutron capture therapy project: Detection of 10B-carrier, l-p-boronophenylalanine-fructose (2005) Eur. J. Radiol., 56 (2), pp. 154-159; Zuo, C.S., Prasad, P.V., Busse, P., Tang, L., Zamenhof, R.G., Proton nuclear magnetic resonance measurement of pboronophenylalanine (BPA): A therapeutic agent for boron neutron capture therapy (1999) Med. Phys., 26 (7), pp. 1230-1236; Bendel, P., Margalit, R., Salomon, Y., Optimized 1H MRS and MRSI methods for the in vivo detection of boronophenylalanine (2005) Magn. Res. Med., 53 (5), pp. 1166-1171; Timonen, M., Kangasmaki, A., Savolainen, S., Heikkinen, S., H-1 MRS phantom studies of BNCT B-10-carrier, BPA-F using STEAM and PRESS MRS sequences: Detection limit and quantification (2004) Spectroscopy, 18 (2), pp. 133-142; Wittig, A., Michel, J., Moss, R.L., Stecher-Rasmussen, F., Arlinghaus, H.F., Bendel, P., Mauri, P.L., Sauerwein, W.A.G., Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT) (2008) Crit. Rev. Onc. Hemat., 68 (1), pp. 66-90; Adam, M.J., Wilbur, D.S., Radiohalogens for imaging and therapy (2005) Chem. Soc. Rev., 34 (2), pp. 153-163; Kabalka, G.W., Smith, G.T., Dyke, J.P., Reid, W.S., Longford, C.P.D., Roberts, T.G., Reddy, N.K., Hubner, K.F., Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning (1997) Journal of Nuclear Medicine, 38 (11), pp. 1762-1767; Imahori, Y., Ueda, S., Ohmori, Y., Kusuki, T., Ono, K., Fujii, R., Ido, T., Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma (1998) Journal of Nuclear Medicine, 39 (2), pp. 325-333; Imahori, Y., Ueda, S., Ohmori, Y., Sakae, K., Kusuki, T., Kobayashi, T., Takagaki, M., Fujii, R., Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Part II (1998) Clinical Cancer Research, 4 (8), pp. 1833-1841; Takahashi, Y., Imahori, Y., Mineura, K., Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas (2003) Clin. Cancer Res., 9 (16), pp. 5888-5895; Chen, J.C., Chang, S.M., Hsu, F.Y., Wang, H.E., Liu, R.S., MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [F-18]FBPA-F in rats with F98 glioma (2004) Appl. Radiat. Isotopes, 61 (5), pp. 887-891; Wang, H.E., Liao, A.H., Deng, W.P., Chang, P.F., Chen, J.C., Chen, F.D., Liu, R.S., Hwang, J.J., Evaluation of 4-borono-2-F-18-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model (2004) J. Nucl. Med., 45 (2), pp. 302-308; Kabalka, G.W., Nichols, T.L., Smith, G.T., Miller, L.F., Khan, M.K., Busse, P.M., The Use of Positron Emission Tomography to Develop Boron Neutron Capture Therapy Treatment Plans for Metastatic Malignant Melanoma (2003) Journal of Neuro-Oncology, 62 (1), pp. 187-195; Aihara, T., Hiratsuka, J., Morita, N., Uno, M., Sakurai, Y., Maruhashi, A., Ono, K., Harada, T., First clinical case of boron neutron capture therapy for head and neck malignancies using F-18-BPA pet (2006) Head &amp; Neck, 28 (9), pp. 850-855; Menichetti, L., Cionini, L., Sauerwein, W.A., Altieri, S., Solin, O., Minn, H., Salvadori, P.A., Positron emission tomography and [(18)F]BPA: A perspective application to assess tumour extraction of boron in BNCT (2009) Applied Radiation and Isotopes, 67 (7-8), pp. S351-S354; Hawthorne, M.F., Maderna, A., Applications of radiolabeled boron clusters to the diagnosis and treatment of cancer (1999) Chem. Rev., 99 (12), pp. 3421-3434; Armstrong, A.F., Valliant, J.F., The bioinorganic and medicinal chemistry of carboranes: From new drug discovery to molecular imaging and therapy (2007) Dalton Trans., pp. 4240-4251; Varadarajan, A., Sharkey, R.M., Goldenberg, D.M., Hawthorne, M.F., Conjugation of Phenyl Isothiocyanate Derivatives of Carborane to Antitumor Antibody and Invivo Localization of Conjugates in Nude-Mice (1991) Bioconjugate Chem., 2 (2), pp. 102-110; Wilbur, D.S., Hamlin, D.K., Livesey, J.C., Srivastava, R.R., Laramore, G.E., Griffin, T.W., (1994) Nucl. Med. Biol., 21, pp. 601-611; Wilbur, D.S., Chyan, M.K., Hamlin, D.K., Perry, M.A., Reagents for Astatination of Biomolecules. 3. Comparison of closo-Decaborate(2-) and closo-Dodecaborate(2-) Moieties as Reactive Groups for Labeling with Astatine-211 (2009) Bioconjugate Chem., 20 (3), pp. 591-602; Wilbur, D.S., Hamlin, D.K., Chyan, M.K., Kegley, B.B., Quinn, J., Vessella, R.L., Biotin reagents in antibody pretargeting. 6. Synthesis and in vivo evaluation of astatinated and radioiodinated aryl-and nido-carboranyl-biotin derivatives (2004) Bioconjugate Chem., 15 (3), pp. 601-616; Wilbur, D.S., Hamlin, D.K., Chyan, M.K., Brechbiel, M.W., Streptavidin in antibody pretargeting. 5. Chemical modification of recombinant streptavidin for labeling with the alpha-particleemitting radionuclides Bi-213 and At-211 (2008) Bioconjugate Chem., 19 (1), pp. 158-170; Wilbur, D.S., Chyan, M.K., Hamlin, D.K., Vessella, R.L., Wedge, T.J., Hawthorne, M.F., Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination (2007) Bioconjugate Chem., 18 (4), pp. 1226-1240; Wilbur, D.S., Thakar, M.S., Hamlin, D.K., Santos, E.B., Chyan, M.K., Nakamae, H., Pagel, J.M., Sandmaier, B.M., Reagents for Astatination of Biomolecules. 4. Comparison of Maleimido-closo-Decaborate(2-) and meta-[(211)At]Astatobenzoate Conjugates for Labeling anti-CD45 Antibodies with [(211)At] Astatine (2009) Bioconjugate Chem., 20 (10), pp. 1983-1991; Wilbur, D.S., Chyan, M.-K., Hamlin, D.K., Perry, M.A., Preparation and in vivo evaluation of radioiodinated closodecaborate (2-) derivatives to identify structural components that provide low retention in tissues (2010) Nucl. Med. Biol., 37 (2), pp. 167-178; Wilbur, D.S., Hamlin, D.K., Srivastava, R.R., Chyan, M.K., Synthesis, radioiodination, and biodistribution of some nido-and closo-monocarbon carborane derivatives (2004) Nucl. Med. Biol., 31 (4), pp. 523-530; Sogbein, O.O., Merdy, P., Morel, P., Valliant, J.F., Preparation of Re(I)-and Tc99m(I)-metallocarboranes in Water under Weakly Basic Reaction Conditions (2004) Inorg. Chem., 43 (10), pp. 3032-3034; Eriksson, L., Tolmachev, V., Sjoberg, S., Feasibility of palladiumcatalyzed isotopic exchange between sodium [I-125]I and 2-iodopara-carborane (2003) J. Labelled Compd. Radiopharm., 46 (7), pp. 623-631; Winberg, K.J., Barbera, G., Eriksson, L.B., Teixidor, F., Tolmachev, V., Vinas, C., Sjoberg, S., High yield [I-125]iodidelabeling of iodinated carboranes by palladium-catalyzed isotopic exchange (2003) J. Organomet. Chem., 680 (1-2), pp. 188-192; Laakso, J., Kulvik, M., Ruokonen, I., Vähätalo, J., Zilliacus, R., Färkkilä, M., Kallio, M., Atomic emission method for total boron in blood during neutron-capture therapy (2001) Clin. Chem., 47, pp. 1796-1803&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>10B NMR</topic>
    </subject>
    <subject>
      <topic>11B NMR</topic>
    </subject>
    <subject>
      <topic>19F NMR</topic>
    </subject>
    <subject>
      <topic>1H-MRI</topic>
    </subject>
    <subject>
      <topic>1H-MRS</topic>
    </subject>
    <subject>
      <topic>4 boron 2 fluoro phenylalanine fructose complex f 18</topic>
    </subject>
    <subject>
      <topic>4 boronophenylalanine</topic>
    </subject>
    <subject>
      <topic>4 boronophenylalanine b 10</topic>
    </subject>
    <subject>
      <topic>Biodistribution</topic>
    </subject>
    <subject>
      <topic>BNCT</topic>
    </subject>
    <subject>
      <topic>boron derivative</topic>
    </subject>
    <subject>
      <topic>BPA</topic>
    </subject>
    <subject>
      <topic>BSH</topic>
    </subject>
    <subject>
      <topic>Carboranes</topic>
    </subject>
    <subject>
      <topic>drug distribution</topic>
    </subject>
    <subject>
      <topic>drug efficacy</topic>
    </subject>
    <subject>
      <topic>fluorine nuclear magnetic resonance</topic>
    </subject>
    <subject>
      <topic>Glioblastoma</topic>
    </subject>
    <subject>
      <topic>Glioma</topic>
    </subject>
    <subject>
      <topic>HeLa cell</topic>
    </subject>
    <subject>
      <topic>human</topic>
    </subject>
    <subject>
      <topic>imaging</topic>
    </subject>
    <subject>
      <topic>in vivo study</topic>
    </subject>
    <subject>
      <topic>levodopa</topic>
    </subject>
    <subject>
      <topic>melanoma</topic>
    </subject>
    <subject>
      <topic>neutron capture therapy</topic>
    </subject>
    <subject>
      <topic>nonhuman</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance</topic>
    </subject>
    <subject>
      <topic>PET</topic>
    </subject>
    <subject>
      <topic>positron emission tomography</topic>
    </subject>
    <subject>
      <topic>proton nuclear magnetic resonance</topic>
    </subject>
    <subject>
      <topic>radiopharmaceutical agent</topic>
    </subject>
    <subject>
      <topic>review</topic>
    </subject>
    <subject>
      <topic>single photon emission computer tomography</topic>
    </subject>
    <subject>
      <topic>sodium mercaptoundecahydro closo dodecaborate</topic>
    </subject>
    <subject>
      <topic>SPECT</topic>
    </subject>
    <subject>
      <topic>squamous cell carcinoma</topic>
    </subject>
    <subject>
      <topic>Therapy</topic>
    </subject>
    <subject>
      <topic>Tumors</topic>
    </subject>
    <subject>
      <topic>unclassified drug</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>High relaxivity supramolecular adducts between human-liver fatty-acid-binding protein and amphiphilic GdIII complexes: Structural basis for the design of intracellular targeting MRI probes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">D'Onofrio</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ceccon</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arena</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zanzoni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fushman</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Molinari</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Assfalg</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>18</number>
        </detail>
        <detail type="issue">
          <number>32</number>
        </detail>
        <extent unit="pages">
          <start>9919</start>
          <end>9928</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84864426926&amp;partnerID=40&amp;md5=7df9cce7aeced7807f151cfd72da5287</url>
    </location>
    <abstract>Gadolinium complexes linked to an apolar fragment are known to be efficiently internalized into various cell types, including hepatocytes. Two lipid-functionalized gadolinium chelates have been investigated for the targeting of the human liver fatty acid binding protein (hL-FABP) as a means of increasing the sensitivity and specificity of intracellular-directed MRI probes. hL-FABP, the most abundant cytosolic lipid binding protein in hepatocytes, displays the ability to interact with multiple ligands involved in lipid signaling and is believed to be an obligate carrier to escort lipidic drugs across the cell. The interaction modes of a fatty acid and a bile acid based gadolinium complex with hL-FABP have been characterized by relaxometric and NMR experiments in solution with close-to-physiological protein concentrations. We have introduced the analysis of paramagnetic-induced protein NMR signal intensity changes as a quantitative tool for the determination of binding stoichiometry and of precise metal-ion-center positioning in protein-ligand supramolecular adducts. A few additional NMR-derived restraints were then sufficient to locate the ligand molecules in the protein binding sites by using a rapid data-driven docking method. Relaxometric and13C NMR competition experiments with oleate and the gadolinium complexes revealed the formation of heterotypic adducts, which indicates that the amphiphilic compounds may co-exist in the protein cavity with physiological ligands. The differences in adduct formation between fatty acid and bile acid based complexes provide the basis for an improved molecular design of intracellular targeted probes. Sensitive MRI probes: Lipid-based gadolinium complexes display good affinity towards the most abundant human liver intracellular lipid carrier, hL-FABP, and increase the relaxivity in the supramolecular adducts. The NMR-derived structural details and results of competition experiments provide the grounds for the design of sensitive magnetic resonance probes (see figure). The formation of heterotypic adducts makes targeting of hL-FABP possible in the presence of the physiological lipid pool. Copyright © 2012 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract>
    <note type="content">AD  - Department of Biotechnology, University of Verona, Strada Le Grazie, 15, 37134 Verona, Italy</note>
    <note type="content">AD  - Department of Chemistry and Biochemistry, Center for Biomolecular Structure and Organization, University of Maryland, College Park, MD 20742, United States</note>
    <note type="content">AD  - Department of Chemistry, IFM and Molecular Imaging Center, University of Torino, Via Nizza, 52, 10126 Torino, Italy</note>
    <note type="content">&lt;p&gt;CODEN: CEUJE&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Assfalg, M.; Department of Biotechnology, University of Verona, Strada Le Grazie, 15, 37134 Verona, Italy; email: michael.assfalg@univr.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1002/chem.201103778&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Haunerland, N.H., Spener, F., (2004) Prog. Lipid Res., 43, pp. 328-349; Chmurzyńska, A., (2006) J. Appl. Genet., 47, pp. 39-48; Makowski, L., Hotamisligil, G.S., (2005) Curr. Opin. Lipidol., 16, pp. 543-548; Coe, N.R., Bernlohr, D.A., (1998) Biochim. Biophys. Acta Lipids Lipid Metab., 1391, pp. 287-306; Wolfrum, C., Borrmann, C.M., Borchers, T., Spener, F., (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 2323-2328; Storch, J., Corsico, B., (2008) Annu. Rev. Nutr., 28, pp. 73-95; Thompson, J., Ory, J., Reese-Wagoner, A., Banaszak, L., (1999) Mol. Cell. Biochem., 192, pp. 9-16; Chuang, S., Velkov, T., Horne, J., Porter, C.J.H., Scanlon, M.J., (2008) J. Med. Chem., 51, pp. 3755-3764; Terreno, E., Castelli, D.D., Viale, A., Aime, S., (2010) Chem. Rev., 110, pp. 3019-3042; Caravan, P., (2009) Acc. Chem. Res., 42, pp. 851-862; Caravan, P., Cloutier, N.J., Greenfield, M.T., McDermid, S.A., Dunham, S.U., Bulte, J.W.M., Amedio Jr., J.C., Horrocks Jr., W.D., (2002) J. Am. Chem. Soc., 124, pp. 3152-3162; Gianolio, E., Giovenzana, G.B., Longo, D., Longo, I., Menegotto, I., Aime, S., (2007) Chem. Eur. J., 13, pp. 5785-5797; Anelli, P.L., Lattuada, L., Lorusso, V., Lux, G., Morisetti, A., Morosini, P., Serleti, M., Uggeri, F., (2004) J. Med. Chem., 47, pp. 3629-3641; Assfalg, M., Gianolio, E., Zanzoni, S., Tomaselli, S., Russo, V.L., Cabella, C., Ragona, L., Molinari, H., (2007) J. Med. Chem., 50, pp. 5257-5268; Tomaselli, S., Zanzoni, S., Ragona, L., Gianolio, E., Aime, S., Assfalg, M., Molinari, H., (2008) J. Med. Chem., 51, pp. 6782-6792; Ragona, L., Catalano, M., Luppi, M., Cicero, D., Eliseo, T., Foote, J., Fogolari, F., Molinari, H., (2005) J. Biol. Chem., 281, pp. 9697-9709; Pedò, M., Löhr, F., D'Onofrio, M., Assfalg, M., Dötsch, V., Molinari, H., (2009) J. Mol. Biol., 394, pp. 852-863; Guariento, M., Raimondo, D., Assfalg, M., Zanzoni, S., Pesente, P., Ragona, L., Tramontano, A., Molinari, H., (2007) Proteins Struct. Funct. Bioinf., 70, pp. 462-472; Martin, G.G., Atshaves, B.P., Huang, H., McIntosh, A.L., Williams, B.J., Pai, P.-J., Russell, D.H., Schroeder, F., (2009) Am. J. Physiol. Gastrointest. Liver Physiol., 297, pp. 1053-1065. , G; Guariento, M., Assfalg, M., Zanzoni, S., Fessas, D., Longhi, R., Molinari, H., (2010) Biochem. J., 425, pp. 413-424; Baranyai, Z., Uggeri, F., Giovenzana, G.B., Bényei, A., Brücher, E., Aime, S., (2009) Chem. Eur. J., 15, pp. 1696-1705; Cistola, D.P., Sacchettini, J.C., Banaszak, L.J., Walsh, M.T., Gordon, J.I., (1989) J. Biol. Chem., 264, pp. 2700-2710; Lipari, G., Szabo, A., (1982) J. Am. Chem. Soc., 104, pp. 4546-4559; Lipari, G., Szabo, A., (1982) J. Am. Chem. Soc., 104, pp. 4559-4570; Solomon, I., (1955) Phys. Rev., 99, pp. 559-565; Bloembergen, N., (1957) J. Chem. Phys., 27, pp. 572-573; Bloembergen, N., Morgan, L.O., (1961) J. Chem. Phys., 34, pp. 842-850; Eliseo, T., Ragona, L., Catalano, M., Assfalg, M., Paci, M., Zetta, L., Molinari, H., Cicero, D.O., (2007) Biochemistry, 46, pp. 12557-12567; Bertini, I., Luchinat, C., (1996) Coord. Chem. Rev., 150, pp. 77-110; Xu, Y., Long, D., Yang, D., (2007) J. Am. Chem. Soc., 129, pp. 7722-7723; He, Y., Yang, X., Wang, H., Estephan, R., Francis, F., Kodukula, S., Storch, J., Stark, R.E., (2007) Biochemistry, 46, pp. 12543-12556; Sharma, A., Sharma, A., (2011) J. Biol. Chem., 286, pp. 31924-31928; Pedò, M., D'Onofrio, M., Ferranti, P., Molinari, H., Assfalg, M., (2009) Proteins Struct. Funct. Bioinf., 77, pp. 718-731; Paulussen, R.J., Van Moerkerk, H.T., Veerkamp, J.H., (1990) Int. J. Biochem., 22, pp. 393-398; Glatz, J.F., Van Der Vusse, G.J., (1996) Prog. Lipid Res., 35, pp. 243-282; Trauner, M., Boyer, J.L., (2003) Physiol. Rev., 83, pp. 633-671; Gimeno, R.E., (2007) Curr. Opin. Lipidol., 18, pp. 271-276; Varadan, R., Assfalg, M., Fushman, D., (2005) Meth. in Enzymol., 399, pp. 177-192; Ryabov, Y., Fushman, D., (2006) Proteins Struct. Funct. Bioinf., 63, pp. 787-796; Keller, R.L.J., (2004) The Computer Aided Resonance Assignment Tutorial, Cantina, Goldau, CH; Dominguez, C., Boelens, R., Bonvin, A.M.J.J., (2003) J. Am. Chem. Soc., 125, pp. 1731-1737; Schüttelkopf, A.W., Van Aalten, D.M.F., (2004) Acta Crystallogr. D Biol. Crystallogr., 60, pp. 1355-1363; Linge, J.P., Nilges, M., (1999) J. Biomol. NMR, 13, pp. 51-59; Daura, X., Gademann, K., Jaun, B., Seebach, D., Van Gunsteren, W.F., Mark, A.E., (1999) Angew. Chem., 111, pp. 249-253; (1999) Angew. Chem. Int. Ed., 38, pp. 236-240; García De La Torre, J., Huertas, M.L., Carrasco, B., (2000) J. Magn. Reson., 147, pp. 138-146; Walker, O., Varadan, R., Fushman, D., (2004) J. Magn. Reson., 168, pp. 336-345&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>Adduct formation</topic>
    </subject>
    <subject>
      <topic>Amphiphilic compound</topic>
    </subject>
    <subject>
      <topic>Amphiphilics</topic>
    </subject>
    <subject>
      <topic>bile acid</topic>
    </subject>
    <subject>
      <topic>Biochemistry</topic>
    </subject>
    <subject>
      <topic>Body Fluids</topic>
    </subject>
    <subject>
      <topic>Cell types</topic>
    </subject>
    <subject>
      <topic>Cytosolic</topic>
    </subject>
    <subject>
      <topic>Docking methods</topic>
    </subject>
    <subject>
      <topic>Experiments</topic>
    </subject>
    <subject>
      <topic>Fatty acid-binding proteins</topic>
    </subject>
    <subject>
      <topic>Fatty acids</topic>
    </subject>
    <subject>
      <topic>Gadolinium</topic>
    </subject>
    <subject>
      <topic>Gadolinium complexes</topic>
    </subject>
    <subject>
      <topic>Gadolinium compounds</topic>
    </subject>
    <subject>
      <topic>Hepatocytes</topic>
    </subject>
    <subject>
      <topic>Human liver</topic>
    </subject>
    <subject>
      <topic>Interaction modes</topic>
    </subject>
    <subject>
      <topic>Ligand molecules</topic>
    </subject>
    <subject>
      <topic>Ligands</topic>
    </subject>
    <subject>
      <topic>Lipid carriers</topic>
    </subject>
    <subject>
      <topic>Lipid pools</topic>
    </subject>
    <subject>
      <topic>Lipid-binding proteins</topic>
    </subject>
    <subject>
      <topic>Lipids</topic>
    </subject>
    <subject>
      <topic>Magnetic resonance</topic>
    </subject>
    <subject>
      <topic>Molecular design</topic>
    </subject>
    <subject>
      <topic>Multiple ligands</topic>
    </subject>
    <subject>
      <topic>NMR</topic>
    </subject>
    <subject>
      <topic>NMR signals</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance</topic>
    </subject>
    <subject>
      <topic>Nuclear magnetic resonance spectroscopy</topic>
    </subject>
    <subject>
      <topic>Paramagnetism</topic>
    </subject>
    <subject>
      <topic>Physiological ligands</topic>
    </subject>
    <subject>
      <topic>physiology</topic>
    </subject>
    <subject>
      <topic>Probes</topic>
    </subject>
    <subject>
      <topic>Protein cavity</topic>
    </subject>
    <subject>
      <topic>Protein concentrations</topic>
    </subject>
    <subject>
      <topic>Protein-binding sites</topic>
    </subject>
    <subject>
      <topic>Proteins</topic>
    </subject>
    <subject>
      <topic>Quantitative tool</topic>
    </subject>
    <subject>
      <topic>Relaxivity</topic>
    </subject>
    <subject>
      <topic>Relaxometry</topic>
    </subject>
    <subject>
      <topic>sensitivity and specificity</topic>
    </subject>
    <subject>
      <topic>stoichiometry</topic>
    </subject>
    <subject>
      <topic>Structural basis</topic>
    </subject>
    <subject>
      <topic>Structural details</topic>
    </subject>
    <subject>
      <topic>Supramolecular adducts</topic>
    </subject>
    <subject>
      <topic>Supramolecular chemistry</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Hyperpolarized 13C-labelled anhydrides as DNP precursors of metabolic MRI agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Colombo Serra</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Karlsson</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallotti</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tedoldi</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>469</start>
          <end>477</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84864133904&amp;partnerID=40&amp;md5=0aa0eb4cf16eb2725291532cf2896498</url>
    </location>
    <abstract>The extraordinary enhancement of the nuclear magnetic resonance (NMR) signal that can be obtained by dynamic nuclear polarization (DNP) techniques is prompting new avenues of research based on the in vivo detection of metabolic abnormalities associated with the onset and progression of human diseases.                         13C-labelled short-chain fatty acids appear to be interesting candidates for this novel class of metabolic-active contrast agents (MCAs), as they have been shown to report on metabolic differences between healthy and ischaemic tissues in mice. In spite of their promising biological efficacy, the formulations of short-chain fatty acids that fulfil the many technical constraints of the DNP procedure, as it is today, may limit their clinical potential. New solutions have been sought to circumvent technology-related challenges and facilitate clinical translation of these molecules. In particular, it has been shown that, by using symmetric anhydrides as chemical precursors for short-chain fatty acids, no glass-forming additives are needed in the DNP formulations. Furthermore, novel esterified trityl radicals and lipophilic gadolinium complexes allow easy removal of the polarization-promoting additives at the end of the DNP process. By applying the three concepts reported, we have succeeded in preparing aqueous formulations of short-chain fatty acids for pharmaceutical use that have favourable properties compared with those obtained from current procedures. The use of organic derivatives as chemical precursors of the MCA of interest appears to be a generally valid concept, not restricted to symmetric anhydrides of fatty acids, which can markedly improve the clinical potential of other                         13C-labelled compounds. © 2012 John Wiley &amp; Sons, Ltd.</abstract>
    <note type="content">AD  - Albeda Research, Gamle Carlsberg Vej 10, Valby Copenhagen, 2500, Denmark</note>
    <note type="content">AD  - CAGE Chemicals Srl, Via Bovio 6, Novara, (NO), 28100, Italy</note>
    <note type="content">AD  - Centro Ricerche Bracco, Bracco Imaging Spa, Via Ribes 5, 10010 Colleretto Giacosa (TO), Italy</note>
    <note type="content">AD  - Dipartimento di Chimica I.F.M., Università degli Studi di Torino, Via Giuria 7, Torino, (TO), 10125, Italy</note>
    <note type="content">AD  - Dipartimento di Fisica Sperimentale, Università degli Studi di Torino, Via Giuria 1, Torino, (TO), 10125, Italy</note>
    <note type="content">AD  - Dipartimento di Scienze Chimiche Alimentari Farmaceutiche e Farmacologiche, Università degli Studi del Piemonte Orientale 'A. Avogadro', Via Bovio 6, Novara, (NO), 28100, Italy</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: butyric acid, 107-92-6, 156-54-7, 461-55-2; gadoteric acid, 92923-44-9; sodium, 7440-23-5&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Cited By (since 1996): 1&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Colombo Serra, S.; Centro Ricerche Bracco, Bracco Imaging Spa, Via Ribes 5, 10010 Colleretto Giacosa (TO), Italy; email: sonia.colombo@bracco.com&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1002/cmmi.1474&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Weissleder, R., Mahmood, U., Molecular imaging (2001) Radiology, 219 (2), pp. 316-333; Carson, E., Precision and accuracy considerations of physiological quantitation in PET (1991) J Cereb Blood Flow Metab, 11, pp. A45-A50; De Leon-Rodriguez, L.M., Lubag, A.J.M., Malloy, C.R., Martinez, G.V., Gillies, R.J., Sherry, A.D., Responsive MRI agents for sensing metabolism in vivo (2009) Acc Chem Res, 42 (7), pp. 948-957; Terreno, E., Delli Castelli, D., Viale, A., Aime, S., Challenges for molecular MRI (2010) Chem Rev, 110 (5), pp. 3019-3042; Kurhanewicz, J., Vigneron, D.B., Brindle, K., Chekmeney, E.Y., Comment, A., Cunningham, C.H., DeBerardinis, R.J., Malloy, C.R., Analysis of cancer metabolism by imaging hyperpolarized nuclei: rospects for translation to clinical research (2011) Neoplasia, 13 (2), pp. 81-97; Ardenkjær-Larsen, J.H., Fridlund, B., Gram, A., Hansson, G., Hansson, L., Lerche, M.H., Servin, R., Golman, K., Increase in signal-to-noise ratio of &gt;10,000 times in liquid-state NMR (2003) Proc Natl Acad Sci, 100 (18), pp. 10158-10163; Day, S.E., Kettunen, M.I., Gallagher, F.A., Hu, D.E., Lerche, M.H., Wolber, J., Golman, K., Brindle, K.M., Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy (2007) Nat Med, 13 (11), pp. 1382-1387; Golman, K., in't Zandt, R., Lerche, M.H., Pehrson, R., Ardenkjaer-Larsen, J.H., Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis (2006) Cancer Res, 66 (22), pp. 10855-10860; (2010), The Clinical Trials Website. Available from: [13 October ]Gallagher, F.A., Kettunen, M.I., Hu, D.E., Jensen, P.R., in't Zandt, R., Karlsson, M., Gisselsson, A., Brindle, K.M., Production of hyperpolarized [1,4-C-13(2)]malate from [1,4-C-13(2)]fumarate is a marker of cell necrosis and treatment response in tumors (2009) Proc Natl Acad Sci, 106 (47), pp. 19801-19806; Jensen, P.R., Peitersen, T., Karlsson, M., in't Zandt, R., Gisselsson, A., Hansson, G., Meier, S., Lerche, M.H., Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo (2009) J Biol Chem, 284 (52), pp. 36077-36082; Karlsson, M., Jensen, P.R., in't Zandt, R., Gisselsson, A., Hansson, G., Duus, J., Meier, S., Lerche, M.H., Imaging of branched chain amino acid metabolism in tumors with hyperpolarized 13C ketoisocaproate (2009) Int J Cancer, 127 (3), pp. 729-736; Gallagher, F.A., Kettunen, M.I., Day, S.E., Hu, D., Karlsson, M., Gisselsson, A., Lerche, M.H., Brindle, K.M., Detection of tumor glutamate metabolism in vivo using 13C magnetic resonance spectroscopy and hyperpolarized [1- 13C]glutamate (2011) Magn Reson Med, 66 (1), pp. 18-23; Gallagher, F.A., Kettunen, M.I., Day, S.E., Hu, D., Ardenkjær-Larsen, J.H., in't Zandt, R., Jensen, P.R., Brindle, K.M., Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate (2008) Nature, 453, pp. 940-943; Stanley, W.C., Recchia, F.A., Lopaschuk, G.D., Myocardial substrate metabolism in the normal and failing heart (2005) Physiol Rev, 85, pp. 1093-1129; Golman, K., Petersson, J.S., Magnusson, P., Johansson, E., Åkeson, P., Chai, C.M., Hansson, G., Månsson, S., Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI (2008) Magn Reson Med, 59, pp. 1005-1013; Schroeder, M.A., Cochlin, L.E., Heather, L.C., Clarke, K., Radda, G.K., Tyler, D.J., In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance (2008) Proc Natl Acad Sci, 105 (33), pp. 12051-12056; Lewandowski, E.D., Kudej, R.K., White, L.T., O'Donnell, J.M., Vatner, S.F., Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction (2002) Circulation, 105, pp. 367-372; Ball, D., Dodd, M., Atherton, H., Schroeder, M., Carr, C., Radda, G., Clarke, K., Tyler, D., (2011), 19, p. 658. , Hyperpolarized Butyrate: novel substrate for assessment of cardiac fatty acid metabolism. Proceedings of the British Chapter of ISMRM ; : Ardenkjaer-Larsen, J.H., Leach, A.M., Clarke, N., Urbahn, J., Anderson, D., Skloss, T.W., Dynamic nuclear polarization polarizer for sterile use intent (2011) NMR Biomed, 24 (8), pp. 927-932; Jannin, S., Bornet, A., Colombo Serra, S., Bodenhausen, G., Low-temperature cross polarization in view of enhancing dissolution dynamic nuclear polarization in NMR (2011) Chem Phys Lett, 517, pp. 234-236; Bunyatova, E.I., New investigation of organic compounds for targets with polarized hydrogen nuclei (1995) Nucl Instrum Meth Phys Res, Sect A, 356, pp. 29-33; Accardo, A., Tesauro, D., Aloj, L., Pedone, C., Morelli, G., Supramolecular aggregates containing lipophilic Gd (III) complexes as contrast agents in MRI (2009) Coord Chem Rev, 253 (17-18), pp. 2193-2213; Macholl, S., Johannesson, H., Ardenkjaer-Larsen, J.H., Trityl biradicals and 13C dynamic nuclear polarization (2010) Phys Chem Chem Phys, 12, pp. 5804-5817; Trach, V., Buschmans-Denkel, E., Schaper, W., Relation between lipolysis and glycolysis during ischemia in the isolated rat heart (1986) Basic Res Cardiol, 81 (5), pp. 454-464; Berenguer, M., Zhang, J., Bruce, M.C., Martinez, L., Gonzalez, T., Gurtovenko, A.A., Xu, T., Govers, R., Dimethyl sulfoxide enhances GLUT4 translocation through a reduction in GLUT4 endocytosis in insulin-stimulated 3T3-L1 adipocytes (2011) Biochimie, 93 (4), pp. 697-709; Johannesson, H., Macholl, S., Ardenkjaer-Larsen, J.H., Dynamic nuclear polarization of [1- 13C]pyruvic acid at 4.6 tesla (2009) J Magn Reson, 197, pp. 167-175; (2011), International Patent Application WO2011/124672, filed on 8 April 2011, published 13 OctoberDhimitruka, I., Velayutham, M., Bobko, A.A., Khramtsov, V.V., Villamena, F.A., Hadad, C.M., Zweier, J.L., Large-scale synthesis of a persistent trityl radical for use in biomedical EPR applications and imaging (2007) Bioorg Med Chem Lett, 17 (24), pp. 6801-6805; Xia, S., Villamena, F.A., Hadad, C.M., Kuppusamy, P., Li, Y., Zhu, H., Zweier, J.L., Reactivity of molecular oxygen with ethoxycarbonyl derivatives of tetrathiatriarylmethyl radicals (2006) J Org Chem, 71, pp. 7268-7279&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>acid anhydride</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>butyric acid</topic>
    </subject>
    <subject>
      <topic>carbon nuclear magnetic resonance</topic>
    </subject>
    <subject>
      <topic>contrast medium</topic>
    </subject>
    <subject>
      <topic>drug structure</topic>
    </subject>
    <subject>
      <topic>drug synthesis</topic>
    </subject>
    <subject>
      <topic>dynamic nuclear polarization</topic>
    </subject>
    <subject>
      <topic>Esterified electron polarizing agent</topic>
    </subject>
    <subject>
      <topic>gadoteric acid</topic>
    </subject>
    <subject>
      <topic>Hydrolysis</topic>
    </subject>
    <subject>
      <topic>hyperpolarization</topic>
    </subject>
    <subject>
      <topic>metabolic active contrast agent</topic>
    </subject>
    <subject>
      <topic>Polarization</topic>
    </subject>
    <subject>
      <topic>priority journal</topic>
    </subject>
    <subject>
      <topic>short chain fatty acid</topic>
    </subject>
    <subject>
      <topic>Short-chain fatty acids</topic>
    </subject>
    <subject>
      <topic>Sodium</topic>
    </subject>
    <subject>
      <topic>Symmetric anhydrides</topic>
    </subject>
    <subject>
      <topic>unclassified drug</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Hyperpolarized 13C-pyruvate magnetic resonance imaging in cancer diagnostics</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>335</start>
          <end>345</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">17530059 (ISSN)</identifier>
      <titleInfo>
        <title>Expert Opinion on Medical Diagnostics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Expert Opin. Med. Diagn.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84863101194&amp;partnerID=40&amp;md5=7d9776a454c163d0eeb3e514bbe21523</url>
    </location>
    <abstract>Introduction: The use of hyperpolarized molecules allows one to obtain information about metabolism in both cells and animals; such a task represents a tremendous advancement with respect to the results achieved so far with in vivo NMR techniques. Pyruvate appears an excellent tumor biomarker as it allows the attainment of early diagnosis, stadiation and monitoring of response to therapy. Areas covered: As pyruvate conversion to lactate in the glycolytic pathway is highly enhanced in tumor cells, the 1-                         13C-lactate levels after administration of hyperpolarized 1-                         13C-pyruvate are markedly higher in tumor tissues and depend on the type and grade of the tumor. This review covers the most recent research results (both in vitro and in vivo) about the use of hyperpolarized 1-                         13C-pyruvate for tumor localization, stadiation and for monitoring the response to therapy. The technique may find application in clinics, especially when other imaging modalities are of difficult applicability. Expert opinion: While                         13C-pyruvate has been shown to be the candidate of choice for metabolic imaging, high expectations are present in the scientific community to see if other hyperpolarized substrates could provide more specific and sensitive biomarkers. The use of hyperpolarized molecules will have a tremendous impact in the armory of diagnostic tools. © 2012 Informa UK, Ltd.</abstract>
    <note type="content">AD  - University of Torino, Department of Chemistry, Molecular Biotechnology Centre, V. Nizza 52, 10126 Torino, Italy</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: carbon 13, 14762-74-4; doxorubicin, 23214-92-8, 25316-40-9; doxycycline, 10592-13-9, 17086-28-1, 564-25-0; etoposide, 33419-42-0; lactic acid, 113-21-3, 50-21-5; pyruvic acid, 127-17-3, 19071-34-2, 57-60-3&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Aime, S.; University of Torino, Department of Chemistry, Molecular Biotechnology Centre, V. Nizza 52, 10126 Torino, Italy; email: silvio.aime@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1517/17530059.2012.687372&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Ross, B.D., The biochemistry of living tissues: Examination by MRS (1992) NMR Biomed., 5, pp. 215-219; Negendank, W., Studies of human tumors by MRS: A review (1992) NMR Biomed., 5, pp. 303-324; Howe, F.A., Barton, S.J., Cudlip, S.A., Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy (2003) Magn. Reson. Med., 49, pp. 223-232; Simonetti, A.W., Melssen, W.J., Van Der Graaf, M., A chemometric approach for brain tumor classification using magnetic resonance imaging and spectroscopy (2003) Anal. Chem., 75, pp. 5352-5361; Overhauser, A.W., Polarization of nuclei in metals (1953) Phys. Rev., 92, pp. 411-415; Golman, K., Zandt, R., Lerche, M., Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis (2006) Cancer Res., 66, pp. 10855-10860; Brindle, K.M., Biomedical applications of hyperpolarized 13C magnetic resonance imaging (2009) Prog. Nucl. Magn. Reson. Spectrosc., 55, pp. 285-295; Kurhanewicz, J., Vigneron, D.B., Brindle, K., Analysis of cancer metabolism by imaging hyperpolarized nuclei: Prospects for translation to clinical research (2011) Neoplasia, 13, pp. 81-97; Kettunen, M.I., Hu, D.-E., Witney, T.H., Magnetization transfer measurements of exchange between hyperpolarized 1-13C pyruvate and 1-13C lactate in a murine lymphoma (2010) Magn. Reson. Med., 63, pp. 872-880; Brindle, K.M., Bohndiek, S.E., Gallagher, F.A., Kettunen, M.I., Tumor imaging using hyperpolarized 13C magnetic resonance spectroscopy (2011) Magn. Reson. Med., 66, pp. 505-519; Larson, P.E.Z., Bok, R., Kerr, A.B., Investigation of tumor hyperpolarized 1-13C-Pyruvate dynamics using time-resolved multiband RF excitation Echo-Planar MRSI (2010) Magn. Reson. Med., 63, pp. 582-591; Lau, A.Z., Chen, A.P., Hurd, R.E., Cunningham, C.H., Spectral-spatial excitation for rapid imaging of DNP compounds (2011) NMR Biomed., 24, pp. 988-996; Smith, M.R., Peterson, E.T., Gordon, J.W., In Vivo imaging and spectroscopy of dynamic metabolism using simultaneous 13 C and 1 H MRI (2011) IEEE Trans. Biomed. Eng., 59, pp. 45-49; Chen, A.P., Hurd, R.E., Cunningham, C.H., Spin tagging for hyperpolarized 13C metabolic studies (2012) J. Magn. Reson., 214, pp. 319-323; Altes, T.A., Salerno, M., Hyperpolarized gas MR imaging of the lung (2004) J. Thorac. Imaging, 19, pp. 250-258; Oros, A.M., Shah, N.J., Hyperpolarized xenon in NMR and MRI (2004) Phys. Med. Biol., 49, pp. R105-R153; Matsuoka, S., Patz, S., Albert, M.S., Hyperpolarized gas MR Imaging of the lung: Current status as a research tool (2009) J. Thorac. Imaging, 24, pp. 181-188; Schroder, L., Lowery, T.J., Hilty, C., Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor (2006) Science, 314, pp. 446-449; Natterer, J., Bargon, J., Parahydrogen induced polarization (1997) Prog. Nucl. Magn. Reson. Spectrosc., 31, pp. 293-2315; Duckett, S.B., Sleigh, C.J., Applications of the parahydrogen phenomenon: A chemical perspective (1999) Prog. Nucl. Magn. Reson. Spectrosc., 34, pp. 71-92; Viale, A., Aime, S., Current concepts on hyperpolarized molecules in MRI (2010) Curr. Opin. Chem. Biol., 14, pp. 90-96; Jensen, P.R., Karlsson, M., Meier, S., Hyperpolarized amino acids for in vivo assays of transaminase activity (2009) Chem. Eur. J., 15, pp. 10010-10012; Jensen, P.R., Peitersen, T., Karlsson, M., Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo (2009) J. Biol. Chem., 284, pp. 36077-36082; Karlsson, M., Jensen, P.R., Zandt, R., Imaging of branched chain amino acid metabolism in tumors with hyperpolarized 13C ketoisocaproate (2010) Int. J. Cancer, 127, pp. 729-736; Wilson, D.M., Keshari, K.R., Larson, P.E.Z., Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo (2010) J. Magn. Reson., 205, pp. 141-147; Hu, S., Zhu, M., Yoshihara, H.A.I., In vivo measurement of normal rat intracellular pyruvate and lactate levels after injection of hyperpolarized 1-13C alanine (2011) Magn. Reson. Imaging, 29, pp. 1035-1040; Kohler, S.J., Yen, Y., Wolber, J., In vivo 13 carbon metabolic imaging at 3T with hyperpolarized 13C-1-pyruvate (2007) Magn. Reson. Med., 58, pp. 65-69; Golman, K., Zandt, R., Thaning, M., Real-time metabolic imaging (2006) Proc. Natl. Am. Soc., 103, pp. 11270-11275; Gallagher, F.A., Kettunen, M.I., Hua, D.-E., Production of hyperpolarized 1 4-13C2 malate from 1 4-13C2 fumarate is a marker of cell necrosis and treatment response in tumors (2009) Proc. Natl. Am. Soc., 106, pp. 19801-19806; Gallagher, F.A., Kettunen, M.I., Day, S.E., Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate (2008) Nature, 453, pp. 940-944; Abragam, A., Goldman, M., Principles of dynamic nuclear polarisation (1978) Rep. Prog. Phys., 41, pp. 395-3467; Comment, A., Van Den Brandt, B., Uffmann, K., Design and performance of a DNP prepolarizer coupled to a rodent MRI scanner (2007) Conc. Magn. Reson. B., 31 B, pp. 255-269; Golman, K., Petersson, J.S., Magnusson, P., Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI (2008) Magn. Reson. Med., 59, pp. 1005-1013; Schroeder, M.A., Cochlin, L.E., Heather, L.C., In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance (2008) Proc. Natl. Am. Soc., 105, pp. 12051-12056; Merritt, M.E., Harrison, C., Storey, C., Inhibition of carbohydrate oxidation during the first minute of reperfusion after brief ischemia: NMR detection of hyperpolarized 13CO2 and H13CO3 (2008) Magn. Reson. Med., 60, pp. 1029-1036; Bhattacharya, P., Ross, B.D., Bunger, R., Cardiovascular applications of yperpolarized contrast media and metabolic tracers (2009) Exp. Biol. Med., 234, pp. 1395-13416; Schroeder, M.A., Atherton, H.J., Ball, D.R., Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy (2009) FASEB J., 23, pp. 2529-2538; Schroeder, M.A., Atherton, H.J., Cochlin, L.E., The effect of hyperpolarized tracer concentration on myocardial uptake and metabolism (2009) Magn. Reson. Med., 61, pp. 1007-1014; Lau, A.Z., Chen, A.P., Ghugre, N.R., Rapid multislice imaging of hyperpolarized 13C pyruvate and bicarbonate in the heart (2010) Magn. Reson. Med., 64, pp. 1323-1331; Malloya, C.R., Merritt, M.E., Sherry, A.D., Could 13C MRI assist clinical decisionmaking for patients with heart disease (2011) NMR Biomed., 24, pp. 973-979; Spielman, D.M., Mayer, D., Yen, Y.-F., In vivo measurement of ethanol metabolism in the rat liver using magnetic resonance spectroscopy of hyperpolarized 1-13C pyruvate (2009) Magn. Reson. Med., 62, pp. 307-313; Hu, S., Chen, A.P., Zierhut, M.L., In vivo carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate (2009) Mol. Imaging Biol., 11, pp. 399-3407; Merritt, M.E., Harrison, C., Sherry, A.D., Flux through hepatic pyruvate carboxylase and phosphoenolpyruvate carboxykinase detected by hyperpolarized 13C magnetic resonance (2011) Proc. Natl. Am. Soc., 47, pp. 19084-19089; Hu, S., Lustig, M., Balakrishnan, A., 3D compressed sensing for highly accelerated hyperpolarized 13C MRSI with in vivo applications to transgenic mouse models of cancer (2010) Magn. Reson. Med., 63, pp. 312-321; Yen, Y.-F., Le Roux, P., Mayer, D., T2 relaxation times of 13C metabolites in a rat hepatocellular carcinoma model measured in vivo using 13C-MRS of hyperpolarized 1-13C pyruvate (2010) NMR Biomed., 23, pp. 414-423; Darpolora, M.M., Yen, Y.-F., Chu, M.-S., In vivo MRSI of hyperpolarized 1-13C pyruvate metabolism in rat hepatocellular carcinoma (2011) NMR Biomed., 24, pp. 506-513; Hu, S., Balakrishnan, A., Bok, R.A., 13C-Pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression (2011) Cell Metabolism, 14, pp. 131-142; Chen, A.P., Albers, M.J., Cunningham, C.H., Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-Initial experience (2007) Magn. Reson. Med., 58, pp. 1099-1106; Albers, M.J., Bok, R., Chen, A.P., Hyperpolarized 13C lactate pyruvate and alanine: Non-invasive biomarkers for prostate cancer detection and grading (2008) Cancer Res., 68, pp. 8607-8615; Lupo, J.M., Chen, A.P., Zierhuta, M.L., Analysis of hyperpolarized dynamic 13C lactate imaging in a transgenic mouse model of prostate cancer (2010) Magn. Reson. Imaging, 28, pp. 153-162; Nelson, S.J., Vigneron, D., Kurhanewicz, J., DNP-Hyperpolarized 13C magnetic resonance metabolic imaging for cancer applications (2008) Appl. Magn. Reson., 34, pp. 533-544; Park, I., Larson, P.E.Z., Zierhut, M.L., Hyperpolarized 13C magnetic resonance metabolic imaging: Application to brain tumors (2010) Neuro.-Oncol., 12, pp. 133-144; Harris, T., Eliyahu, G., Frydman, L., Degani, H., Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells (2009) Proc. Natl. Am. Soc., 106, pp. 18131-18136; Day, S.E., Kettunen, M.I., Gallagher, F.A., Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy (2007) Nat. Med., 13, pp. 1382-7; Witney, T.H., Kettunen, M.I., Day, S.E., A comparison between radiolabeled Fluorodeoxyglucose uptake and hyperpolarized 13C-labelled pyruvate utilization as methods for detecting tumor response to treatment (2009) Neoplasia, 11, pp. 574-582; Bohndiek, S.E., Kettunen, M.I., Hu, D., Detection of tumor response to a vascular disrupting agent by hyperpolarized 13C magnetic resonance spectroscopy (2010) Mol. Cancer Ther., 9, pp. 3278-3288; Ward, C.S., Venkatesh, H.S., Chaumeil, M.M., Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy (2010) Cancer Res., 70, pp. 1296-12305; Chaumeil, M.M., Ozawa, T., Park, I., Hyperpolarized 13C MR spectroscopic imaging can be used to monitor everolimus treatment in vivo in an orthotopic rodent model of glioblastoma Neuroimage, 2012 (59), pp. 193-1201; Dafni, H., Larson, P.E.Z., Hu, S., Hyperpolarized 13C spectroscopic imaging informs on hypoxia-inducible factor-1 and Myc activity downstream of platelet-derived growth factor receptor (2010) Cancer Res., 70, pp. 7400-7410; Seth, P., Grant, A., Tang, J., On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate (2011) Neoplasia, 13, pp. 60-71; Chen, A.P., Bok, R., Zhang, W., Serial hyperpolarized 13C 3D-MRSI following therapy in a mouse model of prostate cancer (2008) Proc. Int. Soc. Magn. Reson. Med., 16, p. 888; Day, S.E., Kettunen, M.I., Cherukuri, M.K., Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized 1-13C pyruvate and 13C magnetic resonance spectroscopic imaging (2011) Magn. Reson. Med., 65, pp. 557-563; Park, I., Bok, R., Ozawa, T., Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging (2011) J. Magn. Reson. Imaging, 33, pp. 1284-1290; Board, M., Humm, S., Newsholme, E.A., Maximum activities of key enzymes of glycolysis glutaminolysis pentose phosphate pathway and tricarboxylic acid cycle in normal neoplastic and suppressed cells (1990) Biochem. J., 265, pp. 503-509; Dastidar, S.G., Sharma, S.K., Activities of glycolytic enzymes in rapidly proliferating and differentiated C6 glioma cells (1989) Exp. Cell. Biol., 57, pp. 159-164; http://clinicaltrials.gov/show/NCT01229618, Available fromWitney, T.H., Kettunen, M.I., Hu, D.-E., Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised 1-13C pyruvate and 14-13C2 fumarate (2010) Br. J. Cancer, 103, pp. 1400-1406; Gabellieri, C., Reynolds, S., Lavie, A., Therapeutic target metabolism observed using hyperpolarized 15N Choline (2008) J. Am. Chem. Soc., 130, pp. 4598-4599&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>1-</topic>
    </subject>
    <subject>
      <topic>13C-pyruvate</topic>
    </subject>
    <subject>
      <topic>biological marker</topic>
    </subject>
    <subject>
      <topic>brain tumor</topic>
    </subject>
    <subject>
      <topic>breast adenocarcinoma</topic>
    </subject>
    <subject>
      <topic>breast cancer</topic>
    </subject>
    <subject>
      <topic>Cancer</topic>
    </subject>
    <subject>
      <topic>cancer diagnosis</topic>
    </subject>
    <subject>
      <topic>carbon 13</topic>
    </subject>
    <subject>
      <topic>carbon nuclear magnetic resonance</topic>
    </subject>
    <subject>
      <topic>Contrast Enhancement</topic>
    </subject>
    <subject>
      <topic>diagnostic imaging</topic>
    </subject>
    <subject>
      <topic>diagnostic value</topic>
    </subject>
    <subject>
      <topic>doxorubicin</topic>
    </subject>
    <subject>
      <topic>doxycycline</topic>
    </subject>
    <subject>
      <topic>dynamic nuclear polarization</topic>
    </subject>
    <subject>
      <topic>Early diagnosis</topic>
    </subject>
    <subject>
      <topic>etoposide</topic>
    </subject>
    <subject>
      <topic>glycolysis</topic>
    </subject>
    <subject>
      <topic>human</topic>
    </subject>
    <subject>
      <topic>hyperpolarization</topic>
    </subject>
    <subject>
      <topic>hyperpolarized pyruvate c 13</topic>
    </subject>
    <subject>
      <topic>in vitro study</topic>
    </subject>
    <subject>
      <topic>in vivo study</topic>
    </subject>
    <subject>
      <topic>lactic acid</topic>
    </subject>
    <subject>
      <topic>liver cancer</topic>
    </subject>
    <subject>
      <topic>Lymphoma</topic>
    </subject>
    <subject>
      <topic>Metabolic imaging</topic>
    </subject>
    <subject>
      <topic>nonhuman</topic>
    </subject>
    <subject>
      <topic>prostate adenocarcinoma</topic>
    </subject>
    <subject>
      <topic>pyruvic acid</topic>
    </subject>
    <subject>
      <topic>review</topic>
    </subject>
    <subject>
      <topic>treatment response</topic>
    </subject>
    <subject>
      <topic>tumor cell</topic>
    </subject>
    <subject>
      <topic>tumor localization</topic>
    </subject>
    <subject>
      <topic>unclassified drug</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Image guided therapy: The advent of theranostic agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>161</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>328</start>
          <end>337</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">01683659 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Controlled Release</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Control. Release</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84862641306&amp;partnerID=40&amp;md5=c89ec8166f751b1fb14f61b6105f89cc</url>
    </location>
    <abstract>Theranostic agents represent a recently introduced class of imaging probes designed to offer to pharmacologists and physicians a robust tool for minimally invasive in vivo visualization of drug delivery/release and therapy monitoring. By means of these agents, novel strategies able to integrate diagnosis and therapy could be developed. This highly interdisciplinary research field is one of the more innovative products resulting from the synergism between molecular imaging and nanomedicine. Potential applications of theranosis include the in vivo assessment of drug biodistribution and accumulation at the target site, visualization of the drug release from a given nanocarrier, and real-time monitoring of the therapeutic outcome. The expected end-point of theranostic agents is to provide a fundamental support for the optimization of innovative diagnostic and therapeutic strategies that could contribute to emerging concepts in the field of the "personalized medicine". This perspective paper aims at providing the reader the basic principles of theranosis with a particular emphasis to the design of theranostic agents. © 2012 Elsevier B.V. All rights reserved.</abstract>
    <note type="content">AD  - Bracco Imaging S.p.A., Centro Ricerche, Colleretto Giacosa (TO), Italy</note>
    <note type="content">AD  - Department of Chemistry and Molecular, Preclinical Imaging Centers, University of Turin, Via Nizza, 52, 10126, Italy</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: doxorubicin, 23214-92-8, 25316-40-9; gadolinium, 7440-54-2; gadoteridol, 112188-16-6, 120066-54-8&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: JCREE&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Terreno, E.; Department of Chemistry and Molecular, Preclinical Imaging Centers, University of Turin, Via Nizza, 52, 10126, Italy; email: enzo.terreno@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1016/j.jconrel.2012.05.028&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Arias, J.L., Clares, B., Morales, M.E., Gallardo, V., Ruiz, M.A., Lipid-based drug delivery systems for cancer treatment (2011) Curr. Drug Targets, 12, pp. 1151-1165; Tanner, P., Baumann, P., Enea, R., Onaca, O., Palivan, C., Meier, W., Polymeric vesicles: From drug carriers to nanoreactors and artificial organelles (2011) Acc. Chem. Res., 44, pp. 1039-1049; Stark, W.J., Nanoparticles in biological systems (2011) Angew. Chem. Int. Ed Engl., 50, pp. 1242-1258; Laza-Knoerr, A.L., Gref, R., Couvreur, P., Cyclodextrins for drug delivery (2010) J. Drug Target., 18, pp. 645-656; Ng, K.K., Lovell, J.F., Zheng, G., Lipoprotein-inspired nanoparticles for cancer theranostics (2011) Acc. Chem. Res., 44, pp. 1105-1113; Kratz, F.J., Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles (2008) J. Control. Release, 132, pp. 171-183; Yoo, J.W., Irvine, D.J., Discher, D.E., Mitragotri, S., Bio-inspired, bioengineered and biomimetic drug delivery carriers (2011) Nat. Rev. Drug Discov., 10, pp. 521-535; Ganta, S., Devalapally, H., Shahiwala, A., Amiji, M., A review of stimuli-responsive nanocarriers for drug and gene delivery (2008) J. Control. Release, 126, pp. 187-202; Weissleder, R., Molecular imaging: Exploring the next frontier (1999) Radiology, 212, pp. 609-614; Chen, X., Gambhir, S.S., Cheon, J., Theranostic nanomedicine (editorial) (2011) Acc. Chem. Res., 44, p. 841; Moonen, C.T., Spatio-temporal control of gene expression and cancer treatment using magnetic resonance imaging-guided focused ultrasound (2007) Clin. Cancer Res., 13, pp. 3482-3489; Li, Z., Jin, Q., Huang, C., Dasa, S., Chen, L., Yap, L.P., Liu, S., Conti, P.S., Trackable and targeted phage as positron emission tomography (PET) agent for cancer imaging (2011) Theranostics, 1, pp. 371-380; Terreno, E., Delli Castelli, D., Viale, A., Aime, S., Challenges for molecular magnetic resonance imaging (2010) Chem. Rev., 110, pp. 3019-3042; Mulder, W.J., Strijkers, G.J., Van Tilborg, G.A., Griffioen, A.W., Nicolay, K., Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging (2006) NMR Biomed., 19, pp. 142-164; Grange, C., Geninatti-Crich, S., Esposito, G., Alberti, D., Tei, L., Bussolati, B., Aime, S., Camussi, G., Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma (2010) Cancer Res., 70, pp. 2180-2190; Cittadino, E., Ferraretto, M., Torres, E., Maiocchi, A., Crielaard, B.J., Lammers, T., Storm, G., Terreno, E., MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate Eur. J. Pharm. Sci., 45 (2012), pp. 436-441; Kievit, F.M., Zhang, M., Surface engineering of iron oxide nanoparticles for targeted cancer therapy (2011) Acc. Chem. Res., 44, pp. 853-862; Kaaki, K., Hervé-Aubert, K., Chiper, M., Shkilnyy, A., Soucé, M., Benoit, R., Paillard, A., Chourpa, I., Magnetic nanocarriers of doxorubicin coatedwith poly(ethylene glycol) and folic acid: Relation between coating structure, surface properties, colloidal stability, and cancer cell targeting (2012) Langmuir, 28, pp. 1496-1505; McCarthy, J.R., Korngold, E., Weissleder, R., Jaffer, F.A., A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis (2010) Small, 6, pp. 2041-2049; Delli Castelli, D., Gianolio, E., Geninatti Crich, S., Terreno, E., Aime, S., Metal containing nanosized systems for MR-molecular imaging applications (2008) Coord. Chem. Rev., 252, pp. 2424-2443; Terreno, E., Sanino, A., Carrera, C., Delli Castelli, D., Giovenzana, G.B., Lombardi, A., Mazzon, R., Aime, S., Determination of water permeability of paramagnetic liposomes of interest in MRI field (2008) J. Inorg. Biochem., 102, pp. 1112-1119; Viglianti, B.L., Abraham, S.A., Michelich, C.R., Yarmolenko, P.S., MacFall, J.R., Bally, M.B., Dewhirst, M.W., In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery (2004) Magn. Reson. Med., 51, pp. 1153-1162; Negussiey, A.H., Yarmolenko, P.S., Partanen, A., Ranjan, A., Jacobs, G., Woods, D., Bryant, H., Dreher, M.R., Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound (2011) Int. J. Hypethermia, 27, pp. 140-155; De Smet, M., Heijman, E., Langereis, S., Hijnen, N.M., Grüll, H., Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: An in vivo proof-of-concept study (2011) J. Control. Release, 150, pp. 102-110; Langereis, S., Keupp, J., Van Velthoven, J.L.J., De Roos, I.H.C., Burdinski, D., Pikkemaat, J.A., Gruell, H., A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug delivery (2009) J. Am. Chem. Soc., 131, pp. 1380-1381; Delli Castelli, D., Dastrù, W., Terreno, E., Cittadino, E., Mainini, F., Torres, E., Spadaro, M., Aime, S., In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes (2010) J. Control. Release, 144, pp. 271-279; Mitra, R.N., Doshi, M., Zhang, X., Tyus, J.C., Bengtsson, N., Fletcher, S., Page, B.D.G., Santra, S., An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery Biomaterials, 33 (2012), pp. 1500-1508; Wang, C.-H., Kang, S.-T., Lee, Y.-H., Luo, Y.-L., Huang, Y.-F., Yeh, C.-K., Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis (2012) Biomaterials, 33, pp. 1939-1947; Lammers, T., Aime, S., Hennink, W.E., Storm, G., Kiessling, F., Theranostic nanomedicines (2011) Acc. Chem. Res., 44, pp. 1029-1038; Baum, R.P., Prasad, V., Muller, D., Schuchardt, C., Orlova, A., Wennborg, A., Tolmachev, V., Feldwisch, J., Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- Or 68Ga-labeled affibodymolecules (2010) J. Nucl. Med., 51, pp. 892-897; Modo, M., Hoehn, M., Bulte, J.W., Cellular MR imaging (2005) Mol. Imaging, 4, pp. 143-164; De Vries, J.M., Lesterhuis, W.J., Barentsz, J.O., Verdijk, P., Van Krieken, J.H., Boerman, O.C., Oyen, W.J.G., Figdor, C.G., Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy (2005) Nat. Biotechnol., 23, pp. 1407-1413; Liu, T.W., Akens, M.K., Chen, J., Wise-Milestone, L., Wilson, B.C., Zheng, G., Imaging of specific activation of photodynamic molecular beacons in breast cancer vertebral metastases (2011) Bioconjug. Chem., 22, pp. 1021-1030; Lim, Y.T., Cho, M.Y., Kim, J.K., Hwangbo, S., Chung, B.H., Plasmonic magnetic nano-structure for bimodal imaging and photonic-based therapy of cancer cells (2007) Chembiochem, 8, pp. 2204-2209; Gains, J.E., Bomanji, J.B., Fersht, N.L., Sullivan, T., D'Souza, D., Sullivan, K.P., Aldridge, M., Gaze, M.N., 177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma (2011) J. Nucl. Med., 52, pp. 1041-1047; Geninatti-Crich, S., Alberti, D., Szabo, I., Deagostino, A., Toppino, A., Barge, A., Ballarini, F., Aime, S., MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters (2011) Chemistry, 17, pp. 8479-8486; Sarantopoulos, A., Beziere, N., Ntziachristos, V., Optical and opto-acoustic interventional imaging (2012) Ann. Biomed. Eng., , http://dx.doi.org/10.1007/s10439-011-0501-4; Van Dam, G.M., Themelis, G., Crane, L.M., Harlaar, N.J., Pleijhuis, R.G., Kelder, W., Sarantopoulos, A., Ntziachristos, V., Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: First in-human results (2011) Nat. Med., 17, pp. 1315-1319&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>Basic principles</topic>
    </subject>
    <subject>
      <topic>Biodistributions</topic>
    </subject>
    <subject>
      <topic>Diagnosis</topic>
    </subject>
    <subject>
      <topic>doxorubicin</topic>
    </subject>
    <subject>
      <topic>drug accumulation</topic>
    </subject>
    <subject>
      <topic>Drug delivery</topic>
    </subject>
    <subject>
      <topic>Drug delivery and release</topic>
    </subject>
    <subject>
      <topic>drug delivery system</topic>
    </subject>
    <subject>
      <topic>drug distribution</topic>
    </subject>
    <subject>
      <topic>drug release</topic>
    </subject>
    <subject>
      <topic>End points</topic>
    </subject>
    <subject>
      <topic>Gadolinium</topic>
    </subject>
    <subject>
      <topic>gadoteridol</topic>
    </subject>
    <subject>
      <topic>human</topic>
    </subject>
    <subject>
      <topic>image guided radiotherapy</topic>
    </subject>
    <subject>
      <topic>Image guided therapy</topic>
    </subject>
    <subject>
      <topic>Image-guided therapies</topic>
    </subject>
    <subject>
      <topic>Imaging probe</topic>
    </subject>
    <subject>
      <topic>In vivo imaging</topic>
    </subject>
    <subject>
      <topic>Innovative product</topic>
    </subject>
    <subject>
      <topic>Interdisciplinary research</topic>
    </subject>
    <subject>
      <topic>In-vivo</topic>
    </subject>
    <subject>
      <topic>In-Vivo imaging</topic>
    </subject>
    <subject>
      <topic>Medical nanotechnology</topic>
    </subject>
    <subject>
      <topic>medical research</topic>
    </subject>
    <subject>
      <topic>Minimally invasive</topic>
    </subject>
    <subject>
      <topic>molecular imaging</topic>
    </subject>
    <subject>
      <topic>monitoring</topic>
    </subject>
    <subject>
      <topic>nanocarrier</topic>
    </subject>
    <subject>
      <topic>Nanocarriers</topic>
    </subject>
    <subject>
      <topic>Nanomedicine</topic>
    </subject>
    <subject>
      <topic>nonhuman</topic>
    </subject>
    <subject>
      <topic>Novel strategies</topic>
    </subject>
    <subject>
      <topic>Personalized medicines</topic>
    </subject>
    <subject>
      <topic>Potential applications</topic>
    </subject>
    <subject>
      <topic>priority journal</topic>
    </subject>
    <subject>
      <topic>Real time monitoring</topic>
    </subject>
    <subject>
      <topic>review</topic>
    </subject>
    <subject>
      <topic>surgical technique</topic>
    </subject>
    <subject>
      <topic>Target sites</topic>
    </subject>
    <subject>
      <topic>theranostic agent</topic>
    </subject>
    <subject>
      <topic>Theranostic agents</topic>
    </subject>
    <subject>
      <topic>Therapeutic strategy</topic>
    </subject>
    <subject>
      <topic>Therapy monitoring</topic>
    </subject>
    <subject>
      <topic>tracer</topic>
    </subject>
    <subject>
      <topic>Treatment Outcome</topic>
    </subject>
    <subject>
      <topic>unclassified drug</topic>
    </subject>
    <subject>
      <topic>Visualization</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>In vivo imaging of inhibitory, GABAergic neurons by MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aswendt</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pariani</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Himmelreich</namePart>
      <namePart type="given">U.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hoehn</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>62</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>1685</start>
          <end>1693</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">10538119 (ISSN)</identifier>
      <titleInfo>
        <title>NeuroImage</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>NeuroImage</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84863518382&amp;partnerID=40&amp;md5=01236e27af70e843689752bb34beaef4</url>
    </location>
    <abstract>The unambiguous detection of specific neuronal subtypes is up to now only possible with invasive techniques or optical imaging after genetic modification. High field magnetic resonance imaging (MRI) has the ability to visualize the brain structure and anatomy noninvasively, with high resolution - but missing the cell specific and functional information. Here we present a new tool for neuroimaging with MRI, enabling the selective detection of GABAergic neurons under in vivo conditions. The specific imaging contrast is achieved by a novel paramagnetic contrast agent, which responds to the activity of the enzyme glutamic acid decarboxylase - expressed solely by inhibitory neurons. The relaxivity of the complex is increased upon decarboxylation of two glutamic acid moieties, thus allowing increased water access to the inner and outer coordination spheres of the paramagnetic ion. The mechanism and specificity of activation were proven with tissue lysates and further applied to a differentiation protocol for murine embryonic stem cells. The relaxation enhancement was studied quantitatively and revealed decreased longitudinal relaxation times in the inhibitory neuron samples compared to the naïve stem cells in vitro and in vivo. Furthermore, this approach offers not only the discrimination of inhibitory, GABAergic neurons in the brain but also may expand the usefulness of MRI for functional imaging on a cellular level. © 2012 Elsevier Inc.</abstract>
    <note type="content">AD  - Biomedical Nuclear Magnetic Resonance Unit, Katolieke Universiteit Leuven, Leuven, Belgium</note>
    <note type="content">AD  - Department of Chemistry IFM and Molecular Imaging Center, University of Torino, Torino, Italy</note>
    <note type="content">AD  - In-vivo-NMR Laboratory, Max Planck Institute for Neurological Research, Cologne, Germany</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: glutamate decarboxylase, 9024-58-2&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: NEIME&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Hoehn, M.; In-vivo-NMR Laboratory, Max Planck Institute for Neurological Research, Gleuelerstrasse 50, D-50931 Köln, Germany; email: mathias@nf.mpg.de&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1016/j.neuroimage.2012.05.029&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Arena, F., Singh, J.B., Gianolio, E., Stefanãa, R., Aime, S., Beta-Gal gene expression MRI reporter in melanoma tumor cells. Design, synthesis, and in vitro and in vivo testing of a Gd(III) Containing probe forming a high relaxivity, melanin-like structure upon β-gal enzymatic activation (2011) Bioconjug. Chem.; Arvidsson, S., Kwasniewski, M., Riano-Pachon, D.M., Mueller-Roeber, B., QuantPrime - a flexible tool for reliable high-throughput primer design for quantitative PCR (2008) BMC Bioinformatics, 9 (1), p. 465; Benes, F.M., Lim, B., Matzilevich, D., Walsh, J.P., Subburaju, S., Minns, M., Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars (2007) Proc. Natl. Acad. Sci. U. S. A., 104, pp. 10164-10169; Brambilla, P., Perez, J., Barale, F., Schettini, G., Soares, J.C., GABAergic dysfunction in mood disorders (2003) Mol. Psychiatry, 8 (721-737), p. 715; Chen, C., Okayama, H., High-efficiency transformation of mammalian cells by plasmid DNA (1987) Mol. Cell. Biol., 7, pp. 2745-2752; de Duve, C., de Barsy, T., Poole, B., Trouet, A., Tulkens, P., Van Hoof, F., Commentary. Lysosomotropic agents (1974) Biochem. Pharmacol., 23, pp. 2495-2531; Deng, Y.P., Albin, R.L., Penney, J.B., Young, A.B., Anderson, K.D., Reiner, A., Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study (2004) J. Chem. Neuroanat., 27, pp. 143-164; Di Cristo, G., Development of cortical GABAergic circuits and its implications for neurodevelopmental disorders (2007) Clin. Genet., 72, pp. 1-8; Graham, F.L., van der Eb, A.J., A new technique for the assay of infectivity of human adenovirus 5 DNA (1973) Virology, 52, pp. 456-467; Guenoun, J., Koning, G.A., Doeswijk, G., Bosman, L., Wielopolski, P.A., Krestin, G.P., Bernsen, M.R., Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI (2011) Cell Transplant, 21 (1), pp. 191-205; Himmelreich, U., Dresselaers, T., Cell labeling and tracking for experimental models using magnetic resonance imaging (2009) Methods, 48 (2), pp. 112-124; Himmelreich, U., Aime, S., Hieronymus, T., Justicia, C., Uggeri, F., Zenke, M., Hoehn, M., A responsive MRI contrast agent to monitor functional cell status (2006) Neuroimage, 32, pp. 1142-1149; Hoehn, M., Himmelreich, U., In vivo molecular MR imaging - potentials and limits (2006) Annual Reports in NMR Spectroscopy - Handbook of Modern Magnetic Resonance, Section Medical Science, pp. 133-148. , Kluwer Academic Publisher, London, G.A. Webb (Ed.); Hoehn, M., Himmelreich, U., Kruttwig, K., Wiedermann, D., Molecular and cellular MR imaging: potentials and challenges for neurological applications (2008) J. Magn. Reson. Imaging, 27, pp. 941-954; Kruttwig, K., Molecular labelling strategies for cellular optical and magnetic resonance tomographic visualisation. (2009) Aachen, Techn. Hochsch., Diss.; Kustermann, E., Himmelreich, U., Kandal, K., Geelen, T., Ketkar, A., Wiedermann, D., Strecker, C., Hoehn, M., Efficient stem cell labeling for MRI studies (2008) Contrast Media Mol. Imaging, 3, pp. 27-37; Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature, 227, pp. 680-685; Lee, S.H., Lumelsky, N., Studer, L., Auerbach, J.M., McKay, R.D., Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells (2000) Nat. Biotechnol., 18, pp. 675-679; Louie, A.Y., Huber, M.M., Ahrens, E.T., Rothbacher, U., Moats, R., Jacobs, R.E., Fraser, S.E., Meade, T.J., In vivo visualization of gene expression using magnetic resonance imaging (2000) Nat. Biotechnol., 18, pp. 321-325; Malizia, A.L., Cunningham, V.J., Bell, C.J., Liddle, P.F., Jones, T., Nutt, D.J., Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study (1998) Arch. Gen. Psychiatry, 55, pp. 715-720; Moats, R.A., Fraser, S.E., Meade, T.J., Ein "intelligentes" Reagens für die NMR-Bildgebung zur Bestimmung spezifischer enzymatischer Aktivität (1997) Angew. Chem. Int. Ed. Engl., 36, p. 726; Modo, M., Hoehn, M., Bulte, J.W., Cellular MR imaging (2005) Mol. Imaging, 4, pp. 143-164; Mueller, P.B., Langemann, H., Distribution of glutamic acid decarboxylase activity in human brain (1962) J. Neurochem., 9, pp. 399-401; Napolitano, R., Pariani, G., Fedeli, F., Aswendt, M., Aime, S., Gianolio, E., in press. Synthesis and Relaxometric Characterization of a MRI Gd-based probe responsive to GAD enzymatic activity. Bioconjugate ChemNeumann, E., Schaefer-Ridder, M., Wang, Y., Hofschneider, P.H., Gene transfer into mouse lyoma cells by electroporation in high electric fields (1982) EMBO J., 1, pp. 841-845; Okabe, S., Forsberg-Nilsson, K., Spiro, A.C., Segal, M., McKay, R.D., Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro (1996) Mech. Dev., 59, pp. 89-102; Paul, S.M., Psychopharmacology: the fourth generation of progress (1995) Drug Development Research, 35, pp. 185-188. , F.E. Bloom, D.J. Kupfer (Eds.); Pfaffl, M.W., Horgan, G.W., Dempfle, L., Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR (2002) Nucleic Acids Res., 30, pp. e36; Reiner, A., Albin, R.L., Anderson, K.D., D'Amato, C.J., Penney, J.B., Young, A.B., Differential loss of striatal projection neurons in Huntington disease (1988) Proc. Natl. Acad. Sci. U. S. A., 85, pp. 5733-5737; Roberts, E., Simonsen, D.G., Some properties of l-glutamic decarboxylase in mouse brain (1963) Biochem. Pharmacol., 12, pp. 113-134; Rudelius, M., Daldrup-Link, H.E., Heinzmann, U., Piontek, G., Settles, M., Link, T.M., Schlegel, J., Highly efficient paramagnetic labelling of embryonic and neuronal stem cells (2003) Eur. J. Nucl. Med. Mol. Imaging, 30, pp. 1038-1044; Saji, M., Cohen, M., Blau, A.D., Wessel, T.C., Volpe, B.T., Transient forebrain ischemia induces delayed injury in the substantia nigra reticulata: degeneration of GABA neurons, compensatory expression of GAD mRNA (1994) Brain Res., 643, pp. 234-244; Schwartz-Bloom, R.D., Sah, R., Gamma-aminobutyric acid(A) neurotransmission and cerebral ischemia (2001) J. Neurochem., 77, pp. 353-371; Shen, J., Cheng, L.N., Zhong, X.M., Duan, X.H., Guo, R.M., Hong, G.B., Efficient in vitro labeling rabbit neural stem cell with paramagnetic Gd-DTPA and fluorescent substance (2009) Eur. J. Radiol., 75, pp. 397-405; Shin, E., Palmer, M.J., Li, M., Fricker, R.A., GABAergic neurons from mouse embryonic stem cells possess functional properties of striatal neurons in vitro, and develop into striatal neurons in vivo in a mouse model of Huntington's disease (2011) Stem Cell Rev., 767 (4). , Pages: 333-341; Siemen, H., Nix, M., Endl, E., Koch, P., Itskovitz-Eldor, J., Brustle, O., Nucleofection of human embryonic stem cells (2005) Stem Cells Dev., 14, pp. 378-383; Strijkers, G.J., Hak, S., Kok, M.B., Springer, C.S., Nicolay, K., Three-compartment T(1) relaxation model for intracellular paramagnetic contrast agents (2009) Magn. Reson. Med., 61, pp. 1049-1058; Terreno, E., Geninatti Crich, S., Belfiore, S., Biancone, L., Cabella, C., Esposito, G., Manazza, A.D., Aime, S., Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons (2006) Magn. Reson. Med., 55, pp. 491-497; Walczak, P., Ruiz-Cabello, J., Kedziorek, D.A., Gilad, A.A., Lin, S., Barnett, B., Qin, L., Bulte, J.W., Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent (2006) Nanomedicine, 2, pp. 89-94; Willems, E., Mateizel, I., Kemp, C., Cauffman, G., Sermon, K., Leyns, L., Selection of reference genes in mouse embryos and in differentiating human and mouse ES cells (2006) Int. J. Dev. Biol., 50, pp. 627-635; Yoo, B., Pagel, M.D., An overview of responsive MRI contrast agents for molecular imaging (2008) Front. Biosci., 13, pp. 1733-1752&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>1 [5 [[n,n' bis (3,10,17 triaza 4,11,18 trioxo 21 carboxy 21 aminoeinecosane)] n methylaminocarbonyl]pentyl] 1,4,7,10 tetraazacyclododecane 4,7,10 triacetate (3) gadolinate</topic>
    </subject>
    <subject>
      <topic>animal cell</topic>
    </subject>
    <subject>
      <topic>animal experiment</topic>
    </subject>
    <subject>
      <topic>animal tissue</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>cell lysate</topic>
    </subject>
    <subject>
      <topic>Contrast Enhancement</topic>
    </subject>
    <subject>
      <topic>contrast medium</topic>
    </subject>
    <subject>
      <topic>controlled study</topic>
    </subject>
    <subject>
      <topic>decarboxylation</topic>
    </subject>
    <subject>
      <topic>embryo</topic>
    </subject>
    <subject>
      <topic>embryonic stem cell</topic>
    </subject>
    <subject>
      <topic>enzyme activity</topic>
    </subject>
    <subject>
      <topic>functional magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>GABAergic system</topic>
    </subject>
    <subject>
      <topic>glutamate decarboxylase</topic>
    </subject>
    <subject>
      <topic>Glutamic acid decarboxylase</topic>
    </subject>
    <subject>
      <topic>glutamic acid derivative</topic>
    </subject>
    <subject>
      <topic>in vitro study</topic>
    </subject>
    <subject>
      <topic>In vivo MRI of GABAergic neurons</topic>
    </subject>
    <subject>
      <topic>in vivo study</topic>
    </subject>
    <subject>
      <topic>mouse</topic>
    </subject>
    <subject>
      <topic>nerve cell</topic>
    </subject>
    <subject>
      <topic>nerve cell differentiation</topic>
    </subject>
    <subject>
      <topic>nerve cell stimulation</topic>
    </subject>
    <subject>
      <topic>nervous tissue</topic>
    </subject>
    <subject>
      <topic>nonhuman</topic>
    </subject>
    <subject>
      <topic>priority journal</topic>
    </subject>
    <subject>
      <topic>protein expression</topic>
    </subject>
    <subject>
      <topic>quantitative analysis</topic>
    </subject>
    <subject>
      <topic>rat</topic>
    </subject>
    <subject>
      <topic>Responsive MRI contrast agent</topic>
    </subject>
    <subject>
      <topic>Stem cell differentiation protocol for GABAergic neurons</topic>
    </subject>
    <subject>
      <topic>unclassified drug</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>In vivo MRI visualization of different cell populations labeled with PARACEST agents</title>
    </titleInfo>
    <typeOfResource manuscript="yes">text</typeOfResource>
    <genre authority="local">manuscript</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Ferrauto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <originInfo>
      <dateCreated>2012</dateCreated>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84864215099&amp;partnerID=40&amp;md5=8324c943c5f7ccd749e3ebccf8bb44d1</url>
    </location>
    <abstract>Conventional T1- or T2-MRI contrast agents do not allow to track the distribution of different cell populations simultaneously because the effects of relaxation enhancers are additive. Herein, it is shown that paramagnetic chemical exchange saturation transfer agents offer the opportunity to visualize different cell populations in vitro and in vivo by 1H-MRI. Yb- and Eu-HPDO3A complexes have been used to label murine macrophages (J774.A1) and melanoma cells (B16-F10), respectively. By selective irradiation of the highly-shifted OH resonances of the two chemical exchange saturation transfer agents, it has been shown that tracking of the two cell types is possible. These PARAmagnetic Chemical Exchange Saturation Transfer agents have a tremendous potential for clinical translation as they share the same stability and in vivo pharmacokinetic properties of Gd-HPDO3A (ProHance ®), which is a widely used clinically approved MRI agent. © 2012 Wiley Periodicals, Inc.</abstract>
    <note type="content">AD  - Molecular Imaging Center, Department of Chemistry, University of Turin, Italy</note>
    <note type="content">&lt;p&gt;Article in Press&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: MRMEE&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Aime, S.; Silvio Aime, Molecular Imaging Center, Department of Chemistry, University of Turin, Via Nizza no 52email: silvio.aime@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1002/mrm.24411&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">JA  - Magn. Reson. Med.</note>
    <note type="content">JF  - Magnetic Resonance in Medicine</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">SN  - 07403194 (ISSN)</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>cell labeling</topic>
    </subject>
    <subject>
      <topic>cell tracking</topic>
    </subject>
    <subject>
      <topic>lanthanides</topic>
    </subject>
    <subject>
      <topic>MRI</topic>
    </subject>
    <subject>
      <topic>PARACEST agents</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Mn loaded apoferritin as an MRI sensor of melanin formation in melanoma cells</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Szabó</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Alberti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kálmán</namePart>
      <namePart type="given">F.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>48</number>
        </detail>
        <detail type="issue">
          <number>18</number>
        </detail>
        <extent unit="pages">
          <start>2436</start>
          <end>2438</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84857071101&amp;partnerID=40&amp;md5=66f6a06337fd2db143179a68093a305c</url>
    </location>
    <abstract>Mn(iii)-loaded apoferritin is promptly reduced to Mn(ii)-apoferritin by the oxidation of l-DOPA to melanin. The process is nicely witnessed by a marked relaxation enhancement of water proton relaxation rate that has been detected both in cultured melanoma cells and in tumor animal models. This journal is © The Royal Society of Chemistry 2012.</abstract>
    <note type="content">AD  - Center for Molecular Imaging, Department of Chemistry IFM, University of Torino, via Nizza 52, Torino, Italy</note>
    <note type="content">AD  - Department of Inorganic and Analytical Chemistry, University of Debrecen, Debrecen, Hungary</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: apoferritin, 9013-31-4; levodopa, 59-92-7; manganese, 16397-91-4, 7439-96-5; melanin, 8049-97-6; Apoferritins, 9013-31-4; Manganese, 7439-96-5; Melanins&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Cited By (since 1996): 1&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: CHCOF&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Aime, S.; Center for Molecular Imaging, Department of Chemistry IFM, University of Torino, via Nizza 52, Torino, Italy; email: silvio.aime@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1039/c2cc17801j&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;PubMed ID: 22273600&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Pan, D., Carauthers, S.D., Chen, J., Winter, P.M., Senpan, A., Schmieder, A.H., Wickline, S.A., Lanza, G.M., (2010) Future Med. Chem., 2, p. 471; Terreno, E., Dastrù, W., Delli Castelli, D., Gianolio, E., Geninatti Crich, S., Longo, D., Aime, S., (2010) Curr. Med. Chem., 17, p. 3684; Caravan, P., (2006) Chem. Soc. Rev., 35, p. 512; Aime, S., Cabella, C., Colombatto, S., Geninatti-Crich, S., Gianolio, E., Maggioni, F., (2002) J. Magn. Reson. Imaging, 16, p. 394; Mulder, W.J., Strijkers, G.J., Van Tilborg, G.A., Griffioen, A.W., Nicolay, K., (2006) NMR Biomed., 19, p. 142; Geninatti Crich, S., Bussolati, B., Tei, L., Grange, C., Esposito, G., Lanzardo, S., Camussi, G., Aime, S., (2006) Cancer Res., 66, p. 9196; Vasalatiy, O., Zhao, P., Zhang, S., Aime, S., Sherry, A.D., (2006) Contrast Media Mol. Imaging, 1, pp. 10-14; Sánchez, P., Valero, E., Gálvez, N., Domínguez-Vera, J.M., Marinone, M., Poletti, G., Corti, M., Lascialfari, A., (2009) Dalton Trans., p. 800; Fries, P.H., Belorizky, E., (2010) J. Chem. Phys., 133, p. 800; Makino, A., Harada, H., Okada, T., Kimura, H., Amano, H., Saji, H., Hiraoka, M., Kimura, S., (2011) Nanomedicine, 7, p. 638; Aime, S., Frullano, L., Geninatti-Crich, S., (2002) Angew. Chem., 41, p. 1017; Kálmán, F.K., Geninatti-Crich, S., Aime, S., (2010) Angew. Chem., 49, p. 612; Riley, P.A., (1988) Ann. N. Y. Acad. Sci., 551, p. 111; Sarangarajan, R., Apte, S.P., (2006) Melanoma Res., 16, p. 3; Riley, P.A., (2003) Pigment Cell Res., 16, p. 548; Pinon, A., Limami, Y., Micallef, L., Cook-Moreau, J., Liagre, B., Delage, C., Duval, R.E., Simon, A., (2011) Exp. Cell Res., 317, p. 1669; Bennett, D.C., (1989) Environ. Health Perspect., 80, p. 49; Laskin, D., Mufson, R.A., Weinstein, I.B., Engelhardt, D.L., (1980) J. Cell Physiol., 103, p. 467; Dan-Ning, H., (2008) Photochem. Photobiol., 84, p. 645&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>animal cell</topic>
    </subject>
    <subject>
      <topic>Animals</topic>
    </subject>
    <subject>
      <topic>Apoferritin</topic>
    </subject>
    <subject>
      <topic>Apoferritins</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>cancer cell culture</topic>
    </subject>
    <subject>
      <topic>Cell Line, Tumor</topic>
    </subject>
    <subject>
      <topic>levodopa</topic>
    </subject>
    <subject>
      <topic>Magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>Manganese</topic>
    </subject>
    <subject>
      <topic>Melanin</topic>
    </subject>
    <subject>
      <topic>Melanins</topic>
    </subject>
    <subject>
      <topic>melanocyte</topic>
    </subject>
    <subject>
      <topic>melanogenesis</topic>
    </subject>
    <subject>
      <topic>melanoma cell</topic>
    </subject>
    <subject>
      <topic>Melanoma, Experimental</topic>
    </subject>
    <subject>
      <topic>Mice</topic>
    </subject>
    <subject>
      <topic>mouse</topic>
    </subject>
    <subject>
      <topic>nonhuman</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>oxidation</topic>
    </subject>
    <subject>
      <topic>pH</topic>
    </subject>
    <subject>
      <topic>phenotype</topic>
    </subject>
    <subject>
      <topic>proton transport</topic>
    </subject>
    <subject>
      <topic>sensor</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Mn-loaded apoferritin: A highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cutrin</namePart>
      <namePart type="given">J.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzardo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Conti</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kálmán</namePart>
      <namePart type="given">F.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Szabó</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lago</namePart>
      <namePart type="given">N.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Iolascon</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>281</start>
          <end>288</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84860358385&amp;partnerID=40&amp;md5=1286e51c4fe1214c2d84255dc351b7f4</url>
    </location>
    <abstract>Mn-Apo is a highly sensitive MRI contrast agent consisting of ca. 1000 manganese atoms entrapped in the inner cavity of apoferritin. Part of the metallic payload is in the form of Mn2+ ions that endow the nano-sized system with a very high relaxivity that can be exploited to detect hepatocellular carcinoma in mice. Cellular studies showed that Mn-Apo is readily taken up by normal hepatocytes via the ferritin transporting route. Conversely, hepatoma cells (HTC) displayed a markedly reduced ability to entrap Mn-Apo from the culture medium. The i.v. administration of Mn-Apo into C57BL/6J mice resulted in a marked liver tissue hyperintensity in T1-weighted MR image20min after injection. When injected into HBV-tg transgenic mice that spontaneously develop hepatocellular carcinoma (HCC), Mn-Apo allowed a clear delineation of healthy liver tissue and tumor lesions as hyperintense and hypointense T1-weighted MR images, respectively. Immunohistochemistry analysis correlated Mn-Apo cellular uptake to SCARA5 receptor expression. When the MRI contrast induced by Mn-Apo was compared with that induced by Gd-BOPTA (a commercial contrast agent known to enter mouse hepatocytes through organic anion transporters) it was found that only some of the lesions were detected by both agents while others could only be visualized by one of the two. These results suggest that Mn-Apo may be useful to detect otherwise invisible lesions and that the extent of its uptake directly reports the expression/regulation of SCARA5 receptors. Mn-Apo contrast-enhanced MR images may therefore contribute to improving HCC lesion detection and characterization. © 2012 John Wiley &amp; Sons, Ltd.</abstract>
    <note type="content">AD  - CEINGE Biotecnologie Avanzate, University of Naples, Naples, Italy</note>
    <note type="content">AD  - Center for Molecular Imaging, Department of Chemistry IFM, University of Turin, Turin, Italy</note>
    <note type="content">AD  - Center of Experimental Pathology, School of Medicine, University of Buenos Aires, Buenos Aires, Argentina</note>
    <note type="content">AD  - Department of Clinical and Biological Sciences, University of Turin, Turin, Italy</note>
    <note type="content">AD  - Department of Inorganic and Analytical Chemistry, University of Debrecen, Debrecen, Hungary</note>
    <note type="content">AD  - ININCA, CONICET, National Council of Scientific and Technical Reserch of Argentina, Buenos Aires, Argentina</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: apoferritin, 9013-31-4; gadobenate dimeglumine, 127000-20-8; gadobenic acid, 113662-23-0; manganese, 16397-91-4, 7439-96-5&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Aime, S.; Center for Molecular Imaging, Department of Chemistry IFM, University of Turin, Turin, Italy; email: silvio.aime@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1002/cmmi.492&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Manufacturers: Bracco, Italy&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Sanyal, A.J., Yoon, S.K., Lencioni, R., The etiology of hepatocellular carcinoma and consequences for treatment (2010) Oncologist, 15, pp. 14-22; Lencioni, R., Chen, X.P., Dagher, L., Venook, A.P., Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? (2010) Oncologist, 15 (SUPPL. 4), pp. 42-52; Digumarthy, S.R., Sahani, D.V., Saini, S., MRI in detection of hepatocellular carcinoma (HCC) (2005) Cancer Imag, 5, pp. 20-24; Shimofusa, R., Ueda, T., Kishimoto, T., Nakajima, M., Yoshikawa, M., Kondo, F., Ito, H., Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging (2010) J Hepatobil Pancreat Sci, 17, pp. 583-589; Edelman, R.R., Siegel, J.B., Singer, A., Dupuis, K., Longmaid, H.E., Dynamic MR imaging of the liver with Gd-DTPA: initial clinical results (1989) Am J Roentgenol, 153, pp. 1213-1219; Seale, M.K., Catalano, O.A., Saini, S., Hahn, P.F., SahanI, D.V., Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree (2009) Radiographics, 29, pp. 1725-1748; Ito, K., Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging (2006) Eur J Radiol, 58, pp. 186-199; Leonhardt, M., Keiser, M., Oswald, S., Kühn, J., Jia, J., Grube, M., Kroemer, H.K., Weitschies, W., Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters (2010) Drug Metab Dispos, 38, pp. 1024-1028; Pascolo, L., Cupelli, F., Anelli, P.L., Lorusso, V., Visigalli, M., Uggeri, F., Tiribelli, C., Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents (1999) Biochem Biophys Res Commun, 257, pp. 746-752; Narita, M., Hatano, E., Arizono, S., Miyagawa-Hayashino, A., Isoda, H., Kitamura, K., Taura, K., Uemoto, S., Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma (2009) J Gastroenterol, 44, pp. 793-798; Wang, J., Pantopoulos, K., Regulation of cellular iron metabolism (2011) Biochem J, 434, pp. 365-381; Arosio, P., Ingrassia, R., Cavadini, P., Ferritins: a family of molecules for iron storage, antioxidation and more (2009) Biochim Biophys Acta, 1790, pp. 589-599; Li, J.Y., Paragas, N., Ned, R.M., Qiu, A., Viltard, M., Leete, T., Drexler, I.R., Barasch, J., Scara5 is a ferritin receptor mediating non-transferrin iron delivery (2009) Dev Cell, 16, pp. 35-46; Troadec, M.B., Ward, D.M., Kaplan, J., A Tf-independent iron transport system required for organogenesis (2009) Dev Cell, 16, pp. 3-4; Huang, J., Zheng, D.L., Qin, F.S., Cheng, N., Chen, H., Wan, B.B., Wang, Y.P., Han, Z.G., Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling (2010) J Clin Invest, 120, pp. 223-241; Kálmán, F.K., Geninatti-Crich, S., Aime, S., Reduction/dissolution of a beta-MnOOH nanophase in the ferritin cavity to yield a highly sensitive, biologically compatible magnetic resonance imaging agent (2010) Angew Chem Int Edn Engl, 49, pp. 612-615; Chisari, F.V., Pinkert, C.A., Milich, D.R., Filippi, P., McLachlan, A., Palmiter, R.D., Brinster, R.L., A transgenic mouse model of the chronic hepatitis B surface antigen carrier state (1985) Science, 230, pp. 1157-1160; Barone, M., Spano, D., D'Apolito, M., Centra, M., Lasalandra, C., Capasso, M., Di Leo, A., Iolascon, A., Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis (2006) Mol Med, 12, pp. 115-123; Dunsford, H.A., Sell, S., Chisari, F.V., Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice (1990) Cancer Res, 50, pp. 3400-3407; Pastor, C.M., Planchamp, C., Pochon, S., Lorusso, V., Montet, X., Mayer, J., Terrier, F., Vallee, J.P., Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation (2003) Radiology, 229, pp. 119-125; Ayyappan, A.P., Jhaveri, K.S., CT and MRI of hepatocellular carcinoma: an update (2010) Expert Rev Anticancer Ther, 10, pp. 507-519; Roskams, T., Kojiro, M., Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis (2010) Semin Liver Dis, 30 (1), pp. 17-25; Aime, S., Aime, S., Delli Castelli, D., Geninatti Crich, S., Gianolio, E., Terreno, E., Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications (2009) Acc Chem Res, 42, pp. 822-831; Caravan, P., Strategies for increasing the sensitivity of gadolinium based MRI contrast agents (2006) Chem Soc Rev, 35, pp. 512-523; Geninatti Crich, S., Bussolati, B., Tei, L., Grange, C., Esposito, G., Lanzardo, S., Camussi, G., Aime, S., Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe (2006) Cancer Res, 66, pp. 9196-9201; Fries, P.H., Belorizky, E., Enhancement of the water proton relaxivity by trapping Gd3+ complexes in nanovesicles (2010) J Chem Phys, 133, p. 024504; Sánchez, P., Valero, E., Gálvez, N., Domínguez-Vera, J.M., Marinone, M., Poletti, G., Corti, M., Lascialfari, A., MRI relaxation properties of water-soluble apoferritin-encapsulated gadolinium oxide-hydroxide nanoparticles (2009) Dalton Trans, 5, pp. 800-804; Kim, J.H., Kim, M.J., Park, Y.N., Lee, J.T., Kim, B.R., Chung, J.B., Choi, J.S., Kim, K.W., Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics (2008) Clin Radiol, 63, pp. 1195-1204; Planchamp, C., Montet, X., Frossard, J.L., Quadri, R., Stieger, B., Meier, P.J., Ivancevic, M.K., Pastor, C.M., Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers (2005) Invest Radiol, 40, pp. 187-194; Di Tommaso, L., Destro, A., Seok, J.Y., Balladore, E., Terracciano, L., Sangiovanni, A., Iavarone, M., Roncalli, M., The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma (2009) J Hepatol, 50, pp. 746-754; Bradford, M.M.A., rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal Biochem, 72, pp. 248-254; Gardini, G., Cabella, C., Cravanzola, C., Vargiu, C., Belliardo, S., Testore, G., Solinas, S.P., Colombatto, S., Agmatine induces apoptosis in rat hepatocyte cultures (2001) J Hepatol, 35, pp. 482-489&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Tradenames: multihance, Bracco, Italy&lt;/p&gt;</note>
    <subject>
      <topic>animal experiment</topic>
    </subject>
    <subject>
      <topic>animal model</topic>
    </subject>
    <subject>
      <topic>animal tissue</topic>
    </subject>
    <subject>
      <topic>Apoferritin</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>cancer diagnosis</topic>
    </subject>
    <subject>
      <topic>Contrast Enhancement</topic>
    </subject>
    <subject>
      <topic>controlled study</topic>
    </subject>
    <subject>
      <topic>correlation analysis</topic>
    </subject>
    <subject>
      <topic>ferritin</topic>
    </subject>
    <subject>
      <topic>gadobenate dimeglumine</topic>
    </subject>
    <subject>
      <topic>gadobenic acid</topic>
    </subject>
    <subject>
      <topic>hepatocellular carcinoma</topic>
    </subject>
    <subject>
      <topic>human</topic>
    </subject>
    <subject>
      <topic>human cell</topic>
    </subject>
    <subject>
      <topic>Immunohistochemistry</topic>
    </subject>
    <subject>
      <topic>liver cell carcinoma</topic>
    </subject>
    <subject>
      <topic>male</topic>
    </subject>
    <subject>
      <topic>Manganese</topic>
    </subject>
    <subject>
      <topic>manganese apoferritin complex</topic>
    </subject>
    <subject>
      <topic>molecular imaging</topic>
    </subject>
    <subject>
      <topic>mouse</topic>
    </subject>
    <subject>
      <topic>MRI</topic>
    </subject>
    <subject>
      <topic>nonhuman</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance imaging agent</topic>
    </subject>
    <subject>
      <topic>priority journal</topic>
    </subject>
    <subject>
      <topic>protein expression</topic>
    </subject>
    <subject>
      <topic>receptor protein</topic>
    </subject>
    <subject>
      <topic>scara5 receptor</topic>
    </subject>
    <subject>
      <topic>transgenic mouse</topic>
    </subject>
    <subject>
      <topic>unclassified drug</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Cittadino</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ferraretto</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Torres</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maiocchi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crielaard</namePart>
      <namePart type="given">B.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lammers</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Storm</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>45</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>436</start>
          <end>441</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">09280987 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Pharmaceutical Sciences</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Pharm. Sci.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84856273620&amp;partnerID=40&amp;md5=e1f4ba8ab7c2364e9dad26b17ebf4ea4</url>
    </location>
    <abstract>The design of long circulating liposomes co-loaded with the glucocorticoid prednisolone phosphate (PLP) and the amphiphilic paramagnetic contrast agent Gd-DOTAMA(C                         18)                         2 allowed the MRI-guided in vivo visualization of the delivery and biodistribution of PLP, as well as the monitoring of drug efficacy. The performance of this theranostic probe was investigated in a mouse model bearing a melanoma B16 syngeneic tumor. The release kinetics of the drug were evaluated in vitro where it displayed a peculiar behavior characterized by a fast process (completed in few hours) involving only a small portion (&amp;lt;5%) of the drug. Interestingly, the incorporation of the amphiphilic imaging reporter in the liposomal bilayer slightly increased the amount of the fast-release portion (&amp;lt;10%), thus suggesting that it could be attributed to a drug fraction embedded in the liposomal bilayer. In fact, the release of a hydrophilic imaging probe encapsulated in the inner core of the same long circulating liposomes formulated for carrying the drug, displayed different, single-step, kinetics. The in vivo monitoring of the antitumor activity of the nanomedicine revealed that the incorporation of the MRI probe into the liposome bilayer did not significantly affect the drug efficacy. The in vivo experiments also indicated a relevant and fast liposome uptake from macrophage-rich organs like spleen and liver, which reduced the tumor accumulation of the liposomes. The accumulation of the amphipatic MRI label caused the occurrence of a long-term residual T                         1 contrast still detectable 1 week after injection. © 2011 Elsevier B.V. All rights reserved.</abstract>
    <note type="content">AD  - Bracco Imaging S.p.A., Bioindustry Park Canavese, Via Ribes 5, Colleretto Giacosa (TO), Italy</note>
    <note type="content">AD  - Department of Chemistry, IFM and Molecular and Preclinical Imaging Centres, University of Torino, Via Nizza 52, I-10126, Torino, Italy</note>
    <note type="content">AD  - Department of Experimental Molecular Imaging, RWTH, Aachen University, Aachen, Germany</note>
    <note type="content">AD  - Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, Netherlands</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: gadolinium, 7440-54-2; gadoteridol, 112188-16-6, 120066-54-8; prednisolone 21 phosphate, 302-25-0; Antineoplastic Agents; Contrast Media; Gadolinium, 7440-54-2; Glucocorticoids; Liposomes; Prednisolone, 50-24-8; prednisolone phosphate, 302-25-0&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Cited By (since 1996): 3&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: EPSCE&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Terreno, E.; Department of Chemistry, IFM and Molecular and Preclinical Imaging Centres, University of Torino, Via Nizza 52, I-10126, Torino, Italy; email: enzo.terreno@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1016/j.ejps.2011.08.022&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;PubMed ID: 21896328&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Anelli, P.L., Lattuada, L., Lorusso, V., Schneider, M., Tournier, H., Uggeri, F., Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents (2001) Magnetic Resonance Materials in Physics, Biology and Medicine, 12 (2-3), pp. 114-120. , DOI 10.1016/S1352-8661(01)00107-7, PII S1352866101001077; Banciu, M., Schiffelers, R.M., Fens, M.H.A.M., Metselaar, J.M., Storm, G., Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice (2006) Journal of Controlled Release, 113 (1), pp. 1-8. , DOI 10.1016/j.jconrel.2006.03.019, PII S0168365906001647; Banciu, M., Schiffelers, R.M., Metselaar, J.M., Janssen, A.P.C.A., Storm, G., Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice (2008) J. Steroid Biochem. Mol. Biol., 111, pp. 101-110; Banciu, M., Fens, M.H.A.M., Storm, G., Schiffelers, R.M., Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice (2008) J. Control. Release, 127, pp. 131-136; Banciu, M., Metselaar, J.M., Schiffelers, R.M., Storm, G., Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue (2008) Neoplasia, 10 (2), pp. 108-117. , http://www.neoplasia.com/pdf/manuscript/neo07913.pdf, DOI 10.1593/neo.07913; Coleman, R.E., Glucorticoids in cancer therapy (1992) Biotherapy, 4, pp. 37-44; Corsi, D.M., Platas-Iglesias, C., Van Bekkum, H., Peters, J.A., Determination of paramagnetic lanthanide(III) concentrations from bulk magnetic susceptibility shifts in NMR spectra (2001) Magn. Res. Chem., 39, pp. 723-726; Delli Castelli, D., Gianolio, E., Geninatti Crich, S., Terreno, E., Aime, S., Metal containing nanosized systems for MR-Molecular Imaging applications (2008) Coord. Chem. Rev., 252, pp. 2424-2443; Herr, I., Pfitzenmaier, J., Glucocorticoid use in prostate cancer and other solid tumours: Implications for effectiveness of cytotoxic treatment and metastases (2006) Lancet Oncol., 7, pp. 425-430; Kluza, E., Yeo, S.Y., Schmid, S., Van Der Schaft, D.W.J., Boekhoven, R.W., Schiffelers, R.M., Storm, G., Nicolay, K., Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity (2011) J. Control. Release, 151, pp. 10-17; Kluza, E., Heisen, M., Schmid, S., Van Der Schaft, D.W.J., Schiffelers, R.M., Storm, G., Ter Haar Romeny, B.M., Nicolay, K., Multi-parametric assessment of the anti-angiogenic effects of liposomal glucocorticoids (2011) Angiogenesis, 14, pp. 143-153; Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K., Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review (2000) Journal of Controlled Release, 65 (1-2), pp. 271-284. , DOI 10.1016/S0168-3659(99)00248-5, PII S0168365999002485; Metselaar, J.M., Wauben, M.H.M., Wagenaar-Hilbers, J.P.A., Boerman, O.C., Storm, G., Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes (2003) Arthritis and Rheumatism, 48 (7), pp. 2059-2066. , DOI 10.1002/art.11140; Mulder, W.J., Strijkers, G.J., Van Tilborg, G.A., Cormode, D.P., Fayad, Z.A., Nicolay, K., Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging (2009) Acc. Chem. Res., 42, pp. 904-914; Rhen, T., Cidlowski, J.A., Antiinflammatory action of glucocorticoids - New mechanisms for old drugs (2005) N. Engl. J. Med., 353, pp. 1711-1723; Schiffelers, R.M., Metselaar, J.M., Fens, M.H.A.M., Janssen, A.P.C.A., Molema, G., Storm, G., Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice (2005) Neoplasia, 7 (2), pp. 118-127. , DOI 10.1593/neo.04340; Schiffelers, R.M., Banciu, M., Metselaar, J.M., Storm, G., Therapeutic application of long-circulating liposomal glucocorticoids in auto-immune diseases and cancer (2006) Journal of Liposome Research, 16 (3), pp. 185-194. , DOI 10.1080/08982100600851029, PII L85884J1015X4444; Terreno, E., Sanino, A., Carrera, C., Delli Castelli, D., Giovenzana, G.B., Lombardi, A., Mazzon, R., Aime, S., Determination of water permeability of paramagnetic liposomes of interest in MRI field (2008) J. Inorg. Biochem., 102, pp. 1112-1119; Terreno, E., Delli Castelli, D., Viale, A., Aime, S., Challenges for molecular magnetic resonance imaging (2010) Chem. Rev., 110, pp. 3019-3042; Terreno, E., Delli Castelli, D., Aime, S., Encoding the frequency dependence in MRI contrast media: The emerging class of CEST agents (2010) Contrast Media Mol. Imaging, 5, pp. 78-98&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>amphophile</topic>
    </subject>
    <subject>
      <topic>animal cell</topic>
    </subject>
    <subject>
      <topic>animal experiment</topic>
    </subject>
    <subject>
      <topic>animal model</topic>
    </subject>
    <subject>
      <topic>animal tissue</topic>
    </subject>
    <subject>
      <topic>Animals</topic>
    </subject>
    <subject>
      <topic>antineoplastic activity</topic>
    </subject>
    <subject>
      <topic>Antineoplastic Agents</topic>
    </subject>
    <subject>
      <topic>bilayer membrane</topic>
    </subject>
    <subject>
      <topic>cancer inhibition</topic>
    </subject>
    <subject>
      <topic>cancer model</topic>
    </subject>
    <subject>
      <topic>Cell Line, Tumor</topic>
    </subject>
    <subject>
      <topic>conference paper</topic>
    </subject>
    <subject>
      <topic>Contrast Enhancement</topic>
    </subject>
    <subject>
      <topic>Contrast media</topic>
    </subject>
    <subject>
      <topic>controlled study</topic>
    </subject>
    <subject>
      <topic>drug delivery system</topic>
    </subject>
    <subject>
      <topic>drug distribution</topic>
    </subject>
    <subject>
      <topic>drug effect</topic>
    </subject>
    <subject>
      <topic>drug efficacy</topic>
    </subject>
    <subject>
      <topic>drug formulation</topic>
    </subject>
    <subject>
      <topic>drug release</topic>
    </subject>
    <subject>
      <topic>drug tumor level</topic>
    </subject>
    <subject>
      <topic>Gadolinium</topic>
    </subject>
    <subject>
      <topic>gadoteridol</topic>
    </subject>
    <subject>
      <topic>Gd-based agent</topic>
    </subject>
    <subject>
      <topic>Glucocorticoid</topic>
    </subject>
    <subject>
      <topic>Glucocorticoids</topic>
    </subject>
    <subject>
      <topic>hydrophilicity</topic>
    </subject>
    <subject>
      <topic>Image-guided drug delivery</topic>
    </subject>
    <subject>
      <topic>liposome</topic>
    </subject>
    <subject>
      <topic>Liposomes</topic>
    </subject>
    <subject>
      <topic>Liver</topic>
    </subject>
    <subject>
      <topic>macrophage</topic>
    </subject>
    <subject>
      <topic>Magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>Magnetics</topic>
    </subject>
    <subject>
      <topic>male</topic>
    </subject>
    <subject>
      <topic>melanoma B16</topic>
    </subject>
    <subject>
      <topic>Melanoma, Experimental</topic>
    </subject>
    <subject>
      <topic>Mice</topic>
    </subject>
    <subject>
      <topic>Mice, Inbred C57BL</topic>
    </subject>
    <subject>
      <topic>molecular imaging</topic>
    </subject>
    <subject>
      <topic>mouse</topic>
    </subject>
    <subject>
      <topic>MRI</topic>
    </subject>
    <subject>
      <topic>Nanomedicine</topic>
    </subject>
    <subject>
      <topic>nonhuman</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance imaging agent</topic>
    </subject>
    <subject>
      <topic>paramagnetic liposome</topic>
    </subject>
    <subject>
      <topic>Prednisolone</topic>
    </subject>
    <subject>
      <topic>prednisolone 21 phosphate</topic>
    </subject>
    <subject>
      <topic>priority journal</topic>
    </subject>
    <subject>
      <topic>spleen</topic>
    </subject>
    <subject>
      <topic>Theranostic agents</topic>
    </subject>
    <subject>
      <topic>Tumor Burden</topic>
    </subject>
    <subject>
      <topic>unclassified drug</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>MRI paramagnetic probes for cellular labeling</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stefania</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Di Gregorio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>1934</start>
          <end>1944</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">14341948 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84859882345&amp;partnerID=40&amp;md5=ec5d3d0a673c0d7248a6c10c4d483155</url>
    </location>
    <abstract>This review discusses the main procedures that have been developed for pursuing the task of an efficient cellular labelling with paramagnetic metal complexes for MRI detection. Although most of the work deals with Gd                         III-based relaxation enhancers it is shown that the emerging class of paraCEST agents can allow the visualization of more cell types in the same MR image. To improve the detection of labelled cells, it is often necessary to deal with the use of nano-sized carriers able to deliver a large number of paramagnetic metal complexes. Finally, selected examples are reported to show how proper design of the paramagnetic complex can offer the way to acquire key information on underlying processes in the labelled cells. The main procedures which allow an efficient cellular labelling with paramagnetic metal complexes for MRI detection are discussed. Systems which use Gd                         III and Mn                         II-based relaxation enhancers as labeling probes have been considered, as well as the emerging class of paraCEST agents which allows the visualization of more cell types in the same MR image. Copyright © 2012 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract>
    <note type="content">AD  - Dept. of Chemistry and Molecular Imaging Center, University of Torino, Via Nizza 52, 10125 Torino, Italy</note>
    <note type="content">AD  - Institute for Advanced Study, Technische Universität München, Lichtenbergstrasse 2a, 85748 Garching, Germany</note>
    <note type="content">&lt;p&gt;CODEN: EJICF&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Aime, S.; Dept. of Chemistry and Molecular Imaging Center, University of Torino, Via Nizza 52, 10125 Torino, Italy; email: silvio.aime@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1002/ejic.201101399&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Arbab, A.S., Frank, J.A., (2008) Regener. Med., 3, pp. 199-215; Modo, M., Hoehn, M., Bulte, J.W.M., (2005) Mol. Imaging, 4, pp. 143-164; Kraitchman, D.L., (2004) NMR in Biomedicine, 17, pp. 484-499. , J. W. M. Bulte; Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., Muller, R.N., (2008) Chem. Rev., 108, pp. 2064-2110; Aime, S., Cabella, C., Colombatto, S., Geninatti Crich, S., Gianolio, E., Maggioni, F., (2002) J. Magn. Reson. Imag., 16, pp. 394-406; Strijkers, G.J., Mulder, M., Willem, J., Van Tilborg, F., Geralda, A., Nicolay, K., (2007) Anti-Cancer Agents Med. Chem., 7, pp. 291-395; Himmelreich, U., Hoehn, M., (2008) Minimally Invasive Ther., 17, pp. 132-142; Lee, G.H., Chang, Y., Kim, T.J., (2012) Eur. J. Inorg. Chem., pp. 1924-1933; Laurent, S., Henoumont, C., Vander Elst, L., Muller, R.N., (2012) Eur. J. Inorg. Chem., pp. 1889-1915; Caravan, P., Zhang, Z., (2012) Eur. J. Inorg. Chem., pp. 1916-1923; Botta, M., Tei, L., (2012) Eur. J. Inorg. Chem., pp. 1945-1960; Liu, W., Frank, J.A., (2009) Eur. J. Radiol., 70, pp. 258-264; Himmelreich, U., Dresselaers, T., (2009) Methods, 48, pp. 112-124; Cabella, C., Geninatti Crich, S., Corpillo, D., Barge, A., Ghirelli, C., Bruno, E., Lorusso, V., Aime, S., (2006) Contrast Media Mol. Imaging, 1, pp. 23-29; Terreno, E., Geninatti Crich, S., Belfiore, S., Biancone, L., Cabella, C., Esposito, G., Manazza, A.D., Aime, S., (2006) Magn. Reson. Med., 22, pp. 491-497; Song, Y., Kohlmeir, E.K., Meade, T.J., (2008) J. Am. Chem. Soc., 130, pp. 6662-6663; Mastarone, D.J., Harrison, V.S.R., Eckermann, A.L., Parigi, G., Luchinat, C., Meade, T.J., (2011) J. Am. Chem. Soc., 133, pp. 5329-5337; Kalish, H., Arbab, A.S., Miller, B.R., Lewis, B.K., Zywicke, H.A., Bulte, J.W.M., Bryant, L.H., Frank, J.A., (2003) Magn. Reson. Med., 50, pp. 275-282; Accardo, A., Tesauro, D., Aloj, L., Pedone, C., Morelli, G., (2009) Coord. Chem. Rev., 253, pp. 2193-2213; Anelli, P.L., Lattuada, L., Lorusso, V., Lux, G., Morisetti, A., Morosini, P., Serleti, M., Uggeri, F., (2004) J. Med. Chem., 47, pp. 3629-3641; Libra, A., Fernetti, C., Lorusso, V., Visigalli, M., Anelli, P.L., Staud, F., Tiribelli, C., Pascolo, L., (2006) J. Pharmacol. Exp. Ther., 319, pp. 809-817; Geninatti Crich, S., Cabella, C., Barge, A., Belfiore, S., Ghirelli, C., Lattuada, L., Lanzardo, S., Aime, S., (2006) J. Med. Chem., 49, pp. 4926-4936; Stefania, R., Tei, L., Barge, A., Geninatti Crich, S., Szabo, I., Cabella, C., Cravotto, G., Aime, S., (2009) Chem. Eur. J., 15, pp. 76-85; Ross, J.F., Chaudhuri, P.K., Ratman, M., (1994) Cancer, 73, pp. 2432-2443; Paulos, C.M., Reddy, J.A., Leamon, C.P., Turk, M.J., Low, P.S., (2004) Molecular. Pharmacol., 66, pp. 1406-1414; Corot, C., Robert, P., Lancelot, E., Prigent, P., Ballet, S., Guilbert, I., Raynaud, J.S., Port, M., (2008) Magn. Reson. Med., 60, pp. 1337-1346; Aime, S., Frullano, L., Geninatti Crich, S., (2002) Angew. Chem., 114, p. 1059. , Angew. Chem. Int. Ed. 2002, 41, 1017 - 1020; Kalman, F.K., Geninatti-Crich, S., Aime, S., (2010) Angew. Chem., 122, p. 622. , Angew. Chem. Int. Ed. 2010, 49, 612 - 615; Geninatti Crich, S., Lanzardo, S., Alberti, D., Belfiore, S., Ciampa, A., Giovenzana, G.B., Lovazzano, C., Aime, S., (2007) Neoplasia, 9, pp. 1046-1056; Briley-Saebo, K.C., Geninatti-Crich, S., Cormode, D.P., Barazza, A., Chen, W., Giovenzana, G.B., Fisher, E.A., Fayad, Z.A., (2009) J. Phys. Chem. B, 113, pp. 6283-6289. , W. J. M Mulder; Eliaz, R.E., Nir, S., Szoka, F.C., (2004) Methods Mol. Med. Methods. Enzymol., 387, pp. 16-33; Rudzki, Z., Jothy, S., (1997) Mol. Pathol., 50, pp. 57-71; Herrera, M.B., Bussolati, B., Bruno, S., Morando, L., Mauriello-Romanazzi, G., Sanavio, F., Stamenkovic, I., Camussi, G., (2007) Kidney Int., 72, pp. 430-441; Esposito, G., Geninatti Crich, S., Aime, S., (2008) ChemMedChem, 3, pp. 1858-1862; Strijkers, G.J., Kluza, E., Van Tilborg, G.A.F., Geralda, A.F., Van Der Schaft, D.W.J., Griffioen, A.W., Mulder, W.J.M., Nicolay, K., (2010) Angiogenesis, 13, pp. 161-173; Kluza, E., Van Der Schaft, D.W.J., Hautvast, P.A.I., Mulder, W.J.M., Mayo, K.H., Griffioen, A.W., Strijkers, G.J., Nicolay, K., (2010) Nano Lett., 10, pp. 52-58; Allen, M.J., MacRenaris, K.W., Venkatasubramanian, P.N., Meade, T.J., (2004) Chem. Biol., 11, pp. 301-307; Anderson, S.A., Lee, K.K., Frank, J.A., (2006) Invest. Radiol., 41, pp. 332-338; Kayyem, J.F., Kumar, R.M., Fraser, S.E., Meade, T.J., (1995) Chem. Biol., 2, pp. 615-620; Oliver, M., Ahmad, A., Kamaly, N., Perouzel, E., Caussin, A., Keller, M., Herlihy, A., Jorgensen, M.R., (2006) Org. Biomol. Chem., 4, pp. 3489-3497; Strijkers, G.J., Hak, S., Kok, M.B., Springer, C.S., Nicolay, K., (2009) Magn. Reson. Med., 61, pp. 1049-1058; Kok, M.B., Hak, S., Mulder, W.J.M., Van Der Schaft, D.W.J., Strijkers, G.J., Nicolay, K., (2006) Magn. Reson. Med., 61, pp. 1022-1032; Plank, C., Oberhauser, B., Mechtler, K., Koch, C., Wagner, E., (1994) J. Biol. Chem., 269, pp. 12918-12924; Midoux, P., Mendes, C., Legrand, A., Raimond, J., Mayer, R., Monsigny, M., Roche, A.C., (1993) Nucleic Acids Res., 21, pp. 871-878; Simoes, S., Moreira, J.N., Fonseca, C., Duzgunes, N., Limade, M.C., (2004) Adv. Drug Delivery Rev., 56, pp. 137-145; Stier, E.M., Mandal, M., Kee, K.D., (2005) Mol. Pharm., 2, pp. 74-82; Magzoub, M., Pramanik, A., Graslund, A., (2005) Biochemistry, 44, pp. 14890-14897; Kloeckner, J., Boeckle, S., Persson, D., Roedl, W., Ogris, M., Berg, K., Wagner, E., (2006) J. Controlled Release, 116, pp. 115-122; Gianolio, E., Arena, F., Strijkers, G.J., Nicolay, K., Hogset, A., Aime, S., (2011) Magn. Reson. Med., 65, pp. 212-219; Hogset, A., Prasmickaite, L., Engesaeter, B.O., Hellum, M., Selbo, P.K., Olsen, V.M., Maelandsmo, G.M., Berg, K., (2003) Curr. Gene Ther., 3, pp. 89-112; Ndoye, A., Dolivet, G., Hgset, A., Leroux, A., Erbacher, P., Berg, K., Behr, J.P., Merlin, J.L., (2006) Mol. Ther., 13, pp. 1154-1162; Berg, K., Dietze, A., Kaalhus, O., Hogset, A., (2005) Clinical Cancer Res., 11, pp. 8476-8485; Lou, P.J., Lai, P.S., Shieh, M.J., MacRobert, A.J., Bergs, K., Bown, S.G., (2006) Int. J. Cancer, 119, pp. 2692-2698; Slotkin, J.R., Cahill, K.S., Tharin, S.A., Shapiro, E.M., (2007) Neurotherapeutics, 4, pp. 428-433; Tang, K.S., Shapiro, E.M., (2011) Magn. Reson. Med., 65, pp. 1564-1569; Chan, G.C.F., Chan, W.K., Sze, D.M.Y., (2009) J. Hematol. Oncol., 2, pp. 25-36; Brown, G.D., Gordon, S., (2001) Nature, 413, pp. 36-37; Brown, G.D., Taylor, P.R., Reid, D.M., Willment, J.A., Williams, D.L.W., Martinez-Pomares, L., Wong, S.Y.C., Gordon, S., (2002) J. Exp. Med., 196, pp. 407-412; Figueiredo, S., Moreira, J.N., Rizzitelli, S., Aime, S., Terreno, E., (2011) Chem. Commun., 47, pp. 10635-10637. , C. F. G. C. Geraldes; Anelli, P.L., Lattuada, L., Lorusso, V., Schneider, M., Tournier, H., Uggeri, F., (2001) Magn. Reson. Mater. Phys. Biol. Med., 12, pp. 114-120; Grange, C., Geninatti-Crich, S., Esposito, G., Alberti, D., Tei, L., Bussolati, B., Aime, S., Camussi, G., (2010) Cancer Res., 70, pp. 2180-2190; Gianolio, E., Giovenzana, G.B., Ciampa, A., Lanzardo, S., Imperio, D., Aime, S., (2008) ChemMedChem, 3, pp. 60-62; Moats, R.A., Fraser, S.E., Meade, T.J., (1997) Angew. Chem. Int. Ed. Engl., 36, pp. 725-728; Louie, A., Huber, M.M., Ahrens, E.T., Rothbacher, U., Moats, R., Jacobs, R.E., Fraser, S.E., Meade, T.J., (2000) Nat. Biotechnol., 18, pp. 321-325; Hanaoka, K., Kikuchi, K., Terai, T., Komatsu, T., Nagano, T., (2008) Chem. Eur. J., 14, pp. 987-995; Chang, Y.T., Cheng, C.M., Su, Y.Z., Lee, W.T., Hsu, J.S., Liu, G.C., Cheng, T.L., Wang, Y.-M., (2007) Bioconjugate Chem., 18, pp. 1716-1727; Keliris, A., Ziegler, T., Mishra, R., Pohmann, R., Sauer, M.G., Ugurbil, K., Engelmann, J., (2011) Biorganic Med. Chem., 19, pp. 2529-2540; Chen, J.W., Pham, W., Weissleder, R., Bogdanov, A.A., (2004) Magn. Reson. Med., 52, pp. 1021-1028; Querol, M., Chen, J.W., Bogdanov, A.A., (2006) Org. Biomol. Chem., 4, pp. 1887-1895; Chen, J.W., Querol, M., Bogdanov, A.A., Weissleder, R., (2006) Radiology, 2, pp. 473-481; Querol, M., Bennett, D.G., Sotak, C., Kang, H.W., Bogdanov, A.A., (2007) ChemBioChem, 8, pp. 1637-1164; Arena, F., Bhagavath Singh, J., Gianolio, E., Stefania, R., Aime, S., (2011) Bioconjugate Chem.; Rolla, G.A., Tei, L., Fekete, M., Arena, F., Gianolio, E., Botta, M., (2011) Bioorg. Med. Chem., 19, pp. 1115-1122; Rocklage, S.M., Cacheris, W.P., Quay, S.C., Hahn, F.E., Raymond, K.N., (1989) Inorg. Chem., 28, pp. 477-485; Grant, D., Zech, K., Holtz, E., (1994) Invest. Radiol., 29. , S249-S250; Major, J.L., Meade, T.J., (2009) Acc. Chem. Res., 42, pp. 893-903; Mizukami, S., Takikawa, R., Sugihara, F., Hori, Y., Tochio, H., Walchli, M., Shirakawa, M., Kikuchi, K., (2008) J. Am. Chem. Soc., 130, pp. 794-795; Ward, K.M., Aletras, A.H., Balaban, R.S., (2000) J. Magn. Reson., 143, pp. 79-87; Zhang, S., Meritt, M., Woessner, D.E., Lenkinsko, R.E., Sherry, A.D., (2003) Acc. Chem. Res., 36, pp. 783-790; Aime, S., Delli Castelli, D., Terreno, E., (2003) Angew. Chem., 115, p. 4665. , Angew. Chem. Int. Ed. 2003, 42, 4527 - 4529; Aime, S., Delli Castelli, D., Terreno, E., (2005) Angew. Chem., 117, p. 5649. , Angew. Chem. Int. Ed. 2005, 44, 5513 - 5515; Pikkemaat, J.A., Wegh, R.T., Lamerichs, R., Van De Molengraf, R.A., Langeris, S., Burdinski, D., Raymond, A.Y.F., Grull, H., (2007) Contrast Med. Mol. Imaging, 2, pp. 229-239; Delli Castelli, D., Dastr, W., Terreno, E., Cittadino, E., Mainini, F., Torres, E., Spadaro, M., Aime, S., (2010) J. Controlled Release, 144, pp. 271-279; Aime, S., Carrera, C., Delli Castelli, D., Geninatti Crich, S., Terreno, E., (2005) Angew. Chem., 117, p. 1847. , Angew. Chem. Int. Ed. 2005, 44, 1813 - 1815; Delli Castelli, D., Terreno, E., Aime, S., (2011) Angew. Chem. Int. Ed., 50, pp. 1798-1800&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>Gadolinium</topic>
    </subject>
    <subject>
      <topic>imaging agents</topic>
    </subject>
    <subject>
      <topic>Magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>molecular imaging</topic>
    </subject>
    <subject>
      <topic>Responsive agents</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gringeri</namePart>
      <namePart type="given">C.V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Menchise</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rizzitelli</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cittadino</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Catanzaro</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dati</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chaabane</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>175</start>
          <end>184</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84858715144&amp;partnerID=40&amp;md5=3f3797c294857c8604347643600065ba</url>
    </location>
    <abstract>Two novel Gd-based contrast agents (CAs) for the molecular imaging of matrix metalloproteinases (MMPs) were synthetized and characterized in vitro and in vivo. These probes were based on the PLG*LWAR peptide sequence, known to be hydrolyzed between Gly and Leu by a broad panel of MMPs. A Gd-DOTA chelate was conjugated to the N-terminal position through an amide bond, either directly to proline (compd Gd-K11) or through a hydrophilic spacer (compd Gd-K11N). Both CA were made strongly amphiphilic by conjugating an alkyl chain at the C-terminus of the peptide sequence. Gd-K11 and Gd-K11N have a good affinity for β-cyclodextrins (K                         D 310 and 670μ m respectively) and for serum albumin (K                         D 350 and 90μ m respectively), and can be efficiently cleaved in vitro at the expected site by MMP-2 and MMP-12. Upon MMP-dependent cleavage, the CAs lose the C-terminal tetrapeptide and the alkyl chain, thus undergoing to an amphiphilic-to-hydrophilic transformation that is expected to alter tissue pharmacokinetics. To prove this, Gd-K11 was systemically administered to mice bearing a subcutaneous B16.F10 melanoma, either pre-treated or not with the broad spectrum MMP inhibitor GM6001 (Ilomastat). The washout of the Gd-contrast enhancement in MR images was significantly faster for untreated subjects (displaying MMP activity) with respect to treated ones (MMP activity inhibited). The washout kinetics of Gd-contrast enhancement from the tumor microenvironment could be then interpreted in terms of the local activity of MMPs. © 2012 John Wiley &amp; Sons, Ltd.</abstract>
    <note type="content">AD  - Department of Chemisty IFM, Center for Molecular Imaging, University of Turin, Via Nizza 52, Torino, 10125, Italy</note>
    <note type="content">AD  - Department of Environmental and Life Sciences, Università del Piemonte Orientale 'A. Avogadro', Viale T. Michel 11, 15121 Alessandria, Italy</note>
    <note type="content">AD  - Institute for Biostructures and Bioimages (CNR), Molecular Biotechnology Center, University of Turin, Via Nizza 52, Torino, 10125, Italy</note>
    <note type="content">AD  - San Raffaele Scientific Institute, INSPE-Division Neuroscience, Via Olgettina 58, Milan, 20132, Italy</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: gadolinium, 7440-54-2; gelatinase A, 146480-35-5; ilomastat, 142880-36-2; tetraxetan, 60239-18-1; Gadolinium, 7440-54-2; Matrix Metalloproteinases, 3.4.24.-; Molecular Probes&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Digilio, G.; Department of Environmental and Life Sciences, Università del Piemonte Orientale 'A. Avogadro', Viale T. Michel 11, 15121 Alessandria, Italy; email: giuseppe.digilio@mfn.unipmn.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1002/cmmi.478&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;PubMed ID: 22434630&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Nagase, H.H., Woessner Jr., J.F., Matrix metalloproteinases (1999) J Biol Chem, 274 (31), pp. 21491-21494; Massova, I., Kotra, L.P., Fridman, R., Mobashery, S., Matrix metalloproteinases: structures, evolution, and diversification (1998) FASEB J, 12, pp. 1075-1095; Sounni, N.E., Janssen, M., Foidart, J.M., Noel, A., Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis (2003) Matrix Biol, 22, pp. 55-61; Sternlicht, M.D., Bergers, G., Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects (2000) Emerging Ther Targets, 4, pp. 609-633; Deryugina, E.I., Quigley, J.P., Matrix metalloproteinases and tumor metastasis (2006) Cancer Metastasis Rev, 25, pp. 9-34; Lampert, K., Machein, U., Machein, M.R., Conca, W., Peter, H.H., Volk, B., Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors (1998) Am J Pathol, 153, pp. 429-437; Van de Wiele, C., Oltenfreiter, R., Imaging probes targeting matrix metalloproteinases (2006) Cancer Biother Radiopharm, 21 (5), pp. 409-417; auf dem Keller, U., Bellac, C.L., Li, Y., Lou, Y., Lange, F.P., Ting, R., Harwig, C., Overall, C.M., Novel MMP inhibitor [ 18F]-Marimastat-aryltrifluoroborate as a probe for in vivo PET imaging in cancer (2010) Cancer Res, 70 (19), pp. 7562-7569; Wagner, S., Breyholz, H.-J., Höltke, C., Faust, A., Schober, O., Schäfers, M., Kopka, K., A new 18F-labelled derivative of the MMP inhibitor CGS27023A for PET: radiosynthesis and initial small-animal PET studies (2009) Applied Radiat Isotopes, 67, pp. 606-610; Wagner, S., Breyholz, H.-J., Law, M.P., Faust, A., Höltke, C., Schröer, S., Haufe, G., Kopka, K., Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET (2007) J Med Chem, 50, pp. 5752-5764; Lancelot, E., Amirbekian, V., Brigger, I., Raynaud, J.-S., Ballet, S., David, C., Rousseaux, O., Fayad, Z.A., Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach (2008) Arterioscler Thromb Vasc Biol, 28, pp. 429-436; Turk, B.E., Huang, L.L., Piro, E.T., Cantley, L.C., Determination of protease cleavage site motifs using mixture-based oriented peptide libraries (2001) Nature Biotechnol, 19, pp. 661-667; Kridel, S.J., Chen, E., Kotra, L.P., Howard, E.W., Mobashery, S., Smith, J.W., Substrate hydrolysis by matrix metalloproteinase-9 (2001) J Biol Chem, 276 (23), pp. 20572-20578; Chen, E.I., Kridel, S.J., Howard, E.W., Li, W., Godzik, A., Smith, J.W., A unique substrate recognition profile for matrix metalloproteinase-2 (2002) J Biol Chem, 277 (6), pp. 4485-4491; Scherer, R.L., McIntyre, J.O., Matrisian, L.M., Imaging matrix metalloproteinases in cancer (2008) Cancer Metastasis Rev, 27, pp. 679-690; Lepage, M., Dow, W.C., Melchior, M., You, Y., Fingleton, B., Quarles, C.C., Pepin, C., McIntyre, J.O., Noninvasive detection of matrix metalloproteinase activity in vivo using a novel MRI contrast agent with a solubility switch (2007) Mol Imag, 6, pp. 393-403; Jastrzebska, B., Lebel, R., Therriault, H., McIntyre, J.O., Escher, E., Guerin, B., Paquette, B., Lepage, M., New enzyme-activated solubility-switchable contrast agent for magnetic resonance imaging: from synthesis to in vivo imaging (2009) J Med Chem, 52, pp. 1576-1581; Lebel, R., Jastrzebska, B., Therriault, H., Cournoyer, M.-M., McIntyre, J.O., Escher, E., Neugebauer, W., Lepage, M., Novel solubility-switchable MRI agent allows the noninvasive detection of matrix metalloproteinase-2 activity in vivo in a mouse model (2008) Magn Reson Med, 60, pp. 1056-1065; Mulder, W.J.M., Strijkers, G.J., Griffioen, A.W., van Bloois, L., Molema, G., Storm, G., Koning, G.A., Nicolay, K., A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets (2004) Bioconjug Chem, 15, pp. 799-806; Mulder, W.J.M., Strijkers, G.J., van Tilborg, G.A.F., Griffioen, A.W., Nicolay, K., Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging (2006) NMR Biomed, 19, pp. 142-164; Park, K., Lee, S., Kang, E., Kim, K., Choi, K., Kwon, I.C., New generation of multifunctional nanoparticles for cancer imaging and therapy (2009) Adv Funct Mater, 19, pp. 1553-1566; Janib, S.M., Moses, A.S., MacKay, J.A., Imaging and drug delivery using theranostic nanoparticles (2010) Advanced Drug Deliv Rev, 62 (11), pp. 1052-1063; Sharon Stack, M., Gray, R.D., Comparison of vertebrate collagenase and gelatinase using new fluorogenic substrate peptide (1989) J Biol Chem, 264 (8), pp. 4277-4281; Berman, J., Green, M., Sugg, E., Anderegg, R., Millington, D.S., Norwood, D.L., McGeehan, J., Wiseman, J., Rapid optimization of enzyme substrates using defined substrate mixtures (1992) J Biol Chem, 267 (3), pp. 1434-1437; Deng, S.-J., Bickett, D.M., Mitchell, J.L., Lamberti, M.H., Blackburn, R.K., Carter, H.L., Neugebauer, J., Moss, M.L., Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library (2000) J Biol Chem, 275 (40), pp. 31422-31427; Delli Castelli, D., Gianolio, E., Geninatti Crich, S., Terreno, E., Aime, S., Metal containing nanosized systems for MR-molecular imaging applications (2008) Coord Chem Rev, 252, p. 2424. , 2443; Falvey, P., Lim, C.W., Darcy, R., Revermann, T., Karst, U., Giesbers, M., Marcelis, A.T.M., Ravoo, B.J., Bilayer vesicles of amphiphilic cyclodextrins: host membranes that recognize guest molecules (2005) Chem Eur J, 11, pp. 1171-1180; Digilio, G., Menchise, V., Gianolio, E., Catanzaro, V., Carrera, C., Napolitano, R., Fedeli, F., Aime, S., Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for MRI cell labelling (2010) J Med Chem, 53, pp. 4877-4890; Carrera, C., Digilio, G., Baroni, S., Burgio, D., Consol, S., Fedeli, F., Longo, D., Aime, S., Synthesis and characterization of a Gd(III) based contrast agent responsive to thiol containing compounds (2007) Dalton Trans, (43), pp. 4980-4987; Geninatti Crich, S., Cabella, C., Barge, A., Belfiore, S., Ghirelli, C., Lattuada, L., Lanzardo, S., Aime, S., In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes (2006) J Med Chem, 49, pp. 4926-4936; De Leòn-Rodrìguez, L.M., Ortiz, A., Weiner, A.L., Zhang, S., Kovacs, Z., Kodadek, T., Sherry, A.D., Magnetic resonance imaging detects a specific peptide-protein binding event (2002) J Am Chem Soc, 124, pp. 3514-3515; Aime, S., Botta, M., Terreno, E., Gd(III)-based contrast agents for MRI (2005) Adv Inorg Chem, 57, pp. 173-237; Caravan, P., Ellison, J.J., McMurry, T.J., Lauffer, R.B., Gadolinium(III) Chelates as MRI contrast agents: structure, dynamics, and applications (1999) Chem Rev, 99, pp. 2293-2352; Kielar, F., Tei, L., Terreno, E., Botta, M., Large relaxivity enhancement of paramagnetic lipid nanoparticles by restricting the local motions of the Gd III Chelates (2010) J Am Chem Soc, 132, pp. 7836-7837; Zhang, Z., Greenfield, M.T., Spiller, M., McMurry, T.J., Lauffer, R.B., Caravan, P., Multilocus binding increases the relaxivity of protein-bound MRI contrast agents (2005) Angew Chem Int Edn, 44, pp. 6766-6769; Aime, S., Chiaussa, M., Digilio, G., Gianolio, E., Terreno, E., 1H and 17O NMR relaxometric investigations on two gadolinium(III) DTPA-like chelates endowed with high binding affinity to human serum albumin (1999) J Biol Inorg Chem (JBIC), 4, pp. 766-774; Rasmussen, H.S., McCann, P.P., Matrix Metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat (1997) Pharmacol Ther, 75, pp. 69-75; Galardy, R.E., Cassabonne, M.E., Giese, C., Gilbert, J.H., Lapierre, F., Lopez Schaeffer, M.E., Stack, R., Holleran, W.M., Low molecular weight inhibitors in corneal ulceration (1994) Ann NY Acad Sci, 732, pp. 315-323; Watt, A.P., Mast cells and peptide induced histamine release (2002) Immunopharmacology, 9, pp. 421-434; Digilio, G., Bracco, C., Barbero, L., Chicco, D., Del Curto, M.D., Esposito, P., Traversa, S., Aime, S., NMR Conformational analysis of antide, a potent antagonist of the gonadotropin releasing hormone (2002) J Am Chem Soc, 124, pp. 3431-3442; Nicolle, G.M., Merbach, A.E., Destruction of perfluoroalkyl surfactant aggregates by β-cyclodextrin (2004) Chem Commun, (7), pp. 854-855; Meding, J., Urich, M., Licha, K., Reinhardt, M., Misselwitz, B., Fayad, Z.A., Weinmann, H.-J., Magnetic resonance imaging of atherosclerosis by targeting extracellular matrix deposition with gadofluorine M (2007) Contrast Media Mol Imag, 2, pp. 120-129&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Tradenames: gm6001&lt;/p&gt;</note>
    <subject>
      <topic>albumin</topic>
    </subject>
    <subject>
      <topic>amino acid sequence</topic>
    </subject>
    <subject>
      <topic>animal experiment</topic>
    </subject>
    <subject>
      <topic>animal model</topic>
    </subject>
    <subject>
      <topic>Animals</topic>
    </subject>
    <subject>
      <topic>antineoplastic activity</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>beta cyclodextrin derivative</topic>
    </subject>
    <subject>
      <topic>cancer cell</topic>
    </subject>
    <subject>
      <topic>Chromatography, High Pressure Liquid</topic>
    </subject>
    <subject>
      <topic>Chromatography, Reverse-Phase</topic>
    </subject>
    <subject>
      <topic>Contrast agent</topic>
    </subject>
    <subject>
      <topic>controlled study</topic>
    </subject>
    <subject>
      <topic>Disease Models, Animal</topic>
    </subject>
    <subject>
      <topic>Gadolinium</topic>
    </subject>
    <subject>
      <topic>gelatinase A</topic>
    </subject>
    <subject>
      <topic>ilomastat</topic>
    </subject>
    <subject>
      <topic>in vitro study</topic>
    </subject>
    <subject>
      <topic>in vivo study</topic>
    </subject>
    <subject>
      <topic>macrophage elastase</topic>
    </subject>
    <subject>
      <topic>Magnetic Resonance Spectroscopy</topic>
    </subject>
    <subject>
      <topic>male</topic>
    </subject>
    <subject>
      <topic>mass spectrometry</topic>
    </subject>
    <subject>
      <topic>matrix metalloproteinase</topic>
    </subject>
    <subject>
      <topic>Matrix Metalloproteinases</topic>
    </subject>
    <subject>
      <topic>melanoma</topic>
    </subject>
    <subject>
      <topic>Mice</topic>
    </subject>
    <subject>
      <topic>Mice, Inbred C57BL</topic>
    </subject>
    <subject>
      <topic>molecular imaging</topic>
    </subject>
    <subject>
      <topic>Molecular Probes</topic>
    </subject>
    <subject>
      <topic>mouse</topic>
    </subject>
    <subject>
      <topic>Mouse melanoma</topic>
    </subject>
    <subject>
      <topic>MRI</topic>
    </subject>
    <subject>
      <topic>nonhuman</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>priority journal</topic>
    </subject>
    <subject>
      <topic>protein cleavage</topic>
    </subject>
    <subject>
      <topic>Solid-Phase Synthesis Techniques</topic>
    </subject>
    <subject>
      <topic>tetrapeptide</topic>
    </subject>
    <subject>
      <topic>tetraxetan</topic>
    </subject>
    <subject>
      <topic>Tumor</topic>
    </subject>
    <subject>
      <topic>tumor microenvironment</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Para-hydrogen induced polarization of Si-29 NMR resonances as a potentially useful tool for analytical applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Ellena</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>50</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>529</start>
          <end>533</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">07491581 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Chem.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84864277796&amp;partnerID=40&amp;md5=2771b0b6901152cf493af134d570df88</url>
    </location>
    <abstract>Para-hydrogen-induced polarization effects have been observed in the 29Si NMR spectra of trimethylsilyl para-hydrogenated molecules. The high signal enhancements and the long T1 values observed for the 29Si hyperpolarized resonances point toward the possibility of using 29Si for hyperpolarization applications. A method for the discrimination of multiple compounds and/or complex mixtures of hydroxylic compounds (such as steroids), consisting of the silylization of alcoholic functionalities with an unsaturated silylalkyl moiety and subsequent reaction with para-H2, is proposed. Copyright © 2012 John Wiley &amp; Sons, Ltd.</abstract>
    <note type="content">AD  - Department of Chemistry, Molecular Biotechnology Centre, Via Nizza 52, 10126 Torino, Italy</note>
    <note type="content">&lt;p&gt;CODEN: MRCHE&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Aime, S.; Department of Chemistry, Molecular Biotechnology Centre, Via Nizza 52, 10126 Torino, Italy; email: silvio.aime@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1002/mrc.3832&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Altes, T.A., Salerno, M., (2004) J. Thorac. Imaging, 19, pp. 250-258; Oros, A.M., Shah, N.J., (2004) Phys. Med. Biol., 49, pp. R105-R153; Matsuoka, S., Patz, S., Albert, M.S., Sun, Y.P., Gefter, W.B., Hatabu, H., (2009) J. Thorac. Imaging, 24, pp. 181-188; Ardenkjaer-Larsen, J.H., Fridlund, B., Gram, A., Hansson, G., Hansson, L., Lerche, M.H., Servin, R., Golman, K., (2003) Proc. Natl. Acad. Sci. U.S.A., 100, pp. 10158-10163; Mansson, S., Johansson, E., Magnusson, P., Chai, C.M., Hansson, G., Petersson, J.S., Stahlberg, F., Golman, K., (2006) Eur. Radiol., 16, pp. 57-67; Golman, K., Petersson, J.S., (2006) Acad. Radiol., 13, pp. 932-942; Gallagher, F.A., Kettunen, M.I., Brindle, K.M., (2009) Prog. Nucl. Magn. Reson. Spectrosc., 55, pp. 285-295; Viale, A., Reineri, F., Santelia, D., Ellena, S., Gobetto, R., Aime, S., (2009) Q. J. Nucl. Med. Mol. Imaging, 53, pp. 604-617; Viale, A., Aime, S., (2010) Curr. Opin. Chem. Biol., 14, pp. 90-96; Bowers, C.R., Weitekamp, D.P., (1986) Phys. Rev. Lett., 57, pp. 2645-2648; Bowers, C.R., Weitekamp, D.P., (1987) J. Am. Chem. Soc., 109, pp. 5541-5542; Eisenberg, R., (1991) Acc. Chem. Res., 24, pp. 110-116; Natterer, J., Bargon, J., (1997) Prog. Nucl. Magn. Reson. Spectrosc., 31, pp. 293-315; Duckett, S.B., Sleigh, C.J., (1999) Prog. Nucl. Magn. Reson. Spectrosc., 34, pp. 71-92; Reineri, F., Santelia, D., Viale, A., Cerutti, E., Poggi, L., Tichy, T., Premkumar, S.D., Aime, S., (2010) J. Am. Chem. Soc., 132, pp. 7186-7193; Reineri, F., Viale, A., Ellena, S., Boi, T., Daniele, V., Gobetto, R., Aime, S., (2011) Angew. Chem. Int. Ed., 50, pp. 7350-7353; Barkemeyer, J., Haake, M., Bargon, J., (1995) J. Am. Chem. Soc., 117, pp. 2927-2928; Aime, S., Gobetto, R., Reineri, F., Canet, D., (2006) J. Magn. Reson., 178, pp. 184-192; Kuhn, L.T., Bommerich, U., Bargon, J., (2006) J. Phys. Chem. A, 110, pp. 3521-3526; Bommerich, U., Trantzschel, T., Mulla-Osman, S., Buntkowsky, G., Bargon, J., Bernarding, J., (2010) Phys. Chem. Chem. Phys., 12, pp. 10309-10312; Reineri, F., Viale, A., Ellena, S., Boi, T., Giovenzana, G., Gobetto, R., Premkumar, S.D., Aime, S., (2012) J. Am. Chem. Soc., , accepted; Jindal, A.K., Merritt, M.E., Hyun Suh, E., Malloy, C.R., Sherry, A.D., Zoltán Ková, C.S., (2010) J. Am. Chem. Soc., 132, pp. 1784-1785; Haake, M., Natterer, J., Bargon, J., (1996) J. Am. Chem. Soc., 118, pp. 8688-8691; Aptekar, J.W., Cassidy, M.C., Johnson, A.C., Barton, R.A., Lee, M., Ogier, A.C., Vo, C., Marcus, C.M., (2009) ACS Nano, 4, pp. 4003-4008; Jóhannesson, H., Axelsson, O., Karlsson, M., (2004) C.R. Phys., 5, pp. 315-324; Reineri, F., Viale, A., Dastrú, W., Gobetto, R., Aime, S., (2011) Contrast Media Mol. Imaging, 6, pp. 77-84; Goldman, M., Johannesson, H., (2005) C.R. Phys., 6, pp. 575-581&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>29Si</topic>
    </subject>
    <subject>
      <topic>analytical methods</topic>
    </subject>
    <subject>
      <topic>hyperpolarization</topic>
    </subject>
    <subject>
      <topic>Para-hydrogen</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Paramagnetic self-assembled nanoparticles as supramolecular MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Besenius</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Heynens</namePart>
      <namePart type="given">J.L.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Straathof</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nieuwenhuizen</namePart>
      <namePart type="given">M.M.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bomans</namePart>
      <namePart type="given">P.H.H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Strijkers</namePart>
      <namePart type="given">G.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nicolay</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Meijer</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>356</start>
          <end>361</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84860388269&amp;partnerID=40&amp;md5=6da686f3c93cc681f857a1dab137d13a</url>
    </location>
    <abstract>Nanometer-sized materials offer a wide range of applications in biomedical technologies, particularly imaging and diagnostics. Current scaffolds in the nanometer range predominantly make use of inorganic particles, organic polymers or natural peptide-based macromolecules. In contrast we hereby report a supramolecular approach for the preparation of self-assembled dendritic-like nanoparticles for applications as MRI contrast agents. This strategy combines the benefits from low molecular weight imaging agents with the ones of high molecular weight. Their in vitro properties are confirmed by in vivo measurements: post injection of well-defined and meta-stable nanoparticles allows for high-resolution blood-pool imaging, even at very low Gd(III) doses. These dynamic and modular imaging agents are an important addition to the young field of supramolecular medicine using well-defined nanometer-sized assemblies. © 2012 John Wiley &amp; Sons, Ltd.</abstract>
    <note type="content">AD  - Biomedical NMR, Department of Biomedical Engineering, Eindhoven University of Technology, Po Box 513, 5600 MB Eindhoven, Netherlands</note>
    <note type="content">AD  - Department of Chemistry, IFM and Molecular Imaging Center, University of Torino, Via Nizza 52, Torino, 10125, Italy</note>
    <note type="content">AD  - Institute for Complex Molecular Systems, Laboratory of Macromolecular and Organic Chemistry, Eindhoven University of Technology, Po Box 513, 5600 MB Eindhoven, Netherlands</note>
    <note type="content">AD  - Laboratory of Materials and Interface Chemistry, Soft Matter Cryo-TEM Research Unit, Eindhoven University of Technology, Po Box513, Eindhoven, 5600MB, Netherlands</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: gadolinium pentetate, 80529-93-7; proton, 12408-02-5, 12586-59-3; water, 7732-18-5&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Meijer, E.W.; Institute for Complex Molecular Systems, Laboratory of Macromolecular and Organic Chemistry, Eindhoven University of Technology, Po Box 513, 5600 MB Eindhoven, Netherlands; email: e.w.meijer@tue.nl&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1002/cmmi.498&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Manufacturers: Bruker, Germany&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Petros, R.A., DeSimone, J.M., Strategies in the design of nanoparticles for therapeutic applications (2010) Nat Rev Drug Discov, 9 (8), pp. 615-627; Mitragotri, S., Lahann, J., Physical approaches to biomaterial design (2009) Nat Mater, 8 (1), pp. 15-23; Mulder, W.J.M., Strijkers, G.J., van Tilborg, G.A.F., Cormode, D.P., Fayad, Z.A., Nicolay, K., Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging (2009) Acc Chem Res, 42 (7), pp. 904-914; Jiang, W., KimBetty, Y.S., Rutka, J.T., Chan, W., Nanoparticle-mediated cellular response is size-dependent (2008) Nat Nanotechnol, 3 (3), pp. 145-150; Farokhzad, O.C., Langer, R., Nanomedicine: developing smarter therapeutic and diagnostic modalities (2006) Adv Drug Deliv Rev, 58 (14), pp. 1456-1459; Johnston, A.P.R., Cortez, C., Angelatos, A.S., Caruso, F., Layer-by-layer engineered capsules and their applications (2006) Curr Opin Colloid Interface Sci, 11 (4), pp. 203-209; Wagner, V., Dullaart, A., Bock, A.-K., Zweck, A., The emerging nanomedicine landscape (2006) Nat Biotechnol, 24 (10), pp. 1211-1217; Elghanian, R., Storhoff, J.J., Mucic, R.C., Letsinger, R.L., Mirkin, C.A., Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles (1997) Science, 277 (5329), pp. 1078-1081; Louie, A., Multimodality imaging probes: design and challenges (2010) Chem Rev, 110 (5), pp. 3146-3195; Terreno, E., Castelli, D.D., Viale, A., Aime, S., Challenges for molecular magnetic resonance imaging (2010) Chem Rev, 110, pp. 3019-3042; Villaraza, A.J.L., Bumb, A., Brechbiel, M.W., Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics (2010) Chem Rev, 110, pp. 2921-2959; Merbach, A.E., Tóth, É., (2001) The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, , Chichester: Wiley; Caravan, P., Ellison, J.J., McMurry, T.J., Lauffer, R.B., Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications (1999) Chem Rev, 99 (9), pp. 2293-2352; Srikun, D., Albers, A.E., Chang, C.J., A dendrimer-based platform for simultaneous dual fluorescence imaging of hydrogen peroxide and pH gradients produced in living cells (2011) Chem Sci, 2, pp. 1156-1165; Welsher, K., Liu, Z., Sherlock, S.P., Robinson, J.T., Chen, Z., Daranciang, D., Dai, H., A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice (2009) Nat Nanotechnol, 4 (11), pp. 773-780; Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J.P., Itty Ipe, B., Bawendi, M.G., Frangioni, J.V., Renal clearance of quantum dots (2007) Nat Biotechnol, 25 (10), pp. 1165-1170; Helms, B.A., Reulen, S.W.A., Nijhuis, S., de Graaf-Heuvelmans, P.T.H.M., Merkx, M., Meijer, E.W., High-affinity peptide-based collagen targeting using synthetic phage mimics: from phage display to dendrimer display (2009) J Am Chem Soc, 131 (33), pp. 11683-11685; Sun, G., Xu, J., Hagooly, A., Rossin, R., Li, Z., Moore, D.A., Hawker, C.J., Wooley, K.L., Strategies for Optimized Radiolabeling of Nanoparticles for in vivo PET Imaging (2007) Adv Mater, 19 (20), pp. 3157-3162; Shokeen, M., Pressly, E.D., Hagooly, A., Zheleznyak, A., Ramos, N., Fiamengo, A.L., Welch, M.J., Anderson, C.J., Evaluation of multivalent, functional polymeric nanoparticles for imaging applications (2011) ACS Nano, 5 (2), pp. 738-747; Floyd, W.C., Klemm, P.J., Smiles, D.E., Kohlgruber, A.C., Pierre, V.C., Mynar, J.L., Fréchet, J.M.J., Raymond, K.N., Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity (2011) J Am Chem Soc, 133 (8), pp. 2390-2393; Röglin, L., Lempens, E.H.M., Meijer, E.W., A synthetic 'tour de force': well-defined multivalent and multimodal dendritic structures for biomedical applications (2011) Angew Chem Int Ed, 50 (1), pp. 102-112; Ali, M.M., Woods, M., Caravan, P., Opina, A.C.L., Spiller, M., Fettinger, J.C., Sherry, A.D., Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent (2008) Chem Eur J, 14 (24), pp. 7250-7258; Langereis, S., Dirksen, A., Hackeng, T.M., Genderen, M.H.P., Meijer, E.W., Dendrimers and magnetic resonance imaging (2007) New J Chem, 31, pp. 1152-1160; Kobayashi, H., Brechbiel, M., Nano-sized MRI contrast agents with dendrimer cores (2005) Adv Drug Del Rev, 57 (15), pp. 2271-2286; Lee, C.C., MacKay, J.A., Frechet, J.M.J., Szoka, F.C., Designing dendrimers for biological applications (2005) Nat Biotechnol, 23 (12), pp. 1517-1526; Wiener, E.C., Brechbiel, M.W., Brothers, H., Magin, R.L., Gansow, O.A., Tomalia, D.A., Lauterbur, P.C., Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents (1994) Magn Reson Med, 31, pp. 1-8; Bull, S.R., Guler, M.O., Bras, R.E., Meade, T.J., Stupp, S.I., Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents (2004) Nano Lett, 5 (1), pp. 1-4; Peters, D., Kastantinc, M., Kotamrajua, V.R., Karmalid, P.P., Gujratya, K., Tirrell, M., Ruoslahti, E., Targeting atherosclerosis by using modular, multifunctional micelles (2009) Proc Natl Acad Sci USA, 106 (24), pp. 9815-9819; Torchilin, V., Micellar nanocarriers: pharmaceutical perspectives (2007) Pharm Res, 24 (1), pp. 1-16; André, J.P., Tóth, E., Fisher, H., Seelig, A., Mäcke, H.R., Merbach, A.E., High relaxivity for monomeric Gd(DOTA)-based MRI contrast agents, thanks to micellar self-organization (1999) Chem Eur J, 5, pp. 2977-2983; Mulder, W.J.M., Strijkers, G.J., Griffioen, A.W., Bloois, L., Molema, G., Storm, G., Koning, G.A., Nicolay, K., A Liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets (2004) Bioconjug Chem, 15, pp. 799-806; Garimella, P.D., Datta, A., Romanini, D.W., Raymond, K.N., Francis, M.B., Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes (2011) J Am Chem Soc, 133 (37), pp. 14704-14709; Lehn, J.-M., (1995) Supramolecular Chemistry, , Wiley-VCH: Weinheim; Whitesides, G.M., Grzybowski, B., Self-assembly at all scales (2002) Science, 295, pp. 2418-2421; Besenius, P., Portale, G., Bomans, P.H.H., Janssen, H.M., Palmans, A.R.A., Meijer, E.W., Controlling the growth and shape of chiral supramolecular polymers in water (2010) Proc Natl Acad Sci USA, 107 (42), pp. 17888-17893; Besenius, P., van den Hout, K.P., Albers, H.M.H.G., Greef, T.F.A., Olijve, L.L.C., Hermans, T.M., de W, B.F.M., Meijer, E.W., Controlled supramolecular oligomerisation of C 3-symmetrical molecules in water: the impact of hydrophobic shielding (2011) Chem Eur J, 17, pp. 5193-5203; Caravan, P., Strategies for increasing the sensitivity of gadolinium based MRI contrast agents (2006) Chem Soc Rev, 35 (6), pp. 512-523; Aime, S., Chiaussa, M., Digilio, G., Gianolio, E., Terreno, E., Contrast agents for magnetic resonance angiographic applications: 1H and 17O NMR relaxometric investigations on two gadolinium(III) DTPA-like chelates endowed with high binding affinity to human serum albumin (1999) J Biol Inorg Chem, 4 (6), pp. 766-774; Longmire, M., Choyke, P.L., Kobayashi, H., Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats (2008) Nanomedicine, 3 (5), pp. 703-717; Kobayashi, H., Kawamoto, S., Jo, S.-K., Bryant Jr., H.L., Brechbiel, M.W., Star, R.A., Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores (2003) Bioconjug Chem, 14, pp. 388-394; Catana, C., Procissi, D., Wu, Y., Judenhofer, M.S., Qi, J., Pichler, B.J., Jacobs, R.E., Cherry, S.R., Simultaneous in vivo positron emission tomography and magnetic resonance imaging (2008) Proc Natl Acad Sci USA, 105 (10), pp. 3705-3710; Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M.B., Heaf, J.G., Thomsen, H.S., Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging (2006) J Am Soc Nephrol, 17 (9), pp. 2359-2362&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Tradenames: BioSpin, Bruker, Germany&lt;/p&gt;</note>
    <subject>
      <topic>amphophile</topic>
    </subject>
    <subject>
      <topic>animal experiment</topic>
    </subject>
    <subject>
      <topic>artery</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>Bio-nanotechnology</topic>
    </subject>
    <subject>
      <topic>blood</topic>
    </subject>
    <subject>
      <topic>Brain</topic>
    </subject>
    <subject>
      <topic>chemical structure</topic>
    </subject>
    <subject>
      <topic>Contrast Enhancement</topic>
    </subject>
    <subject>
      <topic>contrast medium</topic>
    </subject>
    <subject>
      <topic>cryoelectron microscopy</topic>
    </subject>
    <subject>
      <topic>fluorination</topic>
    </subject>
    <subject>
      <topic>Functional materials</topic>
    </subject>
    <subject>
      <topic>gadolinium pentetate</topic>
    </subject>
    <subject>
      <topic>imaging</topic>
    </subject>
    <subject>
      <topic>kinetics</topic>
    </subject>
    <subject>
      <topic>magnetic resonance angiography</topic>
    </subject>
    <subject>
      <topic>male</topic>
    </subject>
    <subject>
      <topic>materials</topic>
    </subject>
    <subject>
      <topic>molecular weight</topic>
    </subject>
    <subject>
      <topic>mouse</topic>
    </subject>
    <subject>
      <topic>nanoparticle</topic>
    </subject>
    <subject>
      <topic>Nanotechnology</topic>
    </subject>
    <subject>
      <topic>neuroimaging</topic>
    </subject>
    <subject>
      <topic>nonhuman</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance imaging agent</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance scanner</topic>
    </subject>
    <subject>
      <topic>oligomer</topic>
    </subject>
    <subject>
      <topic>particle size</topic>
    </subject>
    <subject>
      <topic>priority journal</topic>
    </subject>
    <subject>
      <topic>proton</topic>
    </subject>
    <subject>
      <topic>Self-assembly</topic>
    </subject>
    <subject>
      <topic>Supramolecular chemistry</topic>
    </subject>
    <subject>
      <topic>Supramolecular oligomers</topic>
    </subject>
    <subject>
      <topic>transmission electron microscopy</topic>
    </subject>
    <subject>
      <topic>vein</topic>
    </subject>
    <subject>
      <topic>water</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxometric investigations and mri evaluation of a liposome-loaded ph-responsive gadolinium(III) complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Porto</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>51</number>
        </detail>
        <detail type="issue">
          <number>13</number>
        </detail>
        <extent unit="pages">
          <start>7210</start>
          <end>7217</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84863309656&amp;partnerID=40&amp;md5=51382e9c9af72782ee4dfa32fb91d74f</url>
    </location>
    <abstract>Accurate measurement of the tissue pH in vivo by MRI may be of clinical value for both diagnosis and selection/monitoring of therapy. To act as pH reporters, MRI contrast agents have to provide responsiveness to pH that does not require prior knowledge of the actual concentration of the contrast agent. This work deals with the use of a paramagnetic gadolinium(III) complex, loaded into liposomes, whose relaxometric properties are affected by the pH of the medium. In this system, the amphiphilic metal complex, which contains a moiety whose protonation changes the coordination properties of the metal chelate, experiences a different intraliposomial distribution depending on the pH conditions. The pH of the solution can be unambiguously identified by exploiting the peculiar characteristics of the resulting NMRD profiles, and a ratiometric pH-responsive method has been set up by comparing the relaxation enhancement at different magnetic field strengths. © 2012 American Chemical Society.</abstract>
    <note type="content">AD  - Department of Chemistry, Molecular Imaging Center, University of Torino, Via Nizza 52, Torino, Italy</note>
    <note type="content">AD  - DiSCAFF, Università Del Piemonte Orientale A. Avogadro, Via Bovio 6, 28100 Novara, Italy</note>
    <note type="content">AD  - Invento SRL, University of Torino, Via Nizza 52, Torino, Italy</note>
    <note type="content">&lt;p&gt;CODEN: INOCA&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Aime, S.; Department of Chemistry, Molecular Imaging Center, University of Torino, Via Nizza 52, Torino, Italy; email: silvio.aime@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1021/ic300447n&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Lowe, M.P., Parker, D., Reany, O., Aime, S., Botta, M., Castellano, G., Gianolio, E., Pagliarin, R., (2001) J. Am. Chem. Soc., 123, pp. 7601-7609; Aime, S., Botta, M., Geninatti Crich, S., Giovenzana, G.B., Palmisano, G., Sisti, M., (1999) Chem. Commun., 16, pp. 1577-1578; Zhang, S.R., Wu, K.C., Sherry, A.D., (1999) Angew. Chem., Int. Ed., 38, pp. 3192-3194; Gianolio, E., Napolitano, R., Fedeli, F., Arena, F., Aime, S., (2009) Chem. Commun., 40, pp. 6044-6046; Frullano, L., Catana, C., Benner, T., Sherry, A.D., Caravan, P., (2010) Angew. Chem., Int. Ed., 49, pp. 2382-2384; Gianolio, E., MacIocco, L., Imperio, D., Giovenzana, G.B., Simonelli, F., Abbas, K., Bisi, G., Aime, S., (2011) Chem. Commun., 47, pp. 1539-1541; Aime, S., Barge, A., Delli Castelli, D., Fedeli, F., Mortillaro, A., Nielsen, F.U., Terreno, E., (2002) Magn. Reson. Med., 47, pp. 639-648; Delli Castelli, D., Terreno, E., Aime, S., (2011) Angew. Chem., Int. Ed., 50, pp. 1798-1800; Gallagher, F.A., Kettunen, M.I., Brindle, K.M., (2011) NMR Biomed., 24, pp. 1006-1015; Lokling, K.E., Fossheim, S.L., Skurtveit, R., Bjornerud, A., Klaveness, J., (2001) Magn. Reson. Imaging, 19, pp. 731-738; Lokling, K.E., Fossheim, S.L., Klaveness, J., Skurtveit, R., (2004) J. Controlled Release, 98, pp. 87-95; Torres, E., Mainini, F., Napolitano, R., Fedeli, F., Cavalli, R., Aime, S., Terreno, E., (2011) J. Controlled Release, 154, pp. 196-202; Delli Castelli, D., Gianolio, E., Geninatti Crich, S., Terreno, E., Aime, S., (2008) Coord. Chem. Rev., 252, pp. 2424-2443; Accardo, A., Tesauro, D., Aloj, L., Pedone, C., Morelli, G., (2009) Coord. Chem. Rev., 253, pp. 2193-2213; Accardo, A., Tesauro, D., Morelli, G., Gianolio, E., Aime, S., Vaccaro, M., Mangiapia, G., Schillen, K., (2007) J. Biol. Inorg. Chem., 12, pp. 267-276; Hak, S., Sanders, H.M.H.F., Agrawal, P., Langereis, S., Grüll, H., Keizer, H.M., Arena, F., Nicolay, K., (2009) Eur. J. Pharm. Biopharm., 72, pp. 397-404; Solomon, I., (1955) Phys. Rev., 99, p. 559; Bloembergen, N., (1957) J. Chem. Phys., 27, p. 572; Bloembergen, N., Morgan, L.O., (1961) J. Chem. Phys., 34, p. 842; Nicolle, G.M., Toth, E., Eisenwiener, K.P., MacKe, H.R., Merbach, A.E., (2002) J. Biol. Inorg. Chem., 7, pp. 757-769; Torres, S., Martins, J.A., Andrè, J.P., Geraldes, C.F.G.C., Merbach, A.E., Toth, E., (2006) Chem. - Eur. J., 12, pp. 940-948; Koenig, S.H., Ahkong, Q.F., Brown, R.D., Lafleur, M., Spiller, M., Unger, E., Tilcock, C., (1992) Magn. Reson. Med., 23, pp. 275-286; Huster, D., Jin, A.J., Arnold, K., Gawrisch, K., (1997) Biophys. J., 73, pp. 855-864; Terreno, E., Sanino, A., Carrera, C., Delli Castelli, D., Giovenzana, G.B., Lombardi, A., Mazzon, V., Aime, S., (2008) J. Inorg. Biochem., 102, pp. 1112-1119; Terreno, E., Botta, M., Boniforte, P., Bracco, C., Milone, L., Mondino, B., Uggeri, F., Aime, S., (2005) Chem. - Eur. J., 11, pp. 5531-5537; Aime, S., Gianolio, E., Terreno, E., Giovenzana, G.B., Pagliarin, R., Sisti, M., Palmisano, G., Parker, D., (2000) J. Biol. Inorg. Chem., 5, pp. 488-497; Digilio, G., Menchise, V., Gianolio, E., Catanzaro, V., Carrera, C., Napolitano, R., Fedeli, F., Aime, S., (2010) J. Med. Chem., 53, pp. 4877-4890&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
  </mods>
  <mods>
    <titleInfo>
      <title>Structure-function relationships of iodinated contrast media and risk of nephrotoxicity</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Stratta</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Quaglia</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Airoldi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>19</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>736</start>
          <end>743</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">09298673 (ISSN)</identifier>
      <titleInfo>
        <title>Current Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Curr. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84857773825&amp;partnerID=40&amp;md5=79df90a54da0edcf438445cf0021a6ba</url>
    </location>
    <abstract>Characteristics of CM have greatly changed over time. First-generation ionic CM have many-fold (5-7) greater osmolalities than plasma . Subsequently non ionic CM generations were looked for to reduce osmolality, and encompass nonionic monomers and nonionic dimers reaching osmolality as low as that of plasma (iso-osmolar CM) but paying however dear, as viscosity is considerably increased. Intrarenal microcirculation has its "Achilles" heel in the outer medulla, where the smallness of capillary lumen and the slackness of the capillary mesh render regular blood flow at high risk, mainly because it is the same area in which the only renal work needing oxygen is made and? Iodinated CM may exert their nephrotoxic effects in three different ways: by interfering with vascular hemodynamics, by interfering with intratubular fluid volume and composition, and by producing direct cytotoxic effects to glomerular and tubular cells due to iodine byitself. Furthermore, effects of oxygen free radical can damage glomerular cells by increasing the permeability and tubular cells impairing specific function and leading to apoptosis Although clinical nephrotoxicity has considerably improved over time, there is no evidence for an a priori superiority of a specific CM . In general , low-osmolar (2-3 times blood) and iso-osmolar (the same as blood) CM are recommended, keeping in mind that within last generation CM dimeric iso-somolar compounds reach viscosity values higher than monomeric low-osmolar compounds and hyperviscosity is a neglected mechanisms of nephrotoxicity. We suggest that CM should be classified not only by osmolality, but also by viscosity. © 2012 Bentham Science Publishers.</abstract>
    <note type="content">AD  - Department of Chemistry I.F.M., University of Torino, Italy</note>
    <note type="content">AD  - International Research Centre Autoimmune Diseases (IRCAD), Amedeo Avogadro University, Maggiore Hospital, Corso Mazzini 18, 28100 Novara, Italy</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: diatrizoate, 117-96-4, 737-31-5; iobitridol, 136949-58-1; iodixanol, 92339-11-2; iohexol, 66108-95-0; iomeprol, 78649-41-9; iopamidol, 60166-93-0; iopentol, 89797-00-2; iopromide, 73334-07-3; iotalamic acid, 2276-90-6; iotrolan, 79770-24-4; ioversol, 87771-40-2; ioxaglic acid, 59017-64-0, 67992-58-9; ioxilan, 107793-72-6; ioxitalamic acid, 28179-44-4, 33954-26-6; Contrast Media; Hydrocarbons, Iodinated&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: CMCHE&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Stratta, P.; International Research Centre Autoimmune Diseases (IRCAD), Amedeo Avogadro University, Maggiore Hospital, Corso Mazzini 18, 28100 Novara, Italy; email: piero.stratta@med.unipmn.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.2174/092986712798992084&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;PubMed ID: 22204333&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Glasser, O.W.C., Roentgen and the discovery of the Roentgen rays (1995) Am. J Roentgenol., 165, pp. 1033-40; Guillaumont, R., Kroh, J., Penczek, S., Vairon, J.-P., Marie Curie and her time (2011) Chem. Int., (33), p. 1; Urbanik, A., History of Polish gastrointestinal radiology (2003) Journal of Physiology and Pharmacology, 54 (SUPPL. 3), pp. 211-223; Thieme, G., (1987) Symposium Berlin, , March 27-28 Verlag Stuttgart, New York, NY USA; Osborne, E.D., Sutherland, C.G., Scholl Jr., A.J., Rowntree, L.G., Roentgenography of urinary tract during excretion of sodium iodid (1923) Am. Med. Assoc., 80 (6), pp. 368-373; Swick, M., Darstellung der Niere und Harnwege im R̂ntgenbild durch intraven̂se Einbringung eines neuen Kontraststoffes, des Uroselectans (1929) Klein. Wochenschr., pp. 2087-9; Lichtenberg, A., Swick, M., (1929) Klinische Prufung des Uroselectans, 8, pp. 2089-91. , Klin. Wochenschr; Swick, M., Excretion urography by means of the intravenous and oral administration of sodium ortho-iodohippurate: With some physiological considerations (1933) Surg. Gynecol. Obstet., 56, pp. 62-5; Wade, H., Band, D., Uroselectan: Excretion urography (1929) Trans. Med. Chir. Soc. Edinb. NS, 44, pp. 203-20; Cademartin, F., Mollet, N.R., Van Der Lugt, A., McFadden, E.P., Stijnen, T., De Feyter, P.J., Krestin, G.P., Intravenous contrast material administration at helical 16-detector row CT coronary angiography: Effect of iodine concentration on vascular attenuation (2005) Radiology, 236 (2), pp. 661-665. , DOI 10.1148/radiol.2362040468; Melartin, E., Tuohimaa, P.J., Dabb, R., Neurotoxicity of iothalamates and diatrizoates: I. Significance of concentration and cation (1970) Invest. Radiol., 5, pp. 13-21; Wilson, A.J., Evill, C.A., Sage, M.R., Effects of nonionic contrast media on the blood-brain barrier: Osmolality versus chemotoxicity (1991) Invest. Radiol., 26, pp. 1091-1094; Rapoport, S.I., Levitan, H., Neurotoxicity of X-ray contrast media: Relation to lipid solubility and blood-brain barrier permeability (1974) Am. J. Radiol., 122, pp. 186-193; Junck, L., Marshall, W.H., Neurotoxicity of radiological contrast agents (1983) Annals of Neurology, 13 (5), pp. 469-484; Bonnemain, B., Meyer, D., Schaefer, M., Dugast-Zrihen, M., Legreneur, S., Doucet, D., New iodinated, low osmolar contrast media: A revised concept of hydrophilicity (1990) Invest. Radiol., 25, pp. 160-165; Laffan, M., Dawson, P., Gooding, R.P., A comparison between the platelet activating properties of different contrast media used in radiology and MRI (1997) British Journal of Radiology, 70 (AUG.), pp. 798-804; Thomsen, H.S., European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media. Eur (2006) J Radiol., 60 (3), pp. 307-13; Thomsen, H.S., Contrast media safety-An update (2011) Eur. J. Radiol., pp. 17-21; Bellin, M.F., Stacul, F., Webb, J.A., Thomsen, H.S., Morcos, S.K., Almén, T., Aspelin, P., Van Der Molen, A., Late adverse reactions to intravascular iodine based contrast media: An update (2011) Eur. Radiol., pp. 16-20. , on behalf of the Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR; Heinrich, M.C., Kuhlmann, M.K., Grgic, A., Heckmann, M., Kramann, B., Uder, M., Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro (2005) Radiology, 235 (3), pp. 843-849. , DOI 10.1148/radiol.2353040726; Romano, G., Briguori, C., Quintavalle, C., Zanca, C., Rivera, N.;V., Colombo, A., Condorelli, G., Contrast agents and renal cell apoptosis (2008) Eur. Heart.J., 29 (20), pp. 2569-76; Heinrich, M.C., Scheer, M., Heckmann, M., Kuefner, M.A., Uder, M., Iodixanol induces apoptotic and antiproliferative effects but no necrotic cell death in renal proximal tubular cells in vitro (2009) Rofo., 181 (4), pp. 349-54; Erstad, B.L., Osmolality and osmolarity: Narrowing the terminology gap (2003) Pharmacotherapy, 23 (9), pp. 1085-1086. , DOI 10.1592/phco.23.10.1085.32751; Lenz, C., Rebel, A., Waschke, K.F., Koehler, R.C., Frietsch, T., Blood viscosity modulates tissue perfusion: Sometimes and somewhere (2008) Transfus. Altern. Transfus. Med., 9 (4), pp. 265-272; Solomon, R., The role of osmolality in the incidence of contrast-induced nephropathy: A systematic review of angiographic contrast media in high risk patients (2005) Kidney International, 68 (5), pp. 2256-2263. , DOI 10.1111/j.1523-1755.2005.00684.x, PII 4494871; Liss, P., Persson, P.B., Hansell, P., Lagerqvist, B., Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media (2006) Kidney International, 70 (10), pp. 1811-1817. , DOI 10.1038/sj.ki.5001887, PII 5001887; Jost, G., Lengsfeld, P., Lenhard, D.C., Pietsch, H., Hütter, J., Sieber, M.A., Viscosity of iodinated contrast agents during renal excretion (2011) Eur. J. Radiol., 80 (2), pp. 373-7; Seeliger, E., Flemming, B., Wronski, T., Ladwig, M., Arakelyan, K., Godes, M., Mockel, M., Persson, P.B., Viscosity of contrast media perturbs renal hemodynamics (2007) Journal of the American Society of Nephrology, 18 (11), pp. 2912-2920. , DOI 10.1681/ASN.2006111216; Seeliger, E., Becker, K., Ladwig, M., Wronski, T., Persson, P.B., Flemming, B., Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat (2010) Radiology, 256 (2), pp. 406-14; Laugesen, J., Sosnovtseva, O.V., Mosekilde, E., Holstein-Rathlou, N.H., Marsh, D.J., Coupling-induced complexity in nephron models of renal blood flow regulation (2010) Am. J. Physiol. Regul. Integr. Comp. Physiol., 298 (4), pp. R997-R1006; Ren, Y., Garvin, J.L., Liu, R., Carretero, O.A., Cross-talk between arterioles and tubules in the kidney (2009) Pediatr. Nephrol., 24 (1), pp. 31-5; Cupples, W.A., Braam, B., Assessment of renal autoregulation (2007) American Journal of Physiology - Renal Physiology, 292 (4), pp. F1105-F1123. , http://ajprenal.physiology.org/cgi/reprint/292/4/F1105, DOI 10.1152/ajprenal.00194.2006; Cupples, W.A., Interactions contributing to kidney blood flow autoregulation (2007) Current Opinion in Nephrology and Hypertension, 16 (1), pp. 39-45. , DOI 10.1097/MNH.0b013e3280117fc7, PII 0004155220070100000009; Canavese, C., Stratta, P., Vercellone, A., Oxygen free radicals in nephrology (1987) International Journal of Artificial Organs, 10 (6), pp. 379-389; Canavese, C., Stratta, P., Vercellone, A., The case for oxygen free radicals in the pathogenesis of ischemic acute renal failure (1988) Nephron, 49 (1), pp. 9-15; Stratta, P., Canavese, C., Gurioli, L., Mazzucco, G., Monga, G., Novara, R., Vercellone, A., Oxygen free radicals in mediating tissue damage: Role in nephrological settings (1990) Contrib. Nephrol., 77, pp. 132-41; Stratta, P., Canavese, C., Dogliani, M., Mazzucco, G., Monga, G., Vercellone, A., The role of free radicals in the progression of renal disease (1991) Am. J. Kidney Dis., 17 (5 SUPPL. 1), pp. 33-7; Sendeski, M.M., Pathophysiology of renal tissue damage by iodinated contrast media (2011) Clin. Exp. Pharmacol. Physiol., 38 (5), pp. 292-9; Sendeski, M., Patzak, A., Persson, P.B., Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents (2010) Invest. Radiol., 45 (8), pp. 453-7; Sendeski, M., Patzak, A., Pallone, T.L., Cao, C., Persson, A.E., Persson, P.B., Iodixanol constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy (2009) Radiology, 251 (3), pp. 697-704; Persson, P.B., Tepel, M., Contrast medium-induced nephropathy: The pathophysiology (2006) Kidney Int., 69, pp. S8-S10; Jost, G., Pietsch, H., Lengsfeld, P., Hütter, J., Sieber, M.A., The impact of the viscosity and osmolality of iodine contrast agents on renal elimination (2010) Invest. Radiol., 45 (5), pp. 255-61; Stratta, P., Hemorrheological approach to thrombotic microangiopathies (1985) Nephron, 40 (1), pp. 67-73; Stratta, P., Canavese, C., Mazzuco, G., Monga, G., Novara, R., Vono, P., Donatella, G., Ferrero, T., Mesangiolysis and endothelial lesions due to peroxidative damage in rabbits (1989) Nephron, 51 (2), pp. 250-256; Sendeski, M., Patzak, A., Persson, P.B., Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents (2010) Invest. Radiol., 45 (8), pp. 453-7; Sendeski, M., Patzak, A., Pallone, T.L., Cao, C., Persson, A.E., Persson, P.B., Iodixanol constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy (2009) Radiology., 251 (3), pp. 697-704; Duan, S.B., Wang, Y.H., Liu, F.Y., Xu, X.Q., Wang, P., Zou, Q., Peng, Y.M., The protective role of telmisartan against nephrotoxicity induced by Xray contrast media in rat model (2009) Acta Radiol., 50 (7), pp. 754-9; Toprak, O., Cirit, M., Tanrisev, M., Yazici, C., Canoz, O., Sipahioglu, M., Uzum, A., Sozmen, E.Y., Preventive effect of nebivolol on contrast-induced nephropathy in rats (2008) Nephrology Dialysis Transplantation, 23 (3), pp. 853-859. , DOI 10.1093/ndt/gfm691; Heinrich, M.C., Häberle, L., Müller, V., Bautz, W., Uder, M., Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: Meta-Analysis of randomized controlled trials (2009) Radiology, pp. 68-86; Morcos, S.K., Contrast-induced nephropathy: Are there differences between low osmolar and iso-osmolar iodinated contrast media? (2009) Clin. Radiol., 64 (5), pp. 468-72; Thomsen, H.S., Morcos, S.K., Barret, B.J., Contrast-induced nephropathy: The wheel has turned 360 degrees (2008) Acta Radiol., 49, pp. 646-57; Wong, G.T., Irwin, M.G., Contrast-induced nephropathy (2007) Br. J. Anaesth., 99 (4), pp. 474-8; Canavese, C., Morra, F., Morellini, V., Lazzarich, E., Brustia, M., Bo, M., Stratta, P., How can we be sure that renal dysfunction after coronary angiography is just explained by contrast nephropathy? (2004) Kidney Int., 66 (4), p. 1717; Katzberg, R.W., Lamba, R., Contrast-induced nephropathy after intravenous administration: Fact or fiction? (2009) Radiol. Clin. North. Am., 47, pp. 789-800; Katzberg, R.W., Newhouse, J.H., Intravenous contrast medium-induced nephrotoxicity: Is the medical risk really as great as we have come to believe? (2010) Radiology., 256, pp. 21-8; Rao, Q.A., Newhouse, J.H., Risk of nephropathy after intravenous administration of contrast material: A critical literature analysis (2006) Radiology, 239, pp. 392-7; Josephson, S.A., Dillon, W.P., Smith, W.S., Incidence of contrast nephropathy from cerebral CT angiography and CT perfusion imaging (2005) Neurology, 64 (10), pp. 1805-1806. , DOI 10.1212/01.WNL.0000161845.69114.62; Asif, A., Cherla, G., Merrill, D., Cipleu, C.D., Tawakol, J.B., Epstein, D.L., Lenz, O., Venous mapping using venography and the risk of radiocontrast-induced nephropathy (2005) Seminars in Dialysis, 18 (3), pp. 239-242. , DOI 10.1111/j.1525-139X.2005.18319.x; Ng, C.S., Shaw, A.D., Bell, C.S., Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. Am (2010) J. Roentgenol., 195, pp. 414-22; Langner, S., Stumpe, S., Kirsch, M., No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium. Am (2008) J . Neuroradiol., 29, pp. 1525-9; Pahade, J.K., LeBedis, C.A., Raptopoulos, V.D., Incidence of contrastinduced nephropathy in patients with multiple myeloma undergoing contrastenhanced CT (2011) Am. J. Roentgenol., 196, pp. 1094-101; Lufft, V., Hoogestraat-Lufft, L., Fels, L.M., Egbeyong-Baiyee, D., Tusch, G., Galanski, M., Olbricht, C.J., Contrast media nephropathy: Intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: A prospective randomized trial (2002) American Journal of Kidney Diseases, 40 (2), pp. 236-242. , DOI 10.1053/ajkd.2002.34501; Perazella, M.A., Reilly, R.F., Imaging patients with kidney disease: How do we approach contrast-related toxicity? (2011) Am. J. Med. Sci., 341 (3), pp. 215-21; Briguori, C., Airoldi, F., D'Andrea, D., Bonizzoni, E., Morici, N., Focaccio, A., Michev, I., Colombo, A., Renal insufficiency following contrast media administration trial (REMEDIAL): A randomized comparison of 3 preventive strategies (2007) Circulation, 115 (10), pp. 1211-1217. , DOI 10.1161/CIRCULATIONAHA.106.687152; Weisz, G., Leon, M.B., Interventional cardiology: Hand me your radial artery to protect your kidney (2010) Nat Rev Cardiol., 7, pp. 674-5&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>Acute kidney injury</topic>
    </subject>
    <subject>
      <topic>Acute renal failure</topic>
    </subject>
    <subject>
      <topic>apoptosis</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>bradycardia</topic>
    </subject>
    <subject>
      <topic>bronchospasm</topic>
    </subject>
    <subject>
      <topic>cell function</topic>
    </subject>
    <subject>
      <topic>cell permeabilization</topic>
    </subject>
    <subject>
      <topic>Contrast media</topic>
    </subject>
    <subject>
      <topic>cytotoxicity</topic>
    </subject>
    <subject>
      <topic>diatrizoate</topic>
    </subject>
    <subject>
      <topic>drug mechanism</topic>
    </subject>
    <subject>
      <topic>drug structure</topic>
    </subject>
    <subject>
      <topic>erythema</topic>
    </subject>
    <subject>
      <topic>heart arrest</topic>
    </subject>
    <subject>
      <topic>Hemodynamics</topic>
    </subject>
    <subject>
      <topic>human</topic>
    </subject>
    <subject>
      <topic>Humans</topic>
    </subject>
    <subject>
      <topic>Hydrocarbons, Iodinated</topic>
    </subject>
    <subject>
      <topic>hydrophilicity</topic>
    </subject>
    <subject>
      <topic>hypotension</topic>
    </subject>
    <subject>
      <topic>iobitridol</topic>
    </subject>
    <subject>
      <topic>Iodinated contrast media</topic>
    </subject>
    <subject>
      <topic>iodinated contrast medium</topic>
    </subject>
    <subject>
      <topic>iodixanol</topic>
    </subject>
    <subject>
      <topic>iohexol</topic>
    </subject>
    <subject>
      <topic>iomeprol</topic>
    </subject>
    <subject>
      <topic>Iopamidol</topic>
    </subject>
    <subject>
      <topic>iopentol</topic>
    </subject>
    <subject>
      <topic>iopromide</topic>
    </subject>
    <subject>
      <topic>iotalamic acid</topic>
    </subject>
    <subject>
      <topic>iotrolan</topic>
    </subject>
    <subject>
      <topic>ioversol</topic>
    </subject>
    <subject>
      <topic>ioxaglic acid</topic>
    </subject>
    <subject>
      <topic>ioxilan</topic>
    </subject>
    <subject>
      <topic>ioxitalamic acid</topic>
    </subject>
    <subject>
      <topic>kidney circulation</topic>
    </subject>
    <subject>
      <topic>Kidney Diseases</topic>
    </subject>
    <subject>
      <topic>kidney tubule cell</topic>
    </subject>
    <subject>
      <topic>larynx edema</topic>
    </subject>
    <subject>
      <topic>mumps</topic>
    </subject>
    <subject>
      <topic>nausea</topic>
    </subject>
    <subject>
      <topic>Nephrotoxicity</topic>
    </subject>
    <subject>
      <topic>osmolality</topic>
    </subject>
    <subject>
      <topic>Osmolar Concentration</topic>
    </subject>
    <subject>
      <topic>polyarthritis</topic>
    </subject>
    <subject>
      <topic>Renal microcirculation</topic>
    </subject>
    <subject>
      <topic>respiratory distress</topic>
    </subject>
    <subject>
      <topic>risk factor</topic>
    </subject>
    <subject>
      <topic>structure activity relation</topic>
    </subject>
    <subject>
      <topic>syncope</topic>
    </subject>
    <subject>
      <topic>urticaria</topic>
    </subject>
    <subject>
      <topic>Viscosity</topic>
    </subject>
    <subject>
      <topic>vomiting</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Supramolecular adducts of negatively charged lanthanide(III) DOTP chelates and cyclodextrins functionalized with ammonium Groups: Mass spectrometry and nuclear magnetic resonance studies</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Pereira</namePart>
      <namePart type="given">G.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Peters</namePart>
      <namePart type="given">J.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Laurent</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vander Elst</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Muller</namePart>
      <namePart type="given">R.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geraldes</namePart>
      <namePart type="given">C.F.G.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>2087</start>
          <end>2098</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">14341948 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84859887405&amp;partnerID=40&amp;md5=079419d739cf11dd503ab84abd3a9656</url>
    </location>
    <abstract>The interaction of the negatively charged Ln 
                        3+ chelate Ln-DOTP with β- and γ-cyclodextrins bearing ammonium groups at the upper rim (CD 
                        +s) was investigated using mass spectrometry and NMR spectroscopic techniques. Mass spectroscopy shows the presence of 1:1 adducts of Ln-DOTP and both β- or γ-CD 
                        +. The peak intensities increased upon increasing the pH of the samples from 7 to 9.0, suggesting an increase in the strength of the interaction. Lanthanide induced 
                        1H NMR chemical shifts and relaxation ratesmeasured in aqueous solutions confirmed the presence of these adducts. The strength of the interactions appeared to be dependent on the pH, reflecting the strong electrostatic interactions between the oppositely charged host CD 
                        + and guest Ln-DOTP chelate. Evaluation of the lanthanide induced relaxation rates showed that the Ln-DOTP does not enter the cavity of the CDs, but remains above it with a distance of 10-11 É between the Ln 
                        3+ ion and the centre of the CD. Molecular modelling indicated that hydrogen bonds between the functionalized groups participating in the interaction sites contribute to the adduct stabilization. The apparent binding constants at pH 7 and 9 were obtained by using relaxometric measurements at 9 MHz. Fitting the NMRD profiles showed an increase in the number of second-sphere water molecules surrounding the phosphonate pendant arms of the Ln-DOTP chelate upon its interaction with the CDs. A brief description of the PARACEST properties of the supramolecular systems formed by Tm-DOTP and the positively charged CDs is presented. Both CDs display a shift of the saturation transfer peaks of the ammonium functions by the Tm complex, with an accentuated effect observed for the γ-CD derivative. The negatively charged Ln-DOTP chelate forms relatively strong 1:1 supramolecular adducts with β- and γ-cyclodextrins bearing ammonium groups at the upper rim. The strength of the host-guest interaction depends on the pH. The geometry of the adducts, obtained from paramagnetic shift and relaxation effects, shows that the host is outside the guest cavity. Copyright © 2012 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract>
    <note type="content">AD  - Biocatalysis and Organic Chemistry, Department of Biotechnology, Delft University of Technology, Julianalaan 136, 2628 BL Delft, Netherlands</note>
    <note type="content">AD  - Departamento de Química Fundamental, Universidade Federal de Pernambuco, 50740-560 Recife, Pernambuco, Brazil</note>
    <note type="content">AD  - Department of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy</note>
    <note type="content">AD  - Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons, 7000 Mons, Belgium</note>
    <note type="content">AD  - Department of Life Sciences, Center of Neurosciences and Cell Biology, University of Coimbra, P.O. Box 3046, 3001-401 Coimbra, Portugal</note>
    <note type="content">&lt;p&gt;CODEN: EJICF&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Geraldes, C.F.G.C.; Department of Life Sciences, Center of Neurosciences and Cell Biology, University of Coimbra, P.O. Box 3046, 3001-401 Coimbra, Portugal; email: geraldes@ci.uc.pt&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1002/ejic.201101201&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Caravan, P., Ellison, J.J., McMurry, T.J., Lauffer, R.B., (1999) Chem. Rev., 99, pp. 2293-2352; Jacques, V., Desreux, J.F., (2002) Top. Curr. Chem., 221, pp. 123-164; Peters, J.A., Huskens, J., Raber, D.J., (1996) Prog. Nucl. Magn. Reson. Spectrosc., 28, pp. 283-350; Aime, S., Botta, M., Fasano, M., Terreno, E., (1998) Chem. Soc. Rev., 27, pp. 19-29; Helm, L., Merbach, A.E., (2002) Top. Curr. Chem., 221, pp. 61-101. , É. Tóth; Helm, L., Kellar, K.E., Merbach, A.E., (1999) Chem. Eur. J., 5, pp. 1202-1211. , É. Tóth; Dunand, F.A., Hollister, R., Merbach, A.E., (2001) J. Biol. Inorg. Chem., 6, pp. 247-255. , É. Tóth; Duarte, M.G., Gil, M.H., Peters, J.A., Colet, J.M., Vander Elst, L., Muller, R.N., (2001) Bioconjugate Chem., 12, pp. 170-177. , C. F. G. C. Geraldes; Corsi, D.M., Vander Elst, L., Muller, R.N., Van Bekkum, H., Peters, J.A., (2001) Chem. Eur. J., 7, pp. 64-71; André, J.P., Martins, J.A., Merbach, A.E., Prata, M.I.M., Santos, A.C., De Lima, J.J.P., (2004) Chem. Eur. J., 10, pp. 5804-5816. , C. F. G. C. Geraldes, É. Tóth; Baía, P., André, J.P., Martins, J.A., Merbach, A.E., (2005) Eur. J. Inorg. Chem., pp. 2110-2119. , C. F. G. C. Geraldes, É. Tóth; Aime, S., Fasano, M., Terreno, E., Botta, M., Merbach, A.E., (2001) The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, p. 193. , Protein-Bound Metal Chelates: (Eds.: É. Tóth, Wiley, Chichester; Aime, S., Botta, M., Crich, S.G., Giovenzana, G., Palmisano, G., Sisti, M., (1999) Bioconjugate Chem., 10, pp. 192-199; Aime, S., Botta, M., Fasano, M., Crich, S.G., Terreno, E., (1996) J. Biol. Inorg. Chem., 1, pp. 312-319; Pubanz, D., Vauthey, S., Helm, L., Merbach, A.E., (1996) Chem. Eur. J., 2, pp. 1607-1615. , É. Tóth; Bryant Jr., L.H., Brechbiel, M.W., Wu, C., Bulte, J.W.M., Herynek, V., Frank, J.A., (1999) J. Magn. Reson. Imaging, 9, pp. 348-352; Nicolle, G.M., Schmitt-Willich, H., Radüchel, B., Merbach, A.E., (2002) Chem. Eur. J., 8, pp. 1040-1048. , É. Tóth; Laus, S., Sour, A., Ruloff, R., Merbach, A.E., (2005) Chem. Eur. J., 11, pp. 3064-3076. , É. Tóth; Aime, S., Botta, M., Fasano, M., Crich, S.G., Terreno, E., (1996) J. Biol. Inorg. Chem., 1, pp. 312-319; Aime, S., Botta, M., Crich, S.G., Giovenzana, G.B., Pagliarin, R., Piccinini, M., Sisti, M., Terreno, E., (1997) J. Biol. Inorg. Chem., 2, pp. 470-479; Aime, S., Botta, M., Frullano, L., Crich, S.G., Giovenzana, G.B., Pagliarin, R., Palmisano, G., Sisti, M., (1999) Chem. Eur. J., 5, pp. 1253-1260; Caravan, P., Cloutier, N.J., Greenfield, M.T., McDermid, S.A., Dunham, S.U., Bulte, J.W.M., Amedio Jr., J.C., McMurry, T.J., (2002) J. Am. Chem. Soc., 124, pp. 3152-3162; Thonon, D., Jacques, V., Desreux, J.F., (2007) Contrast Media Mol. Imaging, 2, pp. 24-34; André, J.P., Fisher, H., Seelig, A., MäcKe, H.R., Merbach, A.E., (1999) Chem. Eur. J., 5, pp. 2977-2983. , É. Tóth; Nicolle, G.M., Eisenwiener, K.P., MäcKe, H.R., Merbach, A.E., (2002) J. Biol. Inorg. Chem., 7, pp. 757-769. , É. Tóth; Kimpe, K., Parac-Vogt, T.N., Laurent, S., Piérart, C., Vander Elst, L., Muller, R.N., Binnemans, K., (2003) Eur. J. Inorg. Chem., 16, pp. 3021-3027; Fossheim, S.L., Fahlvik, A.K., Klaveness, J., Muller, R.N., (1999) Magn. Reson. Imaging, 17, pp. 83-89; Weissig, V., Babich, J., Torchilin, V., (2000) Colloids Surf. B, 18, pp. 293-299; Glgard, C., Stensrud, G., Hovland, R., Fossheim, S.L., Klaveness, J., (2002) Int. J. Pharm., 233, pp. 131-140; Lkling, K.-E., Fossheim, S.L., Klaveness, J., Skurtveit, R., (2004) J. Controlled Release, 98, pp. 87-95; Morel, S., Terreno, E., Ugazio, E., Aime, S., Gasco, M.R., (1998) Eur. J. Pharmaceutics Biopharmaceutics, 45, pp. 157-163; Glgrd, C., Stensrud, G., Klaveness, J., (2003) Int. J. Pharm., 253, pp. 39-48; Kean, S.D., Easton, C.J., Lincoln, S.F., (2001) Aust. J. Chem., 54, pp. 535-539; Skinner, P.J., Beeby, A., Dickins, R.S., Parker, D., Aime, S., Botta, M., (2000) J. Chem. Soc. Perkin Trans. 2, pp. 1329-1338; Bonnet, C.S., Fries, P.H., Gadelle, A., Gambarelli, S., Delangle, P., (2008) J. Am. Chem. Soc., 130, pp. 10401-10413; Kotkova, Z., Kotek, J., Jirék, D., Jendelov, P., Herynek, V., Berkov, Z., Hermann, P., Lukeš, I., (2010) Chem. Eur. J., 16, pp. 10094-10102; Guillo, F., Amelin, B., Jullien, L., Canceill, J., Lehn, J.-M., Robertis, L.D., Rodriguez, H., (1995) Bull. Soc. Chim. Fr., 132, pp. 857-866; Saenger, W., (1980) Angew. Chem., 92, p. 343. , Angew. Chem. Int. Ed. Engl. 1980, 19, 344 - 362; Loftsson, T., Duchene, D., (2007) Int. J. Pharm., 329, pp. 1-11; Jaime, C., Redondo, J., Sanchez-Ferrando, F., Virgili, A., (1990) J. Org. Chem., 55, pp. 4772-4776; Rekharsky, M.V., Yamamura, H., Kawai, M., Inoue, Y., (2003) J. Org. Chem., 68, pp. 5228-5235; Vögtle, F., Müller, W.M., (1979) Angew. Chem., 91, p. 676. , Angew. Chem. Int. Ed. Engl. 1979, 18, 623 - 624; Kamitori, S., Hirotsu, K., Higuchi, T., (1986) J. Chem. Soc. Commun., pp. 690-691; Kamitori, S., Hirotsu, K., Higuchi, T., (1987) J. Am. Chem. Soc., 109, pp. 2409-2414; Sherry, A.D., Zarzycki, R., (1994) Magn. Reson. Chem., 32, pp. 361-365. , C. F. G. C. Geraldes; Zitha-Bovens, E., Van Bekkum, H., Peters, J.A., (1999) Eur. J. Inorg. Chem., pp. 287-293. , C. F. G. C. Geraldes; Henriques, E., Bastos, M., Ramos, M.J., (1999) Int. J. Quantum Chem., 73, pp. 237-248. , C. F. G. C. Geraldes; Aime, S., Botta, M., Panero, M., Grandi, M., Uggeri, F., (1991) Magn. Reson. Chem., 29, pp. 923-927; Aime, S., Gianolio, E., Terreno, E., Menegotto, I., Bracco, C., Milone, L., Cravotto, G., (2003) Magn. Reson. Chem., 41, pp. 800-805; Aime, S., Gianolio, E., Terreno, E., Giovenzana, G.B., Pagliarin, R., Sisti, M., Palmisano, G., Parker, D., (2000) J. Biol. Inorg. Chem., 5, pp. 488-497; Aime, S., Botta, M., Fedeli, F., Gianolio, E., Terreno, E., Anelli, P., (2001) Chem. Eur. J., 7, pp. 5261-5269; Battistini, E., Gianolio, E., Gref, R., Couvreur, P., Fuzerova, S., Othman, M., Aime, S., Durand, P., (2008) Chem. Eur. J., 14, pp. 4551-4561; Kitae, T., Nakayama, T., Kano, K., (1998) J. Chem. Soc. Perkin Trans. 2, pp. 207-212; Kano, K., Kitae, T., Takashima, H., Shimofuri, Y., (1997) Chem. Lett., 26, pp. 899-900; Wan, K.X., Gross, M.L., Shibue, T., (2000) J. Am. Soc. Mass Spectrom., 11, pp. 450-457; Guo, M., Zhang, S., Song, F., Wang, D., Liu, Z., Liu, S., (2003) J. Mass Spectrom., 38, pp. 723-731; Henrotte, V., Laurent, S., Gabelica, V., Vander Elst, L., Depauw, E., Muller, R.N., (2004) Rapid Commun. Mass Spectrom., 18, pp. 1919-1924; Zhang, S., Merritt, M., Woessner, D.E., Lenkinski, R.E., Sherry, A.D., (2003) Acc. Chem. Res., 36, pp. 783-790; Hamelin, B., Jullien, L., Guillo, F., Lehn, J.-M., Jardy, A., De Robertis, L., Driguez, H., (1995) J. Phys. Chem., 99, pp. 17877-17885; Sherry, A.D., Ren, J., Huskens, J., Brücher, E., Cacheris, W.P., (1996) Inorg. Chem., 35, pp. 4604-4612. , É. Tóth, C. F. G. C. Geraldes, M. M. C. A. Castro; Avecilla, F., Peters, J.A., (2003) Eur. J. Inorg. Chem., pp. 4179-4186. , C. F. G. C. Geraldes; Sherry, A.D., Kiefer, G.E., (1992) J. Magn. Reson., 97, pp. 290-304. , C. F. C. G. Geraldes; Saenger, W., Jacob, J., Gessler, K., Steiner, T., Hoffmann, D., Sanbe, H., Koizumi, K., Takaha, T., (1998) Chem. Rev., 98, pp. 1787-1802; Botta, M., (2000) Eur. J. Inorg. Chem., pp. 399-407; Freed, J.H., (1978) J. Chem. Phys., 68, pp. 4034-4037; Kowalewski, J., Nordenskiold, L., Benetis, N., Westlund, P.-O., Prog. Nucl. Magn. Reson. Spectrosc., 17, pp. 141-185. , 1985; Lindgren, M., Laaksonen, A., Westlund, P.-O., (2009) Phys. Chem. Chem. Phys., 11, pp. 10368-10376; Belorizky, E., Fries, P.H., Helm, L., Kowalewski, J., Kruk, D., Sharp, R.R., Westlund, P.-O., (2008) J. Chem. Phys., 128. , 052315-1-17; Bertini, I., Kowalewski, J., Luchinat, C., Nilsson, T., Parigi, G., (1999) J. Chem. Phys., 111, pp. 5795-5807; Helm, L., (2006) Prog. NMR Spectrosc., 49, pp. 45-64; Aime, S., Delli Castelli, D., Terreno, E., (2003) Angew. Chem., 115, p. 4665. , Angew. Chem. Int. Ed. 2003, 42, 4527 - 4529; Aime, S., Botta, M., Crich, S.G., Terreno, E., Anelli, P., Uggeri, F., (1999) Chem. Eur. J., 5, pp. 1261-1266; Lahrech, H., Perles-Barbacaru, A.-T., Aous, S., Le Bas, J.-F., Debouzy, J.-C., Gadelle, A., Fries, P.H., (2008) J. Cereb. Blood Flow Metab., 28, pp. 1017-1029; Boger, J., Corcoran, R.J., Lehn, J.-M., (1978) Helv. Chim. Acta, 61, pp. 2190-2218; Lazar, I., Hrncir, D.C., Kim, W.D., Kiefer, G.E., Sherry, A.D., (1992) Inorg. Chem., 31, pp. 4422-4424; Brunisholz, G., Randin, M., (1959) Helv. Chim. Acta, 42, pp. 1927-1938; Barge, A., Cravotto, G., Gianolio, E., Fedeli, F., (2006) Contrast Media Mol. Imaging, 1, pp. 184-188; Glasoe, P.K., Long, F.A., (1960) J. Phys. Chem., 64, pp. 188-189; Dennington, R., Keith, T., Millam, J., (2009) GaussView, Version 5, , Semichem Inc., Shawnee Mission, KS, USA; (1998) Micromath Scientist, Version 2.0, , Salt Lake City, Utah, USA; (2007) OriginPro, Version 7.5 SR0, , Northampton, MA 01060, USA&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>imaging agents</topic>
    </subject>
    <subject>
      <topic>lanthanides</topic>
    </subject>
    <subject>
      <topic>mass spectrometry</topic>
    </subject>
    <subject>
      <topic>NMR spectroscopy</topic>
    </subject>
    <subject>
      <topic>Supramolecular chemistry</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and characterization of a hypoxia-sensitive MRI probe</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rojas-Quijano</namePart>
      <namePart type="given">F.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tircsõ</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tircsõné Benyõ</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baranyai</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tran Hoang</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kálmán</namePart>
      <namePart type="given">F.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gulaka</namePart>
      <namePart type="given">P.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kodibagkar</namePart>
      <namePart type="given">V.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kovács</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sherry</namePart>
      <namePart type="given">A.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>18</number>
        </detail>
        <detail type="issue">
          <number>31</number>
        </detail>
        <extent unit="pages">
          <start>9669</start>
          <end>9676</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2012</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-84864144412&amp;partnerID=40&amp;md5=5f71ad692ff4c089edbfaa3fc90df117</url>
    </location>
    <abstract>Tissue hypoxia occurs in pathologic conditions, such as cancer, ischemic heart disease and stroke when oxygen demand is greater than oxygen supply. An imaging method that can differentiate hypoxic versus normoxic tissue could have an immediate impact on therapy choices. In this work, the gadolinium(III) complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) with a 2-nitroimidazole attached to one carboxyl group via an amide linkage was prepared, characterized and tested as a hypoxia-sensitive MRI agent. A control complex, Gd(DO3A-monobutylamide), was also prepared in order to test whether the nitroimidazole side-chain alters either the water proton T                         1 relaxivity or the thermodynamic stability of the complex. The stabilities of these complexes were lower than that of Gd(DOTA)                         - as expected for mono-amide derivatives. The water proton T                         1 relaxivity (r                         1), bound water residence lifetime (τ                         M) and rotational correlation time (τ                         R) of both complexes was determined by relaxivity measurements, variable temperature                         17O NMR spectroscopy and proton nuclear magnetic relaxation dispersion (NMRD) studies. The resulting parameters (r                         1=6.38 mM                         -1 s                         -1 at 20 MHz, τ                         M=0.71 μs, τ                         R=141 ps) determined for the nitroimidazole derivative closely parallel to those of other Gd(DO3A-monoamide) complexes of similar molecular size. In vitro MR imaging experiments with 9L rat glioma cells maintained under nitrogen (hypoxic) versus oxygen (normoxic) gas showed that both agents enter cells but only the nitroimidazole derivative was trapped in cells maintained under N                         2 as evidenced by an approximately twofold decrease in T                         1 measured for hypoxic cells versus normoxic cells exposed to this agent. These results suggest that the nitroimidazole derivative might serve as a molecular reporter for discriminating hypoxic versus normoxic tissues by MRI. Hunting hypoxic cells: The DO3A-monoamide ligand with a 2-nitroimidazole moiety was synthesized with an aim to complex the Gd                         III ion as well as to target and visualize hypoxic cells by using the MRI technique (see figure). In vitro MRI experiments revealed that the conjugate might be suitable for assessment of hypoxia in vivo as the agent was selectively trapped in hypoxic (9L rat glioma) cells. Copyright © 2012 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract>
    <note type="content">AD  - Advanced Imaging Research Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, United States</note>
    <note type="content">AD  - Chemistry Department, University of Texas at Dallas, 5323 Harry Hines Boulevard, Dallas, TX 75390, United States</note>
    <note type="content">AD  - Department of Chemistry IFM and Molecular Imaging Center, Università Degli Studi di Torino, Via P. Giuria 7, 10125 Torino, Italy</note>
    <note type="content">AD  - Department of Inorganic and Analytical Chemistry, University of Debrecen, Egyetem tér 1, Debrecen, H-4010, Hungary</note>
    <note type="content">AD  - Department of Radiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, United States</note>
    <note type="content">&lt;p&gt;CODEN: CEUJE&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Tircsõ, G.; Department of Inorganic and Analytical Chemistry, University of Debrecen, Egyetem tér 1, Debrecen, H-4010, Hungary; email: gyula.tircso@science.unideb.hu&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1002/chem.201200266&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Wouters, A., Pauwels, B., Lardon, F., Vermorken, J.B., (2007) Oncologist, 12, pp. 690-712; Tatum, J.L., Kelloff, G.J., Gillies, R.J., Arbeit, J.M., Brown, J.M., Chao, K.S.C., Chapman, J.D., Sullivan, D., (2006) Int. J. Radiat. Biol., 82, pp. 699-757; Nakamura, S., (1955) Pharm. Bull., 3, pp. 379-383; Sheldon, P.W., Foster, J.L., Fowler, J.F., (1974) Br. J. Cancer, 30, pp. 560-565; Brown, J.M., (1975) Radiat. Res., 64, pp. 633-647; Edwards, D.I., (1993) J. Antimicrob. Chemother., 31, pp. 9-20; Knox, R.J., Knight, R.C., Edwards, D.I., (1981) Br. J. Cancer, 44, pp. 741-745; Adams, G.E., Clarke, E.D., Flockhart, I.R., Jacobs, R.S., Sehmi, D.S., Stratford, I.J., Wardman, P., Smithen, C.E., (1979) Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med., 35, pp. 133-150; Rasey, J.S., Krohn, K.A., Freauff, S., (1982) Radiat. Res., 91, pp. 542-554; Grierson, J.R., Link, J.M., Mathis, C.A., Rasey, J.S., Krohn, K.A., (1989) J. Nucl. Med., 30, pp. 343-350; Ballinger, J.R., Kee, J.W., Rauth, A.M., (1996) J. Nucl. Med., 37, pp. 1023-1031; Das, T., Chakraborty, S., Banerjee, S., Mukherjee, A., Samuel, G., Sarma, H.D., Nair, C.K.K., Venkatesh, M., (2004) Bioorg. Med. Chem., 12, pp. 6077-6084; Norman, T.J., Smith, F.C., Parker, D., Harrison, A., Royle, L., Walker, C.A., (1995) Supramol. Chem., 4, pp. 305-308; Hoigebazar, L., Jeong, J.M., Hong, M.K., Kim, Y.J., Lee, J.Y., Shetty, D., Lee, Y.-S., Lee, M.C., (2011) Bioorg. Med. Chem., 19, pp. 2176-2181; Maxwell, R.J., Workman, P., Griffiths, J.R., (1989) Int. J. Radiat. Oncol. Biol. Phys., 16, pp. 925-929; Aboagye, E.O., Lewis, A.D., Johnson, A., Workman, P., Tracy, M., Huxham, I.M., (1995) Br. J. Cancer, 72, pp. 312-318; Seddon, B.M., Payne, G.S., Simmons, L., Ruddle, R., Grimshaw, R., Tan, S., Turner, A., Workman, P., (2003) Clin. Cancer Res., 9, pp. 5101-5112; Aime, S., Crich, S.G., Gianolio, E., Giovenzana, G.B., Tei, L., Terreno, E., (2006) Coord. Chem. Rev., 250, pp. 1562-1579; Hylton, N., (2006) J. Clin. Oncol., 24, pp. 3293-3298; De Léon-Rodríguez, L.M., Kovacs, Z., (2008) Bioconjugate Chem., 19, pp. 391-402; Brown, J.M., Workman, P., (1980) Radiat. Res., 82, pp. 171-190; André, J.P., Geraldes, C.F.G.C., Martins, J.A., Merbach, A.E., Prata, M.I.M., Santos, A.C., De Lima, J.J.P., Tõth, E., (2004) Chem. Eur. J., 10, pp. 5804-5816; Hay, M.P., Wilson, W.R., Moselen, J.W., Palmer, B.D., Denny, W.A., (1994) J. Med. Chem., 37, pp. 381-391; Dourtoglou, V., Gross, B., Lambropoulou, V., Zioudrou, C., (1984) Synthesis, pp. 572-574; Knorr, R., Trzeciak, A., Bannwarth, W., Gillessen, D., (1989) Tetrahedron Lett., 30, pp. 1927-1930; Sherry, A.D., Geraldes, C.F.G.C., Koenig, S.H., Kuan, K.T., Spiller, M., (1989) Inorg. Chem., 28, pp. 620-622; Aime, S., Anelli, P.L., Botta, M., Fedeli, F., Grandi, M., Paoli, P., Uggeri, F., (1992) Inorg. Chem., 31, pp. 2422-3428; Aime, S., Barge, A., Bruce, J.I., Botta, M., Howard, J.A.K., Moloney, J.M., Parker, D., Woods, M., (1999) J. Am. Chem. Soc., 121, pp. 5762-5771; Lloyd, G.O., Luckay, R.C., (2005) Acta Crystallogr. Sect. e, 61, pp. o3405-o3407; Kubicek, V., Havlickova, J., Kotek, J., Tircso, G., Hermann, P., Tõth, E., Lukes, I., (2010) Inorg. Chem., 49, pp. 10960-10969; Martell, A.E., Smith, R.M., Motekaitis, R.J., (2004) Critically Selected Stability Constants of Metal Complexes Database, , 8th ed., Texas A&amp;M University, College Station; Chaves, S., Delgado, R., Frausto Da Silva, J.J.R., (1992) Talanta, 39, pp. 249-254; Burai, L., Fabian, I., Kiraly, R., Szilagyi, E., Brucher, E., (1998) J. Chem. Soc. Dalton Trans., pp. 243-248; Keire, D.A., Kobayashi, M., (1999) Bioconjugate Chem., 10, pp. 454-463; Pasha, A., Tircso, G., Benyo, E.T., Brucher, E., Sherry, A.D., (2007) Eur. J. Inorg. Chem., pp. 4340-4349; Kumar, K., Chang, C.A., Francesconi, L.C., Dischino, D.D., Malley, M.F., Gougoutas, J.Z., Tweedle, M.F., (1994) Inorg. Chem., 33, pp. 3567-3575; Cacheris, W.P., Nickle, S.K., Sherry, A.D., (1987) Inorg. Chem., 26, pp. 958-960; Caravan, P., Ellison, J.J., McMurry, T.J., Lauffer, R.B., (1999) Chem. Rev., 99, pp. 2293-2352; Lauffer, R.B., (1987) Chem. Rev., 87, pp. 901-927; Bruce, J.I., Lowe, M.P., Parker, D., (2001) The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, pp. 437-460. , in (Eds.: A. E. Merbach, E. Tõth) Wiley, Chichester, ; Geninatti Crich, S.G., Cabella, C., Barge, A., Belfiore, S., Ghirelli, C., Lattuada, L., Lanzardo, S., Aime, S., (2006) J. Med. Chem., 49, pp. 4926-4936; Aime, S., Botta, M., Crich, S.G., Giovenzana, G., Pagliarin, R., Sisti, M., Terreno, E., (1998) Magn. Reson. Chem., 36, p. 200. , SS 208; Aime, S., Botta, M., Fasano, M., Paoletti, S., Terreno, E., (1997) Chem. Eur. J., 3, pp. 1499-1504; Powell, D.H., Ni Dhubhghaill, O.M., Pubanz, D., Helm, L., Lebedev, Y.S., Schlaepfer, W., Merbach, A.E., (1996) J. Am. Chem. Soc., 118, pp. 9333-9346; Swift, T.J., Connick, R.E., (1962) J. Chem. Phys., 37, pp. 307-320; Viswanathan, S., Kovacs, Z., Green, K.N., Ratnakar, S.J., Sherry, A.D., (2010) Chem. Rev., 110, pp. 2960-3018; Banci, L., Bertini, I., Luchinat, C., (1991) Nuclear and Electronic Relaxation, , VCH, Weinheim; Korb, J.P., Ahadi, M., Zientara, G.P., Freed, J.H., (1987) J. Chem. Phys., 86, pp. 1125-1130; Aime, S., Barge, A., Botta, M., Parker, D., De Sousa, A.S., (1997) J. Am. Chem. Soc., 119, pp. 4767-4768; Tõth, E., Connac, F., Helm, L., Adzamli, K., Merbach, A.E., (1998) Eur. J. Inorg. Chem., pp. 2017-2021; Bertini, I., Luchinat, C., (1996) Coord. Chem. Rev., 150, pp. 1-292; Jounaidi, Y., Waxman, D.J., (2000) Cancer. Res., 60, pp. 3761-3769; Kirkpatrick, J.P., Cardenas-Navia, L.I., Dewhirst, M.W., (2004) Int. J. Radiat. Oncol. Biol. Phys., 59, pp. 822-833; Moriyama, E.H., Jarvi, M., Niedre, M., Mocanu, J.D., Moriyama, Y., Li, B., Lilge, L., Wilson, B.C., (2007) Proc. SPIE-Int. Soc. Opt. Eng., 6449, pp. 64490F1-64490F8; Kodibagkar, V.D., Gulaka, P.K., Rojas-Quijano, F., Kovacs, Z., Mason, R.P., Sherry, A.D., (2011) Proc. Internat. Soc. Magn. Reson. Med. Montreal, Canada, p. 1672&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>Amide linkages</topic>
    </subject>
    <subject>
      <topic>Amides</topic>
    </subject>
    <subject>
      <topic>Bound waters</topic>
    </subject>
    <subject>
      <topic>Carboxyl groups</topic>
    </subject>
    <subject>
      <topic>Cells</topic>
    </subject>
    <subject>
      <topic>Convergence of numerical methods</topic>
    </subject>
    <subject>
      <topic>cytology</topic>
    </subject>
    <subject>
      <topic>Diseases</topic>
    </subject>
    <subject>
      <topic>Gadolinium</topic>
    </subject>
    <subject>
      <topic>Glioma cells</topic>
    </subject>
    <subject>
      <topic>Hypoxic cells</topic>
    </subject>
    <subject>
      <topic>Hypoxic tissues</topic>
    </subject>
    <subject>
      <topic>Imaging agent</topic>
    </subject>
    <subject>
      <topic>imaging agents</topic>
    </subject>
    <subject>
      <topic>Imaging method</topic>
    </subject>
    <subject>
      <topic>imaging of hypoxic tissue</topic>
    </subject>
    <subject>
      <topic>In-vitro</topic>
    </subject>
    <subject>
      <topic>In-vivo</topic>
    </subject>
    <subject>
      <topic>Ischemic heart disease</topic>
    </subject>
    <subject>
      <topic>ligand design</topic>
    </subject>
    <subject>
      <topic>Ligands</topic>
    </subject>
    <subject>
      <topic>Magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>molecular size</topic>
    </subject>
    <subject>
      <topic>MR imaging</topic>
    </subject>
    <subject>
      <topic>nitrogen</topic>
    </subject>
    <subject>
      <topic>Nitroimidazoles</topic>
    </subject>
    <subject>
      <topic>Nuclear magnetic resonance spectroscopy</topic>
    </subject>
    <subject>
      <topic>Pathologic conditions</topic>
    </subject>
    <subject>
      <topic>Proton nuclear magnetic relaxation dispersion</topic>
    </subject>
    <subject>
      <topic>Protons</topic>
    </subject>
    <subject>
      <topic>Rats</topic>
    </subject>
    <subject>
      <topic>relaxation properties</topic>
    </subject>
    <subject>
      <topic>Relaxation property</topic>
    </subject>
    <subject>
      <topic>Relaxivity</topic>
    </subject>
    <subject>
      <topic>Rotational correlation time</topic>
    </subject>
    <subject>
      <topic>Side-chains</topic>
    </subject>
    <subject>
      <topic>stability</topic>
    </subject>
    <subject>
      <topic>Tissue hypoxia</topic>
    </subject>
    <subject>
      <topic>Tumors</topic>
    </subject>
    <subject>
      <topic>Variable temperature</topic>
    </subject>
  </mods>
  
<mods>
    <titleInfo>
      <title>Imaging probes - Introduction</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Schultz</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>19</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>1022</start>
          <end>1022</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">09680896 (ISSN)</identifier>
      <titleInfo>
        <title>Bioorganic and Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Bioorg. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79551485355&amp;partnerID=40&amp;md5=0f2440b7b022ccafde7e2a177d9a9168</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>MRI of cells and mice at 1 and 7Tesla with Gd-targeting agents: When the low field is better!</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Geninatti-Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Szabo</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Alberti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>421</start>
          <end>425</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-83155178515&amp;partnerID=40&amp;md5=2b210362b2889d0e653cf76bcb2a2892</url>
    </location>
    <abstract>Tumor cells were targeted with Gd-loaded/LDL (low density lipoproteins) adducts consisting of ca 300Gd(III) amphiphilic complexes incorporated in the lipophilic LDL particles. The long reorientational time of the Gd(III) complex in the supramolecular adduct yielded a relaxivity peak at ca 1T, whereas its relaxivity at 7T was 5 times less. The field-dependent relaxivity markedly affected the signal enhancement attainable at the two magnetic fields. As tumor cells showed up-regulation of LDL transporters, B16 melanoma cells were labeled with the Gd-loaded/LDL adduct. Each cell contained ca 2×109 Gd atoms. Upon dispersion of 5000 labeled cells in 1μl of agar, signal intensity (SI) enhancements of about 30 and 7% were observed at 1 and 7T, respectively. The results obtained on cellular systems were confirmed in vivo upon the administration of Gd-loaded/LDL particles to C57 mice bearing a transplanted melanoma (B16) tumor. From the herein reported results, one may conclude that, for slowly moving Gd complexes, it is possible to obtain in vivo sensitivity enhancements at 1T several times higher than that attained at high fields. Copyright © 2011 John Wiley &amp; Sons, Ltd. A comparison between the efficiency of slowly moving macromolecular MRI imaging probes at 1 and 7Tesla was carried out using Gd-loaded/LDL (Low Density Lipoproteins) adducts consisting of 250Gd amphiphilic complexes incorporated in the lipophilic LDL particles. The sensitivity enhancement obtained at 1Tesla of B16 melanoma cells labeled with Gd-AAZTAC17/LDL adduct is several times higher than that attained at higher fields. © 2011 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Evaluation of the energy barrier for carbonyl exchange in the highly fluxional Ru3(CO)12 system</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Krause</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>14</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>4435</start>
          <end>4438</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0012816527&amp;partnerID=40&amp;md5=bb325e1597f74f6d547807e00a693941</url>
    </location>
    <abstract>13C spin-lattice (T1) and spin-spin (T2) relaxation times of carbonyl groups measured as a function of temperature in CD2Cl2 solution combined with the data obtained by high-resolution MAS 13C NMR in the solid state have been used to evaluate the activation energy of the intramolecular exchange process in Ru3(CO)12. An independent evaluation of the activation energy by line shape analysis of the broadened single 13C NMR resonance at very low temperature in Freon-22 solution substantially agrees with the value obtained by T1 and T2 measurements. © 1995 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Contrast agents and mechanisms</title>
    </titleInfo>
    <typeOfResource manuscript="yes">text</typeOfResource>
    <genre authority="local">manuscript</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-83755178380&amp;partnerID=40&amp;md5=7a28b96b7909ff7eb01a3c265fdf62ec</url>
    </location>
    <abstract>MRI contrast agents are routinely used in clinical settings. Important advances in their design have been attained in the past few years to overcome sensitivity issues and to make possible molecular imaging applications by means of this modality. Besides the sensitivity enhancement of paramagnetic relaxation probes, outstanding results have been obtained in the development of novel classes of frequency-encoding agents such as chemical exchange saturation transfer and hyperpolarized 13C-enriched molecules. © 2011 Elsevier Ltd. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Hak</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanders</namePart>
      <namePart type="given">H.M.H.F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Agrawal</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Langereis</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grüll</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Keizer</namePart>
      <namePart type="given">H.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arena</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Strijkers</namePart>
      <namePart type="given">G.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nicolay</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>72</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>397</start>
          <end>404</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">09396411 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Pharmaceutics and Biopharmaceutics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Pharm. Biopharm.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-67349146757&amp;partnerID=40&amp;md5=4c57b106d4a4c4cea9678c39b0a65061</url>
    </location>
    <abstract>The field of molecular imaging aims to visualize and quantify (patho)physiological processes at the cellular and molecular level. Sensitive and site-targeted contrast agents are employed to visualize molecular constituents of processes of interest. The principal aim of this study was to develop a magnetic resonance imaging (MRI) detectable liposome with high relaxivity and stability. To this end, Gd(III)DOTA-DSPE was synthesized and incorporated in a liposomal formulation. The resulting liposomes were extensively characterized in vitro in terms of contrast agent efficiency and structural properties. The liposomes were shown to have a high longitudinal relaxivity, which is crucial for the detection of low concentration molecular markers in molecular imaging studies. We also demonstrated that Gd(III)DOTA-DSPE exhibits no detectable transmetallation upon incubation with Zn(II). This is important as it significantly contributes to the biocompatibility of the contrast agent. The present liposome preparation will serve as versatile and well characterized platform for molecular imaging and targeted drug delivery studies. © 2008 Elsevier B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Theranostic nanomedicine</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Lammers</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hennink</namePart>
      <namePart type="given">W.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Storm</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kiessling</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>44</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>1029</start>
          <end>1038</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">00014842 (ISSN)</identifier>
      <titleInfo>
        <title>Accounts of Chemical Research</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Acc. Chem. Res.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-80053605725&amp;partnerID=40&amp;md5=df7cdda1f1bbf6e26deb758312c9994f</url>
    </location>
    <abstract>Nanomedicine formulations aim to improve the biodistribution and the target site accumulation of systemically administered (chemo)therapeutic agents. Many different types of nanomedicines have been evaluated over the years, including for instance liposomes, polymers, micelles and antibodies, and a significant amount of evidence has been obtained showing that these submicrometer-sized carrier materials are able to improve the balance between the efficacy and the toxicity of therapeutic interventions. Besides for therapeutic purposes, nanomedicine formulations have in recent years also been increasingly employed for imaging applications. Moreover, paralleled by advances in chemistry, biology, pharmacy, nanotechnology, medicine and imaging, several different systems have been developed in the last decade in which disease diagnosis and therapy are combined. These so-called (nano) theranostics contain both a drug and an imaging agent within a single formulation, and they can be used for various different purposes.In this Account, we summarize several exemplary efforts in this regard, and we show that theranostic nanomedicines are highly suitable systems for monitoring drug delivery, drug release and drug efficacy. The (pre)clinically most relevant applications of theranostic nanomedicines relate to their use for validating and optimizing the properties of drug delivery systems, and to their ability to be used for pre-screening patients and enabling personalized medicine. Regarding the former, the combination of diagnostic and therapeutic agents within a single formulation provides real-time feedback on the pharmacokinetics, the target site localization and the (off-target) healthy organ accumulation of nanomedicines. Various examples of this will be highlighted in this Account, illustrating that by non-invasively visualizing how well carrier materials are able to deliver pharmacologically active agents to the pathological site, and how well they are able to prevent them from accumulating in potentially endangered healthy tissues, important information can be obtained for optimizing the basic properties of drug delivery systems, as well as for improving the balance between the efficacy and the toxicity of targeted therapeutic interventions. Regarding personalized medicine, it can be reasoned that only in patients which show high levels of target site accumulation, and which respond well to the first couple of treatment cycles, targeted therapy should be continued, and that in those in which this is not the case, other therapeutic options should be considered. Based on these insights, we expect that ever more efforts will be invested in developing theranostic nanomedicines, and that these systems and strategies will contribute substantially to realizing the potential of personalized medicine. © 2011 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>β-Gal gene expression MRI reporter in melanoma tumor cells. Design, synthesis, and in vitro and in vivo testing of a Gd(III) containing probe forming a high relaxivity, Melanin-like structure upon β-Gal enzymatic activation</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Arena</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Singh</namePart>
      <namePart type="given">J.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stefanìa</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>22</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>2625</start>
          <end>2635</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <titleInfo>
        <title>Bioconjugate Chemistry</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <abstract>The aim of this work is to design and test an MRI probe (Gd-DOTAtyr-gal) able to report on the gene expression of β-galactosidase (β-Gal) in melanoma cells. The probe consists of a Gd-DOTA reporter bearing on its surface a tyrosine-galactose-pyranose functionality that, upon the release of the sugar moiety, readily transforms, in the presence of tyrosinase, into melanin oligomeric/polymeric mixture. The formation of Gd-DOTA-containing melanin oligomers and polymers is accompanied by a marked increase of the water proton relaxation rate. The steps involving the release of the galactose-pyranose group and the formation of the melanin-like structure have been carefully investigated in vitro by relaxometric and UV-vis measurements. Cellular uptake studies of Gd-DOTAtyr-gal by melanoma cells have shown that the probe enters the cells, and it appears not to be confined in endosomal vesicles. Using B16-F10LacZ transfected cells, the fast formation of paramagnetic melanin-Gd(III)-containing species has been assessed by the measurement of increased longitudinal relaxation rates of the cellular pellets suspensions. The in vitro results have been confirmed in in vivo MRI investigations on murine melanoma tumor bearing mice. Upon direct injection of Gd-DOTAtyr-gal, a good contrast is observed after 5 h post injection in B16-F10LacZ tumors, but not in B16-F10 tumors lacking the β-Gal enzyme. Gd-DOTAtyr-gal in combination with tyrosinase introduces a novel approach for the detection of β-Gal expression by MRI in vivo. © 2011 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A novel 19F-NMR method for the investigation of the antioxidant capacity of biomolecules and biofluids</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Calzoni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giraudo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maffeo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>27</number>
        </detail>
        <detail type="issue">
          <number>3-4</number>
        </detail>
        <extent unit="pages">
          <start>356</start>
          <end>363</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">08915849 (ISSN)</identifier>
      <titleInfo>
        <title>Free Radical Biology and Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Free Radic. Biol. Med.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032589237&amp;partnerID=40&amp;md5=96ccf9bac95d6879508bc74a7ec7119c</url>
    </location>
    <abstract>A new assay for the measurement of the antioxidant capacity of biomolecules by high resolution 19F-NMR spectroscopy is presented here. This method is based on the use of trifluoroacetanilidic detectors, namely trifluoroacetanilide, N-(4-hydroxyphenyl)-trifluoroacetamide and 2-hydroxy-4- trifluoroacetamidobenzoic acid. Upon hydroxyl radical attack, such fluorinated detectors yield trifluoroacetamide and trifluoroacetic acid that can be quantitatively determined by 19F-NMR spectroscopy. Trifluoroacetamide was found to be a reliable reporter of hydroxyl radical attack on the fluorinated detectors, whereas N-(4-hydroxyphenyl)- trifluoroacetamide was found to be the most sensitive detector amongst the ones considered. Therefore, N-(4-hydroxyphenyl)-trifluoroacetamide has been used in competition experiments to assess the antioxidant capacity of a number of low and high molecular weight antioxidants. The antioxidant capacity of a given compound has been scaled in terms of an adimensional parameter, k(F), that represents the ratio between the scavenger abilities of the fluorinated detector and the competitor. k(F) values obtained for low- molecular-mass compounds fall in the range 0.17 &lt; k(F) &lt; 1.5 and are in good agreement with second order rate constants (k2(OH)) for the reaction of the antioxidant with hydroxyl radicals. The k(F) value for serum albumin is much larger (46.9) than that predicted from the reported k2(OH) value. This finding supports the view that the protein can very effectively scavenge hydroxyl radicals as well as secondary radicals. Human blood serum showed that its antioxidant capacity is even higher than that shown by aqueous solutions of albumin at physiologic concentration suggesting a further contribution from other macromolecular serum components.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>An iron-based T1 contrast agent made of iron-phosphate complexes: In vitro and in vivo studies</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rodríguez</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Simoes</namePart>
      <namePart type="given">R.V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Roig</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Molins</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nedelko</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ślawska-Waniewska</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arús</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabañas</namePart>
      <namePart type="given">M.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanfeliu</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cerdán</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">García-Martín</namePart>
      <namePart type="given">M.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>20</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>27</start>
          <end>37</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">09685243 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance Materials in Physics, Biology and Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Mater. Phys. Biol. Med.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33846947558&amp;partnerID=40&amp;md5=2aa0b96c351314c6cf2222f35919daae</url>
    </location>
    <abstract>A new iron-based T1 contrast agent consisting of a complex of iron ions coordinated to phosphate and amine ligands (Fe(phos) in short) has been characterized by spectroscopic and magnetic measurements. NMR relaxation studies showed r 1 values to be dependent on the phosphate salt concentration, K2HPO4, present in the medium. r 1 reaches a maximum value of 2.5 mM-1 s-1 for measurements carried out at 7 T and 298 K. 31P MRS, Mössbauer spectroscopy and magnetic measurements of Fe(phos) solutions suggest paramagnetic Fe3+ ions present in the studied iron-phosphate complex. In vitro and in vivo toxicity experiments with C6 cells and CD1 mice, respectively, demonstrated lack of toxicity for Fe(phos) at the highest dose tested in the MRI experiments (12 mM iron for C6 cells and 0.32 mmol iron/kg for mice). Finally, T1 weighted images of brain tumours in mice have shown positive contrast enhancement of Fe(phos) for tumour afflicted regions in the brain. © 2007 ESMRMB.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Assessment of iron absorption in mice by ICP-MS measurements of 57Fe levels</title>
    </titleInfo>
    <typeOfResource manuscript="yes">text</typeOfResource>
    <genre authority="local">manuscript</genre>
    <name type="personal">
      <namePart type="family">Fiorito</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Silengo</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Altruda</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tolosano</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <physicalDescription>
      <extent unit="pages">
        <total>1</total>
      </extent>
    </physicalDescription>
    <originInfo>
      <dateCreated>2011</dateCreated>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-80054083880&amp;partnerID=40&amp;md5=197a627d7d4b04b1d7310c431fdf282d</url>
    </location>
    <abstract>Background: The study of iron metabolism is essential in nutritional sciences as iron deficiency is one of the most common nutritional deficiencies in humans and represents a serious health problem worldwide. The mouse is utilized as a unique and powerful model for the identification and characterization of genes involved in iron metabolism and for studying the pathogenesis of iron disorders. Thus, sophisticated and sensitive techniques have been developed to study iron metabolism in this animal model. In particular, iron absorption has been studied in mice by using the radioisotopes 55Fe and 59Fe in tied-off or dissected and everted duodenal segments. Nevertheless, several drawbacks discourage the extended use of these approaches. Methods and results: Here, we report the use of the stable isotope 57Fe to measure iron absorption in mice. We show that after oral administration of 57Fe-containing solutions, it is possible to measure both duodenal iron retention and duodenal iron transfer to specific organs, using inductively coupled plasma mass spectrometry (ICP-MS). As 57Fe is administered orally, no surgical operation is needed before the end of the experiment, thus allowing the measurement of iron absorption under physiologic conditions. Moreover, the use of ICP-MS for 57Fe detection ensures high sensitivity and provides quantitative data. Finally, the use of a stable isotope enables the measurement of both iron absorption and histologic and/or biochemical analyses in the same animal. Conclusions: The use of 57Fe to measure iron absorption in mice, therefore, represents an alternative to radioisotope-based methods, providing a new tool to extend our knowledge on the mechanism of iron absorption. © 2011 Springer-Verlag.</abstract>
    <note type="content">AD  - Department of Chemistry IFM, University of Torino, Turin, Italy</note>
    <note type="content">AD  - Department of Genetics, Biology and Biochemistry, University of Torino, Turin, Italy</note>
    <note type="content">AD  - Molecular Biotechnology Center, Department of Genetics, Biology and Biochemistry, University of Torino, Via Nizza 52, Turin, 10126, Italy</note>
    <note type="content">&lt;p&gt;Article in Press&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Cited By (since 1996): 1&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: EJNUF&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Tolosano, E.; Molecular Biotechnology Center, Department of Genetics, Biology and Biochemistry, University of Torino, Via Nizza 52, Turin, 10126, Italy; email: emanuela.tolosano@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1007/s00394-011-0256-6&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">JA  - Eur. J. Nutr.</note>
    <note type="content">JF  - European Journal of Nutrition</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">SN  - 14366207 (ISSN)</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>ICP-MS</topic>
    </subject>
    <subject>
      <topic>Iron absorption</topic>
    </subject>
    <subject>
      <topic>Mice</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging</title>
    </titleInfo>
    <titleInfo type="abbreviated">
      <title>Compartmentalization of a gadolinium complex in the apoferritin cavity</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">Silvio</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Frullano</namePart>
      <namePart type="given">Luca</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">Simonetta</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>41</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>1017</start>
          <end>1019</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">1433-7851</identifier>
      <titleInfo>
        <title>Angewandte Chemie (International Ed. in English)</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed. Engl.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url dateLastAccessed="2011-11-08 17:08:24">http://www.ncbi.nlm.nih.gov/pubmed/12491298</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Computed tomography and magnetic resonance imaging findings of solitary fibrous tumors in the pelvis: Correlation with histopathological findings</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Zhang</namePart>
      <namePart type="given">W.-D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chen</namePart>
      <namePart type="given">J.-Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cao</namePart>
      <namePart type="given">Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Liu</namePart>
      <namePart type="given">Q.-Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Luo</namePart>
      <namePart type="given">R.-G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>78</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>65</start>
          <end>70</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">0720048X (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Radiology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Radiol.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79954780492&amp;partnerID=40&amp;md5=0a55fe02f888877ca59e7c5fad41e594</url>
    </location>
    <abstract>Objective: We aimed to analyze the computed tomography (CT) and magnetic resonance imaging (MRI) findings of pelvic solitary fibrous tumors (SFTs) and to improve the diagnostic efficacy for such tumors. Methods: Six cases of pelvic SFTs confirmed by histopathology were analyzed retrospectively. Of the 6 patients, 4 had undergone CT scanning, and 2 had undergone magnetic resonance imaging. All the patients had undergone unenhanced and contrast-enhanced examinations, and 2 had also undergone dynamic CT enhancement examination. Image characteristics such as shape, size, number, edge, attenuation or intensity for each lesion before and after contrast enhancement were analyzed and compared with the pathomorphology of the tumors. Results: All the 6 cases showed oval or rounded and well-defined masses. Unenhanced CT images showed heterogeneous masses with patchy, necrotic foci in 3 cases and homogeneous mass in 1 case. None of the tumors showed calcification. Contrast-enhanced CT images showed marked, heterogeneous enhancement in the first and second cases. Dynamic enhancement scan demonstrated mild homogeneous enhancement in the third case and mild prolonged, delayed enhancement and washout in the fourth case. T1-weighted MR images showed heterogeneous mild hypointense lesion with linear hyperintensity in 1 case, and homogeneous isointensity in the other. T2-weighted images showed heterogeneous mixed intensity in 1 case and mostly hyperintensive lesion with hypointense foci in another case. A case showed marked heterogeneous enhancement and another showed marked homogeneous enhancement on contrast-enhanced T1-weighted images. Conclusion: Radiological findings of pelvic SFTs are variable and nonspecific. However, a well-defined, ovoid or rounded mass with hypointense on MR T2-weighted images and variable enhancement on CT and MR images may suggest the diagnosis of SFTs. Pelvic SFTs should be included in the differential diagnosis of regional tumors. © 2009 Elsevier Ireland Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Different stages of rheumatoid arthritis: Features of the synovium in the preclinical phase</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Van De Sande</namePart>
      <namePart type="given">M.G.H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Hair</namePart>
      <namePart type="given">M.J.H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Van Der Leij</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Klarenbeek</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bos</namePart>
      <namePart type="given">W.H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Smith</namePart>
      <namePart type="given">M.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maas</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Vries</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Van Schaardenburg</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dijkmans</namePart>
      <namePart type="given">B.A.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gerlag</namePart>
      <namePart type="given">D.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tak</namePart>
      <namePart type="given">P.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>70</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>772</start>
          <end>777</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">00034967 (ISSN)</identifier>
      <titleInfo>
        <title>Annals of the Rheumatic Diseases</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Ann. Rheum. Dis.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79953300919&amp;partnerID=40&amp;md5=125384688e799e33f5dc45a9f80e8c30</url>
    </location>
    <abstract>Background: The aetiology of rheumatoid arthritis (RA), a prototype immune-mediated inflammatory disorder, is poorly understood. It is currently unknown whether the disease process starts in the synovium, the primary target of RA, or at other sites in the body. Objective: To examine, in a prospective study, the presence of synovitis in people with an increased risk of developing RA. Methods: Thirteen people without evidence of arthritis, who were positive for IgM rheumatoid factor and/or anticitrullinated protein antibodies, were included in the study. To evaluate synovial inflammatory changes, all participants underwent dynamic contrast-enhanced MRI and arthroscopic synovial biopsy sampling of a knee joint at inclusion. Results were compared with knee MRI data and synovial biopsy data of 6 and 10 healthy controls, respectively. Results: MRI findings evaluated by measurement of maximal enhancement, rate of enhancement, synovial volume and enhancement shape curve distribution were similar between the autoantibody-positive subjects and the healthy controls. Consistent with these findings, all but one autoantibody-positive subject showed very low scores for phenotypic markers, adhesion molecules and vascularity, all in the same range as those in normal controls. The one person with higher scores had patellofemoral joint space narrowing. Conclusion: Subclinical inflammation of the synovium does not coincide with the appearance of serum autoantibodies during the pre-RA stage. Thus, systemic autoimmunity precedes the development of synovitis, suggesting that a 'second hit' is involved. This study supports the rationale for exploring preventive strategies aimed at interfering with the humoral immune response before synovial inflammation develops.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Menchise</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cittadino</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Catanzaro</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Carrera</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>8</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>1750</start>
          <end>1756</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">15438384 (ISSN)</identifier>
      <titleInfo>
        <title>Molecular Pharmaceutics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Mol. Pharm.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-80053467204&amp;partnerID=40&amp;md5=f62c8b875f819678d73f06f1b08055dd</url>
    </location>
    <abstract>Murine melanoma B16 cells display on the extracellular side of the plasma membrane a large number of reactive protein thiols (exofacial protein thiols, EPTs). These EPTs can be chemically labeled with Gd-DO3A-PDP, a Gd(III)-based MRI contrast agent bearing a 2-pyridinedithio chemical function for the recognition of EPTs. Uptake of gadolinium up to 109 Gd atoms per cell can be achieved. The treatment of B16 cells ex vivo with a reducing agent such as tris(2-carboxyethyl)phosphine (TCEP) results in an increase by 850% of available EPTs and an increase by 45% of Gd uptake. Blocking EPTs with N-ethylmaleimide (NEM) caused a decrease by 84% of available EPTs and a decrease by 55% of Gd uptake. The amount of Gd taken up by B16 cells is therefore dependent upon the availability of EPTs, whose actual level in turn changes according to the extracellular redox microenvironment. Then Gd-DO3A-PDP has been assessed for the labeling of tumor cells in vivo on B16.F10 melanoma tumor-bearing mice. Gd-DO3A-PDP (or Gd-DO3A as the control) has been injected directly into the tumor region at a dose level of 0.1 μmol and the signal enhancement in MR images followed over time. The washout kinetics of Gd-DO3A-PDP from tumor is very slow if compared to that of control Gd-DO3A, and 48 h post injection, the gadolinium-enhancement is still clearly visible. Therefore, B16 cells can be labeled ex vivo as well as in vivo according to a common EPTs-dependent route, provided that high levels of the thiol reactive probe can be delivered to the tumor. © 2011 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Kinetic deuterium isotope effects on μ-hydride and carbonyl ligand migrations</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anslyn</namePart>
      <namePart type="given">E.V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barner-Thorsen</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>1790</start>
          <end>1795</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0010869414&amp;partnerID=40&amp;md5=5db0cdbeb2d8fda2b4c24629925af2e4</url>
    </location>
    <abstract>Kinetic deuterium isotope effects have been observed on the axial-radial carbonyl exchange process at hydride-bridged metal atoms in H(μ-H)Os3(CO)10L (L = P(C6H5)3, CN-t-Bu) and (μ-H)Ru3(CO)9(μ3-C2-t-Bu) by variable-tennperature 1H and 13C NMR techniques. In (μ-H)2Os3(CO)10 this effect is not observed. Kinetic deuterium isotope effects have also been measured directly on the site exchange of the magnetically inequivalent hydrides in (μ-H)2Ru3(CO)9(μ 3-CH=C-t-Bu)2+, for the mono- and dideuterio derivatives by 1H and 2H NMR. The meaning of these isotope effects for the particular ligand migrations involved is discussed. © 1984 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Ligand dependent structural changes in the acid-base chemistry of electron deficient benzoheterocycle triosmium clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Abedin</namePart>
      <namePart type="given">Md.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rokhsana</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hardcastle</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>334</number>
        </detail>
        <extent unit="pages">
          <start>343</start>
          <end>354</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0012914987&amp;partnerID=40&amp;md5=dd3044fa79de4f51a37017591ffec3f5</url>
    </location>
    <abstract>The reactions of the electron deficient benzoheterocycle clusters Os 3(CO)9(μ3-η2-L-H)(μ-H) (L=phenanthridine, 2; 5,6-benzoquinoline, 3; quinoxaline, 4; 2-methyl benzimidazole, 5; 2-methyl benzotriazole, 6; 2-methyl benzothiazole, 7; benzothiazole, 8; 2-methyl benzoxazole, 9; benzoxazole, 10) with n-butylamine and with the protic acids HBF4 and CF3CO2H are reported. Complexes 2 and 3 behave very similarly to the analogous quinoline complex (L=quinoline, 1) forming adducts with n-butylamine with similar spectral properties to 1 and undergoing simple protonation at the metal core with both HBF4 and CF3CO2H. Complexes 4-10 on the other hand form an additional amine adduct with different spectral characteristics than 1-3 and in the case of 5 this is the only detectable product. In addition, these compounds also form adducts with acetonitrile while 1-3 do not. Compounds 4-9 also exhibit much more complex behavior in the presence of CF3CO2H than 1-3, giving trifluoroacetate adducts subsequent to initial protonation. Although 4, 5 and 10 behave differently than 1 with n-butylamine and protic acids they form exactly the same triphenyl phosphine adduct as 1 and 3 based on multinuclear NMR data. The solid-state structure for the amine adduct of 2 is reported and suggested structures for the other amine and acid adducts, based on NMR data, are presented. The reasons for the differences in the behavior of the three distinct groups of benzoheterocycles (1-3, 4 and 5-10) are discussed. © 2002 Elsevier Science B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>No association of abnormal cranial venous drainage with multiple sclerosis: A magnetic resonance venography and flow-quantification study</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Wattjes</namePart>
      <namePart type="given">M.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Van Oosten</namePart>
      <namePart type="given">B.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Graaf</namePart>
      <namePart type="given">W.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Seewann</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bot</namePart>
      <namePart type="given">J.C.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Van Den Berg</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uitdehaag</namePart>
      <namePart type="given">B.M.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Polman</namePart>
      <namePart type="given">C.H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barkhof</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>82</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>429</start>
          <end>435</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">00223050 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Neurology, Neurosurgery and Psychiatry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Neurol. Neurosurg. Psychiatry</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79952727988&amp;partnerID=40&amp;md5=0529796ffb8ee7eb37bef2829e184c65</url>
    </location>
    <abstract>Background: Recent studies using colour-coded Doppler sonography showed that chronic impaired venous drainage from the central nervous system is almost exclusively found in multiple sclerosis (MS) patients. This study aimed to investigate the intracranial and extracranial venous anatomy and the intracerebral venous flow profile in patients with MS and healthy controls using magnetic resonance venography (MRV). Methods: Twenty patients with definite MS and 20 age-and gender-matched healthy controls were examined. MR imaging was performed on a whole-body 3T MR system including both 3D phase-contrast and dynamic 3D contrast-enhanced MRV as well as flow quantification of the internal cerebral veins and the straight sinus. Image analysis was performed by two experienced interventional neuroradiologists blinded to clinical data and structural brain imaging. The intracranial and extracranial neck veins were analysed for stenosis/ occlusion and alternative venous drainage pattern. Results: A completely normal venous anatomy was observed in 10 MS patients and 12 controls. Anomalies of the venous system (venous stenosis/occlusions) were found in 10 MS patients and eight healthy controls. An anomalous venous system in combination with associated alternative venous drainage was observed in six MS patients and five healthy controls. Flow quantification showed no venous backflow in any MS patient or control. Conclusions: Findings suggestive of anomalies of the cranial venous outflow anatomy were frequently observed in both MS patients and healthy controls. Given the normal intracranial venous flow quantification results, it is likely that these findings reflect anatomical variants of venous drainage rather than clinically relevant venous outflow obstructions.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Properties, solution state behavior, and crystal structures of chelates of DOTMA</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Garda</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kucera</namePart>
      <namePart type="given">B.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tircso</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Young</namePart>
      <namePart type="given">V.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Woods</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>50</number>
        </detail>
        <detail type="issue">
          <number>17</number>
        </detail>
        <extent unit="pages">
          <start>7955</start>
          <end>7965</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-80052221595&amp;partnerID=40&amp;md5=cfcbbfae8284965b671fdbf0472ceb1c</url>
    </location>
    <abstract>The chemistry of polyamino carboxylates and their use as ligands for Ln3+ ions is of considerable interest from the point of view of the development of new imaging agents. Of particular interest is the chemistry of the macrocyclic ligand 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and its derivatives. Herein we report that the tetramethylated DOTA derivative, DOTMA, possess several properties that, from an imaging agent development point of view, are more advantageous than those of the parent DOTA. In particular, the Ln3+ chelates of DOTMA exhibit a marked preference for the monocapped twisted square antiprismatic coordination isomer which imparts more rapid water exchange kinetics on the chelates; τ M298 was determined to be 85 ns for GdDOTMA. Differential analysis of the 17O R2ρ temperature profiles of both GdDOTA and GdDOTMA afforded the τM298 values for the square (SAP) and twisted square antiprismatic (TSAP) isomers of each chelate that were almost identical: 365 ns (SAP) and 52 ns (TSAP). The origin of this accelerated water exchange in the TSAP isomer appears to be the slightly longer Gd-OH2 bond distance (2.50 Å) that is observed in the crystal structure of GdDOTMA which crystallizes in the P2 space group as a TSAP isomer. The Ln3+ chelates of DOTMA also exhibit high thermodynamic stabilities ranging from log KML = 20.5 for CeDOTMA, 23.5 for EuDOTMA and YbDOTMA comparable to, but a shade lower than, those of DOTA. © 2011 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Ratzinger</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Agrawal</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Körner</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lonkai</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanders</namePart>
      <namePart type="given">H.M.H.F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Wirth</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Strijkers</namePart>
      <namePart type="given">G.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nicolay</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gabor</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>31</number>
        </detail>
        <detail type="issue">
          <number>33</number>
        </detail>
        <extent unit="pages">
          <start>8716</start>
          <end>8723</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">01429612 (ISSN)</identifier>
      <titleInfo>
        <title>Biomaterials</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Biomaterials</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77957310514&amp;partnerID=40&amp;md5=1f66d2bb25c2a8896983fd7ae33def28</url>
    </location>
    <abstract>The preparation of particulate contrast agents for magnetic resonance imaging (MRI) based on biodegradable poly(d,l-lactide-co-glycolide) (PLGA) nanocarriers is reported. By spacer-aided covalent surface-grafting of the prominent chelating ligands diethylenetriaminepentaacetic acid (DTPA) and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), respectively, up to 236 μg gadolinium per mg PLGA can be immobilized in a stable manner. Due to the localisation at the particle surface, water protons may effectively interact with the gadolinium chelates and the modified particles exhibit high proton relaxivities as confirmed by T1 relaxivities of up to 17.5 mm-1s-1 (25 °C, 1.41 T) in case of Gd-DOTA-functionalized carriers and also supported by NMRD profiles. The obtained values compare favorably with marketed low-molecular weight contrast agents and thus suggest suitability for in vivo use. © 2010 Elsevier Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and testing of a p-H2 hyperpolarized 13C probe based on the pyrazolo[1,5-a]pyrimidineacetamide DPA-713, an MRI vector to target the peripheral benzodiazepine receptors</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Cerutti</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Damont</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dollé</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>49</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>795</start>
          <end>800</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">07491581 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Chem.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-83855162712&amp;partnerID=40&amp;md5=1c2642af3c825c843e62988803c4227e</url>
    </location>
    <abstract>DPA-713 is the lead compound of a recently developed 2-phenylpyrazolo[1,5- a]pyrimidineacetamide series that has been shown to display a good targeting capability toward peripheral benzodiazepine receptors, recently renamed translocator protein (18 kDa) or in short TSPO. On the basis of this structure, a novel derivative bearing a [13C]butynoate moiety has been designed and synthesized (three steps-42% overall yield) providing, upon rapid and quantitative para-hydrogenation, the corresponding hyperpolarized [ 13C]alkene. Para-hydrogen-induced polarization effects have been detected in both 1H and 13C-NMR spectra. Upon applying a field cycling procedure, the spin order of para-H2 added hydrogens is transferred on the 13 C carboxylate moiety yielding a signal enhancement of approximately 4500 times. T1 of the carboxylate carbon atom is approximately 21.9 s (at 9.37 T). A 13 C-MR image has been acquired by using the 13 C RARE (Rapid Acquisition by Relaxation Enhancement) acquisition protocol on a 10-mM solution. The main limitation to the in vivo use of this novel para-hydrogenated [13 C]derivative is its relatively low solubility in aqueous systems. © 2011 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Use of labile precursors for the generation of hyperpolarized molecules from hydrogenation with parahydrogen and aqueous-phase extraction</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ellena</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Boi</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Daniele</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>50</number>
        </detail>
        <detail type="issue">
          <number>32</number>
        </detail>
        <extent unit="pages">
          <start>7350</start>
          <end>7353</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <abstract>Hyperpolarization using parahydrogen can be more efficient when the reaction is carried out on a precursor that is then quickly transformed into the desired probe. The procedure was tested with [1-13C]succinate prepared from hydrogenation with parahydrogen of maleic anhydride followed by hydrolysis. This method also allows the catalyst to be removed without polarization loss. Copyright © 2011 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Compartmentalization of a gadolinium complex in the apoferritin cavity: A route to obtain high relaxivity contrast agents for magnetic resonance imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Frullano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>41</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>1017</start>
          <end>1019</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037087670&amp;partnerID=40&amp;md5=534d912e14f89b89a4061dbd8e27892d</url>
    </location>
    <abstract>A remarkably high relaxation enhancement of water protons has been observed for solutions containing apoferritin loaded with GdHPDO3A (see schematic representation). The entrapment of the complex within apoferritin (internal diameter: 7.5 nm, external diameter: 12.5 nm) allows an increased number of dipolar interactions with water molecules and exchangeable protons in the protein cavity.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Dendrimeric Gd(III) complex of a monophosphinated DOTA analogue: Optimizing relaxivity by reducing internal motion</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rudovský</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hermann</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lukes</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>18</number>
        </detail>
        <extent unit="pages">
          <start>2390</start>
          <end>2392</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-19944378454&amp;partnerID=40&amp;md5=4e1ec2f719143a2190cfe6c66053c31d</url>
    </location>
    <abstract>A marked increase of relaxivity has been observed upon rigidifying the internal frame of Gd-containing PAMAM dendrimers: the effect has been attained by either protonation of the dendrimer or by forming supramolecular adducts with cationic polyaminoacids. © The Royal Society of Chemistry 2005.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Detection and quantification of lanthanide complexes in cell lysates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Corpillo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>76</number>
        </detail>
        <detail type="issue">
          <number>20</number>
        </detail>
        <extent unit="pages">
          <start>6012</start>
          <end>6016</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">00032700 (ISSN)</identifier>
      <titleInfo>
        <title>Analytical Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Anal. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-6044238254&amp;partnerID=40&amp;md5=b90612c4bfab2c1f63332219cc2bca5a</url>
    </location>
    <abstract>Gadolinium (III) complexes are under intense scrutiny as contrast agents for magnetic resonance imaging. Although currently used mainly as extracellular agents, there is a growing interest to exploit their contrast enhancing ability in the intracellular environment To ascertain the preservation of their chemical integrity upon the intracellular entrapment, it is necessary to have a method for their dosage in the cell lysates. Herein, a mass spectrometric method for detection and quantification of gadolinium complexes in cell lysates is reported. The detection by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) was carried out by using a non-acidic matrix (2,4,6-trihydroxyacetophenone), which does not allow any leakage of gadolinium from the complex. Quantification has been possible by using as an internal standard an ytterbium complex with the same ligand of the analyte. Ytterbium was chosen because, among the lanthanides, it is the one with the isotopic distribution pattern the most similar to that of gadolinium. Sensitivity was enough to detect low micromolar quantities of a cationic complex and high micromolar quantities of a neutral complex in cell lysates of rat hepatoma cells. In the case of anionic complexes, sensitivity was too low for quantitative analysis. To the best of our knowledge, this is the first report concerning the quantification of metal complexes by MALDI-TOF-US.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Extent of hydration of octadentate lanthanide complexes incorporating phosphinate donors: Solution relaxometry and luminescence studies</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Williams</namePart>
      <namePart type="given">J.A.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>17</start>
          <end>23</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">03009246 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society - Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0005366355&amp;partnerID=40&amp;md5=d103f1dbc91559ba2c9928bd32e241b0</url>
    </location>
    <abstract>The behaviour of luminescent (Eu, Tb) and highly paramagnetic (Gd) complexes of 1,4,7,10-tetraazacyclododecane containing one carboxamide and three phosphinate substituents has been studied in solution. Analyses of variable-temperature nuclear magnetic relaxation dispersion profiles indicate that there is no water molecule directly co-ordinated to gadolinium(III) ions. It has been found that the observed relaxation enhancement of solvent protons is determined, in addition to the contribution from water molecules diffusing in close proximity to the paramagnetic complex, by a relatively distant water molecule in the 'second co-ordination sphere'. This is possible because the amide carbonyl oxygen can participate in hydrogen bonding (as a hydrogen-bond acceptor) to a local water molecule, which brings the water molecule close to the metal ion. The luminescence spectra of the complexes of Eu and Tb in water and D2O are also consistent with such a hydration scheme and there is a good correlation between the non-integral q value (number of inner-sphere water molecules) determined by this method and the distance between the metal ion and the water proton estimated by relaxometric methods. It is proposed that the hydration states q = 0 and 1 may be considered to represent boundary conditions and a given complex in solution may possess intermediate values.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Hyperpolarization transfer from parahydrogen to deuterium via carbon-13</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canet</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>119</number>
        </detail>
        <detail type="issue">
          <number>17</number>
        </detail>
        <extent unit="pages">
          <start>8890</start>
          <end>8896</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">00219606 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Chemical Physics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J Chem Phys</title>
      </titleInfo>
    </relatedItem>
    <abstract>A study was performed on hyperpolarization transfer from parahydrogen to deuterium via carbon-13. Calculations involved commutators of the J-coupling Hamiltonian (HJ) with all relevant spin quantities. The results showed that the necessary condition for polarization transfer towards deuterium via carbon-13 does not commute with HJ.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Improving the relaxivity by dimerizing Gd-AAZTA: Insights for enhancing the sensitivity of MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ramalingam</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Song</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kalman</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Swenson</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>13</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>663</start>
          <end>665</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">13877003 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77952102140&amp;partnerID=40&amp;md5=7b066c574f0b2857b98884aa9bb8904a</url>
    </location>
    <abstract>The synthesis of a dimeric derivative of Gd-AAZTA is reported. It retains the basic properties of the parent complex (q = 2, high stability) and displays a relaxivity of 14.0 mM-1 s-1 at 20 MHz and 298 K. The outstanding relaxivity is the result of the increased molecular reorientational time and of the contribution arising from 4 to 5 water molecules in the second coordination sphere of the Gd(III) ions. © 2010 Elsevier B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>In vitro and in vivo study of Solid Lipid Nanoparticles loaded with superparamagnetic iron oxide</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Peira</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Marzola</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Podio</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sbarbati</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gasco</namePart>
      <namePart type="given">M.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>11</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>19</start>
          <end>24</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">1061186X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Drug Targeting</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Drug Targeting</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0038407930&amp;partnerID=40&amp;md5=dd27f28750a667556c19897236b84e01</url>
    </location>
    <abstract>Solid Lipid Nanoparticles (SLN) are already under investigation as a pharmaceutical tool able to change the pharmacokinetic and biodistribution of carried molecules. SLN are able to target drugs to lymph after duodenal administration and to overcome the Blood Brain Barrier (BBB). In this study, superparamagnetic SLN have been prepared, have colloidal size, in vitro analysis showed relaxometric properties similar to Endorem®. In vivo Magnetic Resonance Imaging (MRI) of the central nervous system (CNS) with both SLN and Endorem® showed that superparamagnetic SLN have slower blood clearance than Endorem®. MRI data are consistent with CNS uptake of SLN lasting up to the end of the experiment (135 min). These findings confirm the ability of SLN to overcome the BBB; SLN might be used as a CNS MRI contrast agent.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Ligand Dynamics in H2Os3(CO)10 and H2Os3(CO)10L</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>213</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>207</start>
          <end>213</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1981</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001302617&amp;partnerID=40&amp;md5=74e2acdce77a3b25788edccc585fd159</url>
    </location>
    <abstract>The variable temperature 13C NMR spectra of H2Os3(CO)10 and H2Os3(CO)10L (L P(C6H5)3, P(O-i_C3H7)s3) and P(i_C3H7)3) have been recorded and the results interpreted in terms of a localized exchange process involving concerted motion of the hydride and the carbonyl ligands. Taken along with previously reported variable temperature 1H NMR data the results provide a complete picture of the ligand dynamics in these systems. © 1981.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Modulation of the antioxidant activity of HO. scavengers by albumin binding: A 19F-NMR study</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bruno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mainero</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>307</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>962</start>
          <end>966</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">0006291X (ISSN)</identifier>
      <titleInfo>
        <title>Biochemical and Biophysical Research Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Biochem. Biophys. Res. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037767768&amp;partnerID=40&amp;md5=d5a1fafb10e9026c7c515f310875a042</url>
    </location>
    <abstract>The interaction between different HO. radical scavengers in a three-component antioxidant system has been investigated by means of 19F-NMR spectroscopy. This system is composed of bovine serum albumin (BSA), trolox, and N-(4-hydroxyphenyl)-trifluoroacetamide (CF3PAF). The antioxidant capacity of BSA and trolox has been assessed by measuring the amount of trifluoroacetamide (TFAM) arising from the radical mediated decomposition of CF3PAF. When assayed separately, both trolox and BSA behaved as antioxidants, as they were effective to protect CF3PAF from HO. radical-mediated decomposition. By contrast, trolox enhanced the production of TFAM in the presence of BSA, thus behaving as a pro-oxidant. Urate, carnosine, glucose, and propylgallate showed antioxidant properties both with or without BSA. CF3PAF and trolox were found to bind to BSA with association constants in the order of 5×103M-1 and to compete for the same binding sites. These results have been discussed in terms of BSA-catalysed cross-reactions between trolox-derived secondary radicals and CF3PAF. © 2003 Elsevier Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Proteomics as a tool to improve investigation of substantial equivalence in genetically modified organisms: The case of a virus-resistant tomato</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Corpillo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gardini</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vaira</namePart>
      <namePart type="given">A.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Basso</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Accotto</namePart>
      <namePart type="given">G.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>4</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>193</start>
          <end>200</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">16159853 (ISSN)</identifier>
      <titleInfo>
        <title>Proteomics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Proteomics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0942287050&amp;partnerID=40&amp;md5=da79db47e04cf88bdf7e2baee20e6b54</url>
    </location>
    <abstract>At present, the so-called "substantial equivalence" is the only widely accepted criterion for deciding whether or not a transgenic food is, from an alimentary point of view, to be considered totally correspondent to the "traditional" one from which it derives. Although never exactly defined, it deals with a comparison between the chemical composition of the two foods. A more in-depth analysis can be performed by one of the most suitable methods that allows for the simultaneous screening of many components without prior identification, the analysis of the proteome. As a model for testing this kind of approach, we compared protein expression of two types of tomato plants, having the same genetic background, except for a virus resistance trait introduced by genetic engineering. When proteins extracted from seedlings of the two types were analyzed by two-dimensional electrophoresis, no significant differences, either qualitative or quantitative, were detected, indicating that in this case the expression of major proteins was unmodified by the genetic manipulation. Fifteen proteins were identified by peptide mass fingerprinting.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and NMRD studies of Gd3+ complexes of macrocyclic polyamino polycarboxylic ligands bearing β-benzyloxy-α-propionic residues</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ermondi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>31</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>1100</start>
          <end>1103</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1992</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000203659&amp;partnerID=40&amp;md5=5eefe1110603113b50fa7a3b3c38397e</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Carbon-nitrogen bond cleavage in 1-dimethylaminobut-2-yne and derived ligands in triruthenium and triosmium clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Jannon</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arce</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deeming</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1987</start>
          <end>1991</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049095775&amp;partnerID=40&amp;md5=ff69ae423958a033bb90e5bda0d9219c</url>
    </location>
    <abstract>Dodecacarbonyltriruthenium reacts in refluxing cyclohexane with 1-dimethylaminobut-2-yne (MeC≡ CCH2NMe2) to give good yields of the isomers [Ru3H(CO)9(μ3-MeCCCHNMe2)] (1) and [Ru3H(CO)9-(μ3-MeCCHCNMe2)] (2) which are related in stoicheiometry (although perhaps not in structure) to known complexes containing μ3-allenyl (R1C=C=CHR2) or diosmium-substituted μ3-allyl (R1CCHCR2) ligands. The osmium analogue of complex (1) is obtained similarly from [Os3(CO)12] but [Os3(CO)10-(MeCN)2] reacts at room temperature with the alkyne giving [Os3H(CO)9(μ3-MeC=C=CH2)] by C-N bond cleavage. Rotation about the C-N bond in complex (1) in chloroform solution is restricted but the rate is accelerated by the addition of small amounts of CF3CO2H while, in neat CF3CO2H, compound (1) is protonated to give [Ru3H2(CO)9(MeCCCHNMe2)]+ for which the rotation barrier is much higher. Neutralisation of acidic solutions of complex (1) gives up to 15% of the but-2-ynal compound [Ru3H2(CO)9(μ3-MeC 2CHO)] by hydrolysis. Compound (1) is converted totally into (2) in refluxing hexane but in the presence of H2 hydrogenolysis of the C-N bond also occurs to give the compounds [Ru3H2(CO)9(μ3-MeC 2Me)], [Ru3H(CO)9(μ3-MeC=C=CH2)] and [Ru3H(CO)9(μ3-MeCCHCH)].</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Carbonhalogen bond activation at Ru3(CO)12</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deeming</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Manotti Lanfredi</namePart>
      <namePart type="given">A.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>244</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>C47-C49</start>
          <end>C47-C49</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0002650785&amp;partnerID=40&amp;md5=86bb75c7b94b402d964f5286149e1e82</url>
    </location>
    <abstract>The structure of the complex ClRu3(CO)9(C2Ph), obtained by treating Ru3(CO)12 with PhCCCl, has been determined by X-ray methods. The three Ru and the Cl atoms are in a butterfly arrangement with the RuRu hinge side open. The acetylide interacts through σ and π bonds with all three Ru atoms. © 1983.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A responsive MRI contrast agent to monitor functional cell status</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Himmelreich</namePart>
      <namePart type="given">U.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hieronymus</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Justicia</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zenke</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hoehn</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>32</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>1142</start>
          <end>1149</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">10538119 (ISSN)</identifier>
      <titleInfo>
        <title>NeuroImage</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>NeuroImage</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33748090929&amp;partnerID=40&amp;md5=d298857ed7f4c594fa395ee74d53bf01</url>
    </location>
    <abstract>It has been shown that insoluble Gd chelates are suitable MRI contrast agents for conditional activation by intracellular lipases. The DTPA-based, insoluble, inactive contrast agent was internalized into dendritic cells by phagocytosis. Cleavage of long aliphatic side chains by intracellular lipase activity leads to the contrast agents solubility and hereby its activation depending on the enzyme expression. Uptake and activation of the contrast agent was much reduced in Flt3+ CD11b+ progenitor cells. Detectability limits in the T1-weighted MR images were estimated in phantoms and in vivo in the rat brain. Marginal toxic effects were only observed at very high concentrations of the contrast agent. The chelate can easily be modified to be targeted by enzymes expressed during specific change of cell status like activation or differentiation. Such a system is suitable for functional cellular in vivo MR imaging. © 2006 Elsevier Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>1H-NMR relaxometric study of pancreatic serine (pro)enzyme inhibition by a Gd(III) chelate bearing boronic functionalities</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoletti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viola</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tarricone</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>39</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>741</start>
          <end>746</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">10399712 (ISSN)</identifier>
      <titleInfo>
        <title>Biochemistry and Molecular Biology International</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>BIOCHEM. MOL. BIOL. INT.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0029657993&amp;partnerID=40&amp;md5=36b79a183348b191d678ee4aecebcf69</url>
    </location>
    <abstract>Binding of the paramagnetic N,N'-bis(m-boroxyphenylcarbamoylmethyl)- diethylenetriamine-N,N',N'-triacetic acid Gd(III) complex (GdBB) to chymotrypsin, chymotrypsinogen, trypsin, typsinogen and pancreatic elastase has been investigated by 1H-NMR relaxometry, between pH 6.0 and 8.5, at 25.0°C. Values of Ki for the competitive inhibition of serine proteinases by GdBB are in excellent agreement with values of Kd obtained by 1H-NMR relaxometry, suggesting that the substrate and the paramagnetic complex bind to the same region. Moreover, 1H-NMR relaxometry allowed to determine values of Kd for GdBB binding to chymotrypsinogen and trypsinogen, both devoid of catalytic activity. The increase of the water proton relaxation rate upon GdBB binding to serine (pro)enzymes may be useful in the design of novel functional contrast agents for magnetic resonance imaging.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>13C13C coupling constants in μ2- and μ4-(η2-acetylene) complexes of cobalt</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giamello</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>262</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>c1-c4</start>
          <end>c1-c4</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001930651&amp;partnerID=40&amp;md5=5e63ea908f2ae057fe8b6a1e7fde227b</url>
    </location>
    <abstract>A drastic decrease in 1J(CC) is observed on going from free acetylene to complexes in which the acetylene is bonded to two and four cobalt atoms, respectively. The relationship between 1J(CC) and the hybridization state of the carbon atoms is discussed by working out CNDO calculations in connection with the method developed by Maciel et al. to evaluate the Fermi contact term for directly bonded atoms. © 1984.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>1,2-hydroxypyridonate/terephthalamide complexes of gadolinium(lll): Synthesis, stability, relaxivity, and water exchange properties</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Werner</namePart>
      <namePart type="given">E.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kozhukh</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Moore</namePart>
      <namePart type="given">E.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Avedano</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>48</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>277</start>
          <end>286</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-59849101903&amp;partnerID=40&amp;md5=06391523e8ba956c5f4af79aef871493</url>
    </location>
    <abstract>Four new Gd(lll) complexes based on the 1,2-hydroxypyridinone chelator have been synthesized and evaluated as potential magentic resonance imaging contrast agents. Previously reported work examining Gd-TREN-1,2-HOPO (3; HOPO = hydroxypyridinone) suggests that the 1,2-HOPO unit binds strongly and selectively to Gd(lll), encouraging further study of the stability and relaxivity properties of this class of compounds. Among the new complexes presented in this paper are the homopodal Gd-Ser-TFEN-1,2-HOPO (Gd-5) and three heteropodal bis-1,2-HOPO-TAM complexes (Gd-6, Gd-7, and Gd-8; TAM = terephthalamide). Conditional stability constants were determined, and all pGd values are in the range of 18.5-19.7, comparable to other analogous HOPO complexes and currently used commercial contrast agents. Relaxivities for all complexes are about twice those of commercial agents, ranging from 7.8 to 10.5 mlvr-1 s-1 (20 MHz; 25 °C), and suggest two innersphere water molecules in fast exchange. Luminescent measurements were used to verify the number of coordinated waters for Gd-5, and VT 17O NMR experiments were employed for the highly soluble Gd-TREN-bis-1.2-HOPO-TAM-N3 (Gd-8) complex to measure a fast water exchange rate,298Kex = 1/τM, of 5.1 (±0.4) x 108 s-1 ( 298τ∼ 2 ns). © 2009 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Structural and relaxometric characterization of peptide aggregates containing gadolinium complexes as potential selective contrast agents in MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Vaccaro</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mangiapia</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paduano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Accardo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tesauro</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morelli</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>8</number>
        </detail>
        <detail type="issue">
          <number>17</number>
        </detail>
        <extent unit="pages">
          <start>2526</start>
          <end>2538</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">14394235 (ISSN)</identifier>
      <titleInfo>
        <title>ChemPhysChem</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>ChemPhysChem</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-36849004509&amp;partnerID=40&amp;md5=4715386bf18cb1f474865d62a4104b71</url>
    </location>
    <abstract>The structural and relaxometric characterization of a novel class of supramolecular aggregates, as potential tumor-specific contrast agents in magnetic resonance imaging (MRI), is reported. The aggregates are based on a new monomer with an upsilon shape (MonY) that contains, in the same molecule, all three fundamental tasks that are required: 1) a hydrophobic moiety that allows the formation of supramolecular aggregates; 2) the bioactive CCK8 peptide for target recognition; and 3) a chelating agent able to give stable gadolinium complexes. As indicated by dynamic light scattering and small-angle neutron scattering (SANS) measurements, MonY and its gadolinium complex MonY(Gd) aggregate in aqueous solution to give ellipsoidal micelles with a ratio between the micellar axes of ≈1.7 and an aggregation number Nagg of ≈30. There are no differences in the aggregation behavior of MonY and MonY(Gd), which indicates that the presence of metal ions, and therefore the reduction of the net charge, does not influence the aggregation behavior. When MonY or MonY(Gd) are blended with dioleoyl phosphatidylcholine (DOPC), the aggregation behavior is dictated by the tendency of DOPC to give liposomes. Only when the amount of MonY or MonY(Gd) is higher than 20% is the coexistence of liposomes and micelles observed. The thickness d of the bilayer is estimated by SANS to be ≈35-40 Å, whereas cryogenic transmission electron microscopy images show that the diameter of the liposomes ranges from ≈50 to 150 nm. Self-assembling micelles of MonY(Gd) present high relaxivity values (r 1p-15.03 mM-1 s-1) for each gadolinium complex in the aggregate. Liposomes containing MonY(Gd) inserted in the DOPC bilayer at a molar ratio of 20:80 present slightly lower relaxivity values (r1p = 12.7 mM-1 s-1), independently of their internal or external position in the liposome. © 2007 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Steric control of lanthanide hydration state: Fast water exchange at gadolinium in a mono-amide 'DOTA' complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Congreve</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1441</start>
          <end>1445</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">14779226 (ISSN)</identifier>
      <titleInfo>
        <title>Dalton Transactions</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Dalton Trans.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-2642525373&amp;partnerID=40&amp;md5=debf2046aadca805e5f05a5fc49e0a6d</url>
    </location>
    <abstract>Detailed analyses of the solution structure and exchange dynamics of two sets of homologous mono-amide triacetate lanthanide complexes (Ln = Eu, Gd) of cyclen have been undertaken. The complex [LnL1], bearing an N-linked CH2CH2NHCO-pyridyl moiety, forms mono-aqua (q = 1) species in solution and the Gd complex undergoes rapid water exchange (kex = 11 × 107s-1, 298 K) as a result of the steric destabilisation of the Ln-water binding interaction. The homologous complex with a C-3 spacing chain, [LnL2], forms a q = 0 species.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Responsive Mn(II) complexes for potential applications in diagnostic Magnetic Resonance Imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rolla</namePart>
      <namePart type="given">G.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fekete</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arena</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>19</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>1115</start>
          <end>1122</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">09680896 (ISSN)</identifier>
      <titleInfo>
        <title>Bioorganic and Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Bioorg. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79551495773&amp;partnerID=40&amp;md5=558f9a8ce0f826627a55cfc8818fefbd</url>
    </location>
    <abstract>The investigation of new Mn(II)-based MRI/Molecular Imaging probes responsive to the enzyme tyrosinase for potential diagnostic applications is herein described. The expression of the enzyme tyrosinase, an oxidoreductase, is up-regulated in melanoma cancer cells. Three novel ligands (L1, L2 and L3) were designed as modified acyclic polyaminocarboxylate chelates by introducing an l-tyrosine residue in place of an aminoacetate unit. The corresponding Mn(II) complexes were fully characterised by 1H NMR relaxometric techniques in aqueous media. The responsive activity towards the expression of tyrosinase was then assessed by monitoring the 1H 1/T1 relaxivity changes during incubation experiments in buffered solutions containing tyrosinase at different concentrations and in B16F10 melanoma cell homogenate. New insight on the mechanism of action of these systems was gained by measuring the magnetic field dependence of the relaxivity and ESR spectra of the incubated solutions. The systems developed showed responsive activity to tyrosinase with a relaxation enhancement spanning from 50% (MnL1) to 350% (MnL3) which augurs well for the development of diagnostic probes to detect melanoma cancer. © 2010 Elsevier Ltd. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Polymerized mixed aggregates containing gadolinium complex and CCK8 peptide</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Vaccaro</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mangiapia</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Accardo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tesauro</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Frielinghaus</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morelli</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paduano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>286</number>
        </detail>
        <detail type="issue">
          <text>14-15</text>
        </detail>
        <extent unit="pages">
          <start>1643</start>
          <end>1652</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">0303402X (ISSN)</identifier>
      <titleInfo>
        <title>Colloid and Polymer Science</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Colloid Polym. Sci.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-55649090320&amp;partnerID=40&amp;md5=9e1f9daeb0e382137f50257f1009783b</url>
    </location>
    <abstract>Two novel amphiphilic unimers containing an aliphatic hydrophobic chain (PDA) with two CΞC triple bonds and hydrophilic heads presenting the chelating agent DTPAGlu and the CCK8 bioactive peptide, respectively, have been prepared by solid phase synthesis. Aggregates obtained by mixing together PDA-DTPAGlu, or its Gd(III) complex, and PDA-L2-CCK8 in 70/30 molar ratio before and after a polymerization process carried out by UV irradiation have been structurally characterized by means of small angle neutron scattering. The relaxivity properties of aggregates containing Gadolinium complexes have also been investigated. Elongated mixed micelles have been observed, in which the relaxivity value r1p for each Gadolinium complex, measured at 20 MHz and 298 K, is around 12 mM-1 s-1. © Springer-Verlag 2008.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Physicochemical Properties of Mixed Micellar Aggregates Containing CCK Peptides and Gd Complexes Designed as Tumor Specific Contrast Agents in MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Accardo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tesauro</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Roscigno</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paduano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">D'Errico</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pedone</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morelli</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>126</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>3097</start>
          <end>3107</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-1642312071&amp;partnerID=40&amp;md5=6054514b1d51d9b915ff13815a92a522</url>
    </location>
    <abstract>New amphiphilic molecules containing a bioactive peptide or a claw moiety have been prepared in order to obtain mixed micelles as target-specific contrast agents in magnetic resonance imaging. The first molecule, C 18H37CONH(AdOO)2-G-CCK8 (C18CCK8), contains a C18 hydrophobic moiety bound to the C-terminal cholecystokinin octapeptide amide (CCK 26-33 or CCK8). The second amphiphilic compound, C18H 37CONHLys(DTPAGlu)CONH2 (C18DTPAGlu) or its gadolinium complex, (C18DTPAGlu(Gd)), contains the same C18 hydrophobic moiety bound, through a lysine residue, to the DTPAGlu chelating agent. The mixed aggregates as well as the pure C18DTPAGlu aggregate, in the presence and absence of Gd, have been fully characterized by surface tension measurements, FT-PGSE-NMR, fluorescence quenching, and small-angle neutron scattering measurements. The structural characterization of the mixed aggregates C18DTPAGlu(Gd)-C18CCK8 indicates a spherical arrangement of the micelles with an external shell of ∼21 Å and an inner core of ∼20 Å. Both the DTPAGlu(Gd) complexes and the CCK8 peptides point toward the external surface. The measured values for relaxivity in saline medium at 20 MHz proton Larmor frequency and 25 °C are 18.7 mM-1 s-1. These values show a large enhancement in comparison with the isolated DTPAGlu(Gd) complex.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Nanoparticles containing octreotide peptides and gadolinium complexes for MRI applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Accardo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morisco</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tesauro</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mangiapia</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Radulescu</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Brandt</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morelli</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>17</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>154</start>
          <end>162</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">10752617 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Peptide Science</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Pept. Sci.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-78651440633&amp;partnerID=40&amp;md5=cb827d533998435c893aaac08327b289</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Micelles obtained by aggregation of gemini surfactants containing the CCK8 peptide and a gadolinium complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Accardo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tesauro</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morisco</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mangiapia</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vaccaro</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Heenan</namePart>
      <namePart type="given">R.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paduano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morelli</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>14</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>587</start>
          <end>599</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">09498257 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Biological Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Biol. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-67349182328&amp;partnerID=40&amp;md5=740175be19068ef4ebde06d58bb79814</url>
    </location>
    <abstract>Two gemini surfactants, [C18CysL5CCK8]2 and [C18CysDTPAGlu] 2, containing, respectively, the CCK8 peptide and the DTPAGlu chelating agent or its gadolinium complex have been prepared by linking lipophilic chains through a disulfide bond between two cysteine residues. The two surfactants aggregate in water solution forming pure or mixed micelles, with a critical micellar concentration in the 5 × 10-6-5 × 10-5 mol kg-1 range, as measured by fluorescence spectroscopy. As indicated by small-angle neutron scattering, the shape and size of the micelles are influenced by the temperature: increasing temperature leads to progressive reduction of the size of the supramolecular aggregates. Cylindrical structures found at lower temperatures (10-40 °C) evolve into ellipsoidal micelles at 50-80 °C. Furthermore, the surface-exposed CCK8 peptide changes its conformation above a transition temperature of approximately 45 °C, going from a β-sheet to a random-coil structure, as indicated by circular dichroism measurements. The mixed aggregate obtained by coaggregation of the two gemini-based amphiphilic compounds, [C18CysDTPAGlu(Gd)]2 and [C18CysL5CCK8]2 in 70:30 molar ratio, represents the first example of a peptide-containing gemini surfactant as a potential target-selective contrast agent in MRI. In fact, it presents a high relaxivity value of the gadolinium complex, 21.5 mM-1 s -1, and the CCK8 bioactive peptide exposed on the external surface is therefore capable of selective targeting of the cholecystokinin receptors. © 2009 SBIC.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Micelles derivatized with octreotide as potential target-selective contrast agents in MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Morisco</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Accardo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tesauro</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Benedetti</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morelli</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>242</start>
          <end>250</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">10752617 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Peptide Science</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Pept. Sci.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-63449132697&amp;partnerID=40&amp;md5=d25865a2de1f2c95c49b162cc707ad65</url>
    </location>
    <abstract>New amphiphilic monomers (OCA-DTPAGlu and OCA-DOTA) containing, in the same molecule, three different functions: (i) the chelating agent (DTPAGlu or DOTA) able to coordinate gadolinium ion, (ii) the octreotide bioactive peptide able to target somatostatin receptors, and (iii) a hydrophobic moiety with two 18-carbon atoms alkyl chains have been designed and synthesized by solid-phase methods. The novel amphiphilic monomers aggregate, in water solution, giving stable micelles at very low concentration (cmc values of 2.3 × 10-6 mol kg-1 and 2.5 × 10-6 mol kg-1 for OCA-DTPAGlu and OCA-DOTA, respectively) as confirmed by fluorescence spectroscopy. Fluorescence studies and circular dichroism experiments indicate, for the two compounds as well as for their gadolinium complexes (OCA-DOTA(Gd) and OCA-DTPAGlu(Gd)), the complete exposure of octreotide on the micelle surface, and the predominant presence of an antiparallel β-sheet peptide conformation characterized by a β-like turn. The high relaxivity value (r1p = 13.9mM-1 s-1 at 20 MHz and 25 °C), measured for micelles obtained by the gadolinium complex OCA-DTPAGlu(Gd), indicates these aggregates as promising target-selective magnetic resonance imaging (MRI) contrast agents. Copyright © 2008 European Peptide Society and John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>How to determine free Gd and free ligand in solution of Gd chelates. A technical note.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>184</start>
          <end>188</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">15554317 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast media &amp; molecular imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33947726713&amp;partnerID=40&amp;md5=58420dccd5484ce97b4e0717354ad770</url>
    </location>
    <abstract>Gd(III) chelates are often used as reporting probes in magnetic resonance imaging applications. Their use relies on the assumption that their high stability ensures against the release of free ligand and free Gd(3+) ions, which are both highly toxic to living systems. The presence of free Gd(3+) ions may have a profound effect on the contrast in the MR image as they may form highly hydrated, macromolecular complexes endowed with very high relaxivity thus providing erroneous information on the extent of the contrast effect induced by the given reporting probe. Although the stability of a given complex may be high enough, the complexation step could not have been completed. Therefore any Gd complex preparation has to be carefully checked for the content of free ligand and free metal ions. Herein the currently used procedures that allow an assessment of the amounts of free metal ions and free ligand in a solution of a given Gd complex are described in detail. Copyright 2006 John Wiley &amp; Sons Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Highly luminescent Eu3+ and Tb3+ macrocyclic complexes bearing an appended phenanthroline chromophore</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Quici</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Marzanni</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavazzini</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Accorsi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Armaroli</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barigelletti</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>41</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>2777</start>
          <end>2784</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037140717&amp;partnerID=40&amp;md5=3f96cf0c2540d64248663d775e7c8d24</url>
    </location>
    <abstract>A two-component ligand system (1) containing 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (DO3A) as the hosting unit for the lanthanide cations and an appended asymmetrically functionalized 1,10-phenanthroline (phen) as the chromophore was synthesized. The 1:1 complexes with Eu3+, Gd3+, Tb3+, and Yb3+ have been prepared and studied in aqueous solution. For Gd·1, a relaxivity value of 2.4 mM-1 s-1 has been measured at 20 MHz and 25 °C, which indicates that there are no water molecules in the first coordination sphere of the metal ion. The analysis of high resolution 1H NMR spectra of Yb·1 supports this view and suggests the direct involvement of the phen moiety in the coordination of the metal ion. For Eu·1 and Tb·1, the absorption and luminescence spectra, the overall luminescence efficiencies, and the metal-centered (MC) lifetimes were obtained; coordination features were also determined by comparing luminescence properties in water and deuterated water. For Eu·1 and Tb·1, the overall emission sensitization (se) process in air-equilibrated water was found to be notably effective with se = 0.21 and 0.11, respectively. A detailed study of the steps originating from light absorption at the phen unit and leadinq to MC sensitized emission was performed.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for magnetic resonance imaging cell labeling</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Menchise</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Catanzaro</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Carrera</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>53</number>
        </detail>
        <detail type="issue">
          <number>13</number>
        </detail>
        <extent unit="pages">
          <start>4877</start>
          <end>4890</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">00222623 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77954342954&amp;partnerID=40&amp;md5=b3337a4e78a373ba846d7c6a01aaf531</url>
    </location>
    <abstract>Four novel MRI Gd(III)-based probes have been synthesized and evaluated for their labeling properties on cultured cell lines K562, C6, and B16. The labeling strategy relies upon the fact that cells display a large number of reactive exofacial protein thiols (EPTs) that can be exploited as anchorage points for suitably activated MRI probes. The probes are composed of a Gd(III) chelate (based on either DO3A or DTPA) connected through a flexible linker to the 2-pyridyldithio chemical function for binding to EPTs. GdDO3A-based chelates could efficiently label cells (up to a level of 1.2 × 1010 Gd(III) atoms/cell), whereas GdDTPA-based chelates showed poor or no cell labeling ability at all. Among the GdDO3A based compounds, that having the longest spacer (compound GdL1A) showed the best labeling efficacy. The mechanism of EPT mediated cell labeling by GdL1A involves probe internalization without sequestration of the Gd(III) chelate within subcellular structures such as endosomes. © 2010 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Ln(III)-DOTAMGly Complexes: A Versatile Series to Assess the Determinants of the Efficacy of Paramagnetic Chemical Exchange Saturation Transfer Agents for Magnetic Resonance Imaging Applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>39</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>235</start>
          <end>243</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">00209996 (ISSN)</identifier>
      <titleInfo>
        <title>Investigative Radiology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Invest. Radiol.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-1642351484&amp;partnerID=40&amp;md5=6e1391c98c86be23dd5395c6859524e7</url>
    </location>
    <abstract>Rationale and Objectives: Paramagnetic Ln-DOTAMGly complexes (Ln ≠ La, Lu, and Gd) are the prototypes of a novel class of contrast agents for magnetic resonance imaging based on chemical exchange saturation transfer (CEST). Their ability to reduce the water signal intensity depends on the interplay of several physicochemical properties of the agent and instrumental parameters. This study aims to identify possible routes for their optimization Methods: Saturation transfer (ST) has been measured in vitro at 7.05 T as a function of pH, temperature, and concentration of the agent. Results: Large saturation transfer effects have been observed upon irradiating the coordinated water protons (for Ln = Pr, Nd, Eu, and Tb). The comparison of the results obtained by irradiating water versus amide protons allows the set-up of ratiometric methods through which the ST response can be made independent on the concentration of the agent. Conclusions: The modulation of the magnetic properties along the lanthanide series allows an in-depth understanding of the determinants of ST effect and provides useful insights for the design of more efficient agents.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Metal containing nanosized systems for MR-Molecular Imaging applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>252</number>
        </detail>
        <detail type="issue">
          <text>21-22</text>
        </detail>
        <extent unit="pages">
          <start>2424</start>
          <end>2443</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">00108545 (ISSN)</identifier>
      <titleInfo>
        <title>Coordination Chemistry Reviews</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Coord. Chem. Rev.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-50849137152&amp;partnerID=40&amp;md5=659115e80b364215c5b15189a7f08494</url>
    </location>
    <abstract>This review aims at assessing the role of nanosized systems as MR-imaging reporters in Molecular Imaging applications. The possibility of delivering a high number of imaging agents at the target of interest appears the solution of choice to overcome the drawback associated with the low sensitivity of the MRI approach. The use of metal-based particles entered very early in the armoury of MRI contrast agents with the Superparamagnetic Iron Oxides' family that are still among the most sensitive systems. The review devotes much attention to the design and use of self-assembled systems based on lipophilic molecules, reporting examples taken by products and processes developed in the authors' laboratory. The imaging reporters are invariantly represented by highly stable lanthanide(III) complexes. In general, whether is the paramagnetic lanthanide(III) ion, the particles act as T2-susceptibility agents, whose contrasting abilities increase by increasing the magnetic field strength. In the case of Gd(III)-complexes, the systems mainly act as T1-relaxation agents, whose efficiency is eventually enhanced by the long reorientational time of the supramolecular aggregate. In addition to tackle sensitivity issues, such systems may also be designed in order to become responsive to a specific physical or biochemical parameter of the microenvironment in which they distribute. Moreover, nanosized carriers for Gd(III)-complexes based on naturally occurring systems (apoferritin and lipoproteins) have also been considered for targeting specific epitopes on diseased cells. Finally, liposomes have been exploited to generate a novel class of highly sensitive CEST (Chemical Exchange Saturation Transfer) agents dubbed LIPOCEST. Such systems are characterized by a shifted resonance for the large pool of water molecules entrapped in the liposomal cavity that can be selectively irradiated in order to transfer saturated magnetization to the bulk water signal. © 2008 Elsevier B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Novel pH-reporter MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>41</number>
        </detail>
        <detail type="issue">
          <number>22</number>
        </detail>
        <extent unit="pages">
          <start>4334</start>
          <end>4336</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037112658&amp;partnerID=40&amp;md5=e36477e4abf4cea60d6f2cc8ab8d5da4</url>
    </location>
    <abstract>Attractive alternatives to conventional contrast agents for magnetic resonance imaging applications are the paramagnetic chemical exchange saturation transfer (CEST) agents based on saturation transfer (ST) to the solvent water resonance. The ratio of ST effects obtained upon irradiating Ln-coordinated water and amide protons in [Ln(dotamGly)] (dotam=1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10 -tetrazacyclododecane; see picture) complexes is pH dependent and concentration independent.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Structure, stability and relaxivity of trinuclear triangular complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Zebret</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Torres</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Guénée</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Senatore</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hamacek</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>40</number>
        </detail>
        <detail type="issue">
          <number>16</number>
        </detail>
        <extent unit="pages">
          <start>4284</start>
          <end>4290</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">14779226 (ISSN)</identifier>
      <titleInfo>
        <title>Dalton Transactions</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Dalton Trans.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79953744384&amp;partnerID=40&amp;md5=6a4da5725317154c2534fc3dfd114df8</url>
    </location>
    <abstract>The self-assembly of a carbonylpyridine-based heptadentate ligand with LnIII results in the formation of triangular trinuclear europium complexes, which exhibit interesting luminescent properties in the solid state and in solution. With a view to developing multimodal responsive systems, we report here the preparation and characterisation of analogous complexes with GdIII. The X-ray crystal structure of Gd3L23 indeed reveals the isostructurality with the EuIII complexes. A combination of 1H NMRD and variable temperature studies yields the parameters elucidating the exchange of coordinated water and relaxivity properties. Conveniently, the competitive spectrophotometric titrations with EDTA and NTA are used to determine the thermodynamic stability constants of the europium complexes in aqueous media. In addition, the exchange reaction with EDTA is monitored with NMR and fluorimetry. The interactions of the Eu III trinuclear complex with some potentially interfering ligands are qualitatively investigated by means of luminescence titrations. © 2011 The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The extraordinary ligand binding properties of human serum albumin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Curry</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Galliano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fanali</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Narciso</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Notari</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>57</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>787</start>
          <end>796</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">15216543 (ISSN)</identifier>
      <titleInfo>
        <title>IUBMB Life</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>IUBMB Life</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-30344446232&amp;partnerID=40&amp;md5=affd18adb20d4e0dc29f592dface65b4</url>
    </location>
    <abstract>Human serum albumin (HSA), the most prominent protein in plasma, binds different classes of ligands at multiple sites. HSA provides a depot for many compounds, affects pharmacokinetics of many drugs, holds some ligands in a strained orientation providing their metabolic modification, renders potential toxins harmless transporting them to disposal sites, accounts for most of the antioxidant capacity of human serum, and acts as a NO-carrier. The globular domain structural organization of monomeric HSA is at the root of its allosteric properties which are reminiscent of those of multimeric proteins. Here, structural, functional, biotechnological, and biomedical aspects of ligand binding to HSA are summarized. © 2005 IUBMB.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Large relaxivity enhancement of paramagnetic lipid nanoparticles by restricting the local motions of the GdIII chelates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Kielar</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>132</number>
        </detail>
        <detail type="issue">
          <number>23</number>
        </detail>
        <extent unit="pages">
          <start>7836</start>
          <end>7837</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77953306904&amp;partnerID=40&amp;md5=c9ad8b4218271f48de866f777def669d</url>
    </location>
    <abstract>A GdIII-DOTA-like complex bearing two aliphatic chains on adjacent acetic arms was designed, synthesized, and compared with its analogous monofunctionalized complex. A 1/T1 NMR relaxometric study of the two amphiphilic complexes incorporated into micelles and liposomes showed an unprecedented relaxivity enhancement for the complex with two lipophilic side arms. This remarkable result, which is attributed to a favorable water exchange rate and increased rigidity of the system resulting from limiting of the local motion of the gadolinium center, represents an important advance in the development of highly efficient nanosystems for MRI applications. © 2010 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Kinetics of the formation of [Ln(DOTAM)]3+ complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Baranyai</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bányai</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Brücher</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Király</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>23</number>
        </detail>
        <extent unit="pages">
          <start>3639</start>
          <end>3645</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">14341948 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34548072296&amp;partnerID=40&amp;md5=80dda51ea7857d6801f7eea42c92235f</url>
    </location>
    <abstract>The kinetics of the formation of lanthanide(III) complexes of the neutral ligand DOTAM differ considerably from those of DOTA and its derivatives, which contain negatively charged pendant groups. Formation of the complexes [Ln(DOTAM)]3+ occurs upon direct encounter of the Ln3+ ions and the fully deprotonated ligand in the pH range 4.7-5.8. The formation of a protonated intermediate, which is characteristic of the complexation of DOTA and its derivatives, was not detected. General base catalysis is not valid in the formation reactions of [Ln(DOTAM)]3+, which also indicates the absence of protonated intermediates. The rates of the proton-exchange reactions for the ligand species H2DOTAM2+ and HDOTAM+ have been studied by 1H NMR spectroscopy. Proton exchange was found to be a general base-catalysed process, therefore it cannot play an important role in the formation of these complexes. The second-order rate constants, kL, which characterize the formation of the complexes [Ln(DOTAM)]3+, are lower than the analogous rate constants reported for the Ln3+ complexes of open-chain multidentate ligands by three to four orders of magnitude. These low kL values can be interpreted by assuming an early rate-determining step (probably the second or third Ln 3+-amide bond formation) in the reaction seguence that leads to the [Ln(DOTAM)]3+ complex. Wiley-VCH Verlag GmbH &amp; Co. KGaA, 2007.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gadolinium-doped LipoCEST agents: A potential novel class of dual 1H-MRI probes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Boffa</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Menchise</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Carrera</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>47</number>
        </detail>
        <detail type="issue">
          <number>16</number>
        </detail>
        <extent unit="pages">
          <start>4667</start>
          <end>4669</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79953679575&amp;partnerID=40&amp;md5=e56a49aa8a4d28c5537b21434505101e</url>
    </location>
    <abstract>A novel class of paramagnetic liposome-based systems acting as dual T1 and CEST 1H-MRI contrast agents is described. The vesicles contain a shift reagent in the aqueous core and a Gd-complex on the external surface conjugated through a biodegradable linker. As such, the probe can generate T1 contrast only, but after the cleavage and removal of the Gd-coating, the CEST contrast is switched on. © The Royal Society of Chemistry 2011.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>{DOTA-bis(amide)}lanthanide complexes: NMR evidence for differences in water-molecule exchange rates for coordination isomers</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Zhang</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kovacs</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Burgess</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sherry</namePart>
      <namePart type="given">A.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>288</start>
          <end>296</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem Eur J</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035808372&amp;partnerID=40&amp;md5=7650b5c3320d9963ba5b658ad3e90a76</url>
    </location>
    <abstract>Two derivatives of 1,4,7,10-tetraazacyclododecane with trans-acetate and trans-amide side-chain ligating groups have been prepared and their complexes with lanthanide cations examined by multinuclear NMR spectroscopy. These lanthanide complexes exist in aqueous solution as a mixture of slowly interconverting coordination isomers with 1H chemical shifts similar to those reported previously for the major (M) and minor (m) forms of the tetra-acetate ([Ln(dota)]-) and tetraamide ([Ln(dtma)]3+) complexes. As in the [Ln(dota)]- and [Ln(dtma)]3+ complexes, the m/M ratio proved to be a sensitive function of lanthanide size and temperature. An analysis of 1H hyperfine shifts in spectra of the Yb3+ complexes revealed significant differences between the axial (D1) and non-axial (D2) components of the magnetic susceptibility tensor anisotropy in the m and M coordination isomers and the energetics of ring inversion and m ⇔ M isomerization as determined by two-dimensional exchange spectroscopy (EXSY). 17O shift data for the Dy3+ complexes showed that both have one inner-sphere water molecule. A temperature-dependent 17O NMR study of bulk water linewidths for solutions of the Gd3+ complexes provided direct evidence for differences in water exchange rates for the two coordination isomers. The bound-water lifetimes (τ298M) in the M and m isomers of the Gd3+ complexes ranged from 1.4-2.4 μs and 3-14 ns, respectively. This indicates that 1) the inner-sphere water lifetimes for the complexes with a single positive charge reported here are considerably shorter for both coordination isomers than the corresponding values for the [Gd(dtma)]3+ complex with three positive charges, and 2) the difference in water lifetimes for M and m isomers in these two series is magnified in the [Gd{dota-bis(amide)}] complexes. This feature highlights the remarkable role of both charge and molecular geometry in determining the exchange rate of the coordinated water.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>1,2-Hydroxypyridonates as contrast agents for magnetic resonance imaging: TREN-1,2-HOPO</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Jocher</namePart>
      <namePart type="given">C.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Moore</namePart>
      <namePart type="given">E.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Xu</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Avedano</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>46</number>
        </detail>
        <detail type="issue">
          <number>22</number>
        </detail>
        <extent unit="pages">
          <start>9182</start>
          <end>9191</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-35848961689&amp;partnerID=40&amp;md5=49ee06b82bff9891a61e3555c5576266</url>
    </location>
    <abstract>1,2-Hydroxypyridinones (1,2-HOPO) form very stable lanthanide complexes that may be useful as contrast agents for magnetic resonance imaging (MRI). X-ray diffraction of single crystals established that the solid-state structures of the Eu(III) and the previously reported [Inorg. Chem. 2004, 43, 5452] Gd(III) complex are identical. The recently discovered sensitizing properties of 1,2-HOPO chelates for Eu(III) luminescence [J. Am. Chem. Soc. 2006, 128, 10 067] allow for direct measurement of the number of water molecules coordinated to the metal center. Fluorescence measurements of the Eu(III) complex corroborate that, in solution, two water molecules coordinate the lanthanide (q = 2) as proposed from the analysis of NMRD profiles. In addition, fluorescence measurements have verified the anion binding interactions of lanthanide TREN-1,2-HOPO complexes in solution, studied by relaxivity, revealing only very weak oxalate binding (KA = 82.7 ± 6.5 M-1). Solution thermodynamic studies of the metal complex and free ligand have been carried out using potentiometry, spectrophotometry, and fluorescence spectroscopy. The metal ion selectivity of TREN-1,2-HOPO supports the feasibility of using 1,2-HOPO ligands for selective lanthanide binding [pGd = 19.3 (2), pZn = 15.2 (2), pCa = 8.8 (3)]. © 2007 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>13C N.M.R. spectra of highly 13CO-enriched metal carbonyls: Observation of 2JCC cis coupling constants</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>300</start>
          <end>302</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1981</dateIssued>
      </originInfo>
      <identifier type="issn">00224936 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Chemical Communications</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049096673&amp;partnerID=40&amp;md5=0f28daa985623298ca85e17cac3356d7</url>
    </location>
    <abstract>13C N.m.r. spectra of metal carbonyls (&gt;60% 13CO-enriched) allow the first observation of 2J CC cis values which are an order of magnitude smaller than 2JCC trans; this technique is also useful in the assignment of CO resonances as is shown in the case of H2Os 3(CO)10.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>13C NMR study of methynyltricobalt enneacarbonyls</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valle</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>18</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>9</start>
          <end>11</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1976</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0003123174&amp;partnerID=40&amp;md5=991901966f502455e84630172b52549e</url>
    </location>
    <abstract>The 13C NMR apical carbon resonances for a series of Co3(CO)9CY complexes have been observed to be in the lowfiedl region (310-230 ppm). Variable temperature spectra have shown "thermal decoupling" of carbon from cobalt and scrambling of the carbonyls. © 1976.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>13C solid state CP/MAS NMR studies of EDTA complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Santucci</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>129</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>L23-L25</start>
          <end>L23-L25</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1987</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0002081290&amp;partnerID=40&amp;md5=d4ac07c8af566cbdd1ba58e2895a2640</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>13C solid State MAS NMR spectra of [M3(CO)12] complexes (M = Ru and Os). Evidence for motional effects in [Ru3(CO)12]</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>146</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>151</start>
          <end>152</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1988</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-25744446573&amp;partnerID=40&amp;md5=36e767dcf826419e959c435caf7e4402</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>13C solid-state cross polarization/magic-angle-spinning nuclear magnetic resonance spectra of natural and synthetic melanins.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crippa</namePart>
      <namePart type="given">P.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
      </part>
      <identifier type="issn">08935785 (ISSN)</identifier>
      <titleInfo>
        <title>Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Pigment Cell Res</title>
      </titleInfo>
    </relatedItem>
    <abstract>The availability of NMR spectrometers operating in cross polarization/magic angle spinning (CP-MAS) has provided a powerful tool for the structural elucidation of insoluble materials. In this 13C NMR study of eumelanins we report the first direct evidence of the presence of different chemical functionalities in synthetic and natural eumelanins. These spectra contain useful information for the characterization of melanins from different sources.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>17O NMR spectroscopy of transition metal carbonyls</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>178</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>171</start>
          <end>175</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1979</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0008208657&amp;partnerID=40&amp;md5=40d531cb170821ae746f2a6c5ced6e1c</url>
    </location>
    <abstract>NMR spectra of 17O in natural abundance have been obtained for a range of metal carbonyls. Linewidths of less than 10 Hz for the derivatives of Cr, Mo, W and Fe have been observed, although they are slightly larger for the derivatives of metals having an electric quadrupole moment. Comparison with the corresponding 13C NMR data shows that: (i) the chemical shift ranges are comparable, (ii) the ordering of chemical shifts is not very different, (iii) the linewidths are more favourable for 17O than 13C for some Mn and Co derivatives and allow an extension of the range of temperature in which information on the fluxional dynamics are obtainable in the rapid exchange limit. © 1979.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>187Os subspectra in 1H and 31P{ 1H} spectra of triosmium carbonyl clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Stchedroff</namePart>
      <namePart type="given">M.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Salassa</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nordlander</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>40</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>107</start>
          <end>113</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">07491581 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0012817958&amp;partnerID=40&amp;md5=2710a617b4dc17d0b20f380558c8c8a5</url>
    </location>
    <abstract>A survey of the use of 187Os satellite subspectra in 1H and 31P{1H} spectra of triosmium carbonyl clusters is reported. By varying evolution delays in HMQC spectra of [Os 3(μ-H)2(CO)10] we have selectively extracted the values for 1J(Os,H) and 2J(Os,H), respectively. An analysis of the principal modes of phosphine coordination in triosmium clusters demonstrates that 31P{1H} 187Os satellite subspectra are diagnostic for equatorial coordination [1J(Os, P) = 211-223 Hz] or for axial coordination (perpendicular to the plane of the cluster) [1J(Os, P) ≈ 147 Hz]. Chelating and bridging diphosphines yield 187Os satellite subspectra which are the sum of A2X and AA′X spin systems. If significant P-P coupling is present, the AA′X component requires simulation. All observed 2J(Os,P) trans-equatorial couplings fall in the range 38-65 Hz. Copyright © 2001 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>1H and 13C NMR studies of acetylenic complexes of Co2(CO)8</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rossetti</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stanghellini</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>22</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>135</start>
          <end>139</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1977</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000728590&amp;partnerID=40&amp;md5=05ef1acb1bbe47d36c01a1891e7ff403</url>
    </location>
    <abstract>1H and 13Cnmr spectra of the acetylenic complexesCo2(CO)6(RC2R′) show downfield shifts of the ligand resonance upon complexation. The slight dependence of the chemical shift of C from the substitution on C′ is discussed in terms of the metal-alkyne bonding. Upfield shifts are observed for the acetylenic carbons when L (P- or As-ligand) substitutes one CO. Variable temperature 13Cnmr spectra show that the carbonyl are rapidly interchanging and that the rate of exchange depends on R and R′. © 1977.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>1H and 13C NMR study of cyclopentadienyl metal carbonyls in the solid state</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cordero</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Szalontai</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>49</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1307</start>
          <end>1314</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1993</dateIssued>
      </originInfo>
      <identifier type="issn">05848539 (ISSN)</identifier>
      <titleInfo>
        <title>Spectrochimica Acta Part A: Molecular Spectroscopy</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Spectrochim. Acta Part A Mol. Spectrosc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34548175880&amp;partnerID=40&amp;md5=75689442c86045eee79f5845fa0f760e</url>
    </location>
    <abstract>In this paper we deal with some structural and dynamic properties of Cp2W2(CO)6 (I) and Cp2Ru2(CO)4 (II) as shown by solid state 13C and 1H NMR experiments. The IR and 13C CPMAS spectra of a polycrystalline sample of I show that this compound possesses the anti rotameric structure found in a previously reported X-ray diffraction study. The analysis of the spinning side-band manifold in the 13C CPMAS spectrum of I allows us to assess a different semi-bridging character between two CO-groups not seen from the X-ray results. The spectral features of compound II are fully consistent with the X-ray and solution structures previously reported. In both compounds the cyclopentadienyl ligands are involved in fast reorientation motions which modulate the magnetic interactions responsible for the relaxation of 13C resonances. The activation energies (Ea) associated with this reorientation process of the Cp ring along their C5 coordination axis have been determined to be 15.5 and 10.2 kJ mol-1 for I and II respectively on the basis of 1H T1 measurements at different temperatures. Furthermore, we show that an empirical relationship relates Ea values and Tmin (the temperature at which proton relaxation is more efficient) in a related series of cyclopentadienyl compounds. © 1993.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>1H and 13C NMR study of the solid-state dynamics of H4Ru4(CO)12</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Orlandi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Groombridge</namePart>
      <namePart type="given">C.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mantle</namePart>
      <namePart type="given">M.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sales</namePart>
      <namePart type="given">K.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>13</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>2375</start>
          <end>2379</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1994</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0040730965&amp;partnerID=40&amp;md5=af3d7533c30452d2d842977f3164ea4a</url>
    </location>
    <abstract>Variable temperature 13C-{1H} CP/MAS, 1H MAS and 1H wide-line NMR spectra of H4Ru4(CO)12 are interpreted in terms of a dynamic process involving either the H4Ru4 moiety as a whole or the motion of the hydrides over the surface of the metallic core. The temperature dependence of the 1H spin-lattice relaxation time (T1) values over the range 298-360 K and the temperature dependence of the line width of the static 1H spectrum over the range 153-380 K together give an activation energy for this motional process of 67.2 ± 8.0 kJ mol-1. The rigidity of the carbonyl polyhedron is demonstrated by the fact that the 13C chemical shift tensor components are typical for those in a nonfluxional molecule and are invariant between 200 and 360 K. © 1994 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A R2/R1 ratiometric procedure for a concentration-independent, pH-responsive, Gd(III)-based MRI agent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>128</number>
        </detail>
        <detail type="issue">
          <number>35</number>
        </detail>
        <extent unit="pages">
          <start>11326</start>
          <end>11327</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33748342737&amp;partnerID=40&amp;md5=9ee7b42c94a0218649e0168a39353202</url>
    </location>
    <abstract>A novel procedure for making the pH responsiveness of a Gd-based probe independent of its concentration has been developed. The method is based on a ratiometric approach and requires the measurement, at magnetic fields higher than 1 T, of the paramagnetic contribution to the longitudinal and the transverse NMR relaxation rates of water protons in the presence of a Gd-based probe with a rotational mobility in the nanosecond time scale. The method has been tested and validated in vitro by using a macromolecular adduct based on the polyornithine backbone, whose rotational mobility is pH dependent. The results reported in this communication improve substantially the diagnostic potential of MRI responsive agents. Copyright © 2006 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>1H and 17O relaxometric investigations of the binding of Mn(II) ion to human serum albumin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canton</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>40</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>41</start>
          <end>48</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">07491581 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0142030576&amp;partnerID=40&amp;md5=f3ddbf81f5a2a14a82a879d46f0be0fd</url>
    </location>
    <abstract>Mn(II) ion binds to human serum albumin (HSA) through one strong binding site (KA = 7.9 × 103 M-1) and several weaker binding sites. Through competition assays it has been shown that the strong binding site lies in a region which has been previously identified as the Cd(II)-Zn(II) site. The binding of Mn(II) to HSA is strongly pH dependent (pKa ≈ 6.7), consistent with the involvement of histidine residues in the coordination of the metal ion. The analysis of 1H T1 as function of magnetic field strength and of 17O T2 as function of temperature allowed us to determine the various parameters involved in the relaxation process of the paramagnetic Mn(II)-HSA adduct. The Mn(II) ion bound to HSA maintains three or four coordinated water molecules whose residence lifetime is ca 20 ns at 298 K. Interestingly, a good fitting of the NMRD profile was possible only by assuming that the protons of the coordinated water molecules experience two motional regimes, i.e. a fast local motion (probably the rotation around their coordination axis) and the slower overall motion of the whole protein. Copyright © 2001 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>1H and 17O-NMR relaxometric investigations of paramagnetic contrast agents for MRI. Clues for higher relaxivities</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <text>185-186</text>
        </detail>
        <extent unit="pages">
          <start>321</start>
          <end>333</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">00108545 (ISSN)</identifier>
      <titleInfo>
        <title>Coordination Chemistry Reviews</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Coord. Chem. Rev.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4243528460&amp;partnerID=40&amp;md5=7ba905d54c01afcb7a1718c6e96c695b</url>
    </location>
    <abstract>The analysis of 1H- and 17O-NMR relaxometric data allows us to get a better insight into the understanding of the structural and dynamic factors responsible for the relaxivity of a given paramagnetic system. High relaxivities are obtained in the presence of a long molecular reorientational time and fast exchange of the water molecule(s) coordinated to the paramagnetic metal ion. Long molecular reorientational times are pursued either through the formation of covalent conjugates between a paramagnetic complex and a macromolecular substrate or through the formation of non-covalent adducts between suitably functionalized complexes and endogenous (e.g. serum albumin) or exogenous (e.g. poly-β-cyclodextrin) substrates. Within the class of covalent conjugates, it has been shown that the use of a DOTA-like chelate bearing the squaric acid as linking moiety leads to an improved relaxivity with respect to analogous systems obtained through reactions involving the bifunctional DTPA bisanhydride. As far as the exchange of the coordinated water in Gd(III) chelates is concerned, it depends on the energy difference between the ground ennea-coordinated state and the activated octa-coordinated state. In the presence of bulky substituents, the ground state is destabilized with a consequent increase of the exchange rate. An elongation of the exchange lifetime can occur upon the interaction with serum albumin. This behaviour may result in a decrease of the attainable relaxivity. Finally, it has been shown that Mn(II) chelates may represent a viable alternative to Gd(III) complexes. In fact, in spite of the lower effective magnetic moment, the non-covalent adducts between Mn(II) chelates and albumin display very high relaxivities. This result has been accounted for in terms of the very short exchange lifetime of the Mn(II) coordinated water molecule. © 1999 Elsevier Science S.A. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>1H MAS NMR spectra of transition metal carbonyl hydrides</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barrie</namePart>
      <namePart type="given">P.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Brougham</namePart>
      <namePart type="given">D.F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>34</number>
        </detail>
        <detail type="issue">
          <number>13</number>
        </detail>
        <extent unit="pages">
          <start>3557</start>
          <end>3559</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0038027110&amp;partnerID=40&amp;md5=e7559b1b37f8ead56b7f12e3fa893415</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>1H NMR spin-lattice relaxation studies of hydridometal clusters of ruthenium and osmium</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>26</number>
        </detail>
        <detail type="issue">
          <number>15</number>
        </detail>
        <extent unit="pages">
          <start>2551</start>
          <end>2552</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1987</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-3743080717&amp;partnerID=40&amp;md5=7fadc63a959c3e7e4cab226af8621f78</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>1H spin-lattice NMR relaxation studies of hydride carbonyl clusters. A method to evaluate distances involving hydrido ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cisero</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arce</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>30</number>
        </detail>
        <extent unit="pages">
          <start>1614</start>
          <end>1617</end>
        </extent>
      </part>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <abstract>Proton longitudinal relaxation rates of hydride resonances are dominated by the dipolar interaction with other 1H nuclei in the same molecule and may provide relevant structural information once the molecular correlation times are determined by independent experiments. H-H distances were determined by this route in HOs3(CO)10(O2CH) (I), HOs3(CO)9C2H (II), and HOs3(CO)10OH (III), whose resonances are well separated in their 1H NMR spectra. When the proton NMR spectrum of compound III is recorded in acetone, it shows a mixture of two different isomers differing in the orientation of the lone pair on the μ-oxygen atom, as revealed by a marked difference in the relaxation times of the hydride ligands. Furthermore, an alternative procedure based on the comparison of the proton relaxation rates between H,H and H,D isotopomers has been applied for the dihydride species H2Os3(CO)10 (IV), H2FeCOs3(CO)13 (V), and H2FeRu3(CO)13 (VI), where the hydride ligands are chemically equivalent. © 1991 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>6-carboxamido-5,4-hydroxypyrimidinones: A new class of heterocyclic ligands and their evaluation as gadolinium chelating agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Sunderland</namePart>
      <namePart type="given">C.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>40</number>
        </detail>
        <detail type="issue">
          <number>26</number>
        </detail>
        <extent unit="pages">
          <start>6746</start>
          <end>6756</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035905092&amp;partnerID=40&amp;md5=8a189037e43e731a427e2fe13d4f848f</url>
    </location>
    <abstract>A previously unexplored class of heterocyclic bidentate chelating groups, 6-carboxamido-5,4-hydroxypyrimidinones (6-substituted-HOPYs), have been synthesized by two routes that provide a flexible entry into this ligand system. These are related to, but distinct from, the hydroxypyridonates and have been characterized in this study as a gadolinium chelating agent for magnetic resonance imaging (MRI) applications. The complex Gd[TrenHOPY] demonstrates high stability and high selectivity relative to other ions of biological interest, such as Zn(II) and Ca(II). These stability constants are comparable to those demonstrated by the previously studied 3,2-pyridinone analogues, however, the 5,4-pyrimidinones are at least an order of magnitude more soluble in water. The proton relaxation properties of Gd[TrenHOPY] in water were measured as a function of magnetic field, pH, and temperature. These results support the description of Gd[TrenHOPY] as a complex with two coordinated water molecules in fast exchange with bulk water. In addition, the influence of exogenous anions and blood serum proteins has been investigated. The favorable contrast agent properties emerging from these studies are discussed.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A 13C CP/MAS NMR study of the structure and dynamics of [(η5-C5H5)2Fe 2(CO)4] included in γ-cyclodextrin: Evidence for terminal-bridging exchange in the cis isomer</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Canuto</namePart>
      <namePart type="given">H.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Masic</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rees</namePart>
      <namePart type="given">N.H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Heyes</namePart>
      <namePart type="given">S.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>25</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>2248</start>
          <end>2252</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33646403427&amp;partnerID=40&amp;md5=bf5fe85a22d44d9a9a767c929468819e</url>
    </location>
    <abstract>The novel inclusion compound of γ-cyclodextrin with the binuclear metal carbonyl complex (η5C5)2Fe 2(CO)4 as guest molecule is reported. 13C CP/MAS NMR spectroscopy, in the temperature range 100 to 353 K, is used to probe the structure and dynamics of the included molecules. Specifically, below ca. 240 K evidence is presented for the existence of both cis and trans isomers of included (η5-C5H5)2Fe 2(CO)4. Analysis of the temperature-dependence of the NMR line shapes shows that the microenvironment provided by the γ-cyclodextrin cavity allows much more extensive dynamic rearrangements of the guest molecules, in comparison to pure cis- or trans-(η5-C 5H5)2Fe2(CO)4, for which no isomerization or bridging-terminal carbonyl exchange processes are observed in this temperature regime. Notably, even at 100 K, bridging-terminal carbonyl exchange for the included trans isomer is rapid on the exchange-broadening time scale. However, the inclusion cavity is still more dynamically restrictive than a solution environment, and the rates of various exchange processes are usefully modified compared to those detected in solution. For (η5-C 5H5)2Fe2(CO)4 included in γ-cyclodextrin, contrary to the situation found in solution, the rate of bridging-terminal carbonyl exchange in the cis isomer is greater than the rate of cis-trans isomerization; in solution direct bridging-terminal exchange in the cis isomer could not be studied because indirect exchange via isomerization to the trans form, which undergoes rapid bridging-terminal exchange, is always significantly faster. By restricting isomerization, the inclusion environment thus confirms for the first time that the cis isomer is capable of carbonyl exchange and would allow the study of its rate and activation parameters. © 2006 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A 13C Nmr investigation of stereochemical non rigidity in hydrido olefinic carbonyl clusters of ruthenium</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valle</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>20</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>217</start>
          <end>220</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1976</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-25744435211&amp;partnerID=40&amp;md5=89b86ff603258b5061ed0c2ccb435658</url>
    </location>
    <abstract>13C n.m.r. spectra of hydrido olefinic carbonyl clusters of ruthenium show that localized scrambling of the carbonyls occurs with different energy barriers which depend on the nature of the bonding between the ligand and the metal cluster and on the nature of the substituents in the olefinic chain. Resonances of carbons "sigma" bonded to one ruthenium and "pi" bonded to a second one are in the lowfield region (198-162 ppm). © 1976.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A calix[4]arene GdIII complex endowed with high stability, relaxivity, and binding affinity to serum albumin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casnati</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fragai</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Luchinat</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ungaro</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>40</number>
        </detail>
        <detail type="issue">
          <number>24</number>
        </detail>
        <extent unit="pages">
          <start>4737</start>
          <end>4739</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035905351&amp;partnerID=40&amp;md5=9246fc8ab3fb01d7c6ea24c1741d8b4d</url>
    </location>
    <abstract>Contrasting calixarenes: Thermodynamically stable and water-soluble calix[4]arene-LnIII (see picture) complexes may represent a new class of relaxation (Ln = Gd) or luminescent (Ln = Eu, Tb) probes for biomedical studies. The first complete characterization of one of these complexes in water is reported. The GdIII chelate shows a strong binding affinity with human serum albumin as a result of the cooperative effects of hydrophobic interaction and coordination by donors groups on the protein.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A copper-activated magnetic resonance imaging contrast agent with improved turn-on relaxivity response and anion compatibility</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Que</namePart>
      <namePart type="given">E.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baker</namePart>
      <namePart type="given">S.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chang</namePart>
      <namePart type="given">C.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>39</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>469</start>
          <end>476</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">14779226 (ISSN)</identifier>
      <titleInfo>
        <title>Dalton Transactions</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Dalton Trans.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77149160380&amp;partnerID=40&amp;md5=27fc43e989c46ce6bac6b4cd4c61ff5e</url>
    </location>
    <abstract>We present the synthesis and characterization of Copper-Gad-7 (CG7), a new copper-activated magnetic resonance imaging (MRI) contrast agent that possesses a Gd3+-DO3A scaffold with an appended thioether-rich receptor for copper recognition. Installation of additional carboxylate groups on the periphery of the CG scaffold affords a practical strategy to increase the absolute relaxivity of these types of copper-responsive MRI sensors as well as reduce their sensitivity to biologically abundant anions. Due in large part to restricted access of inner-sphere water molecules to the paramagnetic Gd 3+ core, in the absence of copper ions, CG7 exhibits a relatively low relaxivity value of r1 = 2.6 mM-1 s-1; addition of Cu+ triggers a 340% enhancement in relaxivity to r 1 = 11.4 mM-1 s-1. For comparison, the relaxivity of the analogous CG2 sensor without peripheral carboxylates increases from r1 = 1.5 to 6.9 mM-1 s-1 upon Cu + binding. CG7 features high selectivity for Cu+ over a range of biologically relevant metal ions, including the cellular abundant alkali and alkaline earth cations and d-block ions Zn2+ and Cu 2+. Moreover, the Cu+-response of the CG7 sensor is not significantly affected by bicarbonate, phosphate, citrate, and lactate anions at cellular levels. 17O NMR dysprosium-induced shift (DIS) and nuclear magnetic relaxation dispersion (NMRD) experiments suggest that the origin of the improved anion compatibility of CG7 is a reduced q modulation compared to previous members of the CG family, and T1-weighted phantom images confirm that CG7 can monitor changes in copper levels by MRI at clinically relevant field strengths. © The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A Highly Stable Gadolinium Complex with a Fast, Associative Mechanism of Water Exchange</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Thompson</namePart>
      <namePart type="given">M.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nicolle</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Helm</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Merbach</namePart>
      <namePart type="given">A.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>125</number>
        </detail>
        <detail type="issue">
          <number>47</number>
        </detail>
        <extent unit="pages">
          <start>14274</start>
          <end>14275</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0344875208&amp;partnerID=40&amp;md5=a13cf9fe9f7dfde5049d27b52700231a</url>
    </location>
    <abstract>The stability and water exchange dynamics of gadolinium (GdIII) complexes are critical characteristics that determine their effectiveness as contrast agents for magnetic resonance imaging (MRI). A new heteropodal GdIII chelate, [Gd-TREN-bis(6-Me-HOPO)-(TAM-TRI)(H2O)2] (Gd-2), is presented which is based on a hydroxypyridinate (HOPO)-terephthalamide (TAM) ligand design. Thermodynamic equilibrium constants for the acid?base properties and the GdIII complexation strength of TREN-bis(6-Me-HOPO)-(TAM-TRI) (2) were measured by potentiometric and spectrophotometric titration techniques, respectively. The pGd of 2 is 20.6 (pH 7.4, 25 °C, I = 0.1 M), indicating that Gd-2 is of more than sufficient thermodynamic stability for in vivo MRI applications. The water exchange rate of Gd-2 (kex = 5.3(±0.6) × 107 s-1) was determined by variable temperature 17O NMR and is in the fast exchange regime ? ideal for MRI. Variable pressure 17O NMR was used to determine the volume of activation (ΔV≠) of Gd-2. ΔV≠ for Gd-2 is ?5 cm3 mol-1, indicative of an interchange associative (Ia) water exchange mechanism. The results reported herein are important as they provide insight into the factors influencing high stability and fast water exchange in the HOPO series of complexes, potentially future clinical contrast agents. Copyright © 2003 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A holmium complex of a macrocyclic ligand (DOTA) and its isostructural europium analogue</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Benetollo</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bombieri</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>55</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>353</start>
          <end>356</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">01082701 (ISSN)</identifier>
      <titleInfo>
        <title>Acta Crystallographica Section C: Crystal Structure Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Acta Crystallogr Sect C Cryst Struct Commun</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000622290&amp;partnerID=40&amp;md5=cd5d7fd4754136ea6744bc555b016fc5</url>
    </location>
    <abstract>The holmium and europium complexes of the tetra-anion of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (H4DOTA), namely, sodium aqua-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato)-holmium(III) tetrahydrate, Na[Ho(C16H24N4O8)(H 2O)]·-4H2O, and sodium aqua(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato)europium(III) tetrahydrate, Na[Eu-(C16H24N4O8)(H 2O)]·4H2O, show nine-coordination around the metal ion, with a square antiprismatic coordination geometry involving four N- and four O-donor atoms of the DOTA ligand, and a coordinated water molecule in a capping position.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A macromolecular Gd(III) complex as pH-responsive relaxometric probe for MRI applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>16</number>
        </detail>
        <extent unit="pages">
          <start>1577</start>
          <end>1578</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0033592178&amp;partnerID=40&amp;md5=bbd8c55c547003ccb9048003d7ea443a</url>
    </location>
    <abstract>The ability of the paramagnetic macromolecular complex (GdDO3ASQ)30-Orn114 to enhance the water proton relaxation rate has been found to be a function of pH; this behaviour is related to the structural changes occurring in the polypeptide upon protonation of the side-chain NH2 groups.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A multinuclear NMR relaxometry study of ternary adducts formed between heptadentate GdIII chelates and L-lactate</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Boniforte</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bracco</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mondino</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>11</number>
        </detail>
        <detail type="issue">
          <number>19</number>
        </detail>
        <extent unit="pages">
          <start>5531</start>
          <end>5537</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-25444487756&amp;partnerID=40&amp;md5=4b125dfcbea2f3203b430e8e8ffe8a18</url>
    </location>
    <abstract>Dramatic relaxation enhancements of L-lactate resonances have been observed upon formation of ternary adducts with GdIII complexes of heptadentate DO3A and DO3A-like ligands (DO3A = 1,4,7,10-tetraazaciclododecane- 1,4,7-triacetic acid). Detailed 1H and 17O NMR relaxometry investigations allow us to obtain structural, dynamic and thermodynamic information on the ternary complexes in which L-lactate acts as a bidentate ligand replacing two water molecules in the inner coordination sphere of the GdIII ion. It has been found that the exchange rate of the coordinated L-lactate is modulated by the structural and electronic properties of the parent Gd-heptacoordinated macrocyclic chelate. In addition to the characterisation of the relaxation behaviour of the 1H methyl resonance of L-lactate, this study has been extended to its 13C isomer (fully enriched at the three positions) and to the trifluoro-L-lactate. The obtained results may be relevant to the development of relaxation agents able to promote the relaxation enhancement of specific substrates detectable by in vivo magnetic resonance spectroscopy. © 2005 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A Multinuclear NMR Study on the Structure and Dynamics of Lanthanide(III) Complexes of the Poly(amino carboxylate) EGTA4- in Aqueous Solution</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Borel</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chemerisov</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Merbach</namePart>
      <namePart type="given">A.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Müller</namePart>
      <namePart type="given">U.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pubanz</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>36</number>
        </detail>
        <detail type="issue">
          <number>22</number>
        </detail>
        <extent unit="pages">
          <start>5104</start>
          <end>5112</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000604935&amp;partnerID=40&amp;md5=92b98a08a2a6f3705506e8791b3b8565</url>
    </location>
    <abstract>The structures and intramolecular dynamics of [Ln(EGTA)(H2O)]- (Ln = La3+, Ce3+, Pr3+, Nd3+, Sm3+, Eu3+, Gd3+, Tb3+, Dy3+, Ho3+, Er3+, Tm3+, Yb3+, Lu3+ and EGTA4- = 3,12-bis(carboxymethyl)-6,9-dioxa-3,12- diazatetradecanedioate(4-)) in aqueous solution have been investigated by variable temperature 1H and 13C NMR. The quantitative analysis of the proton hyperfine shifts and considerations about the stereochemical nonrigidity indicate the occurrence of a structural change along the lanthanide series with the crossover between Sm and Eu. Changes of coordination number from 10 to 9 to 8 are proposed to occur across the series. The experimental data from 17O NMR, EPR and NMRD studies for the Gd3+ complex are treated using a self-consistent theoretical model in a simultaneous multiple parameter least-squares fitting procedure (Powell, D. H.; Ni Dhubhghaill, 0. M.; Pubanz, D.; Helm, L.; Lebedev, Y. S.; Schlaepfer, W.; Merbach, A. E. J. Am. Chem. Soc. 1996, 118, 9333). An intermolecular dipole-dipole electronic relaxation mechanism that has very recently been described forGd3+ complexes (Powell et al., op. cit.) is included in the data treatment. The high water exchange rale of [Gd(EGTA)(H2O)]- of keX298 = (3.1 ± 0.2) × 107 s-1 is explained in terms of a limiting dissociative exchange mechanism (ΔV‡ = +10.5 ± 1.0 cm3mol-1), favored by the steric constraints on the water binding site that are revealed by the study on the solution structure.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A new class of contrast agents for magnetic resonance imaging based on selective reduction of water-T2 by chemical exchange</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grandi</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>23</number>
        </detail>
        <detail type="issue">
          <text>SUPPL. 1</text>
        </detail>
        <extent unit="pages">
          <start>S267-S270</start>
          <end>S267-S270</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1988</dateIssued>
      </originInfo>
      <identifier type="issn">00209996 (ISSN)</identifier>
      <titleInfo>
        <title>Investigative Radiology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>INVEST. RADIOL.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0023813807&amp;partnerID=40&amp;md5=56e77cc64503dec0ec43715c9dfdd865</url>
    </location>
    <abstract>Compounds containing mobile protons can act as contrast agents by increasing the value of the term ((T2)(1)-(T1)(1)). The efficiency of this method is markedly pH- and field-dependent. There are many such compounds allowing a choice to be made based on the characteristics of the tissue or organ, magnetic field, strength, and solution pH levels. The properties of some of these chemicals have been investigated at different magnetic field strength and solution pH levels. The authors report herein the properties of iopamidol a well-known x-ray contrast agent, and stress its potential effect as an MRI contrast agent. The influence on the T2 decrease of the chemical shift separation δω (in frequency units) between water and exchangeable proton of the contrast agent may be increased by adding suitable shift reagents which interact with basic sites close to the protons involved in the chemical exchange.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A new method for the determination of 17O electric quadrupole couplings. Terminal, bridging, and capping CO groups in metallocarbonyls</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>68</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>597</start>
          <end>599</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1986</dateIssued>
      </originInfo>
      <identifier type="issn">00222364 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance (1969)</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001063376&amp;partnerID=40&amp;md5=2192db45a86002d2eed9ad2923f52a2d</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>A new ytterbium chelate as contrast agent in chemical shift imaging and temperature sensitive probe for MR spectroscopy</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kinchesh</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Calabi</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paleari</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>35</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>648</start>
          <end>651</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>MAGN. RESON. MED.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0029927852&amp;partnerID=40&amp;md5=19544f139ad669088dabc5c2f4c15694</url>
    </location>
    <abstract>A paramagnetic Yb(III) complex that is the prototype of a novel class of probes for MRI and MRS has been developed. The complex displays highly shifted 1H resonances that are characterized by short relaxation times and, as such, may prove to be a valuable alternative in applications that currently require fluorine-containing probes. Selective excitation of the paramagnetically shifted resonances allows the spatial distribution of the complex to be mapped. This communication reports the images that were obtained by selectively exciting the most intense methyl group (-14.2 ppm at 27°C) for complex concentrations ranging from 0.003-0.1 M. Spectroscopically, the complex may be used as a temperature probe since the proton chemical shifts exhibit a strong temperature dependence. In human serum the chemical shift difference of a selected pair of proton resonances was observed to follow a gradient of -0.42 ± 0.01 ppm/°C. Furthermore, since the chemical shift of the methyl resonance displays a temperature coefficient of -0.04 ± 0.01 ppm/°C, it should be possible to use the image phase for thermal mapping.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A new, easy access to the 6-aminoperhydro-1,4-diazepine scaffold under ultrasound and microwave irradiation</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Füzerová</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Upadhyaya</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Garella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>1879</start>
          <end>1882</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">00397881 (ISSN)</identifier>
      <titleInfo>
        <title>Synthesis</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Synthesis</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-46649093392&amp;partnerID=40&amp;md5=efad5389654497edd68f823df2f22b58</url>
    </location>
    <abstract>A novel, efficient, and rapid synthesis of the 6-aminoperhydro-1,4- diazepine scaffold is reported. It was promoted by microwave or sequential ultrasound/microwave irradiation under solvent-free conditions or in solution. Protected ethylenediamine derivatives and N-Boc-serinol dimesylate underwent rapid cyclization to give 6-aminoperhydro-1,4-diazepine derivatives in excellent yields and with high selectivity, whereas the same reaction failed or gave negligible yields under conventional heating. Cesium or potassium ions catalyzed the ring closure by coordinating the sulfon-amide groups. All relevant work reported to date in the literature mostly concern about the syntheses of either 1H-tetrahydro-1,4-diazepine-2,5-dione or substituted 1,4-benzodiazepines, while the few published procedures for the preparation of 6-aminoperhydro-1,4- diazepines involved several steps, required long reaction times and afforded low yields. By the present method, access to 6-aminoperhydro-1,4-diazepines becomes much easier and faster.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A novel application of para H2: The reversible addition/elimination of H2 at a Ru3 cluster revealed by the enhanced NMR emission resonance from molecular hydrogen</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Russo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canet</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>103</number>
        </detail>
        <detail type="issue">
          <number>48</number>
        </detail>
        <extent unit="pages">
          <start>9702</start>
          <end>9705</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">10895639 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Physical Chemistry A</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Phys. Chem. A</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001350739&amp;partnerID=40&amp;md5=c3cd306feebe82f49d76c78b6c898820</url>
    </location>
    <abstract>Polarization transfer from the NMR silent p-H2 to o-H2 is possible through the intermediacy of a triruthenium bis-hydride cluster. In fact, a strong emission signal for the molecular H2 resonance is observed when p-H2 is allowed to react with Ru3(CO)11(NCCH3) in the NMR tube at RT. The break of symmetry in p-H2 is achieved at the intermediate H(μ-H)Ru3(μ-CO)(CO)10 compound where the two hydrides form an AX spin system; the build-up of the longitudinal magnetization leaves a "memory" of this intermediate in the signal of the H2 molecule formed by reductive elimination from the bis-hydride species. The observed behavior is fully accounted for in terms of the established relaxation theory. © 1999 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A novel method of cellular labeling: Anchoring MR-imaging reporter particles on the outer cell surface</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ciampa</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzardo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Imperio</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>60</start>
          <end>62</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">18607179 (ISSN)</identifier>
      <titleInfo>
        <title>ChemMedChem</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>ChemMedChem</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-48149085590&amp;partnerID=40&amp;md5=30659ba46e61f18c1c8c4fa53e950450</url>
    </location>
    <abstract>Cellular labeling. MR visualization of cells has been attained by anchoring negatively charged Gd-loaded nanoparticles at the cellular membrane by a polycationic linker. Each nanoparticle contains approximately 800 Gd-chelates and each cell has been loaded with approximately 5&lt;106 particles. In this way only 15% of the negative charges on the membrane has been used. The method has been validated by confocal microscopy. (Figure Presented). © 2008 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A novel non-facial mode of azulene cluster co-ordination. Crystal and molecular structure of the dicarbenoid Os3(μ-H)2-(CO)9(μ3-η 1 : η1 : η1-C10H6)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arce</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giusti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Steed</namePart>
      <namePart type="given">J.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>13</number>
        </detail>
        <extent unit="pages">
          <start>2215</start>
          <end>2217</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">1470479X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Chem. Soc. Dalton Trans.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0002677405&amp;partnerID=40&amp;md5=8e3c2b216a8328bf5fb91b9e88b0ecf4</url>
    </location>
    <abstract>Azulene oxidatively added to Os3(CO)11(NCCH3) to afford the triosmium cluster Os3(μ-H)2(CO)9 (μ3-η1 : η1 : η1-C10H6) 1 in high yield. The organic moiety is bound perpendicularly to the trimetallic plane and acts as a 4e- donor forming one terminal and one bridging carbene-metal bond. An X-ray diffraction study of 1 was made and full spectroscopic assignment has been made using 1- and 2-D homo- and hetero-nuclear NMR; 2-D 13C EXSY experiments have also allowed the elucidation of the CO exchange process. © The Royal Society of Chemistry 2000.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A p(O2)-Responsive MRI contrast agent based on the redox switch of manganese(II/III)-porphyrin complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>39</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>747</start>
          <end>750</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034681524&amp;partnerID=40&amp;md5=08e7c719d1c6a6aea90182f7c4cd104c</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>A paramagnetic MRI-CEST agent responsive to lactate concentration</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>124</number>
        </detail>
        <detail type="issue">
          <number>32</number>
        </detail>
        <extent unit="pages">
          <start>9364</start>
          <end>9365</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037077538&amp;partnerID=40&amp;md5=9ffde3239707ee52bfffc49e6ca39c65</url>
    </location>
    <abstract>A paramagnetic Yb(III) complex bearing six exchangeable amide protons, [Yb(MBDO3AM)]3+, has been investigated with the aim of developing a MRI-CEST (chemical exchange saturation transfer) contrast agent responsive to the concentration of L-lactate. The complex binds the substrate quantitatively to yield [Yb(MBDO3AM)L-lactate]2+. The exchange between the free and the L-lactate-bound complex is slow on the NMR time scale, and the resonances of their corresponding amide protons are sufficiently separated (more than 10 ppm) to allow their selective irradiation. Therefore, the CEST properties of the two forms can be independently assessed. In turn, the resulting saturation transfer to the bulk water signal is dependent on the L-lactate concentration. Copyright © 2002 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A paramagnetic probe to localize residues next to carboxylates on protein surfaces</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">D'Amelio</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fragai</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lee</namePart>
      <namePart type="given">Y.-M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Luchinat</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valensin</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0036942344&amp;partnerID=40&amp;md5=c631e99beead3deb32d97de34fd3059f</url>
    </location>
    <abstract>It is shown that the paramagnetic properties of lanthanides can be exploited to obtain information on specific parts of a protein surface. Owing to the high affinity of coordinatively unsaturated lanthanide complexes for oxygen donors, carboxylate groups can be used as preferential targets for the interaction. The DO3A ligand is particularly useful in these studies, as it coordinates lanthanides in a heptadentate fashion, leaving two sites available for exogenous donors. A solution of a 15N-labeled sample protein, calbindin D9k (75 residues), was titrated with up to 200% of Gd(III)-DO3A complex, and an inversion recovery 15N-1HHSQC experiment was used to measure the paramagnetic contributions to the longitudinal relaxation rates of the amide protons. Relaxation data were used as distance constraints to estimate the number of interacting complexes and the occupancies of their binding sites. Four preferential interaction sites on the protein surface are found. Inspection of the various carboxylate side chains on the surface of the protein indicates that Gd(III)-DO3A interacts preferentially with carboxylaterich regions, rather than with isolated carboxylates, suggesting the possibility of chelation of one Gd(III)-DO3A molecule by two carboxylate groups. Gd(III)-DO3A is thus a valuable semi-selective probe for clusters of negative charges on the protein surface.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>A tris-hydroxymethyl-substituted derivative of Gd-TREN-Me-3,2-HOPO: An MRI relaxation agent with improved efficiency [2]</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Hajela</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giraudo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Xu</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>122</number>
        </detail>
        <detail type="issue">
          <number>45</number>
        </detail>
        <extent unit="pages">
          <start>11228</start>
          <end>11229</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034669466&amp;partnerID=40&amp;md5=f92db1445e18b3c5a5c7665313b09ede</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>A versatile route to [Ru3(CO)11(alkyne)] complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>267</start>
          <end>268</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <abstract>Alkynes react at low temperature with [Ru3H(μ-H)(CO)11] to afford the novel [Ru3(CO)11(alkyne)] complexes, which correspond to the first stage of the coordination of alkynes to metal clusters and are the precursors of the previously reported [Ru3(CO)9(μ-CO)(μ3-η 2-alkyne)] derivatives.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Acid-induced isomerisations of osmium and ruthenium clusters involving hydroxide transfer from carbon to metal atoms. X-ray crystal structure of nonacarbonyl-μ3-(3,3-diphenylallene- 1,1-diyl)-μ-hydrido-μ-hydroxo-triosmium(2 Os-Os)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deeming</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hursthouse</namePart>
      <namePart type="given">M.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Backer-Dirks</namePart>
      <namePart type="given">J.D.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>1625</start>
          <end>1629</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1982</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049094019&amp;partnerID=40&amp;md5=47a65677d911f167f6a553c805cc8af1</url>
    </location>
    <abstract>The complexes [M3H(CO)9(μ3-C≡CCPh2OH)] (M = Ru or Os) were prepared by reaction of [M3(CO)12] with HOCPh2C≡CCPh2OH in saturated hydrocarbon at 130 °C for M = Os or in refluxing cyclohexane from M = Ru. In the latter case the yield of cluster is low and there is some 1,1,4,4-tetraphenylbutadiene formed. Treatment of the trinuclear clusters in chloroform with trifluoroacetic acid leads to isomerisation with migration of the OH group from carbon to metal atoms. This was confirmed by an X-ray structure determination for the osmium product [OS3(μ-H)(μ-OH)(CO)9(μ 3-C≡C≡CPh2)]. The crystals are monoclinic, space group P21, a = 10.569(1), b = 20.259(3), c = 12.287(2) Å, β = 95.66(1)°, and Z = 4. The structure was refined to R = 0.0621 for 4 112 observed reflections. There are two independent molecules (A and B) in the unit cell with very closely similar structures. Spectroscopically, an OH group was identified and another hydrogen bound to osmium but neither hydrogen atom was located by X-ray diffraction. The OH group bridges two non-bonded osmium atoms separated by 3.374(5) Å in molecule A [3.372(5) Å in B], while the μ-H was deduced to be across the longer Os-Os bond [2.905(5) versus 2.861(5) Å for molecule A and 2.902(5) versus 2.869(5) Å for molecule B]. The 3,3-diphenylallene-1,1-diyl ligand is bonded through two Os-C σ bonds and a 1,2-η2-co-ordination to the other osmium atom and is bent about the central atom [145(3)° for molecule A and 144(3)° for B]. The orientation of the phenyl substituents at the non-co-ordinated allene carbon atom agrees with this interpretation of the bonding.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Activation of alkynes by transition metals</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>16</number>
        </detail>
        <extent unit="pages">
          <start>704</start>
          <end>705</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1979</dateIssued>
      </originInfo>
      <identifier type="issn">00224936 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Chemical Communications</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049111535&amp;partnerID=40&amp;md5=7ef875fa97d913bea38612755cf9187f</url>
    </location>
    <abstract>Activation of alkynes leading to oxygen incorporation α to the triple bond is observed when [Fe(CO)5], [Co2(CO)8], and an internal alkyne are heated in refluxing acetone; evidence for the possible formation of a mixed acetylenic iron-cobalt cluster has also been obtained.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Activation of the MCO bond in transition metal complexes. CO substitution reactions in di-, tri- and tetra-nuclear metal carbonyl compounds catalyzed by [Fe(CO)2(η5-C5H5)]2</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>115</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>129</start>
          <end>133</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1986</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4244114501&amp;partnerID=40&amp;md5=49b24298ffe4f52863ebed9623fc1e23</url>
    </location>
    <abstract>The catalytic activity of [Fe(CO)2(η5-C5H5)]2 (hereafter [FeCp]2) in the CO substitution reactions has been explored in a number of systems involving binary and organometallic carbonyl complexes of two, three and four nuclearity. The results point out the versatility of [FeCp2] in promoting CO substitution with various Lewis bases where improved selectivity and yields of the substituted products have been achieved. The [FeCp]2 catalyzed reaction between [Fe3(CO)8(PhC2Ph)2] (black isomer) and P(OMe)3 afforded, at room temperature, two isomeric monosubstituted products, whose solution structures and dynamics have been elucidated by NMR spectroscopy. It is noteworthy that no substitution products could be obtained in the absence of the catalyst even at elevated temperatures. © 1986.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Activation of the M-CO bond in transition-metal complexes. Fe2(CO)6(SMe)2 and phosphine-substituted derivatives as good catalysts in metal carbonyl substitution reactions</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>4</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>1475</start>
          <end>1476</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1985</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000624629&amp;partnerID=40&amp;md5=c9fa25175430a3be94b67727eb8d1ada</url>
    </location>
    <abstract>The catalytic activity of Fe2(CO)6(SMe)2 in CO substitution reactions on several transition-metal carbonyl complexes is reported and compared with the results obtained with other reagents. Experimental evidence has been gained to support the view that radical species are involved in these reactions and a possible pathway is proposed to explain the catalytic cycle. © 1985 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Addition of NH3 to the cluster complexes M3H(μ-H)(CO)11 (M - Ru, Os)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>17</number>
        </detail>
        <detail type="issue">
          <number>24</number>
        </detail>
        <extent unit="pages">
          <start>5353</start>
          <end>5357</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001277036&amp;partnerID=40&amp;md5=06bd251a5765565fa51a2a4926e594a7</url>
    </location>
    <abstract>The reactions of ammonia with either Ru3H(μ-H)(μ-CO)(CO)10 (I) or Os3H(μ-H)(CO)11 (II) in CD2Cl2 solutions yield [NH4]+[M3(μ-H)(μ-CO)(CO) 10]- (M = Ru, Os). When the reactions are followed at low temperature (183 K) by means of 1H, 13C, and 15N NMR spectroscopy, it is possible to detect the formation of kinetic products which are derived from the addition of an ammonia molecule to a carbonyl carbon atom. In the Ru case ammonia is bonded to the bridging carbonyl carbon atom and maintains its wholeness. In the Os system a carbamoyl moiety is formed by transfer of one hydrogen from NH3 to the oxygen atom of the carbonyl group to form an O-II bond. The NMR observation of the latter functionality is prevented by the occurrence of a fast proton exchange with the excess of free NH3 present. Two isomers of this carbamoyl-containing species can be detected; the structural difference between them is based only on which carbonyl has undergone the ammonia attack. μ 1998 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Advances in bio-imaging: A survey from WWMR 2010</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>209</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>109</start>
          <end>115</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">10907807 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Magn. Reson.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79953201487&amp;partnerID=40&amp;md5=1f4a136e5a0e7027f945306195a151c5</url>
    </location>
    <abstract>The paper deals with a survey on major advances in the field of bio-imaging presented at the WWMR2010 Conference, held in Florence (Italy) from 4th to 9th July 2010. The selected contributions have been organized into the following headings: Hyperpolarization, Acquisition Methods and Molecular Imaging applications. Overall, the Conference has witnessed an outstanding progress in either methods and applications that further stresses the key-role of MRI in many fields of biomedicine. © 2011 Published by Elsevier Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Advances in metal-based probes for MR molecular imaging applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>17</number>
        </detail>
        <detail type="issue">
          <number>31</number>
        </detail>
        <extent unit="pages">
          <start>3684</start>
          <end>3700</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">09298673 (ISSN)</identifier>
      <titleInfo>
        <title>Current Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Curr. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-78449233292&amp;partnerID=40&amp;md5=997f12319ff07f038a33bf2a95ff33aa</url>
    </location>
    <abstract>The role of MRI in the armory of diagnostic modalities for the medicine of the forthcoming years largely depends on how chemistry will provide advanced tools to meet the medical needs. This review aims at outlining the most innovative approaches that have been undertaken in the recent history of MRI contrast agents for tackling the challenges of sensitivity and specificity required by the new generation of contrast agents that should allow the visualization of pathological processes occurring on cellular and molecular scale (the so-called Molecular Imaging). Most of the classes of MRI agents clinically approved or currently under investigation in a preclinical phase exploit peculiar magnetic properties of metals. The conventional agents acting as T1 or T2/T2* relaxation enhancers are primarily based on the paramagnetic or the superparamagnetic properties of Gd(III)-, Mn(II)- and iron oxides systems. Recently, there has been a renewed interest towards paramagnetic lanthanide complexes with an anisotropic electronic configuration thanks to their ability to induce strong effect on the resonance frequency of the spins dipolarly coupled with them. Such systems, formerly mainly used as shift reagents, have now attracted much attention in the emerging field of Chemical Exchange Saturation Transfer (CEST) MRI agents. © 2010 Bentham Science Publishers Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate [3]</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canavese</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stratta</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>72</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1162</start>
          <end>1163</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">00852538 (ISSN)</identifier>
      <titleInfo>
        <title>Kidney International</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Kidney Int.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-35349028390&amp;partnerID=40&amp;md5=bc007482c40e043ff3666c6181996f73</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Agents for polarization enhancement in MRI.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Santelia</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <text>185 Pt 1</text>
        </detail>
        <extent unit="pages">
          <start>247</start>
          <end>272</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">01712004 (ISSN)</identifier>
      <titleInfo>
        <title>Handbook of experimental pharmacology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Handb Exp Pharmacol</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-52049101580&amp;partnerID=40&amp;md5=2041ab26795bcd375079e327323e5df7</url>
    </location>
    <abstract>The intrinsic low sensitivity of the NMR phenomenon can be overcome thanks to hyperpolarization procedures that break the limits of the Boltzmann equilibrium and may increase the NMR signal by a factor of 10(5). Hyperpolarization procedures have been applied to enhance the signal from noble gases, such as 3He and 129Xe, and small 13C-containing molecules. For the latter class, attention has been focused on the use of methods based on dynamic nuclear polarization (DNP) and para-hydrogen induced polarization (PHIP). After discussion of the basics of the methods, an overview of the main applications with 13C-containing molecules is presented. This includes pre-clinical MR investigations of vascular imaging, perfusion and catheter tracking as well as molecular imaging protocols that allow the development of highly innovative studies in the field of metabolic imaging.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>An examination of the unsaturation in the clusters Fe4(CO)11(μ4-PR)2</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Jaeger</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vahrenkamp</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>5</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>245</start>
          <end>252</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1986</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000472745&amp;partnerID=40&amp;md5=7ace73b507acc8056753e4d841e0e40a</url>
    </location>
    <abstract>The clusters Fe4(CO)11(PR)2 (1, R = t-Bu, Ph, Tol) were investigated chemically and NMR spectroscopically. They easily add one ligand L (CO, P(OMe)3, t-BuNC) to form Fe4(CO)11L(PR)2 (2, 3). Subsequent CO elimination under vacuum forms the new unsaturated clusters Fe4(CO)10L(PR)2 (4). Further addition-elimination cycles allow the introduction of a total of four P(OMe)3 and three t-BuNC ligands. The products with two, three, and four P(OMe)3 and with three t-BuNC ligands can only be obtained in the unsaturated form. 1H and 13C NMR spectroscopy reveals the high fluxionality of the CO and t-BuNC ligands in these compounds. 1H, 13C, and 31P NMR data of the unsaturated clusters can be interpreted in terms of an "aromatic ring current" in the Fe4 system. Crystal structure determinations of Fe4(CO)11[P(OMe)3](PTol)2 [3b, triclinic, P1, a = 1300.0 (2) pm, b = 1506.9 (3) pm, c = 944.5 (2) pm, α = 100.65 (1)°, β = 107.35 (1)°, γ = 84.43 (1)°, V = 1.7339 (3) nm3, Z = 2] and Fe4(CO)10[P(OMe)3](PTol)2 [4b, orthorhombic, P212121, a = 1289.0 (8) pm, b = 1478.5 (4) pm, c = 1819.7 (3) pm, V = 3.4678 (8) nm3, Z = 4] reveal the difficulty of locating a Fe-Fe double bond in the unsaturated systems and the steric strain in the ligand sphere of the saturated systems. © 1986 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>An in vivo model of met-driven lymphoma as a tool to explore the therapeutic potential of met inhibitors</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Accornero</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lattanzio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mangano</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chiarle</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Taulli</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bersani</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Forni</namePart>
      <namePart type="given">P.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Miretti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Scuoppo</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Christensen</namePart>
      <namePart type="given">J.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crepaldi</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ponzetto</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>14</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>2220</start>
          <end>2226</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">10780432 (ISSN)</identifier>
      <titleInfo>
        <title>Clinical Cancer Research</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Clin. Cancer Res.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-42249110570&amp;partnerID=40&amp;md5=a2e0283217ae9c371ad387ee220d2e5f</url>
    </location>
    <abstract>Purpose: Met, the tyrosine kinase receptor for hepatocyte growth factor, is frequently deregulated in human cancer. Recent evidence indicates that Met amplificationmay confer resistance to treatments directed toward other receptor tyrosine kinases. Thus, there is a need to develop Met inhibitors into therapeutic tools, to be used alone or in combination with other molecularly targeted drugs. Preclinical validation of Met inhibitors has thus far been done in nude mice bearing cancer cells xenogratfs. A far superior model would be a transgenic line developing spontaneous Met-driven tumors with high penetrance and short latency. Experimental Design: To this end, we introduced into the mouse genome TPR-MET, the oncogenic form of MET. The Tpr-Met protein ensures deregulation of Met signaling because dimerization motifs in the T pr moiety cause ligand-independent activation of the Met kinase. Results: Here, we describe a TPR-MET transgenic line that develops thymic T-cell lymphoma with full penetrance and very short latency. In the tumors, Tpr-Met and its effectors were phosphorylated. Treatment of tumor-derived T lymphocytes with the selective Met inhibitor PHA-665752 at nanomolar concentrations abolished phosphorylation of Met and downstream effectors and led to caspase-mediated apoptosis. I.v. administration of PHA-665752 to transgenic mice bearing lymphomas in exponential growth phase led to a significant decrease in tumor growth and, in some cases, to tumor regression. Conclusions: Our transgenic line, which within 2 months reliably develops Tpr-Met - driven T-cell lymphoma, represents a valuable tool to explore the efficacy and therapeutic potential of Met kinase inhibitors as anticancer drugs. © 2008 American Association for Cancer Research.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>An inspection into the class of bis(alkyne)-undecacarbonyl-quadro-tetraruthenium complexes. Crystal structure and dynamic behaviour of Ru4(CO)11 (μ4, η2-MeC2Ph)2</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nicola</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Manottti Lanfredi</namePart>
      <namePart type="given">A.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>85</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>161</start>
          <end>168</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0010896481&amp;partnerID=40&amp;md5=05067f2f57ff9e3fcea1aa3ab8c6f5f2</url>
    </location>
    <abstract>The reactions of the butterfly complex Ru4(CO)12(MeC2Ph) with several alkynes give the quasiplanar derivatives Ru4(CO)11(MeC2Ph)(Alkyne) in almost quantitative yields. The structure of Ru4(CO)11(MeC2Ph)2 has been determined by X-ray methods. Crystals are monoclinic, space group C2/c, with Z = 4 in a unit cell of dimensions a 22.383(16), b 9.048(8), c 18.268(12) Å, β = 127.25(4)°. The structure has been solved from diffractometer data by Patterson and Fourier methods and refined by full-matrix least-squares to R = 0.034 for 1420 observed reflections. The complex, having an imposed C2 symmetry, presents a tetranuclear metal cluster in which the Ru atoms are in a tetrahedrally-distorted square arrangement. Ten carbonyls are terminal and one symmetrically bridges an edge of the cluster. Each of the two alkyne ligands is σ-bonded to two Ru atoms on the opposite vertices of the cluster and π-bonded to the other two. The organometallic cluster has a Ru4C4 core in which the metal and carbon atoms occupy the vertices of a triangulated dodecahedron. © 1984.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>An iron-based T1 contrast agent made of iron-phosphate complexes: in vitro and in vivo studies.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rodríguez</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Simoes</namePart>
      <namePart type="given">R.V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Roig</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Molins</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nedelko</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Slawska-Waniewska</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arús</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabañas</namePart>
      <namePart type="given">M.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanfeliu</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cerdán</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">García-Martín</namePart>
      <namePart type="given">M.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>20</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>27</start>
          <end>37</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">09685243 (ISSN)</identifier>
      <titleInfo>
        <title>Magma (New York, N.Y.)</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>MAGMA</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34247892415&amp;partnerID=40&amp;md5=55f0d607452e05141e84269d6c175000</url>
    </location>
    <abstract>A new iron-based T1 contrast agent consisting of a complex of iron ions coordinated to phosphate and amine ligands (Fe(phos) in short) has been characterized by spectroscopic and magnetic measurements. NMR relaxation studies showed r1 values to be dependent on the phosphate salt concentration, K2HPO4, present in the medium. r1 reaches a maximum value of 2.5 mM(-1) s(-1) for measurements carried out at 7 T and 298 K. 31P MRS, Mössbauer spectroscopy and magnetic measurements of Fe(phos) solutions suggest paramagnetic Fe3+ ions present in the studied iron-phosphate complex. In vitro and in vivo toxicity experiments with C6 cells and CD1 mice, respectively, demonstrated lack of toxicity for Fe(phos) at the highest dose tested in the MRI experiments (12 mM iron for C6 cells and 0.32 mmol iron/kg for mice). Finally, T1 weighted images of brain tumours in mice have shown positive contrast enhancement of Fe(phos) for tumour afflicted regions in the brain.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>An NMR relaxation study of aqueous solutions of Gd(III) chelates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ermondi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>92</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>572</start>
          <end>580</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1991</dateIssued>
      </originInfo>
      <identifier type="issn">00222364 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance (1969)</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000056288&amp;partnerID=40&amp;md5=f67f986b5d4f63ecd7e8018d758ced5e</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>An NMR relaxometric indicator of the formation of OH• radicals in Fenton-type reactions</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Calzoni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Demonte</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sottero</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>13</number>
        </detail>
        <extent unit="pages">
          <start>1509</start>
          <end>1510</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0038426939&amp;partnerID=40&amp;md5=303c7253541beb26c8c471fc236a6a33</url>
    </location>
    <abstract>A gadolinium(III) paramagnetic complex bearing salicylate functionalities can be used to evaluate the OH• radical production by measuring water proton relaxation times.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>An NMR study of H(μ-H)Os3(CO)11</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>39</number>
        </detail>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>2422</start>
          <end>2425</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034729037&amp;partnerID=40&amp;md5=084002ba5dc5ce9a0d438134802e4611</url>
    </location>
    <abstract>The title compound appears to be present in solution as one major (98%) and two minor (ca. 1% each) isomers. All three isomers contain one bridging and one terminal hydride ligand. However, they differ in the location of the terminal hydride. Proton T1 measurements at variable temperature have allowed the determination of H(T)-H(B) distances in each isomer. An estimation of the relative 'hydridicity' of bridging and terminal hydrides has been gained by measuring the T1 of 2H(μ-2H)Os3(CO)11, while insights into the terminal/bridging hydride exchange have been gained from 1H variable-temperature NMR.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>An NMR study of the interaction between Melanin Free Acid and Mn2+ ions as a model to mimic the enhanced proton relaxation rates in melanotic melanoma</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sarzanini</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mentasti</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>9</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>963</start>
          <end>968</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1991</dateIssued>
      </originInfo>
      <identifier type="issn">0730725X (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>MAGN. RESON. IMAGING</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0026354034&amp;partnerID=40&amp;md5=9220768c9e2c479537d86226f7b838f1</url>
    </location>
    <abstract>The interaction of a soluble Melanin Free Acid (MFA) from Sepia melanin with Mn2+ ions is investigated by measuring the proton water relaxation rates. The similarity between MFA and the parent melanin is assessed by means of their high resolution 13C cross polarization magic angle spinning NMR spectra. The observed marked increase in longitudinal proton relaxation rates and the characteristic 1/T1 NMRD profile are associated to the formation of a macromolecular metal complex. The presence of similar paramagnetic species is expected to cause the high contrast shown by melanotic tissues in MRI.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>An unusual gadolinium ten-coordinated dimeric complex in the series of MRI contrast agents: Na[Gd(H2O)AAZTA] · 3H2O</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bombieri</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallotti</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Imperio</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Marchini</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>361</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>1534</start>
          <end>1541</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-39549084499&amp;partnerID=40&amp;md5=58dd586a9759e44fbfd3da86b47a3ec7</url>
    </location>
    <abstract>The crystal structures of the ligand AAZTA (6-amino-6-methylperhydro-1,4-diazepine tetraacetic acid) and of its Gd complex Na[Gd(H2O)AAZTA] · 3H2O have been determined by single crystal X-ray diffraction. The AAZTA ligand crystallizes in a zwitterion form with two deprotonated carboxylic groups and two protonated tertiary nitrogen atoms. Two independent molecules of about a similar conformation and three water molecules as asymmetric units, are present in the crystal. In the solid state the gadolinium complex is a centrosymmetric dimer with a bicapped square antiprismatic coordination geometry around each metal ion. Two symmetric bridging carboxylate groups determine the dimer formation with Gd-O(2) and Gd-O(2)′ bond distances rather comparable of 2.526(4) and 2.548(4) Å, respectively, while the Gd-O(1) (inner sphere water) bond distance is 2.443(5) Å. A network of hydrogen bonds between the water of inner and outer spheres and the AAZTA carboxylic groups is present in the crystal structure. © 2007 Elsevier B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Azide, cyanide, fluoride, imidazole and pyridine binding to ferric and ferrous native horse heart cytochrome c and to its carboxymethylated derivative: A comparative study</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Viola</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Coletta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Desideri</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoletti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tarricone</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>62</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>213</start>
          <end>222</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">01620134 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Inorganic Biochemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. INORG. BIOCHEM.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0029867909&amp;partnerID=40&amp;md5=b99e9c8c5a9a9bc5555dbe1edeb60851</url>
    </location>
    <abstract>Azide, cyanide, fluoride, imidazole, and pyridine binding to ferric and ferrous native horse heart cytochrome c and to its carboxymethylated derivative has been investigated, from the thermodynamic viewpoint, at pH 7.5 and 25.0°C. Ligand affinity for ferric and ferrous carboxymethylated cytochrome c is higher by about 30- and 400-fold, respectively, than that observed for the native protein. The results here reported: (i) allow the estimation, for the first time, of the ligand-independent free energy associated with the heme-iron sixth coordination bond in ferric and ferrous native cytochrome c, which turns out to be +8.4 kJ mol-1 and +14.6 kJ mol-1, at 25.0°C, respectively, and (ii) suggest an interplay between redox, structural, ligand binding, and recognition properties of cytochrome c.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Bifunctional ligands based on the DOTA-monoamide cage</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Upadhyaya</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Beltrami</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stefanìa</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1176</start>
          <end>1184</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">14770520 (ISSN)</identifier>
      <titleInfo>
        <title>Organic and Biomolecular Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Org. Biomol. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-41149094025&amp;partnerID=40&amp;md5=27970594524b8e562ed14089dbd6e14c</url>
    </location>
    <abstract>Efficient routes to DOTA-monoamide ligands bearing amino, hydroxyl, aldehyde and maleimido groups are described. These functional groups, which can be spaced at will from the coordination cage, will readily react with suitable groups of targeting moieties. Bioconjugates obtained in this way can be used for diagnostic imaging and therapeutic applications. This journal is © The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Binding and relaxometric properties of heme complexes with cyanogen bromide fragments of human serum albumin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Monzani</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Curto</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Galliano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Minchiotti</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Amoresano</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Salzano</namePart>
      <namePart type="given">A.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pucci</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casella</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>83</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>2248</start>
          <end>2258</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">00063495 (ISSN)</identifier>
      <titleInfo>
        <title>Biophysical Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Biophys. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-18644384550&amp;partnerID=40&amp;md5=d02beb132b1dd732bbfac67c42c07ffe</url>
    </location>
    <abstract>The spectroscopic and reactivity properties of hemin complexes formed with cyanogen bromide fragments B (residues 1-123), C (124-298), A (299-585), and D (1-298) of human serum albumin (HSA) have been investigated. The complex hemin-D exhibits binding, spectral, circular dichroism, and reactivity characteristics very similar to those of hemin-HSA, indicating that fragment D contains the entire HSA domain involved in heme binding, The characteristics of the other hemin complexes are different, and a detailed investigation of the properties of hemin-C has been carried out because this fragment contains the HSA binding region of several important drugs. Hemin-C contains a low-spin Fe(III) center, with two imidazole ligands, but the complex undergoes a reversible structural transition at basic pH leading to a high-spin, five- coordinated Fe(III) species. This change determines a marked increase in the relaxation rate of water protons. Limited proteolysis experiments and mass spectral analysis carried out on fragment C and hemin-C show that the region encompassing residues Glu-208 to Trp-214 is protected from activity of proteases in the complex and, therefore, is involved in the interaction with hemin. A structural model of fragment C enables us to propose that His-242 and His-288 are the axial ligands for the Fe(III) center.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Biodistribution of gadolinium-based contrast agents, including gadolinium deposition</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Caravan</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>30</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>1259</start>
          <end>1267</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">10531807 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Magn. Reson. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-73649089329&amp;partnerID=40&amp;md5=c0117cbe131e50379d2c6068249e1931</url>
    </location>
    <abstract>The biodistribution of approved gadolinium (Gd)-based contrast agents (GBCAs) is reviewed. After intravenous injection GBCAs distribute in the blood and the extracellular space and transiently through the excretory organs. Preclinical animal studies and the available clinical literature indicate that all these compounds are excreted intact. Elimination tends to be rapid and, for the most part, complete. In renally insufficient patients the plasma elimination half-life increases substantially from hours to days depending on renal function. In patients with impaired renal function and nephrogenic systemic fibrosis (NSF), the agents gadodiamide, gadoversetamide, and gadopentetate dimeglumine have been shown to result in Gd deposition in the skin and internal organs. In these cases, it is likely that the Gd is no longer present as the GBCA, but this has still not been definitively shown. In preclinical models very small amounts of Gd are retained in the bone and liver, and the amount retained correlates with the kinetic and thermodynamic stability of the GBCA with respect to Gd release in vitro. The pattern of residual Gd deposition in NSF subjects may be different than that observed in preclinical rodent models. GBCAs are designed to be used via intravenous administration. Altering the route of administration and/or the formulation of the GBCA can dramatically alter the biodistribution of the GBCA and can increase the likelihood of Gd deposition. © 2009 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Bis(diphenylphosphino)methane-substituted products from (μ3-CCH3)Co3(CO)9</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>320</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>229</start>
          <end>237</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1987</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0012959530&amp;partnerID=40&amp;md5=0a5c4c7f5e2ecec6ef624a4b34a4b098</url>
    </location>
    <abstract>The reaction between the alkylidyne cluster (μ3-CCH3)Co3(CO)9 and bis(diphenylphosphino) (dppm) gives two disubstituted stereoisomers of formula (μ3-CCH3)Co3(CO)7(μ-PPh2CH2PPh2) (I and II) and one monosubstituted product containing an uncoordinated phosphoryl group, (μ3-CCH3)Co3(CO)8[PPh2-CH2P(O)Ph2] (III). On heating in toluene under reflux, the kinetically favoured isomer I is transformed into the thermodynamically stable isomer II. Further reaction with a second molecule of dppm gives rise to two derivatives, (μ3-CCH3)CO3(CO)5(μ-dppm)2 (IV) and (μ3-CCH3)Co3(CO)6(μ-dppm)(dppm) (V). All the products have been characterized by IR and 13C and 31P NMR spectroscopy. © 1987.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Blast from the past: The Aluminum's ghost on the Lanthanum salts</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Canavese</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mereu</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nordio</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sabbioni</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>12</number>
        </detail>
        <detail type="issue">
          <number>14</number>
        </detail>
        <extent unit="pages">
          <start>1631</start>
          <end>1636</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">09298673 (ISSN)</identifier>
      <titleInfo>
        <title>Current Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Curr. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-21244478610&amp;partnerID=40&amp;md5=726f152eaf3f6ecef80363466ceaf100</url>
    </location>
    <abstract>Hyperphosphatemia is a common serious complication of chronic renal diseases, which needs appropriate continuous treatment in order to avoid ominous side effects. Therefore, oral chelating agents able to avoid phosphate absorption by the gut are mandatory. In the past, Aluminium salts, and more recently Calcium and Magnesium salts, and a synthetic resin polyallylamine hydrochloride have been employed, but Aluminium was later abandoned, because it has been a silent killer of many uremic patients, due to subtle absorption eventually leading to toxicity on Central Nervous System and bone, with allucinations, seizures, dementia, and osteomalacia, bone pain, fracturing osteodystrophy, and death. Recently, a new chelating agent able to bind dietary phosphate, namely Lanthanum carbonate has been introduced, with a proven efficacy profile for short-term treatment. However, after careful examination of the very few scientific papers available to date, we strongly advise caution before adopting, at present, lanthanum carbonate as a phosphate binder in uremic patients. In fact, notwithstanding minimized, some data are worrying: first, Lanthanum ions are absorbed, though at a minimal extent, by human gut; 2) pharmacokinetic evaluations show a greater exposure to Lanthanum in uremic patients;3) Lanthanum concentration is increased tenfold in blood and fivefold in bone after short-term supplementation in uremic patients; 4) there is no proofs that Lanthanum cannot cross the blood brain barrier in uremic patients; 5)Lanthanum has many biological effects and is potentially highly toxic. The Aluminum story should serve as cautionary tale when considering the use of new metal ions. © 2005 Bentham Science Publishers Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Block copolymer vesicles containing paramagnetic lanthanide complexes: A novel class of T1- and CEST MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Grüll</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Langereis</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Messager</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Torres</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>19</number>
        </detail>
        <extent unit="pages">
          <start>4847</start>
          <end>4850</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">1744683X (ISSN)</identifier>
      <titleInfo>
        <title>Soft Matter</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Soft Matter</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77956931020&amp;partnerID=40&amp;md5=fa01dd09eed1162c21a63dcd5f70f5dc</url>
    </location>
    <abstract>Block copolymer vesicles containing paramagnetic lanthanide complexes represent a versatile class of MRI contrast agents. By exploiting the water flux across the membrane, these nanovesicles can be employed as T1- and CEST MRI contrast agents. The incorporation of paramagnetic amphiphilic lipids (Gd-1 for T1 MRI CAs agents and Tm-2 for CEST MRI CAs) into the polymeric bilayer markedly improves the properties of the MRI contrast agents with respect to the longitudinal relaxivity (22 mM-1 s-1 at 20 MHz) and the chemical shift of the intrapolymersomal water protons. © 2010 The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Butadienic derivatives and metal carbonyls II. Some rearrangements of butadienic ligands in reactions with dodecacarbonyltriruthenium</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gambino</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valle</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vaglio</namePart>
      <namePart type="given">G.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>8</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>71</start>
          <end>75</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1974</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001968912&amp;partnerID=40&amp;md5=06cf50c0fc728f63e30b849baf54de18</url>
    </location>
    <abstract>Isomerization and rearrangement of ligands L, such as 1,4-trans,trans-diphenyl-1,3-butadiene, hexadiene isomers, isoprene and 1,3-butadiene, occur in the reactions with Ru3(CO)12 to give trimetallic complexes of molecular formula HRu3(O)9(L-H), in addition to bi- and monometallic complexes of known structure. On the contrary the diene skeleton is always maintained when L is 2,3-dimethyl-1,3-butadiene. Structures of HRu3(CO)9(L-H) complexes are suggested and some novel features in their proton n.m.r. spectra are described. © 1974.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Carbon coated microshells containing nanosized Gd(III) oxidic phases for multiple bio-medical applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Arrais</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Avedano</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Boccaleri</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stanghellini</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>45</number>
        </detail>
        <extent unit="pages">
          <start>5936</start>
          <end>5938</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-56749152210&amp;partnerID=40&amp;md5=52157514e9763b9104dbf4f69132ea18</url>
    </location>
    <abstract>Novel sub-microsized graphitic carbon shells embedding nanometric Gd(iii) oxidic phases feature thermal and chemical inertness with enhanced T2 relaxation in aqueous dispersions, thus representing potential candidates for dual diagnostic (magnetic resonance imaging) and therapeutic (neutron capture therapy) applications. © The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Carbon-13 nuclear magnetic resonance spectra of σ,η-binuclear complexes prepared from dodecacarbonyltri-iron and acetylenes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>838</start>
          <end>840</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1976</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049100814&amp;partnerID=40&amp;md5=93e91a13025d2266872cb7eea7709db8</url>
    </location>
    <abstract>The binuclear complexes [Fe2(CR1:CR2·CR3:CR 4)(CO)6], (I), and [Fe2(μ-CR1:CR2·CO·CR 3:CR4)(CO)6], (II), have been investigated by 13C n.m.r. spectroscopy (R1, R2, R3, R4 = H, Me, But, Ph, or CH2:CH·CH:CH2). Low-field absorptions observed for carbon atoms σ- and η-bonded to two iron atoms are discussed for the two classes of complex. Variable-temperature 13C n.m.r. spectra show that these complexes are stereochemically non-rigid; steric effects are important in the fluxional behaviour of the Fe(CO)3 moiety in complexes (II).</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Carbon-carbon σ-bond cleavage in α-hydroxyalkynes on reaction with dodecacarbonyl-triosmium and -triruthenium</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
    </name>
    <name type="personal">
      <namePart type="family">Deeming</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>23</number>
        </detail>
        <extent unit="pages">
          <start>1168</start>
          <end>1169</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1980</dateIssued>
      </originInfo>
      <identifier type="issn">00224936 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Chemical Communications</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049108289&amp;partnerID=40&amp;md5=673312568caa5e97e6f018246592e331</url>
    </location>
    <abstract>A carbon-carbon σ-bond is cleaved in the reaction of the diols HOCR2C≡CCR2OH (R = Me or Ph) with the osmium or ruthenium carbonyls [M3(CO)12] to give [HM 3(CO)2(C≡CR2OH)], a reaction which appears to be generally applicable to α-hydroxyalkynes not containing an α-hydrogen atom.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Carbon-hydrogen bond activation in novel cyclopentadienyl acetylenic carbonyl clusters of iron, ruthenium and nickel</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Raverdino</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>30</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>9</start>
          <end>12</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1978</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0010146720&amp;partnerID=40&amp;md5=2b8ce595475d2a9e50c035677da5ced5</url>
    </location>
    <abstract>Condensation of (π-C5H5)2Ni2(HC2Me) with Fe3(CO)12 leads to two novel complexes, Fe2(CO)7(π-C5H5)Ni(CEt) and Fe2(CO)6(π-C5H5)Ni(C2Me) based on a Fe2Ni core; intramolecular and intermolecular hydrogen shifts account for the reduction of the triple bond in one case and for the dehydrogenation of the alkyne in the second. The tetranuclear cluster Fe2(CO)6(π-C5H5)Ni2(C2Et2) is the main product of the reaction of [(π-C5H5)Ni(CO)]2 with Fe3(CO)9C2Et2. Cyclopentadiene reacts with HRu3(CO)9C2But affording (π-C5H5)Ru3(CO)8(CCH2But); also in this case the triple bond is hydrogenated and an apical carbon triply bridging the Ru3 unit is formed. Structures are proposed on i.r., mass spectra and 1H n.m.r. evidence. © 1978.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Carbon-metal hydrogen interchange in organometal clusters of ruthenium and osmium</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Skinner</namePart>
      <namePart type="given">D.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bracker-Novak</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>856</start>
          <end>858</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1988</dateIssued>
      </originInfo>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <abstract>Facile carbon-metal hydrogen exchange is demonstrated by the scrambling of deuterium into the hydrocarbon ligand from the hydride position of (μ-H)(μ3-η3-CH3CH 2C=C=C(H)CH3)Os3(CO)9 (I) at 110 °C in a sample initially 80% enriched in deuterium at the hydride position by 1H NMR techniques. Deuterium was incorporated into the allenic hydrogen position and the methylene hydrogens but not into the methyl groups. The observed scrambling is interpreted in terms of reversible formation of a 46e alkyne complex (μ3-η2-CH3CH2C≡CCH 2CH3)Os3(CO)9. The analogous ruthenium complex I′ was also deuteriated in the hydride position (76%), and the scrambling of deuterium was observed by 1H NMR during its isomerization to the corresponding allylic isomer (μ-H)(μ3-η3-CH3CH 2C=C(H)=CCH3)Ru3(CO)9 (II). A scrambling pattern similar to that seen for I is observed. These results are considered in terms of the known differences in the ligand dynamics of the organic ligands in structural types I and I′, and a two-step mechanism is proposed for the isomerization of I′ to II. © 1988 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Catalytic effects of apoferritin interior surface residues on water proton exchange in lanthanide complexes.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Vasalatiy</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zhao</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zhang</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sherry</namePart>
      <namePart type="given">A.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>10</start>
          <end>14</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">15554317 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast media &amp; molecular imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34547418503&amp;partnerID=40&amp;md5=47ea58e5d7e05efb5cdb87b542e9960a</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Cellular labeling with Gd(III) chelates: only high thermodynamic stabilities prevent the cells acting as 'sponges' of Gd3+ ions.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Corpillo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ghirelli</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bruno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lorusso</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>23</start>
          <end>29</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">15554317 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast media &amp; molecular imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33746894419&amp;partnerID=40&amp;md5=8a04c9d3e023f983cfb0d573fc82b8f6</url>
    </location>
    <abstract>MR-labeling of cells may be carried out by adding a Gd-based contrast agent to the incubation media. The amount of gadolinium internalized in HTC and C6 cells upon incubation with Gd-DTPA-BMA is circa one order of magnitude higher than those found with Gd-DTPA, Gd-DOTA and Gd-HPDO3A, respectively. The comparison of relaxometric and mass spectrometry determinations allows us to establish that only a minor fraction of intact Gd-DTPA-BMA is internalized into the cells. Moreover the binding/uptake behavior shown by Gd-DTPA-BMA resembles that found when GdCl(3) is added to the incubation medium. We suggest that the lower stability of Gd-DTPA-BMA is responsible for a shift in the dissociation equilibrium that results in the net transfer of Gd(3+) ions on the cell membrane followed by a slower internalization process. The transmetallation process is mediated by components of the incubation media, among which a dominant role is represented by phosphate anions. The uptake of Gd(3+) ions is clearly reflected in the drastic decrease of cell viability observed for cells labeled with Gd-DTPA-BMA. Copyright 2006 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Chalcogen derivatives of iron carbonyls. X. Reaction Mechanism of the CO substitution on Fe2(CO)6(μX)2(X = S, Se) with ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gervasio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rossetti</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stanghellini</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>40</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>131</start>
          <end>140</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1980</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000350549&amp;partnerID=40&amp;md5=8549e3e65e4e12f76f874c20a0915998</url>
    </location>
    <abstract>The reaction of the title complexes with phosphine-like ligands proceeds by two competing path, one, first order in [complex] and (L), the other first order in [complex] and second order in (L). The mechanism can be explained by a rate-determining formation of an intermediate Fe2(CO)6L(μX)2, which can lose CO or react further with another L prior to decomposition. The effect of both X and L on the rate of the two paths is discussed. The values of the rate constants show a large discriminating ability of the substrate versus the ligand, and this is tentatively explained by a facile coordination of the ligand on the complex via a low-energy empty M.O. © 1980.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Challenges for molecular magnetic resonance imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>110</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>3019</start>
          <end>3042</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">00092665 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Reviews</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Rev.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77952484017&amp;partnerID=40&amp;md5=8051c4bc980de46a3395964f4627beeb</url>
    </location>
    <abstract>Molecular Magnetic Resonance Imaging (MRI) which aims at visualizing molecules and molecular events which occur at a cellular level has been reported. The improved sensitivity of modern scanners allows the acquisition of images based on the detection of heteronuclear resonances. The role of MRI in the armory of diagnostic modalities for the medicine of the forthcoming years largely depends on how chemistry will provide advanced tools to meet the medical needs. The challenge of high relaxivity has also been tackled by using the huge armory of tools offered by nanotechnology. Molecular imaging is a new science that will have a tremendous impact in understanding biology and in the development of innovative diagnostic tools for early diagnoses and monitoring therapeutic treatments. Simultaneous MRI-PET acquisition will have great advantages if chemists will be able to develop agents that exploit the complementarities between the two modalities.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Characterization of human hair melanin and its degradation products by means of magnetic resonance techniques</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Ghiani</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Burgio</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fukuhara</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Martino</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Monda</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nervi</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kiyomine</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>46</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>471</start>
          <end>479</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">07491581 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-43749096798&amp;partnerID=40&amp;md5=e87b33e880d4f9655e7dbff14d82e1ce</url>
    </location>
    <abstract>Melanin granules (MGs) have been extracted from human Chinese black hairs by either acid hydrolysis (CH-type MGs) or enzymatic digestion (CP-type MGs), and their chemical structure investigated at the solid state by means of 13C cross polarization magic angle spinning (CPMAS NMR) and EPR spectroscopy. Both types of MGs contain a large amount of protein that is tightly bound to the true melanin polymer, with CP-type MGs having a larger protein content than CH-type ones. Moreover, MGs may also contain variable amounts of lipid-like material. A high amount of paramagnetic metals is detected by EPR in CP-type MGs, in particular Fe(III). Iron can be bound in two chemical forms: as isolated high spin Fe(III) ions with rhombic symmetry and as small oxy-hydroxy Fe(III) aggregates. Iron is poorly available to chelators. CH-type MGs contain much fewer metals. CP-type MGs have then been subjected to partial bleaching by hydrogen peroxide in ammonia, yielding a residual solid, called residual oxidized melanin (ROM) and a soluble but still pigmented fraction called melanin free acid (MFA). MFA can be isolated by precipitation at acidic pH. The 13C-CPMAS NMR and EPR spectra of these derivatives indicated that ROM has a structure very similar to that of parent MGs, whereas MFA shows a decrease of the protein content with respect to the melanin and a decreased amount of bound iron. Thus, the oxidative degradation of CP-type MGs is a process not involving the bulk of MGs, but rather it proceeds from the solvent-exposed outer parts to the interior. Copyright © 2008 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Chemistry of molecular imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Meade</namePart>
      <namePart type="given">T.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>42</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>821</start>
          <end>821</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">00014842 (ISSN)</identifier>
      <titleInfo>
        <title>Accounts of Chemical Research</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Acc. Chem. Res.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-67651089639&amp;partnerID=40&amp;md5=6df0b0726eae21b34dde61babb2b7583</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Cluster expansion reactions of HRu3(CO)9MeCCHCMe, a nido-Pentagonal-bipyramidal complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>57</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>207</start>
          <end>210</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1982</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-49049136752&amp;partnerID=40&amp;md5=32dd24a22a321cc730db42a1c27cd721</url>
    </location>
    <abstract>The condensation of [(η-C5H5)Fe(CO)2]2 with HRu3(CO)9C5H7 leads to a novel heterometallic cluster, (η-C5H5)FeRu3(CO)9C5H7, whose structure is inferred to i.r., mass and 1H n.m.r. spectral data and discussed with that of isoelectronic complex (η-C5H5)NiRu3(CO)8C5H7. The formation of both compounds can be rationalized in terms of Wade's approach as a cluster expansion from a nido to a closo polyhedron. The reaction of the title compound with Ru3(CO)12 affords Ru4(CO)12C5H8 in very low yield, for which a closo-octahedral geometry is suggested on the basis of spectroscopical evidence. © 1982.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>CO activation in the reactions of iron carbonyls and alkynes. Syntheses, crystal structures, and nuclear magnetic resonance studies on hydroxyferrole and maleoyliron derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Manotti Lanfredi</namePart>
      <namePart type="given">A.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>1664</start>
          <end>1670</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1979</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049095748&amp;partnerID=40&amp;md5=4594885bfab82ffddd1f600a422fa45f</url>
    </location>
    <abstract>New syntheses are described for the complexes [Fe2(CO)6{C4(OH)2RR′}] ('sawhorse' geometry), and [Fe(CO)4-{(CO)2C2RR′}]; the former are obtained in anhydrous hydrocarbon solvents, and the latter in alkaline methanolic solutions. The structures of [Fe2(CO)6{C2(OH)Et}2] and [Fe(CO)4{(CO)2C2Et2}] have been determined by X-ray diffraction methods; crystals of the binuclear derivative are monoclinic, space group P21/c, with Z = 4, in a unit cell of dimensions: a = 13.392(8), b = 16.242(9), c = 7.617(8) Å, β = 96.05(8)°; crystals of the mononuclear derivative are tetragonal, space group I41/a with Z = 16, in a unit cell of dimensions: a = 20.819(12), c = 12.950(9) Å. The structures have been solved from diffractometer data by Patterson and Fourier methods and refined by full-matrix least squares to R = 0.038 and 0.036 respectively. Both complexes contain a five-membered heterocyclic ring formed upon CO activation. The 1H and 13C n.m.r. spectra indicate CO fluxionality in the binuclear derivative. Chemical and structural relationships between these complexes are discussed and some comments made on CO activation, in the formation of the heterocyclic rings.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Grange</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti-Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Esposito</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Alberti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bussolati</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>70</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>2180</start>
          <end>2190</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">00085472 (ISSN)</identifier>
      <titleInfo>
        <title>Cancer Research</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Cancer Res.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77950273997&amp;partnerID=40&amp;md5=de7f0c6920893a62e57972d3f8895bcd</url>
    </location>
    <abstract>Specific targeting of tumors by combined delivery of drugs and of imaging agents represents an attractive strategy for treatment of cancer. The aim of the present study was to investigate whether neural cell adhesion molecule (NCAM)-targeted liposomes may enhance drug delivery and allow magnetic resonance imaging (MRI) in a severe combined immunodeficient mouse model of NCAM-positive Kaposi's sarcoma. NCAM-binding peptide-coated liposomes loaded with both doxorubicin and a lipophilic gadolinium (Gd) derivative were generated. NCAM-targeted liposomes induced an enhanced in vitro doxorubicin internalization within Kaposi's cells as detected by MRI with respect to untargeted polyethylene glycol liposomes. Internalization resulted in enhanced apoptosis. In vivo weekly administration of NCAM-targeted liposomes containing 5 mg/kg doxorubicin for 4 consecutive weeks induced a significant reduction of tumor mass and vascularization and enhanced cell necrosis and apoptosis with respect to untargeted liposomes. These effects were associated with an enhanced concentration of doxorubicin within the tumor and a reduced systemic toxicity of doxorubicin. By electron microscopy, NCAM-targeted liposomes were detected mainly within tumor cells whereas the untargeted liposomes were mainly accumulated in the extracellular space. Gd-labeled liposomes allowed the MRI visualization of drug delivery in the tumor region. The intensity of MRI signal was partially hampered by the "quenching" of the attainable relaxation enhancement on endosomal entrapment of the Gd-labeled liposomes. In conclusion, targeting NCAM may be a suitable strategy for specific drug delivery and imaging by liposomes in NCAM-expressing tumors. Moreover, treatment with NCAM-targeted liposomes showed enhanced therapeutic effect and reduced toxicity with respect to untargeted liposomes. ©2010 AACR.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Complexes of diethylenetriaminepentaacetic acid as contrast agents in NMR imaging. Computer simulation of equilibria in human blood plasma</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gennaro</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Santucci</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Causa</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Stefano</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>233</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>85</start>
          <end>100</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1990</dateIssued>
      </originInfo>
      <identifier type="issn">00032670 (ISSN)</identifier>
      <titleInfo>
        <title>Analytica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>ANAL. CHIM. ACTA</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0025312557&amp;partnerID=40&amp;md5=e7b4536598c86a5a1e1e54ee299a557b</url>
    </location>
    <abstract>In magnetic resonance imaging (MRI), the degree of contrast can be improved by using suitable contrast agents. The diethylenetriaminepentaacetic acid (DTPA) complexes of paramagnetic ions have been proposed for this purpose. This paper deals with extensive simulations of the distribution of species in blood plasma when solutions of manganese(II), copper(II), cobalt(II), iron(III) and gadolinium(III) ions (as their soluble salts and as DTPA complexes) are injected. The various interaction equilibria, for which formation constants are known, are considered in order to assess toxic side-effects associated with their use in MRI. The data obtained support from the thermodynamic point of view, the use of GdDTPA, and suggest that the administration of a slight excess of ligand would guarantee complete coordination of the toxic gadolinium ion, and only minor interaction with the metal ions naturally present in blood plasma.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Conformational and Coordination Equilibria on DOTA Complexes of Lanthanide Metal Ions in Aqueous Solution Studied by 1H-NMR Spectroscopy</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Marques</namePart>
      <namePart type="given">M.P.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geraldes</namePart>
      <namePart type="given">C.F.G.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pubanz</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Merbach</namePart>
      <namePart type="given">A.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>36</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>2059</start>
          <end>2068</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000865802&amp;partnerID=40&amp;md5=4f9452d11ac53eff7a68197811a6bfca</url>
    </location>
    <abstract>A variable-temperature, -pressure, and -ionic strength 1H NMR study of the DOTA complexes of different trivalent cations (Se, Y, La, Ce → Lu) (DOTA = 1,4,7,10-tetraaza-1,4,7,10-tetrakis(carboxymethyl)cyclododecane) yielded data that are in contradiction with the hitherto used model of only two enantiomeric pairs of diastereoisomers that differ in the ligand conformations. A two-isomer equilibrium cannot explain the newly observed apparent reversal of the isomer ratio at the end of the series. As both conformers may lose their inner sphere water molecule, a coordination equilibrium may be superimposed on this conformational equilibrium, as shown by large positive reaction volumes for the isomerization of [Ln(DOTA)(H2O)x]- (Ln = Yb, Lu; x = 1, 0). The isomerization of [Nd(DOTA)(H2O)]- and [Eu(DOTA)(H2O)]- is purely conformational, as shown by near-zero reaction volumes. The measured isomerization enthalpies and entropies agree with this model. The shift of the isomerization equilibria by a variety of non-coordinative salts depends on the ligand conformation rather than the presence or absence of the inner sphere water molecule. This results from weak ion binding and water solvent stabilization of one ligand conformation, rather than the decrease of the activity of the bulk water in the solution, as shown by UV-vis measurements of the coordination number sensitive transition 5F0 → 7D0 of Eu(III) as a function of ionic strength. Fluoride ions replace a water molecule in the inner coordination sphere, preferentially for one of the conformational isomers, as proven by 19F-NMR shifts and the appearance of a third set of resonances corresponding to [Eu(DOTA)F]2- in the 1H-NMR spectrum of [Eu(DOTA)(H2O)-.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Conformational constraints and σ-π-vinyl interchange in μ3-η3-5,6-dihydroquinoline triosmium complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Beatty</namePart>
      <namePart type="given">S.T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bergman</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <text>593-594</text>
        </detail>
        <extent unit="pages">
          <start>226</start>
          <end>231</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034650020&amp;partnerID=40&amp;md5=92630a1115f6153f9b54fa2f196dbe32</url>
    </location>
    <abstract>The rates of the σ-π-interchange processes in the series of 5,6-dihydro-μ3-η3-quinolyl complexes Os3(CO)9(C9H6(5-R,6-R′)N)(μ-H) (R=R′=H, 1, R=nBu, R′=H, 2; R=allyl, R′=CH3, 3, R=C(CH3)2CN, R′=CH3, 4; R=-CHS(CH2)2S-, R′=CH3, 5; R=CH2CO2tBu, R′=CH3, 6; R=CH2CO2tBu, R′=Cl, 7) have been examined by 1H-NMR spectroscopy using the 187Os-1H satellites as a dynamical probe. It was found that the unsubstituted and monosubstituted derivatives 1 and 2 are dynamic with respect to the σ-π-interchange process throughout the temperature range examined (+25 to -80°C). The disubstituted derivatives 3-6 on the other hand are rigid on the NMR time scale up to +100°C where coalescence of the satellites is observed. For compound 7, the barrier to σ-π-interchange is intermediate between 1 and 2 and 3-6, exhibiting coalescence at +70°C. Compound 7 also exhibits evidence for population of a second isomer as observed from VT 1H-NMR of the vinylic proton. The results are discussed in the context of the conformational constraints around the 5,6-carbon-carbon bond of the carbocyclic ring in these dihydroquinolyl complexes and are compared with previously reported σ-π-vinyl interchange processes. © 2000 Elsevier Science S.A.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Conjugates of cyclodextrins with charged and neutral macrocyclic europium, terbium and gadolinium complexes: Sensitised luminescence and relaxometric investigations and an example of supermolecular relaxivity enhancement</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Skinner</namePart>
      <namePart type="given">P.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Beeby</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dickins</namePart>
      <namePart type="given">R.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1329</start>
          <end>1338</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">03009580 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society. Perkin Transactions 2</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J Chem Soc Perkin Trans 2</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034236761&amp;partnerID=40&amp;md5=9de177a652112f7d734af4f5b023eda4</url>
    </location>
    <abstract>The synthesis and characterisation of lanthanide complexes of mono- and tetra-amide β-cyclodextrin derivatives of 1,4,7,10-tetraazacyclododecane tetraacetate (DOTA) are reported. Luminescence and relaxivity measurements confirm that the Eu, Tb and Gd complexes of the eight-coordinate mono-amide ligand possess one bound water molecule while the tetra-amide complexes are rare examples of q = 0 systems is aqueous solution. The relaxivity of the host β-CD Gd complex (8.50 mM-1 s-1, 20 MHz, 298 K) is enhanced when non-covalently bound to a second gadolinium complex bearing two phenyl moieties with an enhancement that is limited by the slowness of the water exchange rate (τm = 0.6 μs, 298 K). Sensitisation of the terbium luminescence in the mono-amide β-CD complex occurs in the absence of oxygen using various substituted naphthalene derivatives (e.g. naphthalene, K = 1.04 × 104 M-1, 293 K) and methyl p-tert-butylbenzoate. The slowness of the intra-complex energy transfer step severely limits the efficiency of this process and restricts the scope of 'non-covalently triggered luminescence' to a narrow range of guest substrates, as deduced by variable temperature time-resolved luminescence and flash-photolysis studies.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Considerations on high resolution solid state NMR in paramagnetic molecules</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bertini</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Luchinat</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>150</number>
        </detail>
        <extent unit="pages">
          <start>221</start>
          <end>242</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">00108545 (ISSN)</identifier>
      <titleInfo>
        <title>Coordination Chemistry Reviews</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Coord. Chem. Rev.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0010190955&amp;partnerID=40&amp;md5=97c2e1199b734a5663af22f9bc322dc5</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Contrast agents for magnetic resonance angiographic applications: 1H and 17O NMR relaxometric investigations on two gadolinium(III) DTPA-like chelates endowed with high binding affinity to human serum albumin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chiaussa</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>4</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>766</start>
          <end>774</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">09498257 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Biological Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Biol. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032714162&amp;partnerID=40&amp;md5=d3b7c867ed8cbb41eef28cef341c1a23</url>
    </location>
    <abstract>The relaxometric properties of two Gd(III) DTPA-like complexes (DTPA = diethylenetriamine-N,N',N,N'-pentaacetic acid) bearing different substituents for binding to human serum albumin (HSA) are compared. In spite of the structural differences of the recognition synthon and of the residual electric charge, the two chelates display an analogous binding affinity for the serum protein. Upon formation of the adducts with HSA, the exchange rates of the coordinated water appear slowed down by an amount corresponding to ca. 50% of the rates found for the free complexes. The relaxivity of [Gd(BOM)3DTPA (H2O)]2- is significantly higher than that of MS-325 either in the free complex or in the macromolecular adduct. Finally, the effect of pH on the stability of the HSA adducts and on the values of their relaxivities has been investigated.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Contrast agents for magnetic resonance imaging: A novel route to enhanced relaxivities based on the interaction of a Gd(III) chelate with poly-β-cyclodextrins</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Frullano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>5</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>1253</start>
          <end>1260</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032916866&amp;partnerID=40&amp;md5=ee765878933d7227cdf38dfa6411244d</url>
    </location>
    <abstract>This study proposes a novel route to improved contrast agents for magnetic resonance imaging (MRI) applications based on the formation of a non-covalent adduct between a paramagnetic complex and an exogeneous macromolecule. For this purpose a 12-membered pyridine-containing triacerate macrocyclic ligand with a p-bromobenzyloxy substituent on the pyridine moiety was synthesized. The Gd(III) complex containing this ligand shows a relaxivity of 8.25mM-1S-1 at 20MHz and 25°C. The hydrophobic p-bromo- benzyloxy moiety promotes the interaction of the chelate with human serum albumin (HSA) (K(a) x 102M-1) and with β-cyclodextrin (K(a) = 8 x 102M-1). Upon replacing β-cyclodextrin with a poly-β-cyclodextrin substrate (MW = ca. 6000 Da) a further relaxation enhancement is detected as a consequence of the increased molecular size of the resulting inclusion compound. In a typical experiment in blood serum, the observed relaxivity is 32mM-1S-1 (20 MHz, 25°C) when the concentrations are as follows: Gd(III) chelate I mM, poly-β-cyclodextrin 10mM, HSA 0.58mm. Under these conditions the Gd(III) chelate is mainly present as an inclusion compound with the poly-β-CD. This finding suggests a potential use for such a Gd(III) chelate/poly-β-CD system in MR angiographic applications. This study proposes a novel route to improved contrast agents for magnetic resonance imaging (MRI) applications based on the formation of a non-covalent adduct between a paramagnetic complex and an exogeneous macromolecule. For this purpose a 12-membered pyridine-containing triacetate macrocyclic ligand with a p-bromo-benzyloxy substituent on the pyridine moiety was synthesized. The GdIII complex containing this ligand shows a relaxivity of 8.25 mM-1 s-1 at 20 MHz and 25 °C. The hydrophobic p-bromo-benzyloxy moiety promotes the interaction of the chelate with human serum albumin (HSA) (Ka = 4×102 M-1) and with β-cyclodextrin (Ka = 8×102 M-1). Upon replacing β-cyclodextrin with a poly-β-cyclodextrin substrate (MW = ca. 6000 Da) a further relaxation enhancement is detected as a consequence of the increased molecular size of the resulting inclusion compound. In a typical experiment in blood serum, the observed relaxivity is 32 mM-1 s-1 (20 MHz, 25 °C) when the concentrations are as follows: GdIII chelate 1 mM, poly-β-cyclodextrin 10 mM, HSA 0.58 mM. Under these conditions the GdIII chelate is mainly present as an inclusion compound with the poly-β-CD. This finding suggests a potential use for such a GdIII chelate/poly-β-CD system in MR angiographic applications.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Contrast-enhanced MRI of murine sponge model for progressive angiogenesis assessed with gadoteridol (ProHance) and gadocoletic acid trisodium salt (B22956/1)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Ramponi</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rebaudengo</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grotti</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vultaggio</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morisetti</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lorusso</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>27</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>872</start>
          <end>880</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">10531807 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Magn. Reson. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-41949097528&amp;partnerID=40&amp;md5=438d585e7de1da2ca092f623ffdc3def</url>
    </location>
    <abstract>Purpose: To investigate the potential value of MRI for non-invasive assessment of angiogenesis in a murine model exploiting the properties of two contrast agents, gadoteridol (ProHance) and gadocoletic acid trisodium salt (B22956/1). Materials and Methods: Biocompatible sponges were implanted in both mice flanks. Stimulated sponges contained human recombinant basic fibroblast growth factor (bFGF) as the angiogenic agent: control sponges contained vehicle. Angiogenesis was evaluated by MRI after injection of extravascular (ProHance) or blood-pool (B22956/1) contrast agents at different times after sponge implantation. Sponges signal intensity enhancement was calculated both as the relative enhancement and the rate of relative enhancement. Results from MRI were validated by classic biochemical (hemoglobin level and protein content) and morphological (histology) assays. Results: The intrinsic different properties of ProHance and B22956/1 in wash-in and wash-out kinetics were useful to detect progressive vascularization and the establishment of a functional vascular network in the implants. Moreover, MRI allowed the appreciation of differences in neovessel colonization between bFGF-treated sponges and controls. Hemoglobin level, protein content, and histology confirmed the sponge vascularization and MRI results. Conclusion: Contrast-enhanced MRI is a reliable tool to study vascular characteristics in animal models of angiogenesis. The different kinetic properties of contrast agents can provide evidence of different functional neovascularization aspects and levels. © 2008 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Controlling the variation of axial water exchange rates in macrocyclic lanthanide(III) complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Batsanov</namePart>
      <namePart type="given">A.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mortillaro</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Puschmann</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>1120</start>
          <end>1121</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037161776&amp;partnerID=40&amp;md5=f1aced2a3d1cbc9f1ce7d97f88691ca0</url>
    </location>
    <abstract>The rate of axial water exchange in well-defined series of lanthanide complexes depends on the extent of second sphere hydration which is determined by complex hydrophobicity and the nature of the lanthanide ion and its counter-ion.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Coordination equilibrium in an Ln(III) macrocyclic chelate modulated by a reversible interaction with a weakly donor substituent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Dunand</namePart>
      <namePart type="given">F.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Merbach</namePart>
      <namePart type="given">A.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>40</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>87</start>
          <end>92</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">07491581 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0142062505&amp;partnerID=40&amp;md5=8bc853352c8af94b5a46b283ea0992a9</url>
    </location>
    <abstract>The introduction of a squaric acid moiety at the secondary nitrogen center of DO3A [DO3A = 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane] yields the DO3ASQ ligand endowed with a potential octadenticity towards Ln(III) ions. On the basis of 17O NMR investigations on [Gd(DO3ASQ)(H 2O)], 13C NMR observations on [Lu(DO3ASQ)(H2O)] and UV spectra of [Eu(DO3ASQ)(H2O)], it is suggested that [Ln(DO3ASQ)(H2O)] complexes are present in solution as a mixture of two isomers differing in the coordination number of the Ln(III) ion, being 8 and 9, respectively. Only in the latter isomer is the squaric moiety coordinated to the Ln(III) ion. Interestingly, the two isomers display different exchange rates of the coordinated water molecule. Copyright © 2001 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Coordination of an imine ligand on an Os3 cluster stabilized by intramolecular Os-H-H-N hydrogen bonding</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Férriz</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valls</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>18</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>2030</start>
          <end>2032</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001452457&amp;partnerID=40&amp;md5=4548f7685c1dc38432dcfd88571ff878</url>
    </location>
    <abstract>The addition of CH3CHO to a chloroform solution of H(μ-H)Os3(CO)10(NH3) affords the new H(μ-H)Os3(CO)10(HN=CHCH3) derivative where the imine ligand occupies a terminal position. The stereochemistry of the adduct appears to be determined by the occurrence of an unconventional hydrogen-bond interaction involving the N-H moiety and the terminal hydride. © 1999 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Coordination of imines on Os3 clusters: Effect of the solvent in addressing isomer formation</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Férriz</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valls</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>19</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>707</start>
          <end>710</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0003054843&amp;partnerID=40&amp;md5=f1790dcc2cdcf03eccfcb7b86a6bae05</url>
    </location>
    <abstract>Imine ligands terminally bound to triosmium clusters have been prepared by the reaction of Os3(μ-H)2-(CO)10 with NH3 and a keto or aldhehydic substrate. However reactions in nonpolar solvents yield only one of the two possible isomers. In contrast, reactions in polar solvents, such as methanol, yield both isomers. Experimental methods are described that clearly demonstrate that the overall stereochemistry of the resulting complexes is dependent upon the competition between intraand intermolecular hydrogen-bonding interactions. The isomers have been unambiguously assigned using 15N and 13C labeling as well as T1 measurements.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Copper-responsive magnetic resonance imaging contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Que</namePart>
      <namePart type="given">E.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baker</namePart>
      <namePart type="given">S.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Wong</namePart>
      <namePart type="given">A.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chang</namePart>
      <namePart type="given">C.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>131</number>
        </detail>
        <detail type="issue">
          <number>24</number>
        </detail>
        <extent unit="pages">
          <start>8527</start>
          <end>8536</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-67650525081&amp;partnerID=40&amp;md5=a7af82b498ef93909514a35633c27cf5</url>
    </location>
    <abstract>The design, synthesis, and evaluation of the Copper-Gad (CG) family, a new class of copper-activated magnetic resonance imaging (MRI) contrast agents, are presented. These indicators comprise a Gd3+-DO3A core coupled to various thioether-rich receptors for copper-induced relaxivity switching. In the absence of copper ions, inner-sphere water binding to the Gd3+ chelate is restricted, resulting in low longitudinal relaxivity values (r 1 = 1.2-2.2 mM-1 s-1 measured at 60 MHz). Addition of Cu+ to CG2, CG3, CG4, and CG5 and either Cu+ or Cu2+ to CG6 triggers marked enhancements in relaxivity (r 1 = 2.3-6.9 mM-1 s-1). CG2 and CG3 exhibit the greatest turn-on responses, going from r1 = 1.5 mM-1 s-1 in the absence of Cu+ to r1 = 6.9 mM -1 s-1 upon Cu+ binding (a 360% increase). The CG sensors are highly selective for Cu+ and/or Cu2+ over competing metal ions at cellular concentrations, including Zn2+ at 10-fold higher concentrations. 17O NMR dysprosium-induced shift and nuclear magnetic relaxation dispersion measurements support a mechanism in which copper-induced changes in the coordination environment of the Gd3+ core result in increases in q and r1. T1-weighted phantom images establish that the CG sensors are capable of visualizing changes in copper levels by MRI at clinical field strengths. © 2009 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Correlation of water exchange rate with isomeric composition in diastereoisomeric gadolinium complexes of tetra(carboxyethyl)dota and related macrocyclic ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Woods</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Howard</namePart>
      <namePart type="given">J.A.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Moloney</namePart>
      <namePart type="given">J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Navet</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Port</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rousseaux</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>122</number>
        </detail>
        <detail type="issue">
          <number>40</number>
        </detail>
        <extent unit="pages">
          <start>9781</start>
          <end>9792</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034638402&amp;partnerID=40&amp;md5=f23be45c05817d55af99f30577b4e91c</url>
    </location>
    <abstract>The solution structure and dynamics of metal-bound water exchange have been studied in a series of diastereoisomeric gadolinium complexes of tetra(carboxyethyl) derivatives, of 1,4,7,10-tetraazacyclodecane. The structures of the (RRRS), (RSRS), and (RRSS) ligands and the Eu, Gd, and Tb complexes of the (RRRR) isomer have been determined by X-ray crystallography. Luminescence measurements on the Eu and Tb complexes revealed an integral hydration state (q = 1) in each case for the Eu isomers, whereas nonintegral values were measured for the (RRRR) and (RRRS) Tb isomers (e.g., [(RRRR)-Tb·1]-, q = 0.60). The ratio of the twisted and regular monocapped square antiprismatic isomers has been measured in solution by 1H NMR for the Eu and Tb complexes and followed the order, (RRRR) &gt; (RRRS) &gt; (RSRS) &gt; (RRSS). Water exchange rates in the gadolinium complexe have been determined by 17O NMR and were fastest for the (RRRR) isomer [τ(m) = 68 ns (298 K)] and correlated very well with the proportion of the twisted square anti-prismatic isomer. The rate of water exchange in the (RRRR) Gd complexes is likely to be sufficiently fast so as not to limit the overall relaxivity in higher MW conjugates.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Crystal and molecular structure of Ru3(CO)6(C12H20CO)(C12H20): an example of four alkynic groups bonded to a metal cluster</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gervasio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Franchini-Angela</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>27</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>145</start>
          <end>151</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1978</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0010846419&amp;partnerID=40&amp;md5=88e84b6f0294e2d70ee4c91c206b7c3e</url>
    </location>
    <abstract>Ru3(CO)6(C12H20CO)(C12H20), obtained from either Ru3(CO)12 or HRu3(CO)9[C2C(CH3)3] and 3,3-dimethyl-1-butyne, crystallyzes in the triclinic space group P1, with a = 11.942(17), b = 12.877(8), c = 11.219(7) Å, α = 97.86(2), β = 102.41(3), γ = 90.44(1)°, Z = 2; Patterson and Fourier-difference maps revealed the atom positions, all hydrogens included. The refinement, anisotropic only for the ruthenium atoms, led to the final R = 0.037 for 3687 observed reflections. The X-ray structural analysis showed the presence of two organic ligands face-bonded to the triruthenium isosceles cluster. The first ligand originates from two alkynic molecules, each other bonded via a CO bridge, to form with an RuRu bond two penta-atomic adjacent rings. The second consists of a chain formed by two head-to-tail joined alkynic moieties. © 1978.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Crystal structure and NMR investigation of the serine proteinase inhibitor MR889, a cyclic thiolic compound</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rizzi</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casale</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">La Rosa</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Luisetti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bolognesi</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>2253</start>
          <end>2256</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1993</dateIssued>
      </originInfo>
      <identifier type="issn">1472779X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Perkin Transactions 2</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000340880&amp;partnerID=40&amp;md5=90455351e6bc66c94445448703d6d562</url>
    </location>
    <abstract>The serine proteinase inhibitor N-(2-oxo-2,3,4,5-tetrahydro-3-thienyl)-2- (2-thenoylthio)propionamide (MR889) has been crystallised, and its three-dimensional structure studied by X-ray diffraction and by NMR techniques in solution and in the solid state. MR889 crystallises in the monoclinic space group P21/n with cell constants a = 10.539(2), b = 9.647(5), c= 14.654(1) Å, β = 101.62(1)°; the asymmetric unit contains one molecule of MR889. The weighted crystallographic R factor for the refined structure is 0.044. The solution structure of MR889 has been elucidated through the measurement of proton-proton and proton-carbon nuclear Overhauser enhancements. Measurement of the 13C longitudinal relaxation times yields information about the dynamics of MR889 in dimethylsulfoxide solution. The comparison between solid and solution state 13C NMR spectra allows an understanding of the quite different structures in the two states.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Crystal structure and solution dynamics of the lutetium(III) chelate of DOTA</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ayala</namePart>
      <namePart type="given">J.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bombieri</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>246</number>
        </detail>
        <detail type="issue">
          <text>1-2 SPEC. ISSUE</text>
        </detail>
        <extent unit="pages">
          <start>423</start>
          <end>429</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000935213&amp;partnerID=40&amp;md5=ab9ea165331aa11a76bbc3f8cbf1bd2a</url>
    </location>
    <abstract>The X-ray structure of Na[Lu(DOTA)(H2O)]·4H2O consists of (-1) complex anions balanced by sodium cations. The nine-coordinate Lu(III) is linked to the four nitrogen and to four oxygen atoms of the macrocyclic ligand DOTA in a square antiprismatic arrangement with a coordinated water molecule in capping position. In aqueous solution the complex is present under two isomeric forms in the relative ratio of 10:1, as evaluated from the low temperature limiting 13C NMR spectrum. The variable temperature behavior is consistent with the presence of two dynamic processes. One exchanges enantiomeric pairs for both isomers and involves concerted conformational changes of the ethylenic groups of the macrocyclic ring and rotation of the acetate arms. The other corresponds to the interconversion between the two isomers. Complete line-shape analysis of the variable-temperature 13C NMR spectra of Lu-DOTA allowed a quantitative evaluation of the two processes. The enantiomerization is slower than the isomerization: the corresponding calculated free energies of activation are 65.9 ± 1.2, 62.7 ± 2.0 (exchange major⇄minor) and 58.7 ± 2.1 kJ mol-1 (exchange minor ⇄ major), respectively.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Crystal structure and stereochemical non-rigidity of octacarbonyl-(η-1,3-dimethyl-2-vinylcyclopentadienyl)-μ 3-propylidyne-triangulo-tri-iron</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>227</start>
          <end>232</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1977</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049107817&amp;partnerID=40&amp;md5=be393007cb815f6ebbcfd5fd65e6d5b1</url>
    </location>
    <abstract>The title compound has been obtained by treating [Fe3(CO)12] with methylacetylene and is characterized by i.r., mass, 1H, and 13C n.m.r. spectra. The crystal structure has been determined by X-ray methods. Crystals are monoclinic, space group P21/c, with Z = 4, in a unit cell of dimensions a = 7.584(7), b = 15.851(9), c = 18.535(11) Å, and β = 103.3(1)°. The structure has been solved from diffractometer data by Patterson and Fourier methods and refined by block-diagonal least squares to R 0.032 for 3145 observed reflections. The molecule is formed by a Fe3C cluster very similar to the Co3C core in [Co3(CY)(CO)9] (Y = alkyl, aryl, or other group). Trimerization of the alkyne leads to the formation of a cyclopentadienyl unit (bearing one vinyl and two methyl groups) η-bonded to one iron atom. Of the eight carbonyls co-ordinated to the iron atoms, six are terminal and two are bridging the shortest sides of the cluster. Variable-temperature 13C n.m.r. spectra show that a two-stage exchange process occurs.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Current concepts on hyperpolarized molecules in MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>14</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>90</start>
          <end>96</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">13675931 (ISSN)</identifier>
      <titleInfo>
        <title>Current Opinion in Chemical Biology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Curr. Opin. Chem. Biol.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-75149123911&amp;partnerID=40&amp;md5=19751753312b1c98bc90a6ebff41a82f</url>
    </location>
    <abstract>Hyperpolarization provides a strong enhancement of the MR signal and allows the acquisition of images from nuclei other than protons. Besides vascular imaging and perfusion studies the use of hyperpolarized molecules has allowed the visualization of real-time substrate uptake and metabolism in vivo. Metabolic imaging is an outstanding field of research that aims at providing the clinicians with the possibility of interrogating real-time complex metabolic pathways that give a direct insight into the cellular state and activity. © 2009 Elsevier Ltd. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Dependence of the relaxivity and luminescence of gadolinium and europium amino-acid complexes on hydrogencarbonate and pH</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Howard</namePart>
      <namePart type="given">J.A.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kataky</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lowe</namePart>
      <namePart type="given">M.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Moloney</namePart>
      <namePart type="given">J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Sousa</namePart>
      <namePart type="given">A.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>1047</start>
          <end>1048</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <abstract>Reversible binding of hydrogencarbonate to a chiral di-aqua lanthanide complex occurs in the pH range 6.5-8.5, limiting the measured relaxivity in the gadolinium complex and enhancing the metal-based emission in the europium analogue.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Designing novel contrast agents for magnetic resonance imaging. Synthesis and relaxometric characterization of three gadolinium(III) complexes based on functionalized pyridine-containing macrocyclic ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Corpillo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallotti</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>86</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>615</start>
          <end>632</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">0018019X (ISSN)</identifier>
      <titleInfo>
        <title>Helvetica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Helv. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037254308&amp;partnerID=40&amp;md5=cbea0cc7d7687aa1798e83fa5c0a04be</url>
    </location>
    <abstract>The three novel pyridine-containing 12-membered macrocyclic ligands 1-3 were synthesized. The coordinating arms are represented by three acetate moieties in 1 and 3 and by one acetate and two phosphonate moieties in 2. In all three ligands, the acetate arm in the distal position is substituted, with a benzyl group in 1 and 2 and with an arylmethyl moiety in 3. The relaxivities r1p (20 MHz, 25°) of GdIII complexes are: GD · 1, r1p = 8.3 mm-1 s-1; GD · 2, r1p = 8.1 mM-1 s-1; Gd · 3, r1p = 10.5 mM-1 s-1. 1H-NMRD and 17O-NMR T2 data show that Gd · 1 and Gd · 3 contain two H2O molecules in the inner sphere, whereas the presence of two phosphonate arms allows the coordination of only one H2O molecule in Gd · 2. Interestingly, the exchange lifetime of coordinated H2O in the three complexes is similar in spite of the difference in the coordination number of the GdIII ion (i.e., 9 in Gd · 1 and Gd · 3, and 8 in Gd · 2). 1H-Relaxometric measurements at different pH and in the presence of lactate and oxalate were carried out to get some insight into the formation of ternary complexes from Gd · 1 and Gd · 3. Finally, it was found that binding to human-serum albumin (HSA) of Gd · 1 and Gd · 2, though weak, yields limited relaxivity enhancements, likely as a consequence of effects on the hydration sphere caused by donor atoms on the surface of the protein.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Detection of a novel intermediate in the addition of thiols to osmium carbonyl clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Kiriakidou</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Plutino</namePart>
      <namePart type="given">M.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Prestopino</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Monari</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Johansson</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Elding</namePart>
      <namePart type="given">L.I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valls</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nordlander</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>24</number>
        </detail>
        <extent unit="pages">
          <start>2721</start>
          <end>2722</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <abstract>Spectroscopic studies of the reaction of [Os3(CO)11MeCN)] with para-thiocresol to form [Os3(μ-H)(CO)10(μ-SC6H4Me-p)] indicate that the reaction proceeds via a two-step consecutive process involving the intermediate [OS3(CO)11(MeC6H4SH-p)], in which there is an agostic Os-H-S interaction.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Determination of ferric heme-human serum albumin by 1H NMR relaxometry</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mattu</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>95</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>64</start>
          <end>67</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">01620134 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Inorganic Biochemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Inorg. Biochem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037405541&amp;partnerID=40&amp;md5=c85203c526834566e4b846d9dcb96e24</url>
    </location>
    <abstract>A new method for the accurate determination of ferric heme-human serum albumin (heme-HSA) at concentrations down to the physiological level, i.e., in the micromolar concentration range, is proposed. This method is based on the 1H NMR relaxometric properties of heme-HSA. Actually, the binding of the paramagnetic ferric heme to the primary binding site of HSA determines a strong paramagnetic enhancement of the water 1H NMR relaxation rate. Although a linear relationship may be seen by operating at 20 MHz on conventional electromagnets, the method here reported is improved by working at 0.02 MHz on a field-cycling instrument. This 1H NMR relaxometric method does not suffer from the presence in serum of heme catabolites (e.g., bilirubin) that affect significantly the optical determination of ferric heme-HSA in the micromolar concentration range. Paramagnetic ferric hemoglobin contribution may be selectively quenched by cyanide binding. © 2003 Elsevier Science Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Determination of metal-proton distances and electronic relaxation times in lanthanide complexes by nuclear magnetic resonance spectroscopy</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barbero</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ermondi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>225</start>
          <end>228</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1992</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-9544239303&amp;partnerID=40&amp;md5=ea77acee984cdda7235ab3866e3e5b54</url>
    </location>
    <abstract>The longitudinal and transverse relaxation times of the proton resonances of three lanthanide(III) complexes of 1,4,7,10-tetraazacyclododecane-N,N′,N″,N′″-tetraacetate have been measured. This allows determination of the metal-proton distances and the electronic relaxation times of the paramagnetic metal ions by exploiting the Curie-spin mechanism contribution to the transverse relaxation rates, once the molecular reorientational time τr is known by an independent experiment. Values of the parameters calculated from data obtained at a single magnetic field (9.4 T) were in good agreement with those found from the evaluation of the magnetic field-induced line broadening of the proton resonances as measured at 2.1, 4.7 and 9.4 T. A chemical exchange contribution to the linewidths is excluded on the basis of experiments performed at different temperatures.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Determination of the prototropic exchange rate at the water molecule coordinated to an anionic paramagnetic GdIII chelate</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Beltrami</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1283</start>
          <end>1289</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">14341948 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-2742595863&amp;partnerID=40&amp;md5=7ead931067d9fb373bebb0164c7d169a</url>
    </location>
    <abstract>A thorough investigation of the proton and oxygen-17 relaxation rates of water nuclei has been carried out for a solution containing an amphiphilic, paramagnetic GdIII chelate of potential interest as a contrast agent for MRI. It has been found that at pH = 7, 298 K and 20 MHz (proton observation frequency), the contribution to the overall relaxation enhancement from the water molecule in the inner coordination sphere is dominated by the relaxation time ( T1MH) of its protons. However, upon formation of a slowly tumbling adduct with β-cyclodextrin, the observed relaxation enhancement is also affected by the exchange lifetime (τMH) of the coordinated water and by the transfer rate of its protons. This situation has been exploited to assess the prototropic exchange rate from the coordinated water to the bulk, which is base-catalyzed. In fact, under these experimental conditions, at basic pH, the proton transfer is faster than the exchange of the whole water molecule, and it becomes the factor determining the observed relaxation enhancement. The effect is further enhanced at low temperature as a consequence of the concomitant lengthening of either τR (which causes a reduction of T1MH) and/or the exchange lifetime of the coordinated water molecule.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Determination of water permeability of paramagnetic liposomes of interest in MRI field</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Carrera</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lombardi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mazzon</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Visigalli</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>102</number>
        </detail>
        <detail type="issue">
          <text>5-6</text>
        </detail>
        <extent unit="pages">
          <start>1112</start>
          <end>1119</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">01620134 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Inorganic Biochemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Inorg. Biochem.</title>
      </titleInfo>
    </relatedItem>
    <abstract>The water permeability of various liposome membranes has been determined at 298 K by measuring the NMR longitudinal water proton relaxation rate of vesicles encapsulating the clinically approved Gd-HPDO3A complex (HPDO3A = 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid). Two basic formulations based on DPPC (dipalmitoylphosphatidylcholine) and POPC (palmitoyl-oleylphosphatidylcholine) phospholipids were selected and investigated. Furthermore, the permeability changes caused by the membrane incorporation of amphiphiles like cholesterol and/or metal complexes of interest for designing improved liposome-based MRI contrast agents, were also investigated. The incorporation of cholesterol and metal complexes bearing C18 saturated chains in POPC-based liposomes reduces the water diffusivity across the membrane bilayer. On the contrary, the incorporation of a macrocyclic metal complex bearing four C12 alkylic chains, one for each coordination arm of the ligand, considerably enhances the water permeability in DPPC-based liposomes. Finally, it is reported that the permeability of POPC-based bilayer is increased when the liposomes are subjected to an osmotic stress. © 2008 Elsevier Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Development and validation of a smoothing-splines-based correction method for improving the analysis of CEST-MR images</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Stancanello</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>136</start>
          <end>149</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-57649220769&amp;partnerID=40&amp;md5=271c446a1e5ec7af3496db5e4d439afa</url>
    </location>
    <abstract>Chemical exchange saturation transfer (CEST) imaging is an emerging MRI technique relying on the use of endogenous or exogenous molecules containing exchangeable proton pools. The heterogeneity of the water resonance frequency offset plays a key role in the occurrence of artifacts in CEST-MR images. To limit this drawback, a new smoothing-splines-based method for fitting and correcting Z-spectra in order to compensate for low signal-to-noise ratio (SNR) without any a priori model was developed. Global and local voxel-by-voxel Z-spectra were interpolated by smoothing splines with smoothing terms aimed at suppressing noise. Thus, a map of the water frequency offset ('zero' map) was used to correctly calculate the saturation transfer (ST) for each voxel. Simulations were performed to compare the method to polynomials and zero-only-corrected splines on the basis of SNR improvement. In vitro acquisitions of capillaries containing solutions of LIPOCEST agents at different concentrations were performed to experimentally validate the results from simulations. Additionally, ex vivo investigations of bovine muscle mass injected with LIPOCEST agents were performed as a function of increasing pulse power. The results from simulations and experiments highlighted the importance of a proper 'zero' correction (15% decrease of fictitious CEST signal in phantoms and ex vivo preparations) and proved the method to be more accurate compared with the previously published ones, often providing a SNR higher than 5 in different simulated and experimentally noisy conditions. In conclusion, the proposed method offers an accurate tool in CEST investigation. Copyright © 2008 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Developments of magnetic resonance imaging and spectroscopy in the field of molecular imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bisi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>53</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>563</start>
          <end>564</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">18244785 (ISSN)</identifier>
      <titleInfo>
        <title>Quarterly Journal of Nuclear Medicine and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Q. J. Nucl. Med. Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77949867473&amp;partnerID=40&amp;md5=69c6fc8cd88aa1e00ecc0c7bbbfb7ff7</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Dipolar Oscillations in the13C-{1H} Cross-Polarization/Magic- Angle-Spinning Spectrum of H2Os3(CO)10</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">HAWKES</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">MANTLE</namePart>
      <namePart type="given">M.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">SALES</namePart>
      <namePart type="given">K.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">AIME</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">GOBETTO</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">GROOMBRIDGE</namePart>
      <namePart type="given">C.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>116</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>251</start>
          <end>254</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">10641858 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance, Series A</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Magn. Reson. Ser. A</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0008304314&amp;partnerID=40&amp;md5=5722f2ac91ef05c60278179d82ee4837</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Direct NMR spectroscopic observation of a lanthanide-coordinated water molecule whose exchange rate is dependent on the conformation of the complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Sousa</namePart>
      <namePart type="given">A.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>37</number>
        </detail>
        <detail type="issue">
          <number>19</number>
        </detail>
        <extent unit="pages">
          <start>2673</start>
          <end>2675</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032538573&amp;partnerID=40&amp;md5=c228ef4309c410f570b590ba2c5ddc78</url>
    </location>
    <abstract>A large difference in the exchange rate of the coordinated water molecule is seen in solution for the diastereoisomers M and m of a europium(III) complex with an octadentate, neutral macrocyclic ligand (k(ex)(M) &lt; k(ex)(m)). This finding is of high relevance to the design of more efficient contrast agents for magnetic resonance imaging.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Dose estimation in B16 tumour bearing mice for future irradiation in the thermal column of the TRIGA reactor after B/Gd/LDL adduct infusion</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Protti</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ballarini</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bortolussi</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bruschi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stella</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Alberti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Altieri</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>69</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>1842</start>
          <end>1845</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">09698043 (ISSN)</identifier>
      <titleInfo>
        <title>Applied Radiation and Isotopes</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Appl. Radiat. Isot.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-80055079972&amp;partnerID=40&amp;md5=f39e566bd58ca88b405bfc8225c5e8c9</url>
    </location>
    <abstract>To test the efficacy of a new 10B-vector compound, the B/Gd/LDL adduct synthesised at Torino University, in vivo irradiations of murine tumours are in progress at the TRIGA Mark II reactor of the Pavia University. A localised B16 melanoma tumour is generated in C57BL/6 mice and subsequently infused with the adduct. During the irradiation, the mouse will be put in a shield to protect the whole body except the tumour in the back-neck area. To optimise the treatment set-up, MCNP simulations were performed. A very simplified mouse model was built using MCNP geometry capabilities, as well as the geometry of the shield made of 99% 10B enriched boric acid. A hole in the shield is foreseen in correspondence of the back-neck region. Many configurations of the shield were tested in terms of neutron flux, dose distribution and mean induced activity in the tumour region and in the radiosensitive organs of the mouse. In the final set-up, up to five mice can be treated simultaneously in the reactor thermal column and the neutron fluence in the tumour region for 10min of irradiation is of about 5×10 12cm-2. © 2011 Elsevier Ltd.</abstract>
    <note type="content">AD  - National Institute of Nuclear Physics (INFN) Section of Pavia, Via Bassi 6, 27100 Pavia, Italy</note>
    <note type="content">AD  - University of Pavia, Department of Nuclear and Theoretical Physics, via Bassi 6, 27100 Pavia, Italy</note>
    <note type="content">AD  - University of Torino, Chemistry Department, Via Nizza 52, 10126 Torino, Italy</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: boric acid, 10043-35-3, 11113-50-1, 11129-12-7, 14213-97-9; boron 10, 14798-12-0; Boron, 7440-42-8; Isotopes&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: ARISE&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Protti, N.; University of Pavia, Department of Nuclear and Theoretical Physics, Via Bassi 6, 27100 Pavia, Italy; email: nicoletta.protti@pv.infn.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1016/j.apradiso.2011.02.045&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;PubMed ID: 21459587&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Aime, S., Barge, A., Crivello, A., Deagostino, A., Gobetto, R., Nervi, C., Prandi, C., Venturello, P., Synthesis of Gd(III)-C-palmitamidomethyl-C'-DOTAMA-C(6)-o-carborane: a new dual agent for innovative MRI/BNCT applications (2008) Org. Biomol. Chem., 6 (23), pp. 4460-4466; Bethesda, M.D., Photon, electron, proton and neutron interaction data for body tissues. (1992), ICRU Report 46, International Commission on Radiation Units and MeasurementsBortolussi, S., Altieri, S., Thermal neutron irradiation field design for boron neutron capture therapy of human explanted liver (2007) Med. Phys., 34 (12), pp. 4700-4705; (2000), Briesmeister, J.F., (Ed.), J.MCNPTM-a general Monte Carlo N-particle transport code, version 4C, LA-13709-MCarabelli, V., BNCT: ottimizzazione della distribuzione di dose n+γ in fegato espiantato. (1997), Degree Thesis, University of PaviaDierenfeld, E.S., Alcorn, H.L., Jacobsen, K.L., Nutrient composition of whole vertebrate prey (excluding fish) fed in zoos (2002) Natl. Agric. Libr., Z7994, pp. Z65. , http://www.nal.usda.gov/awic/zoo/WholePreyFinal02May29.pdf; Esposito, J., Ceballos, C., Soncin, M., Fabris, C., Friso, E., Moro, D., Colautti, P., Nava, E., Feasibility of BNCT radiobiological experiments at the HYTHOR facility (2008) Nucl. Instrum. Methods-B, 266 (11), pp. 2587-2593; Geninatti-Crich, S., Lanzardo, S., Alberti, D., Belfiore, S., Ciampa, A., Giovenzana, G.B., Lovazzano, C., Aime, S., Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles (2007) Neoplasia, 9 (12), pp. 1046-1056; Hall, E., (2006) Radiobiology for the Radiologist, , Lippincott Williams and Wilkins; Manera, S., Dosimetria n+γ nella facility realizzata per la TCN presso il reattore TRIGA Mark II. (1994), Degree Thesis, University of PaviaWetscott, C.H., Effective cross section values of well moderated thermal reactor spectra. (1960), Report AECL No. 1101Yasumura, S., Jones, K., Spanne, P., Schidlovsky, G., Wielopolski, L., Ren, X., Glaros, D., Xatzikonstantinou, Y., In vivo animal models of body composition in aging (1993) J. Nutr., 123, pp. 459-464&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <subject>
      <topic>Animals</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>B16 melanoma</topic>
    </subject>
    <subject>
      <topic>BNCT</topic>
    </subject>
    <subject>
      <topic>boric acid</topic>
    </subject>
    <subject>
      <topic>Boric acids</topic>
    </subject>
    <subject>
      <topic>boron</topic>
    </subject>
    <subject>
      <topic>boron 10</topic>
    </subject>
    <subject>
      <topic>C57BL/6 mice</topic>
    </subject>
    <subject>
      <topic>controlled study</topic>
    </subject>
    <subject>
      <topic>Dermatology</topic>
    </subject>
    <subject>
      <topic>Dose distributions</topic>
    </subject>
    <subject>
      <topic>Dose estimations</topic>
    </subject>
    <subject>
      <topic>gamma radiation</topic>
    </subject>
    <subject>
      <topic>in vivo study</topic>
    </subject>
    <subject>
      <topic>Induced activity</topic>
    </subject>
    <subject>
      <topic>Inorganic acids</topic>
    </subject>
    <subject>
      <topic>In-vivo</topic>
    </subject>
    <subject>
      <topic>Isotopes</topic>
    </subject>
    <subject>
      <topic>Mammals</topic>
    </subject>
    <subject>
      <topic>MCNP calculations</topic>
    </subject>
    <subject>
      <topic>MCNP simulations</topic>
    </subject>
    <subject>
      <topic>melanoma</topic>
    </subject>
    <subject>
      <topic>melanoma B16</topic>
    </subject>
    <subject>
      <topic>Melanoma, Experimental</topic>
    </subject>
    <subject>
      <topic>Mice</topic>
    </subject>
    <subject>
      <topic>Mice, Inbred C57BL</topic>
    </subject>
    <subject>
      <topic>Monte Carlo method</topic>
    </subject>
    <subject>
      <topic>Mouse irradiation</topic>
    </subject>
    <subject>
      <topic>Mouse models</topic>
    </subject>
    <subject>
      <topic>neutron capture therapy</topic>
    </subject>
    <subject>
      <topic>neutron dosimetry</topic>
    </subject>
    <subject>
      <topic>Neutron fluences</topic>
    </subject>
    <subject>
      <topic>Neutron irradiation</topic>
    </subject>
    <subject>
      <topic>neutron radiation</topic>
    </subject>
    <subject>
      <topic>Oncology</topic>
    </subject>
    <subject>
      <topic>phantom</topic>
    </subject>
    <subject>
      <topic>priority journal</topic>
    </subject>
    <subject>
      <topic>radiation absorption</topic>
    </subject>
    <subject>
      <topic>radiation detection</topic>
    </subject>
    <subject>
      <topic>radiation dose distribution</topic>
    </subject>
    <subject>
      <topic>radiation exposure</topic>
    </subject>
    <subject>
      <topic>radiation shield</topic>
    </subject>
    <subject>
      <topic>radioactivity</topic>
    </subject>
    <subject>
      <topic>Radiosensitive organs</topic>
    </subject>
    <subject>
      <topic>Thermal column</topic>
    </subject>
    <subject>
      <topic>Tissue Distribution</topic>
    </subject>
    <subject>
      <topic>TRIGA Reactor</topic>
    </subject>
    <subject>
      <topic>Tumors</topic>
    </subject>
    <subject>
      <topic>Whole body</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Yeast cell wall particles: A promising class of nature-inspired microcarriers for multimodal imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Figueiredo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Moreira</namePart>
      <namePart type="given">J.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geraldes</namePart>
      <namePart type="given">C.F.G.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rizzitelli</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>47</number>
        </detail>
        <detail type="issue">
          <number>38</number>
        </detail>
        <extent unit="pages">
          <start>10635</start>
          <end>10637</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-80052951955&amp;partnerID=40&amp;md5=de090bbcab31a5d30696d066dcf74d3c</url>
    </location>
    <abstract>This communication demonstrates that yeast cell wall particles (YCWPs) are a promising class of nature-inspired biocompatible microcarriers for the delivery of amphipathic/lipophilic imaging reporters. When a paramagnetic MRI agent is loaded, the longitudinal relaxivity per particle at 0.5 T is the highest ever reported for Gd-based systems. © 2011 The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Dual MRI-SPECT agent for pH-mapping</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">MacIocco</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Imperio</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Simonelli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Abbas</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bisi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>47</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>1539</start>
          <end>1541</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-78751472715&amp;partnerID=40&amp;md5=a04625f015dce2aa43dd2f345adb7bfa</url>
    </location>
    <abstract>A new dual MRI/SPECT pH-responsive agent where the SPECT active moiety acts as reporter of the concentration making it possible to exploit the responsiveness of the MRI probe. © 2011 The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Dynamic 13C NMR spectroscopy of metal carbonyls</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>11</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>183</start>
          <end>210</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1977</dateIssued>
      </originInfo>
      <identifier type="issn">00796565 (ISSN)</identifier>
      <titleInfo>
        <title>Progress in Nuclear Magnetic Resonance Spectroscopy</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Prog. Nucl. Magn. Reson. Spectrosc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0011544133&amp;partnerID=40&amp;md5=29ac36e2d2adf5d3ea588f09fad87850</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Dynamic behavior of the flyover bridge complexes M2(CO)5L{μ-[C(R)=C(R′)]2CO} (M = Ru, Fe; L = CO, PPh3, AsPh3, SbPh3; R, R′ = Me, Ph)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nicola</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>5</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1829</start>
          <end>1833</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1986</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0040502538&amp;partnerID=40&amp;md5=d66b8cd67635bd6556833736b2adf04a</url>
    </location>
    <abstract>The variable-temperature 1H and 13C NMR studies of a series of isomeric "flyover bridge" complexes M2(CO)5L{μ-[C(R)=C(R′]2CO} (M = Ru, Fe; L = CO, PPh3, AsPh3, SbPh3; R, R′ = Me, Ph) show that a fluxional process of the dienone ligand, leading to the exchange of σ- and π-bonds at the two metal centers is occurring in these compounds on the NMR time scale. The activation energy for this process in the entire series is essentially invariant (ΔG‡ = (70-76) ± 5 kJ/mol) with the nature of M and L and is apparently independent of localized carbonyl exchange at each M(CO)3 unit. © 1986 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Dynamic processes in the solid state. Proton relaxation studies and potential energy barrier calculations for (arene)M(CO)3 species. X-ray crystal structures of (1,2,3-C6H3Me3)Cr(CO)3 and (1,2,4,5-C6H2Me4)Cr(CO)3</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Braga</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grepioni</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Orlandi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>30</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>951</start>
          <end>956</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1991</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001500403&amp;partnerID=40&amp;md5=87fe793bd9a932ff6b9fa16edf78092c</url>
    </location>
    <abstract>The dynamic behavior in the solid state of (C6Me6)Cr(CO)3 (1), (1,2,3-C6H3Me3)Cr(CO)3 (2), and (1,2,4,5-C6H2Me4)Cr(CO)3 (3) has been investigated by means of variable-temperature 1H spin-lattice relaxation time T1 measurements and potential energy barrier calculations. Structural characterization of 2 and 3 at room temperature by single-crystal X-ray diffraction has been carried out. Crystal data: 2, space group P21/n, a = 7.289 (4) Å, b = 13.114 (4) Å, c = 12.526 (3) Å, β = 97.64 (4)°, V = 1186.7 Å3, Z = 4; 3, space group P21/n, a = 8.985 (1) Å, b = 12.527 (2) Å, c = 9.011 (1) Å, β = 118.22 (1)°, V = 1275.7 Å3, Z = 4. It is found that, in all cases, the lowest energy dynamic process involves rotation of the methyl groups (Ea = 2-6 kJ/mol). Facile reorientation of the C6Me6 fragment in 1 is also detected (Ea = 25.9 kJ/mol) in good agreement with the results of potential energy barrier calculations. For 2 and 3, it is shown that reorientation, at room temperature, of the arene fragments is forbidden by the crystal packing, while large amplitude motions appear to be responsible for the additional modulation detected in the log T1 versus 103/T plots. The drastic reduction of T1 observed for 2 and 3, as the temperature is increased to ca. 333 K, is interpreted in terms of an order/disorder phase transition associated with full rotational freedom of the arenes or of the entire molecules. Support for this observation comes from the behavior of the diffraction patterns of the two species with temperature and from DSC measurements. © 1991 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Dynamic properties and solution structures of the clusters [Fe3(CO)9X2](X = S, Se, Te, or NMe) and their derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rossetti</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stanghellini</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>46</start>
          <end>51</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1980</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049091527&amp;partnerID=40&amp;md5=b58e473e2cf482f190c1e4f933a5e5e2</url>
    </location>
    <abstract>Variable-temperature 13C n.m.r. spectra of the title species have shown that two distinguishable steps occur in the exchange of carbonyl groups: in the first step the carbonyls at the apical iron atom become equivalent and in the second those at the basal Fe. The replacement of one carbonyl group with a Group 5 ligand yields one isomer, whereas in the case of the disubstituted derivatives two positional isomers have been obtained. The substitution with Group 5 ligands occurs more easily at the basal iron atoms: at the axial position in the monosubstituted derivative and at the axial and an equatorial position at each basal Fe in the most abundant disubstituted isomer. The structure of the adduct [Fe3(CO)9(PBun3)Te2], an intermediate in the formation of the monosubstituted derivatives, is discussed. The dynamic properties of the phosphorus derivatives have also been determined.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Dynamic properties of the trinuclear carbonyl cluster FeCo2(CO)95S and its derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rossetti</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stanghellini</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>25</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>103</start>
          <end>108</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1977</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000954238&amp;partnerID=40&amp;md5=e9faa714cc008f206c9c420170278dd1</url>
    </location>
    <abstract>13C.-n.m.r. spectra show that the replacement of CO by a group V ligand in FeCo2(CO)9S is at one cobalt atom in the monosubstituted derivative, at the two cobalt atoms in the bisubstituted derivative and at the two cobalt and at the iron atom in the tri-substituted derivative. The substitution is at an equatorial position in each case. Multistage exchange of the carbonyls is a common feature of these complexes. The activation energies for the localised scrambling at the unique iron atom have been evaluated and shown to be influenced by the nature and the number of the substitents at the cobalt atoms. Localised scrambling of the CO of any M(CO)2L moiety is not observed to take place prior of internuclear scrambling. © 1977.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Dynamic properties of the trinuclear carbonyl cluster FeCo2(CO)9S and its Derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rossetti</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stanghellini</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>31</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>291</start>
          <end>291</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1978</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-49349136259&amp;partnerID=40&amp;md5=52598aa6137e7ebdecdc277ea3526d06</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Effect of a mesitylene-based ligand cap on the relaxometric properties of Gd(III) hydroxypyridonate MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Werner</namePart>
      <namePart type="given">E.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>4</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>220</start>
          <end>229</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-71649096231&amp;partnerID=40&amp;md5=ee477bab5900ec936344ec36dcb3d1c7</url>
    </location>
    <abstract>A series of new Gd(III) hydroxypyridonate complexes featuring a mesitylene (ME)-derived ligand cap has been prepared. Relaxometric characterization reveals that the complexes tend to form large aggregates in solution with slow tumbling rates, as estimated from NMRD analysis, and unique pH-dependent relaxivities. The solution behavior and relaxometric properties are compared with those observed for analogous TREN-capped compounds, and the potential for use of these new ME-capped complexes as pH-responsive MRI contrast agents is explored. Copyright © 2009 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin: A spectrospic study</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mattu</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vannini</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cipollone</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>268</number>
        </detail>
        <detail type="issue">
          <number>23</number>
        </detail>
        <extent unit="pages">
          <start>6214</start>
          <end>6220</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">00142956 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Biochemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Biochem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035210356&amp;partnerID=40&amp;md5=cc126b14a5a2e52baeb06c49c6e76363</url>
    </location>
    <abstract>Haem binding to human serum albumin (HSA) endows the protein with peculiar spectroscopic properties. Here, the effect of ibuprofen and warfarin on the spectroscopic properties of ferric haem-human serum albumin (ferric HSA-haem) and of ferrous nitrosylated haem-human serum albumin (ferrous HSA-haem-NO) is reported. Ferric HSA-haem is hexa-coordinated, the haem-iron atom being bonded to His105 and Tyr148. Upon drug binding to the warfarin primary site, the displacement of water molecules - buried in close proximity to the haem binding pocket - induces perturbation of the electronic absorbance properties of the chromophore without affecting the coordination number or the spin state of the haem-iron, and the quenching of the 1H-NMR relaxivity. Values of Kd for ibuprofen and warfarin binding to the warfarin primary site of ferric HSA-haem, corresponding to the ibuprofen secondary cleft, are 5.4 ± 1.1 × 10-4 M and 2.1 ± 0.4 × 105 M, respectively. The affinity of ibuprofen and warfarin for the warfarin primary cleft of ferric HSA-haem is lower than that reported for drug binding to haem-free HSA. Accordingly, the Kd value for haem binding to HSA increases from 1.3 ± 0.2 × 10-8 M in the absence of drugs to 1.5 ± 0.2 × 10-7 M in the presence of ibuprofen and warfarin. Ferrous HSA-haem-NO is a five-coordinated haem-iron system. Drug binding to the warfarin primary site of ferrous HSA-haem-NO induces the transition towards the six-coordinated haem-iron species, the haem-iron atom being bonded to His105. Remarkably, the ibuprofen primary cleft appears to be functionally and spectroscopically uncoupled from the haem site of HSA. Present results represent a clear-cut evidence for the drug-induced shift of allosteric equilibrium(a) of HSA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Effect of low and zero magnetic field on the hyperpolarization lifetime in parahydrogenated perdeuterated molecules</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Santelia</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>200</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>15</start>
          <end>20</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">10907807 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Magn. Reson.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-68049113396&amp;partnerID=40&amp;md5=c39eea2bb166c847d33314cf34ff64cf</url>
    </location>
    <abstract>Hyperpolarization can be kept for times longer than T1 if it is maintained in a singlet state, from which transitions are not allowed. Another, more direct, way to slower the relaxation process consists in the use of perdeuterated molecules. Here both methods have been applied and the hyperpolarization (induced by para-H2) decay rate has been measured at two different magnetic fields: earth field and zero field. While relaxation is very slow at earth field, it becomes faster at zero field: this rather unexpected finding has been explained on the basis of isotropic mixing between 1H and 2H. © 2009 Elsevier Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Belfiore</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Biancone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Esposito</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Manazza</namePart>
      <namePart type="given">A.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>55</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>491</start>
          <end>497</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Med.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33644799862&amp;partnerID=40&amp;md5=e0703e28f449bdfad6cb36698b39146d</url>
    </location>
    <abstract>Gd-HPDO3A has been internalized into rat hepatocarcinoma cells in the cytoplasm (by electroporation) or in intracellular vesicles (by pinocytosis), respectively. In the former case, the observed relaxation rates are likely dependent upon the amount of internalized paramagnetic complex, whereas in the latter case the relaxation enhancement is "quenched" to a plateau value (about 3 s-1) when the entrapped amount of Gd-chelate is higher than 1 × 1010 Gd/cell. The observed behavior has been accounted in terms of a theoretical treatment based on equations formally derived by Labadie et al. (J Magn Reson B 1994; 105:99-102). On this basis, entrapment into intracellular vesicles has been treated as a three-site water exchange (extracellular/cytoplasm/vesicle compartments), whereas the cell pellets containing the paramagnetic agent spread out in the cytoplasm can be analyzed by a two-site exchange system. © 2006 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Efficient cellular labeling by CD44 receptor-mediated uptake of cationic liposomes functionalized with hyaluronic acid and loaded with MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Esposito</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>1858</start>
          <end>1862</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">18607179 (ISSN)</identifier>
      <titleInfo>
        <title>ChemMedChem</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>ChemMedChem</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-57549113707&amp;partnerID=40&amp;md5=1589cc38d1326a9ca03d742aa16d83fc</url>
    </location>
    <abstract>(Figure Presented) The supramolecular adducts of negatively charged hyaluronic acid polymers and cationic Gd-liposomes were used for labeling cells that overexpress CD44 receptors. This cellular labeling methodology is very efficient and allows the internalization of a large payload of soluble Gd complexes in a very short timeframe. © 2008 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Efficient relaxivity enhancement in dendritic gadolinium complexes: Effective motional coupling in medium molecular weight conjugates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Fulton</namePart>
      <namePart type="given">D.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">O'Halloran</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Senanayake</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>474</start>
          <end>476</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-13244258348&amp;partnerID=40&amp;md5=de2e2189450d5c43739bb1833e43f65e</url>
    </location>
    <abstract>Enhancement of the relaxivities of Gd-based MRI contrast agents is achieved by placing the metal ion at the barycentre of the molecular complex in order to improve motional coupling.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Electrochemical investigation of a series of organotriruthenium clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Zanello</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1374</start>
          <end>1378</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0039005333&amp;partnerID=40&amp;md5=a5d3d3e6a83a44dc417accada5588fcb</url>
    </location>
    <abstract>The reduction and oxidation behavior of a series of organotriruthenium clusters, namely, HRu3(CO)9(μ3-allenyl), HRu3(CO)9(μ3-allyl), and HRu3(CO)9 (μ3-alkynyl) complexes, is investigated by voltammetric techniques at mercury and platinum microelectrodes. The relationships between the resulting electrode potentials and both 13C NMR chemical shifts and ν(CO) frequencies are presented. © 1984 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Electronic structure of ferracyclopentadienyl derivatives. UV PES and ab initio study of Fe2(μ-CO)(CO)5(C4R4) and Fe3(μ-CO)2(CO)6(C4R4)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Casarin</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ajò</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tondello</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>24</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>1241</start>
          <end>1246</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1985</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33845378163&amp;partnerID=40&amp;md5=6a1c626d54a6304c533585097b883b1f</url>
    </location>
    <abstract>The gas-phase UV PE spectra of metallacyclopentadienyl bi- and trinuclear derivatives of Fe and Ru are reported and discussed. The bonding scheme of these molecules is discussed on the basis of theoretical results obtained by pseudopotential ab initio calculations. The role played by semibridging or asymmetrically bridging carbonyl groups has been clarified. The very high stability of the metallacyclopentadienyl ring has been ascribed to the presence of a very strong M-C interaction, only σ in character. © 1985 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Enantioselective recognition between chiral α-hydroxy-carboxylates and macrocyclic heptadentate lanthanide(III) chelates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mondino</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>42</number>
        </detail>
        <detail type="issue">
          <number>16</number>
        </detail>
        <extent unit="pages">
          <start>4891</start>
          <end>4897</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0043032963&amp;partnerID=40&amp;md5=fe3b5be4e2cf644dba5cf11c0f8ec010</url>
    </location>
    <abstract>Three novel heptacoordinated Ln(III) complexes (Ln = Gd and Yb) have been synthesized and investigated by 1H NMR spectroscopy. These complexes contain two stereogenic centers, one associated with a δδδδ or λλλλ conformation of the ethylenediamine moieties in the tetraazamacrocycle and the latter arises from the orientation (Δ or Δ) of the coordinating arms. Evidence has been gained for the occurrence of a fast exchange between all the possible conformers. Upon addition of several (S)-α-hydroxy-carboxylate substrates, the formation of stable ternary adducts has been obtained. Their 1H NMR spectra are consistent with the presence of two diastereoisomers differing in the conformation adopted by the macrocyclic ligand wrapping the lanthanide(III) ion. The interaction leading to the formation of the ternary complexes is enantioselective depending on the hydrophilicity of the α-hydroxycarboxylate.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Encoding the frequency dependence in MRI contrast media: The emerging class of CEST agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>5</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>78</start>
          <end>98</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77951553892&amp;partnerID=40&amp;md5=624fe6817f8bfea2d79c4068ff24cfcc</url>
    </location>
    <abstract>CESTagents represent a very promising class of MRI contrast media as they encode a frequency dependence that is not like the classical relaxation-based agents. This peculiar property enables novel applications such as the detection of more than one agent in the same MR image as well as the set-up of ratiometric methods for the quantitative assessment of physico-chemical and biological parameters that characterize the micro-environment in which they are distributed. This survey is aimed at providing the reader with the basic properties and the potential of these compounds. Fundamental aspects, such as the theoretical basis of the saturation transfer via chemical exchange, the generation of the CEST contrast, the classification and sensitivity of CEST agents, and some representative examples displaying their potential in the field of MR-molecular imaging, are presented and discussed in detail. Copyright © 2010 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Enhanced mobility of the cluster Ru3(CO)12 in the solid state formed in situ by the reaction of CO and Ru3(CO)'6(μ-CO)(μ3:η2:η3:η5-C12H8) on silica</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arce</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giusti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stchedroff</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>15</number>
        </detail>
        <extent unit="pages">
          <start>1425</start>
          <end>1426</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034617832&amp;partnerID=40&amp;md5=4f2694d0138db06e7f574a36d61f93a6</url>
    </location>
    <abstract>The reaction of Ru3(CO)'6(μ-CO)(μ3:η2:η3:η5-C12H8). (physisorbed on SiO2) with CO in the solid state leads to Ru3(CO)12 and acenaphthylene in quantitative yields; the Ru3(CO)12 generated in situ is highly mobile leading to a reduced chemical shielding anisotropy.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>EPR investigations of the iron domain in neuromelanin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bergamasco</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Biglino</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giamello</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lopiano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1361</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>49</start>
          <end>58</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">09254439 (ISSN)</identifier>
      <titleInfo>
        <title>Biochimica et Biophysica Acta - Molecular Basis of Disease</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>BIOCHIM. BIOPHYS. ACTA MOL. BASIS DIS.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0030927143&amp;partnerID=40&amp;md5=a9b22a05ef8642622081b6d09764e9b1</url>
    </location>
    <abstract>The interactions between iron and neuromelanin (NM) have been studied by means of EPR spectroscopy. The variable temperature EPR spectral features of a specimen of NM extracted from normal human midbrains clearly indicate that iron is present as polynuclear oxy-hydroxy ferric aggregates as well as isolated Fe(III) centres. Ferric oxy-hydroxy phases are typical of the iron storage proteins ferritin and hemosiderin, but the comparison of the variable temperature EPR spectra of ferritin and NM highlights significant differences between the two iron(III)oxy-hydroxy domains. Moreover, further investigations on melanin models synthesised in the presence of either ferritin or a ferric salt as iron sources suggest that the same pathway of formation and inclusion of the polynuclear iron oxide is operating in NM and in the model systems, whatever is the source of iron.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Equilibrium and kinetic properties of the lanthanoids(III) and various divalent metal complexes of the heptadentate ligand AAZTA</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Baranyai</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bényei</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Brücher</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1696</start>
          <end>1705</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-60749113390&amp;partnerID=40&amp;md5=a3ca0ef195ac8dede5d5c62d30485e8a</url>
    </location>
    <abstract>The heptadentate ligand 1,4-bis(hydroxycarbonylmethyl)-6- [bis(hydroxycarbonylmethyl)]amino-6-methylperhydro-1,4-diazepine (AAZTA) and its derivatives were recently reported to give stable complexes with Gd 3+ with superior efficiency as MRI contrast agents. Nevertheless, only preliminary data are available on the coordination behavior of this interesting ligand. In this work, thermodynamic and kinetic stability data are determined for the formation of complexes with AAZTA and the lanthanoid metal ions, and other divalent metal ions of interest for this application. The AAZTA ligand binds the lanthanoid ions with log KML values of 17.53-21.85 with its affinity steadily increasing from La3+ to Lu3+, suggesting that the seven-membered skeleton is better suited to accommodate smaller metal ions. Even though the denticity is lower, the stability of the heavier lanthanoid complexes is comparable to those of the classical ligand diethylenetriaminepentaacetic acid (DTPA). The transmetalation reactions of [Gd-(AAZTA)]- with Cu2+ and Eu3+ predominantly occur through proton-assisted dissociation of the complex. The role of the direct attack of Cu2+ or Eu3+ in the exchange reactions is limited, although the formation of dinuclear complexes decreases the proton-assisted dissociation. Near physiological conditions, [Gd(AAZTA)] - is significantly more inert than [Gd(DTPA)]2-, allowing its potentially safe use as contrast agent in magnetic resonance imaging. © 2009 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Erratum: Novel paramagnetic macromolecular complexes derived from the linkage of a macrocyclic Gd(III) complex to polyamino acids through a squaric acid moiety (Bioconjugate Chemistry (March/April 1999) 10:2 (195))</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>10</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>701</start>
          <end>701</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">10431802 (ISSN)</identifier>
      <titleInfo>
        <title>Bioconjugate Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Bioconjugate Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032839345&amp;partnerID=40&amp;md5=eafef53120877132093df0f9d6a35f8b</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Evidence for a glycidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bergamasco</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lopiano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valente</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>62</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>369</start>
          <end>371</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1994</dateIssued>
      </originInfo>
      <identifier type="issn">00223042 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Neurochemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. NEUROCHEM.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0028115611&amp;partnerID=40&amp;md5=31cf9e98582521becb746fbc9c19fdf9</url>
    </location>
    <abstract>The high-resolution solid-state 13C-NMR spectrum of a neuromelanin specimen (from patients dying from nonneurological diseases) is compared with that obtained from enzymatically prepared dopamine-melanin. The main differences between the two spectra suggest the occurrence in neuromelanin of a glycidic/lipidic matrix tightly associated with the melanin macromolecule. Atomic emission spectroscopy revealed high iron content (1.5%) in the neuromelanin specimen, in full agreement with previous reports. These observations support the view that neuromelanin acts as a strong chelating (and insolubilizing) system for iron ions and further suggest that the attack to this compact composite substrate may be an important step to allow the release of iron ions responsible for the increased lipid peroxidation reported in the pathogenesis of Parkinson's disease.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Evidence for in vivo macrophage mediated tumor uptake of paramagnetic/fluorescent liposomes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chaabane</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzardo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Visigalli</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>22</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>1084</start>
          <end>1092</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">09523480 (ISSN)</identifier>
      <titleInfo>
        <title>NMR in Biomedicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>NMR Biomed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-73349142327&amp;partnerID=40&amp;md5=e2b8417e4dbd9e8c6d574bad8a9fc4ff</url>
    </location>
    <abstract>Dysprosium (Dy)-loaded liposomes act as excellent T2- susceptibility agents at high magnetic field strength. The R2- enhancement increases with the size of the liposomes and the concentration of entrapped paramagnetic metal complexes. Neuro-2a tumor cells are readily labeled when Dy-loaded liposomes, suitably functionalized with glutamine residues (Gln), are added to the culture medium as glutamine receptors are highly expressed in such proliferating tumor cells. By using fluorescent liposomes doped with fluorescent dyes (either incorporated in the membrane or included in the inner cavity), confocal microscopy experiments showed that targeted liposomes are taken up much more avidly than non-targeted vesicles. In vivo studies showed that glutamine-functionalized and nonfunctionalized liposomes accumulate in the tumor region to a similar extent. Confocal images of the excised tumor showed extensive co-localization of liposomes and macrophages in both cases. It is suggested that the loss of tumor specificity, shown by Gln-functionalized liposomes in vivo, has to be associated with the efficient removal of liposomes operated by the RES (reticulo endoplasmatic system) or tumor associated macrophages. Copyright © 2009 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Facile oxidative addition/reductive elimination of HX (X=Cl, Br, I) on (μ-H)2Os3(CO)10</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <text>593-594</text>
        </detail>
        <extent unit="pages">
          <start>135</start>
          <end>141</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034649917&amp;partnerID=40&amp;md5=ddf59e7cf77fe6122500b8c40b1b91c6</url>
    </location>
    <abstract>The addition of an HX molecule (X=Cl, Br, I) to (μ-H)2Os3(CO)10 yields four novel trihydride complexes of formula H(μ-H)2Os3(CO)10(X), which differ in the position occupied by the terminal hydride on the osmium atom. The reaction takes place even at 183 K, and can be followed by NMR spectroscopy. At room temperature elimination of HX yields (partially) the original starting material. This reaction appears to be catalyzed by a base. This observation prompted us to investigate the reaction between H(μ-H)2Os3(CO)10(X) and ammonia. The product of the latter reaction is a mixture of isomers whose structures are related to those of the parent H(μ-H)2Os3(CO)10(X). © 2000 Elsevier Science S.A.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Factors determining the proton T1 relaxivity in solutions containing Gd-DTPA</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>23</number>
        </detail>
        <detail type="issue">
          <text>SUPPL. 1</text>
        </detail>
        <extent unit="pages">
          <start>S264-S266</start>
          <end>S264-S266</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1988</dateIssued>
      </originInfo>
      <identifier type="issn">00209996 (ISSN)</identifier>
      <titleInfo>
        <title>Investigative Radiology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>INVEST. RADIOL.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0023802307&amp;partnerID=40&amp;md5=9c643ce6909768fc1d761555dbbc416a</url>
    </location>
    <abstract>The relaxation times T1 and nuclear Overhauser effects were measured in the 13C nuclear magnetic resonance (NMR) spectra of the diamagnetic calcium (Ca) and lanthanum (La) analogs of Gd-DTPA. From these data the correlation times for the molecular reorientation τ(R) were calculated; it is suggested that this term is the dominant one in the evaluation of the paramagnetic relaxation equation. The similar τ(R) values obtained in water and blood serum ruled out the occurrence of any adduct formation between Gd-DTPA complex and the macromolecular framework in the latter system. The difference in relaxivity shown by Gd-DTPA in the two media is interpreted in terms of influence of the serum components on the dissociation equilibrium of Gd-DTPA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Fast carbonyl exchange in the solid state for β-cyclodextrin/(arene)Cr(CO)3 inclusion complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canuto</namePart>
      <namePart type="given">H.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>281</start>
          <end>282</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0033531355&amp;partnerID=40&amp;md5=d5a3479f185aa72b4c7c08de6e3fec3f</url>
    </location>
    <abstract>The exchange of carbonyls is a common feature for metal carbonyl compounds in solution whereas in the solid state high interatomic potential energy barriers cause this occurrence to be highly unlikely; it is shown that the compartmentalization of (arene)Cr(CO)3 in the β-cyclodextrin cavity removes any constraint and thereby facilitates the rotation of the Cr(CO)3 group in the solid state.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Fast field-cycling magnetic resonance imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Lurie</namePart>
      <namePart type="given">D.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Booth</namePart>
      <namePart type="given">N.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Broche</namePart>
      <namePart type="given">L.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Choi</namePart>
      <namePart type="given">C.-H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Davies</namePart>
      <namePart type="given">G.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ismail</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ó hÓgáin</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pine</namePart>
      <namePart type="given">K.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>11</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>136</start>
          <end>148</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">16310705 (ISSN)</identifier>
      <titleInfo>
        <title>Comptes Rendus Physique</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>C. R. Phys.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77956229493&amp;partnerID=40&amp;md5=e8056c97779a24b56314665d900c0b5f</url>
    </location>
    <abstract>Magnetic resonance imaging (MRI) and fast field-cycling (FFC) NMR are both well-developed methods. The combination of these techniques, namely fast field-cycling magnetic resonance imaging (FFC-MRI) is much less well-known. Nevertheless, FFC-MRI has a number of significant applications and advantages over conventional techniques, and is being pursued in a number of laboratories. This article reviews the progress in FFC-MRI over the last two decades, particularly in the areas of Earth's field and pre-polarised MRI, as well as free radical imaging using field-cycling Overhauser MRI. Different approaches to magnet design for FFC-MRI are also described. The paper then goes on to discuss recent techniques and applications of FFC-MRI, including protein measurement via quadrupolar cross-relaxation, contrast agent studies, localised relaxometry and FFC-MRI with magnetisation-transfer contrast. © 2010 Académie des sciences.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Fe(III)-templated Gd(III) self-assemblies - A new route toward macromolecular MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Pierre</namePart>
      <namePart type="given">V.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>128</number>
        </detail>
        <detail type="issue">
          <number>29</number>
        </detail>
        <extent unit="pages">
          <start>9272</start>
          <end>9273</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <abstract>The self-assembly of supramolcular clusters of Gd(III) hydroxypyridinone complexes, templated by an Fe(III) terephthalamide center, is presented. The peripheral Gd(III) ions are each coordinated by two water molecules which exchange rapidly with the bulk solvent. These properties, along with the high rigidity of the supramolecules, efficiently increase the rotational correlation times of the cluster, resulting in high relaxivities at high magnetic fields and hence making these complexes good candidates for MRI contrast agents. Copyright © 2006 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>First 17O NMR observation of coordinated water on both isomers of [Eu(DOTAM)(H2O)]3+: A direct access to water exchange and its role in the isomerization</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Dunand</namePart>
      <namePart type="given">F.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Merbach</namePart>
      <namePart type="given">A.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>122</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1506</start>
          <end>1512</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0033999758&amp;partnerID=40&amp;md5=f775027c40087d4ebc2268aede51433d</url>
    </location>
    <abstract>A complete mechanistic study of the solution dynamics of [Eu(DOTAM)(H2O)]3+ is performed through 1H and 17O NMR variable pressure and temperature studies. An unambiguous understanding of the water exchange was possible thanks to the first 17O NMR observation of the bound water signal on both the M- and m-isomers (M: k(M)/250 = 0.113 ± 0.013 x 103 s-1, k(M)/298 = 8.3 ± 0.3 s-1, ΔH(+) = 53.1 ± 2 kJ mol-1, ΔS(+) = +8.4 ± 5 J K-1 mol-1, AV(+) = +4.9 ± 1 cm3 mol-1; m: k(M)/250 = 8.9 ± 0.6 s-1, k(M)/269 = 327 ± 60 x 103 s-1, Δ(+) = 44.2 ± 2 kJ mol-1, ΔS(+) = +8.8 ± 7 J K-1 mol-1). The water exchange on m is about 50 times faster than on M, and even though the equilibrium constant K = [M]/[m] equals 4.5, the contribution of m to the overall exchange rate is 90%. These results can be transferred to an aqueous solution since they agree with the overall exchange rate obtained by 17O NMR for an aqueous solution of [Gd(DOTAM)(H2O)]3+. 2D-EXSY and variable temperature and pressure 1H NMR experiments reveal that the interconversion between the M and m isomers happens mainly through a rotation of the amide arms in an interchange activated mechanism. (Interconversion rates measured by magnetization transfer: M → m: k(a)/250 = 60 ± 10 s-1; m → M: K(a)/250 = 260 ± 50 s-1. Activation volumes: M → m: ΔV(+) = -0.5 ± 0.3 cm3 mol-1, m → M: ΔV(+) = -0.5 ± 0.7 cm3 mol-1 and reaction volume ΔV°= 0 ± 1 cm3 mol-1). In light of a simultaneous fitting of the water exchange and interconversion NMR data (M → m: ΔH(+) = 39.1 ± 1.9 kJ mol-1, ΔS(+) = -52.1 ± 7.4 J K-1mol-1, k250 = 68 ± 5 s-1), as well as an interpretation of the activation and reaction volumes, we deduce a correlation between the two processes. A nonhydrated complex is proposed as a common intermediate for both the water exchange and the arm rotation processes, but only one M → m interconversion happens while two to three water exchanges take place.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>First ex-vivo MRI co-localization of two LIPOCEST agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rollet</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stancanello</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Violante</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>38</start>
          <end>43</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <abstract>One of the major advantages of the CEST methodology deals with the possibility of visualizing more probes in the same MR image voxels. This is a unique property within the contrast media that act on the 1H-NMR signal of water protons, and it might considerably improve the potential of the technique. In addition to displaying sufficiently different resonance frequencies of their mobile protons, it is also important that the CEST agents designed for this application are highly sensitive. LIPOCEST agents represent the most sensitive class of CEST systems developed so far. On this basis, two LIPOCEST samples, a spherical one and an osmotically shrunken nonspherical one, endowed with markedly different resonance frequencies of their intraliposomal water protons, 3 ppm and 15 ppm, respectively, were prepared and tested both in vitro and in ex-vivo on a bovine muscle used as tissue-surrogate. The response of the two agents did not interfere each other, thus allowing the multiple visualization of the two agents present at nanomolar concentrations in the same image voxels. Copyright © 2008 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Fluxional behaviour of the binary carbonyls. A comparison of the isoelectronic and isostructural tetranuclear clusters: Co4(CO)12, HFeCo3(CO)12 and[FeCo3(CO)12]-</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Johnson</namePart>
      <namePart type="given">B.F.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>68</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>141</start>
          <end>145</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000280687&amp;partnerID=40&amp;md5=86e0c23321606b52eb30f3cb83f96b02</url>
    </location>
    <abstract>The 13C NMR spectra of 13CO enriched samples of the cluster molecules HFeCo3(CO)12 and [FeCo3(CO)12]- have been recorded over a wide temperature range. In the low temperature limiting spectra of these species four resonances of equal intensity were observed, in each case consistent with their proposed molecular geometries. As the temperature is raised two distinct fluxional processes are observed. The first corresponds to interconversion of the nine CO-ligands about the Co3 basal plane and the second to total scrambling over the FeCo3 tetrahedron. © 1983.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>From spherical to osmotically shrunken paramagnetic liposomes: An Improved generation of LIPOCEST MRI agents with highly shifted water protons</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Carrera</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mazzon</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rollet</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stancanello</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Visigalli</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>46</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>966</start>
          <end>968</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33846696781&amp;partnerID=40&amp;md5=0afebb0c6cd690e4a549abaa400a2d92</url>
    </location>
    <abstract>Honey, I shrunk the ... The chemical shift of intraliposomal water protons of LIPOCEST MRI agents may be enhanced by exploiting a contribution arising from bulk magnetic susceptibility. The effect was attained by osmotically shrinking liposomes to attain nonspherical compartments, with the largest shifts observed for systems containing paramagnetic Tm or Dy complexes either entrapped in the inner cavity or incorporated in the liposome membrane (see picture). (Graph Presented). © 2007 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Functionalized nanocontainers as dual magnetic and optical probes for molecular imaging applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Tsotsalas</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Busby</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Cola</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>20</number>
        </detail>
        <detail type="issue">
          <number>18</number>
        </detail>
        <extent unit="pages">
          <start>5888</start>
          <end>5893</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">08974756 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry of Materials</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Mater.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-53549134440&amp;partnerID=40&amp;md5=3d151878ac71b3eef0c783d9a086a24d</url>
    </location>
    <abstract>A dual-probe optical and magnetic imaging system has been synthesized out of nanometer-sized zeolite L crystals. The zeolite channels contain the optically emitting green pyronine molecules which can be used as fluorescent labels for optical imaging. The surface has been modified by a gadolinium complex which introduces a probe for magnetic resonance imaging (MRI). The combination of the excellent three-dimensional spatial resolution of MRI with the high sensitivity of optical imaging should lead to a system which overcomes the shortcomings of each individual technology. The system has been characterized by fluorescence microscopy and nuclear magnetic resonance dispersion (NMRD) spectroscopy. The results obtained show that the probes open up interesting possibilities for imaging based on multiple read outs. © 2008 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gadolinium(III) complexes of dota-derived N-sulfonylacetamides (H 4(dota-NHSO2R) = 10-{2-[(R)sulfonylamino]-2-oxoethyl}-1,4, 7,10-tetraazacyclododecane-1,4,7-triacetic acid): A new class of relaxation agents for magnetic resonance imaging applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Frullano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>88</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>588</start>
          <end>603</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">0018019X (ISSN)</identifier>
      <titleInfo>
        <title>Helvetica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Helv. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-16444376788&amp;partnerID=40&amp;md5=f84e9d8d7ad2465b9d8936c5099fc6cd</url>
    </location>
    <abstract>Four new ligands for lanthanide ions based on the H3do3a (= 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid) structure and bearing one N-sulfonylacetamide arm were synthesized, i.e., H4dota-NHSO 2R = 10-{2-[(R)sulfonylamino]-2-oxoethyl}-1,4,7,10- tetraazacyclododecane-1,4,7-triacetic acids 1a-e. A 15N-NMR study of the 15N-labelled Eu3+ complex of one such ligands, 1d, showed that the coordination of the N-sulfonylacetamide arm involves the carbonyl O-atom rather than the N-atom. The relaxometric properties of the corresponding Gd3+ complexes were investigated as a function of pH and temperature. These complexes have relaxivities in the range 4.5-5.3 mM -1 s-1, at 20 MHz and 25°, and are characterized by a single H2O molecule in their inner coordination sphere. The mean residence lifetime of this molecule is relatively long (500-700 ns) compared to other anionic complexes. The slow rate of H2O exchange can be justified by the extensive delocalization of the negative charge on the N-sulfonylacetamide arm. The long residence time of the coordinated H 2O allowed the observation of the effect of the prototropic exchange on the relaxivity. The study of the interaction between the complex [Gd(1e)]- and HSA revealed a weak affinity constant highlighting the importance of a localized negative charge on the complex to promote a strong interaction with the protein. © 2005 Verlag Helvetica Chimica Acta AG.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gadolinium-associated nephrogenic systemic fibrosis: The need for nephrologists' awareness</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Canavese</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mereu</namePart>
      <namePart type="given">M.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fenoglio</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Quaglia</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stratta</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>21</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>324</start>
          <end>336</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">11218428 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Nephrology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Nephrol.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-52049094408&amp;partnerID=40&amp;md5=7d4bf1205bf022dc02d6ed5ef40d8895</url>
    </location>
    <abstract>Nephrogenic systemic fibrosis (NSF)/nephrogenic fibrosing dermopathy (NFD) is a recently described disease, occurring only in patients with variable degrees of renal failure (RF) previously exposed to gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging. Public advisories are consistent on some key points including that no cases of NSF/NFD have been reported in patients with normal renal function, and GBCAs may be toxic in patients with RF due to the prolongation of the half-time allowing dissociation and extravasation of highly toxic gadolinium-free ions, potentially linked to the scleroderma-like NSF/NFD, a systemic disabling disease with a mortality rate of up to 30%. The most intriguing feature remains which cofactor might be at play to explain why the disease occurs only in a minority of exposed patients. Therefore, renal dysfunction (substrate) and gadolinium chelates (trigger agent) are necessary but not sufficient. The challenge for nephrologists includes (a) evidence of transmetallation, such as gadolinium deposits in bone, increased urinary zinc excretion, iron-transferrin dissociation or "spurious hypocalcemia" in exposed people; (b) research for uremic cofactors such as increased serum calcium/phosphate, acidosis, use of phosphate-chelating agents able to act as efficient competitor ligands or other drugs; and (c) identification of at-risk patients (with moderate to severe renal dysfunction) and definition of the role of dialysis in removing gadolinium chelates, if any. Nephrologists are called to action to collect and organize information to identify cofactors for NSF/NFD, and therefore they must be aware of this new pathology, as the eye sees only what the mind knows. © Società Italiana di Nefrologia.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Stratta</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canavese</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>1229</start>
          <end>1235</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">09298673 (ISSN)</identifier>
      <titleInfo>
        <title>Current Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Curr. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-45849084241&amp;partnerID=40&amp;md5=9761f91063dd1a6419978d68fb579275</url>
    </location>
    <abstract>First described in 2000, nephrogenic systemic fibrosis (NSF)/nephrogenic fibrosing dermopathy (NFD) is a recently defined and sometimes fatal condition that, so far, has occurred only in people with some degree of renal failure, either during the conservative phase of chronic renal disease, the dialysis phase, or the kidney transplantation phase. The association between NSF/NFD and gadolinium-based magnetic resonance (MR) examination is so strong that public health agencies have sent out warnings concerning the use of gadolinium-enhanced MR in patients with renal failure. The prolonged residence of some gadolinium-chelates in the uremic milieu may allow free toxic gadolinium released from its chelate to extravasate into the extravascular space where it may accelerate fibrillogenesis. The medical community must be apprised of the concern surrounding the use of gadolinium contrast agent in patients with even moderate renal failure, considering that the number of at risk persons is 20 times greater than that of patients needing dialysis/transplantation, remember that the risk is particularly high in patients with liver transplantation in the presence of functional renal impairment, and not to forget that MR examination remains one of the three pillars of molecular medicine. © 2008 Bentham Science Publishers Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gas-phase helium I photoelectron spectra of methinyltricobalt enneacarbonyl clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tondello</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ajò</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casarin</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>21</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>1081</start>
          <end>1084</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1982</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33845554954&amp;partnerID=40&amp;md5=f02e7934a0b87469276eead127c2d210</url>
    </location>
    <abstract>The electronic structure of Co3(CO)9CY clusters, where Y = H, F, Cl, Br, I, CH3, CF3, or COOCH3, is discussed on the basis of their He I excited gas-phase photoelectron spectra. A qualitative energy level diagram has been afforded which allows a satisfactory discussion of the PE data. The most interesting feature of our interpretative model is the presence of a molecular orbital of e symmetry which accounts for a large portion of the interaction between the Co3 triangle and the apical carbon atom Cap and for the electron transmission from the apical substituent Y and the cobalt atoms via a resonance-type mechanism. In agreement with previous NQR and IR data, evidence for significant Y→Cap π-bonding donation with Y = Cl, Br, or I is presented. The relationships existing between the present clusters and molecules of type M3(CO)12 and (μ-CH2)[MLn]2 have been stressed. © 1982 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gas-phase ultraviolet photoelectron spectra of [{Ni(η-C5H5)}2(μ-C2R 2)] (R = H or CF3) complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Casarin</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ajò</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tondello</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>869</start>
          <end>872</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049099028&amp;partnerID=40&amp;md5=e1fdb8988bd5edea082794d792ab8866</url>
    </location>
    <abstract>The u.v. photoelectron (p.e.) spectra of [{Ni(η-C5H5)}2(μ-C2H 2)] and [{Ni(η-C5H5)}2{μ-C2(CF 3)2}] are reported. For the first time p.e. spectral features which are related to ionizations from molecular orbitals involved in metal-alkyne back-donation have been detected. The analysis of p.e. results for the CF3 derivative allow us to discuss in detail the mechanism of interaction between an alkyne and two metallic centres.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gas-phase UV photoelectron spectra of some edge-bridged decacarbonyltriosmium clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Benoni</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tondello</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casarin</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>22</number>
        </detail>
        <detail type="issue">
          <number>26</number>
        </detail>
        <extent unit="pages">
          <start>3899</start>
          <end>3903</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4243551334&amp;partnerID=40&amp;md5=a702e135d529611160c86d1ae1bcf6f7</url>
    </location>
    <abstract>The gas-phase He I and He II excited UV PE spectra of several (X)(Y)Os3(CO)10 cluster derivatives (X, Y = H, OR, SR, Cl, Br) are reported. A qualitative discussion of the spectral data has been made on the basis of MOs that predominantly represent Os-Os bonds, t2g-like nonbonding metallic pairs, or (μ-X)(μ-Y)Os2 bridge bonds. Investigation of the He II spectrum was crucial for assignment. The similarity found between the spectrum of H2Os3(CO)10 and those of the two series (H)(Y)Os3(CO)10 and (Y)2Os3(CO)10 points to a very similar bonding pattern in all the compounds. Evidence for a direct weak interaction between the two bridged osmium atoms via the t2g-like set has been reported. This source of Os-Os bonding progressively reduces its importance on going from H2Os3(CO)10 to (H)(Y)Os3(CO)10 and (Y)2Os3(CO)10. © 1983 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gd(DOTP)5-outer-sphere relaxation enhancement promoted by nitrogen bases</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>30</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>583</start>
          <end>591</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1993</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>MAGN. RESON. MED.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0027484637&amp;partnerID=40&amp;md5=f4c65c7e68c9aaec0ca4743a835a2c6a</url>
    </location>
    <abstract>The relaxation properties of Gd(DOTP)5- (1, 4, 7, 10- tetraazacyclododecane-N,N',N'',N'''-tetrakis(methylenephosphonic acid)) have been investigated as a function of pH, temperature, concentration, and magnetic field strength. We have found that the complex has one exchangeable water molecule in its inner coordination sphere, at a distance of 3.26 Å from the metal ion, and it does not form oligomers in solution in the concentration range 0.2 to 10 mM. The possible presence of two species in solution with an average fractional hydration number is also taken into accounts. The NMRD profiles were recorded at 5°C, 25°C, and 35°C and quantitatively analyzed in terms of the paramagnetic relaxation equations. Interestingly the addition to a solution of the Gd(III)-complex of nitrogen bases results in a marked relaxation enhancement, which shows a strong pH dependence with a maximum around pH = 9. The relaxivity gain has been shown to depend on outer-sphere effects originating from multiple electrostatic interactions between the anionic complex and the organic cations that bring the exchangeable protons of the substrate molecules in to close proximity with the paramagnetic center. High resolution NMR relaxation data for N- methyl-D(-)-glucamine suggest that the hydroxyl group on the β-carbon plays a role in stabilizing the interaction, presumably through a hydrogen bond with an uncoordinated oxygen atom of the complex.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gd(III) complexes as contrast agents for magnetic resonance imaging: A proton relaxation enhancement study of the interaction with human serum albumin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>312</start>
          <end>319</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">09498257 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Biological Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Biol. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000866324&amp;partnerID=40&amp;md5=6488b75fbb2f593675c9555b21335af5</url>
    </location>
    <abstract>The non-covalent interaction between human serum albumin (HSA) and DOTA-like Gd(III) complexes containing hydrophobic benzyloxymethyl (BOM) substituents has been thoroughly investigated by measuring the solvent proton relaxation rates of their aqueous solutions. The binding association constants (KA) to HSA are directly related to the number of hydrophobic substituents present on the surface of the complexes. Furthermore, an estimation of ΔH° and ΔS° has been obtained by the temperature dependence of KA. Assays performed with the competitor probes warfarin and ibuprofen established that the complexes interact with HSA through two nearly equivalent binding sites located in the subdomains IIA and IIIA of the protein. Strong relaxation enhancements, promoted by the formation of slowly tumbling paramagnetic adducts, have been measured at 20 MHz for complexes containing two and three hydrophobic substituents. The macromolecular adduct with the latter species has a relaxivity of 53.2±0.7 mM-1 s-1, which represents the highest value so far reported for a Gd(III) complex. The temperature dependence of the relaxivity for the paramagnetic adducts with HSA indicates long exchange lifetimes for the water molecules dipolarly interacting with the paramagnetic centre. This is likely to be related to the formation, upon hydrophobic interaction of the complexes with HSA, of a clathrate-like, second-coordination-sphere arrangement of water molecules. Besides affecting the dissociative pathway of the coordinated water molecule, this water arrangement may itself significantly contribute to enhancement of the bulk solvent relaxation rate.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gd(III)-BASED CONTRAST AGENTS FOR MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">book</genre>
    <genre authority="marcgt">book</genre>
    <name type="personal">
      <namePart type="family">AIME</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">BOTTA</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">TERRENO</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <part>
      <detail type="volume">
        <number>57</number>
      </detail>
    </part>
    <originInfo>
      <copyrightDate>2006</copyrightDate>
    </originInfo>
    <identifier type="isbn">08988838 (ISSN); 0120236575 (ISBN); 9780120236572 (ISBN)</identifier>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33645674562&amp;partnerID=40&amp;md5=50d0e59a424d0275a60bfbc1a2f8d890</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>[Gd-AAZTA]-: A new structural entry for an improved generation of MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Calabi</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallotti</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maiocchi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>43</number>
        </detail>
        <detail type="issue">
          <number>24</number>
        </detail>
        <extent unit="pages">
          <start>7588</start>
          <end>7590</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-9444270383&amp;partnerID=40&amp;md5=91b718240ed14963dac1bb5e399b045f</url>
    </location>
    <abstract>An innovative MRI contrast agent based on the unprecedented and easily obtained ligand AAZTA is described. The simple and straightforward synthesis of the ligand, together with the potentiometric and relaxometric behavior of the corresponding Gd(III) chelate, is reported. The complex [Gd(AAZTA)]- shows outstanding magnetic properties connected with high thermodynamic stability in aqueous solution and a nearly complete inertness toward the influence of bidentate endogenous anions, placing this compound as one of the most promising candidates for the development of high performance MRI contrast agents.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gd-enhanced MR images of substrates other than water.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>101</start>
          <end>105</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">15554317 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast media &amp; molecular imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34447523009&amp;partnerID=40&amp;md5=4964c1ed651baf4eba725d6c6e798bfd</url>
    </location>
    <abstract>This communication reports the dramatic relaxation enhancements that can be obtained upon the interaction of substrates like lactate, trifluorolactate and inorganic phosphate with the paramagnetic GdDO3A agent. This occurs thanks to the formation of kinetically labile ternary complexes in which the substrate nuclei are in close proximity to the paramagnetic center. It is demonstrated that heteronuclear (13)C, (19)F and (31)P-MR images can be obtained from phantoms containing the substrate in the millimolar concentration range. Copyright 2006 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Gd-loaded liposomes as T1, susceptibility, and CEST agents, all in one</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lawson</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>129</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>2430</start>
          <end>2431</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33847685866&amp;partnerID=40&amp;md5=921e9938de7489c94ea46be981e7a7da</url>
    </location>
    <abstract>Gd-loaded nonspherical liposomes represent a new family of MRI agents that show contrast-enhancing ability upon applying different image acquisition modes. In fact they can act either as T1- or T2- or CEST- agents. For the first time a Gd complex is endowed with detectable shift reagent properties. C. Copyright © 2007 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>[GdPCP2A(H2O)2]-: A paramagnetic contrast agent designed for improved applications in magnetic resonance imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Frullano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sirtori</namePart>
      <namePart type="given">F.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>43</number>
        </detail>
        <detail type="issue">
          <number>21</number>
        </detail>
        <extent unit="pages">
          <start>4017</start>
          <end>4024</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">00222623 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034687242&amp;partnerID=40&amp;md5=22ee12710389ae8da9567a3ac3bc62e4</url>
    </location>
    <abstract>A novel ligand based on a pyridine-containing macrocycle bearing two acetic and one methylenephosphonic arms (PCP2A) has been synthesized. An efficient synthesis of PCP2A is based on the macrocyclization reaction between 2,6-bis(chloromethyl)pyridine and a 1,4,7-triazaheptane derivative bearing a methylenephosphonate group on N-4. The Gd(III) complex of PCP2A displays characteristic properties which make it a very promising contrast agent for improved applications in magnetic resonance imaging. In fact it shows (i) a very high stability constant (log K(GdPCP2A) = 23.4) which should guarantee against the in vivo release of toxic free Gd(III) ions and free ligand molecules and (ii) a relaxivity that is about 2 times higher than the values reported for contrast agents currently used in the clinical practice. Its high relaxivity is the result of the presence of two water molecules in the inner coordination sphere and a significant contribution from water molecule(s) hydrogen bonded to the phosphonate group. Moreover, the inner sphere water molecules are involved in an exchange with the bulk water which is relatively fast. This property is important for the attainment of an even higher relaxivity once the molecular reorientation rate of the [GdPCP2A(H2O)2]- moiety is lengthened by means of conjugation to a macromolecular substrate.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Glycoconjugates of gadolinium complexes for MRI applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Fulton</namePart>
      <namePart type="given">D.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Elemento</namePart>
      <namePart type="given">E.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chaabane</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>1064</start>
          <end>1066</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33644767065&amp;partnerID=40&amp;md5=c8302c68351dae178e0fe5d875be44e3</url>
    </location>
    <abstract>Examples of C-4 symmetric, medium MW conjugates incorporating 12 glucose or galactose groups linked via four dendritic wedges to a central Gd complex have been characterised; their enhanced relaxivity is interpreted in terms of effective motional coupling and large contributions from second sphere water molecules. © The Royal Society of Chemistry 2006.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>H/D isotopic exchange on the surface of a triosmium carbonyl cluster</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Krause</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Matas</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>23</number>
        </detail>
        <extent unit="pages">
          <start>4967</start>
          <end>4970</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000577846&amp;partnerID=40&amp;md5=3d64c06158025464d06416459f254cbf</url>
    </location>
    <abstract>The reactions of both Os3(CO)10(NCCH3)2 and Os3(CO)11(NCCH3) with HD or with a mixture of H2/D2 in chloroform solution at room temperature afford a mixture of H2Os3(CO)10 (Ia), HDOs3(CO)10 (Ib), and D2Os3(CO)10 (Ic). The three isotopomers are also obtained by reacting H2Os3(CO)10 with D2. By measurement of the rates of disappearance of Ia in the latter reaction at four different temperatures, the thermodynamic parameters have been estimated (Ea = 43.7 kJ/mol, ΔH‡ = 41.2 kJ/mol, ΔS‡ = -0.17 kJ/(mol K)). No H/D isotopic exchange has been observed after heating Ia and Ic in toluene for several hours. A mechanism involving the reversible oxidative addition and reductive elimination of molecular hydrogen on H2Os3(CO)10 via the formation of a fluxional tetra(hydrido, deuterio) intermediate is proposed.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Heterodinuclear Ln-Na complexes with an asymmetric macrocyclic compartmental schiff base</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casellato</namePart>
      <namePart type="given">U.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Scalco</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tamburini</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tomasin</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vigato</namePart>
      <namePart type="given">P.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>8</number>
        </detail>
        <detail type="issue">
          <number>17</number>
        </detail>
        <extent unit="pages">
          <start>3917</start>
          <end>3926</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037009145&amp;partnerID=40&amp;md5=cef4bf3e7dda67abb3c5cd0060bc1032</url>
    </location>
    <abstract>Heterodinuclear lanthanide(III)-sodium(I) complexes [LnNa(L)- (Cl)2(CH3OH)] (Ln = La - Nd, Sm - Lu), where H2L is a [1+1] asymmetric compartmental macrocyclic ligand containing a N3O2 Schiff base and a O3O2 crown-ether-like coordination site, have been prepared and characterized by IR, 1H, 13C, and 23Na NMR spectroscopy, mass spectrometry, and electron microscopy. In the solid state, the lanthanide(III) ions coordinate the Schiff-base N3O2 site, and the sodium ion occupies the O3O2 crownlike cavity, as shown by the X-ray crystal structures of the Nd, Eu, Gd, and Yb derivatives. In these complexes, the lanthanide(III) ion is coordinated by two chlorine atoms in the trans position and by three nitrogen and two negatively charged phenol oxygen atoms of the Schiff base, and the ion is heptacoordinated with a pentagonal bipyramidal geometry. The sodium ion is coordinated by three etheric oxygen atoms and the two phenolic oxygens that act as a bridge. A methanol molecule is also coordinated in the apical position of the resulting pentagonal pyramidal polyhedron. A detailed 1H and 13C NMR study was carried out in CD3OD for both diamagnetic and paramagnetic heterodinuclear complexes [LnNa(L)(Cl)2(CH3OH)]. The complexes are also isostructural in solution, and their structures parallel those found in the solid state. Moreover, some significative distances determined in the solid state and in solution are comparable. Finally, the potential use of these complexes as molecular probes for the selective recognition of specific metal ions has been tested. In particular, their ability to act as shift reagents and the selectivity of the O3O2 site towards Li+, Ca2+, and K+ were investigated by 23Na NMR spectroscopy.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Hetero-dinuclear sodium-lanthanide(III) complexes with an asymmetric compartmental macrocycle</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Casellato</namePart>
      <namePart type="given">U.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tamburini</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tomasin</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vigato</namePart>
      <namePart type="given">P.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>145</start>
          <end>146</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034695542&amp;partnerID=40&amp;md5=7bf054307bad64cd7ca345f51a74bfad</url>
    </location>
    <abstract>A heterodinuclear macrocyclic complex containing both Yb3+ and Na+ ions has been synthesized and characterized by X-ray crystallography and 1H and 23Na solution NMR; at room temperature the coordinated Na+ ion is in slow chemical exchange with free Na+ ions and its NMR resonance is strongly shifted.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Hetero-tripodal hydroxypyridonate gadolinium complexes: Syntheses, relaxometric properties, water exchange dynamics, and human serum albumin binding</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Thompson</namePart>
      <namePart type="given">M.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Doble</namePart>
      <namePart type="given">D.M.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tso</namePart>
      <namePart type="given">L.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barra</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>43</number>
        </detail>
        <detail type="issue">
          <number>26</number>
        </detail>
        <extent unit="pages">
          <start>8577</start>
          <end>8586</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-11144252877&amp;partnerID=40&amp;md5=c09968f51efb47401729f5a145bb395d</url>
    </location>
    <abstract>The synthesis and relaxometric properties of hetero-tripodal hydroxypyridonate-terephthalamide gadolinium (Gd3+) chelates with differing structural features for probing human serum albumin (HSA) interactions are reported. The Gd3+ complexes are divided into two series. The first series (3-5) features a benzyl derivative connected to the hydroxypyridonate (HOPO) moiety. The second series of complexes (6-10) has the common feature of a poly(ethylene glycol) (PEG) attached to the terephthalamide (TAM) moiety and is nonbenzylated. The water exchange of the complexes is in the fast exchange regime with rates (kex) in the range 0.45-1.11 × 108 s-1. The complexes have a moderate interaction with HSA with association constants (KA's) in the range 0.7-8.6 × 103 M-1. Protein binding results in an enhancement in proton relaxivity from 7.7-10.4 mM-1 s-1 (r1p) to 15-29 mM-1 s-1 (r1pb). It is concluded that the interaction of the complexes with HSA (i) is enhanced by the presence of benzyl groups, (ii) is entropically driven, and (iii) results in a lower hydration number (q).</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High levels of Cre expression in neuronal progenitors cause defects in brain development leading to microencephaly and hydrocephaly</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Forni</namePart>
      <namePart type="given">P.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Scuoppo</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Imayoshi</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Taulli</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sala</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Betz</namePart>
      <namePart type="given">U.A.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Muzzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Martinuzzi</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vercelli</namePart>
      <namePart type="given">A.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kageyama</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ponzetto</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>26</number>
        </detail>
        <detail type="issue">
          <number>37</number>
        </detail>
        <extent unit="pages">
          <start>9593</start>
          <end>9602</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">02706474 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Neuroscience</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Neurosci.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33748705967&amp;partnerID=40&amp;md5=6a321e2763a0dc59c51c709a482c60d0</url>
    </location>
    <abstract>Hydrocephalus is a common and variegated pathology often emerging in newborn children after genotoxic insults during pregnancy (Hicks and D'Amato, 1980). Cre recombinase is known to have possible toxic effects that can compromise normal cell cycle and survival. Here we show, by using three independent nestin Cre transgenic lines, that high levels of Cre recombinase expression into the nucleus of neuronal progenitors can compromise normal brain development. The transgenics analyzed are the nestin Cre Balancer (Bal1) line, expressing the Cre recombinase with a nuclear localization signal, and two nestin CreERT2 (Cre recombinase fused with a truncated estrogen receptor) mice lines with different levels of expression of a hybrid CreER T2 recombinase that translocates into the nucleus after tamoxifen treatment. All homozygous Bal1 nestin Cre embryos displayed reduced neuronal proliferation, increased aneuploidy and cell death, as well as defects in ependymal lining and lamination of the cortex, leading to microencephaly and to a form of communicating hydrocephalus. Anessentially overlapping phenotype was observed in the two nestin CreERT2 transgenic lines after tamoxifen mediated-CreERT2 translocation into the nucleus. Neither tamoxifen-treated wild-type nor nestin CreERT2 oil-treated control mice displayed these defects. These results indicate that some forms of hydrocephalus may derive from a defect in neuronal precursors proliferation. Furthermore, they underscore the potential risks for developmental studies of high levels of nuclear Cre in neurogenic cells. Copyright © 2006 Society for Neuroscience.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High relaxivity contrast agents for MRI and molecular imaging.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Silengo</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>49</number>
        </detail>
        <extent unit="pages">
          <start>99</start>
          <end>121</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">09476075 (ISSN)</identifier>
      <titleInfo>
        <title>Ernst Schering Research Foundation workshop</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Ernst Schering Res Found Workshop</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-16544380681&amp;partnerID=40&amp;md5=596948a0684160dd08788e64744f668f</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: Nanosized MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Datta</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hooker</namePart>
      <namePart type="given">J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Francis</namePart>
      <namePart type="given">M.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>130</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>2546</start>
          <end>2552</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-39749171706&amp;partnerID=40&amp;md5=83f935d66e55633368dc654194f05e1a</url>
    </location>
    <abstract>High relaxivity macromolecular contrast agents based on the conjugation of gadolinium chelates to the interior and exterior surfaces of MS2 viral capsids are assessed. The proton nuclear magnetic relaxation dispersion (NMRD) profiles of the conjugates show up to a 5-fold increase in relaxivity, leading to a peak relaxivity (per Gd3+ ion) of 41.6 mM-1 s-1 at 30 MHz for the internally modified capsids. Modification of the exterior was achieved through conjugation to flexible lysines, while internal modification was accomplished by conjugation to relatively rigid tyrosines. Higher relaxivities were obtained for the internally modified capsids, showing that (i) there is facile diffusion of water to the interior of capsids and (ii) the rigidity of the linker attaching the complex to the macromolecule is important for obtaining high relaxivity enhancements. The viral capsid conjugated gadolinium hydroxypyridonate complexes appear to possess two inner-sphere water molecules (q = 2), and the NMRD fittings highlight the differences in the local motion for the internal (τRI = 440 ps) and external (τRI = 310 ps) conjugates. These results indicate that there are significant advantages of using the internal surface of the capsids for contrast agent attachment, leaving the exterior surface available for the installation of tissue targeting groups. © 2008 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High sensitivity lanthanide(III) based probes for MR-medical imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>250</number>
        </detail>
        <detail type="issue">
          <text>11-12</text>
        </detail>
        <extent unit="pages">
          <start>1562</start>
          <end>1579</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">00108545 (ISSN)</identifier>
      <titleInfo>
        <title>Coordination Chemistry Reviews</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Coord. Chem. Rev.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33646950283&amp;partnerID=40&amp;md5=4e308f421da5d484632882635bfe378b</url>
    </location>
    <abstract>To date, Gd(III) based contrast agents are commonly used in MR-medical imaging. In the last 15 years, our overall goal has been to develop targeting and responsive Gd(III) containing probes for innovative magnetic resonance imaging (MRI) applications. Understanding the relationships between structure and dynamics of lanthanide(III) chelates has been fundamental for the development of high sensitive Gd(III) based agents. Moreover, the observed relaxivity may act as a reporter of a specific parameter of the microenvironment in which the contrast agent distributes by using properly designed systems in which one structural or motional parameter is affected by the parameter of interest. From targeting human serum albumin for the development of angiographic agents, our research efforts are now addressing the visualization of molecules (characterizing diseased states) that are present at much lower concentration. By different routes, it has become possible to visualize, in an MR image, cells that have been labeled with Gd(III) chelates. Finally, the shift properties of paramagnetic lanthanide(III) complexes (Ln ≠ Gd) have been exploited for designing a novel class of contrast agents based on the transfer of saturated magnetization to the bulk water signal from exchangeable protons on the contrast agent molecules (chemical exchange saturation transfer (CEST) agents) or from water molecules interacting with a lanthanide shift reagent. © 2006 Elsevier B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High-field 17O NMR spectroscopy: Solution structures and dynamics of 17O enriched Co4(CO)12 and HFeCo3(CO)12</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>103</number>
        </detail>
        <detail type="issue">
          <number>19</number>
        </detail>
        <extent unit="pages">
          <start>5920</start>
          <end>5922</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1981</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0347833063&amp;partnerID=40&amp;md5=71e81c265f6b34438dd7e5c52f7826f4</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>High-field magic-angle-spinning 13C NMR spectroscopy of Co4(CO)12</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hanson</namePart>
      <namePart type="given">B.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>28</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>1196</start>
          <end>1198</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1989</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0009228862&amp;partnerID=40&amp;md5=0cc693a84400cfd15f5ae01352ca0366</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Highly sensitive MRI chemical exchange saturation transfer agents using liposomes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>44</number>
        </detail>
        <detail type="issue">
          <number>34</number>
        </detail>
        <extent unit="pages">
          <start>5513</start>
          <end>5515</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-24644481042&amp;partnerID=40&amp;md5=b2d85298fff0fa4fb365e3c85d865a79</url>
    </location>
    <abstract>(Figure Presented) Contrasting views: Entrapment of a paramagnetic shift reagent for water protons inside liposomes dramatically improves the sensitivity of chemical exchange saturation transfer agents. The chemical shift of the water entrapped within the liposomes, relative to bulk water, depends upon the nature and concentration of the shift reagent as well as on the permeability of the liposome membrane (see picture; SR = shift reagent, Ln = lanthanide ion). © 2005 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Beltrami</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Jebasingh</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>8</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>600</start>
          <end>602</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-38349096517&amp;partnerID=40&amp;md5=05575afa54c1dac8983e78fe10348bfe</url>
    </location>
    <abstract>Improved LIPOCEST MRI contrast agents with highly shifted intraliposomal water protons were prepared by entrapping neutral polynuclear Tm(iii)-based paramagnetic shift reagents in phospholipidic vesicles. © The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Beltrami</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Jebasingh</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>600</start>
          <end>602</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical communications (Cambridge, England)</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun. (Camb.)</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-42149183046&amp;partnerID=40&amp;md5=ca4b3d32d81b541a4a5694d9b2311a67</url>
    </location>
    <abstract>Improved LIPOCEST MRI contrast agents with highly shifted intraliposomal water protons were prepared by entrapping neutral polynuclear Tm(III)-based paramagnetic shift reagents in phospholipidic vesicles.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Werner</namePart>
      <namePart type="given">E.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Avedano</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hay</namePart>
      <namePart type="given">B.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Moore</namePart>
      <namePart type="given">E.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>129</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1870</start>
          <end>1871</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33847308628&amp;partnerID=40&amp;md5=09634b5aef4c9d3fc6b7a75431b519a7</url>
    </location>
    <abstract>The design, synthesis, and relaxivity properties of highly soluble TACN-capped trishydroxypyridonate-Gd(III) complexes are presented. Molecular mechanics modeling was used to help design a complex capable of possessing three water molecules in the inner metal coordination sphere, an attractive property for high-relaxivity MRI contrast agents. The measured relaxivities of 13.1 and 12.5 mM-1 s-1 (20 MHz, 298 K) for two TACN-capped complexes are among the highest known relaxivities of low-molecular weight Gd complexes and are consistent with three coordinated waters, an extremely fast water exchange rate, and long electronic relaxation time. Luminescence measurements to confirm the number of coordinated water molecules for the first time in the HOPO series are also discussed. Copyright © 2007 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High-Relaxivity contrast agents for magnetic resonance imaging based on multisite interactions between a beta-cyclodextrin oligomer and suitably functionalized GdIII chelates.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">I.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>24</number>
        </detail>
        <extent unit="pages">
          <start>[d]5261-5269</start>
          <end>[d]5261-5269</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry (Weinheim an der Bergstrasse, Germany)</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035905651&amp;partnerID=40&amp;md5=60ac9a03a6ca43e76e77cc14e7dbfeff</url>
    </location>
    <abstract>The results reported in this work show that tightly assembled adducts formed by trisubstituted GdIII complexes and a beta-CD multimer (Poly-beta-CD, d.p. ca. 12) may represent very interesting candidates for novel MRI applications wherein a high number of paramagnetic ions endowed with high relaxivity (per GdIII ion) are necessary. The relaxivities found for the paramagnetic adducts represent a remarkable step forward on the relaxivity scale. However, a detailed investigation of the determinants of the relaxation enhancement in these systems shows that their relaxivities are still limited by a nonoptimal tauR and a relatively long exchange lifetime of the coordinated water(s). Moreover, the exchange rate of the water molecule(s) coordinated to the GdIII ion further decreases upon binding to the Poly-beta-CD. It is suggested that this finding is related to the structural properties of the supramolecule, which brings a high density of hydroxyl groups into the proximity of the "guest" complexes, and this yields an overall reinforcement of the hydrogen-bonding network involving the coordinated water(s). On the other hand, such a tight arrangement appears responsible for an enhanced contribution to the observed relaxivity arising from water molecules in the second coordination sphere of the metal center.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High-relaxivity contrast agents for magnetic resonance imaging based on multisite interactions between a β-cyclodextrin oligomer and suitably functionalized GdIII chelates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>24</number>
        </detail>
        <extent unit="pages">
          <start>5262</start>
          <end>5269</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0011100583&amp;partnerID=40&amp;md5=d9f02021adbeb8837d61517a4edb310d</url>
    </location>
    <abstract>The results reported in this work show that tightly assembled adducts formed by trisubstituted GdIII complexes and a β-CD multimer (Poly-β-CD, d.p. ca. 12) may represent very interesting candidates for novel MRI applications wherein a high number of paramagnetic ions endowed with high relaxivity (per GdIII ion) are necessary. The relaxivities found for the paramagnetic adducts represent a remarkable step forward on the relaxivity scale. However, a detailed investigation of the determinants of the relaxation enhancement in these systems shows that their relaxivities are still limited by a nonoptimal τR and a relatively long exchange lifetime of the coordinated water(s). Moreover, the exchange rate of the water molecule(s) coordinated to the GdIII ion further decreases upon binding to the Poly-β-CD. It is suggested that this finding is related to the structural properties of the supramolecule, which brings a high density of hydroxyl groups into the proximity of the "guest" complexes, and this yields an overall reinforcement of the hydrogen-bonding network involving the coordinated water(s). On the other hand, such a tight arrangement appears responsible for an enhanced contribution to the observed relaxivity arising from water molecules in the second coordination sphere of the metal center. © Wiley-VCH Verlag GmbH, 2001.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High-relaxivity contrast agents for magnetic resonance imaging based on multisite interactions between β-cyclodextrin oligomer and suitably functionalized GdIII chelates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>24</number>
        </detail>
        <extent unit="pages">
          <start>5261</start>
          <end>5269</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035905572&amp;partnerID=40&amp;md5=45d4535ace04a9c91394c82b7bf32873</url>
    </location>
    <abstract>The results reported in this work show that tightly assembled adducts formed by trisubstituted GdIII complexes and a β-CD multimer (Poly-β-CD, d.p. ca. 12) may represent very interesting candidates for novel MRI applications wherein a high number of paramagnetic ions endowed with high relaxivity (per GdIII ion) are necessary. The relaxivities found for the paramagnetic adducts represent a remarkable step forward on the relaxivity scale. However, a detailed investigation of the determinants of the relaxation enhancement in these systems shows that their relaxivities are still limited by a nonoptimal τR and a relatively long exchange lifetime of the coordinated water(s). Moreover, the exchange rate of the water molecule(s) coordinated to the GdIII ion further decreases upon binding to the Poly-β-CD. It is suggested that this finding is related to the structural properties of the supramolecule, which brings a high density of hydroxyl groups into the proximity of the "guest" complexes, and this yields an overall reinforcement of the hydrogen-bonding network involving the coordinated water(s). On the other hand, such a tight arrangement appears responsible for an enhanced contribution to the observed relaxivity arising from water molecules in the second coordination sphere of the metal center.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Briley-Saebo</namePart>
      <namePart type="given">K.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti-Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cormode</namePart>
      <namePart type="given">D.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barazza</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mulder</namePart>
      <namePart type="given">W.J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chen</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fisher</namePart>
      <namePart type="given">E.A.</namePart>
      <role>
        <roleTerm type="code">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fayad</namePart>
      <namePart type="given">Z.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>113</number>
        </detail>
        <detail type="issue">
          <number>18</number>
        </detail>
        <extent unit="pages">
          <start>6283</start>
          <end>6289</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">15206106 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Physical Chemistry B</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J Phys Chem B</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-66349090172&amp;partnerID=40&amp;md5=cd27622299b46471b1ceadeab0261603</url>
    </location>
    <abstract>There is an ongoing desire to produce high-relaxivity, Gd-based magnetic resonance imaging (MRI) contrast agents. These may allow for lower doses to be used, which is especially important in view of the current safety concerns surrounding Gd in patients. Here we report the synthesis of a high-relaxivity MRI contrast agent, by incorporating Gd-chelating lipids that coordinate two water molecules into high-density lipoprotein (q = 2 HDL). We compared the properties of q = 2 HDL with those of an analogous HDL particle labeled with Gd-chelating lipids that coordinate only one water molecule (q = 1 HDL). We found that the q = 2 HDL possessed an elevated r1 of 41 mM -1 s-1 compared to 9 mM-1 s-1 for q = 1 HDL at 20 MHz, but the q = 2 HDL exhibited high R2z.ast; values at high fields, precluding imaging above 128 MHz. While carrying out this investigation we observed that enlarged, disrupted particles were formed when the synthesis was carried out above the lipid critical micelle concentration (cmc), indicating the importance of synthesis below the cmc when modifying lipoproteins in this manner. The high relaxivity of q = 2 HDL means it will be an efficacious contrast agent for future MR imaging studies. © 2009 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-β-cyclodextrin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Battistini</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gref</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Couvreur</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fuzerova</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Othman</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Badet</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Durand</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>14</number>
        </detail>
        <detail type="issue">
          <number>15</number>
        </detail>
        <extent unit="pages">
          <start>4551</start>
          <end>4561</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-53949093705&amp;partnerID=40&amp;md5=0a165934de94fe9e705249270aaa740f</url>
    </location>
    <abstract>Nanosized contrast agents have great potential in magnetic resonance molecular imaging applications for clinical diagnosis. This study proposes new nanoparticles spontaneously formed under mild conditions and composed of a noncovalent adduct between a gadolinium complex, a polymer of β-cyclodextrin (pβCD: MW 1.5×106 g mol-1) and a dextran grafted with alkyl chains (MD). The formation of this supramolecular nanoassembly is based upon a "lock-and-key" recognition process in which the hydrophobic alkyl chains of MD and the adamantyl moieties of macrocyclic GdIII chelates are included in the cavities of pβCD. The large number of βCDs contained in the pβCD resulted in the formation of 200 nm diameter nanoparticles, each entrapping 1.8 × 105 molecules of a low-molecular-weight Gd complex. This system, which exhibits a great relaxivity enhancement (48.4 mw-1 s -1, at 20MHz and 37°C) compared to the GdIII chelate itself (5.2 mM-1 s-1), appears to be a promising strategy for the in vivo targeted delivery of GdIII complexes. The mechanisms of particle formation, conjugation strategies, and relaxometric characterizations in the field of contrast-enhanced magnetic resonance imaging are discussed. © 2008 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High-relaxivity supramolecular aggregates containing peptides and Gd complexes as contrast agents in MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Accardo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tesauro</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morelli</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vaccaro</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mangiapia</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paduano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Schillén</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>12</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>267</start>
          <end>276</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">09498257 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Biological Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Biol. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33846669975&amp;partnerID=40&amp;md5=731acfe5ae058534655d58f1fc3a9392</url>
    </location>
    <abstract>Mixed supramolecular aggregates, obtained by assembling together two amphiphilic monomers (C18H37)2NCO(CH 2)2CO(AdOO)5-G-CCK8 (AdOO is 8-amino-3,6-dioxaoctanoic acid, CCK8 is C-terminal octapeptide of cholecystokinin) and (C18H37)2NCO(CH 2)2COLys(DTPAGlu)CONH2 (DTPAGlu is N,N-bis[2-[bis(carboxyethyl)amino]ethyl]-l-glutamic acid), are characterized for their structural parameters by dynamic light scattering and for their relaxometric properties, in the absence and in the presence of 0.9 wt% NaCl. Two different aggregates (micelles and bilayer structures) are present in the absence of NaCl, while only bilayer structures are observed at physiological ionic strength. The presence of NaCl increases the ionic strength, promoting a decrease in the repulsions between the polar heads and among the aggregates in solution, thus supporting the formation of large-curvature aggregates such as bilayer structures like vesicles. In these conditions the closed, vesicular shape and the large size (hydrodynamic radius of about 300 Å) of the aggregates allow a high number of paramagnetic gadolinium complexes and bioactive peptides to be accommodated on the inner and external surfaces . The presence of the salt causes a variation in the structural arrangement of the molecules and a partial rigidification of the assembled Gd(III) complexes on the surface vesicles, reducing their internal motions and giving an approximately 15% higher relaxivity value (r 1p = 21.0 and 18.6 Mm-1 s-1 in the presence and in the absence of NaCl, respectively). The vesicles obtained, for the high relaxivity of each gadolidium complex and for the presence of a surface-exposed bioactive peptide, are very promising candidates as target-selective MRI contrast agents. © 2006 SBIC.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High-resolution NMR and relaxometric studies of Ln(III) complexes of relevance to MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nonnato</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>225</number>
        </detail>
        <detail type="issue">
          <text>1-2</text>
        </detail>
        <extent unit="pages">
          <start>274</start>
          <end>278</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">09258388 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Alloys and Compounds</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J Alloys Compd</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0343370426&amp;partnerID=40&amp;md5=dedca3bd7ab125d936c5df7ceb52b89e</url>
    </location>
    <abstract>The solution structure and dynamics and the relaxation properties of the lanthanide(III) complexes with ethylenebis(oxyethylenenitrilo)tetraacetic acid (EGTA) are studied by NMR techniques. The longitudinal water proton relaxation rates as a function of the magnetic field in a solution of Gd(EGTA)- are investigated and analysed. The experimental results are compared with existing data for other linear and macrocyclic complexes and interpreted as indicative of the presence of a single coordinated water molecule and of an unusual symmetry and stereochemical rigidity of the coordination cage. Variable temperature high resolution 1H and 13C NMR spectra for the Eu(III), Ho(III) and Yb(III) complexes confirm the above hypothesis and suggest a dodecahedral geometry for the complexes as well as a marked increase of rigidity along the lanthanide series. © 1995.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>High-resolution NMR studies of (diphosphine)(diene) rhodium complexes in the solid state</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Szalontai</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bakos</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>463</number>
        </detail>
        <detail type="issue">
          <text>1-2</text>
        </detail>
        <extent unit="pages">
          <start>223</start>
          <end>226</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1993</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-2742523264&amp;partnerID=40&amp;md5=17a60ec81c8340a2b52e9be06b1f649d</url>
    </location>
    <abstract>Well-resolved resonances are observed in the 31P-CPMAS NMR spectra of (2S,4S)-2,4-bis(diphenylphosphino)pentane or (S,S)-BDPP (1) and its cationic complexes [(Rh{(S,S)-BDPP}(NBD)]BF4 (2a), [Rh{(S,S)-BDPP}(NBD)]PF6 (2b), [Rh{(S,S)-BDPP}(NBD)]ClO4 (2c) and [Rh{(S,S)-BDPP}(COD)]BF4 (3). Packing forces split the single resonance observed for these systems in solution. The spectral parameters depend remarkably on the counterion in 2a, 2b, and 2c. Complex 3 showed a splitting of every resonance due to the presence of two independent molecules in the unit cell. The complex [Rh{(S, S)-BDPP}(NBD)Cl] (4) showed two broad 31P resonances which are ascribed to a number of closely related structures based on the expected trigonal bipyramidal geometry. © 1993.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>How to design 13C para-hydrogen-induced polarization experiments for MRI applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>77</start>
          <end>84</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79955008461&amp;partnerID=40&amp;md5=c14d20be148bda5d03f284df6c470f0b</url>
    </location>
    <abstract>The application of hyperpolarization techniques for MRI purposes is gathering increasing attention, especially for nuclei such as 13C or 129Xe. Among the different proposed methods, ParaHydrogen Induced Polarization requires relatively cheap equipment. The setup of an MRI experiment by means of parahydrogen requires the application of skills and methodologies that derive from different fields of knowledge. The basic theory and a practical insight of this method are presented here. Parahydrogenation of alkynes, having a labelled 13CO group adjacent to the triple bond, catalyzed by Rh(I) complexes containing a chelating phosphine, represents the best choice for producing and maintaining high heteronuclear polarization effect. In order to transform anti-phase into in-phase (net) 13C polarization for MRI application it is necessary to set up the described magnetic field cycle procedure. In vitro and in vivo images have been acquired using fast imaging sequences (RARE and trueFISP). © 2010 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>HR-MAS of cells: A "cellular water shift" due to water-protein interactions?</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bruno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Colombatto</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mainero</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>54</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>1547</start>
          <end>1552</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Med.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-28444434500&amp;partnerID=40&amp;md5=5a4946a67b0509983c3f7808e6cf89d5</url>
    </location>
    <abstract>Under HR-MAS conditions, cells are subjected to high centrifugal forces that may cause irreversible cell damage. First, conditions have been defined to monitor and keep to a minimum unwanted effects in HR-MAS spectra arising from the loss of cell integrity. Then, the HR-MAS spectra of reasonably intact cells have been analyzed. Cell suspensions subjected to MAS rates as low as 1 kHz split into a two-compartment system that is composed of a cell-rich phase (H2Oi) and a cell-free phase (H2Oo). Each of these phases is characterized by its own water 1H-NMR signal. Transport of water molecules between the cell-rich and cell-free compartments is limited by the very low contact area between the two compartments, and water exchange dynamics consequently fall into the slow exchange limit on the NMR timescale. Since the exchange between the two water populations is "frozen," the separation between the H 2Oo and H2Oi water signals (Δνwater) detected in an HR-MAS experiment is not affected by chemical exchange but reflects only chemical differences in the two environments. Different cell lines show a different Δνwater, leading to the concept of "cellular water shift." This shift roughly correlates with the cellular protein content, supporting the view that the most important determinant of the cellular water shift is the interaction between water and proteins in the intracellular compartment. © 2005 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Hyperpolarized agents for advanced MRI investigations</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Santelia</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cerutti</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ellena</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>53</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>604</start>
          <end>617</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">18244785 (ISSN)</identifier>
      <titleInfo>
        <title>Quarterly Journal of Nuclear Medicine and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Q. J. Nucl. Med. Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77949778525&amp;partnerID=40&amp;md5=9c8289ac576473d3c7e64133f86e16fb</url>
    </location>
    <abstract>The strong signal enhancement attainable by hyperpolarization methods has allowed the detection of heteronuclei in magnetic resonance imaging (MRI), allowing to obtain high quality images with very high signal to noise ratios in few seconds. The four methods to produce hyperpolarized molecules, i.e. the "brute force" approach, optical pumping of noble gases, parahydrogen induced polarization (PHIP) and dynamic nuclear polarization (DNP), are reported. The applications of hyperpolarized probes to MRI range from vascular imaging to interventional imaging and perfusion studies, up to the emerging and challenging field of molecular/metabolic imaging. In fact, the high signal intensities achievable by using hyperpolarized molecules make it possible to detect and image the metabolic products formed upon the administration of the hyperpolarized agent. The most striking examples are surveyed, including the use of hyperpolarized 13C-pyruvate in tumor diagnosis and stadiation, and in myocardium perfusion and activity studies, as well as the recently reported proposal of using 13C-bicarbonate as agent for pH-mapping in vivo.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Improved paramagnetic liposomes for MRI visualization of pH triggered release</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Torres</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mainini</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavalli</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>154</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>196</start>
          <end>202</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
        <issuance>continuing</issuance>
      </originInfo>
      <genre authority="marcgt">periodical</genre>
      <identifier type="issn">01683659 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Controlled Release</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Control. Release</title>
      </titleInfo>
    </relatedItem>
    <originInfo>
      <issuance>monographic</issuance>
    </originInfo>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-80052272297&amp;partnerID=40&amp;md5=3a8074db37c9b9c9707894f91a4ab3ba</url>
    </location>
    <abstract>This work aims at assessing the in vitro potential of paramagnetic pH sensitive liposomes as imaging tools for visualizing drug-delivery and release processes by Magnetic Resonance Imaging (MRI). pH sensitive liposomes (pSLs) were formulated using the fusogenic phospholipid 1-palmitoyl-2-oleoyl-sn- glycero-3-phosphoethanolamine (POPE), the membrane stabilizer D-α-tocopherol-hemisuccinate (THS), and were loaded with several paramagnetic complexes including the clinically approved Gadoteridol (marketed as ProHance™). The proposed formulation allows the fast and full release of Gadoteridol at pH 5.5. The leakage of the imaging reporter from the vesicles was associated with a relaxivity enhancement that allowed its visualization by MRI. It was observed that the release mechanism implies the protonation of the THS basic sites that leads to vesicle aggregation, thus enabling the expression of the fusogenic property of POPE. Attempts for improving the MRI properties of pSLs were pursued through the encapsulation of imaging agents with higher relaxivity than Gadoteridol, but it was observed that the release kinetic can be significantly affected by the probe size. Aiming at preparing stealth pSLs, PEG chains were conjugated to the external surface of the vesicles via cleavable disulphide bridges. Such nanomedicines do not release their content at acidic pH as long as the coating polymer is not removed from the surface. The results obtained suggest that the liposomal formulation investigated in this work has the potential for visualizing drug-delivery and release processes by in vivo MRI preclinical studies. © 2011 Elsevier B.V. All rights reserved.</abstract>
    <note type="content">AD  - Department of Chemistry IFM, Molecular and Preclinical Imaging Centers, University of Torino, Via Nizza 52, 10126, Torino, Italy</note>
    <note type="content">AD  - Department of Drug Science and Technology, University of Torino, Via P. Giuria 9, 10125, Torino, Italy</note>
    <note type="content">AD  - Integrated Laboratory of Advanced Methodology, Bioindustry Park of Canavese, Via Ribes, 5, 10010, Colleretto Giacosa (TO), Italy</note>
    <note type="content">&lt;p&gt;Chemicals/CAS: 2 oleoyl 1 palmitoylphosphatidylcholine, 6753-55-5; gadoteridol, 112188-16-6, 120066-54-8; Heterocyclic Compounds; Liposomes; Organometallic Compounds; gadoteridol, 112188-16-6&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Cited By (since 1996): 7&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;CODEN: JCREE&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Correspondence Address: Terreno, E.; Department of Chemistry IFM, Molecular and Preclinical Imaging Centers, University of Torino, Via Nizza 52, 10126, Torino, Italy; email: enzo.terreno@unito.it&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;doi: 10.1016/j.jconrel.2011.05.017&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Export Date: 5 October 2012&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Language of Original Document: English&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Manufacturers: Bracco, Italy&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;PubMed ID: 21621569&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;References: Ganta, S., Devalapally, H., Shahiwala, A., Amiji, M., A review of stimuli-responsive nanocarriers for drug and gene delivery (2008) J. Control. Release, 126, pp. 187-202; Debbage, P., Jaschke, W., Molecular imaging with nanoparticles: Giant roles for dwarf actors (2008) Histochem. Cell Biol., 130, pp. 845-875; Barry, S., Challenges in the development of magnetic particles for therapeutic applications (2008) Int. J. Hyperthermia, 24, pp. 451-466; Torchilin, V.P., Recent advances with liposomes as pharmaceutical carriers (2005) Nature Reviews Drug Discovery, 4 (2), pp. 145-160. , DOI 10.1038/nrd1632; Sajja, H.K., East, M.P., Mao, H., Wang, Y.A., Nie, S., Yang, L., Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect (2009) Curr. Drug Discov. Technol., 6, pp. 43-51; Mulder, W.J., Strijkers, G.J., Van Tilborg, G.A., Cormode, D.P., Fayad, Z.A., Nicolay, K., Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging (2009) Acc. Chem. Res., 42, pp. 904-914; Guo, X., Szoka Jr., F.C., Chemical approaches to triggerable lipid vesicles for drug and gene delivery (2003) Acc. Chem. Res., 36, pp. 335-341; Geraldes, C.F.G.C., Laurent, S., Classification and basic properties of contrast agents for magnetic resonance imaging (2009) Contrast Media Mol. Imaging, 4, pp. 1-23; Terreno, E., Sanino, A., Carrera, C., Delli Castelli, D., Giovenzana, G.B., Lombardi, A., Mazzon, R., Aime, S., Determination of water permeability of paramagnetic liposomes of interest in MRI field (2008) J. Inorg. Biochem., 102, pp. 1112-1119; Gerweck, L.E., Seetharaman, K., Cellular pH gradient in tumor versus normal tissue: Potential exploitation for the treatment of cancer (1996) Cancer Research, 56 (6), pp. 1194-1198; Simoes, S., Nuno Moreira, J., Fonseca, C., Duzgunes, N., Pedroso De Lima, M.C., On the formulation of pH-sensitive liposomes with long circulation times (2004) Advanced Drug Delivery Reviews, 56 (7), pp. 947-965. , DOI 10.1016/j.addr.2003.10.038, PII S0169409X03002795; Lokling, K.-E., Fossheim, S.L., Skurtveit, R., Bjornerud, A., Klaveness, J., pH-sensitive paramagnetic liposomes as MRI contrast agents: In vitro feasibility studies (2001) Magnetic Resonance Imaging, 19 (5), pp. 731-738. , DOI 10.1016/S0730-725X(01)00380-0, PII S0730725X01003800; Lokling, K.-E., Skurtveit, R., Fossheim, S.L., Smistad, G., Henriksen, I., Klaveness, J., pH-sensitive paramagnetic liposomes for MRI: Assessment of stability in blood (2003) Magnetic Resonance Imaging, 21 (5), pp. 531-540. , DOI 10.1016/S0730-725X(03)00076-6; Lokling, K.-E., Fossheim, S.L., Klaveness, J., Skurtveit, R., Biodistribution of pH-responsive liposomes for MRI and a novel approach to improve the pH-responsiveness (2004) Journal of Controlled Release, 98 (1), pp. 87-95. , DOI 10.1016/j.jconrel.2004.04.015, PII S0168365904001993; Lokling, K.-E., Skurtveit, R., Bjornerud, A., Fossheim, S.L., Novel pH-Sensitive Paramagnetic Liposomes with Improved MR Properties (2004) Magnetic Resonance in Medicine, 51 (4), pp. 688-696. , DOI 10.1002/mrm.20009; Lokling, K.-E., Skurtveit, R., Dyrstad, K., Klaveness, J., Fossheim, S.L., Tuning the MR properties of blood-stable pH-responsive paramagnetic liposomes (2004) International Journal of Pharmaceutics, 274 (1-2), pp. 75-83. , DOI 10.1016/j.ijpharm.2003.12.027, PII S0378517304000195; Jizomoto, H., Kanaoka, E., Hirano, K., pH-Sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinate (1994) Biochimica et Biophysica Acta - Lipids and Lipid Metabolism, 1213 (3), pp. 343-348. , DOI 10.1016/0005-2760(94)00057-3; Frenzel, T., Lengsfeld, P., Schirmer, H., Hütter, J., Weinmann, H.J., Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 °c (2008) Invest. Radiol., 43, pp. 817-828; Anelli, P.L., Lattuada, L., Lorusso, V., Schneider, M., Tournier, H., Uggeri, F., Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents (2001) Magnetic Resonance Materials in Physics, Biology and Medicine, 12 (2-3), pp. 114-120. , DOI 10.1016/S1352-8661(01)00107-7, PII S1352866101001077; Aime, S., Calabi, L., Cavallotti, C., Gianolio, E., Giovenzana, G.B., Losi, P., Maiocchi, A., Sisti, M., [Gd-AAZTA] (-): A new structural entry for an improved generation of MRI contrast agents (2004) Inorg. Chem., 43, pp. 7588-7590; Terreno, E., Barge, A., Beltrami, L., Cravotto, G., Delli Castelli, D., Fedeli, F., Jebasingh, B., Aime, S., Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents (2008) Chem. Commun., pp. 600-602; Corsi, D.M., Platas-Iglesias, C., Van Bekkum, H., Peters, J.A., Determination of paramagnetic lanthanide(III) concentrations from bulk magnetic susceptibility shifts in NMR spectra (2001) Magn. Res. Chem., 39, pp. 723-726; Aime, S., Botta, M., Fasano, M., Terreno, E., Prototropic and water-exchange processes in aqueous solutions of Gd(III) chelates (1999) Acc. Chem. Res., 32, pp. 941-949; Delli Castelli, D., Gianolio, E., Geninatti Crich, S., Terreno, E., Aime, S., Metal containing nanosized systems for MR-molecular imaging applications (2008) Coord. Chem. Rev., 252, pp. 2424-2443; Banciu, M., Metselaar, J.M., Schiffelers, R.M., Storm, G., Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue (2008) Neoplasia, 10 (2), pp. 108-117. , http://www.neoplasia.com/pdf/manuscript/neo07913.pdf, DOI 10.1593/neo.07913; Delli Castelli, D., Dastrù, W., Terreno, E., Cittadino, E., Mainini, F., Torres, E., Spadaro, M., Aime, S., In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes (2010) J. Control. Release, 144, pp. 271-279; Romberg, B., Hennink, W.E., Storm, G., Sheddable coatings for long-circulating nanoparticles (2008) Pharm. Res., 25, pp. 55-71; Meng, F., Hennink, W.E., Zhong, Z., Reduction-sensitive polymers and bioconjugates for biomedical applications (2009) Biomaterials, 30, pp. 2180-2198; Glogard, C., Stensrud, G., Aime, S., Novel radical-responsive MRI contrast agent based on paramagnetic liposomes (2003) Magnetic Resonance in Chemistry, 41 (8), pp. 585-588. , DOI 10.1002/mrc.1208&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Source: Scopus&lt;/p&gt;</note>
    <note type="content">&lt;p&gt;Tradenames: prohance, Bracco, Italy&lt;/p&gt;</note>
    <subject>
      <topic>2 oleoyl 1 palmitoylphosphatidylcholine</topic>
    </subject>
    <subject>
      <topic>Acidic pH</topic>
    </subject>
    <subject>
      <topic>alpha tocopherol derivative</topic>
    </subject>
    <subject>
      <topic>alpha tocopherol hemisuccinate</topic>
    </subject>
    <subject>
      <topic>article</topic>
    </subject>
    <subject>
      <topic>Basic sites</topic>
    </subject>
    <subject>
      <topic>Coating polymers</topic>
    </subject>
    <subject>
      <topic>Contrast agent</topic>
    </subject>
    <subject>
      <topic>Contrast agents</topic>
    </subject>
    <subject>
      <topic>Disulphide bridge</topic>
    </subject>
    <subject>
      <topic>drug delivery system</topic>
    </subject>
    <subject>
      <topic>Drug Delivery Systems</topic>
    </subject>
    <subject>
      <topic>drug release</topic>
    </subject>
    <subject>
      <topic>External surfaces</topic>
    </subject>
    <subject>
      <topic>gadoteridol</topic>
    </subject>
    <subject>
      <topic>Heterocyclic Compounds</topic>
    </subject>
    <subject>
      <topic>Hydrogen-Ion Concentration</topic>
    </subject>
    <subject>
      <topic>Imaging agent</topic>
    </subject>
    <subject>
      <topic>Imaging tools</topic>
    </subject>
    <subject>
      <topic>in vitro study</topic>
    </subject>
    <subject>
      <topic>In-vitro</topic>
    </subject>
    <subject>
      <topic>In-vivo</topic>
    </subject>
    <subject>
      <topic>Liposomal formulation</topic>
    </subject>
    <subject>
      <topic>liposome</topic>
    </subject>
    <subject>
      <topic>Liposomes</topic>
    </subject>
    <subject>
      <topic>Macrophages</topic>
    </subject>
    <subject>
      <topic>Magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>MRI</topic>
    </subject>
    <subject>
      <topic>Nanomedicines</topic>
    </subject>
    <subject>
      <topic>nuclear magnetic resonance imaging</topic>
    </subject>
    <subject>
      <topic>Organometallic Compounds</topic>
    </subject>
    <subject>
      <topic>Paramagnetic complexes</topic>
    </subject>
    <subject>
      <topic>Paramagnetic materials</topic>
    </subject>
    <subject>
      <topic>Paramagnetism</topic>
    </subject>
    <subject>
      <topic>pH</topic>
    </subject>
    <subject>
      <topic>pH measurement</topic>
    </subject>
    <subject>
      <topic>PH sensors</topic>
    </subject>
    <subject>
      <topic>Phospholipids</topic>
    </subject>
    <subject>
      <topic>pH-sensitive liposomes</topic>
    </subject>
    <subject>
      <topic>Preclinical studies</topic>
    </subject>
    <subject>
      <topic>priority journal</topic>
    </subject>
    <subject>
      <topic>Probe size</topic>
    </subject>
    <subject>
      <topic>proton transport</topic>
    </subject>
    <subject>
      <topic>Relaxivity</topic>
    </subject>
    <subject>
      <topic>Release kinetics</topic>
    </subject>
    <subject>
      <topic>Release mechanism</topic>
    </subject>
    <subject>
      <topic>Release process</topic>
    </subject>
    <subject>
      <topic>Resonance</topic>
    </subject>
    <subject>
      <topic>Triggered release</topic>
    </subject>
    <subject>
      <topic>unclassified drug</topic>
    </subject>
    <subject>
      <topic>Vesicle aggregation</topic>
    </subject>
    <subject>
      <topic>Visualization</topic>
    </subject>
  </mods>
  <mods>
    <titleInfo>
      <title>Improved Route for the Visualization of Stem Cells Labeled with a Gd-/Eu-Chelate as Dual (MRI and Fluorescence) Agent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Biancone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cantaluppi</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Duò</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Esposito</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Russo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Camussi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>51</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>938</start>
          <end>944</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Med.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-2342530430&amp;partnerID=40&amp;md5=d6bff44da0e2fde1422e3a483e329414</url>
    </location>
    <abstract>A simple labeling procedure of stem/progenitor cells based on the use of Gd-HPDO3A and Eu-HPDO3A, respectively, is described. The Gd-chelate acts as T1-agent for MRI visualization, whereas the corresponding Eu-chelate acts as reporter in fluorescence microscopy. Owing to their substantial chemical equivalence, the two chelates are equally internalized in EPCs (endothelial progenitor cells), thus allowing their visualization by both techniques. The lanthanide chelates are entrapped in endosomic vesicles and the labeled cells retain biological activity with preservation of viability and pro-angiogenesis capacity. Hyperintense spots in MR have been observed for Gd-labeled EPCs injected under mice kidney capsule or grafted on a subcutaneous Matrigel plug up to 14 days after transplantation. © 2004 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Improved syntheses of bis(β-cyclodextrin) derivatives, new carriers for gadolinium complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Robaldo</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Boffa</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>4</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>1124</start>
          <end>1130</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">14770520 (ISSN)</identifier>
      <titleInfo>
        <title>Organic and Biomolecular Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Org. Biomol. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33644883073&amp;partnerID=40&amp;md5=ec72faa56f3d18d1f146a048b4f5fdfc</url>
    </location>
    <abstract>In the last decade a number of reports have been published on the synthesis and characterization of bridged cyclodextrin dimers (bis-CDs) connected with linkers of different lengths and structures. These dimers, having two hydrophobic cavities in close proximity, display much higher binding affinities and molecular selectivities than parent CDs, forming stable supramolecular adducts. We describe new synthetic protocols for the preparation of bis(β-CDs) bearing 2-2′, 3-3′ and 6-6′ bridges. Some of the critical steps were carried out either under high-intensity ultrasound (US) or microwave (MW) irradiation. Bis(β-CDs) containing 6-6′ ureido- and thioureido-bridges were prepared in high yields by a MW-promoted aza-Wittig reaction using polymer-bound triphenylphosphine, while those containing 2,2′ and 3,3′ bridges were prepared from mono-alkenyl β-CDs by the cross-metathesis reaction (homodimerization) in the presence of 2 nd-generation Grubbs catalyst under sonochemical conditions. By these improved protocols CD dimers could be obtained in gram amounts to prepare stable adducts of bis-CDs with contrast agents (CAs) containing gadolinium(iii) chelates. In the case of Gd(iii) chleate "G-1" the inclusion complexes were found to be 2 to 3 orders of magnitude more stable than that formed by β-CD (Kass = 4.3 × 104 M-1 vs 8.0 × 102 M-1). Relaxivity increased as well by factors of 3 and 4, viz. from 9.1 mM-1 s-1 (β-CD) to 27.7 and 35 mM-1 s-1. © The Royal Society of Chemistry 2006.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Belfiore</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ghirelli</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lattuada</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzardo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mortillaro</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Visigalli</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Forni</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>49</number>
        </detail>
        <detail type="issue">
          <number>16</number>
        </detail>
        <extent unit="pages">
          <start>4926</start>
          <end>4936</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">00222623 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33746927937&amp;partnerID=40&amp;md5=2fafc74be68e686418322a8886529017</url>
    </location>
    <abstract>The glutamine transporting system is up-regulated in tumor cells because cell proliferation requires the uptake of large quantities of glutamine. It has been found that the paramagnetic magnetic resonance imaging (MRI) reporter Gd-DOTAMA-C6-Gln, where the glutamine residue is covalently bound to the Gd chelate through a C6 spacer, accumulates in tumor cells both "in vitro" and "in vivo" experiments. The observation that the relaxivity of cellular pellets does not increase with the increase in the amounts of entrapped Gd chelate is taken as an indication that the internalization has occurred through receptor mediated endocytosis. The iv administration of Gd-DOTAMA-C6-Gln allowed the MRI visualization of tumor masses in A/J mice grafted with the murine neuroblastoma cell line Neuro-2a and in Her-2/neu transgenic mice developing multiple mammary carcinoma, respectively. © 2006 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cittadino</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mainini</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Torres</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Spadaro</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>144</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>271</start>
          <end>279</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">01683659 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Controlled Release</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Control. Release</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77953287998&amp;partnerID=40&amp;md5=7dd77aa67b4e6f571f667f16ef5ffbe2</url>
    </location>
    <abstract>This work aims at developing a MRI method that allows to get more insight into the understanding of the in vivo fate of liposomes and their payload. The method relies on the temporal assessment of the contrast changes induced by the presence of a classical relaxation agent versus the effect induced by a CEST (chemical exchange saturation transfer) agent. Liposomes were loaded with the paramagnetic complexes, Gd-HPDO3A and [Tm-DOTMA]- [Na]+, in order to endow the nanovesicles with the characteristic properties of T1/T2 and CEST/T2 MRI agents, respectively. The paramagnetically loaded liposomes were injected directly into the tumor (B16 melanoma xenograft in mice) where they generate T1, T2, and CEST MR contrasts that were quantitatively monitored over time (0-48h). The kinetic of each contrast enhancement reports about peculiar properties relative to the fate of the liposomes in the tumor environment. A kinetic model has been set-up to fit the experimental multicontrast data in order to extract the relevant information about the cellular uptake of the liposomes and the release of their payload. Upon comparing conventional stealth liposomes with pH-sensitive ones, it has been shown that the latter ones differ essentially in the step associated with the release of the drug that is likely occurring in the endosomal acidic vesicles. © 2010 Elsevier B.V.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Innovative magnetic resonance imaging diagnostic agents based on paramagnetic Gd(III) complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mainero</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>66</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>419</start>
          <end>428</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">00063525 (ISSN)</identifier>
      <titleInfo>
        <title>Biopolymers - Peptide Science Section</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Biopolym. Pept. Sci. Sect.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0036976704&amp;partnerID=40&amp;md5=5a620e57513db2538cb22c50cc446283</url>
    </location>
    <abstract>Gd(III) complexes are under intense scrutiny as contrast agents for magnetic resonance imaging (MRI). They act by enhancing tissutal proton relaxation rates. Much has already been done in order to get an in-depth understanding of the relationships between structure, dynamics, and contrastographic ability of these paramagnetic complexes. Their potential in the assessment of flow, perfusion, and capillary permeability has already been established. The next challenges are in the field of molecular imaging applications, which would allow the attainment of early diagnosis based on the recognition of specific reporters of the onset of the pathological state. To this end, Gd(III) complexes have to be endowed with improved targeting capabilities by conjugating suitable recognition synthons on their surfaces. Small peptides are candidates of choice for the attainment of this goal. Moreover, the intrinsic low sensitivity of the NMR techniques implies the need to deliver large amounts of contrast agents to the target in order to get its visualization in the resulting images. Highly efficient delivery systems have been identified, which bring a great promise for the development of innovative diagnostic agents based on Gd(III) complexes. © 2003 Wiley Periodicals, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Colombatto</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maggioni</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>16</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>394</start>
          <end>406</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">10531807 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Magn. Reson. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0036794367&amp;partnerID=40&amp;md5=15d66b7111747c7c57cb53085bb32b17</url>
    </location>
    <abstract>Can gadolinium III [Gd(III)] complexes be considered good candidates for magnetic resonance (MR)-molecular imaging studies? In this review article, we examine the principal issues that are the basis of successful use of Gd-based protocols in molecular imaging applications. High relaxivity is the primary requisite. Therefore, the design of such paramagnetic probes has to be pursued keeping in mind the relationships between structure, dynamics, and the relevant parameters involved in paramagnetic relaxation processes. Moreover, the limited number of target molecules on cellular membranes makes it necessary to define strategies aimed at delivering many Gd-containing moieties to the sites of interest. Examples are reported for the attainment of very high relaxivities for the design of new routes for pursuing the accumulation of small sized Gd(III) complexes at the targeting sites. An efficient cellular uptake of Gd-containing probes is the key step for attaining the visualization of targeted cells by MR imaging, and selected examples are reported. In this context, the problem of the assessment of the minimum amount of Gd(III) complexes necessary for the MR imaging-visualization of cells has been addressed by reporting the authors' observations on the cell-internalization of Gd(III) complexes. A particularly efficient delivery system is represented by Gd-loaded apoferritin, which allows the MR visualization of hepatocytes when the number of Gd-complexes per cell is 4 ± 1 × 107. Finally, the potential of responsive systems is considered by outlining the exploitation of the amplification effect brought about by the action of a specific enzymatic activity on the relaxivity of a suitably functionalized Gd(III) complex. © 2002 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Interactions of lanthanides and their complexes with proteins. Conclusions regarding magnetic resonance imaging.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>40</number>
        </detail>
        <extent unit="pages">
          <start>643</start>
          <end>682</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">01615149 (ISSN)</identifier>
      <titleInfo>
        <title>Metal ions in biological systems</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Met Ions Biol Syst</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0038544561&amp;partnerID=40&amp;md5=bcad02d03cbb2257c65e136cd43178aa</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Intramolecular host-guest dynamics of FeCp(CO)2X (X = I and CH3) and Mo2Cp2(CO)6 included in β- or γ-cyclodextrin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chierotti</namePart>
      <namePart type="given">M.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Masic</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canuto</namePart>
      <namePart type="given">H.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Heyes</namePart>
      <namePart type="given">S.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>152</start>
          <end>157</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">14341948 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-38349080044&amp;partnerID=40&amp;md5=8aa63e0d107a38c62a7963c431b456de</url>
    </location>
    <abstract>Variable-temperature 13C CPMAS NMR spectra of the metal-carbonyl complexes FeCp(CO)2X (where X = I, CH3) and Mo 2Cp2(CO)6 included in β- or γ-cyclodextrin (CD) cavities were investigated in the temperature range 133 to 293 K. The motion of the guest molecule inside the CD can be detected by comparing these spectra with the static crystalline patterns of FeCp(CO) 2I and Mo2Cp2(CO)6. In the case of FeCp(CO)2CH3, solid-state plastic crystal behaviour is noted for the free guest; the molecular motion is further modified by inclusion within the CD cavity. The nature of the molecular motion found within the metal-carbonyl/CD adducts was shown to be dependent on the symmetry, size and orientation of the guest molecule within the host cavity. In the case of Mo 2Cp2(CO)6 included in γ-CD, the two [MoCp(CO)3] ends of the dimer may be considered as separate dynamic entities: one half of the moiety within the CD cavity exhibits a greater freedom of motion, whereas the other end of the dimer is anchored. © Wiley-VCH Verlag GmbH &amp; Co. KGaA, 2008.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Intramolecular hydrogen bonding in transition metal clusters: NMR evidence for an Os-H⋯H-S interaction in H(μ-H)Os3(CO)10(HSR) (R = ethyl, cyclopentyl)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chierotti</namePart>
      <namePart type="given">M.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Russo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stchedroff</namePart>
      <namePart type="given">M.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>351</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>251</start>
          <end>255</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0038785629&amp;partnerID=40&amp;md5=108e281a9116f43f803bbc850460880c</url>
    </location>
    <abstract>The reaction of H2Os3(CO)10 with RSH (R=CH2CH3, cyclopentylthiol) at low temperatures in CD2Cl2 affords three H(μ-H)Os3(CO)10(RSH) adducts, where, by the 13C NMR carbonyl spectrum, it can be shown that the thiol ligand occupies an axial position. The presence of an intermolecular MH⋯HS interaction in the main isomer has been determined by longitudinal relaxation time measurements. The isolation of the H,H dipolar contribution to the terminal hydride relaxation affords a value of 1.97 Å for the 'unconventional' hydrogen-hydrogen interaction in H(μ-H)Os3(CO)10(RSH) (R=cyclopentylthiol). An intramolecular proton transfer from the thiol ligand RSH to the terminal hydride, via a dihydrogen bonded species, ultimately losing an H2 molecule. leading to the formation of the stable product (μ-H)Os3(CO)10(μ-SR) is proposed. © 2003 Elsevier Science B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Intramolecular motion in tetra-t-butyldiphosphine</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Harris</namePart>
      <namePart type="given">R.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">McVicker</namePart>
      <namePart type="given">E.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fild</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>426</start>
          <end>427</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1974</dateIssued>
      </originInfo>
      <identifier type="issn">00224936 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Chemical Communications</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049134798&amp;partnerID=40&amp;md5=3186b2824f9f23762e81549dce52e563</url>
    </location>
    <abstract>13C and 1H N.m.r. spectra of But2PPBut2 at temperatures well below ambient show that there are two distinct environments for the tertiary butyl groups on the n.m.r. time-scale, whereas 31P spectra show there is only one type of phosphorus; this is attributed to the existence of the gauche isomer in preference to the trans and the two values of |1JPC + 2JPPC| differ markedly.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Intramolecular nucleophilic attack at the α-carbon atom of a μ3-alkynyl ligand in a triosmium cluster</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deeming</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>1807</start>
          <end>1809</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049108510&amp;partnerID=40&amp;md5=41852e5e45be364c5d1e8c9cd27dd127</url>
    </location>
    <abstract>The cluster [Os3(CO)12] reacts with but-3-yn-1-ol, HC=CCH2CH2OH, in hydrocarbon solvent at 130 °C to give the 2,3-dihydrofuran-4,5-diyl complex [Os3H2(CO)9(μ3-C=CCH 2CH2O)] (3) (yield 48%). The probable route to this compound is indicated by the formation of the simple alkyne compound [Os3(CO)10(μ3-HC=CCH2CH 2OH)] (1) from [Os3(CO)10(MeCN)2] and the alkynol at room temperature which at higher temperatures converts to compound (3) probably via its isomer [Os3H(CO)9(μ3-C=CCH2CH 2OH)] (2). This isomerisation occurs because α-carbon atoms of μ3-alkynyl ligands are susceptible to nucleophilic attack which in this case occurs intramolecularly with cyclisation. The dynamic behaviour of clusters (1) and (3) is described; in both cases inversion of the chiral Os3(alkyne) group is observed.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Intramolecular reactivity of a captodative bis-diene</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Oulyadi</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maddaluno</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Venturello</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>1631</start>
          <end>1634</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">15237060 (ISSN)</identifier>
      <titleInfo>
        <title>Organic Letters</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Org. Lett.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000694068&amp;partnerID=40&amp;md5=f404cf06873d5c301100fb5cfc73e3c0</url>
    </location>
    <abstract>(matrix presented). A 1,1-captodative bis-diene (3) has been prepared from crotonaldehyde diethyl acetal through an elimination-metalation sequence. This compound has been reacted with electron-rich and electron-deficient dienophiles. Under both thermal and high-pressure conditions, no intermolecular reaction was observed, the fused (4) and bridged (5) intramolecular bicyclic adducts being recovered. The reduction of the central carbonyl group has led to the corresponding allylic alcohol which, in thermal cycloaddition conditions, also provides an intramolecular adduct that aromatizes in the medium.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Investigating pathways of molecular H2 exchange in (μ-H)2Os3(CO)10</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Russo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>20</number>
        </detail>
        <detail type="issue">
          <number>13</number>
        </detail>
        <extent unit="pages">
          <start>2924</start>
          <end>2927</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035948486&amp;partnerID=40&amp;md5=020c096bbcbdfc7afaeba6c142a989ce</url>
    </location>
    <abstract>The occurrence of two pathways responsible for the reaction of (μ-H)2Os3(CO)10 with molecular hydrogen has been elucidated by comparing the results obtained from H2/D2 isotopic exchange experiments and para-H2 effects observed in the cluster's 1H NMR spectrum. The most efficient exchange process is based on an associative mechanism that leads to the formation of the elusive (η-*H2)(H)(μ-H)Os3(CO)10 species (*H2 is either a D2 or a para-H2 molecule), which undergoes *H-H elimination. The other pathway (whose efficiency increases with temperature) is based on the dissociation of H2 from (μ-H)2Os3(CO)10 to form the highly unsaturated "Os3(CO)10" moiety, which promptly adds a *H2 molecule, yielding the asymmetrical *H(μ-*H)Os3(CO)10S intermediate (where S is a stabilizing solvent molecule), which releases the S molecule to re-form (μ-*H)2Os3(CO)10.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: In vivo studies in mice at 7 T.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Keupp</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Langereis</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzardo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Prestigio</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Steinbach</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>65</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>202</start>
          <end>211</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">15222594 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn Reson Med</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79952784831&amp;partnerID=40&amp;md5=81e021cfc64f67d1bf371be5dd3a56e4</url>
    </location>
    <abstract>Iopamidol (Isovue®-Bracco Diagnostic Inc.) is a clinically approved X-Ray contrast agent used in the last 30 years for a wide variety of diagnostic applications with a very good clinical acceptance. Iopamidol contains two types of amide functionalities that can be exploited for the generation of chemical exchange saturation transfer effect. The exchange rate of the two amide proton pools is markedly pH-dependent. Thus, a ratiometric method for pH assessment has been set-up based on the comparison of the saturation transfer effects induced by selective irradiation of the two resonances. This ratiometric approach allows to rule out the concentration effect of the contrast agent and provides accurate pH measurements in the 5.5-7.4 range. Upon injection of Iopamidol into healthy mice, it has been possible to acquire pH maps of kidney regions. Furthermore, it has been also shown that the proposed method is able to report about pH-changes induced in control mice fed with acidified or basified water for a period of a week before image acquisition. © 2010 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Iopamidol: Exploring the potential use of a well-established x-ray contrast agent for MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Calabi</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Biondi</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Miranda</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ghelli</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paleari</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rebaudengo</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>53</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>830</start>
          <end>834</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Med.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-16444378910&amp;partnerID=40&amp;md5=937313a314fc8c1868f8a5be666ec5d4</url>
    </location>
    <abstract>Iopamidol is one of the most common contrast media used for diagnostic CT-based clinical protocols. Chemically, this molecule contains two pools of mobile protons (amide and alcoholic) that are in exchange with water. At 7.05 T, pH 7.4, and 312 K, the exchange rate of the alcoholic protons is too fast to affect the NMR properties of water protons, whereas the slowly exchanging amide protons induce a T2-shortening effect on the "bulk" water signal that is detectable when the concentration is about 12 mM. Moreover, a more pronounced contrast is observed when the amide resonances are saturated by the application of an appropriate RF irradiation field, making iopamidol a potential chemical exchange saturation transfer (CEST) agent whose effect can be detected at a concentration as low as 7 mM (at 7.05 T). The exploitation of the MRI properties of iopamidol could facilitate novel and interesting diagnostic applications for combined MRI and CT studies. © 2005 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Iron and neuromelanin in Parkinson's disease</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bergamasco</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bolzoni</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crippa</namePart>
      <namePart type="given">P.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giraudo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lopiano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rizzone</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Torre</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>20</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>270</start>
          <end>271</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">03920461 (ISSN)</identifier>
      <titleInfo>
        <title>Italian Journal of Neurological Sciences</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Ital. J. Neurol. Sci.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33746360921&amp;partnerID=40&amp;md5=2eb087adb1a2e70460376a5e118df9e3</url>
    </location>
    <abstract>Introduction: The pigmented dopaminergic neurons in the substantia nigra pars compacta are the most vulnerable in Parkinson's disease (PD). Due to the high iron content of neuromelanin (NM), its potential cytotoxity as a free radical generator and the observed depletion of NM in the course of the disease, the characterization of NM provides a clue to the etiopathology of PD. The structure of the iron-NM assembly in controls (CO) and PD patients was investigated by I3C-NMR spectroscopy, 'HNMR relaxometry (NMRD), EPR spectroscopy and magnetometry. Methods: CO and PD samples were obtained from pooled tissues. The extraction procedure included a lipid extraction followed by a drastic proteolytic treatment. I3C NMR spectroscopy measurements were performed under CPMAS conditions. NMRD allows the measurements of the longitudinal relaxation times of water at different magnetic field strengths, yielding a plot which reports about the mobility of water molecules in the tissue, and its functional form is usually related to the organization of proteins in the tissue. EPR spectroscopy in the Q-band was chosen to study the binding of Fe(III) species to NM. Magnetometric data were obtained on a superconducting quantum interference device and report on the magnetic behavior of iron domains in the sample. Results: C CPMAS NMR of NM from CO shows a pattern close to other natural melanins, plus a characteristic glycolipidic matrix, whereas NM from PD shows typical protein absorptions. From NMRD data we found small differences between NM of PD and CO, meaning that there is no evidence of massive release of paramagnetic species during the progress of the disease. The absence of iron ions chelated by the melanin matrix is assessed by both EPR and magnetometric measurements, although a very small contribution is observed in NM from CO. Both techniques point out the presence of extended iron-oxygen clusters. Conclusions: NM from PD patients contains a proteic component, which is insoluble and protease resistant, not evident in the NM extracted from CO. Our data suggest that in PD a deposition of insoluble, protease resistant material covalently linked to the melanin backbone is occurring. The difference observed in the NMRD profiles of SN from PD patients and CO is consistent with a difference in the concentration and organization of immobilized proteins in the SN tissue. It is definitely demonstrated that iron is organized in a 3D network. The magnetic behavior suggests the occurrence of different iron-oxygen clusters.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Iron-57 satellites in 13C NMR spectra: an aid to elucidation of "hidden-processes" in the dynamics of metal carbonyls</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>214</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>C27-C30</start>
          <end>C27-C30</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1981</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-10944240771&amp;partnerID=40&amp;md5=aaab32dd78d316bb620b5dc53908b056</url>
    </location>
    <abstract>The observation of 57Fe satellites in 13C NMR spectra of Fe2(CO)6S2, syn-and anti-Fe2 (CO)6(SCH3)2 isomers and Fe3(CO)12 adds new information to the understanding of the dynamic behaviour of these molecules. © 1981.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Isolation of a 177Hf complex formed by β-decay of a 177Lu-labeled radiotherapeutic compound and NMR structural elucidation of the ligand and its Lu and Hf complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Cagnolini</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">D'Amelio</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Metcalfe</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nguyen</namePart>
      <namePart type="given">H.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Swenson</namePart>
      <namePart type="given">R.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Linder</namePart>
      <namePart type="given">K.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>48</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>3114</start>
          <end>3124</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-64349106311&amp;partnerID=40&amp;md5=06e2e7e4e52a1b4dcf3feadd0ab646d2</url>
    </location>
    <abstract>177Lu-AMBA (AMBA = DO3A-CH2CO-G-[4-aminobenzoyl]- QWAVGHLM-NH2) is being developed for the radiotherapeutic treatment of tumors that express the gastrin-releasing peptide receptor (GRP-R). In this study we investigated the fate of the 177hafnium (177Hf) that forms upon the decay of 177Lu while the latter is complexed with AMBA. When decayed solutions of 177Lu-AMBA were analyzed, it was found that 177Hf is retained in the DO3A monoamide chelator, forming a pair of interconverting isomers. We report the synthesis and full characterization of natLu-AMBA and the studies performed to demonstrate its correspondence to radioactive 177Lu-AMBA. We also report the synthesis and characterization of Hf-AMBA and, by NMR studies, show structural analogies between Hf-AMBA, its parent compound Lu-AMBA, and the unmetallated AMBA ligand. In the NMR spectra of both the metallated and unmetallated AMBA ligand, a stacking interaction between the amino benzoyl residue in the linker and a tryptophan in the truncated bombesin [BBN(7-14)-NH2] peptide targeting group was found. © 2009 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Jaw-opening dystonia presumably caused by a pontine lesion</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bergamasco</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casu</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giraudo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lopiano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>1026</start>
          <end>1028</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">08853185 (ISSN)</identifier>
      <titleInfo>
        <title>Movement Disorders</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Mov. Disord.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0033814191&amp;partnerID=40&amp;md5=066a0c3a9c5bb62fd902faa651133f30</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Lanthanide(III) complexes of tris(amide) PCTA derivatives as potential bimodal magnetic resonance and optical imaging agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rojas-Quijano</namePart>
      <namePart type="given">F.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Benyó</namePart>
      <namePart type="given">E.T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tircsó</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kálmán</namePart>
      <namePart type="given">F.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baranyai</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sherry</namePart>
      <namePart type="given">D.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kovács</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>47</number>
        </detail>
        <extent unit="pages">
          <start>13188</start>
          <end>13200</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-73349102775&amp;partnerID=40&amp;md5=5b9db9073ca5fa7f76d5159ddc646bf8</url>
    </location>
    <abstract>Lanthanide complexes of two tris(amide) derivatives of PCTA were synthesized and characterized. The relaxometric and luminescence properties of their lanthanide complexes were investigated as bimodal magnetic resonance (MR) and optical imaging agents. Luminescence studies show that one of the Tb III complexes dimerizes in solution at low millimolar concentrations, whereas the other may have a higher than expected coordination number in solution. The corresponding GdIII complexes display unusually high T1 relaxivities and enhanced kinetic inertness compared to GdPCTA. These features suggest that these new chelates may be suitable for in vivo applications. The fast water-exchange rates observed for these complexes make them unsuitable as paramagnetic chemical exchange saturation transfer (PAR-ACEST) agents. © 2009 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Lanthanide(in) chelates for NMR biomedical applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>27</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>19</start>
          <end>29</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">03060012 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Society Reviews</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Soc. Rev.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-1642639621&amp;partnerID=40&amp;md5=d6585a4efe13b6b46c4578d52afd229e</url>
    </location>
    <abstract>The peculiar magnetic properties of lanthanide(III) ions may be exploited for the development of powerful NMR probes for biomedical applications. GdIII chelates are in current clinical use as contrast agents for magnetic resonance imaging. Other paramagnetic lanthanide(III) complexes endowed with shift reagent capabilities are used for the separation of NMR resonances of species present in the inner and outer cellular compartments and for the measurement of pH and temperature.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Lanthanide-loaded paramagnetic liposomes as switchable magnetically oriented nanovesicles</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Carrera</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mazzon</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rollet</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Visigalli</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>47</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>2928</start>
          <end>2930</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-43149121586&amp;partnerID=40&amp;md5=d9a547f2d9841836e76908428a91533c</url>
    </location>
    <abstract>Osmotically shrunken liposomes loaded with paramagnetic lanthanide(III) complexes orient in a static magnetic field according to the sign of their magnetic susceptibility anisotropy (Δχ). The magnitude and sign of Δχ are modulated by the magnetic properties of the LnIII ion, by the structural characteristics of the metal chelate, and by the stereochemical arrangement of the lipophilic substituents. © 2008 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Lanthanide-Loaded Paramagnetic Liposomes as Switchable Magnetically Oriented Nanovesicles</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">book</genre>
    <genre authority="marcgt">book</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <part>
      <detail type="volume">
        <number>464</number>
      </detail>
    </part>
    <originInfo>
      <copyrightDate>2009</copyrightDate>
    </originInfo>
    <identifier type="isbn">00766879 (ISSN)</identifier>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-71549150294&amp;partnerID=40&amp;md5=4b86dadf7e13af2f25de8e47f245916c</url>
    </location>
    <abstract>Magnetically oriented liposomes can be prepared by exposing unilamellar spherical systems loaded with paramagnetic lanthanide(III) complexes to hyperosmotic stress. The resulting nonspherical, lens-shaped, nanoparticles can orient within a static magnetic field, depending on the magnetic properties of their membrane bilayer. The orientation of the vesicles can be easily determined by measuring the paramagnetic contribution to the 1H chemical shift of the intraliposomal water proton resonance. As the latter shift is dominated by the bulk magnetic susceptibility contribution, its sign (negative or positive) reports about the preferred orientation adopted by the nanovesicles. The alignment within the field depends upon the magnetic susceptibility anisotropy of the liposome membrane, ΔχLIPO. When ΔχLIPO has a negative value (e.g., for nonspherical liposomes made of conventional phospholipids), the nanoparticles align with their long axis parallel to the field, whereas when ΔχLIPO &gt; 0 the vesicles flip by 90°. The sign of the chemical shift of the intraliposomal water resonance is positive in the former case and negative in the latter, respectively. The liposome orientation can be switched by incorporating in the liposome bilayer suitable amphiphilic paramagnetic lanthanide(III) complexes. The sign of ΔχLIPO, and consequently the magnetic alignment, will correspond to the sign of the magnetic susceptibility anisotropy of the metal complex. The magnetic susceptibility anisotropy is dependent on both the electronic configuration of the lanthanide ion and the structural characteristics of the amphiphilic complex incorporated in the liposome membrane. The magnetic orientation of such vesicles is maintained in vivo, thus opening promising perspectives for the application of nonspherical liposomes in medical imaging. © 2009 Elsevier Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Longitudinal nuclear relaxation in a A2 spin system initially polarized through para-hydrogen</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canet</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>120</number>
        </detail>
        <detail type="issue">
          <number>27</number>
        </detail>
        <extent unit="pages">
          <start>6770</start>
          <end>6773</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032528057&amp;partnerID=40&amp;md5=5f64b7dddb642d5dc4b88b8b442bf9c6</url>
    </location>
    <abstract>Os3(CO)10(NCCH3)2 has been hydrogenated with para-hydrogen to yield H2Os3(CO)10 where the two hydrogen nuclei remain magnetically equivalent and therefore in a singlet state. Despite this equivalence, an enhanced longitudinal magnetization is observed to decrease toward thermal equilibrium. It is postulated that this enhanced magnetization is created through a nuclear relaxation interference mechanism (cross-correlation between dipolar interaction and chemical shift anisotropy); decay curves are then successfully analyzed by means of a spin relaxation theory adapted to this situation.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzardoy</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Alberti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Belfiore</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ciampa</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lovazzano</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>9</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>1046</start>
          <end>1056</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">15228002 (ISSN)</identifier>
      <titleInfo>
        <title>Neoplasia</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Neoplasia</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37149042647&amp;partnerID=40&amp;md5=ca1192cedd5e9d518257ee0cb20c18dd</url>
    </location>
    <abstract>Gd-DO3A-diph and Gd-AAZTAC17 are lipophilic magnetic resonance imaging (MRI) agents that display high affinity for low-density lipoprotein (LDL) particles. However, on binding to LDL, Gd-DO3A-diph shows a decreased hydration that results in a lower enhancement of water proton relaxation rate. Conversely, Gd-AAZTAC17 displays a strong relaxation enhancement at the imaging fields. Each LDL particle can load up to 100 and 400 UNITS of Gd-DO3A-diph and Gd-AAZTAC17, respectively. Their LDL adducts are taken up by human hepatoblastoma G2 (HepG2) and melanoma B16 tumor cells when added to the incubation medium. T1 measurements of the labeled cells indicate that Gd-AAZTAC17 is significantly more efficient than Gd-DO3A-diph. Furthermore, it has been found that HepG2 hepatoma cells can internalize higher amounts of Gd-AAZTAC17 than B16 cells and the involvement of LDL receptors (LDLRs) has been demonstrated in competition assays with free LDL. Gd-AAZTAC17/LDL adduct proved to be an efficient probe in the magnetic resonance (MR) visualization of subcutaneous tumors in animal models obtained by injecting B16 melanoma cells into the right flank of mice. Finally, confocal microscopy validation of the distribution of LDL-based probes in the tumor has been obtained by doping the Gd-AAZTAC17/LDL adduct with a fluorescent phospholipid moiety. Copyright © 2007 Neoplasia Press, Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Magnetic resonance imaging of gadolinium-labeled pancreatic islets for experimental transplantation</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Biancone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cantaluppi</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Romanazzi</namePart>
      <namePart type="given">G.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Russo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Scalabrino</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Esposito</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Figliolini</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Beltramo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallo Perin</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Segoloni</namePart>
      <namePart type="given">G.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Camussi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>20</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>40</start>
          <end>48</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">09523480 (ISSN)</identifier>
      <titleInfo>
        <title>NMR in Biomedicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>NMR Biomed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33847400162&amp;partnerID=40&amp;md5=d67466a38d92b0ec717b58843eec5e71</url>
    </location>
    <abstract>New imaging techniques that couple anatomical resolution to sensitivity may greatly contribute to improving islet transplantation. In the present work, a report is given of the direct detection of islets by magnetic resonance imaging (MRI) after ex vivo cell labeling with the MRI T1 contrast agent GdHPD03A. Experiments on mouse and human islets demonstrated well-tolerated uptake of GdHPD03A, based on morphology, viability, glucose-dependent insulin response and apoptosis/ toxicity gene array profile. GdHPD03A loading was sufficient for in vitro MRI cell detection. In vivo isotransplanted mouse islets into the kidney capsule and xenotransplanted human islets within the mouse liver were detected. Imaging specificity was supported by the absence of signal in unlabeled islet transplants, its persistence upon using fat-suppression MRI protocols and the colocalization with the transplanted islets. In conclusion, direct islet imaging with high spatial and contrast resolution after labeling with GdHPD03A is demonstrated, allowing visualization of kidney subcapsular mouse islet grafts and intrahepatic human islet xenografts. Copyright © 2006 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Magnetic resonance imaging of the gastrointestinal tract: Investigation of baby milk as a low cost contrast medium</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Balzarini</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barbero</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ceglia</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Petrillo</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reyner</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tesoro Tess</namePart>
      <namePart type="given">J.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Musumeci</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>171</start>
          <end>174</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1992</dateIssued>
      </originInfo>
      <identifier type="issn">0720048X (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Radiology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>EUR. J. RADIOL.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0026765029&amp;partnerID=40&amp;md5=73b2269cb615a8decb334377731f53bb</url>
    </location>
    <abstract>After the incidental observation of the high signal intensity of the upper GI tract in a nourished baby, we tested eight baby milks; five different fresh commercial milks, one sweetened and condensed and two lyophilized milks in order to compare their ability to contrast MR images. The images were obtained with a 1.5 T magnet whereas the 'in vitro' water proton relaxation time (T1 and T2) measurements were carried out at 0.5 T. After having selected the most effective lyophilized product, that was prepared according to the manufacturer's instructions, a group of 23 adult patients, 17 males and 6 females, with a mean age of 55.8 years (range 37 to 71 years) were examined. Thirteen patients had gastric cancer and ten patients had rectal or rectosigmoid junction tumors. The most effective imaging sequence was a spin-echo T1.w. After oral intake of milk a good contrast of the stomach, with sufficient distribution in the duodenum and the very proximal bowel, was achieved in all 13 patients with gastric cancer, as was a good depiction of the rectum and the recto-sigmoid junction after enema achieved in the 10 patients with rectal cancers. Disadvantages of lyophilized milk as a contrast agent are due to partial intestinal absorption, inhomogeneous distribution and irregular intestinal passage, whereas a clear advantage of lyophilized milk as a contrast agent is its good acceptance and palatable, inexpensive and non invasive properties. Because of these limitations lyophilized milk cannot be considered a real oral contrast medium but it can enhance MR imaging of the upper abdomen, and mainly of the lower GI tract in infants and adults.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Magnetic resonance imaging of tumor cells by targeting the amino acid transport system</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Lattuada</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Demattio</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vincenzi</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Visigalli</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>16</number>
        </detail>
        <detail type="issue">
          <number>15</number>
        </detail>
        <extent unit="pages">
          <start>4111</start>
          <end>4114</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">0960894X (ISSN)</identifier>
      <titleInfo>
        <title>Bioorganic and Medicinal Chemistry Letters</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Bioorg. Med. Chem. Lett.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33745171498&amp;partnerID=40&amp;md5=59595f8098d319d274254eed45e16096</url>
    </location>
    <abstract>An early diagnosis of cancer is crucial in the battle against this disease and the in vivo visualization of tumors at cellular level is still the most challenging goal. In order to target tumor cells, we took into account their increased metabolism and amino acid nutrients or pseudo-nutrients, which are actively transported through the cell membrane, have been chosen as vectors for new MRI contrast agents. For this reason new gadolinium complexes conjugated to agmatine, arginine, and glutamine have been synthesized and studied. © 2006 Elsevier Ltd. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Magnetic resonance imaging visualization of targeted cells by the internalization of supramolecular adducts formed between avidin and biotinylated Gd3+ chelates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Battistini</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Coluccia</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mainero</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tarone</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>10</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>78</start>
          <end>86</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">09498257 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Biological Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Biol. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-12944278751&amp;partnerID=40&amp;md5=ad2390a33db83a7b9c7ae33446e1c557</url>
    </location>
    <abstract>The high binding affinity between avidin and biotin has been exploited to develop a procedure for magnetic resonance imaging (MRI) visualization of target cells. SHIN3 and PANC1 tumor cell lines have been used as target cells because they possess on their membranes galactosyl receptors able to bind avidin molecules. Avidin-Gd chelate adducts have been built by using two Gd complexes containing one (Gd-I) and two (Gd-II) biotin residues, respectively. The relaxivities of such supramolecular adducts are significantly higher than those shown by free Gd-I and Gd-II. There is evidence of the occurrence of multilayered adducts in which the bis-biotinylated Gd3+ complex acts as a bridge between adjacent avidin molecules. MRI differentiation of labeled versus unlabeled cells has been attained when approximately 6×10 8 Gd units were internalized in each cell. Furthermore, there is a marked decrease in the measured intracellular T1 relaxivity as the number of internalized Gd complexes increases, probably owing to too short relaxation times of endosomic water protons with respect to their diffusion life-time. © SBIC 2004.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bussolati</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grange</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Esposito</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzardo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Camussi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>66</number>
        </detail>
        <detail type="issue">
          <number>18</number>
        </detail>
        <extent unit="pages">
          <start>9196</start>
          <end>9201</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">00085472 (ISSN)</identifier>
      <titleInfo>
        <title>Cancer Research</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Cancer Res.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33749484037&amp;partnerID=40&amp;md5=0e0f793baaa836d87742f185218c0624</url>
    </location>
    <abstract>Tumor vessel imaging could be useful in identifying angiogenic blood vessels as well as being a potential predictive marker of antiangiogenic treatment response. We recently reported the expression of the neural cell adhesion molecule (NCAM) in the immature and tumor endothelial cell (TEC) lining vessels of human carcinomas. Exploiting an in vivo model of human tumor angiogenesis obtained by implantation of TEC in Matrigel in severe combined immunodeficiency mice, we aimed to image angiogenesis by detecting the expression of NCAM with magnetic resonance imaging. The imaging procedure consisted of (a) targeting NCAMs with a biotinylated derivative of C3d peptide that is known to have high affinity for these epitopes and (b) delivery of a streptavidin/gadolinium (Gd)-loaded apoferritin 1:1 adduct at the biotinylated target sites. The remarkable relaxation enhancement ability of the Gd-loaded apoferritin system allowed the visualization of TEC both in vitro and in vivo when organized in microvessels connected to the mouse vasculature. Gd-loaded apoferritin displayed good in vivo stability and tolerability. The procedure reported herein may be easily extended to the magnetic resonance visualization of other epitopes suitably targeted by proper biotinylated vectors. ©2006 American Association for Cancer Research.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Mannich reaction as a new route to pyridine-based polyaminocarboxylic ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallotti</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>1201</start>
          <end>1204</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">15237060 (ISSN)</identifier>
      <titleInfo>
        <title>Organic Letters</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Org. Lett.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-2542470532&amp;partnerID=40&amp;md5=9e0265eda1f61d7def42bb421ec6acba</url>
    </location>
    <abstract>The Mannich reaction was successfully employed to obtain two pyridine-based ligands 1 and 2. The latter represents the first example of a Mannich reaction leading to a 12-membered pyridine-containing macrocycle.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Maximizing the relaxivity of HSA-bound gadolinium complexes by simultaneous optimization of rotation and water exchange</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Avedano</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lombardi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>45</number>
        </detail>
        <extent unit="pages">
          <start>4726</start>
          <end>4728</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-36148950513&amp;partnerID=40&amp;md5=015e8c8dc91b0b4e56fbf1c6278f2fd9</url>
    </location>
    <abstract>Two new GdEGTA (EGTA = ethylene glycol-bis(2-aminoethylether)-N,N,N′, N′-tetraacetic acid) derivatives incorporating aromatic moieties into the oxoethylenic bridge have been prepared and characterised, their conjugates to HSA investigated and an unprecedented high relaxivity, close to that predicted by theory, interpreted in terms of the combined effect of restricted local rotation and fast rate of water exchange. © The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Mechanism of localized site exchange of carbonyl groups in HM3(CO)9L clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Thorsen</namePart>
      <namePart type="given">C.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>24</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>231</start>
          <end>233</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1985</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-29044444476&amp;partnerID=40&amp;md5=dfeebacdb498bccee754c8c0a0c8e6ed</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Mechanistic and structural studies of electron-deficient quinoline triosmium clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Arcia</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kolwaite</namePart>
      <namePart type="given">D.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hardcastle</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ciurash</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Duque</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrú</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fiedler</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>17</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>415</start>
          <end>426</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-11744303115&amp;partnerID=40&amp;md5=84a9eaa049f86174f73dfcdb974ff5d7</url>
    </location>
    <abstract>Deuterium-labeling experiments on the sequential reactions of the previously reported electron-deficient complexes Os3(CO)9(μ3-η2-C 9H4NRR′)(μ-H)(R = R′ = H, 1a; R = 4-Me, R′ = H, 1b; R = H, R′ = 6-CH3, 1c) with X-/X+ (X = H or D) reveal that initial attack of H- is at the 5-position of the quinoline ring and that the reduction of the C(5)-C(6) double bond to yield Os3(CO)9(μ3-η3-C 9H6RR′N)(μ-H) (2a-c) is not stereoselective. Related experiments with 2a-c reveal that hydride attack at the 7-position is followed by protonation at the metal core to yield Os3(CO)9(μ3-η2-C 9H7RR′N)(μ-H)2 (3a-c). The conversion of 2a to 3a is also achieved by reaction with H2 at 75°C and 100 psi. When this reaction is carried out with excess D2, deuterium incorporation is observed at C(7) and at the metal core, suggesting a concerted, irreversible hydrogen addition or a radical chain reaction. The related 46-electron cluster Os3(CO)9(μ3-η2-C 9H8N)(μ-H) (5) containing a C=N bond in a partially reduced heterocyclic ring, as well as the three-center two-electron bond at C(8), undergoes H- attack at C(2) and not at C(5), as for 1a-c, followed by protonation at the metal core to yield Os3-(CO)9(μ3-η2-C 9H9N)(μ-H)2 (4). Photolysis or thermolysis of the previously reported Os3(CO)9-(μ-η2-(4-Me)C9H 5N)(μ-H)(P(OEt)3) (6b) does not yield the phosphite-substituted 46-electron clusters related to 1a-c but leads only to nonspecific decomposition. Partially selective incorporation of 13CO into 1a-c is observed to yield the corresponding decacarbonyl derivatives, and the pattern of 13CO incorporation helps to elucidate the interconversion of the nona- and decacarbonyl derivatives. The electrochemical behavior of 1a, the dynamical behavior of 2b, and the solid-state structures of 2b, 3a, 5, and 6b are reported.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Metal complexes as allosteric effectors of human hemoglobin: An NMR study of the interaction of the gadolinium(III) bis(m- boroxyphenylamide)diethylenetriaminepentaacetic acid complex with human oxygenated and deoxygenated hemoglobin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoletti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arnelli</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>76</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>2735</start>
          <end>2743</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">00063495 (ISSN)</identifier>
      <titleInfo>
        <title>Biophysical Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Biophys. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032988667&amp;partnerID=40&amp;md5=54a3c41436f72cd24b83a717ee745670</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Metal ion content in Sepia officinalis melanin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Sarzanini</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mentasti</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Abollino</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>39</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>243</start>
          <end>250</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1992</dateIssued>
      </originInfo>
      <identifier type="issn">03044203 (ISSN)</identifier>
      <titleInfo>
        <title>Marine Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Mar. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0003171187&amp;partnerID=40&amp;md5=c4d9b35883aac55a52649184c15b2783</url>
    </location>
    <abstract>A dissolution procedure for the analysis of the metal content in Sepia officinalis melanin has been optimized and checked against a bovine liver Community Bureau of Reference (BCR) certified reference material. The content of several metal ions has been determined by GF-AAS and ICP-AES techniques in samples of Sepia officinalis melanin and the results have been compared with those obtained after a harsh treatment of the melanin with 6 M HCl. Remarkable differences not only on metal distribution but also structural changes induced in the melanin polymer by the acidic treatment have been pointed out and underlined by 13C CPMAS NMR spectroscopy. © 1992.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Methods for an improved detection of the MRI-CEST effect</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stancanello</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanders</namePart>
      <namePart type="given">H.M.H.F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kok</namePart>
      <namePart type="given">M.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>4</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>237</start>
          <end>247</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-71649104936&amp;partnerID=40&amp;md5=0d44178e60e6464effa51e8936662151</url>
    </location>
    <abstract>CEST imaging is a recently introduced MRI contrast modality based on the use of endogenous or exogenous molecules whose exchangeable proton pools transfer saturated magnetization to bulk water, thus creating negative contrast. One of the critical issues for further development of these agents is represented by their limited sensitivity in vivo. The aim of this work is to improve the detection of CEST agents by exploring new approaches through which the saturation transfer (ST) effect can be enhanced. The performance of the proposed methods has been tested in vitro and in vivo using highly sensitive and highly shifted lipoCEST agents, and the results were compared with the standard ST evaluation mode. The acquired Z-spectra were interpolated locally and voxel-by-voxel by smoothing splines. Besides expressing the ST in the standard mode, we explore two methods, enhanced and integral ST, which better exploit all the information contained in the Z-spectrum. By combining different modes for ST assessment a significant improvement in the detection of the lipoCEST agents, both in vitro and in vivo, has been found. The results obtained from the application of the proposed methods outline the importance of post-processing analysis for highlighting the CEST-MRI contrast. Copyright © 2009 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Modulation of the prototropic exchange rate at the water molecule coordinated to a GdIII ion</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kostakis</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Plakatouras</namePart>
      <namePart type="given">I.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hadjiliadis</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>2045</start>
          <end>2048</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">14341948 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037596568&amp;partnerID=40&amp;md5=168ab53fd4b5d886511ca5bd12dc330a</url>
    </location>
    <abstract>The aim of this work is to assess whether it is possible to control the rate of the prototropic exchange in a class of DTPA bis-amide GdIII complexes. © Wiley-VCH Verlag GmbH &amp; Co. KGaA, 69451 Weinheim, Germany, 2003.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Modulation of the water exchange rates in [Gd-DO3A] complex by formation of ternary complexes with carboxylate ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bruce</namePart>
      <namePart type="given">J.I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mainero</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>115</start>
          <end>116</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035819379&amp;partnerID=40&amp;md5=71b2b76a346d94aa25989af65ca06edd</url>
    </location>
    <abstract>Ternary complexes of formula [Gd-DO3A-L-(H20)] (where L is a carboxylate-containing ligand) display exchange lifetimes of the metal-coordinated water that can be modulated as a function of L.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Molecular dynamics simulation of [Gd(egta)(H2O)]- in aqueous solution: Internal motions of the poly(amino carboxylate) and water ligands, and rotational correlation times</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Yerly</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hardcastle</namePart>
      <namePart type="given">K.I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Helm</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Merbach</namePart>
      <namePart type="given">A.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>8</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>1031</start>
          <end>1039</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0036501596&amp;partnerID=40&amp;md5=b9484166dbaff28628c0427de818aa28</url>
    </location>
    <abstract>Molecular dynamics simulations of [Gd(egta)(H2O)]- (egta4-= 3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioate(4-)) have been performed without any artificial constraint on the first coordination sphere, such as covalent bonds between the Gd3+ and the coordination sites. Two new crystallographic structures were determined for this gadolinium chelate and used to start two molecular dynamics simulations. [Gd(egta)(H2O)]- and [Gd(egta)]- were both observed during the simulations, with a mean volume for the reaction of dissociation [Gd(egta)(H2O)]- → [Gd(egta)]- + H2O of +7.2cm3 mol-1, which corroborates the previously published experimental value of +10.5 cm3 mol-1. Changes in the conformation of the complex with the inversion of several dihedral angles are observed in the simulations independently from the water dissociation. Very fast changes of the third-order rotation axis direction of the Gd3+ coordination polyhedron (of symmetry D3h) are observed during the simulations and are related to the mechanism of electronic relaxation of the complex. Different rotational correlation times (τR) were calculated from the simulations on various observables of the complex. Protons of the inner sphere have different τR. The mean τR of the two Gd-HW (HW = hydrogen of water molecule) vectors is 72% lower than τR of the complex, and 75% lower than τR of the vector Gd-OW (OW = oxygen of water molecule). This discrimination of the tumbling rates should be taken into account in future global 17O NMR, EPR and NMRD (nuclear magnetic relaxation dispersion) data analysis.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Molecular recognition of R- and T-states of human adult hemoglobin by a paramagnetic Gd(III) complex by means of the measurement of solvent water proton relaxation rate</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Comoglio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoletti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>117</number>
        </detail>
        <detail type="issue">
          <number>36</number>
        </detail>
        <extent unit="pages">
          <start>9365</start>
          <end>9366</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. AM. CHEM. SOC.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0029121776&amp;partnerID=40&amp;md5=719ceb39a9a29781d31d2365c81631e7</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Molecular recognition of sugars by lanthanide (III) complexes of a conjugate of N,N-bis[2-[bis[2-(1, 1-dimethylethoxy)-2-oxoethyl]amino]ethyl]glycine and phenylboronic acid</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Battistini</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mortillaro</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Peters</namePart>
      <namePart type="given">J.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>2</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>163</start>
          <end>171</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-35148842024&amp;partnerID=40&amp;md5=c25365bc81e9a09ba2ace8e0b17fadb2</url>
    </location>
    <abstract>A novel conjugate of phenylboronic acid and an Ln(DTPA) derivative, in which the central acetate pendant arm was replaced by the methylamide of L-lysine, was synthesized and characterized. The results of a fit of variable 17O NMR data and a 1H NMRD profile show that the water residence lifetime of the Gd(III) complex (150 ns) is shorter than that of the parent compound Gd(DTPA)2- (303 ns). Furthermore, the data suggest that several water molecules in the second coordination sphere of Gd(III) contribute to the relaxivity of the conjugate. The Ln(III) complexes of this conjugate are highly suitable for molecular recognition of sugars. The interaction with various sugars was investigated by 11B NMR spectroscopy. Thanks to the thiourea function that links the phenylboronic acid targeting vector with the DTPA derivative, the interactions are stronger than that of phenylboronic acid itself. In particular, the interaction with N-propylfructosamine, a model for the glucose residue in glycated human serum albumin (HSA), is very strong. Unfortunately, the complex also shows a rather strong interaction with hexose-free HSA (KA = 705 ± 300) Copyright © 2007 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Molecular structures and dynamic behaviour of two isomers of [Ru3(μ-H)-(μ3-Me2NC4H 4)(CO)9] formed from 1-dimethylaminobut-2-yne and containing η2-alkene-1,3-diyl and η2-alkene-1,2-diyl ligands respectively</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deeming</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arce</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hursthouse</namePart>
      <namePart type="given">M.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dawes</namePart>
      <namePart type="given">H.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1459</start>
          <end>1463</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1986</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049083770&amp;partnerID=40&amp;md5=b43fef9e2eaab6347650fbb67d9407fa</url>
    </location>
    <abstract>Single-crystal X-ray structures of the isomeric compounds [Ru3(μ-H) (μ3-MeC=CCH=NMe2)(CO)9] (1) and [Ru3(μ-H)(μ3-MeC=CHC=NMe2)(CO) 9] (2), both prepared from [Ru3(CO)12] and the aminoalkyne MeC≡CCH2NMe2, have been determined. Isomer (1) formally contains the μ3-η2-alkyne MeC≡CCH=N+ Me2 which requires the associated negative charge of the zwitterion to be located at the ruthenium atoms. 13C N.m.r. spectra reveal localised dynamic exchange of axial and equatorial CO ligands at Ru atoms and these processes together with a rotation of the μ3-alkyne lead to a single 13CO n.m.r. signal at +90 °C. The isomer (2) formed by heating (1), contains two 1,3-related Ru-C σ bonds and a η2-alkene group. Although there is localised axial-equatorial CO exchange at two of the three Ru atoms, no μ3 ligand rotation is observed in this case.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>MR "in vivo" preclinical molecular and cellular imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Geninatti-Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzardo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Alberti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>21</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>111</start>
          <end>121</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">11204826 (ISSN)</identifier>
      <titleInfo>
        <title>Minerva Biotecnologica</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Minerva Biotecnol.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-70350049942&amp;partnerID=40&amp;md5=bc10134430212f1e17fc99a792a866e8</url>
    </location>
    <abstract>In respect to other molecular imaging modalities such as PET or SPECT, the low sensitivity is the main limitation of the Magnetic Resonance-Molecular Imaging (MRMI) approach. To overcome this limitation the imaging probe for MRMI applications must identify the target with high specificity and should provide sufficientiy intense signal enhancement within the imaged volume to be easily distinguishable from un-enhanced tissue. Therefore, the success of a MRMI protocol strongly relies on the amplification effects associated to the accumulation of the agents at the cells of interest. A general route to get this goal consists of using nano-sized systems such as liposome, micelles, microemulsions, polymers etc... able to carry a huge payload of Gd complexes. A straightforward extension of this approach involves the use of naturally occurring nanosized aggregates such as apoferritin and lipoproteins (LDL, HDL). The nanocarriers are then functionalized with the suitable vectors that provide the overall particles with the required recognition capabilities towards the selected cellular target. MRI, with its high spatial resolution is also the technique of choice for the visualization of grafted cells (i.e. stem cells, pancreatic inside, T cells, etc.) in cell-based therapies. Examples of labeling strategies with MRI contrast agents are reported.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>MRI contrast agents: Macrocyclic lanthanide(III) complexes with improved relaxation efficiency</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Jommi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>18</number>
        </detail>
        <extent unit="pages">
          <start>1885</start>
          <end>1886</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">00224936 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society - Series Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. CHEM. SOC. SER. CHEM. COMMUN.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0029147152&amp;partnerID=40&amp;md5=ac73bf4f5a432430709fe19f29b1f686</url>
    </location>
    <abstract>Lanthanide(III) complexes of a novel heptadentate chelating ligand display structural and dynamic properties that are particularly interesting in view of potential applications in magnetic resonance imaging (MRI).</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Geninatti-Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Alberti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Szabo</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deagostino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Toppino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ballarini</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bortolussi</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bruschi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Protti</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stella</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Altieri</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Venturello</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>17</number>
        </detail>
        <detail type="issue">
          <number>30</number>
        </detail>
        <extent unit="pages">
          <start>8479</start>
          <end>8486</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79960316458&amp;partnerID=40&amp;md5=420177799792d5c485e6de1c478d9b76</url>
    </location>
    <abstract>The upregulation of low-density lipoprotein (LDL) transporters in tumour cells has been exploited to deliver a sufficient amount of gadolinium/boron/ ligand (Gd/B/L) probes for neutron capture therapy, a binary chemio-radiotherapy for cancer treatment. The Gd/B/L probe consists of a carborane unit (ten B atoms) bearing an aliphatic chain on one side (to bind LDL particles), and a GdIII/1,4,7,10-tetraazacyclododecane monoamide complex on the other (for detection by magnetic resonance imaging (MRI)). Up to 190Gd/B/L probes were loaded per LDL particle. The uptake from tumour cells was initially assessed on cell cultures of human hepatoma (HepG2), murine melanoma (B16), and human glioblastoma (U87). The MRI assessment of the amount of Gd/B/L taken up by tumour cells was validated by inductively coupled plasma-mass-spectrometric measurements of the Gd and B content. Measurements were undertaken in vivo on mice bearing tumours in which B16 tumour cells were inoculated at the base of the neck. From the acquisition of magnetic resonance images, it was established that after 4-6hours from the administration of the Gd/B/L-LDL particles (0.1 and 1mmol kg-1 of Gd and 10B, respectively) the amount of boron taken up in the tumour region is above the threshold required for successful NCT treatment. After neutron irradiation, tumour growth was followed for 20days by MRI. The group of treated mice showed markedly lower tumour growth with respect to the control group. Copyright © 2011 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Multinuclear and multifrequency NMR study of gadolinium(ni) complexes with bis-amide derivatives of ethylenedioxydiethylene-dinitrilotetraacetic acid</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Frullano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Merlo</namePart>
      <namePart type="given">U.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hardcastle</namePart>
      <namePart type="given">K.I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>19</number>
        </detail>
        <extent unit="pages">
          <start>3435</start>
          <end>3440</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">1470479X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Chem. Soc. Dalton Trans.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0002964735&amp;partnerID=40&amp;md5=11b504dc1379c4ec560e33bdcfa26cc9</url>
    </location>
    <abstract>New cationic gadolinium complexes have been synthesized and their 'H and 17O relaxometric properties investigated in view of their possible use as MRI contrast agents. The reaction of the bicyclic anhydride of ethylenedioxydiethylenedinitrilotetraacetic acid (H4egta) with NH3, isobutylamine and phenylpropylamine gave the octadentate bis-amide ligands 1-3 in high yields. The gadolinium(in) complexes were prepared from GdClj and the acid form of the ligands. The stability constants of the complexes were obtained from potentiometric data and are about five orders of magnitude lower than for the parent [Gd(egta)]~ complex. The magnetic field dependence of the proton relaxivity at 6, 25 and 39 °C was quantitatively analysed in order to obtain the relaxation parameters and indicated that one water molecule occupies a site of the co-ordination sphere of the complexes. The temperature dependence of the relaxivity, measured at 20 MHz, suggested that the water exchange rate, A- = I/TM, is sensibly reduced compared to that of the parent compound. "O NMR data were acquired at 2.1 T and allowed an accurate estimation of TM which, at 298 K, resulted to be 230, 133 and 211 ns for Gd-1, Gd-2 and Gd-3 respectively. The two complexes bearing hydrophobic residues on the amide nitrogens form non-covalent adducts with serum albumin whose relaxivity is limited by the water exchange rate. © The Royal Society of Chemistry 2000.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Multinuclear magnetic resonance studies. I. Tetramethyldiphosphine-13C</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Harris</namePart>
      <namePart type="given">R.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>13</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>236</start>
          <end>238</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1974</dateIssued>
      </originInfo>
      <identifier type="issn">00222364 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance (1969)</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4243145938&amp;partnerID=40&amp;md5=37b94ffde9643c8fa86200cb1e24fae8</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Multinuclear magnetic resonance studies. Part 2. Diphosphanes and dithioxodi-λ5-phosphanes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Harris</namePart>
      <namePart type="given">R.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">McVicker</namePart>
      <namePart type="given">E.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fild</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>21</number>
        </detail>
        <extent unit="pages">
          <start>2144</start>
          <end>2153</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1976</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049103383&amp;partnerID=40&amp;md5=6e031c1b78f07155c34406f400af05af</url>
    </location>
    <abstract>Carton-13 and phosphorus-31 n.rn.r. spectra have been obtained for a number of tetra-alkyldiphosphanes and tetra-alkyldithioxodi-λ5- phosphanes of general formulae (R1R2P)2 and [R1R2(S)]2 respectively. Some analogous compounds with phenyl substituents have also been studied. Satellite resonances in 31P resonance due to 13C-containing isotopomers have been examined. The data are treated, together with 1H n.m.r. studies where appropriate, to obtain (P,P) and (P,C) coupling constants, as well as 13C and 31P chemical shifts. These n.m.r. parameters are discussed in terms of steric interactions and stereoisomerism. The values of |1Jpp| for both series of compounds increase markedly as the size of the substituents increases. and this effect correlates with an increase in δp.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Multinuclear n.m.r. studies of transition metal carbonyl clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>62</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>51</start>
          <end>56</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1982</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-26344449425&amp;partnerID=40&amp;md5=be452b575fd2e08daa71f0922600c16b</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Network of excellence: European Molecular Imaging Laboratories - European network for molecular imaging of cancer</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Carpusca</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mergui</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Jacobs</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Löwik</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>297</number>
        </detail>
        <extent unit="pages">
          <start>59</start>
          <end>62</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">02943506 (ISSN)</identifier>
      <titleInfo>
        <title>Biofutur</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Biofutur</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-62949220957&amp;partnerID=40&amp;md5=7a07d27e9759b3cdb2d3983842887541</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Neural-cell adhesion molecule (NCAM) expression by immature and tumor-derived endothelial cells favors cell organization into capillary-like structures</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Bussolati</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grange</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bruno</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Buttiglieri</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deregibus</namePart>
      <namePart type="given">M.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Camussi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>312</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>913</start>
          <end>924</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">00144827 (ISSN)</identifier>
      <titleInfo>
        <title>Experimental Cell Research</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Exp. Cell Res.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33644926386&amp;partnerID=40&amp;md5=fb139c37e108745a2fe023e329da418e</url>
    </location>
    <abstract>The neural cell adhesion molecule (NCAM) is widely expressed during embryogenesis, down-regulated in the course of differentiation to be re-expressed during progression of some tumors. We here found that renal tumor-derived endothelial cells (TEC) but not normal endothelial cells (HMEC) expressed NCAM. In TEC, NCAM expression was regulated by the renal embryonic transcription factor PAX2, as transfection with PAX2 antisense abrogated NCAM expression. NCAM stimulation with an agonistic synthetic NCAM peptide enhanced apoptosis resistance and increased ability of TEC to organize in vessel-like structures. The angiogenic effect of NCAM peptide was, at least in part, mediated by the association of NCAM and FGFR1. HMEC transiently acquired NCAM when organized in vessel-like structures after VEGF stimulation or when transfected with PAX2 gene. During the process of VEGF-induced endothelial differentiation of renal stem cells and of circulating endothelial progenitors, NCAM was transiently expressed to disappear at complete endothelial maturation. Targeting NCAM with a saporin-conjugated peptide induced a cytotoxic effect on TEC but not on HMEC. In conclusion, we identified a new role of NCAM in tumor neo-angiogenesis relevant for endothelial cell organization into capillary-like structures. In addition, we found that NCAM expression was associated with an immature phenotype of endothelial cells. © 2005 Elsevier Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>New CD derivatives as self-assembling contrast agents for magnetic resonance imaging (MRI)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Robaldo</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>57</number>
        </detail>
        <detail type="issue">
          <text>1-4</text>
        </detail>
        <extent unit="pages">
          <start>489</start>
          <end>495</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">09230750 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Inclusion Phenomena and Macrocyclic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Incl. Phenom. Macrocyclic Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34047126265&amp;partnerID=40&amp;md5=ee021849f50143f432757cb6cd736295</url>
    </location>
    <abstract>A way to improve Magnetic Resonance Imaging is to deliver a larger number of Imaging Probe units to the target site. Aiming at this objective, we prepared a self-assembling system consisting of: 1) a β-cyclodextrin (β-CD) bearing a covalently bonded Gd complex (DTPA-Lys); 2) a polypeptide containing a high percentage of tyrosine residues (PLT); 3) a second β-CD derivative bearing a covalently bonded peptide vector (CCK8) that can recognize a specific cell-membrane receptor. Both β-CD derivatives can form stable inclusion complexes with the aromatic moieties of the polypeptide. The formation of a supramolecular adduct having a long reorientational correlation time entailed a marked relaxivity increase (per Gd3+ ion), which recommends it as a promising model for detail enhancement procedures at the target site. Out of three different synthetic pathways that could be used for binding a CD to DTPA, the most convenient one involved a micro-wave(MW)-assisted Mannich aminomethylation of a monopropargyl β-CD by the primary amino group of t-butyl-DTPA-Lys. © 2007 Springer Science+Business Media, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>New cyclodextrin dimers and trimers capable of forming supramolecular adducts with shape-specific ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arena</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Martina</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Heropoulos</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>370</start>
          <end>379</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">14770520 (ISSN)</identifier>
      <titleInfo>
        <title>Organic and Biomolecular Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Org. Biomol. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-58049134934&amp;partnerID=40&amp;md5=cd113b20833b8bc21623aef4d5954f4f</url>
    </location>
    <abstract>Bridged cyclodextrin dimers and trimers, in which respectively two and three hydrophobic cavities lie in close proximity, display much higher binding affinities and molecular selectivities than do parent cyclodextrins (CDs). By joining βCD units with links inserted at different positions (2-2′, 3-2′, 6-2′ or 6-2′-6″) and interposing spacers of different lengths and shapes, multicavity structures can be synthesized that are precisely tailored to fit specific guest molecules. This enzyme-mimicking strategy can also be used to generate stable supramolecular adducts. A series of CD dimers and trimers was prepared in good yields by carrying out the critical synthetic steps under power ultrasound (US) or microwave (MW) irradiation. Starting from azide and acetylenic CD derivatives, we exploited an efficient MW-promoted Huisgen 1,3-dipolar cycloaddition in the presence of Cu(I) salts. The resulting bridged CD derivatives gave stable adducts with magnetic-resonance-imaging contrast agents (MRI CAs) containing gadolinium(III) chelates. These inclusion complexes were found to be 2 to 3 orders of magnitude more stable than those formed by βCD and to be endowed with high relaxivity values. © 2009 The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>New hyperpolarized contrast agents for 13C-MRI from para-hydrogenation of oligooxyethylenic alkynes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Santelia</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>130</number>
        </detail>
        <detail type="issue">
          <number>45</number>
        </detail>
        <extent unit="pages">
          <start>15047</start>
          <end>15053</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-57349183131&amp;partnerID=40&amp;md5=125972452c752c814068a4e5d37463c0</url>
    </location>
    <abstract>Two alkyne derivatives, which contain one and two oligooxyethylenic chains respectively, showed to be good substrates for para-hydrogenation reactions, yielding the corresponding hyperpolarized alkenes in good yields. A suitable theory has been developed to account for the observed results, fully explaining the different para-H2 induced effects observed upon the para-hydrogenation of symmetrically and asymmetrically substituted alkynes in ALTADENA and PASADENA modes. The oligooxyethylenic substituent provides good water solubility to the para-hydrogenated symmetrical derivative. 13C-MR in vitro images of the latter derivative were obtained both in acetone and in water solutions (130 mM), using the ALTADENA procedure and after application of the field cycling procedure which allows acquisition of an in-phase 13C carbonyl resonance. The finding that the hydrogenated product is water-soluble in contrast to the parent alkyne which is not allows for the pursuit of a fast phase-transfer separation from the organic solvent, the unreacted substrate, and the catalyst to obtain a "ready-to-use" water solution suitable for further in vivo MRI applications. © 2008 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>New insights for pursuing high relaxivity MRI agents from modelling the binding interaction of GdIII chelates to HSA</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lovazzano</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>818</start>
          <end>820</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">14394227 (ISSN)</identifier>
      <titleInfo>
        <title>ChemBioChem</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>ChemBioChem</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-21044444021&amp;partnerID=40&amp;md5=a8ebb409d4eedd9058e5582bbdc16d84</url>
    </location>
    <abstract>Sticking out. This work is aimed at obtaining new insights into the design of novel Gd chelates that form high-affinity adducts with HSA. Two new Gd III complexes that differ in the size of the hydrophobic moiety responsible for the interaction with the protein have been synthesised. It was shown that the two complexes protrude to a different extent from the surface of the protein (see picture), and this difference has an effect on the exchange of the coordinated water molecule. © 2005 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>New paramagnetic supramolecular adducts for MRI applications based on non-covalent interactions between Gd(III)-complexes and β- or γ-cyclodextrin units anchored to chitosan</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tagliapietra</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>100</number>
        </detail>
        <detail type="issue">
          <text>5-6</text>
        </detail>
        <extent unit="pages">
          <start>931</start>
          <end>938</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">01620134 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Inorganic Biochemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Inorg. Biochem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33646156401&amp;partnerID=40&amp;md5=2fcb64d709c51249f2f31d556df06b8e</url>
    </location>
    <abstract>Gd(III) complexes are used as magnetic resonance imaging (MRI) contrast agents because they greatly enhance the relaxation rate of water protons of tissues in which they distribute, an effect that is much more marked if the paramagnetic complex is part of a macromolecular system. Furthermore applications in molecular imaging, require that as many units of contrast agent as possible be directed to the site of interest. To this end we synthesised a polymer made of chitosan functionalized with β- and γ-cyclodextrins (CDs) that is able to form high-affinity adducts with suitably functionalized Gd(III) complexes. β- and γ-CDs were first treated with maleic anhydride to afford 6-monosubstituted derivatives that reacted regioselectively with the amino groups of chitosan. Reaction times and yields were markedly improved by carrying out these reactions under high-intensity ultrasound or microwave irradiation. Compared to the CD monomers, β- and γ-CD-chitosan adducts show large increases both in terms of their binding affinity towards Gd(III) complexes and in relaxivity values and they appear promising carriers for the in vivo vehiculation of Gd(III) complexes. © 2005 Elsevier Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Nitrogen derivatives of iron carbonyls. Part 5. New routes in the mechanism of reaction of dodecacarbonyl-triangulo-tri-iron with nitro-alkanes, and X-ray analysis of μ-[acetone oximato(1-)-NO]-μ-isopropyl-amido-bis(tricarbonyliron) (Fe-Fe)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gervasio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rossetti</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stanghellini</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>534</start>
          <end>540</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1978</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049109410&amp;partnerID=40&amp;md5=92779cc42ab3b233e0a207d9c0f3d0e7</url>
    </location>
    <abstract>The reaction of [Fe3(CO)12] with RNO2 (R = Et or Pri) gives, among complexes of well known structures, many other iron-nitrogen-carbonyl complexes which are indicative of novel reaction paths, such as reduction of a nitro-to a nitroso-group, hydrogen abstraction, and N-C bond breakage. The complexes have been fully characterized by means of i.r., mass, and 1H and 13C n.m.r. spectroscopy. The crystal structure of the title complex has been determined by X-ray diffractometry from 2 446 reflections (R 0.037). Crystals are triclinic, space group P1, with Z = 2 in a unit cell of dimensions a = 12.008(5), b = 9.827(4), c = 8.580(4), Å, α = 120.53(4), β = 99.29(1), and γ = 96.80(1)°. The structure consists of two Fe(CO)3 units linked by an Fe-Fe bond and doubly bridged by the nitrogen of the isopropylamido-ligand and the nitrogen and oxygen of the oximato-ligand. The n.m.r. study shows the presence of a substantial torsional barrier about the N-Fe and N-O bonds and localized carbonyl interchange. © Copyright 1978 by The Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR and luminescence studies on the formation of ternary adducts between HSA and Ln(III)-malonate complexes (Ln=Eu, Gd, Tb)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bettinelli</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ferrari</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Razzano</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1385</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>7</start>
          <end>16</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">01674838 (ISSN)</identifier>
      <titleInfo>
        <title>Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Biochim. Biophys. Acta Protein Struct. Mol. Enzymol.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0031806232&amp;partnerID=40&amp;md5=0fbbde1252e5f10e58122d71b8a44bdc</url>
    </location>
    <abstract>At physiological pH and in the presence of an excess of malonate ligand (MAL), the lanthanide ions (Ln=Eu(III), Gd(III) and Tb(III)) are under the form of [Ln(MAL)2(H2O)4]-. Upon addition of human serum albumin (HSA), formation of two different ternary adducts of stoichiometry HSA-Ln(MAL)(x)(H2O)(q) (x=2, q=2; x=2, q=4) is detected. On the basis of the reasonable assumption that the binding strength for the two sites on the protein are inversely proportional to the hydration state of the metal ion, stability constants of 4.0.103 M-1 and 3.5.102 M-1 have been evaluated for the system with q=2 and q=4, respectively. Whereas for the stronger binding site it is suggested that the protein provides two or three donor atoms to the coordination cage of the Ln(III) ion, in the case of the weaker binding site it is likely that it corresponds to a simple electrostatic interaction between the negatively charged [Ln(MAL)2(H2O)4]- and positively charged groups on the surface of the protein. Copyright (C) 1998 Elsevier Science B.V.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR characterization of four new isomers of H(μ-H)Os3(CO)10(phosphine)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valls</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <text>275-276</text>
        </detail>
        <extent unit="pages">
          <start>521</start>
          <end>527</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000330966&amp;partnerID=40&amp;md5=23655eadcdbb1ab05f144a08eacce423</url>
    </location>
    <abstract>An investigation of the low temperature reaction of H2Os3(CO)10 with phosphines afforded four novel isomeric derivatives of the H(μ-H)Os3(CO)10(phosphine) adduct in addition to the previously reported one. Their structures have been suggested on the basis of 1H, 13C and 31P NMR data. They represent the kinetically favoured isomers which slowly transform into the most thermodynamically stable derivative containing the phosphine ligand trans to an Os-Os bond and cis to the bridging hydride. In some cases it has been possible to measure the rate of disappearance of these adducts at different temperatures from which an estimation of the activation energies associated with their transformation to the final product has been obtained. The results herein reported show that the phosphine may occupy either axial and equatorial sites at the osmium bearing the bridging hydride and, in the case of the PPh3 derivative, an equatorial site at the osmium bearing the terminal hydride as well. Thus, five of the 11 theoretically possible isomers of H(μ-H)Os3(CO)10(phosphine) have been detected and characterized. © 1998 Elsevier Science S.A. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR conformational analysis of antide, a potent antagonist of the gonadotropin releasing hormone</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bracco</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barbero</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chicco</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Del Curto</namePart>
      <namePart type="given">M.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Esposito</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Traversa</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>124</number>
        </detail>
        <detail type="issue">
          <number>13</number>
        </detail>
        <extent unit="pages">
          <start>3431</start>
          <end>3442</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037012402&amp;partnerID=40&amp;md5=2a8c9389faa3c6917253a99cd7edeeb3</url>
    </location>
    <abstract>Antide is a decapeptide [(N-Ac-D-Nal1-D-Cpa2-D-Pal3-Ser 4-Lys(Nic)5-D-Lys(Nic)6-Leu7 -Ilys8-Pro9-D-Ala10-NH2] that acts in vivo as an antagonist of GnRH (gonadotropin-releasing hormone). The conformational behavior of antide has been studied in water, TFE, DMF, and DMSO solutions by means of 2D-NMR spectroscopy and molecular dynamics calculations. Antide adopts in aqueous solution a δ-shaped backbone conformation, which is characterized by an irregular turn around residues D-Pal3-Ser4 and by the close spatial proximity of the side chains belonging to D-Nal1 and Ilys8 (as many as 17 NOE peaks were detected between these side chains). The side-chain protons of Ilys8 (especially the Hγ ones) present remarkably upfield shifted resonances, because of ring current effects induced by the naphthyl moiety. The upfield shifted resonances of the Ilys8 Hγ hydrogen atoms are strictly characteristic of the water δ-shaped conformation and can be considered as structure markers. The observation of ring current shifted Ilys8 Hγ resonances under different conditions (temperature, pH, solvent) indicates a remarkable stability of the water δ-shaped conformation. Such a conformation is at least partially disrupted in solvent mixtures containing high percentages of organic solvents. TFE can induce a well-defined conformation, which is characterized by an S-shaped backbone conformation. In DMF and DMSO solution, the molecule is basically endowed with a random coil conformation and high fluxionality. Antide fulfills the conformational requirements that are known to play a crucial role in receptor recognition, namely (i) the presence of a turn in the backbone and (ii) the all-trans nature of peptide bonds. In addition, the structural rigidity of antide likely adds a further contribution to the receptor binding affinity.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR conformational study of the lanthanide(III) complexes of DOTA in aqueous solution</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Marques</namePart>
      <namePart type="given">M.P.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geraldes</namePart>
      <namePart type="given">C.F.G.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sherry</namePart>
      <namePart type="given">A.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Merbach</namePart>
      <namePart type="given">A.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Powell</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pubanz</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>225</number>
        </detail>
        <detail type="issue">
          <text>1-2</text>
        </detail>
        <extent unit="pages">
          <start>303</start>
          <end>307</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">09258388 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Alloys and Compounds</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J Alloys Compd</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001692211&amp;partnerID=40&amp;md5=b76f663cca77f4c4d9d2eda9c3b111ad</url>
    </location>
    <abstract>Variable temperature NMR spectroscopy studies of lanthanide(III) complexes with 1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid (DOTA) provide evidence of the presence of two isomeric forms in aqueous solution. An NMR study was performed in order to gain structural information on the two isomeric species, using a fitting procedure of calculated to experimental dipolar contributions to the paramagnetic shifts. The two isomers show to have identical macrocyclic ring conformations and differ only in the coordination or orientation of the acetate arms of the ligand, yielding either square prismatic and square anti-prismatic coordination geometries, or octadentate and heptadentate coordinations of the ligand relative to the lanthanide ion. Analysis of the dipolar shifts is consistent with both types of acetate conformational equilibria. © 1995.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR evidence for interconversion between two enantiomeric forms of macrocyclic Schiff base lanthanide(III) complexes through reversible ring contraction and expansion</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casellato</namePart>
      <namePart type="given">U.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tamburini</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vigato</namePart>
      <namePart type="given">P.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>34</number>
        </detail>
        <detail type="issue">
          <number>23</number>
        </detail>
        <extent unit="pages">
          <start>5825</start>
          <end>5831</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001143536&amp;partnerID=40&amp;md5=d0313db31c4206c667161762ed10bde6</url>
    </location>
    <abstract>Macrocyclic Schiff base lanthanide(III) complexes, [Ln(H2LA)(NO3)2](NO3) (Ln = Y3+, La3+, Nd3+, Sm3+, Eu3+, Ho3+, Yb3+, Lu3+), have been prepared by cyclocondensation of 2,6-diformyl-4-chlorophenol and 1,5-diamino-3-azapentane, in the presence of the appropriate metal nitrate as templating agent. In these complexes the metal ion occupies only one coordination site of the compartmental ligand, as evidenced by the X-ray structure of [Y(H2LA)(NO3)2](NO3). Crystals of this complex, grown from a dimethylformamide/diethyl ether solution, are monodinic, space group C2/c [No. 15], with cell constants a = 23.717(8) Å, b = 14.651(7) Å, c = 19.019(7) Å, and β = 91.97(5)° for Z = 8. The yttrium atom is nine-coordinated, in a distorted tricapped trigonal prism environment formed by two bidentated nitrate groups and five donor atoms (two phenolic oxygens and three nitrogens) of the cyclic Schiff base H2LA. The third nitrate group is ionic. Metal-ligand interatomic distances: Y-O (nitrate), 2.48 Å (mean); Y-O (phenolic), 2.25 Å (mean). Variable-temperature proton and carbon NMR spectra of the diamagnetic Y(III), La(III), and Lu(III) complexes provide clear evidence for a novel chemical exchange process consisting of the reversible formation and breaking of an imidazole ring formed by the intramolecular nucleophilic attack of a secondary amino group at the imino carbon of a neighboring azomethine group. This dynamic process may be envisaged as a racemization of the enantiomeric forms of the structure found in the solid state. The basicity of the solvent appears to have a pronounced effect on the rearrangement rate. A direct role of the solvent is suggested in the N-H bond activation. The proton NMR spectra of the paramagnetic complexes [Ln(H2LA)(NO3)2](NO3) (Ln = Nd3+, Sm3+, Eu3+, Ho3+, Yb3+) are consistent with the solution structure and dynamics found for the diamagnetic derivatives. © 1995 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR evidence of a long exchange lifetime for the coordinated water in Ln(III)-bis(methyl amide)-DTPA complexes (Ln = Gd, Dy)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoletti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Virtuani</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>33</number>
        </detail>
        <detail type="issue">
          <number>21</number>
        </detail>
        <extent unit="pages">
          <start>4707</start>
          <end>4711</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1994</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001708517&amp;partnerID=40&amp;md5=0492e9e29580721a53d1a861f596a347</url>
    </location>
    <abstract>The magnetic field dependence of the water proton longitudinal relaxation rate for the paramagnetic complex Gd-BMA-DTPA has been measured and analyzed at different temperatures. Interestingly we have found that the solvent relaxivity is largely affected by the residence lifetime (τM) of the water molecule in the coordination site on the metal chelate. The calculated values for τM at 298 K is 0.81 μs, i.e. 4-fold longer than the values recently reported for Gd-DTPA and much longer than the values commonly assumed in the analysis of NMRD profiles of poly(amino carboxylate) complexes. This result has been also confirmed by an alternative approach for the structurally analogous Dy(III) complex. In this latter case, from the measurement of the paramagnetic contribution to 1H NMR chemical shift and transverse relaxation rate of the solvent water protons, we evaluated the residence lifetime τM by solving iteratively the Swift-Connick equations. © 1994 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR relaxometric investigation on human methemoglobin and fluoromethemoglobin. An improved quantitative in vitro assay of human methemoglobin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoletti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arnelli</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>33</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>827</start>
          <end>831</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>MAGN. RESON. MED.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0029065752&amp;partnerID=40&amp;md5=0a06a9cb5c7bc1c960ff7fcb298b438e</url>
    </location>
    <abstract>Longitudinal water proton relaxation rates of methemoglobin solutions show a strong dependence on temperature and pH. The increase of the relaxation rates with temperature is associated with shortened exchange lifetime of the coordinated water molecule. An accurate measurement of the relaxation rate of methemoglobin solutions thus requires careful control of the experimental temperature. This observation prompted the authors to look for an improved version of the relaxometric in vitro determination of methemoglobin. The method is based on transforming methemoglobin into the corresponding fluoromethemoglobin derivative, which shows both a higher relaxivity and a negligible dependence on temperature. The proposed method has been found to be in good agreement with data from spectrophotometric assays.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Morel</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ugazio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gasco</namePart>
      <namePart type="given">M.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>45</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>157</start>
          <end>163</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">09396411 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Pharmaceutics and Biopharmaceutics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Pharm. Biopharm.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0031960549&amp;partnerID=40&amp;md5=f6b17f9c6dd1f8d48b73d5d19bab5937</url>
    </location>
    <abstract>This work deals with the preparation and relaxometric investigations of solid lipid nanoparticles (SLN) containing [Gd-DTPA(H2O)]2- and [Gd-DOTA(H2O)]-. These paramagnetic chelates are commonly used as contrast agents (CA) for magnetic resonance imaging (MRI) owing to their ability to strongly increase the tissue water proton relaxation rate. The amount of gadolinium(III) (Gd(III)) complex included in the SLN has been evaluated and, on this basis, it has been found that the longitudinal relaxivity of these Gd(III) chelates apparently does not vary, at physiological pH, following their inclusion in SLN. We are unable to establish whether this is due to the free exchange of water from the inner compartment containing the Gd(III) chelate to the bulk water or whether the observed relaxation rate is essentially determined by a fraction of the complex which is close to the surface of the SLN in a region easily accessible to the bulk water. At acidic pH values, the relaxivity of the paramagnetic SLN containing the less thermodynamically and kinetically stable [Gd-DTPA(H2O)]2- markedly increases. This effect may be ascribed to an increased immobilization and/or to an enhanced hydration of the complex on SLN.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR relaxometric studies of Gd(III) complexes with heptadentate macrocyclic ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>36</number>
        </detail>
        <detail type="issue">
          <number>998</number>
        </detail>
        <extent unit="pages">
          <start>S200-S208</start>
          <end>S200-S208</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">07491581 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032394734&amp;partnerID=40&amp;md5=5df15109103b387090b03c0345b972a5</url>
    </location>
    <abstract>The water 1H and 17O NMR relaxation properties of solutions containing Gd(III) chelates of the heptadentate DO3A, PCTA[12] and PCTP[12] ligands were thoroughly investigated and the results obtained are compared with those previously reported for other Gd(III) complexes with octadentate ligands {H3DO3A = 1,4,7,10-tetraazacyclododecane 1,4,7-triacetic acid; H3PCTA[12] = 3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene-3,6,9-triacetic acid; H6PCTP[12] = 3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene-3,6,9- tris(methanephosphonic) acid}. The observed behaviour is consistent with a hydration number q = 2 in the case of GdDO3A and GdPCTA[12] and q = 1 in the case of PCTP[12]. The high relaxivity of the latter complex is accounted for in terms of the occurrence of an additional contribution arising from water molecules tightly bound to the phosphonate moieties on the surface of the paramagnetic chelate. Furthermore, it was found that the decreased relaxation rates observed at basic pH in the case of GdDO3A and GdPCTA[12] can probably be ascribed to a partial decrease in their hydration. The measurement of 17O NMR transverse relaxation rates, in the temperature range 273-342 K, allowed the assessment of the water exchange rate between the coordination site and the bulk solvent. A particularly short exchange lifetime was measured for the octacoordinate GdPCTP[12], which suggests the occurrence of an associative exchange mechanism. Further insights into the understanding of the structural properties of the three complexes were gained by measuring the magnetic field dependence (NMRD profiles) of the proton relaxivity on a Koenig-Brown field cycling relaxometer. © 1998 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR structural studies of the supramolecular adducts between a liver cytosolic bile acid binding protein and gadolinium(III)-chelates bearing bile acids residues: Molecular determinants of the binding of a hepatospecific magnetic resonance imaging contrast agent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Assfalg</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zanzoni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tomaselli</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lo Russo</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ragona</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Molinari</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>50</number>
        </detail>
        <detail type="issue">
          <number>22</number>
        </detail>
        <extent unit="pages">
          <start>5257</start>
          <end>5268</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">00222623 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-35848937601&amp;partnerID=40&amp;md5=96efa0c82ee57bb4be1fe374743b8000</url>
    </location>
    <abstract>The binding affinities of a selected series of Gd(III) chelates bearing bile acid residues, potential hepatospecific MRI contrast agents, to a liver cytosolic bile acid transporter, have been determined through relaxivity measurements. The Ln(III) complexes of compound 1 were selected for further NMR structural analysis aimed at assessing the molecular determinants of binding. A number of NMR experiments have been carried out on the bile acid-like adduct, using both diamagnetic Y(III) and paramagnetic Gd(III) complexes, bound to a liver bile acid binding protein. The identified protein "hot spots" defined a single binding site located at the protein portal region. The presented findings will serve in a medicinal chemistry approach for the design of hepatocytes-selective gadolinium chelates for liver malignancies detection. © 2007 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR structure of two novel polyethylene glycol conjugates of the human growth hormone-releasing factor, hGRF(1-29)-NH2</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barbero</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bracco</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Corpillo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Esposito</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Piquet</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Traversa</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>125</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>3458</start>
          <end>3470</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0242585450&amp;partnerID=40&amp;md5=39183bdd0969fcfd77412863f97c96dd</url>
    </location>
    <abstract>Two novel mono-PEGylated derivatives of hGRF(1-29)-NH2 [human growth hormone-releasing factor, fragment 1-29] have been synthesized by regio-specific conjugation of Lys12 or Lys21 to a monomethoxy-PEG5000 chain (compounds Lys12pEG-GRF and Lys21PEG-GRF). The PEG moiety has been covalently linked at the amino group of a norleucine residue via a carbamate bond. The Lys12PEG-GRF regioisomer was found to be slightly less active in vitro than both the unmodified peptide and Lys21PEG-GRF. To assess whether the differences in the biological activity of the PEGylated analogues could be related to conformational rearrangements induced by the PEG moiety, the structure of these PEGylated derivatives has been worked out (TFE solution) by means of NMR spectroscopy and molecular dynamics. Secondary structure shifts, hydrogen/deuterium exchange kinetics, temperature coefficients of amide protons, and NOE-based molecular models point out that hGRF(1-29)-NH2, Lys21PEG-GRF and Lys12PEG-GRF share a remarkably similar pattern of secondary structure. All three compounds adopt an α-helix conformation which spans the whole length of the molecule, and which becomes increasingly rigid on going from the N-terminus to the C-terminus. Residues Lys12 and Lys21 are enclosed in all the compounds considered into well-defined α-helical domains, indicating that PEGylation either at Lys12 or Lys21 does not alter the tendency of the peptide to adopt a stable α-helix conformation, nor does it induce appreciable conformational mobility in the proximity of the PEGylation sites. No significant variation of the amphiphilic organization of the α-helix is observed among the three peptides. Therefore, the different biological activities observed for the PEGylated analogues are not due to conformational effects, but are rather due to sterical hindrance effects. The relationship between the biological activitiy of the mono-PEGylated derivatives and sterical hindrance is discussed in terms of the topology of interaction between hGRF(1-29)-NH2 and its receptor.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR studies of L-Dopa melanin-manganese (II) complex in water solution</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Camurati</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>36</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>1</start>
          <end>9</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1989</dateIssued>
      </originInfo>
      <identifier type="issn">01620134 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Inorganic Biochemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. INORG. BIOCHEM.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0024574245&amp;partnerID=40&amp;md5=ea3c83a370455f0ccf61eedba6de5e67</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR studies of melanins: characterization of a soluble melanin free acid from Sepia ink.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Groombridge</namePart>
      <namePart type="given">C.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>4</number>
        </detail>
        <detail type="issue">
          <text>5-6</text>
        </detail>
        <extent unit="pages">
          <start>216</start>
          <end>221</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1991</dateIssued>
      </originInfo>
      <identifier type="issn">08935785 (ISSN)</identifier>
      <titleInfo>
        <title>Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Pigment Cell Res</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0026307243&amp;partnerID=40&amp;md5=759853b635cd5b7cf53ad5e01b503998</url>
    </location>
    <abstract>This paper deals with the nuclear magnetic resonance characterization of a soluble derivative (melanin free acid) of Sepia melanin obtained by a peroxidative treatment of the parent (insoluble) species. High resolution 13C and 15N solid state NMR spectroscopies allow the assessment of the chemical changes occurring in the macromolecule upon solubilization. 1H and 13C NMR solution spectra are discussed in light of the results obtained from the solid state spectra. Furthermore, the coordination properties of melanin have been investigated through 27Al NMR spectroscopy and proton relaxation enhancement studies of the paramagnetic gadolinium complex of melanin free acid. Through these experiments it has been possible to evaluate the molecular reorientational time tau R (and from it an estimated molecular weight close to 20 KDa) and the strength of the metal-macromolecule interaction.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR study of solution structures and dynamics of lanthanide(III) complexes of DOTA</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ermondi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>31</number>
        </detail>
        <detail type="issue">
          <number>21</number>
        </detail>
        <extent unit="pages">
          <start>4291</start>
          <end>4299</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1992</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33751391354&amp;partnerID=40&amp;md5=c8895be6942ae95e4b1bf03b636c2cb5</url>
    </location>
    <abstract>The low-temperature limiting NMR spectra (1H and 13C) of 12 LnDOTA- complexes (Ln = La, Pr, Nd, Sm, Eu, Tb, Dy, Ho, Er, Tm, Yb, and Lu) support the presence in solution of two isomeric forms. The relative abundance of the two isomers changes markedly along the lanthanide series with no apparent trend; NMR data suggest that the structure of the major isomer of LaDOTA- corresponds to that one of the minor isomer of the corresponding Lu3+ complex. The solution structures of the two isomers are assigned on the basis of a fitting procedure of calculated to experimental chemical shifts of the resonances of the proton spectrum of YbDOTA-. The Yb3+-hydrogen distances utilized in these calculations are determined by exploiting the Curie spin mechanism contribution to the longitudinal and transverse proton relaxation rates. The solution structures of the two isomers differ for the layout of the acetate arms, the cyclododecane ring conformation being identical in both species. The interconversion between the two isomers occurs as the temperature is increased and this process may be independent of the rearrangement involving the cyclododecane ring, as shown from the 13C-VT NMR spectra of the Nd3+ complex and 2D-EXSY experiments on the Yb3+ complex respectively. © 1992 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR study of the chemical exchange of the hydrido ligands in the bis(bis(diphenylphosphino)ethane)trihydridodiplatinum(II) cation by T1, T2, and HD isotopic perturbation</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bandini</namePart>
      <namePart type="given">A.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Banditelli</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Minghetti</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>30</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>316</start>
          <end>318</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1991</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4243976812&amp;partnerID=40&amp;md5=b4294c98712e9579bb5496e6c830f5fd</url>
    </location>
    <abstract>Proton longitudinal and transverse relaxation rates of hydrido resonances of different isotopomers in [H3Pt2(Dpe)2][BF4] [Dpe = bis(diphenylphosphino)ethane] show significant differences in the satellite peaks with respect to the central ones that can be used to evaluate the activation energy of the intramolecular exchange process and the chemical shift separation between bridging and terminal sites. An alternative route to get an estimation of the chemical shift values of the bridging and terminal hydrides in this derivative has been pursued by considering the isotopic shift of the three H3, H2D, and HD2 isotopomers at different temperatures. © 1991 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NMR, relaxometric, and structural studies of the hydration and exchange dynamics of cationic lanthanide complexes of macrocyclic tetraamide ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bruce</namePart>
      <namePart type="given">J.I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Howard</namePart>
      <namePart type="given">J.A.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Moloney</namePart>
      <namePart type="given">J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Sousa</namePart>
      <namePart type="given">A.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Woods</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>121</number>
        </detail>
        <detail type="issue">
          <number>24</number>
        </detail>
        <extent unit="pages">
          <start>5762</start>
          <end>5771</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0033597628&amp;partnerID=40&amp;md5=bf8f0c18093c2d4958bdd2e148a7eff6</url>
    </location>
    <abstract>The solution structure and dynamics of metal-bound water exchange have been investigated in a series of lanthanide complexes of primary, secondary, and tertiary tetraamide derivatives of 1,4,7,10-tetraazacyclododecane. In the gadolinium complexes at ambient pH, water exchange lifetimes (τ(m)) determined by 17O NMR were sufficiently long (19 μs for [Gd · 2]3+, 298 K, 17 μs for [Gd · 3]3+, and 8 μs for [Gd · 4]3+) to limit the measured relaxivity. Direct 1H NMR observation of the bound water resonance is possible for the corresponding Eu complexes at low temperature in CD3CN, and the rate of water proton exchange is about 50 times faster in the twisted square antiprismatic isomer (m) than in the isomeric square antiprismatic (M) complex. The ratio of these two isomers in solution is sensitive to the steric demand of the amide substituent, with m/M = 2 for [Eu · 4]3+, but 0.25 for [Eu · 2]3+. The slowness of coordinated water exchange has allowed the rate of prototropic exchange to be studied: in basic media deprotonation of the bound water molecule or of proximate ligand amide NH protons leads to relaxivity enhancements, whereas in acidic media, hydration around the strongly ion-paired complexes is perturbed, facilitating water exchange. The X-ray crystal structure of ligand 3 reveals a hydrogen-bonded structure with two pairs of ring N-substituents related in a trans arrangement, contrasting with the structure of diprotonated DOTA in which the ligand is predisposed to bind metal ions. In the dysprosium complex [Dy · 3 · OH2](PF6)3, the metal ion adopts a regular monocapped square antiprismatic coordination geometry, with a water Dy-O bond length of 2.427(3) Å, and a PF6 counterion is strongly hydrogen-bonded to this bound water molecule.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NOE (Nuclear Overhauser Effect) transfers from para-H2 enhanced magnetizations in alkene moieties at Rh(I) centers</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canet</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>105</number>
        </detail>
        <detail type="issue">
          <number>26</number>
        </detail>
        <extent unit="pages">
          <start>6305</start>
          <end>6310</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">10895639 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Physical Chemistry A</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J Phys Chem A</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035811440&amp;partnerID=40&amp;md5=2466d4888642d171709ba96f72ab1967</url>
    </location>
    <abstract>The hydrogenation of symmetric dienes with para-H2 catalyzed by Rhodium complexes leads to remarkable effects in the 1H NMR spectra of the corresponding alkene derivatives, namely, an emission peak (negative peak) in the aliphatic region ascribed to protons of the hydrogenated double bond and one or more enhanced absorption peaks. The strongest absorption peak is invariantly assigned to the two equivalent olefinic protons in the free alkene. The possibility that the observed behavior could be associated with a reversible exchange between para-H2 and the olefinic hydrogens has been ruled out on the basis of the lack of deuterium incorporation when the experiments are carded out with D2. Variable magnetic field experiments have indicated that the positive peaks arise from relaxation processes, i.e., from cross-relaxation transfers (generally denoted as NOE transfers; NOE = nuclear Overhauser effect) originating from the enhanced magnetization at the hydrogenation sites in the product or, more likely, at the hydride ligands in intermediate species.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Non-covalent conjugates between cationic polyamino acids and GdIII chelates: A route for seeking accumulation of MRI-contrast agents at tumor targeting sites</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Garino</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>14</number>
        </detail>
        <extent unit="pages">
          <start>2609</start>
          <end>2617</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem Eur J</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034679499&amp;partnerID=40&amp;md5=5c7a4ed5595b0f2a5cca05caf133378b</url>
    </location>
    <abstract>Three novel Gd chelates containing on their external surface pendant phosphonate and carboxylate groups, which promote the interaction with the positively charged groups of polyornithine and polyarginine, have been synthesized. Their solution structures have been assessed on the basis of 1H- and 31P-NMR spectra of the Eu and Yb analogues. A thorough investigation of the relaxometric (1H and 17O) properties of the Gd chelates has been carried out and the observed relaxivities have been accounted for the sum of three contributions arising from water molecules in the first, second, and outer coordination layers, respectively. It has been found that the occurrence of a tight second coordination coating renders the dissociation of the water molecule directly coordinated to the Gd ion more difficult. The binding interactions between the negatively charged Gd chelates and the positively charged groups of polyornithine (ca. 140 residues) and polyarginine (ca. 204 residues) have been evaluated by means of the proton relaxation enhancement (PRE) method. Although the binding interaction decreases markedly in the presence of competitive anions in the solution medium, the affinity is strong enough that in blood serum it is possible to meet the conditions where most of the chelate is bound to the polyamino acid substrate. On this basis one may envisage a novel route for a MRI location of tumors as it is known that positively charged polyamino acids selectively bind to tumors having a greater negative charge than non-tumor cells.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Non-ionic Ln(III) chelates as MRI contrast agents: Synthesis, charactetisation and 1H NMR relaxometric investigations of bis(benzylamide)diethylenetriaminepentaacetic acid Lu(III) and Gd(III) complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Benetollo</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bombieri</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Colla</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoletti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>254</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>63</start>
          <end>70</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0002814236&amp;partnerID=40&amp;md5=834b436e967352aff1dd7d5b9b5e75bf</url>
    </location>
    <abstract>The syntheses of the ligand bis(benzylamide)diethylenetriaminepentaacetic acid (BBA-DTPA) and its Gd(III) and Lu(III) complexes are reported. The solid state structure of Lu(III)BBA-DTPA was determined in a single crystal X-ray diffraction study. The lutetium ion adopts a nine-coordinate geometry, which is best described as a distorted tricapped prism. Eight coordination sites are occupied by the ligand (three nitrogen atoms, two carboxamide oxygens and three carboxylate oxygens) and the ninth site is occupied by the oxygen atom of a water molecule. The VT 13C NMR spectra of Lu(III)BBA-DTPA are consistent with the presence of three isomers in solution. Water proton relaxation rates have shown that Gd(III)BBA-DTPA displays an analogous behaviour to that observed for other Gd(III) complexes of related bisamide derivatives of DTPA. The solubility of Gd(III)BBA-DTPA has been markedly improved by the presence of an excess of hydroxypropyl-β-cyclodextrin. The thermodynamic stability of the inclusion complex has been evaluated by measuring the proton relaxation enhancement upon addition of β-cyclodextrin.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>NorDATA: An original ligand based on the norbornane skeleton. Synthesis and thermodynamic characterization of metal complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baranyai</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallotti</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Imperio</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>27</number>
        </detail>
        <detail type="issue">
          <number>18</number>
        </detail>
        <extent unit="pages">
          <start>3683</start>
          <end>3687</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">02775387 (ISSN)</identifier>
      <titleInfo>
        <title>Polyhedron</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Polyhedron</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-56349092889&amp;partnerID=40&amp;md5=3ee8ec8e4e73e8787c0a9c8d1c7446fe</url>
    </location>
    <abstract>An original diaminotetracarboxylic ligand based on the rigid bicyclic norbornane skeleton was synthesized in four steps. The stability of its metal complexes was measured in water by potentiometric titration and discussed. © 2008 Elsevier Ltd. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Note. Two-dimensional nuclear magnetic resonance for the analysis of the carbon-13 spectra of carbonyl groups in metallocarbonyls</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lian</namePart>
      <namePart type="given">L.Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sales</namePart>
      <namePart type="given">K.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>225</start>
          <end>227</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1985</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049091650&amp;partnerID=40&amp;md5=f5b2e452a85083c2ed2d30b8b6c57d41</url>
    </location>
    <abstract>The 13C homonuclear two-dimensional n.m.r. shift correlation experiment COSY on the 13C-enriched complex [Os3H2(CO)10] established the presence of two-and three-bond scalar couplings which partially invalidates previous assignement of the 13C spectrum. A related two-dimensional experiment (NOESY) was used to detect slow localised carbonyl group exchange. The intensities of the slowly exchanging peak and the associated correlation peak in the NOESY experiment were analysed quantitatively to yield 13C spin-lattice relaxation rates and a value for the exchange rate constant (1.21 s1-).</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Notes. Carbon-13 and oxygen-17 nuclear magnetic resonance relaxation studies of [M3(CO)12] derivatives (M = Fe, Ru, or Os)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>791</start>
          <end>792</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1988</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049081744&amp;partnerID=40&amp;md5=f3ee68ad7c243e1afa89935bff0ed2d5</url>
    </location>
    <abstract>The combined use of 13C and 17O spin-lattice relaxation times for co-ordinated carbonyl ligands in [M3(CO)12] clusters (M = Fe, Ru, or Os) allows the determination of 17O quadrupolar coupling constants and the correlation times for molecular tumbling at different temperatures.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Novel contrast agents for magnetic resonance imaging. Synthesis and characterization of the ligand BOPTA and its Ln(III) complexes (Ln = Gd, La, Lu). X-ray structure of disodium (TPS-9-145337286-C-S)-[4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8, 11-triazatridecan-13-oato(5-)]gadolinate(2-) in a mixture with its enantiomer</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Brocchetta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Haën</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ermondi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grandi</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoli</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>34</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>633</start>
          <end>642</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001507242&amp;partnerID=40&amp;md5=a66ac42081c48016beb030eb9c311344</url>
    </location>
    <abstract>The syntheses of the ligand BOPTA, (4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13- oic acid; benic acid) and its Gd(III), La(III), and Lu(III) complexes are reported. Protonation constants for BOPTA have been determined by potentiometry, and the microscopic protonation sequence has been investigated by 1H NMR. The results obtained together with the value of the Gd-BOPTA2- stability constant (log KML = 22.59) show that the complexing properties of the ligand, in comparison with DTPA, are little affected by the presence of the benzyloxymethyl residue in the structure. The solid state structure of Gd-BOPTA disodium salt [C22H26N3O11(H 2O)Gd]Na2·3/2H2O was determined in a single-crystal X-ray diffraction study. The structure consists of [C22H26N3O11(H2O)Gd] 2- anions, sodium cations, and water molecules; the space group is P1 (Z = 2), with a = 9.083(6) Å, b = 9.469(2) Å, c = 16.698(6) Å, α = 102.22(3)°, β = 92.48(4)°, γ = 102.26(3)°, V = 1366(1) Å3, and d = 1.84 g/mL. The gadolinium ion adopts a nine-coordinate geometry, which is best described as a distorted tricapped trigonal prism. Eight coordinating sites are occupied by the ligand (three nitrogen atoms and five carboxylate oxygens), and the ninth site is occupied by the oxygen atom of a water molecule. Relaxation studies have shown that in solution also Gd-BOPTA2- has one water molecule directly coordinated to the metal ion. 139La NMR studies on the La-BOPTA2- complex have further supported the view that such complexes maintain in solution the same kind of coordination as found in the solid state for Gd-BOPTA disodium salt. 13C NMR spectra of the diamagnetic La- and Lu-BOPTA2- complexes at various temperatures are consistent with the presence of two couples of isomers interconverting through a dynamic process. Such a process has previously been reported for the parent Ln-DTPA2- complexes. © 1995 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Novel MRI and fluorescent probes responsive to the Factor XIII transglutaminase activity</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mazooz</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Shellef</namePart>
      <namePart type="given">Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Avni</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vandoorne</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kalchenko</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dewhirst</namePart>
      <namePart type="given">M.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chaabane</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Miragoli</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Neeman</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>5</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>213</start>
          <end>222</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77956150271&amp;partnerID=40&amp;md5=c228e79b5a0fb99d1097edd9b3e3af5c</url>
    </location>
    <abstract>Transglutaminases, including factor XIII and tissue transglutaminase, participate in multiple extracellular processes associated with remodeling of the extracellular matrix during wound repair, blood clotting, tumor progression and fibrosis of ischemic injuries. The aim of this work was to evaluate a novel substrate analog for transglutaminase optimized by molecular modeling calculations (DCCP16), which can serve for molecular imaging of transglutaminase activity by magnetic resonance imaging and by near-infrared imaging. Experimental data showed covalent binding of Gd-DCCP16 and DCCP16-IRIS Blue to human clots, to basement membrane components and to casein in purified systems as well as in three-dimensional multicellular spheroids. In vivo, DCCP16 showed enhancement with a prolonged retention in clots and tumors, demonstrating the ability to detect both factor XIII and tissue transglutaminase mediated covalent binding of the contrast material. Copyright © 2010 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Novel paramagnetic macromolecular complexes derived from the linkage of a macrocyclic Gd(III) complex to polyamino acids through a squaric acid moiety</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>10</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>192</start>
          <end>199</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">10431802 (ISSN)</identifier>
      <titleInfo>
        <title>Bioconjugate Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Bioconjugate Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0033104354&amp;partnerID=40&amp;md5=f212d30482593effbded988d4d7c7c4a</url>
    </location>
    <abstract>Macromolecular Gd(III) complexes may find useful application as contrast agents for magnetic resonance angiography (MRA). Herein two novel systems are reported, namely Gd(DO3ASQ)3-lys16 and Gd(DO3ASQ)30-orn114. Their syntheses are based on the ability of the squaric acid moiety to act as a linker between the DO3A (1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid) chelate moiety and the polyamino acidic chain. Moreover, the squaric acid participates in the coordination cage of the Gd(III) ion. The investigation of 1H and 17O NMR relaxation processes of solvent water nuclei allowed a detailed characterization of the systems under study. Gd(DO3ASQ)30-orn114 displays a remarkable ability to enhance the water proton relaxation rate of its solutions, and it may be considered as potential contrast agent for MRA applications.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Novel radical-responsive MRI contrast agent based on paramagnetic liposomes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gløgård</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stensrud</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>41</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>585</start>
          <end>588</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">07491581 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0142119587&amp;partnerID=40&amp;md5=909115bd639f8e93435f027f1d315dcb</url>
    </location>
    <abstract>A novel, radical responsive MRI contrast agent based on a gadolinium chelate conjugated to a liposome through a disulfide linker was synthesized, with the aim of pursuing the in vivo mapping of radicals. The liposome was prepared by incorporating a thiol-activated phospholipid, which was subsequently reacted with a gadolinium chelate containing a free thiol group. The long reorientational motion of the supramolecular adduct endows the paramagnetic agent with a relaxivity significantly higher than that of the free complex. The disulfide bond represents a radical-sensitive moiety and a large decrease in contrast efficacy (T1 relaxivity) is shown upon its cleavage. A preliminary assessment of the system was made by means of in vitro gamma-irradiation and thiol-disulfide bond exchange with dithiothreitol. Both methods showed a clear dose-dependent decrease in T1-relaxivity. Copyright © 2003 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Novel synthesis, solution structure, dynamics, and protonation of H(μ-H)Ru3(CO)11</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>17</number>
        </detail>
        <detail type="issue">
          <number>15</number>
        </detail>
        <extent unit="pages">
          <start>3182</start>
          <end>3185</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001644467&amp;partnerID=40&amp;md5=c2cfbd7dc5f7554aa367634f923f0652</url>
    </location>
    <abstract>The reaction of the lightly stabilized cluster Ru3(CO)11(NCCH3) with H2 quantitatively affords H2Ru3(CO)11, which is sufficiently stable under an H2 atmosphere to be characterized by 1H and 13C spectroscopy. In solution, the structure of the dihydride product is different from that previously reported, and it corresponds to a novel bonding scheme, intermediate between those of the two structures previously reported for H2M3(CO)11 species (M = Fe, Ru, Os). The stereochemical nonrigidity of the title compound is investigated by VT 13C NMR spectroscopy, and an exchange mechanism involving edge hopping of the bridging hydride in concert with the motion of the carbonyl ligands is proposed. The reactivity of the title compound with CF3COOH is also investigated. At low temperature, the addition of the strong acid to the cluster yields a reversible O-protonation at the bridging carbonyl site. When the temperature is raised, the formation of (μ-H)Ru3(μ-η3-OOCCF3)(CO) 10 is observed.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Nuclear Magnetic Relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Lopiano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giraudo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Koenig</namePart>
      <namePart type="given">S.H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Torre</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bergamasco</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>37</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>331</start>
          <end>336</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">01970186 (ISSN)</identifier>
      <titleInfo>
        <title>Neurochemistry International</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Neurochem. Int.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034309848&amp;partnerID=40&amp;md5=450c6c66ccae7aa912d17020bf000b73</url>
    </location>
    <abstract>Nuclear Magnetic Relaxation field-cycling relaxometry is a technique, able to report on water mobility in tissues. By means of this technique, post-mortem specimens from both controls and idiopathic Parkinson's disease patients have been investigated. Results show different relaxometric behavior between the groups, which is consistent with protein aggregation in Parkinson's disease specimens. Copyright (C) 2000 Elsevier Science Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Nuclear magnetic resonance of binuclear complexes containing a metallacyclopentadiene system</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Occhiello</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1863</start>
          <end>1865</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1986</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049078375&amp;partnerID=40&amp;md5=98aba9287ed68fcb9388e546b06adb6d</url>
    </location>
    <abstract>A comparative study of the 1H and 13C n.m.r. spectra of complexes [M2(CO)6{(HC2H)2}] (M = Fe, Ru, or Os) is reported. Carbon-carbon coupling constants have been observed for 13C-enriched acetylene samples of iron and ruthenium. In the ruthenium complex the T1 and nuclear Overhauser enhancement (n.O.e.) measurements of the 13C nuclei of the organic moiety allowed the calculation of the correlation time for the molecular reorientation; furthermore the T1 and n.O.e. data for the 1H nuclei povided an opportunity to estimate the HA-HX distance (CHA = CHX) in the metallacycle. An improvement in the evaluation of this distance has been gained by measuring the 1H spinlattice relaxation time in a highly deuteriated sample.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Nuclear magnetic resonance spectroscopy characterization and iron content determination of human mesencephalic neuromelanin.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bergamasco</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lopiano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Quattrocolo</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>69</number>
        </detail>
        <extent unit="pages">
          <start>263</start>
          <end>270</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">00913952 (ISSN)</identifier>
      <titleInfo>
        <title>Advances in neurology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Adv Neurol</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0029690726&amp;partnerID=40&amp;md5=b0795183b669c95611e701edef60c53c</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Nuclear magnetic resonance studies of neutral lanthanide(III) complexes with tetraaza-macrocyclic ligands containing three phosphinate and one carboxamide co-ordinating arms</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Williams</namePart>
      <namePart type="given">J.A.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>13</number>
        </detail>
        <extent unit="pages">
          <start>2259</start>
          <end>2266</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049071766&amp;partnerID=40&amp;md5=c71d2de55f798d8b20d7d92d4f86f7a5</url>
    </location>
    <abstract>Novel, neutral EuIII, GdIII and YbIII complexes have been obtained with tetraaza-macrocyclic ligands containing three phosphinate and one carboxamide co-ordinating arms. The overall results are consistent with a co-ordination geometry based on the octadenticity of these ligands. Among the possible 16 enantiomeric pairs one is largely dominant as ascertained by the high resolution 1H, 13C and 31P NMR spectra of the EuIII and YbIII complexes. Partial assignment of 1H and 13C resonances was possible for one EuIII complex on the basis of homo- and hetero-correlated two-dimensional NMR experiments. The evaluation of the Curie contribution to the longitudinal relaxation rates of the 31P resonances has provided a route to the determination of the Yb-P distances. The addition of the chiral solvating agent β-cyclodextrin to a solution of the YbIII complex containing benzylic substituents on the amido nitrogen allowed the chiral resolution of an enantiomeric pair by 31P NMR spectroscopy. The measurement of water proton longitudinal relaxation rates of solutions of the GdIII complexes indicated that these chelates have one inner-sphere co-ordinated water molecule whereas the parent tetraphosphinate complexes have none.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Nuclear magnetic resonance, luminescence and structural studies of lanthanide complexes with octadentate macrocyclic ligands bearing benzylphosphinate groups</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Batsanov</namePart>
      <namePart type="given">A.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dickins</namePart>
      <namePart type="given">R.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Faulkner</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Foster</namePart>
      <namePart type="given">C.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Harrison</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Howard</namePart>
      <namePart type="given">J.A.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Moloney</namePart>
      <namePart type="given">J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Norman</namePart>
      <namePart type="given">T.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Royle</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Williams</namePart>
      <namePart type="given">J.A.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>19</number>
        </detail>
        <extent unit="pages">
          <start>3623</start>
          <end>3636</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">03009246 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society - Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33749107444&amp;partnerID=40&amp;md5=2a5012bd8a7d09bd9cc749730c7ac702</url>
    </location>
    <abstract>The solution and solid-state structures of lanthanide complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10- tetryltetramethylenetetra(benzylphosphinate), L1a, and of its o-, m- and p-methoxybenzyl analogues (L2, L3, L4) have been investigated by NMR, relaxometry, crystallographic and photophysical methods. It has been shown that the number of proximate water molecules is dependent on the size of the bound lanthanide ion: the complex [LaL1a] is nine-co-ordinate and adopts a twisted square-antiprismatic structure with one bound water molecule. The analogous [YL1a]-, [YbL1a]-, [GdL1a]- and [EuL1a]- complexes also adopt a twisted square-antiprismatic geometry, but are eight-co-ordinate, with no metal-bound water. Relaxivity studies with the gadolinium complexes showed that they are purely 'outer-sphere' contrast agents, but they associate strongly with proteins leading to a pronounced relaxivity enhancement. Detailed biodistribution studies with [GdL1a]- revealed avid biliary uptake at low doses and a well defined tendency for the complex to be cleared more slowly from tumour tissue, allowing tissue differentiation.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Observation of localised CO exchange mechanisms at the iron and ruthenium centres of di-μ-carbonyl (Fe : Ru2, Ru3)-di-μ- hydrido (Ru1 : Ru2, Ru3)-tetrahedro- tris(tricarbonylruthenium)dicarbonyliron(3Fe-Ru, 3Ru-Ru) by 13C n.m.r spectroscopy</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>452</start>
          <end>454</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1975</dateIssued>
      </originInfo>
      <identifier type="issn">00224936 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Chemical Communications</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049141037&amp;partnerID=40&amp;md5=59069ca309b48a0224508436b67b620c</url>
    </location>
    <abstract>Variable temperature 13C n.m.r. studies show that [H 2FeRu3(CO)13] is undergoing intramolecular carbonyl exchange in three distinguishable stages: the first localised at iron; the second localised at the three rutheniums; and the last general over all metal centres.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>On the role of the counter-ion in defining water structure and dynamics: Order, structure and dynamics in hydrophilic and hydrophobic gadolinium salt complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Thompson</namePart>
      <namePart type="given">A.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fulton</namePart>
      <namePart type="given">D.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Howard</namePart>
      <namePart type="given">J.A.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pandya</namePart>
      <namePart type="given">S.U.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Puschmann</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Senanayake</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stenson</namePart>
      <namePart type="given">P.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Badari</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Avedano</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>47</number>
        </detail>
        <extent unit="pages">
          <start>5605</start>
          <end>5616</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">14779226 (ISSN)</identifier>
      <titleInfo>
        <title>Dalton Transactions</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Dalton Trans.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33846312485&amp;partnerID=40&amp;md5=bf89648a0906b6d9b8e6b55ac62c0ca0</url>
    </location>
    <abstract>The crystal structures of the hydrated salts of [Gd.DOTAM]3+ and its more hydrophobic derivative [Gd.2]3+, bearing 4 α-phenylethyl groups, (both Gd and Yb salts) are reported and compared. The nature of the anion determines the degree of ordering in the lattice and the extent of hydration. These effects are correlated with the results of 17O and 1H NMR measurements of water exchange dynamics in solution. With [Gd.DOTAM]3+, structural ordering or the extent of hydration in the hydrated lattice follows the sequence Cl- &gt; Br- &gt; I- and this order also defines the water exchange rate in solution: 7.3, 19.5, 33.3 × 104 s-1 (298 K), respectively. For [Gd.2]3+ salts, the measured relaxivity is determined purely by the outer sphere term and the water exchange rate at 298 K is very similar (typically 1 × 104 s-1) for chloride, bromide, iodide, acetate, triflate and nitrate salts, notwithstanding the different nature and extent of hydration found in the crystalline lattice. © The Royal Society of Chemistry 2006.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>One-step synthesis of a new eight-membered cyclic ligand from glycine, formaldehyde and hypophosphorous acid</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallotti</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>43</number>
        </detail>
        <detail type="issue">
          <number>46</number>
        </detail>
        <extent unit="pages">
          <start>8387</start>
          <end>8389</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">00404039 (ISSN)</identifier>
      <titleInfo>
        <title>Tetrahedron Letters</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Tetrahedron Lett.</title>
      </titleInfo>
    </relatedItem>
    <abstract>The eight-membered 3,7-dihydroxy-3,7-dioxoperhydro-1,5,3,7-diazadiphosphocine-1,5-diacetic acid was obtained with a one-step reaction of glycine, formaldehyde and hypophosphorous acid in acidic aqueous medium. A preliminary investigation of its coordination properties is reported. © 2002 Elsevier Science Ltd. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Optimization of the relaxivity of MRI contrast agents: Effect of poly(ethylene glycol) chains on the water-exchange rates of GdIII complexes [11]</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Doble</namePart>
      <namePart type="given">D.M.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Wang</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>123</number>
        </detail>
        <detail type="issue">
          <number>43</number>
        </detail>
        <extent unit="pages">
          <start>10758</start>
          <end>10759</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035980352&amp;partnerID=40&amp;md5=6cbcb34d1ff73826c4a33bf3759fb7ae</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Optimized relaxivity and stability of [Gd(H(2,2)-1,2-HOPO)(H 2O)]- for use as an MRI contrast agent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Jocher</namePart>
      <namePart type="given">C.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Avedano</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Moore</namePart>
      <namePart type="given">E.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Xu</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>46</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>4796</start>
          <end>4798</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34347248044&amp;partnerID=40&amp;md5=a92bedeb662df574b6c58967a3b44774</url>
    </location>
    <abstract>Relaxometry and solution thermodynamic measurements show that Gd(H(2,2)-1,2-HOPO) is a good candidate as a contrast agent for magnetic resonance imaging (MRI-CA). Acidic, octadentate H(2,2)-1,2-HOPO forms a very stable Gd(III) complex [pGd = 21.2(2)]. The coordination sphere at the Gd(III) center is completed by one water molecule that is not replaced by common physiological anions. In addition, this ligand is highly selective for Gd(III) binding in the presence of Zn(II) or Ca(II). The symmetric charge distribution of the 1,2-HOPO chelates is associated with favorably long electronic relaxation time T1,2e comparable to those of GdDOTA. This, in addition to the fast water exchange rate typical of HOPO chelates, improves the relaxivity to r1p = 8.2 mM-1 s-1 (0.47 T). This remarkably high value is unprecedented for small-molecule, q = 1 MRI-CA. © 2007 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Organomental clusters as models for corrosion inhibitors. The reaction of Os3(CO) 10(NCCH3)2 with benzotriazole</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Padovan</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>353</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>251</start>
          <end>257</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1988</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000321787&amp;partnerID=40&amp;md5=8e3a2402c263c15074fc21913c5b5e25</url>
    </location>
    <abstract>The products of the reaction between Os3(CO)10(NCMe)2 and benzotriazole, a widely used corrosion inhibitor, are discussed in the light of their spectroscopic data. The structural, chemical and electrochemical properties of these molecular clusters are considered, with the aim of providing new insights into the actual mechanism of protection of metallic surfaces from corrosion. © 1988.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Osmotically shrunken LIPOCEST Agents: An innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Violante</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanders</namePart>
      <namePart type="given">H.M.H.F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sommerdijk</namePart>
      <namePart type="given">N.A.J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>1440</start>
          <end>1448</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-60749121437&amp;partnerID=40&amp;md5=482d3548b5d8b9be01c06d174a2e8d5c</url>
    </location>
    <abstract>The peculiar properties of osmotically shrunken liposomes acting as magnetic resonance imaging-chemical exchange saturation transfer (MRI-CEST) contrast agents have been investigated. Attention has been primarily devoted to assessing the contribution arising from encapsulated and incorporated paramagnetic lanthanide(III)-based shift reagents in determining the chemical shift of the intraliposomal water protons, which is a relevant factor for generating the CEST contrast. It is demonstrated that a highly shifted resonance for the encapsulated water can be attained by increasing the percentage of the amphiphilic shift reagent incorporated in the liposome bilayer. It is also demonstrated that the shift contribution arising from the bulk magnetic susceptibility can be optimized through the modulation of the osmotic shrinkage. In terms of sensitivity, it is shown that the saturation transfer efficiency can be significantly improved by increasing the size of the vesicle, thus allowing a high number of exchangeable protons to be saturated. In addition, the role played by the intensity of the saturating radiofrequency field has also been highlighted. © 2009 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Oximation of acetyl(hydroxyimino)acetone: Nuclear magnetic resonance spectroscopic, chemical, and X-ray crystallographic studies of the reaction products</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Fruttero</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Calvino</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ferrarotti</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gasco</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chiari</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Calestani</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>523</start>
          <end>529</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1987</dateIssued>
      </originInfo>
      <identifier type="issn">1472779X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Perkin Transactions 2</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049073785&amp;partnerID=40&amp;md5=e98998a984218890e452268d841d2f43</url>
    </location>
    <abstract>The oximation of acetyl(hydroxyimino)acetone (1) with hydroxylamine affords a mixture of oxime derivatives. The products obtained by the action of an equimolar amount of hydroxylamine on (1) are the two 3,5-dimethyl-5-hydroxy-4- hydroxyimino-2-isoxazoline isomers (3a and b). The main products obtained by the action of an excess of hydroxylamine on (1) are two pentane-2,3,4-trione trioxime isomers (4a and b) and a little amount of 4-acetyl-3-methylfuroxan oxime (5). N.m.r. and chemical data of all these derivatives are discussed in order to determine both structures and configuration. X-Ray analysis of (3a), (4a), and (5) are also reported.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Oxygen-17 and carbon-13 relaxation studies of metal carbonyls: Improved determination of 17O electric quadrupole couplings</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1863</start>
          <end>1866</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049091335&amp;partnerID=40&amp;md5=8b219ae8531b1c221db10cbc657f981a</url>
    </location>
    <abstract>Rotational correlation times for six organometallic carbonyl complexes have been measured by 13C spin-lattice relaxation time and 13C-{1H} nuclear Overhauser enhancement measurements of the organic ligands. Oxygen-17 T1 n.m.r. measurements on the carbonyl groups yielded the 17O electric quadrupole-coupling constants. The values show structural variation and so could be useful in the assignment of 17O resonances.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Oxygen-17 relaxation times of metallocarbonyls: The use of the 17O electric quadrupole coupling as a new structural probe</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>15</number>
        </detail>
        <extent unit="pages">
          <start>794</start>
          <end>796</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">00224936 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Chemical Communications</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049106137&amp;partnerID=40&amp;md5=66b2557b78037040f9f2c1d3381fa63b</url>
    </location>
    <abstract>The 17O spin-lattice relaxation times at 54.25 MHz for seven selected metallocarbonyls are in the range 8 to 50 ms at 298 K; the variations are dependent upon the molecular size, the transition metal, and the stereochemical position of the CO group, and may be interpreted in terms of variation of 17O electric quadrupole coupling constants which show stereochemical dependence, when the effects of correlation times have been allowed for.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>PAMAM dendrimeric conjugates with a Gd-DOTA phosphinate derivative and their adducts with polyaminoacids: The interplay of global motion, internal rotation, and fast water exchange</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rudovsky</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hermann</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hardcastle</namePart>
      <namePart type="given">K.I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lukeš</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>17</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>975</start>
          <end>987</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">10431802 (ISSN)</identifier>
      <titleInfo>
        <title>Bioconjugate Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Bioconjugate Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33746720887&amp;partnerID=40&amp;md5=8c1f2c50430f0f3451ce3e7a96a3dcc9</url>
    </location>
    <abstract>A series of dendrimeric conjugates based on a PAMAM (polyamidoamine) backbone with macrocyclic Gd-DO3A-PN2n complexes (monophosphinated analogue of DOTA) was prepared. The chelates were covalently attached to the G1-, G2-, and G4-PAMAM dendrimers through a thiourea linker in high loads (&gt;90%). The prepared conjugates G1-(Gd-DOSA-PBnN{CS})8, G2-(Gd-DO3A-PBnN{CS})16, and G4-(Gd-DO3A-P BnN{CS})59 showed relaxivities of 10.1, 14.1, and 18.6 s-1 mM-1 at 20 MHz and 37 °C and pH = 7.5, respectively. A variable-pH study (range 2-12) revealed up to 30% increase in the relaxivity at low pH for the G2-(Gd-DO3A-PBnN{CS})16 conjugate. As confirmed by 1H NMR titration of the unmodified G2 dendrimer, this is due to protonation of core tertiary amines leading to a more open and rigid structure. The variable-temperature 17O NMR and 1H NMRD relaxometric studies confirmed that the relaxivity is not controlled by water exchange but by rotational dynamics. A multiparametrical data evaluation using the Lipari-Szabo approach revealed that the water residence lifetime, 298τM, for the conjugates studied was ca. 45-70 ns, which is longer than the value found for the monomeric model compound Gd-DO3A-PN2n (16 ns) but short enough so as not to limit the relaxivity. The global rotational correlation time, 298τ Rg, varied from 1.5 to 3.1 ns and seemed to indicate a sufficiently slow molecular tumbling to achieve the high relaxivities measured; however, the rigidity factor S2 (∼0.26), describing the internal flexibility, was far from optimum. The overall relaxivity was significantly increased (e.g. by a factor of 1.8 for the G1-(Gd-DO3A-PBnN{CS})8 conjugate) when a positively charged polyaminoacid like poly(Arg) or poly(Lys) was added to the conjugate solutions. The electrostatic interactions partially "freeze" the internal mobility of the conjugate and also slow down global motion. This assumption was confirmed by an evaluation of 1H relaxometric data obtained for the G2-(Gd-DO3A-PBnN{CS}) 16-poly(Lys)59 adduct. Importantly, it was proved that the adduct formation did not hamper the water exchange process. © 2006 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Para-hydrogen enrichment and hyperpolarization</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Canet</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aroulanda</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mutzenhardt</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>28</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>321</start>
          <end>330</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">15466086 (ISSN)</identifier>
      <titleInfo>
        <title>Concepts in Magnetic Resonance Part A: Bridging Education and Research</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Concepts Magn. Reson. Part A. Bridging Educ. Res.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33749381836&amp;partnerID=40&amp;md5=4291db504421a4d3018580485c74706a</url>
    </location>
    <abstract>This article begins with general considerations about enrichment of hydrogen gas into its para isomer (corresponding to nuclear spins in the singlet state); this is a necessary condition to obtain hyperpolarization from transfer of the relevant population excess. This transfer is generally mediated by a hydrogenation reaction such that the two protons become nonequivalent. The energy level populations of this new spin system can be calculated unambiguously using a density matrix formalism. This formalism is reviewed, and the authors propose a simple method that leads to the spin state after the hydrogenation reaction and the insertion of the sample in the NMR magnet. The effect of radiofrequency pulses is also considered. © 2006 Wiley Periodicals, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Para-hydrogenated glucose derivatives as potential 13c- hyperpolarized probes for magnetic resonance imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Santelia</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cerutti</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Poggi</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tichy</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Premkumar</namePart>
      <namePart type="given">S.S.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>132</number>
        </detail>
        <detail type="issue">
          <number>20</number>
        </detail>
        <extent unit="pages">
          <start>7186</start>
          <end>7193</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77952570560&amp;partnerID=40&amp;md5=cd8650da1c0a2f140f4ad5da0c2d4a84</url>
    </location>
    <abstract>A set of molecules in which a glucose moiety is bound to a hydrogenable synthon has been synthesized and evaluated for hydrogenation reactions and for the corresponding para-hydrogen-induced polarization (PHIP) effects, in order to select suitable candidates for an in vivo magnetic resonance imaging (MRI) method for the assessment of glucose cellular uptake. It has been found that amidic derivatives do not yield any polarization enhancement, probably due to singlet-triplet state mixing along the reaction pathway. In contrast, ester derivatives are hydrogenated in high yield and afford enhanced 1H and 13C NMR spectra after para-hydrogenation. The obtained PHIP patterns are discussed and explained on the basis of the calculated spin level populations in the para-hydrogenated products. These molecules may find interesting applications in 13C MRI as hyperpolarized probes for assessing the activity of glucose transporters in cells. © 2010 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Para-Hydrogenation of unsaturated moieties on poly(lysine) derived substrates for the development of novel hyperpolarized MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>21</number>
        </detail>
        <extent unit="pages">
          <start>3948</start>
          <end>3954</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">14770520 (ISSN)</identifier>
      <titleInfo>
        <title>Organic and Biomolecular Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Org. Biomol. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-27844585170&amp;partnerID=40&amp;md5=76c60f7c887cbb516630d603761315d7</url>
    </location>
    <abstract>Four alkyne-functionalized poly(lysine) derivatives have been synthesized and characterized by 1H and 13C NMR spectroscopy. In the first poly(lysine) derivative, phenylpropiolate moieties are directly bound to the aminic arms, whereas in the other derivatives, propargylamine moieties are bound to the aminic poly(lysine) arms through glucaric acid and diethylene glycol (DG) chains, respectively. para-Hydrogenation of the alkyne- functionalized poly(lysine) compounds has been investigated and the results have been discussed in terms of spin lattice relaxation properties of the hydrogenated products. It is shown that the longer the mobile chain separating the unsaturation from the poly(lysine) backbone, the more intense the polarized signals when para-hydrogenation is carried out. This is due to (a) the maintenance of short reorientational times on the unsaturated ends, and therefore a sufficiently long T1 of the protons added during hydrogenation, and (b) the minor effect of steric hindrance by the poly(lysine) backbone that decreases interaction of the unsaturation with the catalyst, allowing higher hydrogenation rates. © The Royal Society of Chemistry 2005.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Paramagnetic complexes as novel NMR pH indicators</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>1265</start>
          <end>1266</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0002272572&amp;partnerID=40&amp;md5=c1ee60ec9e0346976dc665faceed44a0</url>
    </location>
    <abstract>The remarkable pH dependence of the chemical shift separation (7.0 ± 0.1 ppm/pH unit) observed between the outer 1H NMR resonances on the spectrum of the paramagnetic complex [Yb(dotp)]5- [H8dotp = 1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetrakis- (methylenephosphonic acid)] in the pH range 5.0-7.5 at 39°C enables this compound to be considered as a potential NMR probe for in vivo pH measurements.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Paramagnetic GdIIIFeIII heterobimetallic complexes of DTPA-bis-salicylamide</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>49</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1315</start>
          <end>1322</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1993</dateIssued>
      </originInfo>
      <identifier type="issn">05848539 (ISSN)</identifier>
      <titleInfo>
        <title>Spectrochimica Acta Part A: Molecular Spectroscopy</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Spectrochim. Acta Part A Mol. Spectrosc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0343822789&amp;partnerID=40&amp;md5=e20e3a13f3011b2f4347562b1ed535d2</url>
    </location>
    <abstract>The reaction between DTPA (diethylenetriaminepenta-acetic acid)-anhydride and p-aminosalicylic acid (PAS) affords a novel ligand, [DTPA(PAS)2], able to form stable heterobimetallic complexes with Gd3+ and Fe3+ ions. The lanthanide ion occupies an internal coordination cage formed by three nitrogen atoms, two carboxylate and two carboxoamido groups of the ligand, whereas the outer salicylic moieties form stable chelate rings with FeIII ions. The stoichiometry of the resulting heterobimetallic complexes, established by measurements of water proton relaxation enhancement, is [(H2O)-Gd-DTPA(PAS)2]2-Fe(H2O)2 or [(H2O)-Gd-DTPA(PAS)2]3-Fe depending on the pH of the aqueous solution. The individual contributions to the observed relaxation enhancement from Gd3+ and Fe3+ paramagnetic ions have been clearly distinguished and analysed. © 1993.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mortillaro</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nielsen</namePart>
      <namePart type="given">F.U.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>47</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>639</start>
          <end>648</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Med.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0036204319&amp;partnerID=40&amp;md5=0d72c596b76116b2c1ab9d63a3642bcb</url>
    </location>
    <abstract>The recently introduced new class of contrast agents (CAs) based on chemical exchange saturation transfer (CEST) may have a huge potential for the development of novel applications in the field of MRI. In this work we explored the CEST properties of a series of Lanthanide(III) complexes (Ln = Eu, Dy, Ho, Er, Tm, Yb) with the macrocyclic DOTAM-Gly ligand, which is the tetraglycineamide derivative of DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid). These complexes possess two pools of exchangeable protons represented by the coordinated water and the amide protons. Yb-DOTAM-Gly displays the most interesting CEST properties when its amide N-H resonance (16 ppm upfield H2O signal) is irradiated. Up to 70% suppression of the water signal is obtained at pH 8. As the exchange rate of amide protons is base-catalyzed, Yb-DOTAM-Gly results to be an efficient pH-responsive probe in the 5.5-8.1 pH range. Moreover, a ratiometric method has been set up in order to remove the dependence of the observed pH responsiveness from the absolute concentration of the paramagnetic agent. In fact, the use of a mixture of Eu-DOTAM-Gly and Yb-DOTAM-Gly, whose exchangeable proton pools are represented by the coordinated water (ca. 40 ppm downfield H2O signal at 312K) and amide protons, respectively, produces a pH-dependent CEST effect which is the function of the concentration ratio of the two complexes. © 2002 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Paramagnetic liposomes as innovative contrast agents for magnetic resonance (MR) molecular imaging applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stancanello</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>5</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>1901</start>
          <end>1912</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">16121872 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry and Biodiversity</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Biodiversity</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-58149327209&amp;partnerID=40&amp;md5=d0af40fc26499e99cc5917cd45add5e9</url>
    </location>
    <abstract>This article illustrates some innovative applications of liposomes loaded with paramagnetic lanthanide-based complexes in MR molecular imaging field. When a relatively high amount of a GdIII chelate is encapsulated in the vesicle, the nanosystem can simultaneously affect both the longitudinal (R1) and the transverse (R2) relaxation rate of the bulkH2O H-atoms, and this finding can be exploited to design improved thermosensitive liposomes whose MRI response is not longer dependent on the concentration of the probe. The observation that the liposome compartmentalization of a paramagnetic LnIII complex induce a significant R2 enhancement, primarily caused by magnetic susceptibility effects, prompted us to test the potential of such agents in cell-targeting MR experiments. The results obtained indicated that these nanoprobes may have a great potential for the MR visualization of cellular targets (like the glutamine membrane transporters) overexpressing in tumor cells. Liposomes loaded with paramagnetic complexes acting as NMR shift reagents have been recently proposed as highly sensitive CEST MRI agents. The main peculiarity of CEST probes is to allow the MR visualization of different agents present in the same region of interest, and this article provides an illustrative example of the in vivo potential of liposome-based CEST agents. © 2008 Verlag Helvetica Chimica Acta AG, Zürich.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Paramagnetic water proton relaxation enhancement: From contrast agents in MRI to reagents for quantitative 'in vitro' assays</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ermondi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>10</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>849</start>
          <end>854</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1992</dateIssued>
      </originInfo>
      <identifier type="issn">0730725X (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>MAGN. RESON. IMAGING</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0026768532&amp;partnerID=40&amp;md5=fef62cfbaff04f64547d1be388ba6672</url>
    </location>
    <abstract>The use of stable complexes of paramagnetic metal ions as probes in analytical applications of the NMR technique is discussed. Two examples are given that involve the determination of the total Fe3+ content of human serum transferrin (Tf) and the extent of glycation of human serum albumin (HSA). The method is based on the measurement of the longitudinal water proton relaxation times, conveniently altered following a selective chemical interaction between the substrate and the paramagnetic probe.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Peptide derivatized lamellar aggregates as target-specific MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Tesauro</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Accardo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paduano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Teixeira</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Schillén</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Morelli</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>8</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>950</start>
          <end>955</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">14394227 (ISSN)</identifier>
      <titleInfo>
        <title>ChemBioChem</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>ChemBioChem</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34447512737&amp;partnerID=40&amp;md5=e25a6181479644fd92c0891ccd38d6e6</url>
    </location>
    <abstract>The relaxivity behaviour and the structural characterization of new supramolecular aggregates (bilayer structures and micelles) obtained by combining two different amphiphilic monomers are reported. One monomer, (C18)2DTPAGlu-Gd, contains a very stable gadolinium complex, and the other, DSPE-PEG2000-CCK8, contains the bioactive CCK8 peptide. Samples that contained only DSPE-PEG2000-CCK8, or up to 50% (C18)2DTPAGlu-Gd, aggregated as double-layer structures (lamellar aggregates) with a thickness of ∼80-100 Å, as evaluated by SANS measurement and Cryo-TEM imaging. A transition to micelle formation was observed when the amount of (C18)2DTPAGlu-Gd in the aggregate was increased. These were rod-like micelles ∼40 Å in radius and &gt; 200 Å in length. The proton relaxivities for both lamellar aggregates and rod-like micelles were the same (17.2 mM-1 s-1), although the values were the results of different combinations of local and global contributions. The in vitro target selectivity of aggregates that contained the CCK-8 peptide was demonstrated by using nuclear medicine techniques. © 2007 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Lowe</namePart>
      <namePart type="given">M.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reany</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castellano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>123</number>
        </detail>
        <detail type="issue">
          <number>31</number>
        </detail>
        <extent unit="pages">
          <start>7601</start>
          <end>7609</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <abstract>A series of macrocyclic Eu, Gd, and Tb complexes has been prepared in which the intramolecular ligation of a β-arylsulfonamide nitrogen is rendered pH-dependent, giving rise to changes in the hydration state, q, at the lanthanide center. In complexes based on DO3A, variation of the p-substituent in the arylsulfonamide moiety determines'the apparent protonation constant log KMLH with values of 5.7, 6.4, and 6.7 for the -CF3, -Me, and -OMe substituents, respectively. Introducti0n of three β-carboxyalkyl substituents, αto three ring nitrogens, inhibits displacement of the bound water by added protein and also suppresses intermolecular binding by endogenous anions (lactate, HCO3-). Measurements of the pH dependence of the form and intensity of the Eu complexes revealed that intramolecular carboxylate coordination occurred competitively. This was reduced either by enhancing the electron density at the sulfonamide nitrogen or by enlarging the chelate ring from 7-8. Amplification of the relaxivity changes in the pH range 8-5 occurred on protein binding, and over the pH range 7.4-6.8 a 48% change in relaxivity was defined for [Gd·3a] (298 K, 65.6 MHz) in 50% human serum solution.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Ciraolo</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Iezzi</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Marone</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Marengo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Curcio</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Costa</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Azzolino</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gonella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rubinetto</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Wu</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Martin</namePart>
      <namePart type="given">E.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Silengo</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Altruda</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Turco</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzetti</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Musiani</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rückle</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rommel</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Backer</namePart>
      <namePart type="given">J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Forni</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Wymann</namePart>
      <namePart type="given">M.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hirsch</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1</number>
        </detail>
        <detail type="issue">
          <number>36</number>
        </detail>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">19379145 (ISSN)</identifier>
      <titleInfo>
        <title>Science signaling</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Sci Signal</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-55649084906&amp;partnerID=40&amp;md5=2b886171c7b1194ab00edda418e26413</url>
    </location>
    <abstract>The phosphoinositide 3-kinase (PI3K) pathway crucially controls metabolism and cell growth. Although different PI3K catalytic subunits are known to play distinct roles, the specific in vivo function of p110beta (the product of the PIK3CB gene) is not clear. Here, we show that mouse mutants expressing a catalytically inactive PIK3CB(K805R) mutant survived to adulthood but showed growth retardation and developed mild insulin resistance with age. Pharmacological and genetic analyses of p110beta function revealed that p110beta catalytic activity is required for PI3K signaling downstream of heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors as well as to sustain long-term insulin signaling. In addition, PIK3CB(K805R) mice were protected in a model of ERBB2-driven tumor development. These findings indicate an unexpected role for p110beta catalytic activity in diabetes and cancer, opening potential avenues for therapeutic intervention.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Photochemical activation of endosomal escape of MRI-Gd-agents in tumor cells.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arena</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Strijkers</namePart>
      <namePart type="given">G.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nicolay</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Högset</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>65</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>212</start>
          <end>219</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">15222594 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn Reson Med</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79954426721&amp;partnerID=40&amp;md5=715b64665fe8f06db8737f783d5a2c53</url>
    </location>
    <abstract>Endocytosis is a common internalization pathway for cellular labeling with MRI contrast agents. However, the entrapment of the Gd(III) complexes into endosomes results in a "quenching" of the attainable relaxivity when the number of Gd(III) complexes reaches the number of ca. 1 × 10(9)/cell. Herein we show that the use of the newly developed photochemical internalization technique provides an efficient method for attaining the endosomal escape of GdHPDO3A molecules entrapped by pinocytosis into different kind of cells. Furthermore, it has been found that a new "quenching" limit is observed when the number of Gd-HPDO3A complexes is ca. five times higher than the value observed for the endosome entrapped conditions. The observed behavior is explained in terms of the attainment of the conditions in which the difference in proton relaxation rates between the cytoplasmic and the extracellular compartment is higher than the exchange rate of water molecules across the cellular membrane. The experimental data points have been reproduced by using a properly designed theoretical compartment T(1)-relaxation model. © 2010 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Photochemistry of hydrido ruthenium clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Amadelli</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Carassiti</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maldotti</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>81</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>L11-L13</start>
          <end>L11-L13</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-48749136279&amp;partnerID=40&amp;md5=b940b79a04a3a8dcf182ab6769beb23a</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Polarization transfer from para-hydrogen to heteronuclei: Effect of H/D substitution. the case of AA′X and A2A2′X spin systems</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canet</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>178</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>184</start>
          <end>192</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">10907807 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Magn. Reson.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-30844450310&amp;partnerID=40&amp;md5=82aa3d7f1960bea42117010f31c7a83e</url>
    </location>
    <abstract>Upon hydrogenation from para-hydrogen (p-H2), hyperpolarization transfer toward a heteronucleus may be possible even if the two protons are chemically equivalent in the final product (but not magnetically equivalent), provided that J couplings with the heteronucleus exist. It is however shown (theoretically and experimentally) that this transfer effectively occurs if the spin system in the hydrogenated molecule is of the type AA′X (A and A′ denoting the two protons originating from p-H2 and X the heteronucleus) but does not occur for a spin system of the A2A2′X type. A theory has been worked out for assessing the details of the X spectrum (multiplet patterns) in the case of ALTADENA and PASADENA experiments. Experimental verifications are provided. © 2005 Elsevier Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Poly-beta-cyclodextrin based platform for pH mapping via a ratiometric 19F/1H MRI method.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arena</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>40</number>
        </detail>
        <extent unit="pages">
          <start>6044</start>
          <end>6046</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">1364548X (ISSN)</identifier>
      <titleInfo>
        <title>Chemical communications (Cambridge, England)</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun. (Camb.)</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-75549085835&amp;partnerID=40&amp;md5=9f52f8d494e5a1741f87650f894ace92</url>
    </location>
    <abstract>The in vitro validation of a new pH mapping MRI method based on a supramolecular poly-beta-cyclodextrin-19F-Gd adduct is reported.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Poly-β-cyclodextrin based platform for pH mapping via a ratiometric 19F/1H MRI method</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arena</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>40</number>
        </detail>
        <extent unit="pages">
          <start>6044</start>
          <end>6046</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77950154039&amp;partnerID=40&amp;md5=f2bb8c50c33ca8cdb0864d9c849591cc</url>
    </location>
    <abstract>The in vitro validation of a new pH mapping MRI method based on a supramolecular poly-β-cyclodextrin-19F-Gd adduct is reported. © 2009 The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Products of the reaction of Ru3(CO)12 with 1,3-cyclohexadiene. X-ray structure of (η-benzene)nonacarbonyl-1-cyclohexen-1,2-ylenetetraruthenium, Ru4(CO)9(C6H6)(C6H8)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Angelo Vaglio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valle</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Camellini</namePart>
      <namePart type="given">M.T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>34</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>49</start>
          <end>55</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1979</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0010869198&amp;partnerID=40&amp;md5=9f23cb49c907ae426f018c6a93a54104</url>
    </location>
    <abstract>The reaction between Ru3(C0)12 and 1,3-cyclohexadiene has been carried on under different conditions: contrary to previous findings Ru3(CO)12 does not catalyze the cleavage and the hydrogenation of 1,3-cyclohexediene. The products of the reaction have been characterized by i.r., n.m.r. and mass spectrometry. The crystal structure of the novel complex Ru4(CO)9(C6H6)(C6H8) has been determined by X-ray methods. Crystals are monoclinic, space group P21/2c with Z = 4 in a unit cell of'dimensions: a = 15.167(15), b = 10.114(9), c = 15.517(12) Å, β = 87.1(1)°. The structure has been solved from diffractometer data by Patterson and Fourier methods and refined by full-matrix least squares to R = 0.058 for 3828 observed reflections. A four metal atom cluster, in a "butterfly" arrangement, is coordinated by nine terminal CO groups, by a benzene molecule and a 1-cyelohexen-1,2-ylene unit obtained, respectively, by dehydrogenation and isomerization of two diene molecules. © 1979.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Proteomic analysis of a genetically modified maize flour carrying Cry1Ab gene and comparison to the corresponding wild-type</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Giuliano Albo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mila</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Motto</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Corpillo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>52</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>443</start>
          <end>455</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">00256153 (ISSN)</identifier>
      <titleInfo>
        <title>Maydica</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Maydica</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-40449128214&amp;partnerID=40&amp;md5=d5503abb491b2c5d429825d712169297</url>
    </location>
    <abstract>Protein expression in a maize hybrid flour (hereafter called WT) and its corresponding transgenic version resistant to European corn borer (hereafter called BT and carrying a gene encoding for the Bacillus thuringiensis insecticidal protein Cry1Ab) has been studied by means of two-dimensional gel electrophoresis coupled with mass spectrometry. This comparison has been chosen as a model to verify proteomics capability in detecting unexpected differences between near-isogenic lines (differing in the ideal case only for the presence of the transgenic protein). Some unpredictable differences were detected: i) glucose and ribitol dehydrogenase spot was unique of BT maize; ii) endochitinase A spot was unique of WT maize; iii) triosephosphate isomerase 1 and one spot of globulin-1 S were overexpressed while cytosolic 3-phosphoglycerate kinase and one spot of aldose reductase were down-regulated in BT maize with respect to WT. These results outline the potential of the new non-targeted "-omics" technologies (in particular proteomics) in the detection of unexpected, unintended and unwanted variations in Genetically Modified (GM) versus non-GM food comparison and suggest the possible employment of these technologies in substantial equivalence evaluation. Moreover, a reference map for maize flour was built: forty spots, corresponding to twenty-five different proteins, were successfully identified.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Prototropic and water-exchange processes in aqueous solutions of Gd(III) chelates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>32</number>
        </detail>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>941</start>
          <end>949</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">00014842 (ISSN)</identifier>
      <titleInfo>
        <title>Accounts of Chemical Research</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Acc. Chem. Res.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032745713&amp;partnerID=40&amp;md5=e48481d5e72f7c4644156f64ce022eea</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Prototropic vs whole water exchange contributions to the solvent relaxation enhancement in the aqueous solution of a cationic Gd3+ macrocyclic complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Sousa</namePart>
      <namePart type="given">A.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>119</number>
        </detail>
        <detail type="issue">
          <number>20</number>
        </detail>
        <extent unit="pages">
          <start>4767</start>
          <end>4768</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. AM. CHEM. SOC.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0031003651&amp;partnerID=40&amp;md5=610de09b38c9198333286a0e85f1792f</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>42</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>822</start>
          <end>831</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">00014842 (ISSN)</identifier>
      <titleInfo>
        <title>Accounts of Chemical Research</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Acc. Chem. Res.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-67651102587&amp;partnerID=40&amp;md5=c4662265a4c37907ef38a82ae7b759b5</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Quantification of the expression level of integrin receptor αvβ3 in cell lines and MR imaging with antibody-coated iron oxide particles</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Benedetto</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pulito</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tarone</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Silengo</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hamm</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>56</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>711</start>
          <end>716</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Med.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33749161674&amp;partnerID=40&amp;md5=aac885b92c7355eb689efd2bcc45e3e1</url>
    </location>
    <abstract>Targeted imaging requires site-specific accumulation of a contrast agent (CA), and the properties of that agent must be selected according to the abundance of the target to obtain a signal above the detection limit of the instrument. However, numerical estimates of receptors per cell are rarely found in the literature. Integrin receptors would be particularly promising targets because of their accessibility from the blood stream and expression on activated neovascular endothelial cells. We systematically estimated the number of integrin receptors of cell lines and primary cells by flow cytometry analysis. Since integrin receptors are heterodimeric molecules, and αv forms complexes with various β subunits, the numbers of αv and β3 subunits are therefore dissimilar. The observed values are 3 · 103-1.4 · 104/cell for αv, and 5.3 · 102-1.1 · 10 4/cell for β3. Despite the low number of exposed receptors, we show that up to single-cell MR visualization can be achieved with the use of iron oxide beads complexed with antibodies as CAs. © 2006 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Quantitative determination of methemoglobin by measuring the solvent- water proton-nuclear magnetic resonance relaxation rate</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastru</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arnelli</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castagnola</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giardina</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>38</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>2401</start>
          <end>2404</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1992</dateIssued>
      </originInfo>
      <identifier type="issn">00099147 (ISSN)</identifier>
      <titleInfo>
        <title>Clinical Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>CLIN. CHEM.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0027049167&amp;partnerID=40&amp;md5=d692ecbffcff2906f482c3b253ea9fd2</url>
    </location>
    <abstract>We report a new method for the quantitative determination of human methemoglobin (metHb) based on the measurement of the solvent-water proton- nuclear magnetic resonance (NMR) relaxation rate R1 [normalized to 1 mmol/L hemoglobin (Hb) concentration]. MetHb (%) is estimated from the linear dependence of R1 on the metHb concentration, taking into account the simple relationship [MetHb] = [(R1 - R1/(HbO2)/(R1/(metHb) - R1/(HbO2))] · 100, where R1/(HbO2) and R1/(metHb) are values for the solvent-water relaxation rate of standard 1.0 mmol/L solutions of the oxygenated derivative of human hemoglobin (HbO2) and of metHb, respectively. The minimum metHb that may be determined from the analysis of the experimental data is 0.5 ± 0.4%.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reaction of 4-methylpent-2-yne with dodecacarbonyltriruthenium. The structure of a novel alkyne dimerization dehydrogenation product</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanfredi</namePart>
      <namePart type="given">A.M.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>2023</start>
          <end>2028</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1981</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049096572&amp;partnerID=40&amp;md5=c8da6db4ef9027d99eb152553cf5c27f</url>
    </location>
    <abstract>Reaction of [Ru3(CO)12] with 4-methylpent-2-yne yields, as the major product, an open cluster [Ru3(CO)8(C12H18)], the result of an unusual type of dimerization and dehydrogenation of an internal alkyne. The crystal structure of [Ru3(CO)8(C12H18)] has been determined by X-ray methods. Crystals are triclinic, space group P1̄, with Z = 2 in a unit cell of dimensions a = 9.719(8), b = 13.862(10), c = 9.039(8) Å, α = 103.40(8), β = 103.60(7), and γ = 87.76(6)°. The structure has been solved from diffractometer data by Patterson and Fourier methods and refined by full-matrix least squares to R = 0.033 for 3 701 observed reflections. The complex consists of a bent arrangement of three Ru atoms (with Ru-Ru bonds of 2.661 and 2.645 Å and Ru-Ru-Ru angle of 89.1°) co-ordinated by eight (six terminal and two bridging) carbonyls and by an organic ligand, derived from dimerization and dehydrogenation of 4-methylpent-2-yne. This organic ligand forms two σ bonds with the central Ru atom, giving rise to a metallocyclopentadiene ring in which the terminal Ru atoms are on opposite sides of this ring and are η interacting with its four carbon atoms.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reaction of Ru3(CO)12 with styrene</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Johnson</namePart>
      <namePart type="given">B.F.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lewis</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>233</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>247</start>
          <end>252</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1982</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0010803964&amp;partnerID=40&amp;md5=e0787fd687c01a87486d2f44f0e3f7f5</url>
    </location>
    <abstract>The reaction of styrene with Ru3(CO)12 yields the known complex Ru4(CO)12(PhCCH) and the new cluster Ru4(CO)9(PhCCH)(PhEt), in which a second molecule of styrene is hydrogenated and η6-bonded. © 1982.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reactions of 3-hexyne with cobalt and iron carbonyls. Crystal structure and fluxionality of FeCo2(CO)9C2Et2</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanfredi</namePart>
      <namePart type="given">A.M.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>21</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>501</start>
          <end>505</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1982</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000494751&amp;partnerID=40&amp;md5=35b0763c9fa8c3275fab3d8306597c58</url>
    </location>
    <abstract>Oxygen incorporation α to the triple bond occurs by reacting a mixture of Co2(CO)8 and Fe(CO)5 or HFeCo3(CO)12 with 3-hexyne: Co2(CO)6EtC2CHOHCH3 and Co2(CO)6EtC2COCH3 are obtained. Other products of the reactions are the two novel mixed-metal derivatives FeCo2(CO)9C2Et2 and FeCo(CO)6EtC2CHCH3; the latter is obtained also by dehydroxylation of Co2(CO)6EtC2CHOHCH3 with Fe(CO)5. The structure of FeCo2(CO)9C2Et2 has been determined by X-ray methods. It crystallizes in the triclinic space group P1, with two molecules in a unit cell of dimensions a = 9.558 (8) Å, b = 10.449 (9) Å, c = 9.343 (8) Å, α = 96.94 (7)°, β = 90.95 (9)°, and γ = 86.54 (8)°. The structure has been solved from diffractometer data by Patterson and Fourier methods and refined by full-matrix least-squares methods to R = 4.1% for 2306 observed reflections. The complex consists of an isosceles triangle of two Co atoms and one Fe atom (Fe-Co = 2.479 and 2.489 Å, Co-Co = 2.576 Å) bound to nine terminal carbonyls (three per each metal) and to one diethylacetylene ligand. The alkyne, σ bonded to the Co atoms and π bonded to the Fe atom, is disposed nearly parallel to the Co-Co side of the cluster. The fluxionality of FeCo2(CO)9C2Et2 has been investigated and compared with that of FeCo2(CO)9S. © 1982 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reactions of alkynes with HFeCO3(CO)12. Crystal structure of FeCO3(CO)9[PhC2(H)Ph] (PhC2Ph)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milome</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maria Manotti Lanfredi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>71</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>141</start>
          <end>147</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-49049123732&amp;partnerID=40&amp;md5=d36eaee6dfe79e3430783b73935a9627</url>
    </location>
    <abstract>The reaction of HFeCO3(CO)12 with alkynes follow different pathways depending on the solvent characteristics. In apolar water-free solvent the major product are the novel tetranuclear derivatives Fe Co3(CO)9[RC2(H)R](RC2R), in which hydrogen shift is occurred from the Co3 face of the hydrido complex to an acetylenic moiety. The structure of the complex with R = Ph has been determined by X-ray method. The compound crystallizes in the space group P1 with Z = 2 in a unit cell of dimensions a = 13.259(7), b = 12.994(8), c = 11.681(8) Å, α = 114.26(4), β = 11066(3), γ 71.32(4)°. The Structure has been solvent from diffractometer data by direct and Fourier methods and refined by full-matrix least -squares to R = 4.4% for 1789 observed reflections. The complex is characterized by tetranuclear cluster of three Co and one Fe atoms, in a butterfly arrangement, coordinated by nine carbonyls (seven terminal and two asymmetrically bridging the two FeCo Sides). The two starting C2Ph2 molecules are bound to the cluster in a different way: the former interacts with all the metals in a μ4-η2 fashion being σ-bond to the Co and Fe Atoms on the hinge and π-bonded to the Co atoms on the wings; the latter, on which the hydridic hydrogen of the starting complex is shifted, interacts only with two Co Atoms on one side of the cluster through one σ and one π bond respectively. © 1983.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reactions of protic acids with a hydridoorganometal cluster: HRu3(CO)9(C2C(CH3)3)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Barner-Thorsen</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Saatjian</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>20</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>1592</start>
          <end>1597</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1981</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4244045151&amp;partnerID=40&amp;md5=543e208b81adf0f53e62b5f352059f74</url>
    </location>
    <abstract>The titrations of HRu3(CO)9C6H9 (I), HRu3(CO)8(C6H9)PR3 (R = C6H5, OCH3) (II), and HRu3(CO)7(C6H9)(PR3) 2 (R = C6H5, OCH3) (III) with CF3SO3H in CD2Cl2 have been followed by variable-temperature 1H NMR. Initial protonation takes place at the metal core, but significant differences in the relative basicities and the rates of inter- and intramolecular hydride exchange are observed. In neat sulfuric acid a second protonation of I takes place at the organic ligand to yield a dicationic dihydrido complex H2Ru3(CO)9(HC=CC(CH3) 3)2+. In the case of II two isomeric dications are obtained as kinetic products with subsequent rearrangement to the more thermodynamically stable isomer. In D2SO4 II gives only the more thermodynamically stable product while deuterated II in H2SO4 gives a different isomer ratio than II in H2SO4. A mechanism explaining this unusual deuterium isotope effect is presented and discussed. © 1981 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reactions of solid H2Os3(CO)10 with gaseous CO, NH3, and H2S</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arce</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>13</number>
        </detail>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>4232</start>
          <end>4236</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1994</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000163490&amp;partnerID=40&amp;md5=c794a37bb975af1a4b0d0d211aa76665</url>
    </location>
    <abstract>The coordinatively unsaturated H2Os3(CO)10 (1) cluster reacts readily in the solid state with gaseous reactants L (L = CO, NH3, H2S) to afford the electron-precise adducts H2Os3(CO)10L (2, L = CO; 3, L = NH3; 4, L = H2S). In the case of the reaction with CO, the solid product 2 was unambiguously characterized by means of 1H magic angle spinning NMR spectroscopy. Upon longer reaction times compound 2 releases H2 and transforms into Os3(CO)12 (5). The novel NH3 adduct 3 exists in solution as a mixture of two isomers, differing in the relative orientation of the ammonia and the terminal hydride ligands with respect to the Os3 plane (syn and anti). Variable-temperature (VT) 1H and 13C NMR spectroscopy revealed that these isomers interconvert in solution. The novel H2S adduct 4 was much less stable than the other two, and upon dissolution in dichloromethane, it immediately transformed into the known compound H2Os3(CO)9S (6). © 1994 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reactivity of the ruthenium carbonyl hydride HRu3(CO)9C2C(CH3)3</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gervaso</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Franchini-Angela</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>26</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>223</start>
          <end>226</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1978</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0008667994&amp;partnerID=40&amp;md5=e92cecab4ac8f628ef61450e89030ea6</url>
    </location>
    <abstract>In the products of the reaction of Ru3(CO)12 and 3,3-dimethyl-1-butyne, hydrogen transfer and alkyne oligomerization are observed. The behaviour of the main product, HRu3(CO)9C2C(CH3)3 towards electrophilic reagents hat been investigated. By deuterium labelling some insight has been gained into the mechanism of the reaction. © 1978.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reactivity studies of para-hydrogen with μ3-quinolyl triosmium clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Bergman</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>21</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1508</start>
          <end>1511</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0012815223&amp;partnerID=40&amp;md5=2a02e1f81f869772c874f6f338c4526c</url>
    </location>
    <abstract>The reactions of the cluster complexes Os3(CO)9(μ3-η3-C9H 7(4-CH3)N(μ-H)(1), Os3(CO)9(μ3-η2-C9H 5(n-NH2)N)(μ-H) (n = 3, 2, n = 5, 3), Os3(CO)9(μ3-η2-C9H 6(4-C(CH3)2CN)(5-NH2)N)(μ-H) (4), and Os3(CO)9(μ3-η2-C9H 6(4-C(CH3)2CN)(5-F)N)(μ-H) (5) with para-hydrogen have been studied at ∼3 atm and 90-110 °C. In all cases, reaction at the metal core is the initial product and polarization enhanced polyhydride intermediates are observed. The chemical shifts and relative intensities of these resonances are used to extract mechanistic information about the reactivity of 1-5. As with previous studies on related electron-deficient complexes, 3-5 show reactivity that is very sensitive to the substituent in the 5-position.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reduction/Dissolution of a β-MnOOH nanophase in the ferritin cavity to yield a highly sensitive, biologically compatible magnetic resonance imaging agent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Kálmán</namePart>
      <namePart type="given">F.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti-Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>49</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>612</start>
          <end>615</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-74549215980&amp;partnerID=40&amp;md5=20a61fcfa5b0f744eb678cfd75d7e9d5</url>
    </location>
    <abstract>(Figure Presented) A manganese-based contrast agent for magnetic resonance imaging has been obtained by partial reduction/dissolution of solid β-MnOOH inside the cavity of apoferritin (see scheme). The resulting nanocarriers contain up to 300-400 Mn aqua ions and have a remarkable relaxivity of 4000-7000 m M-1 s-1 per apoferritin unit. © 2010 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Regiospecific substitution of trialkylphosphines for carbon monoxide in hydridoorganoruthenium clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Jangala</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Skinner</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>19</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>1571</start>
          <end>1575</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1980</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0039597953&amp;partnerID=40&amp;md5=e089f9a075281c0dfbed45e5421fb91a</url>
    </location>
    <abstract>The reaction of two structural types of hydridoorganoruthenium clusters HRu3(CO)9(C6H9) (I) and HRu3(CO)9(C5H7) (IIa, IIb) with triphenylphosphine and trimethyl phosphite have been studied. The major product for both structural types is a monophosphine derivative (I → III; IIa → V; IIb → VI) in which a carbonyl group has been replaced only on ruthenium atoms having a σ bond with the organic ligand. Solution structures are assigned on the basis of variable-temperature 13C and 1H NMR studies. In III, only conformers with the phosphine ligand in a radial position are populated from -80 to +40°C. However, axial-radial carbonyl exchange at the substituted ruthenium atom occurs at about the same rate as in I. A bis(phosphine) derivative of I has also been isolated and characterized (IV). © 1980 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reinvestigation of the solution structure of Co4(CO)12 by 13C and 59Co NMR. 2.</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milonej</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>65</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>308</start>
          <end>315</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1985</dateIssued>
      </originInfo>
      <identifier type="issn">00222364 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance (1969)</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-46549093605&amp;partnerID=40&amp;md5=6efa9e1392dab49eda23bcba52b4a0bb</url>
    </location>
    <abstract>High-field 13C NMR studies at various temperatures on 13C enriched samples of Co4(CO)12 and mono substituted derivatives, together with new 59Co results can be interpreted in terms of CO exchange and 13C relaxation of the second kind caused by 13C59Co coupling. Erstwhile missing 13C lines have now been observed and the details of the effects of relaxation used to assign these lines to apical CO ligands in a C3ν structure. © 1985.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relationship between Solid State NMR Parameters and X-ray Structural Data in Tricadmium Phosphates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bigi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ripamonti</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Roveri</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gazzano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>35</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>149</start>
          <end>154</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000051378&amp;partnerID=40&amp;md5=cdf0d1d2a64c3fc2946d8105757ae536</url>
    </location>
    <abstract>31P and 113Cd MAS NMR spectra of solid β'-tricadmium phosphate (β'-TCdP) show a number of highly resolved resonances that agree well with the number of independent crystallographic sites indicated by the results of X-ray diffraction studies. A correlation of the 31P chemical shifts with the crystallographic sites for the six different PO43- groups in the unit cell of β'-TCdP has been obtained by a method based on the computation of bond strength at oxygen atoms in phosphate moieties. The assignment of the 113Cd resonances has been carried out on the basis of the relationship between the asymmetry of the chemical shift tensor (evaluated by analysis of the spinning side bands intensities in the MAS spectrum) and a geometric parameter related to the distortion from the bipyramidal trigonal coordination at each cadmium center. Samples of tricadmium phosphate with different degrees of magnesium substitution for cadmium were investigated by 31P MAS NMR, 113Cd MAS NMR, and X-ray diffraction. The results of these investigations showed that the magnesiums distribute randomly in the cadmium sites, inducing a marked decrease in the order of the structure.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relationships between structure and ligand dynamics in organometal clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>1</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>640</start>
          <end>644</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1982</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0040729495&amp;partnerID=40&amp;md5=42646a4982b1a3e1edec68c8be37000d</url>
    </location>
    <abstract>The variable-temperature 1H and 13C NMR spectra of the hydrido orgenometal clusters HM3(CO)9[CH3C=C=C(CH3)2] (M = Ru, Oa) have been examined. When M = Ru, a dynamic process a observed which avarages the mignetically inequivalent methyl groups on the ligand and also results in a twofold symmetry plane at the metal cluster with raspect to the corbonyl ligands. These observations are explained in terms of edge hopping of the hydride ligand and a simultaneous "wagging" motion of the organic ligand. © 1982 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relationships between structure and ligand dynamics. II. Alkyne and carbonyl dynamics in Os3(CO)9(alkyne)(L) (L = CO, PR3)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bracker-Novak</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gellert</namePart>
      <namePart type="given">R.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>365</number>
        </detail>
        <detail type="issue">
          <text>1-2</text>
        </detail>
        <extent unit="pages">
          <start>163</start>
          <end>185</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1989</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001048424&amp;partnerID=40&amp;md5=36d53618b7853a1c431f4cf3d9fc781a</url>
    </location>
    <abstract>The synthesis of the phosphine substituted complexes Os3(CO)9(μ3-η2-CH3CH2-CCCH2CH3)L (L = P(C6H5)3 (III), P(CH3)3 (IV)) and Os3(CO)9(μ3-η2-CH3CCCH3)L (L = P(OCH3)3 (V)) are reported. A detailed analysis of the VT-1H and VT-13C NMR of these complexes is presented and compared with the same studies on the parent complexes Os3(CO)9(μ3-η2-RCCR)(μ-CO) (R = CH2CH3 (I), CH3 (II)). In the parent complexes I and II a two stage exchange process is observed: (1) a low energy process involving axial radial exchange at the carbonyl bridged osmium atoms, (2) a higher energy exchange process in which alkyne motion over the face of the metal triangle is coupled with bridge-terminal exchange of the carbonyls, and with axialradial exchange at the unique osmium atom. The phosphine derivatives III-V, all show a three stage exchange process: (1) a localized axial-radial exchange at the unsubstituted osmium atoms; (2) a semibridging terminal carbonyl exchange at the phosphine substituted osmium coupled with a restricted oscillation of the alkyne, pivoted on this osmium atom; (3) free motion of the alkyne and averaging of all the carbonyl groups. The relationship between the differences in the observed dynamic processes are understood by a comparison of the solid state structures of I and III which are also reported. Compound I crystallizes in the triclinic space group P1, with unit cell parameters a 9.292(2), b 15.340(3), c 8.391(2) Å, α 91.27(2), β 116.70 (1), γ 105.24(2)°, V 1017.3(4) Å3, and Z = 2. Compound III belongs to the monoclinic space group P21/c, with a 14.271(4), b 11.370(2), c 21.192(5) Å, β 104.43(2)3, V 3330(1) Å3, and Z = 4. The structures were refined by full matrix least squares to RF = 0.044, RwF = 0.058 for I, and RF = 0.033, RwF = 0.041 for III, respectively. © 1989.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxivity modulation in Gd-functionalised mesoporous silicas</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Carniato</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Marchese</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>1246</start>
          <end>1248</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-60849135431&amp;partnerID=40&amp;md5=7c6b6fb13ed0892e29c105c077cb6cb8</url>
    </location>
    <abstract>Two hybrid materials based on mesoporous silicas SBA-15 and MCM-41 functionalized with stable and electrically neutral Gd(iii) macrocyclic complexes were prepared, and their 1H NMR relaxometric properties investigated as a function of temperature and magnetic field strength. © The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxometric and luminescence behaviour of triaquahexaazamacrocyclic complexes, the gadolinium complex displaying a high relaxivity with a pronounced pH dependence</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Hall</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Häner</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Faulkner</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Sousa</namePart>
      <namePart type="given">A.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>22</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>627</start>
          <end>631</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">11440546 (ISSN)</identifier>
      <titleInfo>
        <title>New Journal of Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>New J. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000226220&amp;partnerID=40&amp;md5=77d66fbcd6ddea86816c1cda377eb6b8</url>
    </location>
    <abstract>The relaxivity of [GdL1]3+ in aqueous solution has been studied as a function of temperature and magnetic field strength. The complex possesses a high relaxivity at pH 6 (12.8 mmol-1 s-1) that diminishes as successive water molecules are deprotonated, leading to a complex species whose relaxivity is typical of a purely outer-sphere complex. Measurements of the luminescence lifetime of a very similar complex, [YbL2]3+, in H2O and D2O were used to confirm that the complex possesses three bound waters at pH 5.5, but above pH 11 there are no bound OH groups in the putative di-oxo-bridged dimer.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxometric and modelling studies of the binding of a lipophilic Gd-AAZTA complex to fatted and defatted human serum albumin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Menegotto</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>13</number>
        </detail>
        <detail type="issue">
          <number>20</number>
        </detail>
        <extent unit="pages">
          <start>5785</start>
          <end>5797</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34547169915&amp;partnerID=40&amp;md5=133df5a73a83087a01f2a107da031882</url>
    </location>
    <abstract>A new lipophilic gadolinium chelate consisting of a long aliphatic chain bound to the AAZTA coordination cage (Gd-AAZTAC17) has been synthesised. It possesses two coordinated water molecules (q = 2) in fast exchange with the solvent (τM298 = 67 ns), which yields a relaxivity of 10.2 mM-1 s-1. At concentrations greater than 0.1 mM, it forms micelles (average diameter 5.5 nm) characterised by a relaxivity of approximately 30 mM-1 s-1 at 20 MHz and 298 K. The latter value appears to be "quenched" by magnetic interactions among the GdIII ions on the surface of the micelle that cause a decrease in the electronic relaxation time. A relaxivity of 41 mM-1 s-1 was recorded for this micellar system when 98% of the GdIII ions were replaced by diamagnetic YIII. Gd-AAZTAC17 exhibits a better affinity for fatted human serum albumin (HSA) than for defatted HSA, whereas the relaxivities of the supramolecular adducts are reversed. The relaxivity shown by Gd-AAZTAC17/defatted HSA (r1b(20 MHz, 298 K) = 84 mM -1 s-1) is by far the highest relaxivity reported so far for non-covalent paramagnetic adducts with slow-moving substrates. As shown by molecular docking calculations, the gadolinium complex enters a hydrophobic pocket present in fatted HSA more extensively than the corresponding adduct with defatted HSA. Interestingly, no marked difference was observed in either the relaxation enhancement or the binding affinity between fatted and defatted HSA when the binding titrations were carried out at a Gd-AAZTAC17 concentration higher than its critical micellar concentration (cmc). This behaviour has been attributed to the formation of an association between the negatively charged micelle of the lipophilic metal complexes and the positive residues on the surface of the protein. © 2007 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxometric and solution NMR structural studies on ditopic lanthanide(iii) complexes of a phosphinate analogue of DOTA with a fast rate of water exchange</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rudovský</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hermann</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Koridze</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>19</number>
        </detail>
        <extent unit="pages">
          <start>2323</start>
          <end>2333</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">14779226 (ISSN)</identifier>
      <titleInfo>
        <title>Dalton Transactions</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Dalton Trans.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33646698179&amp;partnerID=40&amp;md5=2f814d44181b77ff20d8a717492171dc</url>
    </location>
    <abstract>A novel "ditopic" ligand containing two monophosphinate triacetate DOTA-like units linked by a thiourea bridge has been synthesized and its complexes with Ln3+ ions (Ln = Y, Eu, Gd, Dy) investigated by NMR spectroscopy and relaxometry. The presence of one water molecule in the first coordination sphere has been determined by the measurement of the dysprosium(iii)-induced 17O NMR shifts. The 1H and 31P NMR spectra of the EuIII derivative indicate a higher abundance of the fast-exchanging twisted square antiprismatic (m) isomer than the isomeric square antiprismatic (M; m/M = 3: 2) complex. The analysis of the 89Y and 13C T1 NMR relaxation times in the GdIII/YIII mixed complex have provided useful structural information. Values of ca. 6.3 and 8.2 Å for the Gd⋯Y and Gd⋯C distances, respectively, have been estimated which indicate a rather compact solution structure. This result finds support in the value of the relaxivity whose increase (at 20 MHz and 298 K) on passing from the monomeric (5.7 s-1 mM-1) to the ditopic complex (8.2 s-1 mM-1) can be attributed to the doubling of the inner-sphere term following the doubling of the molecular size. The structural and dynamic relaxivity-controlling parameters were assessed by a simultaneous fitting of the variable temperature 17O NMR and 1H NMRD relaxometric data. The mean water residence lifetime (298τM) has been found to be 53 ns, one of the shortest values reported for ditopic complexes. The reorientational correlation time is two times longer ( 298τR = 183 ps) than the corresponding value of the parent monomeric GdIII complex, thus supporting the view of a limited degree of internal rotation. The possible influence of magnetic Gd-Gd coupling has been excluded by a comparison of the 1H NMRD profiles of the homodinuclear GdIII/GdIII and the heterodinuclear Gd III/YIII complexes. © The Royal Society of Chemistry 2006.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxometric characterization of human hemalbumin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vannini</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <text>5-6</text>
        </detail>
        <extent unit="pages">
          <start>650</start>
          <end>658</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">09498257 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Biological Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Biol. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034840271&amp;partnerID=40&amp;md5=b1fff68c46c0e81c3d2a53333ed3e6c5</url>
    </location>
    <abstract>Hemalbumin [i.e., Fe(III)-protoporphyrin IX-human serum albumin; Fe(III)heme-HSA] is an important intermediate in the recovery of heme iron following hemolysis. Relaxometric data are consistent with the occurrence of a hexacoordinated high-spin Fe(III) center with no water in the inner coordination sphere. The relatively high relaxation enhancement observed for an aqueous solution of Fe(III)heme-HSA (r1p=4.8 mM-1 s-1 at 20 MHz, pH 7, and 25°C) is ascribed to the occurrence of a strong contribution from water molecules in the second coordination sphere. Structural analysis of the putative binding region has been performed by a Monte Carlo simulated annealing procedure, which allowed us to identify His105 and Tyr148 as axial ligands. The role of a tyrosinate as the sixth Fe(III)heme ligand is supported by the pH-dependent analysis. Interestingly, when Fe(III) is replaced by Mn(III), the occurrence of a fast exchanging water molecule at pH values close to neutrality is detected. As the pH is increased, the Mn(III) containing system behaves analogously to Fe(III)heme-HSA. At higher pH, the phenolate ligand is eventually displaced by OH- from both Fe(III) and Mn(III) centers. Support for the proposed bonding scheme has been gained also from competitive binding assays for the sixth coordination site by fluoride, azide, and imidazole ligands.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxometric determination of the exchange rate of the coordinated water protons in a neutral Gd(III) chelate</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoletti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1499</start>
          <end>1504</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>CHEM. EUR. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0030869972&amp;partnerID=40&amp;md5=454adcb78dbfea1e80a24e74eae3f6e1</url>
    </location>
    <abstract>The exchange rate of the coordinated water molecule in the neutral complex [Gd(DTPA-BBA)(H2O)] (DTPA-BBA = 1,7-bis[(N-benzylcarbamoyl)methyl]-l,4,7-triazaheptane-l,4,7-triacetate or diethylenetriaminopentaacetate N.N'-bis(benzylamide)) is slower than in the parent complex [Gd(DTPA)(H2O)]2. From the analysis of the temperature dependence of the solvent 17O NMR transverse relaxation time in an aqueous solution of the paramagnetic complex, a value of 4.5 x 105 s-1 (at 298 K) is obtained for the exchange rate of the coordinated water molecule. This rate constant does not vary in the pH range 7-12. Conversely, over the same pH range and at 298 K and 20 MHz, the longitudinal water proton relaxivity increases from 4.8 to 6.5 s- mM-1. The analysis of the dependence of the longitudinal water proton relaxation rate on magnetic field and temperature at pH 7 and pH 12 shows that the increase in relaxivity at basic pH has to be assigned to the contribution of the prototropic exchange at the water molecule in the inner coordination sphere of the metal ion. This exchange process is catalyzed by OH- ions (k(p)=l.7x 109M-1S-1 at 298 K) and causes an increase in the observed relaxivity when it occurs at a rate larger than the exchange rate of the entire water molecule. At pH 12 the limiting effect of the slow exchange rate for the coordinated water molecule is removed, and the longitudinal water proton relaxivity measured at this pH then represents the maximum value attainable for this complex.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Brocchetta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canton</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <text>1-2</text>
        </detail>
        <extent unit="pages">
          <start>58</start>
          <end>67</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">09498257 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Biological Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Biol. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0036366267&amp;partnerID=40&amp;md5=8f492cfd31ebae031a280e4f1bdfe80a</url>
    </location>
    <abstract>Three novel Mn(II) complexes bearing benzyloxymethyl functionalities are reported and their ability to enhance water (1H and 17O) relaxation times is investigated in detail. Two of them contain one coordinated water molecule and display relaxivity values only slightly smaller than those shown by the most clinically used contrast agents (e.g. [Gd(DTPA)(H 2O)]2-). Moreover, in these Mn(II) chelates the exchange rate of the coordinated water is ca. one order of magnitude higher if compared to the exchange rates previously reported for Gd(III) complexes with octadentate ligands. The occurrence of such fast exchange rates of the coordinated water is exploited in the formation of macromolecular adducts with human serum albumin to attain systems displaying relaxivity values in the upper range of those so far reported for analogous Gd(III) systems. These results strongly support the view that Mn(II) complexes, in spite of the lower effective magnetic moment, can be considered as viable alternatives to the currently used Gd(III) complexes as contrast agents for MRI applications.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxometric studies for food characterization: The case of balsamic and traditional balsamic vinegars</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Consonni</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ferrante</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>57</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>3028</start>
          <end>3032</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">00218561 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Agricultural and Food Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Agric. Food Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-65349185125&amp;partnerID=40&amp;md5=4d7baf214d892a4b01547d5d2cbc8425</url>
    </location>
    <abstract>NMR spectroscopy is a powerful technique for investigating the structure and composition, as well as the physicochemical properties, of foodstuff. NMR-field cycling modality reports about the relaxation times of solvent molecules as a function of the applied magnetic field strength. In the case of aqueous solutions, this methodology is particularly valuable in assessing the interactions of water molecules with paramagnetic and large-size macromolecular systems. 1H NMR field cycling relaxometry has been used to characterize traditional balsamic vinegars and balsamic vinegars of Modena. It has been found that the longitudinal relaxation time (T1) of the water proton resonance is mainly determined by the water molar fraction and the occurrence of dissolved macromolecules and paramagnetic metal ions. Actually, the observed 1H nuclear magnetic resonance dispersion (NMRD) profiles appear markedly affected by the formation of paramagnetic macromolecular adducts. It has been shown that counterfeit specimens can be identified on the basis of the comparison of their T1 and T2 (transverse relaxation time) values with respect to the corresponding values of genuine samples. For the latter ones, a relationship has been found that relates the observed T1 to the age of the vinegar. © 2009 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxometric study of a series of monoaqua GdIII complexes of rigidified EGTA-Like chelators and their noncovalent interaction with human serum albumin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Avedano</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lombardi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cassino</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>802</start>
          <end>810</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">14341948 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79951652417&amp;partnerID=40&amp;md5=a752dc250cc46401c147ae4cd6feda8c</url>
    </location>
    <abstract>The lanthanide(III) complexes of five EGTA [ethyleneglycol-bis(2- aminoethyl) ether-N,N,N′,N′-tetraacetic acid] derivatives fused with aromatic (benzene: L1; naphthalene: L2) and functionalized aromatic (L3-L5) moieties on the oxyethylene bridge were investigated in aqueous solution. 1H and 13C NMR spectra of the LaIII and Lu III complexes of L1 and L2 indicate that the structural differences across the Ln series found for the [Ln(EGTA)]- complexes is maintained in the new derivatives. The presence of the aromatic moiety favours an increased stereochemical rigidity, as assessed by VT 13C NMR spectra. Temperature-dependent 17O NMR spectroscopic data and 1/T11H NMRD profiles of the GdIII complexes of L1-L3 were measured and globally analyzed to obtain the parameters influencing the water exchange rate, kex, and rotational dynamics. The k ex values are ca. twice as high as the corresponding value of [Gd(EGTA)]- and very close to optimal. The lipophilic complexes [GdL4]- and [GdL5]- form micellar aggregates whose NMRD profiles were measured and analyzed in terms of a model that allows separation of global motion and local rotation. The noncovalent binding interaction of the complexes to human serum albumin and the relaxivity of the macromolecular conjugates were investigated with relaxometric techniques at 20 MHz and 298 K, and the importance of a restricted local motion of the complex at the binding site for attaining large relaxivity enhancement outlined. Theoretical docking simulations and relaxometric competition experiments provided insights into the binding modes of the complexes. © 2011 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Relaxometric, Structural, and Dynamic NMR Studies of DOTA-like Ln(III) Complexes (Ln = La, Gd, Ho, Yb) Containing a p-Nitrophenyl Substituent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ermondi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>35</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>2726</start>
          <end>2736</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001237608&amp;partnerID=40&amp;md5=795cb4c92c55c8c13f8c640c2a2a84a3</url>
    </location>
    <abstract>We report here the synthesis of the ligand 1-((p-nitrophenyl)carboxymethyl)-4,7,10-tris(carboxymethyl)-1,4,7,10- tetraazacyclododecane (3) and its La(III), Gd(III), Ho(III), and Yb(III) complexes. The introduction of the p-nitrophenyl substituent on the methylenic carbon of one acetate group does not alter the overall chelating ability of 3 with respect to the parent DOTA ligand. The [Gd(3)]- complex displays a slightly higher relaxivity than that of [Gd(DOTA)]-, mainly as a consequence of a longer molecular reorientational correlation time (τR), due to the increased molecular dimension of the complex, and of limited changes to the other relaxation parameters. A further increase of relaxivity has been observed upon formation of an inclusion compound with β-cyclodextrin. The solution structure and dynamics were thoroughly investigated by high-resolution NMR spectroscopy. Of the four possible enantiomeric pairs that could be present in the solutions of monosubstituted derivatives of [Ln(DOTA)]- complexes, the proton spectra of Ho and Yb derivatives are consistent with the occurrence of only two isomeric species whose structures have been elucidated through analysis of dipolar shifts and 2D-EXSY data. In both species the bulky aromatic group has replaced the acetate proton pointing outward from the coordination cage. Unlike in the DOTA case, in [Ln(3)]- complexes the isomerization process involves the inversion of the ethylenic groups of the macrocycle rather than the motion of the acetate arms. This behavior is rationalized in terms of steric crowding at the substituent site: minimization of the steric interactions between the aromatic group and the macrocyclic ring protons results in both structural and dynamic selectivity. Interestingly, in the case of the diamagnetic La(III) complex the variable temperature behavior of the 13C NMR spectra is consistent with an exchange process involving one major species and at least one minor isomer of very low concentration, whose relative population increases with temperature. This causes a persistent exchange broadening of the resonances over a wide range of temperatures.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Release of toxic Gd3+ ions to tumour cells by vitamin B12 bioconjugates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Siega</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Wuerges</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arena</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedosov</namePart>
      <namePart type="given">S.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dreos</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geremia</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randaccio</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>32</number>
        </detail>
        <extent unit="pages">
          <start>7980</start>
          <end>7989</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-68349101066&amp;partnerID=40&amp;md5=85203620aa6930c4f9df276a7f9b181a</url>
    </location>
    <abstract>Two probes consisting of vitamin B12 (CNCbl) conjugated to Gd chelates by esterification of the ribose 5'-OH moiety, Gd-DTPA-CNCb1 (1; DTPA = diethylenetriamineN,N,N' ,N" ,N"-pentaacetic acid) and Gd-TTHA-CNCbl (2; TTHA = triethylenetetramine-N, N, N,',N,",N,'",N'"'hexaacetic acid), have been synthesised and characterised. The crystal structure of a dimeric form of 1, obtained by crystallisation with an excess of GdCl 3, has been determined. The kinetics of binding to and dissociation from transcobalamin II show that 1 and 2 maintain high-affinity binding to the vita-min B12 transport protein. Complex 2 is very stable with respect to Gd3+ release owing to the saturated co-ordination of the Gd 3+ ion by four amino and five carboxylate groups. Hydrolysis of the ester functionality occurs on the time scale of several hours. The lack of saturation and the possible involvement of the ester functionality in co-ordination result in lower stability of 1 towards hydrolysis and in a considera-ble release of Gd3+ in vitro. Gd3+ ions released from 1 are avidly taken up by the K562 tumour cells to an extent corresponding to approximately 1010 Gd3+ per cell. The internalisation of toxic Gd3+ ions causes a marked decrease in cell viability as assessed by Trypan blue and WST-I tests. On the contrary, the experiments with the more stable 2 did not show any significant cell internalisation of Gd 3+ ions and any influence on cell viability. The results point to new avenues of in situ generation of cytotoxic pathways based on the release of toxic Gd3+ ions by vitamin B12 bioconjugates. © 2009 Wiley-VCH Verlag GmbH &amp; Co.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Reorientational motions of permethylated cyclopentadienyl rings in polycrystalline organometallic compounds</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Braga</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cordero</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grepioni</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Righi</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sostero</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>31</number>
        </detail>
        <detail type="issue">
          <number>14</number>
        </detail>
        <extent unit="pages">
          <start>3054</start>
          <end>3059</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1992</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000888354&amp;partnerID=40&amp;md5=6ef6e926998476c565baa1bfc3df79c3</url>
    </location>
    <abstract>The dynamic behavior in the solid state of (C5Me5)2Fe (I), (C5Me5)Rh(CO)2 (II), (C5Me5)2Cr2(CO)4 (III), (C5Me5)Fe2(μ2-CO) 2(CO)2 (IV), and (C5Me5)2Rh2(μ 2-Cl)2Cl2 (V) has been investigated by variable-temperature 1H spin-lattice relaxation time measurements and potential energy barrier calculations within the pairwise atom-atom approach. In all the cases two different processes have been detected corresponding to the rotation of the methyl group about its C3 axis and to the reorientation of the cyclopentadienyl ligand about its C5 axis, respectively. The separate intramolecular and intermolecular contributions to the total reorientational barriers have been evaluated. It has been shown that in crystalline III and IV a synchronous motion of the methyl groups during ring reorientation reduces intramolecular repulsions between the H atoms of the methyl groups and the CO ligands and affords a low-energy reorientational path. 13C spin-lattice relaxation times have also been determined for the individual carbon atoms by using Torchia's pulse sequence. The 13C-T1 values observed for ring carbons have been rationalized on the basis of two relaxation interactions (dipole-dipole and chemical shift anisotropy) modulated by the motions involving the permethylated cyclopentadienyl rings. The chemical shift anisotropies of cyclopentadienyl 13C resonances have been determined on chloroform solutions of compounds II-V at different magnetic field strengths. A qualitative comparison between solution- and solid-state 13C relaxation data shows that the same relaxation mechanisms are operative in both physical states. © 1992 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Response to 'Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate'</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Canavese</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stratta</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>74</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>536</start>
          <end>537</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">00852538 (ISSN)</identifier>
      <titleInfo>
        <title>Kidney International</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Kidney Int.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-48649109814&amp;partnerID=40&amp;md5=41313f133d39c7f122d45b2e166171f9</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Ring-opening polymerisation of norbornene by (μ-H)2Os3(CO)10 complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arce</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chiantore</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Russo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Sanctis</namePart>
      <namePart type="given">Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>622</number>
        </detail>
        <detail type="issue">
          <text>1-2</text>
        </detail>
        <extent unit="pages">
          <start>43</start>
          <end>46</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0010970239&amp;partnerID=40&amp;md5=7bfcaa2b0e700e1dee5f96181feb637c</url>
    </location>
    <abstract>The (μ-H)2Os3(CO)10 catalyses the ring opening polymerisation of norbornene to give high molecular weight poly (1,3-cyclopentylene-vinylene) in high yield. Initially IR and 13C-NMR data reveal the presence of an all cis structure of the polymer, whereas for longer reaction times there is a progressive increase in the trans content. A reaction mechanism for the polymerisation is proposed involving the formation of a dimetallacyclopentene intermediate. © 2001 Elsevier Science B.V.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Role of Os-H⋯H-N interactions in directing the stereochemistry of carbonyl cluster hydride derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valls</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>16</number>
        </detail>
        <detail type="issue">
          <number>24</number>
        </detail>
        <extent unit="pages">
          <start>5140</start>
          <end>5141</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <abstract>Unconventional hydrogen-bond interactions involving metal hydrides as proton acceptors from N-H bonds have been recently discovered in mononuclear organometallic systems. The work herein reported on H2Os3(CO)10L (L= NH2Et, NHEt2) suggests that this type of interaction may be even more important in cluster chemistry in directing the stereochemistry of the products as well as affecting the intramolecular ligand exchange processes.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Separation of intra- and extracellular lactate NMR signals using a lanthanide shift reagent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mainero</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>47</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>10</start>
          <end>13</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Med.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0036135411&amp;partnerID=40&amp;md5=4b02c4f1519edc1e149e90dbea811cff</url>
    </location>
    <abstract>This work describes the use of [Pr-DO3A] as a shift reagent for differentiating intra- and extracellular L-lactate resonance in 1H- and 13C-NMR spectra. DO3A acts as heptadentate ligand towards lanthanide(lll) ions, leaving two coordination vacancies for the coordination of the L-lactate ion. The exchange between free and [Pr-DO3A]-bound L-lactate is fast on the NMR timescale, thus yielding a paramagnetically shifted L-lactate signal for the substrate in the compartment containing the paramagnetic chelate. The evaluation of the method was carried out on a model system based on sealed ghosts from human red blood cells. © 2002 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Slow clearance gadolinium-based extracellular and intravascular contrast media for three-dimensional MR angiography</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Bremerich</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Colet</namePart>
      <namePart type="given">J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Scheffler</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Laurent</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bongartz</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Muller</namePart>
      <namePart type="given">R.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>13</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>588</start>
          <end>593</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">10531807 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Magn. Reson. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035077608&amp;partnerID=40&amp;md5=ae01a1e637e3ac5361d0213171f51ee3</url>
    </location>
    <abstract>The objective of this study was to assess two new slow-clearance contrast media with extracellular and intravascular distribution for magnetic resonance angiography (MRA). Extracellular Gd-DTPA-BC2glucA and intravascular Gd(DO3A)3-lys16, were developed within the European Biomed2 MACE Program and compared with two reference compounds, intravascular CMD-A2-Gd-DOTA and extracellular GdDOTA, in 12 rats. Pre- and post-contrast three-dimensional MR (TR/TE = 5 msec/2.2 msec; isotropic voxel size 0.86 mm3) was acquired for 2 hours. Signal-to-noise enhancement (ΔSNR) was calculated. Two minutes after injection, all contrast media provided strong vascular signal enhancement. The ΔSNR for Gd-DTPA-BC2glucA, Gd(DO3A)3-lys16, CMD-A2-Gd-DOTA, and GdDOTA were 13.0 ± 1.8, 25.0 ± 3.2, 25.0 ± 4.0, and 18.0 ± 3.4, respectively. Gd-DTPA-BC2glucA, Gd(DO3A)3-lys16, and CMD-A2-Gd-DOTA cleared slowly from the circulation, whereas GdDOTA cleared rapidly. Vascular ΔSNR at 2 hours were 2.9 ± 0.6, 25.0 ± 3.2, 25.0 ± 4.0, and 0.4 ± 1.0. Gd(DO3A)3-lys16 provided strong vascular and minor background enhancement, and thus may be useful for MRA or perfusion imaging. Gd-DTPA-BC2glucA produces persistent enhancement of extracellular water, and thus may allow quantification of extracellular distribution volume and assessment of myocardial viability. © 2001 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solid state 13C CP-MAS NMR spectra of iron (alkyne) carbonyl compounds</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sales</namePart>
      <namePart type="given">K.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lian</namePart>
      <namePart type="given">L.-Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>368</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>331</start>
          <end>338</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1989</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-45149146832&amp;partnerID=40&amp;md5=7658cecd90311f68feb09e18b2e2316d</url>
    </location>
    <abstract>The solid state 13C NMR spectra of a series of iron (alkyne) carbonyl complexes, enriched in 13C at the carbonyl groups, have been obtained using 13C-{1H} cross-polarisation (CP) and slow magic angle spinning (MAS). In general, more resonances are observed from the solid state than from samples in solution; this may be due either to crystal packing effects lifting the degeneracy of certain signals or to a slowing of carbonyl fluxionality in the solid state. The intensities of the spinning side bands in the 13C spectra have been used to derive values for the components of the 13C shielding tensor. The component of the shielding tensor assigned to the CO bond axis (σ33) is sensitive to the bonding of the CO group, i.e. whether it is a terminal or asymmetrically bridging group. © 1989.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solid state13C NMR spectra of metal carbonyl clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>4</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>1</start>
          <end>8</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1993</dateIssued>
      </originInfo>
      <identifier type="issn">10407278 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Cluster Science</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J Clust Sci</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0042299736&amp;partnerID=40&amp;md5=994c32a48eae31f0c8d99c3e4b33ef46</url>
    </location>
    <abstract>The solid state13C NMR spectra of four13CO enriched carbonyl clusters having a tri-iron metallic core have been analyzed to provide structural and dynamic information. In Fe3(CO)12 (1), the high temperature spectra suggest the occurrence of large amplitude motions of the CO groups around their position at the vertexes of the coordination polyhedron in addition to the motion involving the Fe3-triangle previously detected in the VT-13C MAS spectra.13C and31P NMR data of Fe3(CO)11PPh3 (2) indicates the presence of one molecule in the asymmetric unit in apparent disagreement with the previously reported X-ray data. Furthermore, we show that structural information can be obtained from the chemical shift tensor components readily available from the analysis of the spinning sideband manifold. © 1993 Plenum Publishing Corporation.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solid-gas reactions of metal carbonyl clusters. Hydrogenation of 1,4-cyclohexadiene and hex-3-yne in the presence of H4Ru4(CO)12, Ru3(CO)12 or Ru3(CO)3(μ-CO)(μ3-CO)(μ3 - C2Ph2)(η-C5H5)2</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Campagnola</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castiglioni</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deabate</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giordano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">King</namePart>
      <namePart type="given">P.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>262</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>157</start>
          <end>165</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0040516699&amp;partnerID=40&amp;md5=1d67ecd7ad33b30d3da23a033d7a18a1</url>
    </location>
    <abstract>The clusters H4Ru4(CO)12 (1), Ru3(CO)12 (2) and Ru3(CO)3(μ-CO)(μ3-CO)(μ3 - C2Ph2)(η-C5H5)2 (3), which are homogeneous hydrogenation catalysts for alkynes and cyclic dienes, have been investigated in solid-gas hydrogenation reactions. The clusters were deposited on porous glass discs in a new reaction vessel and reacted with the vapours of 1,4-cyclohexadiene or hex-3-yne and dihydrogen, giving monoenes selectively. The apparatus is easy to use and allows the collection and analysis of the gaseous phase with time; limitations are discussed. The reactions are catalytic, with low turnover numbers (TON). Sublimation of the clusters and of reaction products onto the glass walls of the apparatus, formation and recondensation of metal fragments and/or of metallacyclic derivatives were observed during the experiments. The behaviour of the clusters under solid-gas conditions was found to be similar to that under homogeneous conditions. Comparable organometallic intermediates or byproducts have been isolated suggesting that the same reaction pathways occur. This work shows for the first time that electronically saturated clusters in the solid state can react with mixtures of gases under relatively mild conditions.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solid-gas reactions of molecular organometallic complexes. Detection of a metastable intermediate in the carbonylation of a nickel(0) complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Bianchini</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zanobini</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Psaro</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sordelli</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>12</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>4757</start>
          <end>4763</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1993</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0041153932&amp;partnerID=40&amp;md5=46b639a0c60ba7cbd41a35093c6efa29</url>
    </location>
    <abstract>The reaction of the trigonal pyramidal Ni(0) complex [Ni(NP3)] (1) with CO in tetrahydrofuran (THF) solution has been re-investigated [NP3 = N(CH2CH2PPh2)3]. Depending on the experimental conditions, the reaction gives either the monocarbonyl [Ni(η3-NP3-P,P′,P″)(CO)] (2) or the dicarbonyl [Ni(η2-NP3-P,P′)(CO)2] (3a). Both products exhibit a distorted tetrahedral coordination geometry; in the monocarbonyl complex, the NP3 ligand uses the three phosphorus atoms to bind the metal center, whereas it uses two phosphorus only in 3a. Compounds 2 and 3a have been characterized by IR and 31P and 13C NMR spectroscopies in both the solid state and solution. Compound 3a is thermally stable in the solid state under inert atmosphere even at high temperature whereas, in ambient temperature solutions, it readily converts to 2 via CO elimination. The solid-gas reaction between crystals of 1 and CO (1 atm) at room temperature gives a mixture of 2 and of a new species 3b, which has the same stoichiometry as 3a but exhibits a different 31P CPMAS spectrum. On dissolution in THF saturated with CO, 3b converts to 3a whereas, under inert atmosphere, it dissolves to give initially 3a and later 2 and CO. In light of in situ DRIFT and 31P CPMAS spectroscopies, 3b is suggested to be an ensemble of metastable species in which a phosphine arm from NP3, although unfastened, is located close to the metal center as a consequence of the constraining environment of the crystal lattice. The proximity of the free phosphine arm to nickel makes solid 3b capable of losing one CO ligand, thus converting to 2. Unlike in solution, the latter compound undergoes thermal dissociation of CO in the solid state to generate the starting complex 1. © 1993 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solid-gas reactions of the "lightly stabilized" Os3(CO)11L (L = NCCH3, C2H4) clusters with CO, NH3, and H2</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Krause</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>14</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>3224</start>
          <end>3228</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000345228&amp;partnerID=40&amp;md5=5f4ec3414b1cb588571a990ef4d82c2e</url>
    </location>
    <abstract>The solid-gas reactions of the "lightly stabilized" Os3(CO)11L (L = NCCH3 (1), L = C2H4 (2)) clusters with gaseous reactants as CO, NH3, and H2 have been investigated. At 80°C polycrystalline samples (ca. 50 mg) of 1 and 2 undergo substitution of the axially bound acetonitrile ligand and the equatorially coordinated ethene ligand by the gaseous reactants. 1 and 2 react with 13CO to form Os3(CO)11(13CO) (3a), but no site selectivity is observed for the labeled carbonyl ligand (as shown by 13C MAS NMR). On reaction with NH3 both 1 and 2 afford Os3(CO)11(NH3) (4) with the ammonia ligand coordinated in an axial position. The observed stereochemistry of the reaction products of 1 and 2 with CO and NH3 suggests the presence of an unsaturated intermediate Os3(CO)11, which displays an intramolecular axial-equatorial exchange of the vacant coordination site. Reaction with dihydrogen of solid Os3-(CO)11(NCCH3) (1) or Os3(CO)11(C2H4) (2) gives H2Os3(CO)11 as first product, which under the experimental conditions affords Os3(CO)12 and H2Os3(CO)10. © 1995 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solid-state 31P CP MAS NMR vs. solution study of bis(tertiary phosphines)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Szalontai</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bakos</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>2</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>245</start>
          <end>251</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1993</dateIssued>
      </originInfo>
      <identifier type="issn">09262040 (ISSN)</identifier>
      <titleInfo>
        <title>Solid State Nuclear Magnetic Resonance</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Solid State Nucl Magn Reson</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0027687050&amp;partnerID=40&amp;md5=eff6b4a73c2c321882d2c55c25fae973</url>
    </location>
    <abstract>Solid-state 31P and 13C CP MAS results of several diphosphines are compared with solution phase data. Non-equivalence of the P atoms are observed in the solid state for the less flexible derivatives (including all chiral diphosphines studied), whereas the more flexible compounds with a linear alkyl chain such as the 1,2-ethane and the 1,4-butane derivatives give only rise to a single resonance. For the more strained bis(diphenylphosphino)methane contradictory data have been reported. Our experiments confirm the existence of an N2 spin system, i.e., two different P atoms in solid state. Substantial chemical shift difference between P atoms have been observed in the solid state but not in solution of the chiral compounds. A possible explanation is suggested in terms of the concerted anisotropic effect of the phenyl rings attached to the phosphorus atom. © 1993.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution and solid-state characterization of highly rigid, eight-coordinate lanthanide(III) complexes of a macrocyclic tetrabenzylphosphinate</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Batsanov</namePart>
      <namePart type="given">A.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Howard</namePart>
      <namePart type="given">J.A.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Senanayake</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Williams</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>33</number>
        </detail>
        <detail type="issue">
          <number>21</number>
        </detail>
        <extent unit="pages">
          <start>4696</start>
          <end>4706</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1994</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33751158156&amp;partnerID=40&amp;md5=5de0b7a0ea61bd43490c7f7943fdd4ab</url>
    </location>
    <abstract>The ligand 1,4,7,10-tetraazacyclododecanetetrakis(methylenebenzylphosphinic acid), I, forms kinetically stable complexes with lanthanide ions (Ln = Eu, Gd, Tb, Yb, and Y) which are eight-coordinate (no bound water), with single diastereoisomers being preferentially formed (RRRR or SSSS at each stereogenic phosphorus centre). The 1H NMR spectra for the Eu and Yb complexes have been assigned and no significant fluxional behavior is observed in the temperature range 5-80°C at 400 MHz. The gadolinium complex is a promising outer-sphere contrast agent for magnetic resonance imaging, and analyses of variable temperature NMRD profiles suggest that the nearest water molecule is 4.25 Å distant from Gd (cf. 3.82 Å for the P-Me analogue). A relatively strong complex is formed with bovine serum albumin (Kd = 2.8 × 10-4 dm3 mol-1) leading to a significantly enhanced relaxivity in which a major contribution may arise from the exchange of mobile protons on the protein which undergo rapid dipolar relaxation caused by the proximity of the paramagnetic Gd ion. The crystal structures of the monohydrochloride salt of the free ligand and of the anionic yttrium(III) complex (as its oxonium salt) are reported. In the structure of the yttrium complex there is no metal-bound water molecule, with the nearest water being 5.62 Å from the yttrium atom. Crystal data for [(1)H]Cl: monoclinic, C2/c, a = 48.21(3) Å, b = 11.455(4) Å, c = 18.474(11) Å, β = 103.88(4)°, V = 9905(9) Å3, Z = 8, 2484 reflections, R = 0.078. Crystal data for H3O[Y(1)]: orthorhombic, Pbcn, a = 22.332(5) Å, b = 23.052(9) Å, c = 21.301(8) Å, V = 10 965 Å3, Z = 8, 1625 reflections. R = 0.089. © 1994 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution and solid-state NMR studies of MeHgII and RSHgII (R = Me, Et) complexes with pyrazolyl-containing ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cecchi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lobbia</namePart>
      <namePart type="given">G.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Camalli</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>13</number>
        </detail>
        <detail type="issue">
          <number>18</number>
        </detail>
        <extent unit="pages">
          <start>2695</start>
          <end>2702</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1994</dateIssued>
      </originInfo>
      <identifier type="issn">02775387 (ISSN)</identifier>
      <titleInfo>
        <title>Polyhedron</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Polyhedron</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001051031&amp;partnerID=40&amp;md5=9660c19778674861549fab995dae0626</url>
    </location>
    <abstract>The solid state and solution NMR spectra of the tetrakis(pyrazol-l-yl) borate (La) and tris(3,5-dimethylpyrazol-l-yl) hydroborate (Lb) ligands and their complexes with MeHgII and RSHgII (R = Me, Et) are reported. The solid state 13C and 15N solid state NMR spectra of the MeHgLa complex are consistent with the reported X-ray structure. The close similarity of the spectral data shown by MeHgLa and MeSHgLa suggests that the two species have the same structure. In order to confirm this hypothesis, the structure of MeSHgLa has been determined by single crystal X-ray diffraction. The chemical shift anisotropy (CSA) of 199Hg resonance is too large in these T-shaped complexes and does not allow the observation of the 199Hg resonance under cross polarisation-magic angle spinning (CPMAS) experimental mode. On the other hand 199Hg CPMAS NMR spectra were obtained for the complexes with the Lb ligand. The reduced 199Hg CSA value together with the information gained from the 13C and 15N CPMAS NMR spectra suggest a tetra coordination around mercury in these complexes. The tight co-ordination mode shown by complexes with the Lb ligand is reflected in a decrease in the thiol intermolecular exchange rate in solution. This decreased ligand lability allows the detection of 3JHg-H couplings (inside HgSCH3 and HgSCH2CH3 moieties) in the low temperature NMR limiting spectra. © 1994.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution dynamics of the osmium cluster [Os3(μ-H)2(CO)10] by 13C and 17O nuclear magnetic resonance. Estimation of the 13C chemical shift anisotropy and 17O quadrupole coupling constant</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Elliot</namePart>
      <namePart type="given">J.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>279</start>
          <end>284</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049100480&amp;partnerID=40&amp;md5=6bd164d8ad9ca272bf3a5e0243079f71</url>
    </location>
    <abstract>Application of the saturation-transfer technique to 13C n.m.r. spectra of 13C-enriched [Os3(μ-H)2(CO)10] shows that only localised 13C exchange occurs, involving two of the four types of carbonyl ligand. Equations are derived to describe the recovery of the exchanging AX2 spin system towards equilibrium, after an initial perturbation. When the initial perturbation is a selective inversion of A or X2, values for the 13C relaxation parameters and the A ⇋ X2 exchange rate constant can be determined. The rate constant for this localised process is 0.36 s-1 at 300 K in CDCl3 solution. An estimate of the quadrupole coupling constant for 17O in the complex (1.59 MHz), together with 17O spin-lattice relaxation time measurements, yielded a value for the correlation time for molecular reorientation of 22 ± 4 ps. The 13C spin-lattice relaxation rates are strongly field dependent and values for the 13C shielding anisotropy in the region of 383 ± 50 p. p. m. were obtained.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution structure and dynamic behaviour of two isomers of [Fe3(CO)9{P(OR3)}3] (R = Me, Et, or Ph) derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gambino</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1277</start>
          <end>1281</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1989</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049084083&amp;partnerID=40&amp;md5=1a903acb5b310380653383de7f680a15</url>
    </location>
    <abstract>The reaction between [Fe3(CO)12] and P(OR)3 (R = Me, Et, or Ph) in the presence of the bimetallic catalyst [{Fe(CO)2(PPh3)(SEt)}2] affords two 1,2,3-trisubstituted isomers which rapidly interconvert at room temperature on the n.m.r. time-scale. The solution structures and dynamics have been elucidated for both isomers by means of variable-temperature 31P and 13C n.m.r. studies. In polar solvents the major isomer shows a [Fe3(CO)12]-like structure whereas the minor one contains only terminally bonded CO groups. The observation of three equally intense carbonyl resonances in the low-temperature-limiting spectra (R = Me or Et) supports a D3 structure for this isomer. The equilibration of axial CO ligands occurs readily as the temperature is increased; this rearrangement may be ascribed to the motion of the Fe3 triangle inside the polyhedral cloud of ligands or alternatively to an interconversion between a left-hand screw with a right-hand screw.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution structure and dynamics of DTPA-Ln(III) complexes (DTPA=diethylene triamine penta acetate; LnLa, Pr, Eu)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>177</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>101</start>
          <end>105</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1990</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001495698&amp;partnerID=40&amp;md5=aa93c666ae7e96e27771ab32e087d15b</url>
    </location>
    <abstract>Variable temperature 1H and 13C NMR spectra and proton and carbon longitudinal relaxation times allow the complete characterization of the solution structure and dynamics of three Ln(III) complexes of DTPA (LnLa, Pr and Eu). Our results show that a rapid interconversion between octadentate structures occurs on the NMR time scale which can be 'frozen out' at low temperature for Pr and Eu complexes. © 1990.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution structure and dynamics of H2Ru4(CO)13</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>29</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>L211-L212</start>
          <end>L211-L212</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1978</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4243835532&amp;partnerID=40&amp;md5=0e19f9d24ddd12dc140f61ec2d8a612b</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution structure and dynamies of H2Ru4(CO)13</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>30</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
      </part>
      <originInfo>
        <dateIssued>1978</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-49349133416&amp;partnerID=40&amp;md5=b7041f8efa34e06ed030a7f7377f0f0e</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution structure of the supramolecular adduct between a liver cytosolic bile acid binding protein and a bile acid-based gadolinium(III)-chelate, a potential hepatospecific magnetic resonance imaging contrast agent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Tomaselli</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zanzoni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ragona</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Assfalg</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Molinari</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>51</number>
        </detail>
        <detail type="issue">
          <number>21</number>
        </detail>
        <extent unit="pages">
          <start>6782</start>
          <end>6792</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">00222623 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-56249124978&amp;partnerID=40&amp;md5=c9bf5f5f525ac84e7a96c78c9b007116</url>
    </location>
    <abstract>Bile acid-conjugated gadolinium chelates were shown to display promising features for the development of hepatospecific constrast agents for magnetic resonance imaging (MRI). The study of the pharmacokinetics of these compounds should address their possible interaction with the bile acid protein transporters. We have previously shown that a 5β-cholanoic acid-based contrast agent is efficiently internalized in hepatocytes and is able to bind to a liver bile acid binding protein (BN2P) in vitro. Here we report the solution structure of the adduct between a BN2P and a gadolinium chelate/bile acid conjugate. The identification of unambiguous intermolecular distance restraints was possible through 3D edited/filtered NOESY-HSQC experiments, together with distance information derived from paramagnetic relaxation enhancements. These intermolecular contacts were used for the structure determination of the complex, using the data-driven docking software HADDOCK. The obtained results represent the starting point for the design of new and more efficient MRI contrast agents. © 2008 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution structures and dynamic behaviour of some iron chalcogen derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rossetti</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stanghellini</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>4</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>322</start>
          <end>325</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1979</dateIssued>
      </originInfo>
      <identifier type="issn">03404285 (ISSN)</identifier>
      <titleInfo>
        <title>Transition Metal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Transition Met Chem</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34250272425&amp;partnerID=40&amp;md5=691dbe9de403a7158c3ca5fd9c363ad8</url>
    </location>
    <abstract>13C-n.m.r. spectra of (μ-SR)2Fe2(CO)6, (μ-SR)2Fe2(CO)5P(n-Bu)3 and (μ-X)2Fe2(CO)6 (X=S or Se) show that the solid state structure is maintained in solution. N.m.r. evidence indicates that two isomeric species, not separable by means of the usual physicochemical methods, are present for (μ-SPh)2Fe2(CO)6 with an overwhelming predominance of the anti form. The phosphine substitutes a CO trans to the iron-iron bond. For any of the iron chalcogen derivatives examined, variable temperature13C-n.m.r. spectra show that carbonyl exchange occur in one step. The energy barrier for the exchange of carbon monoxide in the phosphine derivative is lower than that in the unsubstituted complex. © 1979 Verlag Chemie, GmbH.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution structures and dynamics of [HOs3(CO)10(σ,π vinyl)] complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anslyn</namePart>
      <namePart type="given">E.V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>111</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>95</start>
          <end>98</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1986</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0002355253&amp;partnerID=40&amp;md5=b535c958895488e1dc1f9ccbd3001c52</url>
    </location>
    <abstract>No interconversion has been found to occur on the NMR time scale between the structural arrangements found in the solid state. The σ, π motion of the vinyl group does not cause a cis-trans interconversion of the terminal hydrogens in [HOs3(CO)10(CHCH2)] which simply takes place by alternating the π-electron cloud to opposite osmium centres. The 1H chemical shift of the =C {A figure is presented} moieties is a useful probe to assess the coordination mode of the vinyl ligand. In [HOs3(CO)10(CPhC(H)Ph)], a trigonal twist process has been shown to occur at the Os(CO)4 unit. For the same unit 2Jc-c trans have been obtained for all the reported derivatives and their magnitude is almost unchanged along the series. Further Jcc information has been obtained from a sample of [HOs3(CO)10(CHCH2)] C-13 labelled in the vinyl ligand. © 1986.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution structures and dynamics of Co4(CO)12 and HFeCo3(CO)12-xLx (x = 0-3; L = group V Ligand)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Poli</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>30</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>45</start>
          <end>49</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1978</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0041606072&amp;partnerID=40&amp;md5=ee89cd904552669b75e9b72dc7d8d990</url>
    </location>
    <abstract>Variable temperature p13C-n.m.r. spectra of CO4(CO)12 in viscous solution show that in solid state structure is maintained in solution and that total scrambling of the COs occurs. Variable temperature 13C-n.m.r. spectra of HFeCo3(CO)12, isostructural with Co4(CO)12, show that this molecule is stereochemically non rigid only in the Co3 unit. In the derivatives in which one or more COs are substituted with a group V ligand the cobalt bonded carbonyls are rigid. The substitution occurs by stepwise replacement of one carbonyl group on each of the cobalt atoms. © 1978.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution structures and dynamics of M3(CO)12-x(NCCH3)x (MRu, x = 1, 2, 3; MOs, x = 1, 2)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Krause</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Violano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>235</number>
        </detail>
        <detail type="issue">
          <text>1-2</text>
        </detail>
        <extent unit="pages">
          <start>357</start>
          <end>366</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000423831&amp;partnerID=40&amp;md5=7e59b985a1a107d12fda7d1bc0ae74c2</url>
    </location>
    <abstract>The solution structures and the dynamic behavior of the acetonitrile substituted cluster compounds M3(CO)12-x(NCCH3)x MOs, x = 1 (1), x = 2 (2); MRu, x = 1 (3), x = 2 (4), x = 3 (5)) have been investigated by 13C NMR spectroscopy. The acetonitrile ligands in (1-5) adopt axial positions. In the bisubstituted derivatives 2 and 4 the nitriles are bound to different metal atoms on opposite sides of the metal plane and in the trisubstituted compound 5 two of the three nitrile ligands lie on the same side of the metal plane. Like the parent metal carbonyls M3(CO)12 (MRu, Os) the osmium derivatives 1 and 2 and the ruthenium derivative 3 have ground state structures in which all CO ligands are terminally bound, whereas 4 and 5 display also bridging CO ligands. 1-5 are fluxional in solution and the fluxionality is dependent upon the degree of nitrile substitution. The low energy CO exchange processes are of the delocalized type following merry-go-round mechanisms (involving two or three metal centers) whereas localized exchange processes are found to be of higher energy. The solution structures and the fluxional behavior of 1-5 are in agreement with a general ability of the nitrile ligand(s) to stabilize bridging carbonyls. © 1995.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Solution structures and dynamics of Ru4(μ-H)4(CO)12-xLx (x = 1-4, L = P(OEt)3, PPh3; x = 1, 2, L = AsPh3) derivatives by VT multinuclear NMR spectroscopy. X-ray structure determination of Ru4(μ-H)4(CO)10(P(OEt)3) 2</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gellert</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>14</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>3693</start>
          <end>3703</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1995</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000802277&amp;partnerID=40&amp;md5=403c40dd02a1057c83029229224db7dd</url>
    </location>
    <abstract>The addition of the catalyst (FeCp(CO)2)2 to the solution reactions of Ru4(μ-H)4(CO)12 with L (L = P(OEt)3, PPh3, AsPh3) affords the substitution derivatives Ru4(μ-H)4(CO)12-xLx (x = 1-4, L = P(OEt)3, PPh3; x = 1, 2, L = AsPh3) with good selectivity modulated by the carbonyl to ligand ratio and in satisfactory yield. Multinuclear variable temperature NMR studies at different temperatures show that the tri- and tetrasubstituted products are each obtained in only one isomeric form while for L = P(OEt)3 the monosubstituted derivative exists as two isomers in solution. The disubstituted derivatives form only one isomer for L = P(OEt)3, whereas two isomers are observed for L = PPh3, AsPh3. The stereochemical nonrigidity of the title compounds has been investigated, and correlations between solid-state and solution structures are discussed. © 1995 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Spectral discrimination of chiral macrocyclic paramagnetic metal complexes by NMR techniques</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>5</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>1261</start>
          <end>1266</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032892759&amp;partnerID=40&amp;md5=6326be923fe13c06957fb6271d8d06b6</url>
    </location>
    <abstract>The anionic lanthanide(III) complexes of the macrocyclic ligand 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetramethylenephosphonate (DOTP) are present in aqueous solution as a racemic mixture of two enantiomeric forms interconverting slowly on the NMR time scale. The metal chelates form diasteroisomeric complexes with the organic base N-methyl-D(-)-glucamine which, in the case of the Eu(III) derivative, have distinguishable 1H, 13C and 31P NMR spectra The bonding interaction responsible for the spectral resolution has been studied as a function of pH, temperature and complex/substrate molar ratio. Qualitative analysis of the Dy(TOTP)-induced shift and line broadening of the 13C resonance of N-methyl-D(-)-glucamine has suggested that the ion-pairing interaction involves bridging by the organic base between two uncoordinated oxygen atoms of two adjacent phosphonate groups of the metal complex. This bonding scheme combines electrostatic and hydrogen-bonding interactions and results in a marked stereoselectivity. The association equilibria were obtained by analysis of NMR titration data and by considering a 1:2 bonding model for the complex/substrate adduct.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Stabilization of the T-state of ferrous human adult and fetal hemoglobin by Ln(III) complexes: A thermodynamic study</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoletti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bellelli</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Coletta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>71</number>
        </detail>
        <detail type="issue">
          <text>1-2</text>
        </detail>
        <extent unit="pages">
          <start>37</start>
          <end>43</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">01620134 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Inorganic Biochemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Inorg. Biochem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0031688172&amp;partnerID=40&amp;md5=0e23db567278ecbf8459d2a70b760aa7</url>
    </location>
    <abstract>The effect of the lanthanide(III) complexes [Gd(1,4,7,10- tetraazacyclododecane- N,N',N'',N'''-tetrakis(methylenephosphonate))]5- (Gd-DOTP) and La-DOTP on the oxygen binding and spectroscopic properties of human adult and fetal hemoglobin (HbA and HbF, respectively) has been investigated. The affinity of Gd-DOTP and La-DOTP for oxygenated HbA (HbAO2; K(HbAO2) =2.6 X 10-3 M) is closely similar to that observed for Ln(III) complexes association to nitrosylated HbA (HbANO K(HbANO) = 1.8 x 10-3 M) and to aquo-met HbA (met-HbA; K(met-HbA) = 1.9 X 10-3 M), being lower than that determined for GdDOTP and La-DOTP binding to the deoxygenated form of the tetramer (HbAd; K(HbAd) = 3.0 x 10-4 M). The affinity of Gd-DOTP for deoxygenated HbF (HbFd; K(HbFd) =9.5 x 10-4 M) and oxygenated HbF (HbFO2; K(HbFO2) = 3.7 X 10-3 M) is lower than that observed for Ln(III) complexes association to HbAd and HbAO2, respectively. Gd-DOTP and La-DOTP bind to HbA and HbF with a 1:1 stoichiometry per tetramer. Increasing Gd-DOTP and La- DOTP concentration, oxygen affinity for HbA decreases (i.e. P50 increases), this effect being minor for HbF. Upon binding of Ln(III) complexes to HbANO, the X-band EPR spectrum and the absorption spectrum in the Soret region display the characteristics which have been attributed to the T-state of the ligated tetramer. These results represent a clear cut evidence for the specific binding of Gd-DOTP and La-DOTP to the 2,3-D-glycerate bisphosphate (BPG) pocket (i.e. at the dyad axis, in between the β-chains) of HbA and HbF. The effect of Ln(III) complexes on the ligand binding and spectroscopic properties of HbA and HbF is reminiscent that of BPG, the physiological modulator of human Hb action.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Stereochemical nonrigidity in (μ2-H)(H)Os3(CO)11. Evidence for the occurrence of a racemization process at low temperature</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrú</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arce</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>13</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>3737</start>
          <end>3739</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1994</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001618303&amp;partnerID=40&amp;md5=9d7fe693cdf1d472fbbb8b4b6d3f5ac6</url>
    </location>
    <abstract>A 13C-2D EXSY experiment on a 13C-enriched sample of H2Os3CO)11 at 220 K and at the observation frequency of 100.25 MHz indicates that this compound is involved in an intramolecular exchange between two enantiomeric structures prior to undergoing the axial/ equatorial hydride motion typical of this type of adduct. © 1994 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Stereochemically non rigid acetylenic carbonyl complexes of iron and cobalt</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>16</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>L7-L8</start>
          <end>L7-L8</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1976</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-49549134769&amp;partnerID=40&amp;md5=19514d855c5502b9c7131bd86d1f4e0f</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Stereochemically nonrigid carbonyl complexes of group VIII B metal clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gambino</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>53</start>
          <end>56</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1975</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0002643310&amp;partnerID=40&amp;md5=b25448a92a9c0826be684723f9b51908</url>
    </location>
    <abstract>The variable temperature 13C-nmr of M3(CO)12 (M = Fe, Ru, Os) have been studied. Fe3(CO)12 and Ru3(CO)12 give one sharp resonance down to -100° C. Os3(CO)12 shows two resonances at room temperature which coalesce to a single resonance at +150 C. Possible mechanisms for carbonyl averaging are considered. The 13C-nmr of the acetylenic complexes HM3(CO)9C2C(CH3)3 (M = Ru, Os) were examined and shown to be stereochemically nonrigid. Both the osmium and ruthenium compounds show axial equatorial exchange on the metal atom which is sigmabonded to one of the acetylenic carbons. Only the ruthenium compound shows exchange between metal atoms in the temperature range examined. The importance of bridging intermediates in this exchange process is discussed. © 1975.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Stoichiometric and catalytic hydrogenation of the [Co2(CO)6(μ2-η2-alkyne)] complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Boccardo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castiglioni</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>100</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>97</start>
          <end>105</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1985</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-46549095122&amp;partnerID=40&amp;md5=268b3118da1e698befa8d95ee3de452f</url>
    </location>
    <abstract>The [Co2(CO)6(RC2R′)] complexes (R, R′ = H, Me, Et, Prn) react with molecular hydrogen under mild conditions of temperature and pressure, at low but appreciable rates. The effect of the steric hindrance of the substituents and the strength of the metalcarbon bonds are discussed. The kinetic data measured for [Co2(CO)6(HC2H)], suggest that both H2-coordination and CO-dissociation are involved in the rate-determining step of the overall hydrogenation process. The catalytic activity of [Co2(CO)6(HC2H)] in the homogeneous hydrogenation of acetylene is described. At low substrate/catalyst ratio the initial hydrogenation rate is equal, within experimental error, to that found for the stoichiometric reaction; on increasing the acetylene concentration, cyclotrimerization to benzene becomes the dominant process. Interestingly C4 hydrocarbons (mainly butadiene and 1-butene) are produced in measurable yield (≤8%). The formation of these products is interpreted as the result of the hydrogenation of the elusive [Co2(CO)5(HC2H)2] complex, an unstable intermediate in the cyclotrimerization chain. © 1985.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Stoichiometric hydrogenation of the heterobimetallic (α-alkynyl) complex [μ(1σ, 23η3H2CC CCH3)] [(CO)3FeCo(CO)3]</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castiglioni</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>175</start>
          <end>181</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">02775387 (ISSN)</identifier>
      <titleInfo>
        <title>Polyhedron</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Polyhedron</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-48749141805&amp;partnerID=40&amp;md5=51249325d60ff781e73443a1784a1d73</url>
    </location>
    <abstract>The title compound reacts with molecular hydrogen at 60°C giving rise to the homometallic complexes Fe(CO)5 and Co2(CO)8, and a very rich mixture of gaseous hydrocarbons (e.g. butenes from partial hydrogenation, butane from total hydrogenation and methane and propene from selective hydrogenolysis of the organic chain). The influence of concentration of the title complex, and partial pressure of hydrogen or carbon monoxide on the hydrogenation rate have been investigated. Although an unequivocal mechanism cannot be ascertained from the kinetic data owing to the complexity of the reaction, the pattern of products strongly indicates that the σ-interaction between the iron atom and the organic chain is preserved in the transition state. © 1984.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Structural and spectroscopic study of the dihydrogen bond in an imine triosmium complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Diana</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milanesio</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Valls</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viterbo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>21</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>50</start>
          <end>57</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0012006750&amp;partnerID=40&amp;md5=6dbd4322885674e9b267c56b25c9973b</url>
    </location>
    <abstract>The presence of an intramolecular XH⋯HM interaction between the imine proton donor and the terminal hydride in H(μ-H)Os3(CO) 10(HN=CPh2) has been investigated by X-ray analysis, NMR and IR spectroscopy and theoretical calculations. The localization of the hydrogen atoms in the crystal structure yielded a H⋯H distance of 1.79(6) Å for this "unconventional" H⋯H interaction; theoretical calculations suggested an H⋯H distance of 1.89 Å in the solid state. A NMR determination of the interproton distance, obtained from the isolation of the selective H,H dipolar contribution to the hydride relaxation time, afforded a value of 2.00 ± 0.05 Å. The difference between NMR and solid state determinations may be explained on the basis of the occurrence, in solution, of a large amplitude oscillatory motion of the imine ligand along the N-Os coordination axis. Further evidence of the presence of the favorable N-H⋯H-M intramolecular hydrogen bond interaction has been obtained from the red shift of the v(N-H) stretching in H(μ-H)Os3(CO) 10(HN=CPh2) with respect to that of the related Os 3(CO)11(HN=CPh2) compound. DFT(B3LYP) calculations gave results in agreement with the experimental findings and allowed further insight into the nature of the N-H⋯H-M dihydrogen bond, pinpointing the electrostatic nature of this interaction and the role of the high polarizability of the Os-H bond. © 2002 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Structural determinants of fluoride and formate binding to hemoglobin and myoglobin: Crystallographic and 1H-NMR relaxometric study</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoletti</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cutruzzolà</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Desideri</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bolognesi</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rizzi</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>70</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>482</start>
          <end>488</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">00063495 (ISSN)</identifier>
      <titleInfo>
        <title>Biophysical Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>BIOPHYS. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0030048309&amp;partnerID=40&amp;md5=6344e6d423013a1f9ea45bc879d2bc43</url>
    </location>
    <abstract>The x-ray crystal structure of the fluoride derivative of ferric sperm whale (Physeter catodon) myoglobin (Mb) has been determined at 2.5 Å resolution (R = 0.187) by difference Fourier techniques. The fluoride anion, sitting in the central part of the heme distal site and coordinated to the heme iron, is hydrogen bonded to the distal His(64)E7 NE2 atom and to the W195 solvent water molecule. This water molecule also significantly interacts with the same HisE7 residue, which stabilizes the coordinated fluoride ion. Moreover, fluoride and formate binding to ferric Aplysia limacina Mb, sperm whale (Physeter catodon) Mb, horse (Caballus caballus) Mb, loggerhead sea turtle (Caretta caretta) Mb, and human hemoglobin has been investigated by 1H-NMB relaxometry. A strong solvent proton relaxation enhancement is observed for the fluoride derivatives of hemoproteins containing HisE7. Conversely, only a small outer-sphere contribution to the solvent relaxation rate has been observed for all of the formate derivatives considered and for the A. limacina Mb:fluoride derivative, where HisE7 is replaced by Val.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Structural variations across the lanthanide series of macrocyclic DOTA complexes: Insights into the design of contrast agents for magnetic resonance imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Benetollo</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bombieri</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Calabi</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>42</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>148</start>
          <end>157</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037242463&amp;partnerID=40&amp;md5=66f67133ea3bf34828b06942962b539f</url>
    </location>
    <abstract>It was early shown that the macrocyclic Ln(DOTA) complexes (DOTA = 1,4,7,10-tetra-azacyclododecane-N,N′,N″,N‴tetraacetic acid) exists in solution as a mixture of two enantiomeric pairs of diastereoisomers differing in the ligand conformation, namely, square antiprismatic (SA) and twisted square antiprismatic (TSA) geometries, respectively. Later, extensive 1H NMR investigations suggested that a coordination change may be superimposed on this conformational equilibrium involving two additional structures in which the metal ion possesses a coordination number of eight (CN 8). It was predicted that these two species, lacking the apical coordinated water molecule, would maintain the SA and TSA coordination geometries, and therefore, they have been labeled as SA′ and TSA′, respectively. In this work we report the X-ray solid-state crystal structure determination of six Ln(DOTA) complexes representative of all four coordination geometry typologies deduced from NMR solution studies. A distinctive structural feature that discriminates SA (and SA′) and TSA (and TSA′) structures is represented by the twist angle between the two square planes of the antiprism, the basal four nitrogen, and the apical four oxygen planes. [Ce(DOTA)(H2O)]-displays a TSA structural typology with a twist angle of 25° and a Ce-Owater distance of 2.59 Å. The SA-type structure has been found in the case of complexes with Pr(III), Nd(III), and Dy(III), where the twist angle is 39, 39, and 38°, respectively, and the metal-water oxygen distance varies significantly (Pr-Ow 2.529 Å; Nd-Ow 2.508 Å; and Dy-Ow 2.474 A). [Tm(DOTA)]- displays a TSA′-type structure with a twist angle of 24°. As compared with the TSA structure of the corresponding Ce(III) complex, the Tm(III) complex shows an overall marked shrinkage of all metal-nitrogen and metal-oxygen distances (ca. 0.2 Å), which reflects the contraction of the metal ionic radius across the series but also the effect associated with the decrease of the CN from 9 to 8. In [Sc(DOTA)]-, the even smaller ionic radius of Sc(III) shifts the geometry of the coordination cage to the more compact SA′ typology with a twist angle of 41°, a value very similar to that found in the SA structures of lanthanide(III) ions with CN 9. Finally, an investigation was made into the hydration spheres of the complexes with SA and TSA geometries to account for the experimental evidence of a markedly different rate of water exchange for the two isomeric structures. This is of fundamental importance to the understanding of the corresponding Gd(III) complexes as MRI contrast agents.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Structural, luminescence, and NMR studies of the reversible binding of acetate, lactate, citrate, and selected amino acids to chiral diaqua ytterbium, gadolinium, and europium complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Dickins</namePart>
      <namePart type="given">R.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Batsanov</namePart>
      <namePart type="given">A.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Beeby</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bruce</namePart>
      <namePart type="given">J.I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Howard</namePart>
      <namePart type="given">J.A.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Love</namePart>
      <namePart type="given">C.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Peacock</namePart>
      <namePart type="given">R.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Puschmann</namePart>
      <namePart type="given">H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>124</number>
        </detail>
        <detail type="issue">
          <number>43</number>
        </detail>
        <extent unit="pages">
          <start>12697</start>
          <end>12705</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037202136&amp;partnerID=40&amp;md5=cc46e3bd4534af08ad2a2a242bea740b</url>
    </location>
    <abstract>The nature of the ternary complexes formed in aqueous media at ambient pH on reversible binding of acetate, lactate, citrate, and selected amino acids and peptides to chiral diaqua europium, gadolinium, or ytterbium cationic complexes has been examined. Crystal structures of the chelated ytterbium acetate and lactate complexes have been defined in which the carboxylate oxygen occupies an "equatorial" site in the nine-coordinate adduct. The zwitterionic adduct of the citrate anion with [EuL1] was similar to the chelated lactate structure, with a 5-ring chelate involving the apical 3-hydroxy group and the α-carboxylate. Analysis of Eu and Yb emission CD spectra and lifetimes (H2O and D2O) for each ternary complex, in conjunction with 1H NMR analyses of Eu/Yb systems and 17O NMR and relaxometric studies of the Gd analogues, suggests that carbonate, oxalate, and malonate each form a chelated (q = 0) square-antiprismatic complex in which the dipolar NMR paramagnetic shift (Yb, Eu) and the emission circular polarization (gem for Eu) are primarily determined by the polarizability of the axial ligand. The ternary complexes with hydrogen phosphate, with fluoride, and with Phe, His, and Ser at pH 6 are suggested to be monoaqua systems with Eu/Gd with an apical bound water molecule. However, for the ternary complexes of simple amino acids with [YbL1]3+, the enhanced charge demand favors a chelate structure with the amine N in an apical position. Crystal structures of the Gly and Ser adducts confirm this. In peptides and proteins (e.g. albumin) containing Glu or Asp residues, the more basic side chain carboxylate may chelate to the Ln ion, displacing both waters.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Structure and relaxivity of macrocyclic gadolinium complexes incorporating pyridyl and 4-morpholinopyridyl substituents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Batsanov</namePart>
      <namePart type="given">A.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Howard</namePart>
      <namePart type="given">J.A.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lowe</namePart>
      <namePart type="given">M.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>23</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>669</start>
          <end>670</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1999</dateIssued>
      </originInfo>
      <identifier type="issn">11440546 (ISSN)</identifier>
      <titleInfo>
        <title>New Journal of Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>New J. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0032798407&amp;partnerID=40&amp;md5=e79d5b1da31481b315be8cd717c47eaa</url>
    </location>
    <abstract>Octadentate N5O3 ligands containing a coordinating pyridyl group form kinetically stable complexes with Eu and Gd that resist protonation; the structure of a representative Gd complex reveals a short Gd-N(py) bond [2.535(1) Å], and the water exchange rate (k(ox)/298 = 2.7 x 106 s-1) is sufficiently fast so as not to limit the pH independent relaxivity (R(1p)/298 = 5.3 mM-1 s-1, 20 MHz).</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Substituent effects on Gd(III)-based MRI contrast agents: Optimizing the stability and selectivity of the complex and the number of coordinated water molecules</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Pierre</namePart>
      <namePart type="given">V.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>45</number>
        </detail>
        <detail type="issue">
          <number>20</number>
        </detail>
        <extent unit="pages">
          <start>8355</start>
          <end>8364</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33750298318&amp;partnerID=40&amp;md5=85503b3a7d0311ecf230e777814dac60</url>
    </location>
    <abstract>Hydroxypyridinone (HOPO)-based Gd(III) complexes have previously been shown to exhibit high relaxivity, especially at the high magnetic fields that are clinically relevant for present and future clinical use. This is due to more than one coordinated water molecule exchanging rapidly with bulk solvent. These complexes, however, present poor water solubility. Heteropodal complexes which include a terephthalamide (TAM) moiety maintain the high relaxivity characteristics of the HOPO family and have been functionalized with solubilizing substituents of various charges. The charge of the substituent significantly affects the stability of the Gd(III) complex, with the most stable complex presenting a neutral charge. The solubilizing substituent also moderately affects the affinity of the complex for physiological anions, with the highest affinity observed for the positively charged complex. In any case, only two anions, phosphate and oxalate, measureably bind the Gd(III) complex with weak affinities that are comparable to other q = 1 complexes and much weaker than DO3A, q = 2 based complexes. Furthermore, unlike poly(aminocarboxylate)-based complexes, HOPO-based Gd(III) complexes do not show any noticeable interaction with carbonates. The nature of the substituent can also favorably stabilize the coordination of a third water molecule on the Gd(III) center and lead to a nine-coordinate ground state. Such complexes that attain q = 3 incorporate a substituent β to the terminal amide of the TAM podand that is a hydrogen-bond acceptor, suggesting that the third water molecule is coordinated to the metal center through a hydrogen-bond network. These substituents include alcohols, primary amines, and acids. Moreover, the coordination of a third water molecule has been achieved without destabilizing the complex. © 2006 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Supramolecular adducts between poly-L-arginine and [TmIIIdotp]: A route to sensitivity-enhanced magnetic resonance imaging-chemical exchange saturation transfer agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">D.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>42</number>
        </detail>
        <detail type="issue">
          <number>37</number>
        </detail>
        <extent unit="pages">
          <start>4527</start>
          <end>4529</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0141670309&amp;partnerID=40&amp;md5=8d9745ec71a3fbd87daa735145110369</url>
    </location>
    <abstract>Markedly improved sensitivity is achieved in a contrast agent through formation of a supramolecular adduct between a diamagnetic system endowed with a high number of exchangeable protons (poly-L-arginine) and a paramagnetic shift reagent ([Tm(Hdotp)]4-). The increase in the chemical shift separation between the two exchanging proton pools, induced by the shift reagent, allows irradiation of the mobile guanidine protons of the polymer, thus resulting in a very efficient saturation transfer (see graph).</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Supramolecular protamine/Gd-loaded liposomes adducts as relaxometric protease responsive probes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Figueiredo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Moreira</namePart>
      <namePart type="given">J.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geraldes</namePart>
      <namePart type="given">C.F.G.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>19</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>1131</start>
          <end>1135</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">09680896 (ISSN)</identifier>
      <titleInfo>
        <title>Bioorganic and Medicinal Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Bioorg. Med. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79551487375&amp;partnerID=40&amp;md5=0eeb9f2a00fc041490293bc130126969</url>
    </location>
    <abstract>A new approach to enzyme-responsive MRI agents based on the use of liposomes loaded with a high number of paramagnetic metal complexes (Gd-HPDO3A) is presented. It relies on the disruption of low relaxivity aggregates formed by liposomes and a macromolecular substrate that is selectively cleaved by the enzyme of interest. The interaction of anionic liposomes composed of POPC:CHOL:DPGS and the cationic protein protamine yields a poorly soluble supramolecular assembly endowed with a low relaxivity. The action of the serine protease trypsin causes the digestion of protamine and the consequent de-assembly of the supramolecular adduct. The process is accompanied by an overall relaxation enhancement of solvent water protons as consequence of the dissolution of the aggregated liposomes. The observed increase of relaxivity is linearly dependent on the enzyme concentration. An illustrative example of the possible use of the herein presented responsive agent has been reported. It consists of the entrapment of the supramolecular assembly in alginate microcapsules that have often been used as envelopes for in vivo applications of stem cells and pancreatic islets. The change in the observed longitudinal relaxation rate R1 (leading to an hyperintense signal in the corresponding MR images) may act as a sensor of the protease activity in the biological environment in which the capsules is located. © 2010 Elsevier Ltd. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Cohen</namePart>
      <namePart type="given">S.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Xu</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Radkov</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>39</number>
        </detail>
        <detail type="issue">
          <number>25</number>
        </detail>
        <extent unit="pages">
          <start>5747</start>
          <end>5756</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <abstract>The tripodal ligand tris[(3-hydroxy-1-methyl-2-oxo-l,2-didehydropyridine-4-carboxamido)ethyl]amin e (TREN-Me-3,2-HOPO) forms a stable Gd3+ complex that is a promising candidate as a magnetic resonance imaging (MRI) contrast agent. However, its low water solubility prevents detailed magnetic characterization and practical applicability. Presented here are a series of novel mixed ligand systems that are based on the TREN-Me-3,2-HOPO platform. These new ligands possess two hydroxypyridinone (HOPO) chelators and one other chelator, the latter of which can be easily functionalized. The ligands described use salicylamide, 2-hydroxyisophthalamide, 2,3-dihydroxyterephthalamide, and bis(acetate) as the derivatizable chelators. The solution thermodynamics and relaxivity properties of these new systems are presented. Three of the four complexes (salicylamide-, 2-hydroxyisophthalamide-, and 2,3-dihydroxyterephthalamide-based ligands) possess sufficient thermodynamic stability for in vivo applications. The relaxivities of the three corresponding Gd3+ complexes range from 7.2 to 8.8 mM-1 s-1 at 20 MHz, 25 °C, and pH 8.5, significantly higher than the values for the clinically employed polyaminocarboxylate complexes (3.5-4.8 mM-1 s-1). The high relaxivities of these complexes are consistent with their faster rates of water exchange (&lt;100 ns), higher molecular weights (&gt;700), and greater numbers of inner-sphere coordinated water molecules (q = 2) relative to those of polyaminocarboxylate complexes. A mechanism for the rapid rates of water exchange is proposed involving a low energy barrier between the 8- and 9-coordinate geometries for lanthanide complexes of HOPO-based ligands. The pathway is supported by the crystal structure of La[TREN-Me-3,2-HOPO] (triclinic P1̄: Z = 4, a = 15.6963(2) Å, b = 16.9978(1) Å, c = 17.1578(2) Å, α = 61.981(1)°, β = 75.680(1)°, γ = 71.600(1)°), which shows both 8- and 9-coordinate metal centers in the asymmetric unit, demonstrating that these structures are very close in energy. These properties make heteropodate Gd3+ complexes promising candidates for use in macromolecular contrast media, particularly at higher magnetic field strengths.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and characterization of a Gd(III) based contrast agent responsive to thiol containing compounds</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Carrera</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Burgio</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Consol</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mortillaro</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>43</number>
        </detail>
        <extent unit="pages">
          <start>4980</start>
          <end>4987</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">14779226 (ISSN)</identifier>
      <titleInfo>
        <title>Dalton Transactions</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Dalton Trans.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-35548932542&amp;partnerID=40&amp;md5=125b04a342f3b0b7ad464ba48e475990</url>
    </location>
    <abstract>A novel Gd(iii) complex with a modified DO3A-like chelating cage has been synthesized and characterized as a candidate contrast agent responsive to the concentration of free thiols in tissues (essentially represented by reduced glutathione, GSH). The novel compound (called Gd-DO3AS-Act) bears a flexible linker ending with a 2-pyridyl-dithio group, that can promptly react with free thiols (XSH) to form mixed disulfides of the form Gd-DO3AS-SX. Compound Gd-DO3AS-Act is characterized by a millimolar relaxivity as high as 8.1 mM -1 s-1 (at 20 MHz, 25 °C and pH 7.4). Upon reaction with GSH, the Gd-DO3AS-SG covalent adduct is formed and the millimolar relaxivity drops to 4.1 mM-1 s-1. Such a decrease in relaxivity is explained on the basis of the formation of an intramolecular coordinative bond between one of the glutathionyl carboxyl groups and the Gd(iii) centre, lowering the hydration state of the paramagnetic centre. 1H-NMR dispersion profiles together with 17O-NMR transverse relaxation time versus temperature profiles confirm that the hydration of the Gd(iii) centre is strongly reduced ongoing from Gd-DO3AS-Act to the Gd-DO3AS-SG adduct. The relaxivity difference brought about by the reaction of Gd-DO3AS-Act with GSH can be enhanced up to 60% in the presence of poly-β-cyclodextrin. This journal is © The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and characterization of a macrocyclic Schiff base Gd III complex as a relaxation agent for a faster acquisition of 2H NMR spectra of ethanol</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Tamburini</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tomasin</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vigato</namePart>
      <namePart type="given">P.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cremonini</namePart>
      <namePart type="given">M.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>357</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>1374</start>
          <end>1380</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-1842524318&amp;partnerID=40&amp;md5=1a45e7d5b0c0462dac511f575f33ecc1</url>
    </location>
    <abstract>Quantitative 2H NMR analysis at the natural abundance represents a well-recognized and efficient method for the identification of the origin of ethanol from different sources. An intrinsic limitation of the protocol used is the long time required, about 8 h, because of the long T1 values of the 2H resonances. In this work we propose the use a paramagnetic relaxation agent that significantly catalyzes the relaxation times and reduces the total time of the analysis. This agent is the macrocyclic Schiff base complex [Gd(H2L)(H2O) 3(EtOH)](Cl)3·2 EtOH (H2L is the [1+1] macrocycle derived from the condensation of 3,3′-(3-oxapentane- 1,5-diyldioxy)bis(2-hydroxybenzaldehyde) with 1,5-diamino-3-azamethylpentane), which is highly stable and soluble in the alcoholic solution used. Elemental analysis, IR and mass spectrometry have characterized this complex. The homogeneity of the complex and the correct Gd:Cl=1:3 ratio was established by SEM-EDS measurements. Further characterization of the paramagnetic complex has been achieved by measuring the magnetic field dependence of the 1H longitudinal nuclear magnetic relaxation time of a 1 mM solution in CH 3OD with a field-cycling relaxometer. The GdIII ion accommodates up to four methanol molecules in its inner coordination sphere, whose rapid exchange with the bulk provides an efficient relaxation mechanism. The addition of about 37 mg of the complex to a solution of ethanol (3.0 g) and tetramethylurea (TMU) (1.5 g) results in the reduction of the experimental time of more than 50% with a S/N ratio compatible with that required for this application. © 2003 Elsevier B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and characterization of a novel DTPA-like gadolinium(III) complex: A potential reagent for the determination of glycated proteins by water proton NMR relaxation measurements</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrú</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Panero</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arnelli</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>32</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>2068</start>
          <end>2071</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1993</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33751386073&amp;partnerID=40&amp;md5=a5fb5ccf9a0e27200e7e74b4382adb86</url>
    </location>
    <abstract>The synthesis of a novel DTPA-like ligand 2 containing two boronic acid phenylamide substituents and its Gd(III) complex 3 is reported. The measurement of the proton relaxation rate over the proton Larmor frequency range from 0.01 to 50 MHz of an aqueous solution of this paramagnetic complex suggests that it contains only one water molecule in its inner coordination sphere, as was previously found for the parent DTPA complex. Competition trials in presence of variable amounts of [Gd-EDTA]- afford a Kf value of 2.0 × 1016. Since the boronic functionalities form stable linkages with sin-diol moieties, the interaction of complex 3 with glycated albumin leads to the formation of a ternary albumin-3 complex. The large size of this adduct is responsible for a lengthening of the molecular reorientational time τR, which in turn results in an increase of water proton relaxation rate (R1p). The observed R1p enhancement then provides a direct evaluation of the extent of glycation of the albumin specimen. © 1993 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and characterization of a novel macrocyclic ligand containing nine donor atoms</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Jommi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>115</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>94</start>
          <end>98</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1996</dateIssued>
      </originInfo>
      <identifier type="issn">01650513 (ISSN)</identifier>
      <titleInfo>
        <title>Recueil des Travaux Chimiques des Pays-Bas-Journal of the Royal Netherlands</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-1842830510&amp;partnerID=40&amp;md5=1492038cf8304628bdddc1d976907acf</url>
    </location>
    <abstract>The synthesis of a novel macrocyclic ligand containing nine potential coordination sites (six nitrogens and three oxygens) formed by a triazacyclododecane ring trisubstituted with -CH2-CH2-N(CH2Ph)-CH2COOH groups is reported. The protonation scheme of this ligand has been elucidated by measuring the proton NMR shifts of the various methylenic resonances upon changing the pH of the solution. This ligand affords stable metal complexes with Cd2+ ion, whose 1H- and 13C-NMR spectra suggest a remarkable kinetic inertia and stereochemical rigidity.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and crystal structure of heptacarbonyl-Hydrido-(t-butylethynyl)-(2,4-hexadiene)-triangulo-triruthenium, HRu3(CO)7(C6H9)(C6H10)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio Camellini</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>32</number>
        </detail>
        <detail type="issue">
          <text>C</text>
        </detail>
        <extent unit="pages">
          <start>163</start>
          <end>169</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1979</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4143095607&amp;partnerID=40&amp;md5=d71c705e96b15d5ab8e3a8b633bfd9d5</url>
    </location>
    <abstract>The reactions of HRu3(CO)9C2C(CH3)3 with 2cis, 4trans-hexadiene and 1,5-hexadiene afford as main product the same complex HRu3(CO)7(C6H9)(C6H10)suggesting that isomerization of the non conjugated species occurs in the reactiotion. The crystal structure of this compound has been determined by X-ray methods. Crystals are triclinic, space group P1, with Z = 2, in a unit cell of dimensions a = 10.230(8), b = 10.487(9), c = 19.084(13) Å α = 49.3(1), ß = 126.4(1), and γ = 127.9(1)°. The structure has been solved from diffractometer data by Patterson and Fourier methods and refined by full-matrix least-squares to R = 0.054 for 4303 observed reflections. The molecule is formed by a three-metal atom cluster with seven terminal CO groups; one hydridic hydrogen atom is bridge-bonding two ruthenium atoms on one side of the cluster. A t-butylethynyl group it bound to the three metals via a σ bond to one Ru and two η bonds to the other two Ru atoms; opposite to this group with respect to the cluster a 2trans, 4trans-hexadienic unit bridges two Ru atoms via two η bonds. © 1979.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and NMR Studies of Three Pyridine-Containing Triaza Macrocyclic Triacetate Ligands and Their Complexes with Lanthanide Ions</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Jommi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>36</number>
        </detail>
        <detail type="issue">
          <number>14</number>
        </detail>
        <extent unit="pages">
          <start>2992</start>
          <end>3000</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000664179&amp;partnerID=40&amp;md5=9cdd0423e066f621557bd8b91325693e</url>
    </location>
    <abstract>The synthesis of three triazamacrocycles containing the pyridine moiety and three acetate pendant arms (PCTA) is reported. The three systems differ due to the number of carbon atoms in the macrocyclic ring forming ligands PCTA-[12], -[13], and -[14], endowed with different coordination capabilities toward lanthanide(III) ions. Microscopic protonation sequences for the three ligands have been investigated by 1H NMR spectroscopy. Complexes of PCTA-[12], -[13], and -[14] with La(III), Gd(III), and Lu(III) have been prepared. Relaxometric measurements on the aqueous solutions of the paramagnetic Gd(III) complexes in the presence of competitive ligands gave the following stability constants: log Kf = 20.8 for Gd-PCTA-[12], log Kf = 19.3 for GdPCTA[13], and log Kf = 12.5 for GdPCTA-[14]. The measurement of water relaxation rates indicated a tendency to decrease the degree of hydration upon increasing the ring size. The VT 1H and 13C-NMR spectra of the diamagnetic La(III) and Lu(III) complexes exhibit a large variability of the solution structures dictated by the matching of the size of the lanthanide ion and the macrocyclic cavity. This results in noticeable differences in their stereochemical nonrigidity. hydration state, and thermodynamic stability. To some extent the changes observed in continuing from the 12-14-membered ring macrocyclic complexes parallels the behaviors shown by the octacoordinated lanthanide(III) complexes with DOTA and TETA. GdPCTA-[12] and -[13] feature promising properties in view of their possible use as contrast agents for magnetic resonance imaging.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and physicochemical characterization of carbon backbone modified [Gd(TTDA)(H2O)]2- derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Chang</namePart>
      <namePart type="given">Y.-H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chen</namePart>
      <namePart type="given">C.-Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Singh</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Chen</namePart>
      <namePart type="given">H.-Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Liu</namePart>
      <namePart type="given">G.-C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Goan</namePart>
      <namePart type="given">Y.-G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Wang</namePart>
      <namePart type="given">Y.-M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>50</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>1275</start>
          <end>1287</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79951586470&amp;partnerID=40&amp;md5=cdab1117c41f3c6421912634d9642ec0</url>
    </location>
    <abstract>The present study was designed to exploit optimum lipophilicity and high water-exchange rate (kex) on low molecular weight Gd(III) complexs to generate high bound relaxivity (r1b), upon binding to the lipophilic site of human serum albumin (HSA). Two new carbon backbone modified TTDA (3,6,10-tri(carboxymethyl)-3,6,10-triazadodecanedioic acid) derivatives, CB-TTDA and Bz-CB-TTDA, were synthesized. The complexes [Gd(CB-TTDA)(H 2O)]2- and [Gd(Bz-CB-TTDA)(H2O)]2- both display high stability constant (log KGdL = 20.28 and 20.09, respectively). Furthermore, CB-TTDA (log K(Gd/Zn) = 4.22) and Bz-CB-TTDA (log K(Gd/Zn) = 4.12) exhibit superior selectivity of Gd(III) against Zn(II) than those of TTDA (log K(Gd/Zn) = 2.93), EPTPA-bz-NO2 (log K(Gd/Zn) = 3.19), and DTPA (log K (Gd/Zn) = 3.76). However, the stability constant values of [Gd(CB-TTDA)(H2O)]2- and [Gd(Bz-CB-TTDA)(H 2O)]2- are lower than that of MS-325. The parameters that affect proton relaxivity have been determined in a combined variable temperature 17O NMR and NMRD study. The water exchange rates are comparable for the two complexes, 232 × 106 s-1 for [Gd(CB-TTDA)(H2O)]2- and 271 × 106 s -1 for [Gd(Bz-CB-TTDA)(H2O)]2-. They are higher than those of [Gd(TTDA)(H2O)]2- (146 × 10 6 s-1), [Gd(DTPA)(H2O)]2- (4.1 × 106 s-1), and MS-325 (6.1 × 106 s-1). Elevated stability and water exchange rate indicate that the presence of cyclobutyl on the carbon backbone imparts rigidity and steric constraint to [Gd(CB-TTDA)(H2O)]2-and [Gd(Bz-CB-TTDA) (H2O)]2-. In addition, the major objective for selecting the cyclobutyl is to tune the lipophilicity of [Gd(Bz-CB-TTDA)(H 2O)]2-. The binding affinity of [Gd(Bz-CB-TTDA)(H 2O)]2- to HSA was evaluated by ultrafiltration study across a membrane with a 30 kDa MW cutoff, and the first three stepwise binding constants were determined by fitting the data to a stoichiometric model. The binding association constants (KA) for [Gd(CB-TTDA)(H 2O)]2- and [Gd(Bz-CB-TTDA)(H2O)]2- are 1.1 × 102 and 1.5 × 103, respectively. Although the KA value for [Gd(Bz-CB-TTDA)(H2O)] 2- is lower than that of MS-325 (KA = 3.0 × 10 4), the r1b value, r1b = 66.7 mM-1 s-1 for [Gd(Bz-CB-TTDA)(H2O)] 2-, is significantly higher than that of MS-325 (r1b = 47.0 mM-1 s-1). As measured by the Zn(II) transmetalation process, the kinetic stabilities of [Gd(CB-TTDA)(H 2O)]2-, [Gd(Bz-CB-TTDA)(H2O)]2-, and [Gd(DTPA)(H2O)]2- are similar and are significantly higher than that of [Gd(DTPA-BMA)(H2O)]2-. High thermodynamic and kinetic stability and optimized lipophilicity of [Gd(CB-TTDA)(H2O)]2- make it a favorable blood pool contrast agent for MRI. © 2011 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and reactivity of trinuclear osmium and dinuclear and trinuclear ruthenium compounds derived from hydroxyalkynes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deeming</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>828</start>
          <end>832</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1981</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049103362&amp;partnerID=40&amp;md5=bb4171fb389447654f5a54b8dc7c84f4</url>
    </location>
    <abstract>3-Hydroxy-3-methylbut-1-yne (HC≡CCMe2OH) reacts with [Ru3(CO)12] to give [Ru3H(CO)9(C≡CCMe2OH)] in very low yield as already described, but we can now report that the main products are isomeric compounds with empirical formula [Ru2(CO)6(alkyne)2], which contain ruthenacyclopentadiene groups, and substituted benzenes formed by oligomerisation of three alkyne molecules. Much better yields of [Os3H(CO)9(C2CMe2OH)] are obtained in a similar way with no evidence for alkyne trimerisation or complex dimer formation. The complex [Os3H2(CO)10] reacts at room temperature with HC2CMe2OH to give [Os3(CO)10(HC2CMe2OH)] and [Os3H(Co)10(CH=CHCMe2OH)]. The dynamic n.m.r. behaviour of the first of these and the thermal decarbonylations of both are described. The 1H n.m.r. spectra of cationic clusters formed by hydroxide-ion loss in acidic solution are reported and the involvement of such cations in substitution and dehydration reactions of the η3 ligands.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and relaxometric properties of gadolinium(III) complexes of new triazine-based polydentate ligands</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Benzi</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kielar</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallotti</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>92</number>
        </detail>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>2414</start>
          <end>2426</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">0018019X (ISSN)</identifier>
      <titleInfo>
        <title>Helvetica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Helv. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-73449131890&amp;partnerID=40&amp;md5=73cd11413ac152ef696096eec20d6054</url>
    </location>
    <abstract>Two new derivatives based on an s-triazine structural motif were synthesized by attaching two 2,2′-hydrazinylidenebis[acetic acid] moieties to the triazine ring to reach an overall heptadenticity for the complexation of lanthanide(III) cations. The remaining reactive site was exploited for the substitution with a functionizable amino group (see H4L1) and a lipophilic moiety (see H4L2). Luminescence-lifetime determinations revealed the presence of a single H2O molecule coordinated for [Eu(L1)]. A complete 1H-NMR relaxometric study was carried out for the octacoordinated [Gd(L1)] and [Gd(L2)] complexes. A remarkably long H 2O residence lifetime (298τM=5.2 μs) was found by 17O-NMR in the case of [Gd(L1)]. Micelle formation of the lipophilic complex [Gd(L2)] was evidenced, the critical micellization concentration (cmc) determined, and relaxometric properties of the system investigated. © 2009 Verlag Helvetica Chimica Acta AG.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and solution thermodynamic study of rigidified and functionalised EGTA derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baranyai</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Piscopo</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>13</number>
        </detail>
        <extent unit="pages">
          <start>2361</start>
          <end>2368</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">14770520 (ISSN)</identifier>
      <titleInfo>
        <title>Organic and Biomolecular Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Org. Biomol. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-45449085059&amp;partnerID=40&amp;md5=f64013e6f96472278a197d09d666d570</url>
    </location>
    <abstract>The synthesis of a new series of EGTA (ethyleneglycol-bis(2- aminoethylether)-N,N,N′,N′-tetraacetic acid) derivatives incorporating aromatic and functionalized aromatic moieties into the oxoethylenic bridge is described. A solution thermodynamic study was carried out to determine the influence of structural modifications on the coordinating ability towards lanthanide and alkaline earth metal ions. The presence of remote functional groups on the aromatic moiety would allow the conjugation of the complexes to macromolecules or other biological targets. © 2008 The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and spectroscopic characterization of heterobimetallic (α-alkynyl)iron-cobalt hexacarbonyl complexes, μ-(1-σ, 2-3, η2-R2C-CCR′)][(CO)3Fe-Co(CO) 3] and [μ-(1-σ, 2-3, η2-H2C-CCCH2OH)] [(CO)3Fe-Co(CO)2(PPh3)]</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>2</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>77</start>
          <end>81</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">02775387 (ISSN)</identifier>
      <titleInfo>
        <title>Polyhedron</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Polyhedron</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0002672784&amp;partnerID=40&amp;md5=8cd4b32051f6260fc16ab500c8287b88</url>
    </location>
    <abstract>The title compounds have been prepared from reactions of Co2(CO)6(μ-HOR2CC2R ′) or Co2(CO)6(μ-HOR2CC2CR2OH) complexes with Fe(CO)5 in acetone. In the latter set of reactions the homobimetallic butatriene compounds, Fe2(CO)6-(μ-R2CCCCR2), are also obtained. The striking feature of these reactions is the ability of Fe(CO)5 to dehydroxylate the organic moiety and to replace a Co(CO)3 unit forming mixed iron-cobalt derivatives. A direct interaction between the iron and the carbon atom, originally bearing the lost -OH group, is evident from the bulk of the spectroscopic data; thus the organic chain acts as an overall 5 electron donor, according to the E.A.N. formalism. The heterobimetallic compounds have been characterized by elemental analysis, mass spectrometry, IR spectroscopy and NMR studies. For the phosphine derivative FeCo(CO)5(PPh3)(H2CC2OH) a crudely refined X-ray analysis has been performed. © 1983.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis and VT-NMR studies of cationic hydride platinum clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Minghetti</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bandini</namePart>
      <namePart type="given">A.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Banditelli</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>5</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>523</start>
          <end>533</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1994</dateIssued>
      </originInfo>
      <identifier type="issn">10407278 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Cluster Science</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J Clust Sci</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0242482016&amp;partnerID=40&amp;md5=2ab35c70dc2610a9e1c2553cc55338e5</url>
    </location>
    <abstract>The synthesis of three trinuclear platinum hydrides [Pt3(L-L)3(H)3]+ (L-L = 1,2-bis(diphenylphosphino)ethane, dppe, l; 1-diphenylphosphino-2-diphenylarsinoethane, dppae. 2; 1,2-bis(diphenylarsino)ethane, dpae, 3) is reported. The complexes were characterized by IR, FN2-MS, and NMR (1H,31P and195Pt) spectroscopic techniques. The fast exchange of the hydride ligands, observed at ambient temperature, is frozen out at low temperature. The low-temperature1H and31P NMR spectra are consistent with an open array of Pt atoms in the clusters, in keeping with a 16-electron configuration on each platinum atom. Two of the hydride ligands are terminally bonded to two metal centers, whereas the third one is μ3-coordinated, interacting more tightly with the unique platinum atom. © 1994 Plenum Publishing Corporation.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis of a bifunctional monophosphinic acid DOTA analogue ligand and its lanthanide(III) complexes. A gadolinium(III) complex endowed with an optimal water exchange rate for MRI applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rudovský</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kotek</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hermann</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lukeš</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mainero</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>112</start>
          <end>117</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">14770520 (ISSN)</identifier>
      <titleInfo>
        <title>Organic and Biomolecular Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Org. Biomol. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-11844280273&amp;partnerID=40&amp;md5=e8942990cd5017a20ee17cf560c9f26b</url>
    </location>
    <abstract>A new bifunctional octa-coordinating ligand containing an aminobenzyl moiety, DO3APN2n (H4DO3APN2n = 1,4,7,10-tetraazacyclododecane-4,7,10-triacetic-1-{methyl[(4-aminophenyl)methyl] phosphinic acid}), has been synthesized. Its lanthanide(III) complexes contain one water molecule in the first coordination sphere. The high-resolution 1H and 31P spectra of [Eu(H2O) (DO3AP N2n)- show that the twisted square-antiprismatic form of the complexes is more abundant in respect to the corresponding Eu(III)-DOTA complex. The 1H NMRD and variable-temperature 17O relaxation measurements of [Gd(H2O)(DO3APN2n)]- show that the water residence time is short (298TM = 16 ns) and falls into the optimal range predicted by theory for the attainment of high relaxivities once this complex would be endowed by a slow tumbling rate. The relaxivity (298r1 = 6.7 mM-1 s-1 at 10 MHz) is higher than expected as a consequence of a significant contribution from the second hydration sphere. These results prompt the use of [Gd(H 2O)(DO3APN2n)]- as a building block for the set-up of highly efficient macromolecular MRI contrast agents.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis of characterization of triosmium clusters containing the bidentate ligand Ph2PCH2CH2SMe: Detection of an isomerization reaction involving bridging and chelating ligand coordination modes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Persson</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Monari</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Russo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Calhorda</namePart>
      <namePart type="given">M.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nordlander</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>20</number>
        </detail>
        <detail type="issue">
          <number>20</number>
        </detail>
        <extent unit="pages">
          <start>4150</start>
          <end>4160</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2001</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0035497141&amp;partnerID=40&amp;md5=f8de0a17a50c4134e2b6480da9912fd3</url>
    </location>
    <abstract>Diphenylphosphinoethylene methyl sulfide, Ph2PCH2CH2SMe, reacts with [Os3(CO)11-(NCMe)] yielding [Os3(CO)11(Ph2PCH2 CH2SMe)]. Treatment of [Os3(CO)10 (NCMe)2] with 1 equiv of the P,S ligand initially yields the cluster 1,2-[Os3(CO)10(μ-Ph2PCH2 CH2SMe)], i which the phosphine and the thioether moieties coordinate to different metal atoms of the metal triangle; addition of two or more equivalents of the ligand yields 1,2-[Os3(CO)10 (μ-Ph2PCH2CH2SMe)] and [Os3(CO)10(Ph2PCH2CH2SMe) 2]. The cluster 1,2-[Os3(CO)10(μ-Ph2PCH2 CH2SMe)] is metastable and undergoes a slow isomerization reaction at room temperature to form 1,1-[Os3(CO)10(Ph2PCH2CH2 SMe)], in which the ligand chelates one Os atom. Computational modeling of 1,2- and 1,1-[Os3(CO)10(Ph2PCH2 CH2 SMe)] indicates that the two clusters are of similar stability, with the latter isomer being of slightly lower energy. The dynamic behavior of the clusters have been investigated by variable-temperature 13 C{1H} and 31P{1H} NMR, and the kinetics of the isomerization reaction have been measured. The latter indicate that the isomerization proceeds via an associative mechanism which is proposed to involve an intramolecular nucleophilic attack by the coordinated sulfur on an osmium atom. The solid state structures of [Os3(CO)11 (Ph2PCH2CH2SMe)]. 1,2-[Os3(CO)10(μ-Ph2PCH2 CH2SMe)], and 1,1-[Os3(CO)10(Ph2PCH2CH2 SMe)] are reported.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis of Gd(III)-C-palmitamidomethyl-C′-DOTAMA-C 6-o-carborane: A new dual agent for innovative MRI/BNCT applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crivello</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deagostino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nervi</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Prandi</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Toppino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Venturello</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>23</number>
        </detail>
        <extent unit="pages">
          <start>4460</start>
          <end>4466</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">14770520 (ISSN)</identifier>
      <titleInfo>
        <title>Organic and Biomolecular Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Org. Biomol. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-56349130670&amp;partnerID=40&amp;md5=c5cf599da3ffacdbaa8e676bd6b96700</url>
    </location>
    <abstract>C-(2-Benzyloxy)-ethyl-C′-N-tert-butoxycarbonyl-aminomethyl-o- carborane (8), a potentially useful intermediate for BNCT, has been synthesised. This intermediate can be readily functionalised with several biological vectors and MRI contrast agents. In this work intermediate 8 has been functionalised with a palmityl chain for lipophilic targeting and with Gd(III)-DOTAMA-C 6-NH2 as MRI detector. This combination yielded Gd(III)-C-palmitamidomethyl-C′-DOTAMA-C6-o-carborane (14) as a dual MRI-BNCT agent. © 2008 The Royal Society of Chemistry.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis of new polyoxapolycarboxylic ligands for lanthanide(III) ions complexation</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cavallotti</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>45</number>
        </detail>
        <detail type="issue">
          <number>30</number>
        </detail>
        <extent unit="pages">
          <start>5901</start>
          <end>5903</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">00404039 (ISSN)</identifier>
      <titleInfo>
        <title>Tetrahedron Letters</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Tetrahedron Lett.</title>
      </titleInfo>
    </relatedItem>
    <abstract>The multidentate polyoxapolycarboxylic ligands 1 and 2 were obtained by a two-step synthesis from easily available chemicals. Preliminary data on their coordination properties are reported. © 2004 Elsevier Ltd. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis of the alkoxo(hydrido)-clusters [Ru3(μ-H)(CO)10(μ-OR)] [R = Me, Et, Prn, or Bun] catalysed by dinuclear carbonyl iron complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Padovan</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>253</start>
          <end>254</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1987</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049090057&amp;partnerID=40&amp;md5=f2f995c40aa52212cfbc2de63521d359</url>
    </location>
    <abstract>The use of dinuclear carbonyl iron complexes, namely [Fe2(η5-C5H5) 2(CO)4] and [Fe2(CO)4(PPh3)2(SMe)2], as catalysts in reactions of CO replacement by the weak nucleophilic molecules ROH (R = Me, Et, Prn, or Bun) allows the isolation of the novel series of derivatives [Ru3(μ-H)(CO)10(μ-OR)], previously inaccessible by thermal routes.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis of the Gd(III) complex with a tetrazole-armed macrocyclic ligand as a potential MRI contrast agent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ferrari</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>43</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>783</start>
          <end>786</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">00404039 (ISSN)</identifier>
      <titleInfo>
        <title>Tetrahedron Letters</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Tetrahedron Lett.</title>
      </titleInfo>
    </relatedItem>
    <abstract>We report the synthesis and the properties of the Gd(III) complex with 4 (H4dotetra), a novel mixed pendant-arm macrocyclic ligand embodying a tetrazole subunit in a N5O3 donor set as a potential magnetic resonance imaging (MRI) contrast agent. © 2002 Elsevier Science Ltd. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis, characterization, and 1/T1 NMRD profiles of gadolinium(III) complexes of monoamide derivatives of DOTA-like ligands. X-ray structure of the 10-[2-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-1-[(phenylmethoxy)methyl]-2-oxo- ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid-gadolinium(III) complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Anelli</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grandi</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paoli</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Uggeri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>31</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>2422</start>
          <end>2428</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1992</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0001476523&amp;partnerID=40&amp;md5=88ab10a0f416927b13b1545a67e3a347</url>
    </location>
    <abstract>The synthesis of two novel DOTA-like ligands (5a,b) containing a polyhydroxy(benzyloxy)propionamide substituent and their Gd(III) complexes (6a,b) is reported. Debenzylation by hydrogenolysis of the latter complexes in the presence of Pd/C leads to the corresponding derivatives (7a,b) with a primary alcoholic function. Water proton relaxation rates of aqueous solutions of 6a,b and 7a,b strongly suggest that these complexes contain only one water molecule in their inner coordination sphere, as was previously found for the parent DOTA complex. The high formation constants measured for complexes 6a,b (log KML = 25.9 and 26.4, respectively) support the hypothesis of a direct involvement of the amide functionality in the coordination cage. This was shown by the determination of the solid-state structure of 6a, which was accomplished in a single-crystal X-ray diffraction study. The structure consists of a Gd(C27H40N5O10)(H2O) unit and three water molecules; space group P21/c (Z = 4) with a = 17.378 (4) Å, 6 = 8.283 (7) Å, c = 22.813 (5) Å, β = 100.33 (2)°, V = 3230 (3) Å3, d = 1.590 g/mL. The coordination polyhedron around the gadolinium ion is best described by a distorted-square antiprism capped by the coordinated water oxygen. All Gd-O distances (ranging from 2.34 to 2.43 Å) are very similar and this unambiguously proves the coordination of the carboxamide oxygen to the gadolinium ion. The 1/T1 NMRD profiles of aqueous solutions of 6a,b and 7a,b reveal that at the higher frequencies, the solvent proton relaxation rates are dominated by the molecular reorientational time τR; i.e., the observed relaxivities are linearly related to the molecular size. However, the main effect associated with the transformation of carboxylate to carboxamide is the drastic reduction of the electronic relaxation time τSO, which is responsible for a decrease in relaxivity at the low fields. © 1992 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis, crystal structure and mass transport properties of novel thallium ion precursors for MOCVD applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Malandrino</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Borzì</namePart>
      <namePart type="given">A.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Castelli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fragalà</namePart>
      <namePart type="given">I.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rossi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dapporto</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>369</start>
          <end>374</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society. Dalton Transactions</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J Chem Soc Dalton Trans</title>
      </titleInfo>
    </relatedItem>
    <abstract>The reaction of Tl2CO3 with 1,1,1,5,5,5-hexafluoro-2,4-pentanedione (Hhfa) and diglyme {CH3O(CH2CH2O)2CH3} or tetraglyme {CH3O(CH2CH2O)4CH3} in dichloromethane yields the anhydrous, thermally and air stable, volatile Tl(hfa)·diglyme and Tl(hfa)·tetraglyme adducts. They have been characterized by single crystal X-ray diffraction, elemental analysis, 1H and 13C NMR, IR and mass spectroscopy. Thermal and mass-transport properties have been investigated using thermogravimetric and differential scanning calorimetric measurements. There is evidence that both precursors are very low melting and volatile, and can be used as liquid Tl sources. Both adducts have been successfully applied to metal-organic chemical vapor deposition of thallium containing films.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis, crystal structure and solid-state dynamics of the La(hfa)3·Me(OCH2CH2)4OMe (Hhfa = 1,1,1,5,5,5-hexafluoropentane-2,4-dione) precursor for MOCVD applications</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Malandrino</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fragalà</namePart>
      <namePart type="given">I.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Benelli</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1509</start>
          <end>1512</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">03009246 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society - Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33748493183&amp;partnerID=40&amp;md5=f4b9602e67aa1ad12be2057e175d03c0</url>
    </location>
    <abstract>The reaction of La2O3 with 1,1,1,5,5,5-hexafluoropentane-2,4-dione (Hhfa) and tetraglyme [Me(OCH2CH2)4-OMe] in hexane yielded the air stable, ten-co-ordinate La(Hfa)3·Me(OCH2CH2)4OMe adduct. This new adduct represents a promising volatile lanthanum precursor for low-pressure MOCVD applications. It displays a high volatility, which can be related to a fast molecular reorientation in the solid state as established by combined DSC, 1H and 13C NMR investigations.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis, crystal structure, and stereochemical non-rigidity of μ-[1-σ:1-2-η-2-carboxylato-1-ethylbut-1-enyl-O(2Fe)]- bis(tricarbonyl-iron) (Fe-Fe), a new complex obtained from iron carbonyls under apolar conditions</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sappa</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Camellini</namePart>
      <namePart type="given">M.T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1155</start>
          <end>1159</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1979</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049091299&amp;partnerID=40&amp;md5=4f2e4c08755533fee1baac4560609b22</url>
    </location>
    <abstract>The title complex [Fe2(CO)6{CEt=CEt(CO2)}] has been obtained from [Fe3(CO)12] and hex-3-yne in hydrocarbon solvents and characterized by i.r., mass, and 1H and 13C n.m.r. spectra. The crystal structure has been determined by X-ray diffraction methods. The crystals are triclinic, space group P1, with Z = 2, in a unit cell of dimensions a = 9.500(9), b = 10.627(11), c = 9.140(9) Å, α = 109.61(8), β = 117.27(8), and γ = 79.71(7)°. The structure has been solved from diffractometer data by Patterson and Fourier methods and refined by full-matrix least squares to R = 0.027 for 3 295 observed reflections. The complex is formed by two non-equivalent iron atoms (Fe-Fe 2.438 Å), both co-ordinated by three terminal CO, and by a diethyl-substituted 'acrylate' ligand bound to both irons via Fe-C π and Fe-C and Fe-O σ bonds. This ligand is derived by insertion of a CO2 group between the alkyne and the metal atoms. In the complex an unusual five atom carbon-oxygen-iron heterocycle is present and an oxygen of the carboxyl group symmetrically bridges both iron atoms (Fe-O 1.950 and 1.990 Å). Variable-temperature 13C n.m.r. studies in solution show localized exchange of the CO groups at lower temperatures, whereas at room temperature a bonding interchange within the organic moiety and the iron atoms is proposed. Some comments on the factors influencing the formation of this complex and on the possible intermediates in the reaction are made.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis, molecular structure, crystal packing, and dynamic behaviour in the solid state of [Fe2(η5-C5H5) 2-(μ-CO)(CO)2{μ-CR(CN)}] (R = H or CN)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cordero</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bordoni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Busetto</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zanotti</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Albano</namePart>
      <namePart type="given">V.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Braga</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grepioni</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>20</number>
        </detail>
        <extent unit="pages">
          <start>2961</start>
          <end>2966</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1992</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049087554&amp;partnerID=40&amp;md5=70eb733b77408f927ed24fd339bf27ad</url>
    </location>
    <abstract>The dinuclear complexes [Fe2(η5-C5H5) 2(μ-CO)(CO)2{μ-CH(CN)}] 1 and [Fe2(η5-C5H5) 2(μ-CO)(CO)2{μ-C(CN)2}] 2 have been obtained from the sulfonium cation [Fe2(η5-C5H5) 2(μ-CO)(CO)2{μ-C(SMe2)(CN)}]+ via SMe2 displacement with H- and CN-, respectively. Complex 1 is present in solution and in the solid state as a mixture of isomers, the relative composition depending on the solvent. The structures of the cis isomers of 1 (cis-1a) and 2 (cis-2) have been determined by single-crystal X-ray diffraction: cis-1a, monoclinic, space group P21/m, a = 6.408(1), b = 13.58(1), c = 8.004(1) Å, β = 93.17(2)°, Z = 2, 2225 measured, 1392 unique observed reflections [I &gt; 2.0σ(I)], R = 0.035, R′ = 0.036; cis-2, orthorhombic, space group Pnma, a = 10.346(3), b = 12.313(4), c = 12.590(3) Å, Z = 4, 1645 measured, 1115 unique observed reflections [I &gt; 2.0σ(I)], R = 0.027, R′ = 0.029. The dynamic behaviour of the two complexes in the solid state has been investigated by variable-temperature 1H spin-lattice relaxation time measurements and 13C magic angle spinning NMR spectroscopy. The activation energies for the reorientational processes have been estimated. The separate intra- and intermolecular contributions to the total reorientational barriers have been evaluated by means of potential-energy barrier calculations within the pairwise atom-atom approach.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis, NMR, relaxometry and circularly polarised luminescence studies of macrocyclic monoamidetris(phosphinate) complexes bearing a remote chiral centre</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dickins</namePart>
      <namePart type="given">R.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maupin</namePart>
      <namePart type="given">C.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Riehl</namePart>
      <namePart type="given">J.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Williams</namePart>
      <namePart type="given">J.A.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>881</start>
          <end>892</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">03009246 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society - Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33748477684&amp;partnerID=40&amp;md5=87986cedf860d704da68eab6fe71afc5</url>
    </location>
    <abstract>Lanthanide complexes of macrocyclic monoamidetris(phosphinate) ligands are partially hydrated in aqueous solution. Introduction of a chiral centre into the amide group leads to the formation of only two non-interconverting complex diastereoisomers (2:1 for α-phenylethyl and 4:1 for α-1-naphthylethyl). Proton, 31P NMR and circularly polarised luminescence studies indicated that the configuration at the chiral carbon centre determines the helicity of the layout of the pendent arms and the macrocyclic ring conformation, with an RRR or SSS configuration preferred at the phosphorus centres.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis, potentiometric, kinetic, and NMR studies of 1,4,7,10- tetraazacyclododecane-1,7-bis(acetic acid)-4,10-bis(methylenephosphonic acid) (DO2A2P) and its complexes with Ca(II), Cu(II), Zn(II) and lanthanide(III) ions</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Kálmán</namePart>
      <namePart type="given">F.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baranyai</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tóth</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bányai</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Király</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Brücher</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sun</namePart>
      <namePart type="given">X.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sherry</namePart>
      <namePart type="given">A.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Kovács</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>47</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>3851</start>
          <end>3862</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-44249099488&amp;partnerID=40&amp;md5=47e81972b5ca479853ca794f172340f2</url>
    </location>
    <abstract>A cyclen-based ligand containing trans-acetate and trans- methylenephosphonate pendant groups, H6DO2A2P, was synthesized and its protonation constants (12.6, 11.43, 5.95, 6.15, 2.88, and 2.77) were determined by pH-potentiometry and 1H NMR spectroscopy. The first two protonations were shown to occur at the two macrocyclic ring N-CH 2-PO32- nitrogens while the third and fourth protonations occur at the two phosphonate groups. In parallel with protonation of the two -PO32- groups, the protons from the NH +-CH2-PO32- are transferred to the N-CH2-COO- nitrogens. The stability constants of the Ca2+, Cu2+, and Zn2+ (ML, MHL, MH2L, and M2L) complexes were determined by direct pH-potentiometry. Lanthanide(III) ions (Ln3+) form similar species, but the formation of complexes is slow; so, "out-of-cell" pH-potentiometry (La 3+, Eu3+, Gd3+, Y3+) and competitive spectrophotometry with Cu(II) ion (Lu3+) were used to determine the stability constants. By comparing the log KML values with those of the corresponding DOTA (H4DOTA = 1,4,7,10-tetraazacyclododecane-1,4, 7,10-tetraacetic acid) and DOTP (H8DOTP = 1,4,7,10- tetraazacyclododecane-1,4,7,10-tetramethylenephosphonic acid) complexes, the order DOTA &lt; DO2A2P &lt; DOTP was found for all the metal ion complexes examined here with the exception of the Ca2+ complexes, for which the order is reversed. The relaxivity of Gd(DO2A2P) decreases between pH 2 and 7 but remains constant in the pH range of 7 &lt; pH &lt; 12 (r1 = 3.6 mM-1 s-1). The linewiths of the 17O NMR signals of water in the absence and presence of Gd(DO2A2P) (at pH = 3.45 and 8.5) between 274 and 350 K are practically the same, characteristic of a q = 0 complex. Detailed kinetic studies of the Ce3+ and Gd3+ complexes with DO2A2P showed that complex formation is slow and involves a high stability diprotonated intermediate Ln(H2DO2A2P)*. Rearrangement of the diprotonated intermediate into the final complex is an OH- assisted process but, unlike formation of Ln(DOTA) complexes, rearrangement of Ln(H2DO2A2P)* also takes place spontaneously likely as a result of transfer of one of the protons from a ring nitrogen to a phosphonate group. The order of the OH- assisted formation rates of complexes is DOTA &gt; DO2A2P &gt; DOTP while the order of the proton assisted dissociation rates of the Gd3+ complexes is reversed, DOTP &gt; DO2A2P &gt; DOTA. 1H and 13C NMR spectra of Eu(DO2A2P) and Lu(DO2A2P) were assigned using two-dimensional correlation spectroscopy (2D COSY), heteronuclear multiple quantum coherence (HMQC), heteronuclear chemical shift correlation (HETCOR), and exchange spectroscopy (EXSY) NMR methods. Two sets of 1H NMR signals were observed for Eu(DO2A2P) characteristic of the presence of two coordination isomers in solution, a twisted square antiprism (TSAP) and a square antiprism (SAP), in the ratio of 93% and 7%, respectively. Line shape analysis of the 1H NMR spectra of Lu(DO2A2P) gave lower activation parameters compared to La(DOTP) for interconversion between coordination isomers. This indicates that the Ln(DO2A2P) complexes are less rigid probably due to the different size and spatial requirements of the carboxylate and phosphonate groups. © 2008 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis, reactivity, and ligand dynamics of Ru3(CO)9(μ-CO) (μ3-η2-alkyne) compounds</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Violano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arce</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Sanctis</namePart>
      <namePart type="given">Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>10</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>2854</start>
          <end>2856</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1991</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000146708&amp;partnerID=40&amp;md5=e7916d0e581d77bd4c6e7d2edc66dc4c</url>
    </location>
    <abstract>Acetylene, terminal HC2R (R = COOH, CHO), and nonterminal RC2R (R = Et, CH2OH, Ph) alkynes react at room temperature with Ru3(CO)10(MeCN)2 to give almost quantitatively Ru3(CO)9(μ-CO)(μ3-η 2-alkyne) compounds, which are shown to be the precursors of the acetylides Ru3(CO)9(μ-H)(C2R) in the case of acetylene and of terminal alkynes or of the allenic Ru3(CO)9(μ-H)(RC=C=CR′R″) complexes in the case of internal alkynes. Ru3(CO)9(μ-CO)(C2H2) at room temperature adds H2 to give Ru3(CO)9(μ-H)2(HC=CH), which is further hydrogenated at 3 atm to give Ru3(CO)9(μ-H)3CCH3. Ru3(CO)9(μ-CO)(C2H2) is stereochemically nonrigid: a low-energy process averages, on the NMR time scale, the semibridging CO with two pairs of terminal carbonyls at the bridged Ru atoms, and it is coupled to an alternate lengthening of one of the Ru-C σ bonds at the same metal atoms. At high temperature, all the carbonyls are equivalent. © 1991 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis, structure, and isomerisation of triruthenium and triosmium clusters derived from 3-dimethylaminoprop-1-yne; X-ray crystal structure of [Ru3-H(CO)9(Me2N+=C-C =CH2)]</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arce</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deeming</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hursthouse</namePart>
      <namePart type="given">M.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Galas</namePart>
      <namePart type="given">A.M.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>1981</start>
          <end>1986</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049094923&amp;partnerID=40&amp;md5=c5594b027a9f3f66d34953081d8b9461</url>
    </location>
    <abstract>Both [Ru3(CO)12] and [Os3(CO)12] react with 3-dimethylaminoprop-1-yne (HC≡CCH2NMe2) to give fairly low yields of the compounds [M3H(CO)9(Me2NCCCH2)] (M = Ru or Os), apparently derived by oxidative addition with cleavage of the terminal C-H bond and a 1,3 shift of the NMe2 group. Crystals of [Ru3H(CO)9(Me2NCCCH2)] are monoclinic, space group P21/n with Z = 4 and cell dimensions a = 13.067(2), b = 10.398(2), c = 15.544(2) Å, and β = 112.78(2)° the X-ray structure was refined to R = 0.019 8 for 3 138 observed reflections. The μ3 ligand is not bound like the μ3-allenyl ligand in [Ru3H(CO)9(μ3-EtC=C=CHMe)] but extensive π donation from the NMe2 group modifies the ligand-to-metal bonding and makes a zwitterionic description [Ru3-H(CO)9(Me2N +=C-C=CH2)] more realistic. In spite of the different bonding, the terminal CH2 protons of the triruthenium compound exchange (n.m.r. coalescence), corresponding to the methyl exchange previously observed for [Ru3H(CO)9-(μ3-MeC=C=CMe2)]. The triruthenium compound much less readily undergoes a hydrogen-atom shift observed generally for compounds of type [Ru3H(CO)9(R1C=C=CHR2)], being stable up to at least 140 °C. However, a PPh3-catalysed shift is observed at 55 °C to give [Ru3H(CO)9(Me2NCCHCH)] as well as the substitution product [Ru3H(CO)8(PPh3)(Me2NCCCH 2)].</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Synthesis, structure, and ligand dynamics pf (μ-H)(μ3-η2-CH3C=NCH 2CH3)Ru3(CO)9</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Radovan</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gellert</namePart>
      <namePart type="given">R.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>6</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>2074</start>
          <end>2078</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1987</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0010817569&amp;partnerID=40&amp;md5=f2a96ef7682514d61e7f1b24bf5ebfb4</url>
    </location>
    <abstract>The reaction of triethylamine with Ru3(CO)12 in refluxing hexanes catalyzed by Fe2(CO)4(SEt)2(PPh3)2 is shown to yield the complex (μ-H)Ru3(CO)9(μ3-η 2-CH3C=NCH2CH3) (I) as the major product (30%). An X-ray crystallographic investigation of I reveals that the organic ligand is parallel to one edge of the metal triangle and acts as a five-electron donor. The hydride was located; it symmetrically bridges the two metal atoms parallel to the C-N vector and is in the plane of the metal triangle. Compound I crystallizes in the P1 space group with α = 8.396 (2) Å, b = 15.198 (3) Å, c = 8.093 (2) Å, α = 102.95 (2)°, β = 108.63 (2)°, and γ = 90.33 (2)°. Least-squares refinement based on 2867 observed reflections led to a final R value of 3.3% (Rw = 4.4%). The variable-temperature 1H and 13C NMR spectra reveal that the organic ligand is fluxional, undergoing restricted oscillatory motion which is coupled to hydride edge hopping and axial-radial exchange on two of the three ruthenium atoms. © 1987 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Target visualization by MRI using the avidin/biotin amplification route: Synthesis and testing of a biotin-Gd-DOTA monoamide trimer</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Negri</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ramella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>16</number>
        </detail>
        <detail type="issue">
          <number>27</number>
        </detail>
        <extent unit="pages">
          <start>8080</start>
          <end>8087</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2010</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77954736331&amp;partnerID=40&amp;md5=5151682dc373e24dfe9694b7f82b2a35</url>
    </location>
    <abstract>To design efficient targeting strategies in magnetic resonance (MR) molecular imaging applications, the formation of supramolecular adducts between (strept)avidin ((S)Av) and tribiotinylated Gd-DOTA-monoamide complexes (DOTA = 1,4,7,10-tetraazacyclododecane-N, N', N", N"'-tetraacetic acid) was explored. Two compounds based on the trivalent core of tris(2aminoethyl)amine each containing three biotin molecules and one (Ll) or three (L2) DOTA-monoamide (DOTAMA) ligands were synthesized. In these tribiotinylated derivatives the biotins are spaced far enough apart to allow the formation of the supramolecular adduct with the protein and to host the chelating units in between the (S)Av layers. Size exclusion HPLC analyses indicated complete formation of very high molecular weight polymers (&gt;2MDa) with (S)Av in solution. A 1H NMR spectroscopy relaxometric study on the obtained polymeric adducts showed a marked increase of the relaxivity at 35-40 MHz as a consequence of the lengthening of the tumbling time due to the formation of Gdchelates/(S)Av polymers. The most effi-cient Gd3L2/(S)Av polymeric system was used for a test in cell cultures. The target is represented by a neural cell adhesion molecule (NCAM), which is overexpressed in Kaposi's sarcoma cells and tumor endothelial cells (TEC) and that is efficiently recognized by a biotinylated tetrameric peptide (C3dBio). In vitro experiments showed that only cells incubated with both C3d-Bio and Gd3L2/SAv polymer were hyperintense with respect to the control. Relaxation rates of cell pellets incubated with Gd3L2/SAv alone were not significantly different from the untreated cells demonstrating the absence of a specific binding. © 2010 Wiley-VCH Verlag GmbH &amp; Cu. KGaA. Weinheim.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>5</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>509</start>
          <end>518</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">13892010 (ISSN)</identifier>
      <titleInfo>
        <title>Current Pharmaceutical Biotechnology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Curr. Pharm. Biotechnol.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-10644293769&amp;partnerID=40&amp;md5=48dc839d38ff71d511a53fa15bc304e2</url>
    </location>
    <abstract>The low sensitivity is the major disadvantage of MRI as compared to PET. Therefore, amplification strategies are necessary for specific pathway labeling. This survey is aimed at exploring different routes to the entrapment of Gd(III) chelates in various type of cells at amounts sufficiently large to allow MRI visualization. Namely, the obtained results have been summarized in terms of internalization via i) pinocytosis; ii) phagocytosis; iii) receptors; iv) receptor mediated endocytosis; v) transporters; vi) transmembrane carrier peptides. MRI visualization of cells appears possible when the number of internalized Gd(III) chelates is of the order of 107-108/cell. Pinocytosis shows to be particularly useful for labeling cells that can be incubated for several hours in the presence of high concentrations of Gd-agent. This approach appears very effective for labeling stem cells. Nanoparticles filled with Gd-chelates can be used for an efficient loading of cells endowed with a good phagocytic activity. Entrapment via receptors most often results in receptor mediated endocytosis. Suitably functionalized monomeric and multimeric Gd-chelates can be considered for being internalized by this route as well as supramolecular systems such as those formed between Avidin and biotinylated Gd-complexes. Exploitation of up-regulated transporters of nutrients in tumor cells appears to be a promising route for their differentiation from healthy cells. Finally, properly designed systems entering the cells by means of penetrin-like peptides deserve great attention. © 2004 Bentham Science Publishers Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Targeting exofacial protein thiols with GdIII complexes. An efficient procedure for MRI cell labelling</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Catanzaro</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Menchise</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gringeri</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>893</start>
          <end>895</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">13597345 (ISSN)</identifier>
      <titleInfo>
        <title>Chemical Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-61449093769&amp;partnerID=40&amp;md5=95b045fea12c1ea1bc59d31b3845b9e2</url>
    </location>
    <abstract>Cells display on the outer surface of the plasma membrane a large number of protein thiols that can be reversibly labelled with suitably designed Gd III-based contrast agents for cell tracking by MRI. © The Royal Society of Chemistry 2009.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Targeting of human renal tumor-derived endothelial cells with peptides obtained by phage display</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Bussolati</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grange</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deregibus</namePart>
      <namePart type="given">M.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ercolani</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Camussi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>85</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>897</start>
          <end>906</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">09462716 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Molecular Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Mol. Med.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34447512451&amp;partnerID=40&amp;md5=94c7dc60bb70f72f7766a72ae4872da8</url>
    </location>
    <abstract>The phenotypic and molecular diversity of tumor-associated vasculature provides a basis for the development of targeted diagnostics and therapeutics. In the present study, we have developed a peptide-based targeting of human tumor endothelial cells (TEC) derived from renal carcinomas. We used a murine model of human tumor angiogenesis, in which TEC injected subcutaneously in severe combined immunodeficiency (SCID) mice organized in vascular structures connected with the mouse circulation, to screen in vivo a phage display library of random peptides. Using this approach, we identified cyclic peptides showing specific binding to TEC and not to normal human endothelial cells or to murine tumor endothelial cells. In particular, the peptide CVGNDNSSC (BB1) bound to TEC in vitro and in vivo. Using BB1 peptide conjugated with the ribosome-inactivating toxin saporin, we targeted TEC in vivo. Injection of BB1-saporin but not saporin alone or control modified BB-1ala saporin induced a selective cell apoptosis and disruption of the TEC vessel network. No increase in cell apoptosis was found in other murine organs. In conclusion, the identification of peptide sequences able to bind selectively human tumor-derived endothelial cells may represent a tool to deliver antiangiogenic or antitumor agents within the neoplastic vessels. © 2007 Springer-Verlag.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Ternary complexes between cationic GdIII chelates and anionic metabolites in aqueous solution: An NMR relaxometric study</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bobba</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dickins</namePart>
      <namePart type="given">R.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>9</number>
        </detail>
        <detail type="issue">
          <number>9</number>
        </detail>
        <extent unit="pages">
          <start>2102</start>
          <end>2109</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0038814010&amp;partnerID=40&amp;md5=c603c67cc0a4de70c2f4b7d9ae036551</url>
    </location>
    <abstract>The 1H and 17O NMR relaxometric properties of two cationic complexes formed by GdIII with a macrocyclic heptadentate triamide ligand, L1, and its N-methylated analogue, L2, have been investigated in aqueous media as a function of pH, temperature and magnetic field strength. The complexes possess two water molecules in their inner coordination sphere for which the rate of exchange has been found to be sensibly faster for the N-methylated derivative and explained in terms of electronic effects (decrease of the charge density at the metal center) and perturbation of the network of hydrogen-bonded water molecules in the outer hydration sphere. The proton relaxivity shows a marked dependence from pH and decreases of about six units in the pH range 6.5 to 9.0. This has been accounted for by the displacement of the two water molecules by dissolved carbonate which acts as a chelating anion. The formation of ternary complexes with lactate, malonate, citrate, acetate, fluoride and hydrogenphosphate has been monitored by 1H NMR relaxometric titrations at 20 MHz and pH 6.3 and the value of the affinity constant, K, and of the relaxivity of the adducts could be obtained. Lactate, malonate and citrate interact strongly with the complexes (log K ≥ 3.7) and coordinate in a biden-date mode by displacing both water molecules. Larger affinity constants have been measured for GdL2. Acetate, fluoride and hydrogenphosphate form monoaqua ternary complexes which were investigated in detail with regard to their relaxometric properties. The NMR dispersion (NMRD) profiles indicate a large contribution to the relaxivity of the adducts from water molecules belonging to the second hydration shell of the complexes and hydrogen-bonded to the anion. A VT 17O NMR study has shown a marked increase of the rate of water exchange upon binding which is explained by coordination of the anion in an equatorial site, thus leaving the water molecule in an apical position, more accessible for interactions with the solvent molecules of the second hydration shell which facilitate the exchange process.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Ternary Gd(III)L-HSA adducts: Evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palmisano</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lowe</namePart>
      <namePart type="given">M.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>5</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>488</start>
          <end>497</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">09498257 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Biological Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Biol. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0033847507&amp;partnerID=40&amp;md5=3f5b6aca259ef7473aa961b7c2d7d7bd</url>
    </location>
    <abstract>Two novel gadolinium(III) chelates based on the structure of the heptadentate macrocyclic 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (DO3A) ligand have been synthesized and their relaxometric and luminescent properties thoroughly investigated. They contain two water molecules in the inner coordination sphere in fast exchange with the bulk solvent and bear either a p-bromobenzyl or a p-phosphonatomethylbenzanilido substituent for promoting further interaction with macromolecular substrates. Upon interaction with human serum albumin the expected relaxation enhancement is not observed owing to displacement of the two inner-sphere water molecules of the complexes by a donor atom (likely from a carboxylate group) on the protein and possibly the phosphate anion of the buffered solution, respectively. We modeled the observed behavior by measuring the decrease of the relaxation rate of the water protons upon addition of malonate anion to aqueous solutions of the complexes. Conversely, no change in the hydratation state of the Gd(III) center for both complexes has been observed when the substrate for the formation of the macromolecular adduct is represented by poly-β-cyclodextrin.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The 1H And 2H NMR Spectra Of HFeCo3 (CO)12</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>2</number>
        </detail>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>1235</start>
          <end>1240</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">02775387 (ISSN)</identifier>
      <titleInfo>
        <title>Polyhedron</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Polyhedron</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-49049125280&amp;partnerID=40&amp;md5=b3bf9a2a01568fd62024f35af8ee1907</url>
    </location>
    <abstract>The detection of the 2H resonance of 2HfeCo3 (CO)12 led to the detection of the broader 1H resonance of the 1H isotopomer. The shift is -21.4 ppm. © 1983.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The alkyne-cluster interaction in a ruthenium "butterfly" acetylenic carbonyl complex. An UV-PES and theoretical study</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bertoncello</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Acampora</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ajò</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>244</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>383</start>
          <end>391</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33748636126&amp;partnerID=40&amp;md5=70173b20050e5817a9604629d82be424</url>
    </location>
    <abstract>The electronic structure of "butterfly" Ru4(CO)12(RC2R) cluster complexes is discussed on the basis of He(I) PE spectroscopy and CNDO quantum mechanical calculations. The theoretical results contribute to the discussion of the PE data and provide novel insights into the alkyne-cluster bonding scheme. The most interesting feature emerging from this study is the different roles of the "hinge" and "wing" ruthenium atoms: the former are involved in both donation and back-donation with the alkyne, whereas the latter are primarily involved in the donation only. This gives rise to a particularly stable arrangement, because the two highly polarizable Ru3 triangles provide a mechanism for balancing the charges. © 1983.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The alkyne-cluster interaction: Structural, theoretical, and mechanistic studies on the M2M′(CO)9(μ3-η2-alkyne) complex (M = Fe; M′ = Fe and Ru)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Busetti</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>3</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>1510</start>
          <end>1515</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000768069&amp;partnerID=40&amp;md5=91b96129ae9fc42b66a19b3e7ff9ed8b</url>
    </location>
    <abstract>The thermal and photochemical reactions between Fe3(CO)12, Ru3(CO)12, and alkynes (PhC2Ph, EtC2Et) afford three novel heterometallic derivatives, namely, Fe2Ru(CO)9(alkyne), Fe2Ru(CO)8(alkyne)2, and FeRu(CO)6(alkyne)2. The fact that Fe2Ru(CO)9(alkyne) is obtained also from the thermal reaction of Fe3(CO)9(alkyne) and Ru3(CO)12 suggests that a possible pathway to its formation passes through the coordinatively unsaturated Fe2(CO)6(alkyne) complex. The solid-state X-ray structure of Fe2Ru(CO)9(PhC2Ph) is reported, and its electronic structure is discussed on the basis of CNDO calculations. © 1984 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The alkyne-cluster interaction: Structural, theoretical, and spectroscopic study on the parallel μ3-η2 bonding mode in trinuclear carbonyl clusters of ruthenium and osmium</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bertoncello</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Busetti</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>25</number>
        </detail>
        <detail type="issue">
          <number>22</number>
        </detail>
        <extent unit="pages">
          <start>4004</start>
          <end>4010</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1986</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000063264&amp;partnerID=40&amp;md5=8b89fb3c64259a488943c82287db87b0</url>
    </location>
    <abstract>The parallel μ3-η2 alkyne-cluster interaction in compounds of formula H2M3(CO)9(RC2R′) (M = Ru, Os) has been studied by means of X-ray diffraction, 1H and 13C VT (variable temperature) NMR and UV-PES spectroscopy, and CNDO theoretical techniques. Crystals of H2Os3(CO)9(CH3C2CH 3) belong to the monoclinic space group P21/n with unit cell dimensions of a = 14.538 (4) Å, b = 13.004 (4) Å, c = 9.817 (3) Å, β = 100.17 (5)°, and Z = 4. Full-matrix least-squares refinement converged to R = 4.95% for 3223 unique reflections. Relevant interatomic distances (Å): Os(1)-Os(2) = 3.016 (1), Os(1)-Os(3) = 2.763 (1), Os(2)-Os(3) = 2.858 (1), C(42)-C(43) = 1.434 (36), Os(1)-C(42) = 2.067 (24), Os(2)-C(43) = 2.198 (26), Os(3)-C(42) = 2.364 (28), Os(3)-C(43) = 2.263 (27). The small differences observed between the Os(1)-C(42) and Os(2)-C(43) distances are thought to reflect the charge imbalance on the metal atoms. The lowest energy dynamic process observed in the 13C NMR spectra is consistent with an oscillatory motion of the alkyne and of the hydride bridging the Os(1)-Os(2) edge (Ha) coupled with the edge hopping of the second hydride (Hb). Subtle electronic changes induced by different substituents on the alkyne cause remarkable differences in the 2JC,H coupling pattern between Ha and CO ligands. The results of CNDO calculations have been used for the interpretation of the UV-PE spectra and for discussion of the bonding scheme of the studied molecules. © 1986 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The crystallized solvent could influence the lanthanide water bonding?</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Bombieri</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Marchini</namePart>
      <namePart type="given">N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ciattini</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mortillaro</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>359</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>3405</start>
          <end>3411</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33745197511&amp;partnerID=40&amp;md5=d9034f2afb2db690eb8a61d4238b0486</url>
    </location>
    <abstract>Two gadonilium DOTAM complexes [Gd(DOTAM)H2O](CF3SO3)3 · 3H2O (1) and [Gd(DOTAM)H2O](CF3SO3)3 · 0.5H2O · CH3CN (2) have the structure of the M isomer, with coordination geometry around the Gd ion capped square antiprismatic (SA). They differ for the Gd-Owater bond lengths of 2.396(6) and 2.474(7) Å in (2) where two independent molecules are present in the crystal cell. The factors influencing the Gd-Owater bond distance, important for the water exchange rate in MRI experiments, have been correlated to the different network of hydrogen bonds involving the Gd coordinated water molecule. The X-ray structure of the parent compound [Pr(DOTAM)H2O](CF3SO3)3 · H2O · CH3CN (3) reveals an unexpected twisted square antiprismatic (TSA) coordination geometry characteristic of the m isomer. © 2006 Elsevier B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The detection of PHIP effects allows new insights into the mechanism of olefin isomerisation during catalytic hydrogenation</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Santelia</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>28</number>
        </detail>
        <extent unit="pages">
          <start>4348</start>
          <end>4351</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2008</dateIssued>
      </originInfo>
      <identifier type="issn">14341948 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-53549106363&amp;partnerID=40&amp;md5=af58753e8604d671bc700f37d95021ce</url>
    </location>
    <abstract>PHIP (parahydrogen-induced polarisation) effects in the 1H NMR spectra of the products of Rh-complex-catalysed alkyne hydrogenation brings to light the fact that the cis-trans isomerisation of the formed olefin occurs through the formation of a σ-bonded intermediate stabilised by the reversible addition of a hydrogen molecule at the metal centre. © Wiley-VCH Verlag GmbH &amp; Co. KGaA, 2008.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The effect of ligand basicity on the unconventional hydrogen-bond in H(μ-H)Os3(CO)10L (L=amine) derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bertone</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Russo</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stchedroff</namePart>
      <namePart type="given">M.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milanesio</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>334</number>
        </detail>
        <extent unit="pages">
          <start>448</start>
          <end>454</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2002</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0038815563&amp;partnerID=40&amp;md5=f7e1473f173c7ea9da453372209d1bfa</url>
    </location>
    <abstract>The reaction of amine ligands with the unsaturated 46 e- cluster Os3(μ-H2)(CO)10 yields a series of complexes of formula Os3H(μ-H)(CO)10(amine). In these derivatives the presence of an unconventional hydrogen-bond M-H⋯H-N is detected by the evaluation of proton spin-lattice relaxation times. In order to elucidate the relationship between pKb and H⋯H length, the M-H⋯H-N distances were quantified for amines of known pKb. In practice, this was achieved by comparing the T1 values of the terminal hydride resonances of the protonated isotopomer with the T1 values of the corresponding derivative containing selectively deuterated amine. A nice correlation between the M-H⋯H-N distances and the pKb of the amine ligands was found. DFT calculations were carried out for the cluster on Os3H(μ-H)(CO)10(Benzylamine) to gain a fuller understanding of the possible coordination geometries of an amine ligand on the surface of a tri-osmium cluster. © 2002 Elsevier Science B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The effect of ligand scaffold size on the stability of tripodal hydroxypyridonate gadolinium complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">O'Sullivan</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Doble</namePart>
      <namePart type="given">D.M.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Thompson</namePart>
      <namePart type="given">M.K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Siering</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Xu</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>42</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>2577</start>
          <end>2583</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0037460005&amp;partnerID=40&amp;md5=12b9076ab2303eadf87db29d44fc0892</url>
    </location>
    <abstract>The variation of the size of the capping scaffold which connects the hydroxypyridonate (HOPO) binding units in a series of tripodal chelators for gadolinium (Gd) complexes has been investigated. A new analogue of TREN-1-Me-3,2-HOPO (1) (TREN = tri(ethylamine)amine) was synthesized: TREN-Gly-1-Me-3,2-HOPO (2) features a glycine spacer between the TREN cap and HOPO binding unit. TRPN-1-Me-3,2-HOPO (3) has a propylene-bridged cap, as compared to the ethylene bridges within the TREN cap of the parent complex. Thermodynamic equilibrium constants for the acid-base properties of 2 and the Gd3+ complexation strength of 2 and 3 were measured and are compared with that of the parent ligand. The most basic ligand is 2 while 3 is the most acidic. Both 2 and 3 form Gd3+ complexes of similar stability (pGd = 16.7 and 15.6, respectively) and are less stable than the parent complex Gd-1 (pGd = 19.2). Two of the three complexes are more stable than the bis(methylamide)diethylenetriamine pentaacetate complex Gd(DTPA-BMA) (pGd = 15.7) while the other is of comparable stability. Enlargement of the ligand scaffold decreases the stability of the Gd3+ complexes and indicates that the TREN scaffold is superior to the TRPN and TREN-Gly scaffolds. The proton relaxivity of Gd-2 is 6.6 mM-1 s-1 (20 MHz, 25 °C, pH 7.3), somewhat lower than the parent Gd-1 but higher than that of the MRI contrast agents in clinical practice. The pH-independent relaxivity of Gd-2 is uncharacteristic of this family of complexes and is discussed.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The effects of intramolecular H-bond formation on the stability constant and water exchange rate of the Gd(III)-diethylenetriamine-N′-(3-amino-1,1-propylenephosphonic)-N, N,N″,N″-tetraacetate complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Baranyai</namePart>
      <namePart type="given">Z.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ramalingam</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Swenson</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ranganathan</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Brücher</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>2</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>94</start>
          <end>102</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2007</dateIssued>
      </originInfo>
      <identifier type="issn">15554309 (ISSN)</identifier>
      <titleInfo>
        <title>Contrast Media and Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Contrast Media Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-34249871935&amp;partnerID=40&amp;md5=6e62a6ef1443e9b05970f125b7d68080</url>
    </location>
    <abstract>The binding interaction of metal chelates to biological macromolecules, though driven by properly devoted recognition synthons, may cause dramatic changes in some property associated with the coordination cage such as the thermodynamic stability or the exchange rate of the metal coordinated water. Such changes are due to electrostatic and H-bonding interactions involving atoms of the coordination cage and atoms of the biological molecule at the binding site. To mimic this type of H-bonding interactions, lanthanide(III) complexes with a DTPA-monophosphonate ligand bearing a propylamino moiety (H6NP-DTPA) were synthesized. Their thermodynamic stabilities and the exchange lifetime of the coordinated water molecule (for the Gd-complex) were compared with those of the analog complexes with DTPA and the parent DTPA-monophosphonate derivative (H6P-DTPA). It was found that the intramolecular H-bond between the -̇amino group and the phosphonate moiety in NP-DTPA complexes causes displacements of electric charges in their coordination cage that are markedly pH dependent. In turn, this affects the characteristic properties of the coordination cage. In particular it results in a marked elongation of the exchange lifetime of the coordinated water molecule. Copyright © 2007 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The influence of strong acidic proton donors on the reactivity of H 2Ir(CO)Cl(PPh3)2 with D2</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Demaria</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Diana</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Reineri</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <text>204-205</text>
        </detail>
        <extent unit="pages">
          <start>371</start>
          <end>379</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">13811169 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Molecular Catalysis A: Chemical</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Mol. Catal. A Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-18544392755&amp;partnerID=40&amp;md5=de81b9b2703e014ae6fd47e0359a93e6</url>
    </location>
    <abstract>The interaction of the complex H2Ir(CO)Cl(PPh3) 2 with various proton donors of increasing acidity, namely 2,2,2-trifluoro ethanol (TFE), 1,1,1,3,3,3-hexafluor-2-propanol (HFIP), perfluoro tert-butylalcohol (PFTB) and trifluoroacetic acid (TFA), has been investigated. The gradual proton downfield shift of the hydride trans to the chlorine, in the presence of increasing amounts of the proton donors, and the T1 measurements have shown that the chlorine ligand is the basic counterpart in the hydrogen bond interaction. This intermolecular hydrogen bond influences the reactivity of the complex and particularly the H 2/D2 exchange process. The HDIr(CO)Cl(PPh 3)2 isotopomer obtained by reacting H 2Ir(CO)Cl(PPh3)2 with D2 in dichloromethane is formed in greater amount when one of the proton donors is added to the reaction mixture; furthermore the stronger the acid, the larger the amount of HDIr isotopomer formed. © 2003 Elsevier Science B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The management of HCV infected pregnant women and their children European paediatric HCV network</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Pembrey</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Newell</namePart>
      <namePart type="given">M.-L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tovo</namePart>
      <namePart type="given">P.-A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Amoroso</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bevilaqua</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Asensi-Botet</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pereda</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Balossini</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bona</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zaffaroni</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bandelloni</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Coscia</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fabris</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Belloni</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bossi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Salati</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Boucher</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Buffolano</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Butler</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Roura</namePart>
      <namePart type="given">L.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanges</namePart>
      <namePart type="given">J.M.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cigna</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ciria</namePart>
      <namePart type="given">L.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ginard</namePart>
      <namePart type="given">C.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Teruel</namePart>
      <namePart type="given">G.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fortuny</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Coll</namePart>
      <namePart type="given">O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Corrias</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ledda</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Floris</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Maria</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Echeverria</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cilla</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Faldella</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanari</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tridapalli</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Venturi</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fischler</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bohlin</namePart>
      <namePart type="given">A.-B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lindgren</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lindh</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giacomet</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Merlo</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Figini</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Erba</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viganò</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hannam</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mieli-Vergani</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Hatzakis</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Inchley</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fjaerli</namePart>
      <namePart type="given">H.O.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maccabruni</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Marcellini</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sartorelli</namePart>
      <namePart type="given">M.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fontelos</namePart>
      <namePart type="given">P.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mazza</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mok</namePart>
      <namePart type="given">J.Y.Q.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mûr</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viñolas</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Paternoster</namePart>
      <namePart type="given">D.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grella</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Polywka</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Quinti</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casadei</namePart>
      <namePart type="given">A.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rojahn</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Berg</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosso</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ferrando</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bassetti</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Contreras</namePart>
      <namePart type="given">J.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Manzanares</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Extremera</namePart>
      <namePart type="given">A.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Salvini</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zuccotti</namePart>
      <namePart type="given">G.V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Schmitz</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Grosch-Wörner</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sperling</namePart>
      <namePart type="given">C.F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Piening</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Vegnente</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Iorio</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Versace</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lazier</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Palomba</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gabiano</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Balbo</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Zanetti</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tanzi</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>43</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>515</start>
          <end>525</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">01688278 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Hepatology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Hepatol.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-23444431790&amp;partnerID=40&amp;md5=e730f86a138d09b29bb7c8edcbb9ea7b</url>
    </location>
    <abstract>Background/Aims: As evidence accumulates relating to mother-to-child (vertical) transmission of hepatitis C virus (HCV), it is timely to draw up guidelines for the clinical management of HCV infected pregnant women and their children. Methods: A review of evidence from the European Paediatric HCV Network (EPHN) prospective study of HCV infected women and their children and other published studies. Meeting of EPHN clinical experts to reach a consensus on recommendations for management. Each recommendation was graded according to the level of evidence. Results/conclusions: Although several risk factors for mother-to-child transmission have been identified, none are modifiable and there are currently no interventions available to prevent vertical transmission of HCV. Data on timing of loss of maternal antibodies and reliability of diagnostic tests inform the optimum follow-up schedule for confirmation or exclusion of infection in children born to HCV infected women. Based on the current evidence, routine antenatal screening for HCV should not be introduced and neither elective caesarean section nor avoidance of breastfeeding should be recommended to HCV infected women to prevent mother-to-child transmission of HCV. HCV/HIV co-infected women should follow existing HIV guidelines. © 2005 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The reaction of Co4(CO)12 with Ph2PCH2CH2PPh2. Spectroscopic identification of polymeric products</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Jannon</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>309</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>C51-C55</start>
          <end>C51-C55</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1986</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4243583962&amp;partnerID=40&amp;md5=2973f745f539f3ad3e1a92eb4072a3bc</url>
    </location>
    <abstract>Co4(CO)12 readily undergoes replacement of CO by 1,1-bis(diphenylphosphino)ethane (DPPE) and several derivatives have been characterized. In addition to {[Co4(CO)11]2(μ-DPPE)} (I) and [Co4(CO)10(DPPE)] (II), two polymeric products have been identified by IR and 31P NMR spectroscopy. The 13C and 31P variable temperature NMR spectra of I and II are reported. © 1986.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The role of molecular shape and axial symmetry in the solid state molecular dynamics of metal carbonyl compounds included in cyclodextrin cavities</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Canuto</namePart>
      <namePart type="given">H.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Eyes</namePart>
      <namePart type="given">S.J.H.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Napolitano</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>22</number>
        </detail>
        <extent unit="pages">
          <start>4075</start>
          <end>4077</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">1470479X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Chem. Soc. Dalton Trans.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0009844228&amp;partnerID=40&amp;md5=54b9e0d173025980c7a77fa1744fc1df</url>
    </location>
    <abstract>13C CP/MAS NMR spectra of the metal carbonyl complexes Cr(CO)6, Fe(CO)5 and Mn2(CO)10 included in β- and γ-cyclodextrin (CD) cavities have been studied in the temperature range 133 to 423 K. Cr(CO)6 molecules reorient effectively isotropically within γ-cyclodextrin, Fe(CO)5 molecules in β-cyclodextrin reorient effectively isotropically and show rapid axial-equatorial exchange, but Mn2(CO)10 in the super-cage defined by two γ-cyclodextrin molecules shows MAS sidebands at lower temperatures indicative of a more restricted motion such as molecular gyration. The important role of guest and host molecular shape and symmetry match in the reorientational dynamics of the metal carbonyls is discussed. © The Royal Society of Chemistry 2000.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The selectivity of reversible oxy-anion binding in aqueous solution at a chiral europium and terbium center: Signaling of carbonate chelation by changes in the form and circular polarization of luminescence emission</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Bruce</namePart>
      <namePart type="given">J.I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dickins</namePart>
      <namePart type="given">R.S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Govenlock</namePart>
      <namePart type="given">L.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gunnlaugsson</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lopinski</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lowe</namePart>
      <namePart type="given">M.P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Peacock</namePart>
      <namePart type="given">R.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Perry</namePart>
      <namePart type="given">J.J.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>122</number>
        </detail>
        <detail type="issue">
          <number>40</number>
        </detail>
        <extent unit="pages">
          <start>9674</start>
          <end>9684</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2000</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0034638406&amp;partnerID=40&amp;md5=432ca032ed7d29c01b6b9c815bd89999</url>
    </location>
    <abstract>Reversible anion binding in aqueous media at chiral Eu(III) and Tb(III) centers has been characterized by 1H NMR and by changes in the emission intensity and circular polarization following direct or sensitized (365 nm) excitation via an alkylphenanthridinium chromophore. Using a series of heptadentate tri-amide or polycarboxylate hgands, the affinity for CO3/2-/HCO3-, phosphate, lactate, citrate, acetate, and malonate at pH 7.4 was found to decrease as a function of the overall negative charge on the complex: citrate and malonate bound most strongly, and lactate and hydrogen carbonate also formed chelated ternary complexes in which displacement of both of the metal-bound water molecules occurred, which was confirmed by VT 17-O NMR measurements of the corresponding Gd complexes. The binding of carbonate was studied in particular, and 1H NMR and CPL data were obtained that were consistent with the formation of a complex with a reduced helical twist about the metal center. Monohydrogen phosphate was bound in a monodentate manner, giving a mono-aqua adduct. The binding of carbonate to cationic Eu complexes in the presence of a simulated extra-cellular anionic background at pH 7.4 was monitored by variation in the emission intensity, ratio of intensities (615/594 nm), and dissymmetry factors as a function of added total carbonate.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The solution dynamics of adduct formation and electronic communication between ligand and metal core in electron deficient quinoline triosmium clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Din</namePart>
      <namePart type="given">A.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bergman</namePart>
      <namePart type="given">B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rosenberg</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Smith</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dastrù</namePart>
      <namePart type="given">W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Viale</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>17</number>
        </detail>
        <detail type="issue">
          <number>17</number>
        </detail>
        <extent unit="pages">
          <start>2975</start>
          <end>2984</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1998</dateIssued>
      </originInfo>
      <identifier type="issn">02775387 (ISSN)</identifier>
      <titleInfo>
        <title>Polyhedron</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Polyhedron</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000672133&amp;partnerID=40&amp;md5=1d60939a8ceb9059f40ff17a7f9b680c</url>
    </location>
    <abstract>The coordination of ammonia and of aliphatic amines (RNH2(R = Et, n-Bu, S-Bu, t-Bu, cyclohexyl) and Et2NH) to the electron deficient clusters Os3(CO)9(μ3-η2-C 9H6N) (μ-H) (1) and Os3(CO)9(μ3-η2-XC 9H5N)(μ-H) (X = 5-NH2, 4; 3-NH2, 5; 6-NH2, 6; 5-Br, 7; 5-CH3, 8) has been studied. The initially formed adducts of the amines with 1 gradually isomerize to give a mixture of two isomers whose ratio varies with the cluster, the solvent and the amine. Studies of the variation of the isomer ratio with temperature yield ΔH° and ΔS° values for the isomer equilibrium. The primary cause of the change in the isomer ratio is the variation in ΔS° which is rationalized as being due to solvation effects. The overall structure of the two isomers is assigned on the basis of NMR measurements to one where the amine occupies an axial position on the cluster and where the hydride and quinoline ring bridge different edges of the cluster. The equilibrium constant for amine complex formation is primarily determined by the steric bulk of the amine. The amine substituted complex 4 shows absolutely no tendency to coordinate amines and this is ascribed to relief of the electron deficiency at the metal core by the mesomeric effects of the para-amino group. The isomeric 5 and 6, however, do undergo coordination of amines at the metal core. The 5-methyl substituted complex 8 does not complex amine either. Compounds 1,4-8 all undergo simple protonation with both coordinating (CF3CO2H) and non-coordinating acids (HBF4) to give cationic dihydrido complexes whose solution structures are elucidated by NMR techniques. The chemistry of these electron deficient clusters is compared with related μ3-η2 imidoyl complexes and can be understood in terms of the Hammett equation, at least for protonation. © 1998 Elsevier Science Ltd. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The structure of the sugar residue in glycated human serum albumin and its molecular recognition by phenylboronate</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Rohovec</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maschmeyer</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Peters</namePart>
      <namePart type="given">J.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>9</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>2193</start>
          <end>2199</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <abstract>Quantification of the extent of glycation of human serum albumin (HSA) and of haemoglobin provides a record of average mid- and long-term blood-sugar concentrations, respectively; this is very useful for the management of diabetes. The reaction of D-glucose with propylamine affords the corresponding Schiff base, N-propyl-amino-D-glucoside, in the cyclic form. This compound is not stable: upon standing or treatment with acid it is converted, by an Amadori rearrangement, into N-propylfructosamine. Both amino sugars occur predominantly in the β-pyranose form. Phenylboronate forms highly stable boronate esters through binding of the cis 1,2-diol moiety in the furanose form of N-propyl-fructosamine. Between pH 5 and 10, an electrostatic interaction between the protonated amino group and the negatively charged boronate moiety affords an additional stabilisation of the ester. The Schiff base, however, has no observable interaction with phenylboronate. In aqueous solution the Schiff base is in equilibrium with propylamine and glucose. Upon addition of phenylboronate, this equilibrium shifts to the side of glucose due to the formation of highly stable phenylboronate esters of the β-furanose form of this compound. After Amadori rearrangement, the sugar moieties in glycated human serum albumin have a similar structure, they occur as an equilibrium of the β-pyranose (59%), a-furanose (19%) and β-furanose (24%) anomers. The open form was not observed. The β-furanose anomer is selectively recognised by phenylboronate.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The structures and fluxional behaviour of the binary carbonyls; A new approach. Part 3. The fluxional behaviour of [fe3(CO)11L], L = PR3 or P(OR)3</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Benfield</namePart>
      <namePart type="given">R.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gavens</namePart>
      <namePart type="given">P.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Johnson</namePart>
      <namePart type="given">B.F.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mays</namePart>
      <namePart type="given">M.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1535</start>
          <end>1539</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1981</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049101244&amp;partnerID=40&amp;md5=1392484d6d3a8cca3562e4eff2fccde8</url>
    </location>
    <abstract>The stereodynamic behaviour of the complexes [Fe3(CO)11L] [L = PR3 or P(OR)3], as determined by 13C n.m.r. spectroscopy over a wide temperature range, has been interpreted in terms of an icosahedral ⇌ cube-octahedral interchange of ligands of the type previously postulated for [M4(CO)12] (M = Co, Rh, or lr) and their derivatives.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The use of contrast agents with fast field-cycling magnetic resonance imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Ó Hógáin</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Davies</namePart>
      <namePart type="given">G.R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lurie</namePart>
      <namePart type="given">D.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>56</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>105</start>
          <end>115</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">00319155 (ISSN)</identifier>
      <titleInfo>
        <title>Physics in Medicine and Biology</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Phys. Med. Biol.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79551680377&amp;partnerID=40&amp;md5=f18a7267501aef1543a0dc278fadaac6</url>
    </location>
    <abstract>Fast field-cycling (FFC) MRI allows switching of the magnetic field during an imaging scan. FFC-MRI takes advantage of the T1 dispersion properties of contrast agents to improve contrast, thus enabling more sensitive detection of the agent. A new contrast agent designed specifically for use with FFC was imaged using both a homebuilt FFC-MRI system and a 3 T Philips clinical MRI scanner. T1 dispersion curves were obtained using a commercial relaxometer which showed large changes in relaxation rate between fields. A model of magnetization behaviour was used to predict optimum evolution times for the maximum T1 contrast between samples at each field. Images were processed and analysed to create maps of R1 values using a set of images at each field. The R1 maps produced at two different fields were then subtracted from each other in order to create a map of ΔR1 in which pixel values depend on the change in R1 of the sample between the two fields. The dispersion properties of the agent resulted in higher contrast in a ΔR1 image compared with a standard T1-weighted image. © 2011 Institute of Physics and Engineering in Medicine.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>The Water-Exchange Rate in Neutral Heptadentate DO3A-Like GdIII Complexes: Effect of the Basicity at the Macrocyclic Nitrogen Site</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Boniforte</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fedeli</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mortillaro</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>19</number>
        </detail>
        <extent unit="pages">
          <start>3530</start>
          <end>3533</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">14341948 (ISSN)</identifier>
      <titleInfo>
        <title>European Journal of Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Eur. J. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0142152520&amp;partnerID=40&amp;md5=456c85984cf5a5e5c477f4e0c17b9eed</url>
    </location>
    <abstract>The rate of exchange of the two water molecules coordinated to a Gd III centre in neutral complexes with heptadentate DO3A derivatives is modulated by the basicity of the macrocyclic nitrogen bearing the pendant group: a lower basicity results in a slower water-exchange rate. © Wiley-VCH Verlag GmbH &amp; Co. KGaA, 69451 Weinheim, Germany, 2003.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Theoretical and spectroscopic studies of (μ-butatriene)hexacarbonyldiiron compounds</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casarin</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>21</number>
        </detail>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>4073</start>
          <end>4076</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1982</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33845554516&amp;partnerID=40&amp;md5=d0c05b3d49ff8322b8de53d2c020f328</url>
    </location>
    <abstract>The bonding scheme in (μ-butatriene)hexacarbonyldiiron complexes is discussed on the basis of their 13C NMR and He I excited-gas-phase photoelectron spectra. 13C butatriene resonances have been assigned by using the proton-coupled NMR spectra. At room temperature a single resonance is seen in the carbonyl region, which splits into three resonances at lower temperatures. PE data are analyzed by comparison arguments with related M2(CO)6L systems and qualitative quantum-mechanical considerations. CNDO type calculations, which are in qualitative agreement with the proposed assignments, outline the presence of two strong Fe-C bonds accounting for the major Fe2(CO)6-butatriene interaction. © 1982 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Thermal and photochemical behaviour of organotetraruthenium clusters: Solution structures and dynamics of phosphine-substituted derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nicola</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Amadelli</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Carassiti</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>349</start>
          <end>353</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1987</dateIssued>
      </originInfo>
      <identifier type="issn">14727773 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Dalton Transactions</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049072057&amp;partnerID=40&amp;md5=d5ca53fe4535a1ba1f6436641010df81</url>
    </location>
    <abstract>The thermal and photochemical behaviour of the organotetraruthenium clusters [Ru4(CO)12(PhC2R)] (R = Me or H) and [Ru4(CO)11(PhC2Me)2] is described. Interestingly the reactions of these complexes with phosphorus donor ligands are highly regioselective, as determined by variable-temperature n.m.r. studies. The dynamic behaviour of [Ru4(CO)10{P(OMe)3}(PhC2Me) 2] shows for the first time the occurrence of a 'merry-go-round' CO exchange process around the quasi-planar Ru4 framework.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Thermodynamic analysis of hydration in human serum heme-albumin</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pariani</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fanali</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Longo</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Ascenzi</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fasano</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>385</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>385</start>
          <end>389</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">0006291X (ISSN)</identifier>
      <titleInfo>
        <title>Biochemical and Biophysical Research Communications</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Biochem. Biophys. Res. Commun.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-67349117642&amp;partnerID=40&amp;md5=b8276ce979a68f60935c982d4f7e0b5c</url>
    </location>
    <abstract>Ferric human serum heme-albumin (heme-HSA) shows a peculiar nuclear magnetic relaxation dispersion (NMRD) behavior that allows to investigate structural and functional properties. Here, we report a thermodynamic analysis of NMRD profiles of heme-HSA between 20 and 60 °C to characterize its hydration. NMRD profiles, all showing two Lorentzian dispersions at 0.3 and 60 MHz, were analyzed in terms of modulation of the zero field splitting tensor for the S =5/2 manifold. Values of correlation times for tensor fluctuation (τv) and chemical exchange of water molecules (τM) show the expected temperature dependence, with activation enthalpies of -1.94 and -2.46 ± 0.2 kJ mol-1, respectively. The cluster of water molecules located in the close proximity of the heme is progressively reduced in size by increasing the temperature, with ΔH = 68 ± 28 kJ mol-1 and ΔS = 200 ± 80 J mol-1 K-1. These results highlight the role of the water solvent in heme-HSA structure-function relationships. © 2009 Elsevier Inc. All rights reserved.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Towards improved boron neutron capture therapy agents: Evaluation of in vitro cellular uptake of a glutamine-functionalized carborane</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Crivello</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nervi</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Szabo</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Toppino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deagostino</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Venturello</namePart>
      <namePart type="given">P.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>14</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>883</start>
          <end>890</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">09498257 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Biological Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Biol. Inorg. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-70349287653&amp;partnerID=40&amp;md5=7b9a2a593bddd1b5aa3305a618b9914a</url>
    </location>
    <abstract>Sodium borocaptate (BSH) is widely used for boron neutron capture therapy (BNCT) of brain tumors. One drawback is the large uptake by the liver causing a decrease of its availability at the tumor region as well as bringing about toxicity problems. A novel carborane-based compound containing a boron payload very similar to that of BSH has been synthesized and tested on rat glioma (C6) cells, hepatoma tissue culture (HTC) cells, and hepatocytes. The newly synthesized system consists of an o-carborane unit (C2B 10H11, o-CB) conjugated to a glutamine residue through a proper spacer, namely, o-CB-Gln. As compared with BSH, it showed the same uptake by C6 cells, but a 50% decrease in uptake by HTC cells and an 80% decrease in uptake by healthy hepatocytes. On this basis o-CB-Gln appears an interesting candidate for BNCT of brain tumors as it is expected to have a therapeutic index analogous to that of BSH accompanied by a much lower liver toxicity. A novel carborane based compound, consisting in an o-carborane unit (C2B10H11, o-CB) conjugated to a glutamine residue through a proper spacer (namely o-CB-Gln) has been synthesized, characterized and tested on rat glioma (C6), hepatoma (HTC) and hepatocytes. As compared to sodium borocaptate (BSH), widely used for boron neutron capture therapy (BNCT) of brain tumors, the newly synthesized system showed the same uptake by C6 cells, but a 50% decrease by HTC and 80% decrease by healthy hepatocytes. On this basis o-CB-Gln appears an interesting candidate for BNCT of brain tumors as it is expected to have a therapeutic index analogous to BSH accompanied by a much lower liver toxicity. © 2009 SBIC.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Towards MRI contrast agents of improved efficacy. NMR relaxometric investigations of the binding interaction to HSA of a novel heptadentate macrocyclic triphosphonate Gd(III)-complex</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geninatti Crich</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Giovenzana</namePart>
      <namePart type="given">G.B.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pagliarin</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Piccinini</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sisti</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>2</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>470</start>
          <end>479</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1997</dateIssued>
      </originInfo>
      <identifier type="issn">09498257 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Biological Inorganic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. BIOL. INORG. CHEM.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0030760503&amp;partnerID=40&amp;md5=c580a09e1932f5ca851f3cdf4c9a6f32</url>
    </location>
    <abstract>A novel heptacoordinating ligand consisting of a thirteen-membered tetraazamacrocycle containing the pyridine ring and bearing three methylenephosphonate groups (PCTP-[13]) has been synthesized. Its Gd(III) complex displays a remarkably high longitudinal water proton relaxivity (7.7mM-1 s-1 at 25°C, 20 MHz and pH 7.5) which has been accounted for in terms of contributions arising from (1) one water molecule bound to the metal ion, (2) hydrogen-bonded water molecules in the second coordination sphere, or (3) water molecules diffusing near the paremagnetic chelate. Variable- temperature 17O-NMR transverse relaxation data indicate that the residence lifetime of the metal-bound water molecule is very short (8.0 ns at 25°C) with respect to the Gd(III) complexes currently considered as contrast agents for magnetic resonance imaging. Furthermore, GdPCTP-[13] interacts with human serum albumin (HSA), likely through electrostatic forces. By comparing water proton relaxivity data for the GdPCTP-[13]-HSA adduct, measured as a function of temperature and magnetic field strength, with those for the analogous adduct with GdDOTP (a twelve-membered tetraaza macrocyclic tetramethylenephosphonate complex lacking a metal-bound water molecule), it has been possible to propose a general picture accounting for the main determinants of the relaxation enhancement observed when a paramagnetic Gd(III) complex is bound to HSA. Basically, the relaxation enhancement in these systems arises from (1) water molecules in the hydration shell of the macromolecule and protein exchangeable protons which lie close to the interaction site of the paramagnetic complex and (2) the metal bound water molecule(s). As far as the latter contribution is concerned, the interaction with the protein causes an elongation of the residence lifetime of the metal- bound water molecule, which limits, to some extent, the potential relaxivity enhancement expected upon the binding of the paramagnetic complex to HSA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Towards targeted MRI: New MRI contrast agents for sialic acid detection</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Frullano</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rohovec</namePart>
      <namePart type="given">J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Maschmeyer</namePart>
      <namePart type="given">T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Isabel Prata</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Pedroso De Lima</namePart>
      <namePart type="given">J.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Geraldes</namePart>
      <namePart type="given">C.F.G.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Peters</namePart>
      <namePart type="given">J.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>10</number>
        </detail>
        <detail type="issue">
          <number>20</number>
        </detail>
        <extent unit="pages">
          <start>5205</start>
          <end>5217</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2004</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-7044235191&amp;partnerID=40&amp;md5=3fece35255cc19412c3e080187f0170a</url>
    </location>
    <abstract>The detection of sialic acid in living systems is of importance for the diagnosis of several types of malignancy. We have designed and synthesized two new lanthanide ion ligands (L1 and L2) that are capable of molecular recognition of sialic acid residues. The basic structure of these ligands consists of a DTPA-bisamide (DTPA, diethylenetriamine pentaacetic acid) whose amide moieties each bear both a boronic function for interaction with the diol groups in the side chain of sialic acid, and a functional group that is positively charged at physiologic pH values and is designed to interact with the carboxylate anion of sialic acid. The relaxometric properties of the Gd 3+ complexes of these two ligands were evaluated. The relaxivity of the GdL1 complex has a significant second-sphere contribution at pH values above the pKa of its phenylboronic acid moiety. The interaction of the Gd3+ complexes of L1 and L2 with each of several saccharides was investigated by means of a competitive fluorescent assay. The results show that both complexes recognize sialic acid with good selectivity in the presence of other sugars. The adduct formed by GdL2 with sialic acid has the higher conditional formation constant (50.43 ± 4.61 M-1 at pH 7.4). The ability of such complexes to recognize sialic acid was confirmed by the results of a study on the interaction of corresponding radio-labeled complexes (153SmL 1 and 153SmL2) with C6 glioma rat cells. 153SmL2 in particular is retained on the cell surface in significant amounts.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Trends in NMR studies of paramagnetic Gd(III) complexes as potential contrast agents in MRI</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barbero</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>9</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>843</start>
          <end>847</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1991</dateIssued>
      </originInfo>
      <identifier type="issn">0730725X (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>MAGN. RESON. IMAGING</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0026315628&amp;partnerID=40&amp;md5=c73255bbb60948c1f1b0dfc3f92f7c94</url>
    </location>
    <abstract>The paramagnetic Gd(III) complexes with polyaminocarboxylate ligands are intensively studied as possible Contrast Agents for Magnetic Resonance Imaging (M.R.I.). Their ability to enhance the solvent proton relaxation rate is mainly determined by the molecular reorientational time (τ(R)). In order to increase τ(R) we studied the formation of non-covalent interactions between functionalized Gd(III)-complexes and micelles. The N.M.R.D. (Nuclear Magnetic Relaxation Dispersion) profiles of aqueous solutions of these paramagnetic complexes with hexadecyltrimethylammonium bromide (CTN2r) were measured and the results could be accounted for by difference in negative charge and number of hydrophobic aromatic residues among the different complexes.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Trinuclear osmium and ruthenium clusters containing ligands formed by dehydration and rearrangement of 1,4-dihydroxybut-2-yne</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tiripicchio</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Camellini</namePart>
      <namePart type="given">M.T.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deeming</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>20</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>2027</start>
          <end>2031</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1981</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000846107&amp;partnerID=40&amp;md5=ff7e69c272d29c3dbfb9fc480da1b670</url>
    </location>
    <abstract>1,4-Dihydroxybut-2-yne, HOCH2C≡CCH2OH, reacts with Ru3(CO)12 or H4Ru4(CO)12 in refluxing cyclohexane to give the products Ru2(CO)6[C4(CH2OH)4], HRu3(CO)9[CHCHC(CHO)], and HRu3(CO)9[CHCHC(CH2OH)], the clusters being obtained only in very low yield by combinations of dehydration, hydrogen atom transfer, and oxidation of a primary alcohol to an aldehyde. The course of the reaction is better understood for the conversion of Os3(CO)10(HOCH2O≡CCH2OH) (formed from the diol and H2Os3(CO)10 at room temperature) at 96°C to the CHO-substituted μ3-allenyl cluster HOs3(CO)9[CH2CC(CHO)] by a decarbonylation at the metal, dehydration of the diol, and a hydrogen atom transfer from carbon to osmium. Finally at 132°C a 1,2-hydrogen atom shift occurs to give HOs3(CO)9[CHCHC(CHO)], the crystal and molecular structure of which has been determined by X-ray methods. The compound crystallizes in space group P21/n with Z = 4 in a unit cell of dimensions a = 8.598 (9) Å, b = 30.328 (16) Å, c = 6.930 (8) Å, and β = 106.28 (8)°. The structure has been solved from diffractometer data by Patterson and Fourier methods and refined by full-matrix least squares to R = 0.066 for 1598 independent observed reflections. The complex has approximate Cs symmetry and consists of an isosceles triangular arrangement of osmium atoms, each linked to three carbonyls. The more elongated Os(1)-Os(2) side (2.961 (2) against 2.837 (2) and 2.801 (2) Å for the other two sides) should be bridged by a hydride ligand (not directly located by the X-ray analysis but supported by 1H NMR evidence) on the basis of some structural features. A formyl-substituted allyl ligand interacts with all the metal atoms, the terminal carbon atoms being σ bonded to two osmium atoms and all the three carbon atoms being involved in a η-bonding system to the third osmium atom. © 1981 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Triruthenium clusters containing dinethylamino-substituted allyl and allenyl ligands: The transmission of electronic substituent effects through clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Jannon</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Deeming</namePart>
      <namePart type="given">A.J.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>214</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>C15-C18</start>
          <end>C15-C18</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1981</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4243952906&amp;partnerID=40&amp;md5=a3ceb976155599acdc19cbeba427331e</url>
    </location>
    <abstract>The NMe2 substituent in CH3C≡CCH2NMe2 facilitates oxidative addition to RU3(CO)12 to give the isomeric allenyl cluster HRU3(CO)9(MeCCCHNMe2) and allylic cluster HRu3 (CO)g (MeCCHCNMe2). The barrier to rotation about the internal ligand CNMe2 bond is sensitive to the nature of L in HRu3(CO)8L(MeCCHCNMe2), even though L is remote from this bond, and also to protonation of the cluster. Lower barriers are associated with increased electronavailability on the cluster. © 1981.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Tunable imaging of cells labeled with MRI-PARACEST agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Carrera</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>44</number>
        </detail>
        <detail type="issue">
          <number>12</number>
        </detail>
        <extent unit="pages">
          <start>1813</start>
          <end>1815</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-17044392297&amp;partnerID=40&amp;md5=c6c12d6058fec6dd07b7feb8b867838a</url>
    </location>
    <abstract>(Figure Presented) Cell-tracking experiments by MRI are possible with a novel class of Tb and Eu paramagnetic imaging agents, with which contrast is generated upon irradiation at a specific frequency (see picture). Middle: A) unlabeled; B) Tb-labeled; C) Eu-labeled; D) Tb- and Eu-labeled cells. Left: irradiation at ± 180 kHz (Tb-agent-specific). Right: irradiation at ± 15 kHz (Eu-agent-specific). © 2005 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Tuning glutamine binding modes in Gd-DOTA-based probes for an improved MRI visualization of tumor cells</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Stefania</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Szabo</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>15</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>76</start>
          <end>85</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">09476539 (ISSN)</identifier>
      <titleInfo>
        <title>Chemistry - A European Journal</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Chem. Eur. J.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-58449094540&amp;partnerID=40&amp;md5=ee51d724632e6fe59a73f12ba092c50c</url>
    </location>
    <abstract>Three new magnetic resonance imaging probes that target glutamine transporters have been synthesized. They consist of a Gd-DOTA-monoamide moiety (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) linked through a six carbon atom chain to a vector represented by a glutamine residue bound through α-carboxylic, γ-carboxamidic, or α-amino functionalities. Their uptake by HTC (rat hepatocarcinoma) and healthy rat hepatocytes has shown that the system containing the glutamine vector bound through the a-carboxylic group displays a markedly higher affinity for tumor cells. The observed behavior is rationalized in terms of the exploitation of an additional glutamine transporter active in hepatic tumor cells. © 2009 Wiley-VCH Verlag GmbH &amp; Co. KGaA.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Tuning the coordination number of hydroxypyridonate-based gadolinium complexes: Implications for MRI contrast agents</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Pierre</namePart>
      <namePart type="given">V.C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Botta</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Raymond</namePart>
      <namePart type="given">K.N.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>128</number>
        </detail>
        <detail type="issue">
          <number>16</number>
        </detail>
        <extent unit="pages">
          <start>5344</start>
          <end>5345</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33646452296&amp;partnerID=40&amp;md5=5d25a4d175d0c6fbb6ff971e5a09ff97</url>
    </location>
    <abstract>Eight-coordinate hydroxypyridinone/terephthalamide GdIII complexes display high relaxivities due to their two inner sphere water molecules. This relaxivity can be further increased by functionalizing the terephthalamide moiety with an amine. A significant hydrogen bonding interaction between the amine and another water molecule close to the GdIII apparently facilitates its coordination on the open site of the metal. The resulting nine-coordinate complex has three inner sphere water molecules, while maintaining high stability and fast ligand exchange rates. Copyright © 2006 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Two-dimensional nuclear magnetic resonance for the quantitative analysis of three-site exchange in the ruthenium cluster [Ru3(μ-H)(CO)9(MeCCHCme)]</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lian</namePart>
      <namePart type="given">L.Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Randall</namePart>
      <namePart type="given">E.W.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sales</namePart>
      <namePart type="given">K.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>65</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>173</start>
          <end>177</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1985</dateIssued>
      </originInfo>
      <identifier type="issn">00222364 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Magnetic Resonance (1969)</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000696426&amp;partnerID=40&amp;md5=b28142b28534c546cdb479cc4634bb00</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>Use of solid-state 13C NMR spectroscopy to quantify the degree of asymmetry of bonding for semibridging CO groups in iron carbonyl complexes</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Hawkes</namePart>
      <namePart type="given">G.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sales</namePart>
      <namePart type="given">K.D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gobetto</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lian</namePart>
      <namePart type="given">L.-Y.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>30</number>
        </detail>
        <detail type="issue">
          <number>7</number>
        </detail>
        <extent unit="pages">
          <start>1489</start>
          <end>1493</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1991</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0343459343&amp;partnerID=40&amp;md5=549ca6696d61d630b0bd89d7db75649c</url>
    </location>
    <abstract>The solid-state 13C NMR spectra of some substituted iron carbonyl complexes have been analyzed to give values for the carbonyl carbon chemical shift tensor components. It is shown that the lowest frequency tensor component and the chemical shift anisotropy correlate with the degree of bonding asymmetry in double-bridging carbonyl groups, whereas the 13C isotropic chemical shift does not correlate. The correlations are proposed to form the basis for a method of estimating iron-carbon bond lengths for μ2-CO groups in this type of complex. © 1991 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>UV photoelectron and theoretical studies of organometal carbonyl clusters of ruthenium and osmium. μ-hydrido-μ3-alkynyl triangulo cluster compounds</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tondello</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bertoncello</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>22</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>744</start>
          <end>748</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0009497783&amp;partnerID=40&amp;md5=549227526250349db0ef983fa95aa290</url>
    </location>
    <abstract>The electronic structure of μ-hydrido-μ3-alkynyl triangulo clusters of ruthenium and osmium is discussed on the basis of their He I excited vapor-phase photoelectron spectra and on the basis of CNDO quantum-mechanical calculations. The theoretical results contribute to the discussion of the highly complex PE spectra and provide novel insights into the bonding scheme of these molecules. The most interesting feature that emerges from this study is the inadequacy of the usual representation of the molecular structure with three metal-metal bonds since the μ-H-bridged metal atoms show a very low bond overlap population. On the other hand, the commonly accepted qualitative description of the alkynyl-cluster interactions, in terms of one σ bond and two weaker π interactions, receives strong support. Some selected features of the reactivity of these clusters are discussed on the basis of the emerging electronic structural picture. © 1983 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>UV photoelectron and theoretical studies of organometal carbonyl clusters of ruthenium and osmium. μ-hydrido-μ3-allyl and μ-hydrido-μ3-allenyl triangulo cluster compounds</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tondello</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bertoncello</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>24</number>
        </detail>
        <detail type="issue">
          <number>4</number>
        </detail>
        <extent unit="pages">
          <start>570</start>
          <end>575</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1985</dateIssued>
      </originInfo>
      <identifier type="issn">00201669 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganic Chemistry</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0010777483&amp;partnerID=40&amp;md5=9f2c11bc077370ec2720f6c0033c35ae</url>
    </location>
    <abstract>The electronic structures of μ-hydrido-μ3-allyl and μ-hydrido-μ3-allenyl triangulo clusters of ruthenium and osmium are discussed on the basis of both He I and He II gas-phase UV-PE spectra and CNDO quantum-mechanical calculations. The theoretical results contribute to the discussion of the PE data and to a deeper understanding of the bonding scheme in these very complex organometallic clusters. The description of the allyl cluster interactions in terms of one π and two σ bonds seems to be adequate. On the other hand, the formal distinction into one σ and two π bonds of the allenyl ligand cluster interaction is quite an oversimplification of the actual bonding scheme. The differences in thermodynamical stability between the allenyl and allyl derivatives are in agreement with the CNDO-computed total energies. © 1985 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>UV photoelectron spectra of some organometallic carbonyl osmium clusters</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bertoncello</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>229</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>C27-C30</start>
          <end>C27-C30</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1982</dateIssued>
      </originInfo>
      <identifier type="issn">0022328X (ISSN)</identifier>
      <titleInfo>
        <title>Journal of Organometallic Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Organomet. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-49049136385&amp;partnerID=40&amp;md5=a60bf220300d972c30717792ad717283</url>
    </location>
    <abstract>The He(I) excited PE spectra of HOs3(μ3-L)(CO)9 (L allenyl, allyl) and of HOs3(μ2-vinyl)(CO)10 are presented. Some gross spectral features are discussed on the basis of a direct comparison with previous results for Os3(CO)12 and the alkynyl corresponding cluster derivative. Large perturbations in the OsOs bonding levels are induced by the bridging hydride and the interaction with the organic substrate. © 1982.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>UV-PES, 13C NMR, and theoretical studies on the alkyne-cluster interaction in Fe3(CO)9(μ3-η2-EtC 2Et)</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tondello</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Casarin</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>2</number>
        </detail>
        <detail type="issue">
          <number>3</number>
        </detail>
        <extent unit="pages">
          <start>430</start>
          <end>434</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1983</dateIssued>
      </originInfo>
      <identifier type="issn">02767333 (ISSN)</identifier>
      <titleInfo>
        <title>Organometallics</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0000735931&amp;partnerID=40&amp;md5=1ab2cf983eb4ce36bb1e79b5e92df7c4</url>
    </location>
    <abstract>13C NMR, UV-PES, and CNDO theoretical results of Fe3(CO)9(μ3-η2-EtC 2Et) are reported. 13C alkyne resonances have very different chemical shifts according to the different coordination environments of the two acetylenic carbon atoms. Variable-temperature NMR experiments indicate localized exchange processes of the carbonyls at each Fe(CO)3 unit. The gas-phase UV-PE spectrum is assigned by comparison arguments with data on simpler related systems. The CNDO results contribute to the discussion of the PE data and provide interesting insights into the alkyne-cluster bonding mechanism. The relevant role of the cluster→alkyne back-donation is stressed by both the experimental and theoretical data. The qualitative picture of the electronic structure proposed by Blount et al. receives strong support by the present theoretical data. © 1983 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Variation of water exchange dynamics with ligand structure and stereochemistry in lanthanide complexes based on 1,4-diazepine derivatives</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Elemento</namePart>
      <namePart type="given">E.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Parker</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lattuada</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>7</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>1120</start>
          <end>1131</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">14770520 (ISSN)</identifier>
      <titleInfo>
        <title>Organic and Biomolecular Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Org. Biomol. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-62249165116&amp;partnerID=40&amp;md5=2f0b129f3fb57be4d2f4c4380479fed3</url>
    </location>
    <abstract>Complexes of Gd, Eu and Yb(iii) have been prepared with a series of heptadentate ligands related to the parent complex AAZTA, based on the 6-methyl-6-aminoperhydrodiazepine moiety. For (RR) and (RS)-diastereoisomers of a di-glutarate ligand, solution NMR studies revealed the presence of two major species that undergo water exchange rates at Gd differing by a factor of six. Comparison of solution hydration states for Eu(iii) complexes reveals that each complex possesses two bound water molecules. The absence of a good correlation of 1H NMR pseudo-contact shifts for Eu and Yb analogues is suggested to arise from a change in hydration state between Eu and Yb. © The Royal Society of Chemistry 2009.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Visualization through magnetic resonance imaging of DNA internalized following "In vivo" electroporation</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Crich</namePart>
      <namePart type="given">S.G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Lanzardo</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Barge</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Esposito</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Tei</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Forni</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>4</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>7</start>
          <end>17</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2005</dateIssued>
      </originInfo>
      <identifier type="issn">15353508 (ISSN)</identifier>
      <titleInfo>
        <title>Molecular Imaging</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Mol. Imaging</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-26944449754&amp;partnerID=40&amp;md5=9b3f4d12c05884c2cea7242fdeb97a5d</url>
    </location>
    <abstract>The ability to visualize plasmid DNA entrapment in muscle cells undergoing an "in vivo" electroporation treatment was investigated on BALB/c mice using a 7-T magnetic resonance imaging (MRI) scanner using the paramagnetic Gd-DOTA-spd complex as imaging reporter. Gd-DOTA-spd bears a tripositively charged spermidine residue that yields a strong binding affinity toward the negatively charged DNA chain (6.4 kb, Ka = 2.2 × 103 M-1 for approximately 2500 ± 500 binding sites). Cellular colocalization of Gd-DOTA-spd and plasmid DNA has been validated by histological analysis of excised treated muscle. In vivo MRI visualization of Gd-DOTA-spd distribution provides an excellent route to access the cellular entrapment of plasmid DNA upon applying an electroporation pulse. © 2005 Neoplasia Press, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Water exchange across the erythrocyte plasma membrane studied by HR-MAS NMR spectroscopy</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Bruno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Digilio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cabella</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Reggi</namePart>
      <namePart type="given">A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Baroni</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mainero</namePart>
      <namePart type="given">V.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>56</number>
        </detail>
        <detail type="issue">
          <number>5</number>
        </detail>
        <extent unit="pages">
          <start>978</start>
          <end>985</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2006</dateIssued>
      </originInfo>
      <identifier type="issn">07403194 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Medicine</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Med.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-33750609206&amp;partnerID=40&amp;md5=359d574feefff20718b67a1ff24bac8a</url>
    </location>
    <abstract>Water exchange across the plasma membrane of erythrocytes (red blood cells (RBCs)) was studied by means of high-resolution magic angle spinning (HR-MAS) NMR spectroscopy. Under HR-MAS conditions, the centrifugal force causes the splitting of RBC suspensions into a two-phase system composed of a central core of cell free water and an outer layer of tightly packed cells. Water belonging to each of these phases gives rise to two separated resonances. Chemical exchange between them is not detectable on the chemical shift or saturation transfer (ST) NMR time scale because of the physical separation between the phases. When the RBCs are dispersed and immobilized within a matrix made of cross-linked albumin, the splitting into a two-phase system is prevented and a single exchange-averaged peak for water is detected in 1H HR-MAS NMR spectra. The lineshape of this peak is dependent on transmembrane exchange kinetics, since MAS averages out all the anisotropic magnetic interactions that are responsible for additional line-broadening under conventional liquid conditions. Line-shape analysis according to a two-site exchange model yielded a residence lifetime on the order of about 10 ms (at 37°C) for a water molecule within the intracellular compartment, which is not too far from the generally accepted value of 9.6-14.8 ms. © 2006 Wiley-Liss, Inc.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Well-defined, multifunctional nanostructures of a paramagnetic lipid and a lipopeptide for macrophage imaging</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Vucic</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sanders</namePart>
      <namePart type="given">H.M.H.F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Arena</namePart>
      <namePart type="given">F.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nicolay</namePart>
      <namePart type="given">K.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Leupold</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Dathe</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sommerdijk</namePart>
      <namePart type="given">N.A.J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Fayad</namePart>
      <namePart type="given">Z.A.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mulder</namePart>
      <namePart type="given">W.J.M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>131</number>
        </detail>
        <detail type="issue">
          <number>2</number>
        </detail>
        <extent unit="pages">
          <start>406</start>
          <end>407</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2009</dateIssued>
      </originInfo>
      <identifier type="issn">00027863 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the American Chemical Society</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>J. Am. Chem. Soc.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-62849090945&amp;partnerID=40&amp;md5=3dc7f612c68f68ee43eb62594c5a7e1f</url>
    </location>
    <abstract>In the field of nanomedicine there is a great demand for technologies that allow the creation of self-assembled structures of which the size and morphology can be accurately controlled. In the current study, we report a nanoparticle platform that is composed of a paramagnetic lipid and a fluorescently labeled lipopeptide. By judiciously controlling the ratio of the aforementioned amphiphilic molecules, a variety of well-defined nanosized supramolecular structures with different sizes and morphologies could be created. The hydrodynamic radii of the different structures were determined by dynamic light scattering. Cryo-TEM revealed the aggregate morphology to vary from small micellar structures to plate-like and even full grown ribbons of which the aspect ratios varied from a diameter of 5-8 nm to structures with a width of up to 25 nm and infinite length. Interestingly, nuclear magnetic resonance dispersion profiling revealed excellent properties for MRI and also showed that the relaxivity of the structures was tunable and morphology dependent. Finally, macrophage cells were treated with two selected nanoparticles and were shown to be avidly taken up. In conclusion we demonstrate a methodology to create structures that (1) are paramagnetic to enable their detection with MRI, (2) exhibit fluorescent properties, (3) can be tuned to defined sizes and shapes, and (4) are efficiently taken up by macrophage cells in vitro. Copyright © 2009 American Chemical Society.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>Where have all the lanthanum salts gone, long time passing? [6]</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Canavese</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Mereu</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Nordio</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Sabbioni</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">De Broe</namePart>
      <namePart type="given">M.E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>64</number>
        </detail>
        <detail type="issue">
          <number>6</number>
        </detail>
        <extent unit="pages">
          <start>2327</start>
          <end>2328</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">00852538 (ISSN)</identifier>
      <titleInfo>
        <title>Kidney International</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Kidney Int.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0344083346&amp;partnerID=40&amp;md5=0ed24b71404a1a52d81945a86a772023</url>
    </location>
  </mods>
  <mods>
    <titleInfo>
      <title>X-Ray molecular structure of μ-(isopropylamino)-μ-(propanone oximato-O,N)-bis(tricarbonyliron) (Fe-Fe): A new unsymmetrical nitroso binuclear compound</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gervasio</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Rossetti</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Stanghellini</namePart>
      <namePart type="given">P.L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="issue">
          <number>11</number>
        </detail>
        <extent unit="pages">
          <start>370</start>
          <end>371</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1976</dateIssued>
      </originInfo>
      <identifier type="issn">00224936 (ISSN)</identifier>
      <titleInfo>
        <title>Journal of the Chemical Society, Chemical Communications</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-37049110318&amp;partnerID=40&amp;md5=c387a309ce79732a12c58f631302b306</url>
    </location>
    <abstract>X-Ray analysis of μ-(isopropylamino)-μ-(propanone oximato)-bis(tricarbonyliron)(Fe-Fe), the main product of the reaction between [Fe3(CO)12] and 2-nitropropane, shows an unusual structure with an Fe-N-O-Fe ring, which can be related to the nature of novel intermediates in the reduction of nitro-compounds by iron carbonyls.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>YbIII-HPDO3A: A dual pH- and temperature-responsive CEST agent</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Delli Castelli</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>50</number>
        </detail>
        <detail type="issue">
          <number>8</number>
        </detail>
        <extent unit="pages">
          <start>1798</start>
          <end>1800</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2011</dateIssued>
      </originInfo>
      <identifier type="issn">14337851 (ISSN)</identifier>
      <titleInfo>
        <title>Angewandte Chemie - International Edition</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Angew. Chem. Int. Ed.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-79951797279&amp;partnerID=40&amp;md5=c2de51a0dfcd50b0f2d066b865f9d63b</url>
    </location>
    <abstract>A multiple response: YbIII-HPDO3A has been used for the development of a magnetic resonance imaging method that is able to assess pH value and temperature simultaneously, irrespective of the concentration of the complex (see graph). This contrast agent has potential in a clinical setting as it shows the same stability and invivo pharmacokinetic properties as Gd III-HPDO3A, which is already used in clinical practices under the trade name of ProHance. © 2011 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>β-Cyclodextrin adducts of Gd(III) chelates: Useful models for investigating the structural and dynamic determinants of the relaxivity of gadolinium-based systems</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Gianolio</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Terreno</namePart>
      <namePart type="given">E.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Menegotto</namePart>
      <namePart type="given">I.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Bracco</namePart>
      <namePart type="given">C.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Milone</namePart>
      <namePart type="given">L.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Cravotto</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>41</number>
        </detail>
        <detail type="issue">
          <number>10</number>
        </detail>
        <extent unit="pages">
          <start>800</start>
          <end>805</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>2003</dateIssued>
      </originInfo>
      <identifier type="issn">07491581 (ISSN)</identifier>
      <titleInfo>
        <title>Magnetic Resonance in Chemistry</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Magn. Reson. Chem.</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-0242362095&amp;partnerID=40&amp;md5=5eeb32d23ff29ed459445b25509928fe</url>
    </location>
    <abstract>Gadolinium-chelates bearing hydrophobic substituents on their surfaces form inclusion complexes with β-cyclodextrin. When the chelate contains more than one substituent, the observed relaxation enhancement has to be analysed on the basis of the contributions arising from the actual speciation of the resulting inclusion complexes. This analysis allows the assessment of the binding constants for the individual inclusion complexes, as well as their specific relaxation enhancements. The relaxivities obtained of the supramolecular adducts display a good linearity with their molecular weights to outline that, in these systems, the main determinant of the relaxation enhancement is represented by the overall molecular reorientational time. Copyright © 2003 John Wiley &amp; Sons, Ltd.</abstract>
  </mods>
  <mods>
    <titleInfo>
      <title>μ3-S bonding mode in H2M3(CO)9S clusters of Ru and Os. An UVPES and theoretical study</title>
    </titleInfo>
    <typeOfResource>text</typeOfResource>
    <genre authority="local">journalArticle</genre>
    <genre authority="marcgt">periodical</genre>
    <name type="personal">
      <namePart type="family">Granozzi</namePart>
      <namePart type="given">G.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Benoni</namePart>
      <namePart type="given">R.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Acampora</namePart>
      <namePart type="given">M.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Aime</namePart>
      <namePart type="given">S.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <name type="personal">
      <namePart type="family">Osella</namePart>
      <namePart type="given">D.</namePart>
      <role>
        <roleTerm type="code" authority="marcrelator">aut</roleTerm>
      </role>
    </name>
    <relatedItem type="host">
      <part>
        <detail type="volume">
          <number>84</number>
        </detail>
        <detail type="issue">
          <number>1</number>
        </detail>
        <extent unit="pages">
          <start>95</start>
          <end>100</end>
        </extent>
      </part>
      <originInfo>
        <dateIssued>1984</dateIssued>
      </originInfo>
      <identifier type="issn">00201693 (ISSN)</identifier>
      <titleInfo>
        <title>Inorganica Chimica Acta</title>
      </titleInfo>
      <titleInfo type="abbreviated">
        <title>Inorg. Chim. Acta</title>
      </titleInfo>
    </relatedItem>
    <location>
      <url>http://www.scopus.com/inward/record.url?eid=2-s2.0-4244185184&amp;partnerID=40&amp;md5=bd3d5b528edd6c14fc7fa6dd923f4267</url>
    </location>
    <abstract>The electronic structure of H2M3(CO)9S clusters (M = Ru, Os) is discussed on the basis of their He I and He II excited gas-phase photoelectron spectra and on the basis of CNDO quantum mechanical calculations. The PE data clearly demonstrate the cleavage of two direct MM interactions by operation of the bridging hydrides, giving rise to three-center two-electron MHM levels. The μ3-S bonding mode has been described in detail and compared with previous results on related μ3-CY cluster derivatives. The CNDO results on Ru3(CO)9S=, HRu3(CO)9S- and H2Ru3(CO)9S indicate that the μ3-S-cluster interaction is mostly independent of the presence of the bridging hydrides. © 1984.</abstract>
  </mods>
</modsCollection>